{"meta":{"query_hash":"9bd2f9de5b61","filters":{"venue":"American Journal of Hematology"},"cohort_total":385,"direct_labels_cover":0,"predictions_cover":385,"exported":385,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9bd2f9de5b61","api":"https://metacan.xera.ac/api/v1/cohort?venue=American+Journal+of+Hematology"},"results":[{"id":"W1490900965","doi":"10.1002/ajh.23788","title":"Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Bosutinib; Medicine; Internal medicine; Gastroenterology; Imatinib; Neutropenia; Dysgeusia; Adverse effect; myalgia; Myeloid leukemia; Nilotinib; Toxicity","score_opus":0.017983480108602515,"score_gpt":0.33338896278461944,"score_spread":0.3154054826760169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1490900965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994545,0.0016412165,0.00025674357,0.0014616485,0.00048392,0.00081751635,0.0000108697695,0.00001254937,0.00077056873],"genre_scores_gemma":[0.9979045,0.0005722423,0.0006942091,0.00022868125,0.00048671482,0.00003824408,0.00002169684,0.00003947719,0.000014238538],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957369,0.0007742548,0.0019461164,0.00033189214,0.0005351801,0.00067567587],"domain_scores_gemma":[0.99510103,0.0022602074,0.0016942554,0.00063006935,0.00011953384,0.00019487609],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014689362,0.00035568583,0.0018907886,0.00049260154,0.000053110416,0.000009822674,0.00050093315,0.00014121199,0.00023877922],"category_scores_gemma":[0.0011252151,0.00025413436,0.00034144765,0.0007676852,0.00073878025,0.00012558125,0.00005886464,0.0009172849,0.00002099305],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38022208,0.00870288,0.0061655277,0.00049778813,0.0013543427,0.0052091996,0.006160586,0.00062695314,0.0056726416,0.0026909395,0.0024187793,0.5802783],"study_design_scores_gemma":[0.91766834,0.060525455,0.0018741017,0.0007614834,0.000506705,0.0036897573,0.0017794812,0.0018584204,0.0029770287,0.00012485981,0.007875064,0.0003593192],"about_ca_topic_score_codex":0.00038016302,"about_ca_topic_score_gemma":0.0003731914,"teacher_disagreement_score":0.579919,"about_ca_system_score_codex":0.0030434867,"about_ca_system_score_gemma":0.0035407378,"threshold_uncertainty_score":0.99999106},"labels":[],"label_agreement":null},{"id":"W1492560350","doi":"10.1002/ajh.23725","title":"A double‐blind, placebo‐controlled phase II study of the efficacy and safety of 2,2‐dimethylbutyrate (HQK‐1001), an oral fetal globin inducer, in sickle cell disease","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"University of North Carolina at Chapel Hill; University of Illinois at Urbana-Champaign; Cairo University; Ain Shams University; Children's National Hospital; University of South Alabama; Virginia Commonwealth University; American University of Beirut","keywords":"Medicine; Fetal hemoglobin; Placebo; Internal medicine; Nausea; Gastroenterology; Adverse effect; Vomiting; Surgery; Anesthesia; Fetus; Pregnancy; Pathology","score_opus":0.012204111064161386,"score_gpt":0.29671073486938554,"score_spread":0.2845066238052242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1492560350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707216,0.000683186,0.00004089223,0.0009474879,0.00013603325,0.00089915405,0.000003909432,0.0000064306037,0.00021073582],"genre_scores_gemma":[0.99953085,0.00009132155,0.00013771195,0.00014911457,0.000028783532,0.0000070277842,0.0000016628419,0.00002186193,0.000031636686],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99727476,0.0006828084,0.0012033875,0.00022439055,0.00031215735,0.00030251328],"domain_scores_gemma":[0.99763703,0.0002732546,0.0012431676,0.00035817333,0.00017579486,0.00031258972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009093068,0.00022760703,0.0016175056,0.00027844458,0.00008527298,0.000005548476,0.00023051935,0.00008684422,0.00002880669],"category_scores_gemma":[0.0002586495,0.00013876728,0.00018074627,0.00047529713,0.00060595485,0.000080116944,0.00009889491,0.00053068565,9.2408334e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74762577,0.043902088,0.12401761,0.00033825805,0.0016905923,0.0006233824,0.01523692,0.0011201344,0.014741407,0.00057777757,0.00019598164,0.04993007],"study_design_scores_gemma":[0.8855027,0.06018174,0.020075507,0.0005168245,0.0024364197,0.0010976258,0.023451848,0.0019662592,0.0036479102,0.00018279775,0.00041765408,0.00052269053],"about_ca_topic_score_codex":0.00021108486,"about_ca_topic_score_gemma":0.000047739275,"teacher_disagreement_score":0.13787694,"about_ca_system_score_codex":0.000029018225,"about_ca_system_score_gemma":0.00027258857,"threshold_uncertainty_score":0.56587654},"labels":[],"label_agreement":null},{"id":"W1492831809","doi":"10.1002/ajh.23712","title":"A Phase III, randomized, open‐label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Covis Pharma; McGill University","keywords":"Ferumoxytol; Iron sucrose; Iron-deficiency anemia; Medicine; Clinical endpoint; Anemia; Gastroenterology; Hemoglobin; Internal medicine; Iron deficiency; Transferrin saturation; Ferritin; Randomized controlled trial; Intravenous iron; Magnetic resonance imaging","score_opus":0.021196190934312013,"score_gpt":0.30059390926182455,"score_spread":0.27939771832751253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1492831809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947021,0.0022745463,0.0006756448,0.00011007365,0.00012125631,0.002004917,0.0000100474335,0.0000025966735,0.00009881565],"genre_scores_gemma":[0.99791944,0.00032938374,0.0015529013,0.000081224076,0.000016516498,0.00004629698,0.000008096784,0.000019722169,0.000026397885],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99791205,0.00035842616,0.0010166349,0.00017071531,0.0003073669,0.00023480477],"domain_scores_gemma":[0.9967843,0.00062010763,0.001984954,0.00030389655,0.00022329738,0.000083433326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005294818,0.0002194716,0.0023125059,0.00021026372,0.000025244053,0.0000027176084,0.00021506182,0.000046446756,0.00003105009],"category_scores_gemma":[0.00008192966,0.000111391244,0.0001448329,0.00014789581,0.001318035,0.00007142569,0.000011818167,0.00010729881,1.4712732e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94098043,0.00849687,0.023954444,0.00011790102,0.00007017682,0.000005491977,0.0032814573,0.00003445025,0.00035154464,0.00018506503,0.000110109184,0.022412036],"study_design_scores_gemma":[0.9414314,0.05187329,0.004311798,0.00007493608,0.00054044137,0.000036088244,0.0009490758,0.000048005095,0.0003785906,0.000016444175,0.00021984692,0.00012010196],"about_ca_topic_score_codex":0.0006914838,"about_ca_topic_score_gemma":0.000077744735,"teacher_disagreement_score":0.043376416,"about_ca_system_score_codex":0.00010872809,"about_ca_system_score_gemma":0.00044890476,"threshold_uncertainty_score":0.48563546},"labels":[],"label_agreement":null},{"id":"W1505869554","doi":"10.1002/ajh.24169","title":"Outcome prediction by extranodal involvement, IPI, R‐IPI, and NCCN‐IPI in the PET/CT and rituximab era: A <scp>D</scp>anish–<scp>C</scp>anadian study of 443 patients with diffuse‐large <scp>B</scp>‐cell lymphoma","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Danish; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Lymphoma","score_opus":0.011077441676237773,"score_gpt":0.23967480393728618,"score_spread":0.2285973622610484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1505869554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953583,0.0024043913,0.000024285042,0.00021360625,0.00020705306,0.0010888887,0.00010447747,0.00002321075,0.00057578017],"genre_scores_gemma":[0.9983208,0.00029795905,0.00028016345,0.00075688434,0.00007119453,0.000076601274,0.000040902207,0.00006398628,0.00009147114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99578273,0.0005176296,0.001388562,0.0005748462,0.0009189687,0.0008172329],"domain_scores_gemma":[0.9957651,0.0013748887,0.0012972499,0.00049875374,0.0003738157,0.00069019943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007733214,0.0005651269,0.0018082873,0.00050630356,0.00017197474,0.00006730649,0.0003221104,0.00005924125,0.0000034288096],"category_scores_gemma":[0.00054150086,0.00037452887,0.00015631672,0.00053917227,0.0005334589,0.0002743744,0.00010941401,0.0003858272,0.000006561364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008841018,0.017605416,0.9650039,0.0000876998,0.00055014144,0.0018132501,0.0076040523,0.0000014902265,0.00001794493,0.000060679253,0.0065601394,0.0006068677],"study_design_scores_gemma":[0.08442642,0.019255247,0.8066097,0.00022295602,0.0010970546,0.0066892765,0.075943604,0.0000777759,0.00034094692,0.0000779542,0.00515509,0.000103977225],"about_ca_topic_score_codex":0.0010409285,"about_ca_topic_score_gemma":0.0005402987,"teacher_disagreement_score":0.1583942,"about_ca_system_score_codex":0.00029375637,"about_ca_system_score_gemma":0.0003400325,"threshold_uncertainty_score":0.99987066},"labels":[],"label_agreement":null},{"id":"W1514606780","doi":"10.1002/ajh.23640","title":"Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"Leukemia and Lymphoma Society","keywords":"Medicine; Dosing; Pharmacology; Pharmacokinetics; Adverse effect; Drug; Pharmacodynamics","score_opus":0.017367300387844092,"score_gpt":0.31955335801566315,"score_spread":0.302186057627819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1514606780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784553,0.000066511275,0.000107193046,0.0009511825,0.000039659226,0.0009309567,0.000002338043,0.000012574781,0.00004403175],"genre_scores_gemma":[0.9978137,0.000027028513,0.0018715372,0.00018704479,0.0000128581805,0.00005511944,0.0000032903727,0.000019856825,0.000009549692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975928,0.00045057514,0.00071081775,0.00030835433,0.0003543735,0.000583102],"domain_scores_gemma":[0.9983735,0.00032508597,0.0005445185,0.00027242018,0.0002769501,0.0002075258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041810592,0.00025025805,0.0015384678,0.0005283029,0.000030581243,0.000010759362,0.00024717257,0.000080186444,0.00012040361],"category_scores_gemma":[0.00043102767,0.00015203241,0.00007649766,0.0008063962,0.0005547457,0.00021911079,0.00009786261,0.000742781,0.000018026798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004115052,0.004577517,0.97741604,0.000022724835,0.00007701719,0.0015239822,0.00035898783,0.0000049089676,0.0014795568,0.000030440497,0.00006381804,0.010329933],"study_design_scores_gemma":[0.018838195,0.0237999,0.952683,0.000114575014,0.000025338251,0.0011258607,0.0024229335,0.000058459205,0.0006859444,0.00005306405,0.0000183502,0.00017438483],"about_ca_topic_score_codex":0.000171169,"about_ca_topic_score_gemma":0.000054380605,"teacher_disagreement_score":0.024733067,"about_ca_system_score_codex":0.0002701424,"about_ca_system_score_gemma":0.00022410187,"threshold_uncertainty_score":0.61997014},"labels":[],"label_agreement":null},{"id":"W1514929400","doi":"10.1002/ajh.23868","title":"A phase 2, randomized, double‐blind, placebo‐controlled study of siltuximab (anti‐IL‐6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"National Cancer Institute; Janssen Scientific Affairs; Leukemia and Lymphoma Society","keywords":"Medicine; Bortezomib; Internal medicine; Multiple myeloma; Gastroenterology; Neutropenia; Placebo; Dexamethasone; Refractory (planetary science); Discontinuation; Febrile neutropenia; Oncology; Toxicity; Pathology","score_opus":0.0191206186390491,"score_gpt":0.31776368782950626,"score_spread":0.29864306919045713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1514929400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964672,0.00020176334,0.00009002452,0.0001843931,0.00011099916,0.002812223,0.0000084314015,0.000013314744,0.000111697576],"genre_scores_gemma":[0.99844605,0.000083476625,0.0011947111,0.00004641766,0.000041871514,0.00010594439,0.00001393583,0.000045023044,0.000022587506],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99601346,0.00087544287,0.001488641,0.00038207218,0.00070657395,0.00053381635],"domain_scores_gemma":[0.994571,0.0024812745,0.0016220099,0.00042416033,0.00047761356,0.00042395093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010953255,0.00037527658,0.003949831,0.00075144885,0.0000715457,0.000016173779,0.00018985954,0.000093515315,0.000054192984],"category_scores_gemma":[0.0016469373,0.00022059967,0.0002064545,0.00041835252,0.0006804059,0.00016384777,0.00006276562,0.00052406546,0.000004023971],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8365354,0.010148515,0.14138602,0.000045856563,0.0022432262,0.0007139295,0.00062053197,0.000006240042,0.00006242277,0.00001335159,0.000029272485,0.008195267],"study_design_scores_gemma":[0.93263954,0.045434378,0.018144285,0.00015503503,0.00082162063,0.00033061818,0.0015780645,0.0005133652,0.00016626477,0.0000062105023,0.000026797297,0.00018381557],"about_ca_topic_score_codex":0.000285836,"about_ca_topic_score_gemma":0.00024799423,"teacher_disagreement_score":0.12324174,"about_ca_system_score_codex":0.00009478705,"about_ca_system_score_gemma":0.000281901,"threshold_uncertainty_score":0.89957935},"labels":[],"label_agreement":null},{"id":"W1548156058","doi":"10.1002/ajh.24025","title":"Pitfalls in the diagnosis of heparin‐Induced thrombocytopenia: A 6‐year experience from a reference laboratory","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Immunoassay; Heparin-induced thrombocytopenia; Heparin; Medicine; Platelet factor 4; False positive paradox; False Negative Reactions; Platelet; Internal medicine; Immunology; Antibody","score_opus":0.07706783411056425,"score_gpt":0.34719750561698365,"score_spread":0.2701296715064194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1548156058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963401,0.00034716426,0.000021694934,0.001732084,0.00017168943,0.00022095302,0.000010054036,0.000010329618,0.0011459589],"genre_scores_gemma":[0.9973436,0.00023378784,0.0014768582,0.0008115367,0.000074955286,0.000029938185,0.0000029398175,0.000022684671,0.000003711001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734753,0.00049818796,0.0009983968,0.00027201572,0.0005092603,0.00037460646],"domain_scores_gemma":[0.99732935,0.0005470903,0.0008621852,0.00056266785,0.00042282412,0.0002758905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006996575,0.00023321202,0.0016469905,0.00024123589,0.00003658745,0.0000168406,0.0006007796,0.00012007236,0.00010300755],"category_scores_gemma":[0.00068246754,0.00015814109,0.00013856405,0.00080726796,0.00053026114,0.00020343589,0.000099417906,0.00062824396,0.00003388463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070355757,0.0009344433,0.95651853,0.000027869068,0.00028208375,0.0007989612,0.017898109,0.0000020322536,0.01664088,0.0031005847,0.00091537077,0.0021775998],"study_design_scores_gemma":[0.008231568,0.009142655,0.78622544,0.0008290481,0.00055285596,0.0030317095,0.0663061,0.000019378409,0.118347816,0.0013936318,0.0052264645,0.0006933119],"about_ca_topic_score_codex":0.001487922,"about_ca_topic_score_gemma":0.00019067337,"teacher_disagreement_score":0.17029305,"about_ca_system_score_codex":0.00010937411,"about_ca_system_score_gemma":0.0007195709,"threshold_uncertainty_score":0.64488065},"labels":[],"label_agreement":null},{"id":"W1565948695","doi":"10.1002/ajh.23707","title":"<i>BCR/ABL</i> level at 6 months identifies good risk CML subgroup after failing early molecular response at 3 months following imatinib therapy for CML in chronic phase","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Imatinib; Medicine; Internal medicine; Myeloid leukemia; Gastroenterology; Imatinib mesylate; Immunology; Surgery; Oncology","score_opus":0.012166135326978689,"score_gpt":0.3005888551829361,"score_spread":0.2884227198559574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1565948695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889594,0.0063481,0.0026905588,0.0008364183,0.00029218764,0.0007662532,0.000030877345,0.00003064265,0.000045605917],"genre_scores_gemma":[0.9942299,0.00032016254,0.00444374,0.00040894095,0.00011809098,0.00013004243,0.000012545085,0.000104823535,0.00023171827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99617636,0.0006913551,0.0013057457,0.00050841534,0.0004928442,0.0008252617],"domain_scores_gemma":[0.99633706,0.0013325112,0.0012407784,0.0006210347,0.00016193921,0.00030668388],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013929895,0.00045715965,0.0016656339,0.0004485062,0.00014945453,0.000029768176,0.000295793,0.00015836363,0.000086016764],"category_scores_gemma":[0.00069592404,0.00038697565,0.00069979293,0.00033132968,0.0003270889,0.00021623344,0.00010862799,0.00048031023,0.000035337926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1271709,0.002333487,0.33828935,0.0003984709,0.005122649,0.01125725,0.010644477,0.00049720175,0.42429024,0.00013773805,0.0014976659,0.07836057],"study_design_scores_gemma":[0.2395026,0.057692997,0.13572286,0.0033439507,0.0033698191,0.01664471,0.0036466827,0.0066803494,0.51273805,0.0013273718,0.016413292,0.0029173163],"about_ca_topic_score_codex":0.00036583043,"about_ca_topic_score_gemma":0.00026551218,"teacher_disagreement_score":0.20256647,"about_ca_system_score_codex":0.002246198,"about_ca_system_score_gemma":0.00061791233,"threshold_uncertainty_score":0.9998582},"labels":[],"label_agreement":null},{"id":"W1568897463","doi":"10.1002/ajh.23955","title":"Mycophenolate‐based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative‐related donor stem cell transplantation","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Methotrexate; Graft-versus-host disease; Transplantation; Stem cell; Mycophenolate; Surgery; Disease; Internal medicine; Biology","score_opus":0.02844093436943884,"score_gpt":0.29789371182022495,"score_spread":0.2694527774507861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1568897463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99177086,0.00019029714,0.004463204,0.0023163017,0.00032606116,0.0005273708,0.000028374814,0.000028387478,0.00034911511],"genre_scores_gemma":[0.99295104,0.000054892396,0.0062473114,0.0005919949,0.00002787942,0.00002044923,0.000013736628,0.000043668726,0.000049030285],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972849,0.00041821957,0.0010839399,0.00031758918,0.0004968809,0.0003984525],"domain_scores_gemma":[0.99750096,0.00048417828,0.0006321003,0.00025959386,0.00036787806,0.00075526506],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000574299,0.0002845192,0.0009901003,0.0006980272,0.00003496438,0.000015546015,0.00017025406,0.000101911544,0.00008124334],"category_scores_gemma":[0.00008243932,0.0002455776,0.00017274554,0.00088494434,0.00018409015,0.00014134798,0.000010604435,0.0004081796,0.00008321227],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17460102,0.0030130958,0.584294,0.0038807432,0.0012693628,0.024912603,0.08833993,0.002449918,0.08674423,0.0008366171,0.00065181724,0.029006656],"study_design_scores_gemma":[0.09389747,0.039409168,0.38199273,0.0037689998,0.0036307753,0.0072200852,0.018721338,0.0027405748,0.44439217,0.0003137205,0.001415894,0.0024970751],"about_ca_topic_score_codex":0.000097023665,"about_ca_topic_score_gemma":0.000016243717,"teacher_disagreement_score":0.35764796,"about_ca_system_score_codex":0.00017482307,"about_ca_system_score_gemma":0.00068534835,"threshold_uncertainty_score":0.99999964},"labels":[],"label_agreement":null},{"id":"W1644692312","doi":"10.1002/ajh.23690","title":"How common are myeloproliferative neoplasms? A systematic review and meta‐analysis","year":2014,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Queen's University; Queen's University Belfast","keywords":"Incidence (geometry); Essential thrombocythemia; Medicine; Polycythemia vera; Meta-analysis; Publication bias; Myelofibrosis; Internal medicine; Demography","score_opus":0.03890305758919121,"score_gpt":0.3476482793114404,"score_spread":0.30874522172224916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1644692312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001476955,0.99266595,0.000121977195,0.004889489,0.000044001023,0.002161352,0.00004427831,0.000015861771,0.00004233635],"genre_scores_gemma":[0.0005842162,0.99552846,0.0010137489,0.0020535667,0.00005560603,0.00048399204,0.000030056986,0.00006652736,0.00018382874],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9942859,0.0019546333,0.0023232815,0.0005317339,0.00048781998,0.0004166234],"domain_scores_gemma":[0.989174,0.0017812051,0.007313358,0.0007047836,0.00056167075,0.00046497205],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0008364566,0.0009304949,0.036643345,0.0008612394,0.000099008554,0.00007035843,0.00027784056,0.00020302378,0.00007997807],"category_scores_gemma":[0.00059630215,0.0004998303,0.0042614215,0.0011150663,0.00042067372,0.00008946683,0.00008143757,0.00079343625,0.000019084344],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015952597,0.00016916041,0.00012432762,0.6216224,0.37380537,0.00068474485,0.000058072685,1.1287335e-7,6.262098e-9,0.0005214422,0.00038925305,0.0026091773],"study_design_scores_gemma":[0.00029798222,0.0012071602,0.000005330889,0.082733996,0.87186056,0.020637274,0.00012122581,0.0000016112657,0.0000010555149,0.000018906505,0.022789685,0.00032523222],"about_ca_topic_score_codex":0.000008933138,"about_ca_topic_score_gemma":0.000031146057,"teacher_disagreement_score":0.5388884,"about_ca_system_score_codex":0.00012600615,"about_ca_system_score_gemma":0.0003013135,"threshold_uncertainty_score":0.9997453},"labels":[],"label_agreement":null},{"id":"W1827459324","doi":"10.1002/ajh.24120","title":"Age and d<scp>PCR</scp> can predict relapse in <scp>CML</scp> patients who discontinued imatinib: The <scp>ISAV</scp> study","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Regione Lombardia; Associazione Italiana per la Ricerca sul Cancro","keywords":"Imatinib; Medicine; Cancer research; Myeloid leukemia","score_opus":0.014613517413403032,"score_gpt":0.26853034137151954,"score_spread":0.2539168239581165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1827459324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409366,0.001430367,0.000030083367,0.00047904564,0.00049385976,0.0012312448,0.000033806642,0.00004776534,0.002160194],"genre_scores_gemma":[0.99717706,0.00022042665,0.00056472805,0.0005915304,0.00022063503,0.000066336506,0.000027321677,0.00010876682,0.0010231948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946041,0.0009122574,0.0017206441,0.00063067704,0.0010280426,0.0011042608],"domain_scores_gemma":[0.99305767,0.0029221948,0.0019397278,0.00083788694,0.00039102818,0.00085148215],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012056748,0.0006382298,0.00224883,0.00052658573,0.00015084668,0.0000664887,0.0006029198,0.00018320113,0.0000063207353],"category_scores_gemma":[0.006998259,0.00043627678,0.00024359743,0.00079323037,0.0011071841,0.0002558519,0.00029744057,0.0012715561,0.000030408677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005075192,0.0015815814,0.9386661,0.000062029634,0.00078301894,0.0033632028,0.027671048,0.000020131734,0.000058260666,0.00007288049,0.025058428,0.0026125486],"study_design_scores_gemma":[0.031550918,0.013932719,0.8249524,0.0007293915,0.0012195156,0.00721972,0.107304946,0.00022364805,0.0005443212,0.0005222928,0.01168429,0.00011580281],"about_ca_topic_score_codex":0.00064556807,"about_ca_topic_score_gemma":0.0004717082,"teacher_disagreement_score":0.11371368,"about_ca_system_score_codex":0.0007483898,"about_ca_system_score_gemma":0.0008717009,"threshold_uncertainty_score":0.9998089},"labels":[],"label_agreement":null},{"id":"W1920875642","doi":"10.1002/ajh.23713","title":"Reference intervals of complete blood count constituents are highly correlated to waist circumference: Should obese patients have their own “normal values?”","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Red blood cell distribution width; Mean corpuscular volume; Medicine; Complete blood count; White blood cell; Waist; Mean corpuscular hemoglobin; Hematocrit; Absolute neutrophil count; Body mass index; Mean corpuscular hemoglobin concentration; Internal medicine; Mean platelet volume; Hemoglobin; Hematology; Gastroenterology; Obesity; Immunology; Platelet","score_opus":0.026027793562909192,"score_gpt":0.2795449404333959,"score_spread":0.2535171468704867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1920875642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967955,0.00022142692,0.00048678045,0.00054674794,0.00044450993,0.00033355862,0.00007957835,0.000026504697,0.0010654398],"genre_scores_gemma":[0.99744266,0.000043955584,0.0012092803,0.0011724785,0.000051788018,0.00001171294,0.000021841524,0.00003168815,0.000014581955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682343,0.00039767748,0.0014122658,0.00031247214,0.00058872806,0.00046544563],"domain_scores_gemma":[0.9952891,0.00036579414,0.0019623754,0.00047894305,0.0014088342,0.00049496314],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055532466,0.00033170043,0.001530728,0.00040060031,0.00008202082,0.000015974118,0.0004793059,0.00013377493,0.0001552971],"category_scores_gemma":[0.0009199623,0.00025583024,0.0002479351,0.00029822465,0.0011057643,0.00010514406,0.0001530807,0.00048040104,0.000033472395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016899055,0.00078550266,0.9867008,0.00021784242,0.00081317866,0.00020113538,0.0005826913,0.000006885144,0.0015329041,0.00038634232,0.0017480132,0.0053348374],"study_design_scores_gemma":[0.012700808,0.011965864,0.933786,0.0056023733,0.0021281273,0.0045080245,0.0035933494,0.00038746552,0.01829762,0.00079778477,0.0051870635,0.0010455642],"about_ca_topic_score_codex":0.00003229,"about_ca_topic_score_gemma":0.0000090781805,"teacher_disagreement_score":0.05291481,"about_ca_system_score_codex":0.000091766306,"about_ca_system_score_gemma":0.0002316178,"threshold_uncertainty_score":0.9999894},"labels":[],"label_agreement":null},{"id":"W1927141198","doi":"10.1002/ajh.24183","title":"Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Fludarabine; Alemtuzumab; Transplantation; Hemoglobinopathy; Surgery; Immunosuppression; Internal medicine; Thalassemia; Cord blood; Gastroenterology; Hemolytic anemia; Cyclophosphamide; Chemotherapy","score_opus":0.00893459279584028,"score_gpt":0.2525848785514647,"score_spread":0.24365028575562445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1927141198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964356,0.0004800683,0.0005607453,0.0019030279,0.0001590934,0.00017547632,0.0000017550896,0.000024343237,0.00025989744],"genre_scores_gemma":[0.9964587,0.00012333553,0.0029105977,0.00041688516,0.000040389587,0.0000033149558,0.000015787791,0.000023314704,0.00000767696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852365,0.00011226024,0.0006023092,0.00018129552,0.00027150224,0.0003089694],"domain_scores_gemma":[0.99886197,0.000059209644,0.0004954828,0.00012646629,0.00023339564,0.00022350396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004218643,0.00017813768,0.00087118207,0.00043931487,0.00005382118,0.00001722875,0.000105216815,0.0000898469,0.000008225028],"category_scores_gemma":[0.00011248537,0.00013456678,0.0001258071,0.00058655743,0.0002566765,0.0001914238,0.000012821331,0.0004933613,0.0000049604378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016501881,0.00014661312,0.9902228,0.000035381054,0.0003498118,0.0014366187,0.0024362113,0.0002677452,0.0019420829,0.00006819926,0.00012512483,0.0013191986],"study_design_scores_gemma":[0.03656877,0.011224116,0.5397234,0.0036249962,0.0023470782,0.2645646,0.10142779,0.0005010889,0.03748279,0.0011353431,0.0000842176,0.0013158213],"about_ca_topic_score_codex":0.0002187174,"about_ca_topic_score_gemma":0.000024613204,"teacher_disagreement_score":0.45049945,"about_ca_system_score_codex":0.000090419344,"about_ca_system_score_gemma":0.00031318158,"threshold_uncertainty_score":0.5487474},"labels":[],"label_agreement":null},{"id":"W1931277076","doi":"10.1002/ajh.24006","title":"The platelet serotonin‐release assay","year":2015,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Platelet factor 4; Heparin; Platelet; Medicine; Coagulopathy; Heparin-induced thrombocytopenia; Platelet activation; Context (archaeology); Immunoassay; Immunology; Internal medicine; Antibody; Biology","score_opus":0.0590633344323724,"score_gpt":0.38027587658416717,"score_spread":0.3212125421517948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1931277076","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007586675,0.99532664,0.000028054088,0.0008790965,0.00063109415,0.0005416032,0.0000073348415,0.000021262922,0.0018062383],"genre_scores_gemma":[0.0013865209,0.9972515,0.00049492554,0.00021755292,0.00033325027,0.000027080187,0.000010380662,0.000089681635,0.00018912349],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961784,0.0008537525,0.0016359135,0.00028771922,0.00046373822,0.0005805079],"domain_scores_gemma":[0.99469906,0.0010116815,0.0025526558,0.0006637952,0.00046213655,0.00061066507],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015116757,0.00049842225,0.0058357567,0.00029845317,0.00013576506,0.000036331272,0.0006116243,0.0002761423,0.000078284],"category_scores_gemma":[0.0006261358,0.00027007217,0.00097314845,0.00056376745,0.0007407291,0.00006723197,0.00012235636,0.0015808464,0.00029165807],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007209097,0.00010331443,0.00004252958,0.0010596294,0.0013640703,0.00118279,0.000062283805,9.246317e-8,9.360217e-7,0.00066692603,0.00688414,0.9885612],"study_design_scores_gemma":[0.00052416883,0.001206803,0.000008797031,0.003577328,0.0014243873,0.053024985,0.00017948785,0.0000011480067,0.000011463967,0.00007786263,0.93973523,0.0002283275],"about_ca_topic_score_codex":0.00002647172,"about_ca_topic_score_gemma":0.000005529783,"teacher_disagreement_score":0.98833287,"about_ca_system_score_codex":0.00026062573,"about_ca_system_score_gemma":0.0025813999,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W1940067247","doi":"10.1002/ajh.23888","title":"Clinical outcomes of splenectomy in children: Report of the splenectomy in congenital hemolytic anemia registry","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Alberta Children's Hospital","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute","keywords":"Splenectomy; Medicine; Anemia; Adverse effect; Pediatrics; Hereditary spherocytosis; Spherocytosis; Clinical trial; Hemolytic anemia; Surgery; Internal medicine; Spleen","score_opus":0.015096725203558755,"score_gpt":0.33887633355245683,"score_spread":0.3237796083488981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1940067247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976025,0.00023042245,0.00007069046,0.00094567816,0.00023521729,0.00015876886,0.0000022522336,0.000005578804,0.0007488955],"genre_scores_gemma":[0.99885696,0.000065689674,0.00069750904,0.00027499223,0.000057548772,0.000003063671,7.151406e-7,0.000014581997,0.000028952529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693733,0.00034476767,0.0020042455,0.00018629845,0.0002940839,0.00023325664],"domain_scores_gemma":[0.9961403,0.000827645,0.002291886,0.00044383534,0.00021261076,0.000083742125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011440242,0.00016238035,0.0018184157,0.0002869786,0.000017988696,0.0000018023924,0.0002045955,0.00008970599,0.000025134535],"category_scores_gemma":[0.002925843,0.00010771796,0.00035101312,0.0004727995,0.0009990793,0.000043877222,0.000084305226,0.00055755937,0.000004557872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017692585,0.00027764347,0.9973522,0.000028820092,0.00023704686,0.00022176717,0.00009128701,0.000007552032,0.00016345424,0.0001309037,0.00024614966,0.0010662639],"study_design_scores_gemma":[0.0024541686,0.00041235544,0.9735407,0.000117261545,0.00012630965,0.021325337,0.0002436692,0.00000740484,0.0013539685,0.00009808594,0.00023612684,0.00008456465],"about_ca_topic_score_codex":0.00031212988,"about_ca_topic_score_gemma":0.00012213518,"teacher_disagreement_score":0.023811437,"about_ca_system_score_codex":0.00005199232,"about_ca_system_score_gemma":0.00026490272,"threshold_uncertainty_score":0.43926108},"labels":[],"label_agreement":null},{"id":"W1964003009","doi":"10.1002/ajh.21850","title":"Comprehensive evaluation of time‐to‐response parameter as a predictor of treatment failure following imatinib therapy in chronic phase chronic myeloid leukemia: Which parameter at which time‐point does matter?","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Imatinib; Internal medicine; Oncology; Hazard ratio; Myeloid leukemia; Proportional hazards model; Receiver operating characteristic; Nilotinib; Survival analysis; Confidence interval","score_opus":0.014152098318423739,"score_gpt":0.31747014263009415,"score_spread":0.3033180443116704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964003009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957954,0.0006497877,0.000031908057,0.0017088292,0.00018475659,0.001508593,0.00003480492,0.000018508274,0.000067396584],"genre_scores_gemma":[0.99632174,0.00009690012,0.0029446958,0.00018286299,0.000103000864,0.00012415944,0.000034743098,0.000076099204,0.00011581489],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952704,0.0009875109,0.0017323717,0.00052025315,0.0008526417,0.00063682557],"domain_scores_gemma":[0.99437857,0.0018372716,0.0016913897,0.000825348,0.0009387842,0.0003286598],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010947909,0.00053754984,0.0023486218,0.00071039685,0.000057512192,0.000013091896,0.00030600265,0.00023533653,0.0033562288],"category_scores_gemma":[0.00079684245,0.00037030532,0.00047047524,0.000750153,0.00036282695,0.00017130392,0.00008826369,0.00057938724,0.00026591506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.015946414,0.00146177,0.019242108,0.00018351551,0.0032306644,0.00031566067,0.003398331,0.0009892617,0.92405975,0.000004189698,0.0007610465,0.03040728],"study_design_scores_gemma":[0.15367258,0.119878106,0.041827157,0.002834549,0.0042904457,0.015245821,0.0014773883,0.028394267,0.6276967,0.00034060937,0.0028684288,0.0014739821],"about_ca_topic_score_codex":0.00023205258,"about_ca_topic_score_gemma":0.0002527119,"teacher_disagreement_score":0.2963631,"about_ca_system_score_codex":0.006657645,"about_ca_system_score_gemma":0.006098682,"threshold_uncertainty_score":0.9998749},"labels":[],"label_agreement":null},{"id":"W1964239136","doi":"10.1002/ajh.23235","title":"Autologous stem cell transplant for light chain deposition disease: Incorporating bortezomib to the induction therapy","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Induction therapy; Oncology; Disease; Autologous stem-cell transplantation; Stem cell; Multiple myeloma; Internal medicine; Biology; Chemotherapy; Genetics","score_opus":0.010477279161658686,"score_gpt":0.25739473633693877,"score_spread":0.24691745717528008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964239136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978636,0.0036869533,0.011534043,0.005441387,0.00033453145,0.00032266192,0.000017043916,0.000008032071,0.000019319677],"genre_scores_gemma":[0.9963217,0.00033113098,0.0017836012,0.0010963836,0.000316026,0.00008592582,0.000019162897,0.000025941325,0.000020147014],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988557,0.00018667184,0.00038438514,0.0001635556,0.00011022069,0.00029943662],"domain_scores_gemma":[0.99887943,0.000069681584,0.000563138,0.00020861434,0.000090564914,0.00018856964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026955144,0.00017193428,0.00032764388,0.00007489937,0.00012248564,0.000012242271,0.00019177615,0.0000662965,0.000003147909],"category_scores_gemma":[0.0000196816,0.00011459673,0.00017543415,0.00010804331,0.00009064696,0.000011970156,0.000021106365,0.00009836765,0.0000038624594],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038834452,0.0016363533,0.46867558,0.000087694374,0.0011875589,0.00008617546,0.003433977,0.00034905574,0.33392397,0.0012923682,0.00834217,0.17710166],"study_design_scores_gemma":[0.0025435206,0.005877153,0.06655179,0.000086061584,0.00040116362,0.0025369911,0.0029638617,0.00004009177,0.89991,0.00009896689,0.01835391,0.0006365369],"about_ca_topic_score_codex":0.000008870782,"about_ca_topic_score_gemma":0.0000085369065,"teacher_disagreement_score":0.565986,"about_ca_system_score_codex":0.000030771065,"about_ca_system_score_gemma":0.00007909248,"threshold_uncertainty_score":0.46731192},"labels":[],"label_agreement":null},{"id":"W1965889017","doi":"10.1002/ajh.21034","title":"Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Mitoxantrone; Medicine; Cytarabine; Internal medicine; Etoposide; Induction chemotherapy; Chemotherapy; Myeloid leukemia; Oncology; Leukemia; Regimen; Bone marrow; Surgery; Gastroenterology","score_opus":0.010878838440427353,"score_gpt":0.2888395293219061,"score_spread":0.27796069088147873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965889017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96994406,0.00002533262,0.02162677,0.0073003066,0.00013807106,0.0008931892,0.000017575068,0.000022141456,0.000032557444],"genre_scores_gemma":[0.96139157,0.00009631336,0.037029438,0.00093216554,0.00026089494,0.000012980181,0.000018924242,0.0000912154,0.00016648609],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99734765,0.00017098381,0.00090091745,0.0003626799,0.000701267,0.0005165173],"domain_scores_gemma":[0.9963878,0.00033469414,0.0012251408,0.00041537962,0.0012232165,0.00041377184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012941154,0.00030197704,0.0012034787,0.0006876061,0.00009124697,0.000010264548,0.00024005592,0.00014829944,0.000036404086],"category_scores_gemma":[0.00023707701,0.00020217011,0.00013824085,0.00073898846,0.0005118406,0.00016283612,0.000026747291,0.0005795893,0.0000018621405],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67392594,0.0006289595,0.08114206,0.00009161614,0.0020087648,0.00018297769,0.0026829115,0.00007736906,0.16421111,0.000048327984,0.006570577,0.06842938],"study_design_scores_gemma":[0.05967005,0.15240899,0.4949932,0.001612765,0.0008153421,0.012162992,0.0039732344,0.0002028302,0.24999857,0.000092296126,0.023062324,0.0010074031],"about_ca_topic_score_codex":0.00003808492,"about_ca_topic_score_gemma":0.0000052758623,"teacher_disagreement_score":0.6142559,"about_ca_system_score_codex":0.00082054094,"about_ca_system_score_gemma":0.00080283935,"threshold_uncertainty_score":0.82442576},"labels":[],"label_agreement":null},{"id":"W1965922185","doi":"10.1002/ajh.23281","title":"A genome‐wide single‐nucleotide polymorphism‐array can improve the prognostic stratification of the core binding factor acute myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Research Foundation of Korea","keywords":"Core binding factor; SNP array; SNP; Single-nucleotide polymorphism; Myeloid leukemia; Internal medicine; Cytogenetics; Leukemia; Medicine; Oncology; Gastroenterology; Biology; Pathology; Genetics; Gene; Genotype; Chromosome; Transcription factor","score_opus":0.024239111791797253,"score_gpt":0.28446918928598314,"score_spread":0.26023007749418586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965922185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913183,0.00048150276,0.00030838154,0.006667805,0.00040450372,0.00053640886,0.000025739639,0.000014350077,0.00024300987],"genre_scores_gemma":[0.9978847,0.00008712908,0.0010132263,0.00051945465,0.00028018642,0.00001301155,0.0000059601016,0.00004714598,0.00014917723],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973758,0.00028390926,0.00089794956,0.00019427086,0.00058184407,0.000666218],"domain_scores_gemma":[0.99638206,0.0007757122,0.0015853334,0.00058237993,0.00037354088,0.00030094624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005838798,0.00024550842,0.0008048314,0.0002403203,0.00016571398,0.000019049476,0.0006113341,0.000093462346,0.00007720957],"category_scores_gemma":[0.00079392234,0.00013337491,0.00027204579,0.0006533872,0.0012062287,0.00013795338,0.00009594902,0.0009363301,0.000014267208],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029011944,0.00013109444,0.19614577,0.00004713407,0.00053349126,0.0000437757,0.0022049274,0.0000019029835,0.79654074,0.00018392253,0.00029313215,0.0035840129],"study_design_scores_gemma":[0.0027304392,0.0037175866,0.5433332,0.0003401465,0.0013015184,0.01662141,0.0106457705,0.000056409026,0.4184778,0.00018733439,0.0021019499,0.00048644972],"about_ca_topic_score_codex":0.00010418313,"about_ca_topic_score_gemma":0.000016144191,"teacher_disagreement_score":0.37806293,"about_ca_system_score_codex":0.0007145441,"about_ca_system_score_gemma":0.0012232286,"threshold_uncertainty_score":0.54388714},"labels":[],"label_agreement":null},{"id":"W1966047453","doi":"10.1002/ajh.23114","title":"Liver iron overload assessment by <i>T</i> magnetic resonance imaging in pediatric patients: An accuracy and reproducibility study","year":2012,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Reproducibility; Magnetic resonance imaging; Hereditary hemochromatosis; Liver biopsy; Intraclass correlation; Hemochromatosis; Thalassemia; Liver disease; Nuclear medicine; Internal medicine; Gastroenterology; Biopsy; Radiology; Chemistry","score_opus":0.0064878308965340215,"score_gpt":0.2707239944682171,"score_spread":0.26423616357168306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966047453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9176953,0.030891618,0.000004768001,0.050153665,0.00046474565,0.0006480076,0.0000122015135,0.000012955445,0.00011678285],"genre_scores_gemma":[0.92151564,0.004891848,0.00040741585,0.07237493,0.00063750695,0.000014718966,0.00003699992,0.000069398346,0.000051514602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963177,0.00068679126,0.0011592704,0.00079947413,0.00047772544,0.00055907917],"domain_scores_gemma":[0.9971935,0.00027947317,0.001200598,0.00091079087,0.00022648044,0.00018915828],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010780101,0.00036253504,0.0013205872,0.00038186077,0.000053714666,0.000019207755,0.00021975524,0.00021641736,0.000059640442],"category_scores_gemma":[0.00045443026,0.00028743295,0.00011404218,0.0003528548,0.00034604,0.00021385726,0.00009858568,0.0024419033,0.0000038917074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013951193,0.0013026667,0.8277989,0.00013415779,0.00001599091,0.0011433403,0.0006267586,1.8840962e-7,0.0000041836524,5.8900423e-7,0.11848673,0.050347],"study_design_scores_gemma":[0.0053891777,0.0076617845,0.8653634,0.00020167287,0.0008934025,0.002749163,0.0019898827,0.000017700406,0.000004128069,0.000019660589,0.11514792,0.0005620935],"about_ca_topic_score_codex":0.0002855352,"about_ca_topic_score_gemma":0.000008327775,"teacher_disagreement_score":0.049784906,"about_ca_system_score_codex":0.00015330336,"about_ca_system_score_gemma":0.0002227466,"threshold_uncertainty_score":0.9999578},"labels":[],"label_agreement":null},{"id":"W1966765074","doi":"10.1002/ajh.10423","title":"β‐thalassemia in association with a new δ‐chain hemoglobin variant [δ116(g18)Arg→Leu]: Implications for carrier screening and prenatal diagnosis","year":2003,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; McMaster University; Hamilton Regional Laboratory Medicine Program; McMaster University Medical Centre","funders":"","keywords":"Hemoglobinopathy; Hydrops fetalis; Missense mutation; Genetic counseling; Thalassemia; Genetics; Medicine; Mutation; Prenatal diagnosis; Beta thalassemia; Hemolytic anemia; Pediatrics; Fetus; Gene; Biology; Internal medicine; Pregnancy","score_opus":0.007806648338934649,"score_gpt":0.25690089344622197,"score_spread":0.2490942451072873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966765074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719433,0.001808784,0.012018842,0.013517625,0.00007107355,0.00037849435,0.000012675,0.000012556118,0.00023660374],"genre_scores_gemma":[0.9863338,0.00039782806,0.0126015395,0.000517581,0.000032462136,0.00002846939,0.0000050368362,0.000024123432,0.00005919221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874467,0.00009371943,0.0004965676,0.0001889822,0.00013872718,0.00033732053],"domain_scores_gemma":[0.99843717,0.0004241575,0.0006019282,0.00013196208,0.00016604512,0.00023874176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039803132,0.00015108635,0.000634893,0.0002166448,0.00006666169,0.000013252124,0.00006718955,0.00012001935,0.000016764367],"category_scores_gemma":[0.0006832032,0.00011677104,0.000091734706,0.00038422472,0.00010675993,0.0000826924,0.00001268765,0.00032767918,6.594441e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031443321,0.00014979222,0.9805458,0.000046294263,0.0003062042,0.00011387783,0.0007043292,0.00006714312,0.00018835143,0.0026937476,0.001965319,0.012904703],"study_design_scores_gemma":[0.057945833,0.020302122,0.70466757,0.0040131593,0.0032919322,0.10217722,0.027555747,0.0009900613,0.014850724,0.0072252722,0.054786623,0.0021937517],"about_ca_topic_score_codex":0.0001171726,"about_ca_topic_score_gemma":0.000049156086,"teacher_disagreement_score":0.27587825,"about_ca_system_score_codex":0.00012677956,"about_ca_system_score_gemma":0.00036536736,"threshold_uncertainty_score":0.4761785},"labels":[],"label_agreement":null},{"id":"W1967239210","doi":"10.1002/ajh.23142","title":"von Willebrand disease: Clinical and laboratory lessons learned from the large von Willebrand disease studies","year":2012,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; Canadian Hemophilia Society; Heart and Stroke Foundation of Canada","keywords":"Von Willebrand disease; Von Willebrand factor; Desmopressin; Medicine; Immunology; Disease; Genetic testing; Mucocutaneous zone; Pathology; Internal medicine","score_opus":0.09793278708351735,"score_gpt":0.4271209498048195,"score_spread":0.32918816272130214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967239210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029876785,0.96407527,0.000008427162,0.004800168,0.00043674526,0.00040366245,0.0003679216,0.000014840881,0.000016188515],"genre_scores_gemma":[0.02394193,0.9745983,0.00008623221,0.0007609586,0.0003987421,0.000022936676,0.00007273321,0.0000654353,0.000052731484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964749,0.0009886703,0.0012920846,0.00041721392,0.00033353647,0.0004935647],"domain_scores_gemma":[0.9951153,0.0017223554,0.0016245053,0.00050485664,0.00019616337,0.0008368539],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006630238,0.000527233,0.0047452967,0.00014484438,0.00018362128,0.000022480666,0.0002360775,0.00015222067,0.000056931018],"category_scores_gemma":[0.0007764425,0.0002831075,0.0007390471,0.00027172122,0.001293935,0.000110767345,0.00013288339,0.0008808517,0.000029517158],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013090565,0.0011133882,0.14076692,0.0027756703,0.008395852,0.0058792178,0.00029601392,6.61055e-8,7.339944e-8,0.0003297207,0.0055087865,0.83362526],"study_design_scores_gemma":[0.002934382,0.00045929357,0.0055717356,0.0061487094,0.014880305,0.00087738637,0.00053523504,9.657482e-7,1.0609447e-7,0.00032255074,0.9679555,0.0003137804],"about_ca_topic_score_codex":0.00000687705,"about_ca_topic_score_gemma":0.000009088365,"teacher_disagreement_score":0.96244675,"about_ca_system_score_codex":0.000046475892,"about_ca_system_score_gemma":0.00071911624,"threshold_uncertainty_score":0.9999621},"labels":[],"label_agreement":null},{"id":"W1967769769","doi":"10.1002/ajh.21014","title":"Azathioprine‐associated acute myeloid leukemia in a patient with Crohn's disease and thiopurine <i>S</i>‐methyltransferase deficiency","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Thiopurine methyltransferase; Mercaptopurine; Azathioprine; Medicine; Myeloid leukemia; Leukemia; Immunology; Internal medicine; Disease; Gastroenterology; Cancer research","score_opus":0.005749631895019002,"score_gpt":0.25839464130702955,"score_spread":0.25264500941201057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967769769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555606,0.00058427296,0.002035292,0.0011857144,0.000049783084,0.00026989958,0.0000068436516,0.00001874979,0.0002934138],"genre_scores_gemma":[0.99625,0.00031765195,0.0024386924,0.0008878456,0.000033618482,0.0000056071704,0.0000041867493,0.00003618213,0.000026222655],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99748135,0.00012917176,0.00080885855,0.00028863066,0.00061691983,0.0006750995],"domain_scores_gemma":[0.99786,0.0004654748,0.00041872935,0.00023972488,0.00033811203,0.00067794014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065079454,0.00024879587,0.000925768,0.00057244074,0.000059700153,0.000013721425,0.00016690804,0.000074693395,0.000026775468],"category_scores_gemma":[0.0004196031,0.00017701673,0.00009983431,0.0008340108,0.0007694898,0.00010990135,0.00005986586,0.0006556061,0.0000044585627],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04302847,0.0020255037,0.43568382,0.000378003,0.0014377602,0.44446707,0.005052476,0.00016103052,0.014537043,0.0017624835,0.0007291068,0.050737254],"study_design_scores_gemma":[0.030900951,0.021380747,0.78523934,0.001562116,0.0015416188,0.13642412,0.0054706736,0.00071081927,0.014427874,0.0005946759,0.0006262126,0.0011208312],"about_ca_topic_score_codex":0.00015383103,"about_ca_topic_score_gemma":0.00006416918,"teacher_disagreement_score":0.34955552,"about_ca_system_score_codex":0.00093885337,"about_ca_system_score_gemma":0.0017501618,"threshold_uncertainty_score":0.72185326},"labels":[],"label_agreement":null},{"id":"W1969822989","doi":"10.1002/ajh.23127","title":"HITlights: A career perspective on heparin‐induced thrombocytopenia","year":2012,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Heparin-induced thrombocytopenia; Heparin; Medicine; Platelet factor 4; Discontinuation; Thrombosis; Platelet activation; Venous thrombosis; Internal medicine; Platelet; Intensive care medicine; Immunology","score_opus":0.1102006222201683,"score_gpt":0.39364517943620486,"score_spread":0.28344455721603656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969822989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057737124,0.98094624,0.000014104818,0.0007899546,0.0011720636,0.00090020226,0.000016308337,0.000054177923,0.010333249],"genre_scores_gemma":[0.076400496,0.9211853,0.0006598002,0.0004587951,0.00090382854,0.000040392028,0.000015142378,0.0002120664,0.00012413399],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994921,0.0007198409,0.0019968487,0.0006592634,0.0006736273,0.0010294148],"domain_scores_gemma":[0.99386203,0.0006288813,0.0029512793,0.001009731,0.00068045495,0.00086761295],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00060620386,0.001020729,0.010630596,0.0010561326,0.0001348462,0.00003853932,0.0007311568,0.00056744146,0.00044369392],"category_scores_gemma":[0.00029037776,0.00070192234,0.0018957985,0.00093235646,0.0005598678,0.0001831786,0.00018167192,0.002384084,0.00075623614],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004624601,0.0017886077,0.0004003794,0.0048198365,0.009494488,0.0025177854,0.001923373,1.2671285e-7,0.000071051116,0.024404762,0.0021376726,0.95197946],"study_design_scores_gemma":[0.001364805,0.005746539,0.00023400305,0.010793182,0.010605668,0.04262867,0.0014297923,3.1494403e-7,0.00015452695,0.00014347499,0.92596924,0.00092979596],"about_ca_topic_score_codex":0.00019818111,"about_ca_topic_score_gemma":0.000022213111,"teacher_disagreement_score":0.9510497,"about_ca_system_score_codex":0.0013322417,"about_ca_system_score_gemma":0.0018697047,"threshold_uncertainty_score":0.99991745},"labels":[],"label_agreement":null},{"id":"W1969826448","doi":"10.1002/ajh.23415","title":"Sweet's syndrome in chronic myelomonocytic leukemia","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre","funders":"","keywords":"Medicine; Sweet's syndrome; Chest radiograph; Chills; Pneumonia; Erythrocyte sedimentation rate; Absolute neutrophil count; Gastroenterology; Pathology; Monocytosis; Prednisone; Leukemia; Complete blood count; Internal medicine; Bone marrow; Lung; Neutropenia; Chemotherapy","score_opus":0.007110658152241725,"score_gpt":0.2508595251202777,"score_spread":0.243748866968036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969826448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948372,0.0016680271,0.00011712855,0.0018622826,0.00009474854,0.00013931647,1.3213877e-7,0.000012304302,0.0012688495],"genre_scores_gemma":[0.9985807,0.00018946802,0.0004720403,0.00057735405,0.000029759703,0.000007876234,7.9797604e-7,0.000019318435,0.00012270616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998667,0.00006865145,0.00068578834,0.000115185976,0.00014650609,0.00031685052],"domain_scores_gemma":[0.99902904,0.000078049205,0.00047781251,0.00020108087,0.00009464481,0.000119356475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015495236,0.00013301906,0.00081739377,0.00031121264,0.000021966272,0.0000072675143,0.00014813595,0.00005679999,0.00048817875],"category_scores_gemma":[0.00007364472,0.00010688293,0.00013217083,0.0002778268,0.0003336097,0.00016531814,0.000026933643,0.0003876761,0.0002558669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009872215,0.0006848289,0.51593447,0.0008107056,0.0015629394,0.018736435,0.00363584,0.0007696857,0.020648023,0.007088215,0.018020377,0.41112128],"study_design_scores_gemma":[0.008533751,0.010145089,0.8392422,0.000946804,0.00022715556,0.115570754,0.0065813,0.0012040557,0.0022022396,0.0019966085,0.012716638,0.00063335465],"about_ca_topic_score_codex":0.00016643533,"about_ca_topic_score_gemma":0.000008595733,"teacher_disagreement_score":0.41048792,"about_ca_system_score_codex":0.00043108125,"about_ca_system_score_gemma":0.00082917116,"threshold_uncertainty_score":0.5345215},"labels":[],"label_agreement":null},{"id":"W1970155654","doi":"10.1002/ajh.20833","title":"Imatinib mesylate responsiveness in aggressive systemic mastocytosis: Novel association with a platelet derived growth factor receptor beta mutation","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Hematopathology; Systemic mastocytosis; Medicine; Imatinib mesylate; PDGFRA; Library science; Family medicine; Imatinib; Pathology; Internal medicine; Bone marrow; Biology; Genetics; Myeloid leukemia; GiST","score_opus":0.007452370465555895,"score_gpt":0.24460344501564774,"score_spread":0.23715107455009185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970155654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954686,0.0005615335,0.0011520056,0.0023507755,0.00009843331,0.00025459635,0.000012627648,0.000014677438,0.00008675997],"genre_scores_gemma":[0.99662095,0.00006234774,0.0030319183,0.00014981172,0.00004267931,0.000014571912,0.00001346827,0.000026773449,0.00003749519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981983,0.0001989129,0.0007657556,0.00018487357,0.00035701523,0.00029518324],"domain_scores_gemma":[0.99673283,0.0003486433,0.0022803773,0.000118062315,0.0004376434,0.00008243166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028932097,0.0001855824,0.0010146042,0.0004009606,0.000041953495,0.000015306383,0.00010259814,0.00009516019,0.000031660005],"category_scores_gemma":[0.00028688708,0.0001402442,0.000101372956,0.00040381448,0.00013352782,0.00013437688,0.000013839202,0.00028804052,0.0000075300163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008680414,0.0012497925,0.8825125,0.0005236237,0.001197954,0.00421088,0.005306254,0.00031247883,0.08691831,0.0017033467,0.0006430764,0.006741342],"study_design_scores_gemma":[0.032848936,0.014587944,0.7287338,0.0077537014,0.0007533306,0.11477463,0.020215381,0.00038200556,0.07739126,0.000934631,0.00028696007,0.0013374513],"about_ca_topic_score_codex":0.00015332221,"about_ca_topic_score_gemma":0.00003387673,"teacher_disagreement_score":0.15377876,"about_ca_system_score_codex":0.0002466381,"about_ca_system_score_gemma":0.00026669123,"threshold_uncertainty_score":0.57189924},"labels":[],"label_agreement":null},{"id":"W1970453456","doi":"10.1002/ajh.21179","title":"Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary‐care population","year":2008,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"National Center for Research Resources; National Human Genome Research Institute; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; Deutsches Krebsforschungszentrum","keywords":"Transferrin saturation; Phlebotomy; Pacific islanders; Medicine; Ferritin; Serum ferritin; Hereditary hemochromatosis; Hemochromatosis; Serum iron; Internal medicine; Population; Gastroenterology; Physiology; Anemia; Immunology; Environmental health","score_opus":0.010090391402769428,"score_gpt":0.2761692197154976,"score_spread":0.2660788283127282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970453456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994399,0.004449701,0.00011062214,0.0006502452,0.00010080782,0.0001362138,0.0000029634914,0.0000075297394,0.00014291008],"genre_scores_gemma":[0.99586904,0.00081464334,0.002739817,0.00049747294,0.00003830326,0.0000023013345,0.000012919751,0.000010559643,0.000014938956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906605,0.00010511157,0.0003998646,0.000110589775,0.00013560652,0.00018275883],"domain_scores_gemma":[0.9993821,0.00006394207,0.0002744968,0.0000906489,0.000083410414,0.000105418454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007275501,0.00009718762,0.00046861367,0.00016475051,0.000048623744,0.0000031826655,0.00004622191,0.00003996768,0.000014060871],"category_scores_gemma":[0.00008280694,0.00008381623,0.000055461434,0.00012053243,0.00025695644,0.00007519019,0.000014157001,0.00019249429,0.0000016842421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000309949,0.00014015051,0.9893007,0.0000854266,0.000009810099,0.00019354148,0.0023280077,0.000014883558,0.000536776,0.00012667806,0.00006335462,0.0068906695],"study_design_scores_gemma":[0.0034839395,0.00042300206,0.9889866,0.00007393258,0.000050360042,0.0020638313,0.004453219,0.000044074794,0.00012607888,0.000012415086,0.00020376011,0.00007880248],"about_ca_topic_score_codex":0.00017414922,"about_ca_topic_score_gemma":0.00009884406,"teacher_disagreement_score":0.006811867,"about_ca_system_score_codex":0.000046885354,"about_ca_system_score_gemma":0.000089464964,"threshold_uncertainty_score":0.34179267},"labels":[],"label_agreement":null},{"id":"W1970526583","doi":"10.1002/ajh.10191","title":"Health status and health‐related quality of life associated with hemophilia","year":2002,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Regional Municipality of Niagara; Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Medicine; Health Utilities Index; Clotting factor; Quality of life (healthcare); Population; Cohort; Haemophilia; Disease; Pediatrics; Environmental health; Internal medicine; Health related quality of life","score_opus":0.05858427877993451,"score_gpt":0.3631025268245747,"score_spread":0.3045182480446402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970526583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94968176,0.0064641004,0.000013081408,0.043406237,0.000033168308,0.00017185666,0.0000054963016,0.00001132088,0.00021298867],"genre_scores_gemma":[0.9969496,0.0015201533,0.0005484324,0.0007983009,0.000016941793,0.0000012664998,0.0000047369076,0.000016594047,0.00014396975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751705,0.00044059815,0.00104374,0.00014959431,0.00038829862,0.00046074373],"domain_scores_gemma":[0.99718535,0.00029110638,0.0014563437,0.00016155587,0.0002447551,0.0006608809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008919693,0.00013688815,0.0016008149,0.00023452418,0.00006866734,0.000003928618,0.00006459389,0.0000516348,0.00011200086],"category_scores_gemma":[0.0003744869,0.00009004168,0.000091073816,0.00042961718,0.0006457471,0.00004494277,0.00001978649,0.00036778708,0.000004035864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006223628,0.00090067525,0.9711756,0.00019917003,0.00085223845,0.0001421054,0.0017324201,0.0000019008424,0.000050491988,0.0005480766,0.0019293973,0.021845566],"study_design_scores_gemma":[0.011684572,0.026152221,0.95419323,0.00076354365,0.00009587823,0.003260262,0.0027133944,0.00011353592,0.00016593577,0.00027245842,0.0003516054,0.00023334286],"about_ca_topic_score_codex":0.00046729663,"about_ca_topic_score_gemma":0.000053981687,"teacher_disagreement_score":0.047267854,"about_ca_system_score_codex":0.00013361193,"about_ca_system_score_gemma":0.00054054824,"threshold_uncertainty_score":0.3671793},"labels":[],"label_agreement":null},{"id":"W1971844177","doi":"10.1002/ajh.20481","title":"Osteonecrosis of the jaw associated with pamidronate therapy","year":2005,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Bone health and treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Osteonecrosis of the jaw; Discontinuation; Multiple myeloma; Osteomyelitis; Bisphosphonate; Surgery; Osteoporosis; Bone pain; Adverse effect; Adjuvant therapy; Zoledronic acid; Internal medicine; Chemotherapy","score_opus":0.011706102906241462,"score_gpt":0.2782029998680319,"score_spread":0.2664968969617904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971844177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98987985,0.00044568977,0.000013316348,0.009120374,0.00004802454,0.00010734935,0.000002107934,0.000004963991,0.0003782997],"genre_scores_gemma":[0.99752647,0.00015680192,0.0005890445,0.0016128419,0.000005662834,0.000002094073,6.929791e-7,0.00001179996,0.0000945805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990868,0.00009893814,0.0003642584,0.00006837408,0.00019294149,0.00018869847],"domain_scores_gemma":[0.99867344,0.00012265191,0.0007826353,0.00014649364,0.00016902477,0.00010576868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013520269,0.0000894995,0.0005437597,0.00006228737,0.000039302708,0.0000016410343,0.000082020124,0.000032871954,0.00003960844],"category_scores_gemma":[0.00005657865,0.00004429354,0.000104168896,0.00022067233,0.00032317746,0.00003174294,0.0000088522365,0.0001831068,0.000003521027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014407962,0.0007537156,0.92094016,0.000013113215,0.0007336256,0.0000988168,0.0006167145,0.0000067256556,0.00052002,0.00020048894,0.0004942772,0.074181564],"study_design_scores_gemma":[0.009789039,0.008686492,0.9531668,0.0003834414,0.0003030911,0.007075593,0.00055243354,0.000020727228,0.015454068,0.000106479376,0.004326465,0.00013539701],"about_ca_topic_score_codex":0.00016297054,"about_ca_topic_score_gemma":0.00013459612,"teacher_disagreement_score":0.07404617,"about_ca_system_score_codex":0.000051055693,"about_ca_system_score_gemma":0.00021848109,"threshold_uncertainty_score":0.18062381},"labels":[],"label_agreement":null},{"id":"W1973610900","doi":"10.1002/ajh.10393","title":"Case of acute lymphoblastic leukemia presenting with t(14;18)/<i>BCL2</i>, t(8;14)/cMYC, and t(1;2)/<i>FCGR2B</i>","year":2003,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Chromosomal translocation; BCL6; Cancer research; Lymphoma; Lymphoblastic lymphoma; Phenotype; Follicular lymphoma; Biology; Molecular biology; T cell; Antibody; Immunology; Gene; B cell; Genetics; Immune system; Germinal center","score_opus":0.009367562735246984,"score_gpt":0.2615077763345461,"score_spread":0.2521402135992991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973610900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657506,0.0010484809,0.0002003947,0.00031588876,0.00009532351,0.00015895256,0.0000062844615,0.0000105074005,0.0015891124],"genre_scores_gemma":[0.99318546,0.0003263387,0.0060344194,0.00031996166,0.000032776094,0.0000076792185,0.000001360411,0.000028433205,0.00006356582],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9983898,0.00013458055,0.0006570961,0.00022636502,0.00023653667,0.00035561953],"domain_scores_gemma":[0.9979041,0.00038384405,0.0008916946,0.00025225186,0.00027630635,0.00029178354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019948238,0.00023685023,0.0011142938,0.00019947898,0.0000702077,0.000012025342,0.00007510302,0.00005841717,0.00006003815],"category_scores_gemma":[0.000132619,0.00016005537,0.00014352493,0.0002717286,0.0005844534,0.00008836605,0.000029061168,0.00015720988,0.0000042212973],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017722913,0.0013234449,0.82449746,0.00031087332,0.004956991,0.1449109,0.0015027869,0.00004372139,0.001680359,0.004397906,0.0036615194,0.010941741],"study_design_scores_gemma":[0.009182118,0.0055748895,0.010930855,0.00033232625,0.0024105622,0.94194126,0.0013522705,0.000057417397,0.026239457,0.00019505681,0.0015134469,0.00027034708],"about_ca_topic_score_codex":0.000099644785,"about_ca_topic_score_gemma":0.000012777255,"teacher_disagreement_score":0.8135666,"about_ca_system_score_codex":0.00013364143,"about_ca_system_score_gemma":0.00048292507,"threshold_uncertainty_score":0.65268683},"labels":[],"label_agreement":null},{"id":"W1974058071","doi":"10.1002/ajh.20956","title":"Immune complex binding by immunocamouflaged [poly(ethylene glycol)‐grafted] erythrocytes","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"Canadian Institutes of Health Research; Canadian Blood Services","keywords":"Flow cytometry; Chemistry; Red blood cell; Ethylene glycol; PEG ratio; Immune system; Alkaline phosphatase; Biochemistry; Molecular biology; Immunology; Medicine; Enzyme; Biology","score_opus":0.009675783027959685,"score_gpt":0.27114300607176794,"score_spread":0.26146722304380826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974058071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845492,0.006889493,0.0051214704,0.0023979612,0.00026780932,0.00014395648,0.0000049884648,0.000032326643,0.0005927944],"genre_scores_gemma":[0.99328405,0.000486489,0.005363739,0.0006257165,0.000115451796,0.0000014871811,0.000014441499,0.00003923463,0.0000693784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99781644,0.000096224416,0.0010269773,0.00019709187,0.00033602078,0.00052723073],"domain_scores_gemma":[0.99823916,0.00031476776,0.0007123028,0.00026054555,0.0002091146,0.00026412867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007321562,0.0002333214,0.0011568171,0.0003559207,0.00013740841,0.000012654992,0.00020167592,0.00009901287,0.00022941316],"category_scores_gemma":[0.00007889747,0.00018793767,0.00028701307,0.0005058469,0.0005283056,0.00009623673,0.000036125984,0.0005950611,0.000029941339],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029610922,0.0008179302,0.037749562,0.00008481193,0.00077380677,0.0017401853,0.00079831487,5.242205e-7,0.87912375,0.0005323255,0.0023161038,0.07310162],"study_design_scores_gemma":[0.016569093,0.015121148,0.10813127,0.00084125623,0.0012383629,0.08913849,0.011075951,0.00003462356,0.72225356,0.00028322623,0.034336783,0.00097622833],"about_ca_topic_score_codex":0.00014405619,"about_ca_topic_score_gemma":0.000015271997,"teacher_disagreement_score":0.15687016,"about_ca_system_score_codex":0.00006750973,"about_ca_system_score_gemma":0.00009095196,"threshold_uncertainty_score":0.7663875},"labels":[],"label_agreement":null},{"id":"W1976299049","doi":"10.1002/ajh.1102","title":"Systemic anaplastic large‐cell lymphoma: Results from the non‐Hodgkin's lymphoma classification project","year":2001,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; U.S. Public Health Service; U.S. Department of Health and Human Services","keywords":"Anaplastic large-cell lymphoma; Lymphoma; Anaplastic lymphoma kinase; Medicine; Large-cell lymphoma; Null cell; Stage (stratigraphy); International Prognostic Index; Peripheral T-cell lymphoma; Internal medicine; Pathology; Non-Hodgkin's lymphoma; Not Otherwise Specified; Bone marrow; Oncology; Diffuse large B-cell lymphoma; T cell; Immunology; Biology","score_opus":0.03797715189213066,"score_gpt":0.32788348335132883,"score_spread":0.2899063314591982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976299049","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006869871,0.98976135,0.00010527754,0.00045637065,0.00065005233,0.001083483,0.00023099745,0.000029213616,0.00081340136],"genre_scores_gemma":[0.06499922,0.93325084,0.00042529425,0.00023908961,0.0005589967,0.00010354792,0.00023807316,0.000085516374,0.00009939687],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950986,0.0007352189,0.002418767,0.000594588,0.00054822717,0.0006045915],"domain_scores_gemma":[0.9908439,0.0026672606,0.0049769995,0.00095202983,0.0003170007,0.00024280208],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005888985,0.00069106446,0.004579581,0.0004151425,0.00014875861,0.00004653395,0.00056949165,0.00031652732,0.000019481173],"category_scores_gemma":[0.00039141582,0.000377818,0.0011310445,0.0009278043,0.0003397334,0.00007116616,0.00008573725,0.00028016968,0.00016645687],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006211743,0.0020931405,0.00068815186,0.0015713273,0.0016709055,0.003239521,0.00034778306,2.644357e-7,7.0116863e-7,0.000094587245,0.012423489,0.97724897],"study_design_scores_gemma":[0.010979051,0.0024058267,0.00082593533,0.017409446,0.0071151583,0.055786967,0.001457274,0.000022885866,0.0000060003727,0.00001082621,0.90358317,0.0003974491],"about_ca_topic_score_codex":0.0003225056,"about_ca_topic_score_gemma":0.000023317218,"teacher_disagreement_score":0.9768515,"about_ca_system_score_codex":0.0009116279,"about_ca_system_score_gemma":0.0026212838,"threshold_uncertainty_score":0.9998674},"labels":[],"label_agreement":null},{"id":"W1979470678","doi":"10.1002/1096-8652(200008)64:4<306::aid-ajh12>3.0.co;2-v","title":"Prolonged complete remission of myelodysplastic syndrome treated with danazol, retinoic acid and low-dose prednisone","year":2000,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Pancytopenia; Macrocytosis; Gastroenterology; Prednisone; Internal medicine; Danazol; Myelodysplastic syndromes; Bone marrow; Myeloid; Anemia","score_opus":0.009845085584709527,"score_gpt":0.25939139876208434,"score_spread":0.2495463131773748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979470678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975776,0.00042079043,0.000054930904,0.0013002735,0.0000145566655,0.00025867063,0.0000062629256,0.000016396036,0.00035050072],"genre_scores_gemma":[0.9967919,0.0002793508,0.0025866823,0.00011205593,0.000024083283,0.0000048368115,0.0000062699073,0.000033606462,0.00016122968],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9981144,0.00021352869,0.00065893104,0.00023704069,0.00039367107,0.00038240413],"domain_scores_gemma":[0.9983044,0.00023727342,0.00056193664,0.00028839934,0.0002600599,0.0003478854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028807958,0.00020554672,0.00122613,0.0002928865,0.000056361816,0.0000068423005,0.00016971053,0.00007818732,0.0004241466],"category_scores_gemma":[0.00016462737,0.00013850055,0.00007521764,0.00047302144,0.0010396278,0.000079552,0.000034475543,0.00051516487,0.000011198948],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07533631,0.001846724,0.38959256,0.0016870401,0.0030001742,0.03611293,0.0023108164,0.000062937375,0.36909497,0.00015786463,0.0028333892,0.117964305],"study_design_scores_gemma":[0.024141591,0.052350402,0.30898705,0.0035249894,0.0011996962,0.548661,0.0015832348,0.0018004703,0.055704392,0.00009700778,0.0012554764,0.00069470983],"about_ca_topic_score_codex":0.000037772123,"about_ca_topic_score_gemma":0.0000025343138,"teacher_disagreement_score":0.512548,"about_ca_system_score_codex":0.000093471026,"about_ca_system_score_gemma":0.00034875644,"threshold_uncertainty_score":0.5647888},"labels":[],"label_agreement":null},{"id":"W1979478767","doi":"10.1002/ajh.20809","title":"Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi‐center study of iron overload","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Deutsches Krebsforschungszentrum","keywords":"Medicine; Thalassemia; Internal medicine; Chelation therapy; Transfusion therapy; Hemoglobinopathy; Ferritin; Mortality rate; Disease; Acute chest syndrome; Gastroenterology; Sickle cell anemia; Pediatrics; Anemia; Beta thalassemia; Blood transfusion","score_opus":0.007330059617678686,"score_gpt":0.2553811969636909,"score_spread":0.2480511373460122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979478767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738616,0.0015605254,0.000056391014,0.0006355797,0.00003049165,0.0002619325,0.0000055738788,0.00000447047,0.000058881964],"genre_scores_gemma":[0.9994837,0.00024343634,0.00015760782,0.00007416697,0.00001804894,0.0000026892321,0.0000030496415,0.000011098772,0.0000062047234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878854,0.00014153386,0.0005260819,0.00018129154,0.00019827997,0.00016430591],"domain_scores_gemma":[0.9990598,0.0001385212,0.00043425796,0.0002008237,0.000059024078,0.00010756947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001949981,0.00012683551,0.0005997316,0.000049270904,0.000029244817,0.0000052093847,0.00006074687,0.000041914194,0.000008025367],"category_scores_gemma":[0.000035938567,0.00007233026,0.000049626604,0.00012769375,0.00044133217,0.000043406777,0.000017775938,0.00030197066,1.5044006e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007208678,0.0016379787,0.99349403,0.00003931886,0.00008431718,0.0023522666,0.00072997366,0.000020012174,0.0006616859,0.000003372168,0.00006263211,0.0001935538],"study_design_scores_gemma":[0.0068034986,0.0012026923,0.986271,0.000113798116,0.00026746135,0.0014115094,0.0035594797,0.000059801994,0.00017869574,0.000018456169,0.000037743972,0.00007584983],"about_ca_topic_score_codex":0.0035233716,"about_ca_topic_score_gemma":0.0017256786,"teacher_disagreement_score":0.007223008,"about_ca_system_score_codex":0.00002335619,"about_ca_system_score_gemma":0.00015301273,"threshold_uncertainty_score":0.53263074},"labels":[],"label_agreement":null},{"id":"W1979616872","doi":"10.1002/ajh.22193","title":"Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Internal medicine; Myeloid leukemia; Gastroenterology; Medicine; Leukemia; Oncology; Multiple drug resistance; Drug resistance; Biology; Genetics","score_opus":0.02171115480259071,"score_gpt":0.2723642155425807,"score_spread":0.25065306073999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979616872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781126,0.00016643562,0.00011026516,0.0011618019,0.00008518424,0.00021496495,0.000011328859,0.000017880813,0.00042090396],"genre_scores_gemma":[0.992387,0.00028821413,0.0066166404,0.00015178917,0.00005421335,0.000014223121,0.000004061393,0.000028774284,0.0004550678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831,0.0001810144,0.00048168757,0.00027123364,0.00033487545,0.00042116974],"domain_scores_gemma":[0.9984509,0.00028871465,0.0005804748,0.00021584201,0.00019173566,0.0002723372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024850783,0.00023553608,0.0010046278,0.00032060104,0.000059896163,0.0000051116726,0.00011281392,0.00009144305,0.00007359679],"category_scores_gemma":[0.00011258249,0.0001629042,0.00009540417,0.00030386983,0.00056541973,0.00018973449,0.00004627035,0.0005218489,0.0000092504215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011462691,0.00033647192,0.978608,0.000029353698,0.000824517,0.0036854753,0.00075951306,0.000006335624,0.0012394758,0.00020328125,0.00024595688,0.0025989183],"study_design_scores_gemma":[0.006763364,0.003915645,0.98041797,0.000091180256,0.0002648132,0.0039031184,0.0006733255,0.00006221842,0.003532269,0.000076019416,0.00013947574,0.00016062892],"about_ca_topic_score_codex":0.0005374636,"about_ca_topic_score_gemma":0.0003019956,"teacher_disagreement_score":0.0065063755,"about_ca_system_score_codex":0.0011141016,"about_ca_system_score_gemma":0.0007646182,"threshold_uncertainty_score":0.664304},"labels":[],"label_agreement":null},{"id":"W1980928845","doi":"10.1002/ajh.22043","title":"Chills and limb pain following administration of low‐molecular‐weight heparin for treatment of acute venous thromboembolism","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"Pfizer Canada; Sanofi; Heart and Stroke Foundation of Canada; GlaxoSmithKline; Pfizer","keywords":"Medicine; Warfarin; Heparin; Thrombosis; Surgery; Aortic valve replacement; Low molecular weight heparin; Anesthesia; Stenosis; Placebo; Aortic valve; Bicuspid aortic valve; Internal medicine; Atrial fibrillation","score_opus":0.013334043417539158,"score_gpt":0.2794444136735976,"score_spread":0.2661103702560585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980928845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995383,0.0008526816,0.002494165,0.0004256358,0.0001322195,0.00037556316,0.0000064905275,0.0000057689062,0.0003244563],"genre_scores_gemma":[0.99105567,0.0006872895,0.007973873,0.00020012869,0.000034940254,0.000016008162,0.0000052993,0.000020287976,0.000006497553],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875295,0.000090762456,0.0006508468,0.00014833866,0.00014805587,0.00020907409],"domain_scores_gemma":[0.9986562,0.00012694777,0.00079939544,0.00018468985,0.00011704643,0.0001156898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002769462,0.00015603525,0.0015665628,0.00018015117,0.000029910605,0.0000031109203,0.00008073268,0.000048893224,0.000017172437],"category_scores_gemma":[0.00004863885,0.00012184161,0.00031203768,0.000108180626,0.00019907206,0.00004608513,0.000017754619,0.00004429541,5.045314e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013150402,0.05651111,0.13991077,0.0031219271,0.05450588,0.008107074,0.04145971,0.0000149753805,0.11791174,0.07111031,0.0024185418,0.49177757],"study_design_scores_gemma":[0.013633419,0.21501419,0.22490093,0.0013710217,0.0127203865,0.0062019345,0.0047246343,0.00013856943,0.5140287,0.004742601,0.0017371211,0.0007864471],"about_ca_topic_score_codex":0.00005572662,"about_ca_topic_score_gemma":0.0000067446904,"teacher_disagreement_score":0.49099112,"about_ca_system_score_codex":0.00003163654,"about_ca_system_score_gemma":0.00012078152,"threshold_uncertainty_score":0.49685568},"labels":[],"label_agreement":null},{"id":"W1981232641","doi":"10.1002/ajh.22211","title":"Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti‐platelet GPIIbIIIa versus GPIbα antibodies","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Antibody; Medicine; Platelet; Immune thrombocytopenia; Autoantibody; Immune system; Immunology; Refractory (planetary science); Internal medicine; Pharmacology","score_opus":0.025032111086878472,"score_gpt":0.29517928663196097,"score_spread":0.2701471755450825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981232641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946266,0.0037652676,0.000022494592,0.0003013971,0.00015351648,0.00019159878,0.00000888893,0.000009380199,0.0009208926],"genre_scores_gemma":[0.9965741,0.002481376,0.0008032234,0.000080737474,0.0000088077895,0.0000018182787,0.0000137338475,0.000023195402,0.00001300791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837315,0.00014423243,0.0008074331,0.00017293908,0.00019946387,0.0003028041],"domain_scores_gemma":[0.99824953,0.0003448547,0.00094605656,0.00020058197,0.00015606085,0.0001029216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018654503,0.00021225552,0.0016818382,0.00026700876,0.000029376111,0.0000033591843,0.00016400336,0.00008313446,0.00013240858],"category_scores_gemma":[0.00014287239,0.00015376114,0.0001715768,0.00033342966,0.0005400243,0.00015104917,0.000029397526,0.0003082637,0.000016033167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03789328,0.0076650972,0.81762224,0.000084686035,0.006965033,0.011927552,0.01592721,0.0000031323846,0.05255718,0.0007411271,0.0010794859,0.047533948],"study_design_scores_gemma":[0.06995341,0.031162014,0.7459551,0.00057746866,0.0004386489,0.0073429793,0.004591507,0.000020343567,0.13803872,0.00051751576,0.0007990408,0.0006032681],"about_ca_topic_score_codex":0.00023661766,"about_ca_topic_score_gemma":0.00001171158,"teacher_disagreement_score":0.08548154,"about_ca_system_score_codex":0.000038516027,"about_ca_system_score_gemma":0.00010959725,"threshold_uncertainty_score":0.62701976},"labels":[],"label_agreement":null},{"id":"W1982548570","doi":"10.1002/ajh.23299","title":"Platelet count or bleeding as the outcome in ITP trials?","year":2012,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"","keywords":"Romiplostim; Medicine; Eltrombopag; Rituximab; Randomized controlled trial; Clinical trial; Surrogate endpoint; Intensive care medicine; Population; Immune thrombocytopenia; Clinical endpoint; Platelet transfusion; Thrombopoietin; Internal medicine; Platelet; Pediatrics","score_opus":0.053693725698102816,"score_gpt":0.354241109787535,"score_spread":0.30054738408943216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982548570","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38678715,0.0025596546,0.000016737786,0.6083013,0.0009996806,0.00041897636,0.00001291041,0.000011810662,0.00089179643],"genre_scores_gemma":[0.48067224,0.00089520414,0.00044288338,0.5150062,0.0019651086,0.000022195109,0.000032865515,0.00009141839,0.00087187754],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966622,0.0004115323,0.0016559134,0.00020131494,0.0004573123,0.00061169866],"domain_scores_gemma":[0.99548465,0.0017069532,0.0022756523,0.0002929954,0.00011851618,0.00012120316],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001227676,0.00037172873,0.0035727744,0.00043762237,0.000053028285,0.000019804149,0.00029219504,0.00035171167,0.0005165795],"category_scores_gemma":[0.00078428094,0.00018133745,0.000446098,0.0002876513,0.0003463174,0.0000790824,0.00004193099,0.0023130577,0.0001059154],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031479313,0.0004851281,0.06988436,0.00026143866,0.0033655737,0.14507622,0.0010758516,0.0000018884559,0.000019581541,0.00012494098,0.75750923,0.01904788],"study_design_scores_gemma":[0.0054083443,0.0022560942,0.0011106518,0.00044285387,0.0011475504,0.1638136,0.0009524024,0.000003657033,0.00006122025,0.00026623157,0.8242295,0.00030791044],"about_ca_topic_score_codex":0.0001734985,"about_ca_topic_score_gemma":0.000013466596,"teacher_disagreement_score":0.09388511,"about_ca_system_score_codex":0.00016102783,"about_ca_system_score_gemma":0.00034606692,"threshold_uncertainty_score":0.9999887},"labels":[],"label_agreement":null},{"id":"W1984359522","doi":"10.1002/ajh.22188","title":"Is HbA<sub>2</sub>level a reliable diagnostic measurement for β‐thalassemia trait in people with iron deficiency?","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Associazione Italiana per la Ricerca sul Cancro; National Natural Science Foundation of China","keywords":"Thalassemia; Medicine; Iron deficiency; Pediatrics; Hemoglobin A2; Beta thalassemia; Internal medicine; Anemia","score_opus":0.0223781394122578,"score_gpt":0.23916650008224782,"score_spread":0.21678836066999002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984359522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936264,0.0012302016,0.0024962686,0.0016570083,0.00011472493,0.00034131666,0.0000042139673,0.000011254569,0.0005185794],"genre_scores_gemma":[0.99565476,0.00040845532,0.0031648278,0.00068551773,0.000020319469,0.000024493615,0.000001258904,0.000031276973,0.000009066211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830914,0.00004976517,0.00062188983,0.00021455137,0.00034834718,0.0004562949],"domain_scores_gemma":[0.9986272,0.0001754243,0.00049474265,0.00018373111,0.000321648,0.0001972822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045082116,0.00019170134,0.0007901959,0.00025796914,0.000052403953,0.0000050885933,0.00013585872,0.00009607404,0.000030652645],"category_scores_gemma":[0.00040261622,0.00013569348,0.00014280569,0.00041215224,0.0002455029,0.00006538479,0.000016069502,0.000347929,0.000007812832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063401465,0.0044469675,0.88251185,0.0011573912,0.00058143976,0.002177313,0.024673734,0.00015527788,0.016587928,0.0013730406,0.013190003,0.046804905],"study_design_scores_gemma":[0.03288847,0.0520071,0.6884118,0.005144058,0.002743809,0.05232434,0.04386247,0.0004541507,0.11505692,0.0022398976,0.0029828243,0.0018841972],"about_ca_topic_score_codex":0.000148873,"about_ca_topic_score_gemma":0.0001401963,"teacher_disagreement_score":0.19410008,"about_ca_system_score_codex":0.00012181138,"about_ca_system_score_gemma":0.00047231273,"threshold_uncertainty_score":0.5533419},"labels":[],"label_agreement":null},{"id":"W1987310638","doi":"10.1002/ajh.23139","title":"New oral anticoagulants: A view from the laboratory","year":2012,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Warfarin; Medicine; Clotting factor; Coagulation; Pharmacology; Intensive care medicine; Atrial fibrillation; Internal medicine","score_opus":0.10860307122521635,"score_gpt":0.4028264263322955,"score_spread":0.29422335510707914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987310638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007228309,0.9965393,0.0003644632,0.0019341963,0.00070374564,0.00026146162,0.000009474628,0.000013115586,0.00010195363],"genre_scores_gemma":[0.0001566123,0.9945101,0.002340548,0.00062391994,0.0021782059,6.201917e-7,0.000015918771,0.000038354203,0.00013572142],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978953,0.00041841017,0.0010239914,0.00013841814,0.00026557944,0.00025830365],"domain_scores_gemma":[0.9967273,0.0007542547,0.0018792284,0.00033758505,0.00009530917,0.00020631569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004177148,0.00027985996,0.0036864441,0.00015643939,0.00004060908,0.00001660617,0.00027824528,0.00010580557,0.00044925968],"category_scores_gemma":[0.00017410758,0.00014498249,0.000675646,0.00045610496,0.00017065386,0.00007324633,0.00006863217,0.00043540928,0.00018070734],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003407231,0.0000063197144,0.003996822,0.0006021977,0.0011202376,0.00009809698,0.00005165679,2.7048296e-8,1.5587305e-7,0.00043579788,0.00752946,0.9861252],"study_design_scores_gemma":[0.000336804,0.00016984929,0.00031745035,0.0027862424,0.005545988,0.0010482414,0.00009337651,1.4330412e-7,4.983171e-7,0.0000338108,0.9895377,0.00012986724],"about_ca_topic_score_codex":0.000047218957,"about_ca_topic_score_gemma":0.0000037161365,"teacher_disagreement_score":0.9859953,"about_ca_system_score_codex":0.000046708003,"about_ca_system_score_gemma":0.00055202795,"threshold_uncertainty_score":0.59122145},"labels":[],"label_agreement":null},{"id":"W1988316234","doi":"10.1002/ajh.23476","title":"Microfluidic analysis of cellular deformability of normal and oxidatively damaged red blood cells","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"Canadian Institutes of Health Research; Health Canada; Centre for Blood Research, University of British Columbia; Michael Smith Health Research BC; University of British Columbia; Government of Canada; Canadian Blood Services; Australian Government","keywords":"Red blood cell; Microfluidics; Chemistry; In vivo; Erythrocyte deformability; Whole blood; Biophysics; Venous blood; Biomedical engineering; Materials science; Biochemistry; Medicine; Biology; Immunology; Internal medicine; Nanotechnology","score_opus":0.007802928624233493,"score_gpt":0.23280573695972823,"score_spread":0.22500280833549474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988316234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773306,0.00089428015,0.00074170047,0.00036354433,0.000062143976,0.000094567666,0.0000053500034,0.0000038952876,0.000101479396],"genre_scores_gemma":[0.99658835,0.0005241246,0.0026492663,0.00018600328,0.00001781174,0.000001401361,0.0000053919803,0.0000073172855,0.000020347677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998525,0.00023131807,0.0008091364,0.00013179384,0.00013261428,0.00017008762],"domain_scores_gemma":[0.99791807,0.00021556363,0.0010730958,0.00021382778,0.00044397678,0.00013547241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027460075,0.0001186629,0.0013019271,0.00045141135,0.000023403018,0.0000017975788,0.00008863808,0.00006322447,0.0003828605],"category_scores_gemma":[0.00010329081,0.00008967174,0.00024986587,0.00057915004,0.0007901413,0.00007414748,0.000034780653,0.00020947176,0.0000030694566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035969762,0.00025515066,0.10696326,0.00007921761,0.001381835,0.000025738724,0.0003950518,0.0000025731351,0.8892723,0.000038383696,0.00040373564,0.0008230688],"study_design_scores_gemma":[0.0018732722,0.0041033495,0.19544144,0.000042470365,0.0029416953,0.00086302083,0.0019449982,0.00006493725,0.792377,0.000069012036,0.00016338256,0.00011543582],"about_ca_topic_score_codex":0.00011843466,"about_ca_topic_score_gemma":0.0000025589652,"teacher_disagreement_score":0.0968953,"about_ca_system_score_codex":0.000010944339,"about_ca_system_score_gemma":0.000088891386,"threshold_uncertainty_score":0.4192054},"labels":[],"label_agreement":null},{"id":"W1988750456","doi":"10.1002/ajh.1149","title":"Gelatinous transformation of bone marrow from a starch‐free diet","year":2001,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hereditary Neurological Disorders","field":"Neuroscience","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Anorexia nervosa; Bone marrow; Wasting; Complication; Atrophy; Medicine; Hypoplasia; Internal medicine; Hematology; Endocrinology; Pathology; Surgery; Gastroenterology; Physiology; Eating disorders","score_opus":0.020442679851243654,"score_gpt":0.2557655206603293,"score_spread":0.23532284080908566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988750456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239737,0.00011445704,0.001607565,0.004183172,0.00015927652,0.00008868672,0.000024578609,0.000017736333,0.0014071461],"genre_scores_gemma":[0.99772805,0.00022216079,0.0008762243,0.0011213984,0.000032556014,0.0000018409909,0.0000011221399,0.000012390555,0.0000042558954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980574,0.00037994017,0.0007738911,0.000168981,0.00033132092,0.0002884665],"domain_scores_gemma":[0.99808306,0.0007719392,0.00071915996,0.00023363599,0.00006482358,0.00012737124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016973169,0.00013310951,0.0006049168,0.00016333898,0.00004333577,0.0000065937566,0.00039958733,0.00004933633,0.00029618343],"category_scores_gemma":[0.0009168369,0.000107311615,0.00014882308,0.00035641438,0.00062218844,0.00021973367,0.000037894184,0.00032489435,0.00001717363],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0222422,0.0030556265,0.079016894,0.00013476229,0.00024376334,0.009901659,0.013760973,0.0011994151,0.7290154,0.014624758,0.004914823,0.12188973],"study_design_scores_gemma":[0.025262047,0.1371574,0.12296815,0.00050749496,0.0006661659,0.06155861,0.014921944,0.0058157537,0.3518023,0.22885859,0.047279347,0.0032022088],"about_ca_topic_score_codex":0.00008810532,"about_ca_topic_score_gemma":0.000026026344,"teacher_disagreement_score":0.37721312,"about_ca_system_score_codex":0.000014595275,"about_ca_system_score_gemma":0.000055138553,"threshold_uncertainty_score":0.43760407},"labels":[],"label_agreement":null},{"id":"W1990760693","doi":"10.1002/ajh.1123","title":"Therapeutic choices for patients with hemophilia and high‐titer inhibitors","year":2001,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Hemostasis; Recombinant factor VIIa; Dosing; PROTHROMBIN COMPLEX; Intensive care medicine; Prothrombin complex concentrate; Factor IX; Coagulation; Thrombosis; Surgery; Pharmacology; Internal medicine; Warfarin","score_opus":0.027118402901943242,"score_gpt":0.34546792371876234,"score_spread":0.3183495208168191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990760693","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012691193,0.985712,0.00002316561,0.0005103473,0.00014271813,0.00083733886,0.00001109767,0.0000082452,0.00006393053],"genre_scores_gemma":[0.0040374557,0.994233,0.0009465205,0.00011231622,0.00026523464,0.00003189478,0.000030439825,0.00006255737,0.0002805599],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832433,0.00011844343,0.00066814123,0.00024181503,0.00029113368,0.00035610312],"domain_scores_gemma":[0.99794644,0.0004687311,0.00087325735,0.00019788835,0.00027922075,0.00023443796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000163922,0.0003313996,0.0027244978,0.00046482292,0.000057985246,0.000015651554,0.00012945209,0.00013802703,0.00003595763],"category_scores_gemma":[0.00005182921,0.00017132337,0.00031658425,0.00035190326,0.0004910764,0.000057007117,0.000027978322,0.00040112704,0.000006689057],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030306866,0.00029354,0.011871196,0.003209631,0.0010706425,0.00018365847,0.000031982523,1.421947e-8,1.1632186e-7,0.00005661001,0.00022124678,0.9827583],"study_design_scores_gemma":[0.002747961,0.008861792,0.00050159445,0.007260748,0.0024492412,0.004761968,0.000042106505,4.731247e-7,0.000002897839,0.00006938103,0.97305995,0.00024185912],"about_ca_topic_score_codex":0.0000068417535,"about_ca_topic_score_gemma":0.0000013131571,"teacher_disagreement_score":0.9825164,"about_ca_system_score_codex":0.000072881594,"about_ca_system_score_gemma":0.00030623705,"threshold_uncertainty_score":0.6986364},"labels":[],"label_agreement":null},{"id":"W1991802905","doi":"10.1002/ajh.23169","title":"Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: Proceedings from the 6th international post‐ASH symposium","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Incyte; National Cancer Institute; National Heart, Lung, and Blood Institute; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Disease; Internal medicine","score_opus":0.01614833568897234,"score_gpt":0.2788131011693511,"score_spread":0.26266476548037876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991802905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95844424,0.001541968,0.00024052225,0.03915202,0.00012943771,0.00043132144,0.000017008062,0.0000059314366,0.0000375492],"genre_scores_gemma":[0.9960512,0.00053203205,0.0004273193,0.0027974364,0.00013849793,0.000024054936,0.0000018792524,0.000021505679,0.0000060798134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869794,0.00023375035,0.00037473868,0.00018134479,0.0002765048,0.00023573957],"domain_scores_gemma":[0.9966524,0.0023170805,0.00044796037,0.00012275935,0.00019982929,0.0002599477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059141865,0.0002196943,0.0005405368,0.00011110356,0.00015009564,0.00003480709,0.00012583088,0.00003447395,0.0000150094975],"category_scores_gemma":[0.00030479644,0.00010423632,0.00008803424,0.00013990678,0.00045430116,0.00007608294,0.000053659736,0.0002344765,0.0000013959473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016347822,0.00029486613,0.95377225,0.000017232049,0.0011197479,0.00004647325,0.016564757,0.000015281386,0.005959606,0.0024395315,0.00024408232,0.0031783434],"study_design_scores_gemma":[0.003991337,0.010805515,0.948925,0.0007177731,0.0004918849,0.0018458015,0.016691802,0.00014097513,0.015095374,0.0006008087,0.00045713678,0.00023656392],"about_ca_topic_score_codex":0.000023258428,"about_ca_topic_score_gemma":0.0000035927935,"teacher_disagreement_score":0.03760695,"about_ca_system_score_codex":0.00009715307,"about_ca_system_score_gemma":0.00013365161,"threshold_uncertainty_score":0.42506337},"labels":[],"label_agreement":null},{"id":"W1992703709","doi":"10.1002/ajh.21970","title":"Concurrent chronic lymphocytic leukemia and prolymphocytic leukemia derived from two separate B‐cell clones","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Prolymphocytic leukemia; CD5; Chronic lymphocytic leukemia; Biology; Population; Immunophenotyping; Molecular biology; Chlorambucil; Gene rearrangement; CD23; Lymphocytosis; Pathology; Leukemia; Flow cytometry; Immunology; Medicine; Antibody; Gene; Chemotherapy; Genetics","score_opus":0.009449893434788895,"score_gpt":0.2977117687352977,"score_spread":0.2882618753005088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992703709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99283,0.00487356,0.00044154725,0.00027322318,0.0007350361,0.00039022366,0.00000947274,0.00005103308,0.00039591294],"genre_scores_gemma":[0.9962218,0.00085808284,0.001604749,0.00040336602,0.00067228044,0.000017368615,0.0000120827235,0.00007906548,0.00013123154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964591,0.0002242489,0.0011807722,0.000557345,0.0006687054,0.0009097815],"domain_scores_gemma":[0.99624157,0.00084455573,0.0010501815,0.0006397219,0.00041911448,0.0008048305],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049697794,0.00046588902,0.0017164556,0.00037691987,0.00013027742,0.000054748318,0.00045306032,0.0001916097,0.00027519692],"category_scores_gemma":[0.00031559597,0.0003770748,0.00027725656,0.00042315345,0.001969104,0.00018472559,0.00020721939,0.0010676609,0.00013124652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.006657748,0.00037190868,0.022405243,0.0016108273,0.0030532985,0.02081637,0.004399297,0.001539215,0.7242281,0.0029349192,0.0049597058,0.20702337],"study_design_scores_gemma":[0.19144703,0.011143997,0.005954985,0.0013355499,0.0022212465,0.19303335,0.002335666,0.15543741,0.42077464,0.0013397132,0.012875196,0.0021012041],"about_ca_topic_score_codex":0.002423134,"about_ca_topic_score_gemma":0.00021357775,"teacher_disagreement_score":0.30345345,"about_ca_system_score_codex":0.03725262,"about_ca_system_score_gemma":0.06939223,"threshold_uncertainty_score":0.9998681},"labels":[],"label_agreement":null},{"id":"W1993165009","doi":"10.1002/ajh.22115","title":"Cyclophosphamide and prednisone induction followed by cyclophosphamide mobilization effectively decreases the incidence of engraftment syndrome in patients with POEMS syndrome who undergo stem cell transplantation","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health; National Cancer Institute; Children's Cancer Research Fund","keywords":"Medicine; Cyclophosphamide; Autologous stem-cell transplantation; Internal medicine; Prednisone; Gastroenterology; Melphalan; Transplantation; POEMS syndrome; Rash; Chemotherapy; Polyneuropathy","score_opus":0.006099188971106451,"score_gpt":0.2084050559448589,"score_spread":0.20230586697375244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993165009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788296,0.00087540894,0.0006489322,0.00007936679,0.00006507219,0.00041215357,0.0000046910377,0.0000075684998,0.000023841205],"genre_scores_gemma":[0.99898463,0.00061689253,0.0002299329,0.00012420533,0.0000020911812,0.000013614645,0.0000049471996,0.000017946331,0.0000057538386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998702,0.00019411911,0.0004953768,0.00017840954,0.00024955423,0.00018054857],"domain_scores_gemma":[0.99887156,0.00014535696,0.0006465125,0.00012368006,0.00010904801,0.00010383104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016476528,0.00016500578,0.00056802464,0.00012767994,0.00004488645,0.0000048738207,0.000084403924,0.000048570277,0.0000079389465],"category_scores_gemma":[0.000031619697,0.00010940723,0.000053810214,0.00032557876,0.00031509105,0.00016388115,0.000012697968,0.00017846386,3.4794093e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033396927,0.0006272206,0.9916123,0.00016013505,0.000075669,0.0003184295,0.0018227091,0.0000470503,0.00043244488,0.000040768915,0.000024717152,0.0014988716],"study_design_scores_gemma":[0.0032579296,0.007866579,0.98146796,0.00031849922,0.0001537416,0.002166763,0.0012184584,0.0000098040355,0.0033432585,0.00008212335,0.0000040768514,0.000110822286],"about_ca_topic_score_codex":0.00036808662,"about_ca_topic_score_gemma":0.000054178523,"teacher_disagreement_score":0.010144347,"about_ca_system_score_codex":0.00004835792,"about_ca_system_score_gemma":0.0000841987,"threshold_uncertainty_score":0.44614974},"labels":[],"label_agreement":null},{"id":"W1993863211","doi":"10.1002/ajh.21810","title":"Unexpectedly low pulse oximetry measurements associated with variant hemoglobins: A systematic review","year":2010,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Hemoglobin; Pulse oximetry; Hemoglobin variants; Asymptomatic; Medicine; Hemoglobinopathy; Hypoxemia; Hemoglobin A2; Hemoglobin s; Gastroenterology; Internal medicine; Anesthesia; Hemolytic anemia; Sickle cell anemia","score_opus":0.01412093847816723,"score_gpt":0.2785655720174043,"score_spread":0.26444463353923703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993863211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001592754,0.99783593,0.00046386488,0.000037166243,0.00041770394,0.00085078593,0.000026869231,0.000011377163,0.00019700924],"genre_scores_gemma":[0.0010772602,0.99722886,0.00056981685,0.00055979786,0.0002011736,0.000056918514,0.00016529924,0.00009310994,0.00004775925],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9958544,0.000957887,0.0018060624,0.00044955348,0.0004802551,0.00045189058],"domain_scores_gemma":[0.99379295,0.00011049156,0.004514641,0.0007247465,0.00062695175,0.0002302253],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00094889686,0.000628124,0.004915939,0.00022602761,0.00007291434,0.000026922644,0.0006388988,0.00047152612,0.000032627206],"category_scores_gemma":[0.0014743005,0.00040086228,0.00078808866,0.0006361384,0.00027989765,0.000008788421,0.00007612102,0.00083587517,0.000014918909],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018707899,0.0006156527,0.00007576883,0.83517337,0.011511293,0.0011790798,0.0000445487,0.0000013721117,0.00041216533,0.00006028575,0.004593648,0.14614573],"study_design_scores_gemma":[0.001188657,0.003968269,0.0000058256524,0.75275844,0.017270172,0.052525926,0.00008010699,0.0000010959718,0.00026332404,0.000019069175,0.17042992,0.0014891856],"about_ca_topic_score_codex":0.000005211635,"about_ca_topic_score_gemma":0.000011368409,"teacher_disagreement_score":0.16583627,"about_ca_system_score_codex":0.000093502786,"about_ca_system_score_gemma":0.00071355,"threshold_uncertainty_score":0.9998443},"labels":[],"label_agreement":null},{"id":"W1994288316","doi":"10.1002/ajh.10366","title":"Thrombotic thrombocytopenic purpura associated with a prolactin‐producing pituitary adenoma","year":2003,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Thrombotic thrombocytopenic purpura; Galactorrhea; Pituitary adenoma; Autopsy; Prolactin; Von Willebrand factor; Schistocyte; Internal medicine; Pituitary gland; Pathology; Adenoma; Pituitary tumors; Platelet","score_opus":0.012392505174086117,"score_gpt":0.25812190846937455,"score_spread":0.24572940329528845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994288316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481773,0.0015476949,0.00019846852,0.0010612991,0.00010506876,0.00021945205,0.00000174261,0.000021262636,0.0020272648],"genre_scores_gemma":[0.9975622,0.000064898086,0.0017775377,0.00046719366,0.000026601574,0.0000042718398,0.0000054651346,0.00003049106,0.000061328916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985257,0.00015765117,0.00045462584,0.00022568973,0.0002591723,0.00037718215],"domain_scores_gemma":[0.99863267,0.00012972105,0.0006153638,0.00024331018,0.00018147693,0.00019743701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002273217,0.0002094383,0.0010510461,0.000164023,0.000092438124,0.000010875345,0.0001030456,0.000050185787,0.00013926133],"category_scores_gemma":[0.00029156654,0.00013645386,0.00013896875,0.00035120922,0.00027256887,0.00013918207,0.000013438973,0.00030681002,0.00001650085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014518965,0.0018949452,0.98203367,0.000047589278,0.0025635082,0.004647663,0.0011606704,0.000017463864,0.00037701055,0.00079599174,0.0009829999,0.0040266137],"study_design_scores_gemma":[0.01578042,0.023835076,0.8515691,0.0007711759,0.0021815111,0.09443252,0.0057652015,0.000023216013,0.0025141258,0.0017484645,0.0007436704,0.00063550635],"about_ca_topic_score_codex":0.000027444428,"about_ca_topic_score_gemma":0.00001965133,"teacher_disagreement_score":0.13046452,"about_ca_system_score_codex":0.00009033335,"about_ca_system_score_gemma":0.0003301746,"threshold_uncertainty_score":0.5564427},"labels":[],"label_agreement":null},{"id":"W1994523135","doi":"10.1002/ajh.20250","title":"Helicobacter pylori eradication: Novel therapy for immune thrombocytopenic purpura? A review of the literature","year":2005,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Helicobacter pylori; Thrombocytopenic purpura; Medicine; Immunology; Immune system; Pathogenesis; Platelet; Population; Gastroenterology; Internal medicine","score_opus":0.032831262567224344,"score_gpt":0.3459523162898362,"score_spread":0.31312105372261184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994523135","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028547813,0.98422736,0.00010056564,0.012840533,0.000637593,0.0017878764,0.00006657635,0.000013093183,0.000040953328],"genre_scores_gemma":[0.00014424685,0.99341494,0.0019794833,0.0035914232,0.0005098797,0.00014091145,0.000043624506,0.000088460314,0.00008705356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954413,0.000438394,0.0028579126,0.00038689692,0.00036684124,0.0005086503],"domain_scores_gemma":[0.9917713,0.00047693445,0.0055280915,0.0009502243,0.0011193942,0.00015406794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076826126,0.0006402201,0.0069852853,0.00034093607,0.0000910603,0.000012419523,0.0008590565,0.0003122522,0.000059222028],"category_scores_gemma":[0.00051610917,0.0003478476,0.0022033784,0.0009930629,0.0008918604,0.00010462095,0.000127631,0.0014719332,0.000009492251],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033376928,0.00051700685,0.00023179314,0.033831436,0.007110677,0.000042119947,0.00034226757,7.042603e-8,0.000026065138,0.0001771302,0.0048679337,0.9525197],"study_design_scores_gemma":[0.0013848286,0.0017448887,0.00023627098,0.12824793,0.002978464,0.021530516,0.0000303428,1.5829261e-7,0.000013267717,0.0000062866075,0.8436446,0.00018246032],"about_ca_topic_score_codex":0.0000023602402,"about_ca_topic_score_gemma":0.000001158171,"teacher_disagreement_score":0.95233727,"about_ca_system_score_codex":0.00017318207,"about_ca_system_score_gemma":0.00075904076,"threshold_uncertainty_score":0.99989736},"labels":[],"label_agreement":null},{"id":"W1995133375","doi":"10.1002/ajh.10453","title":"Mcl‐1 and Bcl‐2/Bax ratio are associated with treatment response but not with Rai stage in B‐cell chronic lymphocytic leukemia","year":2003,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Saskatchewan; Royal University Hospital","funders":"Saskatchewan Health Research Foundation","keywords":"Chronic lymphocytic leukemia; Chlorambucil; Prednisone; Internal medicine; Medicine; Stage (stratigraphy); Gastroenterology; Apoptosis; Complete response; Bcl-2-associated X protein; Blot; Leukemia; Immunology; Chemotherapy; Chemistry; Biology; Caspase 3; Programmed cell death; Cyclophosphamide; Gene; Biochemistry","score_opus":0.013810373300852078,"score_gpt":0.2753354294564033,"score_spread":0.26152505615555127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995133375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756205,0.0011269421,0.0002069463,0.00039090906,0.00003399084,0.00037881854,0.000006706026,0.000018731733,0.00027492575],"genre_scores_gemma":[0.9973484,0.00028197985,0.00058161776,0.0002861466,0.000029153443,0.000021007478,0.0000029523865,0.00005598083,0.0013927331],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99705845,0.0007241387,0.0006562791,0.00035527337,0.0005246993,0.0006811367],"domain_scores_gemma":[0.9970493,0.001135851,0.0008147338,0.00037346827,0.00025721276,0.0003694593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077855866,0.0003286163,0.0013443598,0.0004451696,0.00007370924,0.000023603154,0.00013275376,0.00010793945,0.00007594518],"category_scores_gemma":[0.00053972926,0.00021609305,0.00008541532,0.0005904644,0.00088716863,0.000106187166,0.000024666695,0.00037381548,0.000009912769],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.30862215,0.0042877207,0.3306429,0.0018664442,0.008523378,0.2401541,0.01650408,0.016940309,0.054558758,0.0033174814,0.0022255983,0.012357038],"study_design_scores_gemma":[0.4249922,0.11336841,0.04105117,0.0039381078,0.0015293333,0.17209375,0.023308335,0.012949973,0.19944644,0.00008409156,0.0052931136,0.0019450719],"about_ca_topic_score_codex":0.0007112196,"about_ca_topic_score_gemma":0.0005767783,"teacher_disagreement_score":0.28959173,"about_ca_system_score_codex":0.064255476,"about_ca_system_score_gemma":0.04700783,"threshold_uncertainty_score":0.95839477},"labels":[],"label_agreement":null},{"id":"W1995158011","doi":"10.1002/ajh.10109","title":"Cytogenetic findings in reactive lymphoid hyperplasia: Significance of non‐clonal t(3;14) and t(3;22)","year":2002,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Lymphoid hyperplasia; clone (Java method); Chromosomal translocation; Pathology; Karyotype; Cytogenetics; Population; Immunology; Biology; Medicine; Chromosome; Genetics","score_opus":0.010786895183906534,"score_gpt":0.25618099078977613,"score_spread":0.2453940956058696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995158011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961496,0.0016805094,0.000018211987,0.0011989257,0.000057617533,0.0001249007,0.000003872819,0.0000029419664,0.00076340564],"genre_scores_gemma":[0.9970411,0.00073973584,0.0019145905,0.00022494263,0.000031098767,0.00000855838,6.8305644e-7,0.000012635358,0.000026634276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988373,0.000057965968,0.0005257593,0.00016668001,0.00019140966,0.00022087469],"domain_scores_gemma":[0.9988992,0.00028920945,0.00042953625,0.0001323461,0.000109419285,0.00014026782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118034666,0.00014415107,0.00089905574,0.00024396564,0.000020545129,0.0000038875864,0.000076694494,0.0000510777,0.00008806503],"category_scores_gemma":[0.00009308299,0.00011248292,0.000100214456,0.00023934233,0.00040013186,0.000048675764,0.00002123516,0.00011840403,0.000007379379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035241127,0.00075843604,0.9724825,0.00003834066,0.0002042773,0.0013188368,0.00070143817,0.000004528406,0.0059252833,0.00016357651,0.0005207625,0.017529577],"study_design_scores_gemma":[0.0114133265,0.00840699,0.81328183,0.00058429583,0.00043354338,0.07903896,0.002080167,0.00023816821,0.082940504,0.00018545843,0.0010976725,0.00029910594],"about_ca_topic_score_codex":0.00008039219,"about_ca_topic_score_gemma":0.0000071970185,"teacher_disagreement_score":0.15920073,"about_ca_system_score_codex":0.000116115574,"about_ca_system_score_gemma":0.00009193778,"threshold_uncertainty_score":0.45869204},"labels":[],"label_agreement":null},{"id":"W1995362916","doi":"10.1002/ajh.10044","title":"CD5‐negative phenotype of monoclonal B‐lymphocytosis of undetermined significance (MLUS)","year":2002,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Lymphocytosis; Immunophenotyping; CD5; Chronic lymphocytic leukemia; Monoclonal; Phenotype; Immunology; Pathology; Medicine; Leukemia; Monoclonal antibody; Biology; Lymphoma; Flow cytometry; Antibody; Genetics","score_opus":0.02587918797391073,"score_gpt":0.2973255777432644,"score_spread":0.27144638976935365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995362916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954764,0.0009778668,0.00075364555,0.00067658647,0.00009937307,0.00017394882,0.000008079323,0.000008158467,0.0018259268],"genre_scores_gemma":[0.99394387,0.00028339578,0.0053916164,0.00015446293,0.0000738206,0.0000040794575,7.972117e-7,0.00002669219,0.00012126541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976127,0.00017851325,0.0010535156,0.0001971837,0.0005883649,0.00036973474],"domain_scores_gemma":[0.9965771,0.00091420684,0.001332892,0.00035161793,0.0005991322,0.0002250583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030983856,0.00018177548,0.0013736631,0.0003405768,0.000026502714,0.0000032499838,0.0003076377,0.00007722332,0.00053094415],"category_scores_gemma":[0.0006244657,0.0001466164,0.00026199134,0.00058269664,0.0014301975,0.000075653676,0.00006247621,0.00027108478,0.000019594083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044034723,0.011312016,0.08165597,0.00541533,0.013764088,0.014243451,0.028520519,0.0011271347,0.37529096,0.027645132,0.028200565,0.3687901],"study_design_scores_gemma":[0.06821139,0.028813612,0.006730995,0.0019273272,0.0013291698,0.04062885,0.0074105235,0.024654984,0.8145429,0.0032841382,0.0014871277,0.0009789887],"about_ca_topic_score_codex":0.00038806573,"about_ca_topic_score_gemma":0.000009410373,"teacher_disagreement_score":0.43925193,"about_ca_system_score_codex":0.0016777085,"about_ca_system_score_gemma":0.0023932667,"threshold_uncertainty_score":0.5978843},"labels":[],"label_agreement":null},{"id":"W1995635002","doi":"10.1002/ajh.23210","title":"Controversies in heparin monitoring","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Heparin; Medicine; Intensive care medicine; Internal medicine","score_opus":0.013570675991604159,"score_gpt":0.29891386127132147,"score_spread":0.2853431852797173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995635002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409145,0.0015043799,0.00007627315,0.0023508272,0.00037744598,0.0000629499,1.4552684e-7,0.0000041926714,0.0015323191],"genre_scores_gemma":[0.99742687,0.00033004995,0.0014117972,0.00060310256,0.00019970452,0.0000023967511,1.2403015e-7,0.000008107719,0.00001782603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921846,0.000043451,0.00030597087,0.00005151994,0.000119604876,0.00026096177],"domain_scores_gemma":[0.9992962,0.00019889367,0.00025034748,0.000089184556,0.000045061774,0.00012033895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002497324,0.00007091855,0.0006337649,0.00018172429,0.000014686006,0.0000032692417,0.00006057112,0.000019894791,0.000037417132],"category_scores_gemma":[0.00016810239,0.000057319365,0.000076142256,0.00012567273,0.00009926561,0.00006485512,0.000025072693,0.00014517656,0.000014091028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100431724,0.00043675827,0.98188215,0.000022285249,0.00013275167,0.00015235189,0.00079573423,0.0000044841236,0.00031727267,0.0028022735,0.0020585426,0.011294949],"study_design_scores_gemma":[0.0018121611,0.0012726403,0.9647584,0.00019912567,0.00018032386,0.002388875,0.00644859,0.0000052081423,0.0030324128,0.00010592743,0.019674765,0.00012156947],"about_ca_topic_score_codex":0.00007188146,"about_ca_topic_score_gemma":0.0000029454964,"teacher_disagreement_score":0.017616224,"about_ca_system_score_codex":0.000057801626,"about_ca_system_score_gemma":0.000030028694,"threshold_uncertainty_score":0.23374158},"labels":[],"label_agreement":null},{"id":"W1997569947","doi":"10.1002/ajh.20882","title":"Inv (11)(p15q21) in donor‐derived Ph‐negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stemcell transplantation","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Imatinib mesylate; Medicine; Myeloid leukemia; Transplantation; Philadelphia chromosome; Hematopoietic stem cell transplantation; Internal medicine; Imatinib; Stem cell; Dysplasia; Oncology; Gastroenterology; Immunology; Chromosomal translocation; Biology","score_opus":0.005524933062993245,"score_gpt":0.2350075105700737,"score_spread":0.22948257750708045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997569947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980744,0.00037442974,0.00016494945,0.00025555328,0.00005316081,0.0008306075,0.000011954843,0.000017790631,0.00021716679],"genre_scores_gemma":[0.9969107,0.00036672427,0.0023461937,0.00020903564,0.000023268702,0.000030092737,0.000031076826,0.00006136198,0.000021554606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657184,0.0003270621,0.0014659122,0.00045032214,0.00042463865,0.0007602395],"domain_scores_gemma":[0.9974994,0.00046516446,0.0012699615,0.0002871562,0.00023108925,0.0002472044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044566143,0.00045197274,0.0015138394,0.001114732,0.00003501553,0.00001167354,0.00018885102,0.00014611635,0.000051340525],"category_scores_gemma":[0.000040938397,0.0003274487,0.00009807461,0.0011979955,0.00046554607,0.00021791298,0.000020574404,0.00072834536,0.000008648023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028981078,0.0010563503,0.8149564,0.00045984605,0.0005579805,0.06454349,0.017021907,0.0050332663,0.055682186,0.000040839815,0.000016409896,0.011650232],"study_design_scores_gemma":[0.07341983,0.032422878,0.4572143,0.00487656,0.0006031253,0.046920896,0.011912608,0.00068798714,0.37069333,0.000037794245,0.000084789004,0.0011259025],"about_ca_topic_score_codex":0.0055237343,"about_ca_topic_score_gemma":0.030618064,"teacher_disagreement_score":0.35774213,"about_ca_system_score_codex":0.0045936573,"about_ca_system_score_gemma":0.002243234,"threshold_uncertainty_score":0.99991775},"labels":[],"label_agreement":null},{"id":"W1998550373","doi":"10.1002/ajh.22094","title":"Published guidelines versus real‐life practice in the diagnosis and treatment of essential thrombocythemia","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Essential thrombocythemia; Medicine; Thrombocytosis; Myeloproliferative neoplasm; Bone marrow; Internal medicine; Hydroxycarbamide; Thrombosis; Biopsy; Hematologist; Gene mutation; Anagrelide; Oncology; Surgery; Myelofibrosis; Polycythemia vera; Mutation; Chemotherapy; Platelet; Disease; Gene","score_opus":0.07414932893291384,"score_gpt":0.37263746025234146,"score_spread":0.29848813131942764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998550373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847198,0.0018524338,0.000018714367,0.01108991,0.00013949689,0.00023524562,0.0000030723902,0.000004083947,0.0019372515],"genre_scores_gemma":[0.983691,0.010649731,0.0050130114,0.0004947607,0.00009092857,0.000043626183,0.0000021658445,0.000011363992,0.0000034646398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984505,0.00023732644,0.0007371973,0.00016083727,0.00022849474,0.00018562737],"domain_scores_gemma":[0.99710685,0.0013198825,0.0008292469,0.00022138857,0.000400491,0.00012212257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033073343,0.0001635494,0.00087378145,0.00015944506,0.00003316772,0.000010103894,0.000098971286,0.00004580572,0.00011337752],"category_scores_gemma":[0.0012389171,0.00008943531,0.00012146422,0.0002199278,0.00033944703,0.00014146781,0.000017910359,0.00011383995,0.0000022105155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008267216,0.006122585,0.90824425,0.000044001474,0.002290455,0.002211121,0.017770385,0.0000025060426,0.00011483106,0.0092825955,0.0042251097,0.04142494],"study_design_scores_gemma":[0.04851639,0.097613536,0.68622905,0.00070267596,0.006081528,0.023806816,0.078805566,0.0000564711,0.039652765,0.0009450887,0.016823294,0.0007668458],"about_ca_topic_score_codex":0.0008577395,"about_ca_topic_score_gemma":0.00010536173,"teacher_disagreement_score":0.22201522,"about_ca_system_score_codex":0.000051767955,"about_ca_system_score_gemma":0.00021858329,"threshold_uncertainty_score":0.36470658},"labels":[],"label_agreement":null},{"id":"W2000138691","doi":"10.1002/ajh.23506","title":"Pregnancy outcomes in women with thalassemia in North America and the United Kingdom","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Toronto General Hospital","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Heart, Lung, and Blood Institute; National Institutes of Health; Translational Cancer Research Network; New England Research Institutes; University Health Network; Harvard Catalyst","keywords":"Medicine; Pregnancy; Thalassemia; Obstetrics; Childbirth; Infertility; Pediatrics; Advanced maternal age; Blood transfusion; Fetus; Internal medicine","score_opus":0.006265726617148967,"score_gpt":0.23683291516407767,"score_spread":0.2305671885469287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000138691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99091625,0.0005055801,0.000031947944,0.00813157,0.00002706077,0.00022123751,3.1617614e-7,0.0000053578315,0.0001606584],"genre_scores_gemma":[0.997918,0.0004342948,0.00034092387,0.0012581093,0.000004625194,0.000013537957,5.790284e-7,0.000012582476,0.000017313758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888235,0.00014501975,0.00043817845,0.000106162515,0.00013194497,0.00029631797],"domain_scores_gemma":[0.9990476,0.00026288303,0.00036790664,0.00013564178,0.000075551594,0.0001104178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009398868,0.00012671661,0.0007879257,0.00032721876,0.00002366256,0.000008495419,0.00009812038,0.000039895967,0.00003539356],"category_scores_gemma":[0.000118399854,0.00006108765,0.000036067977,0.0007122843,0.00081193144,0.00006657555,0.000024918503,0.00045661855,0.000004645526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059215,0.00014015808,0.9804969,0.000024316887,0.00012677058,0.0003959045,0.0042481045,0.000045842033,0.000011065254,0.00014737605,0.00005661506,0.0137147885],"study_design_scores_gemma":[0.0101217935,0.002009983,0.96133965,0.0005061226,0.00005580909,0.0029267007,0.02184723,0.00019631664,0.000008269365,0.00018799659,0.0006455593,0.00015454224],"about_ca_topic_score_codex":0.00087187125,"about_ca_topic_score_gemma":0.000084971034,"teacher_disagreement_score":0.01915723,"about_ca_system_score_codex":0.000047229456,"about_ca_system_score_gemma":0.00009534056,"threshold_uncertainty_score":0.29915953},"labels":[],"label_agreement":null},{"id":"W2001481776","doi":"10.1002/ajh.21768","title":"Phosphatidylserine exposure and other apoptotic‐like events in Bernard‐Soulier syndrome platelets","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; Institut National de la Santé et de la Recherche Médicale; Heart and Stroke Foundation of Canada","keywords":"Platelet; Phosphatidylserine; Annexin; Platelet activation; Annexin A5; Thrombin; Chemistry; Flow cytometry; Apoptosis; Cell biology; Immunology; Biophysics; Molecular biology; Biochemistry; Biology; Membrane","score_opus":0.005256162202560619,"score_gpt":0.23025639797588737,"score_spread":0.22500023577332676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001481776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968268,0.0017725494,0.00004110269,0.00046456076,0.0007171848,0.000082311395,0.0000030118313,0.000008239263,0.000084188265],"genre_scores_gemma":[0.9991876,0.000083542196,0.0003341746,0.00024007494,0.0000153953,0.000003122609,0.0000029248804,0.000018166722,0.00011499227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987971,0.00014929408,0.00056286436,0.00015938331,0.000043959015,0.0002874045],"domain_scores_gemma":[0.9990677,0.00011964162,0.00054636516,0.0001715806,0.000056251378,0.000038441485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030615405,0.00015984675,0.0006463875,0.00019930003,0.000050736704,0.000004267301,0.000184587,0.00014221002,0.00028443246],"category_scores_gemma":[0.000055010445,0.00013056054,0.00007917079,0.00014473483,0.00036736365,0.00011766451,0.00005029731,0.0005094551,0.00004006696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074796757,0.00046856795,0.6438603,0.000030451673,0.0005108087,0.00020410612,0.0010900536,0.000012138888,0.32318065,0.0021161053,0.000424924,0.027353985],"study_design_scores_gemma":[0.006569206,0.003069948,0.80699503,0.00017280751,0.00010803048,0.08036758,0.00088854675,0.000011728077,0.07013275,0.0010003182,0.030127276,0.0005567921],"about_ca_topic_score_codex":0.00006398507,"about_ca_topic_score_gemma":0.0000331314,"teacher_disagreement_score":0.25304788,"about_ca_system_score_codex":0.000015026447,"about_ca_system_score_gemma":0.000043462198,"threshold_uncertainty_score":0.53241044},"labels":[],"label_agreement":null},{"id":"W2004178456","doi":"10.1002/ajh.20034","title":"Prompt response to rituximab of severe hemolytic anemia with both cold and warm autoantibodies","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Rituximab; Medicine; Hemolysis; Cold Agglutinin; Autoimmune hemolytic anemia; Prednisone; Hemolytic anemia; Hemoglobin; Cyclophosphamide; Haptoglobin; Autoantibody; Gastroenterology; Anemia; Immunology; Antibody; Internal medicine; Chemotherapy","score_opus":0.004869729385145392,"score_gpt":0.24358144924755717,"score_spread":0.23871171986241177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004178456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99072045,0.00047078778,0.00040514127,0.008132995,0.000030494057,0.00016335183,0.0000026237403,0.000009147576,0.000064984626],"genre_scores_gemma":[0.9882595,0.000060611084,0.010965991,0.00065008044,0.00001965917,0.0000016450768,3.5223846e-7,0.0000160737,0.000026096726],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9990579,0.000054592678,0.00036437163,0.00013388282,0.00019481471,0.00019443361],"domain_scores_gemma":[0.9991532,0.000111901034,0.0002680254,0.00014054305,0.00014211056,0.00018422355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022623964,0.00012509579,0.0007855798,0.0001992651,0.000035367182,0.0000041766866,0.000067099834,0.000038248247,0.000012157173],"category_scores_gemma":[0.000056717632,0.00008504007,0.00005666395,0.00023318213,0.00035784618,0.00005826773,0.00001757437,0.00020038676,0.000002227571],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13048549,0.0059999167,0.2977665,0.0020407557,0.0019254708,0.017011441,0.019307574,0.0003176723,0.49265945,0.008256801,0.0010422785,0.023186635],"study_design_scores_gemma":[0.059934657,0.100575626,0.19659261,0.0052862465,0.0017084634,0.35211614,0.011963437,0.0000203421,0.26578495,0.0010237853,0.0039903144,0.0010034308],"about_ca_topic_score_codex":0.000060352802,"about_ca_topic_score_gemma":0.00001294489,"teacher_disagreement_score":0.3351047,"about_ca_system_score_codex":0.000027930975,"about_ca_system_score_gemma":0.0002627527,"threshold_uncertainty_score":0.34678334},"labels":[],"label_agreement":null},{"id":"W2007715200","doi":"10.1002/ajh.10327","title":"Health status and health‐related quality of life associated with von Willebrand disease","year":2003,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Regional Municipality of Niagara; Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Medicine; Health Utilities Index; Quality of life (healthcare); Von Willebrand disease; Disease; Population; Cohort; Cross-sectional study; Cohort study; Pediatrics; Health related quality of life; Immunology; Von Willebrand factor; Environmental health; Internal medicine; Pathology","score_opus":0.019486218808333317,"score_gpt":0.31730413778056066,"score_spread":0.2978179189722273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007715200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851921,0.008246539,0.000047813577,0.0062280265,0.000033426357,0.00014697619,0.000011616534,0.000007128729,0.00008634879],"genre_scores_gemma":[0.9976649,0.0008323921,0.00037104046,0.0010881001,0.0000028914794,0.0000011751483,0.000009652334,0.000013427072,0.00001637325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820566,0.00036833299,0.000785212,0.00012660315,0.00020363608,0.00031053022],"domain_scores_gemma":[0.99736315,0.00014797077,0.0015882549,0.000113868366,0.00012174668,0.00066498463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047541584,0.00012608965,0.0014201925,0.00012163187,0.000053549615,0.0000029706403,0.000029751332,0.000027696944,0.000021505186],"category_scores_gemma":[0.0003665486,0.00008765906,0.00007095678,0.00023266606,0.00030891973,0.000042823325,0.000005942039,0.0001717829,7.0062623e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010070403,0.0005974409,0.9931752,0.000089634705,0.0006091959,0.00019762784,0.00043503632,0.000003589124,0.0000033136741,0.00086248264,0.00024463588,0.0027747848],"study_design_scores_gemma":[0.009815106,0.006106348,0.98022026,0.0003401377,0.000119140204,0.0012288066,0.0012259325,0.0000081243315,0.000015810981,0.0006257555,0.00017121767,0.00012336577],"about_ca_topic_score_codex":0.00033725338,"about_ca_topic_score_gemma":0.00006812343,"teacher_disagreement_score":0.012954963,"about_ca_system_score_codex":0.00007041349,"about_ca_system_score_gemma":0.0010710633,"threshold_uncertainty_score":0.35746324},"labels":[],"label_agreement":null},{"id":"W2012542492","doi":"10.1002/ajh.10220","title":"Tumor lysis syndrome induced by hydroxyurea therapy for leukemic transformation of polycythemia vera","year":2002,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Queen (butterfly); Tumor lysis syndrome; Medicine; Citation; Polycythemia vera; Classics; Family medicine; History; Library science; Internal medicine; Biology; Computer science; Chemotherapy","score_opus":0.01617246754057505,"score_gpt":0.26341960910665413,"score_spread":0.24724714156607908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012542492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8956712,0.0013535667,0.00069119566,0.10105855,0.00028708795,0.00058927364,0.00007079162,0.00002257302,0.00025579825],"genre_scores_gemma":[0.9356741,0.00038662253,0.0015614532,0.061472975,0.0003533335,0.00003857601,0.0001428626,0.000119584605,0.00025049117],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99633706,0.000223458,0.0018979388,0.0003270616,0.0006492383,0.0005652192],"domain_scores_gemma":[0.99545676,0.00050173176,0.0030187839,0.00049606164,0.00035438262,0.00017228356],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003525273,0.00051834795,0.0035076062,0.0008441855,0.000053441287,0.000011233473,0.00043347015,0.0004056462,0.00033319005],"category_scores_gemma":[0.00011477917,0.0004071977,0.0010584013,0.00051838387,0.00035711934,0.00011724758,0.00001396236,0.0015729048,0.0000144846335],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029203936,0.0007867255,0.0012093688,0.0022909322,0.0075626955,0.00615619,0.0020099524,0.000005076902,0.06870342,0.00008940439,0.8821801,0.02608575],"study_design_scores_gemma":[0.029626345,0.0515283,0.00091526535,0.00322745,0.0068443194,0.50862455,0.0012471052,0.00032330552,0.09129141,0.0013749638,0.30231276,0.0026842095],"about_ca_topic_score_codex":0.000042051473,"about_ca_topic_score_gemma":2.443363e-7,"teacher_disagreement_score":0.57986736,"about_ca_system_score_codex":0.00020554084,"about_ca_system_score_gemma":0.00034029302,"threshold_uncertainty_score":0.999838},"labels":[],"label_agreement":null},{"id":"W2014034847","doi":"10.1002/ajh.20263","title":"A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: Is it safe and useful?","year":2005,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; McMaster University; London Health Sciences Centre; Alberta Hospital Edmonton; Dalhousie University; University of Toronto; University Health Network; University of Alberta Hospital; University of Calgary; Western University; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Liver biopsy; Cirrhosis; Liver disease; Hepatitis C; Biopsy; Clotting factor; Internal medicine; Population; Gastroenterology; Asymptomatic; Surgery","score_opus":0.014837403998793042,"score_gpt":0.304212387585317,"score_spread":0.28937498358652397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014034847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712473,0.00018819263,0.00002578444,0.0019904014,0.000026157666,0.00047565214,0.000010007678,0.0000025638362,0.00015652018],"genre_scores_gemma":[0.99738765,0.00015775014,0.0020542517,0.00033345754,0.000024031238,0.0000069024813,0.0000011999834,0.000021738719,0.000013020942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998438,0.00016578216,0.00041717655,0.00022666613,0.0003829863,0.00036941454],"domain_scores_gemma":[0.999002,0.00008480113,0.000188548,0.00010589192,0.0002705077,0.0003482875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034985432,0.00015119197,0.00058201526,0.0004717708,0.00007115106,0.000021508213,0.000069215566,0.000040786214,0.0001594689],"category_scores_gemma":[0.00017106147,0.00012350362,0.000033265595,0.00025733229,0.00032721402,0.00016997219,0.00002159104,0.00037072564,0.0000038027451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041098092,0.00020800484,0.97032917,0.000011596942,0.00023821607,0.00027181732,0.0073214937,0.0000016199934,0.000011518959,0.0000036383615,0.000031161035,0.02116081],"study_design_scores_gemma":[0.005708363,0.005992161,0.98356324,0.00009648395,0.00011902129,0.00030943984,0.003118389,0.0008559361,0.000013198883,0.00000380294,0.00009182288,0.00012813171],"about_ca_topic_score_codex":0.042541966,"about_ca_topic_score_gemma":0.15378459,"teacher_disagreement_score":0.11124263,"about_ca_system_score_codex":0.00028002317,"about_ca_system_score_gemma":0.00022416604,"threshold_uncertainty_score":0.9638338},"labels":[],"label_agreement":null},{"id":"W2017949613","doi":"10.1002/ajh.21584","title":"A young woman with episodic angioedema, papilledema, and eosinophilia","year":2009,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Hyperviscosity syndrome; Thrombocytosis; Organomegaly; Eosinophilia; Angioedema; Surgery; Internal medicine; Gastroenterology; Polyneuropathy; Multiple myeloma","score_opus":0.005367527602862001,"score_gpt":0.24313264080198763,"score_spread":0.23776511319912563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017949613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98213947,0.0030905777,0.00021462752,0.012361845,0.000049562484,0.00010841881,6.8638394e-7,0.0000157927,0.002019012],"genre_scores_gemma":[0.9944287,0.0003182708,0.0029341334,0.002113554,0.00005132367,0.0000013092605,9.865925e-7,0.00001499623,0.00013670938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988132,0.00005919402,0.00043406634,0.00017343582,0.00022668195,0.00029339595],"domain_scores_gemma":[0.99897015,0.00006291751,0.0004161307,0.00018542977,0.00012036728,0.00024502046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017859573,0.0001740921,0.000927767,0.00022676987,0.00006030195,0.000013264918,0.000094779505,0.00004886255,0.000053644744],"category_scores_gemma":[0.000053897413,0.00011692927,0.00010373031,0.0002442737,0.00048398456,0.00008317224,0.000013002838,0.00022186701,0.0000057772545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002884693,0.0013226261,0.8036317,0.00015187346,0.0010101862,0.009569182,0.0042572618,0.00000479443,0.0024233123,0.012467044,0.007671744,0.15460555],"study_design_scores_gemma":[0.0075684115,0.04008421,0.5930826,0.00078300777,0.00076430256,0.3404722,0.0071705645,0.000053525437,0.00055770756,0.005208801,0.003611863,0.0006428236],"about_ca_topic_score_codex":0.000018849658,"about_ca_topic_score_gemma":0.000007663593,"teacher_disagreement_score":0.33090302,"about_ca_system_score_codex":0.000019907764,"about_ca_system_score_gemma":0.00009950841,"threshold_uncertainty_score":0.47682372},"labels":[],"label_agreement":null},{"id":"W2018664064","doi":"10.1002/ajh.21293","title":"Laboratory testing for fibrinogen abnormalities","year":2008,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"","keywords":"Fibrinogen; Fibrin; Medicine; Afibrinogenemia; Coagulation; Abnormality; Coagulation Disorder; Internal medicine; Pathology; Immunology","score_opus":0.06458634447870937,"score_gpt":0.33575130189687086,"score_spread":0.2711649574181615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018664064","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005188809,0.99866104,0.000080056234,0.00010390759,0.00016342895,0.00026202208,0.000012361027,0.000013412324,0.00018488352],"genre_scores_gemma":[0.00029585534,0.9922104,0.0067157876,0.00018592496,0.00044481797,0.000017279664,0.000008819911,0.00004665005,0.00007447535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998441,0.00011719546,0.000930615,0.00013107975,0.00014501647,0.00023513679],"domain_scores_gemma":[0.9972764,0.00046350245,0.0015114562,0.00017167776,0.00046356424,0.00011337398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015446768,0.00022002263,0.0025925157,0.0002107724,0.000059050646,0.000006637623,0.0001233738,0.00010956621,0.0000137283205],"category_scores_gemma":[0.00030628173,0.00015116877,0.00044736962,0.0002676058,0.000236355,0.000051288946,0.000023707213,0.00029365884,0.0000071089066],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005545568,0.000038221035,0.00029217664,0.0056568244,0.00045407255,0.00017772442,0.000075953474,4.3317223e-7,0.0000012047019,0.000119871605,0.002034722,0.99109334],"study_design_scores_gemma":[0.0002988728,0.0019830551,0.00001525538,0.0062404093,0.0009806511,0.040052265,0.00014224753,0.0000024854394,0.00001210336,0.000015929125,0.95010614,0.00015055886],"about_ca_topic_score_codex":0.000010272568,"about_ca_topic_score_gemma":3.7523813e-7,"teacher_disagreement_score":0.9909428,"about_ca_system_score_codex":0.000048928672,"about_ca_system_score_gemma":0.0009648312,"threshold_uncertainty_score":0.61644834},"labels":[],"label_agreement":null},{"id":"W2019023281","doi":"10.1002/ajh.23220","title":"No association between cigarette smoking and incidence of plasma cell myeloma: A meta‐analysis of 17 observational studies","year":2012,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple myeloma; Incidence (geometry); Internal medicine; Plasma Cell Myeloma; Observational study; Bone marrow; Meta-analysis; Oncology; Pathology","score_opus":0.18598639532587363,"score_gpt":0.4185439652328027,"score_spread":0.23255756990692905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019023281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028611112,0.97082436,0.000019382784,0.000114878276,0.00004466981,0.00022280002,0.000088456385,0.000003140024,0.0000711706],"genre_scores_gemma":[0.09078318,0.9073257,0.0015920403,0.000025004772,0.00007931416,0.000016802607,0.000053860043,0.000021354634,0.00010274504],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967319,0.0004978212,0.001524096,0.00019426168,0.00074682984,0.0003051408],"domain_scores_gemma":[0.9898093,0.0036087248,0.00518509,0.00020945049,0.0010064367,0.00018104953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010983442,0.0002833708,0.0076938346,0.0008754073,0.00003953462,0.0000045626525,0.00016836407,0.00014767113,0.00006253136],"category_scores_gemma":[0.000868021,0.00018954492,0.001345249,0.0008544834,0.00031364348,0.00009384914,0.00009610736,0.00044516695,0.0000016899476],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086031716,0.00018987857,0.21800096,0.006478772,0.688792,0.000114959665,0.0002514374,9.846223e-7,0.0000030452816,0.00003135006,0.00017189933,0.08587868],"study_design_scores_gemma":[0.00092868076,0.0011486625,0.020993993,0.0017750169,0.9487299,0.00041161716,0.00019324868,0.000008955976,0.00007668646,0.0000135933415,0.025497371,0.00022230986],"about_ca_topic_score_codex":0.000042921853,"about_ca_topic_score_gemma":0.000009465243,"teacher_disagreement_score":0.25993785,"about_ca_system_score_codex":0.00022024286,"about_ca_system_score_gemma":0.00040179995,"threshold_uncertainty_score":0.77294177},"labels":[],"label_agreement":null},{"id":"W2019593279","doi":"10.1002/ajh.20737","title":"Fatal postlymphoma chemotherapy hepatitis B reactivation secondary to the emergence of a YMDD mutant strain with lamivudine resistance in a noncirrhotic patient","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; AIDS Vancouver; University of British Columbia","funders":"","keywords":"Lamivudine; Medicine; Virology; Hepatitis B; Drug resistance; Hepatitis B virus; Chemotherapy; Cirrhosis; Gastroenterology; Internal medicine; Virus; Biology; Microbiology","score_opus":0.005732124867826355,"score_gpt":0.23810466213588025,"score_spread":0.2323725372680539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019593279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917922,0.00049333175,0.00069692754,0.0060970546,0.000061517334,0.00027857465,0.000026705919,0.0000066388966,0.00054702756],"genre_scores_gemma":[0.99480194,0.00015963052,0.0041795694,0.0007626621,0.00004280511,0.0000126100595,0.0000036973224,0.000020789626,0.000016320477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836624,0.00011442623,0.0007652624,0.00016606429,0.00033274444,0.00025529056],"domain_scores_gemma":[0.9984955,0.00015595042,0.00077164517,0.000211807,0.00029989023,0.00006517807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022285893,0.000157156,0.0007296171,0.0002096595,0.000041606305,0.0000038056107,0.000119681,0.000029710667,0.000058147776],"category_scores_gemma":[0.00013917791,0.00010329856,0.00007183187,0.00057873264,0.00030581234,0.000070403104,0.000021846645,0.00020250275,0.0000025638426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044514798,0.00086306746,0.90490246,0.00017670092,0.00042256643,0.0019697167,0.009373903,0.00008270602,0.038074873,0.0016822045,0.003216946,0.034783397],"study_design_scores_gemma":[0.0023947705,0.005444883,0.9604502,0.00074874685,0.00007256855,0.0031038008,0.0022439861,0.000033312328,0.023319567,0.00031341962,0.0016503142,0.00022444625],"about_ca_topic_score_codex":0.0027697189,"about_ca_topic_score_gemma":0.0145409675,"teacher_disagreement_score":0.055547748,"about_ca_system_score_codex":0.000101484904,"about_ca_system_score_gemma":0.00027596744,"threshold_uncertainty_score":0.81142014},"labels":[],"label_agreement":null},{"id":"W2021706185","doi":"10.1002/ajh.21670","title":"Pain as an emergent issue in thalassemia","year":2010,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Hospital for Sick Children","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Thalassemia; Medicine; Intensive care medicine; Internal medicine","score_opus":0.005991613823772109,"score_gpt":0.2732161678628304,"score_spread":0.26722455403905826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021706185","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25091138,0.0012222175,0.000045475943,0.74520874,0.0010181308,0.0001848878,0.000002556845,0.000017159275,0.0013894244],"genre_scores_gemma":[0.10297218,0.0014855047,0.0015882932,0.8905638,0.0023629256,0.000008743284,0.000054087006,0.00013055965,0.00083393406],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972636,0.00049778185,0.0010242315,0.00028455147,0.00038673336,0.000543084],"domain_scores_gemma":[0.99790704,0.000212431,0.0010507551,0.00040532835,0.00019030567,0.0002341462],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00072010496,0.00033398814,0.0016239937,0.0006078299,0.000033693592,0.000009659071,0.00030655783,0.0013070412,0.0009654576],"category_scores_gemma":[0.0003857628,0.00025214092,0.0002967155,0.0003324219,0.00045193013,0.00005535204,0.000033547145,0.007956606,0.00009007833],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018880802,0.00022913492,0.009531652,0.00016107876,0.00026661766,0.023647033,0.00053235085,0.0000021923854,0.00023475295,0.000026085982,0.94234794,0.022832338],"study_design_scores_gemma":[0.0010040784,0.00336235,0.00044387885,0.00040047697,0.00019728167,0.02628651,0.0014499166,0.000022673015,0.00010513271,0.00026193867,0.96618015,0.0002855883],"about_ca_topic_score_codex":0.00027219238,"about_ca_topic_score_gemma":0.00003325539,"teacher_disagreement_score":0.1479392,"about_ca_system_score_codex":0.00006935107,"about_ca_system_score_gemma":0.0005004614,"threshold_uncertainty_score":0.9999931},"labels":[],"label_agreement":null},{"id":"W2024979995","doi":"10.1002/ajh.21108","title":"Multicentric Castleman's disease treated with combination chemotherapy and rituximab in four HIV‐positive men: A case series","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University; Montreal General Hospital","funders":"","keywords":"Rituximab; Medicine; Immunosuppression; Chemotherapy; Oncology; Internal medicine; Disease; CD20; Castleman disease; Immunology; Lymphoma","score_opus":0.005309175492526143,"score_gpt":0.25668893642208007,"score_spread":0.25137976092955394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024979995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99476624,0.0007916819,0.0003566366,0.0036504387,0.00001620898,0.00017436384,0.00000399602,0.000008288238,0.00023217789],"genre_scores_gemma":[0.99862623,0.00025381945,0.0005529381,0.00049302116,0.0000150274145,0.000002469813,0.000002992477,0.000015944532,0.00003756671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991259,0.00006600094,0.00030944092,0.00012444833,0.00013670835,0.00023751549],"domain_scores_gemma":[0.99911195,0.000091947644,0.00037440384,0.00007148258,0.0001537293,0.0001965024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001812216,0.00012690312,0.0005205565,0.0002627659,0.000043353826,0.000007481254,0.000030086792,0.00003472196,0.000014524043],"category_scores_gemma":[0.000048651353,0.00009667648,0.000046086505,0.00030714204,0.00025858227,0.00010239303,0.0000066808,0.00017397804,0.0000011571606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01928537,0.0018144633,0.85115844,0.00007657231,0.0004089768,0.09902148,0.0026688876,0.000009799721,0.00012706913,0.00040698954,0.00043333674,0.024588645],"study_design_scores_gemma":[0.13802233,0.015710944,0.4756131,0.00069541857,0.0010529734,0.3180995,0.046305638,0.0009720366,0.0019582647,0.0003917938,0.00041955177,0.0007584402],"about_ca_topic_score_codex":0.00020394962,"about_ca_topic_score_gemma":0.0001364558,"teacher_disagreement_score":0.37554532,"about_ca_system_score_codex":0.00012413724,"about_ca_system_score_gemma":0.00010870433,"threshold_uncertainty_score":0.39423522},"labels":[],"label_agreement":null},{"id":"W2025604364","doi":"10.1002/ajh.20821","title":"Very severe thrombocytopenia and fragmentation hemolysis mimicking thrombotic thrombocytopenic purpura associated with a giant intracardiac vegetation infected with <i>Staphylococcus epidermidis</i>: Role of monocyte procoagulant activity induced by bacterial supernatant","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Infective Endocarditis Diagnosis and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Staphylococcus epidermidis; Hemolysis; Thrombotic thrombocytopenic purpura; Thrombocytopenic purpura; Intracardiac injection; Monocyte; Immunology; Microbiology; Staphylococcus aureus; Platelet; Bacteria; Internal medicine; Biology","score_opus":0.006352346136597916,"score_gpt":0.23443646606140475,"score_spread":0.22808411992480684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025604364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786747,0.00032124855,0.0006214826,0.00017695781,0.00007538518,0.0007447072,0.00001662416,0.000022650385,0.00015350885],"genre_scores_gemma":[0.9989214,0.00016144435,0.00062889804,0.00009382881,0.00005897949,0.000038834416,0.000053860796,0.000041645293,0.000001114129],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978682,0.00033378133,0.0006681461,0.00033050904,0.00043223068,0.000367145],"domain_scores_gemma":[0.99752957,0.00029167297,0.0014619553,0.00020414157,0.00040219922,0.00011046083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031869716,0.0003224383,0.0017207481,0.00024853318,0.000092093345,0.000039115384,0.00009815354,0.000084551866,0.000014773664],"category_scores_gemma":[0.000096854914,0.00023802201,0.00014960676,0.00043220716,0.0003377797,0.0003980169,0.000050250343,0.00032836548,0.0000012499054],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018646981,0.0014469366,0.32689992,0.00021798085,0.003622342,0.00040039016,0.0007813887,0.00026111514,0.6544489,0.00037748908,0.00018922759,0.009489555],"study_design_scores_gemma":[0.005054763,0.0041820914,0.8192722,0.000606398,0.0011927984,0.0012203964,0.00073132815,0.00010695794,0.16721666,0.00008559155,0.000024140916,0.00030665376],"about_ca_topic_score_codex":0.00043400103,"about_ca_topic_score_gemma":0.0001552249,"teacher_disagreement_score":0.4923723,"about_ca_system_score_codex":0.00022584821,"about_ca_system_score_gemma":0.0002095092,"threshold_uncertainty_score":0.9706256},"labels":[],"label_agreement":null},{"id":"W2029430078","doi":"10.1002/ajh.21273","title":"Delayed‐onset HIT caused by low‐molecular‐weight heparin manifesting during fondaparinux prophylaxis","year":2008,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Fondaparinux; Heparin; Medicine; Heparin-induced thrombocytopenia; Low molecular weight heparin; Platelet factor 4; Anticoagulant; Platelet; Immunology; Internal medicine; Gastroenterology; Anesthesia; Thrombosis","score_opus":0.01221561422676701,"score_gpt":0.2602082745691867,"score_spread":0.2479926603424197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029430078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655765,0.0004523684,0.00034849046,0.00093257177,0.00026988515,0.00023492781,0.000005288902,0.0000525713,0.0011462342],"genre_scores_gemma":[0.99679595,0.00019731237,0.002245437,0.00042621815,0.00010297524,0.0000105896515,0.000008035063,0.00007349803,0.00013996796],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970783,0.00023008086,0.0011259767,0.00039045291,0.00045769056,0.00071751745],"domain_scores_gemma":[0.99760765,0.00016795125,0.00095474935,0.0004440143,0.00030353473,0.0005220755],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025360018,0.00037010526,0.0016455757,0.0003520981,0.00022418446,0.00001599196,0.0003171435,0.00015355137,0.00014006555],"category_scores_gemma":[0.00026872993,0.00032156694,0.00031828365,0.00056014984,0.0006311787,0.00015469675,0.00011371095,0.0008447403,0.00007616851],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013186197,0.0013799795,0.5290806,0.00029621154,0.0021457232,0.03381721,0.0017669643,0.000015179555,0.4222838,0.0005424429,0.0033937641,0.003959457],"study_design_scores_gemma":[0.008740142,0.009424588,0.20529339,0.00066213554,0.00081789657,0.32455367,0.0010485062,0.00007873032,0.4458426,0.00019545677,0.002054403,0.0012884807],"about_ca_topic_score_codex":0.00019273686,"about_ca_topic_score_gemma":0.000012847964,"teacher_disagreement_score":0.32378727,"about_ca_system_score_codex":0.00019423955,"about_ca_system_score_gemma":0.00049432466,"threshold_uncertainty_score":0.99992365},"labels":[],"label_agreement":null},{"id":"W2029627784","doi":"10.1002/ajh.10440","title":"Warfarin‐associated multiple digital necrosis complicating heparin‐induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma‐associated thrombotic endocarditis","year":2003,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Warfarin; Heparin-induced thrombocytopenia; Surgery; Thrombosis; Argatroban; Gangrene; Heparin; Aortic valve; Internal medicine; Cardiology; Thrombin; Atrial fibrillation; Platelet","score_opus":0.026236921263214284,"score_gpt":0.2847006454334744,"score_spread":0.2584637241702601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029627784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962025,0.0005584341,0.000540799,0.00052897073,0.00031460094,0.0010557105,0.000046190173,0.00006697199,0.00068578654],"genre_scores_gemma":[0.99689645,0.000112322086,0.0020860215,0.00053844816,0.00006314803,0.000110939945,0.000039037997,0.000115941075,0.00003768945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99576175,0.00034188575,0.0016462432,0.000707138,0.00047116893,0.0010718039],"domain_scores_gemma":[0.9955117,0.0010611569,0.0016897507,0.00056685926,0.000583675,0.00058686803],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007491044,0.000584007,0.003016994,0.00031463747,0.000285551,0.00012932342,0.0002732057,0.00021649845,0.00008996093],"category_scores_gemma":[0.0019616624,0.0005331928,0.000639113,0.0005508435,0.00052579085,0.00035286858,0.0001364672,0.00062948687,0.00001989708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066670246,0.0011210365,0.97706324,0.000121970545,0.003760366,0.00009618622,0.0015286407,0.000004609757,0.011624035,0.00050581445,0.00025228853,0.0032551119],"study_design_scores_gemma":[0.011571713,0.008386487,0.96017236,0.0005460046,0.0021249312,0.0038471445,0.0025487721,0.0003024404,0.008142819,0.0010362468,0.00039369296,0.0009273938],"about_ca_topic_score_codex":0.00013766614,"about_ca_topic_score_gemma":0.00003936349,"teacher_disagreement_score":0.016890882,"about_ca_system_score_codex":0.00054240896,"about_ca_system_score_gemma":0.0003973428,"threshold_uncertainty_score":0.999712},"labels":[],"label_agreement":null},{"id":"W2029918987","doi":"10.1002/1096-8652(200009)65:1<25::aid-ajh4>3.0.co;2-8","title":"Pneumococcal vaccine administration associated with splenectomy: The need for improved education, documentation, and the use of a practical checklist","year":2000,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Abdominal Trauma and Injuries","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kelowna General Hospital; Canadian Blood Services; BC Cancer Agency","funders":"","keywords":"Splenectomy; Medicine; Checklist; Vaccination; Pneumococcal vaccination; Documentation; Audit; Pneumococcal vaccine; Pediatrics; General surgery; Surgery; Internal medicine; Immunology; Streptococcus pneumoniae; Spleen","score_opus":0.01597655908146362,"score_gpt":0.32452005635841985,"score_spread":0.30854349727695624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029918987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522227,0.00009742923,0.00048784632,0.04672374,0.00003314787,0.0003670063,0.0000031974184,0.0000036759116,0.000061259474],"genre_scores_gemma":[0.9951335,0.00007902998,0.0033292107,0.0011864011,0.000058805635,0.000020688853,0.000007016366,0.0000096073845,0.00017572199],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9990963,0.00014551192,0.00046415356,0.00008042237,0.00010094498,0.00011270453],"domain_scores_gemma":[0.99766916,0.0010813798,0.00067891896,0.000111905785,0.00039842073,0.000060232418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031962228,0.00009035053,0.00045732394,0.000044049546,0.000078475736,0.00002124558,0.000051533098,0.000028596774,0.000058156435],"category_scores_gemma":[0.0007429737,0.000042670694,0.00006831001,0.00015424352,0.00056906353,0.00015926883,0.0000046888435,0.00015153599,3.9299394e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3612535,0.0073708603,0.19321738,0.00050298654,0.008012547,0.00012970135,0.01956038,0.000028790932,0.017285068,0.07815822,0.04510783,0.26937273],"study_design_scores_gemma":[0.07101975,0.07277464,0.6058852,0.0013110598,0.009843654,0.0662733,0.04598772,0.0026382783,0.029345216,0.0072774757,0.086574465,0.0010692205],"about_ca_topic_score_codex":0.000038850012,"about_ca_topic_score_gemma":0.000027926808,"teacher_disagreement_score":0.41266784,"about_ca_system_score_codex":0.00002000759,"about_ca_system_score_gemma":0.0005065558,"threshold_uncertainty_score":0.20967382},"labels":[],"label_agreement":null},{"id":"W2030527052","doi":"10.1002/ajh.21782","title":"Coagulopathy in a patient with nephrotic syndrome","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Coagulopathy; Nephrotic syndrome; Medicine; Intensive care medicine; Pediatrics; Internal medicine","score_opus":0.0033025653591573782,"score_gpt":0.2279215170942125,"score_spread":0.2246189517350551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030527052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984382,0.0002943149,0.00014621943,0.000762337,0.00013807298,0.000108512795,0.0000027769527,0.0000039693,0.00010560406],"genre_scores_gemma":[0.9958639,0.0000728621,0.0033685828,0.0006123839,0.000028208713,0.00001691647,0.0000035849687,0.000023080665,0.000010458572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998919,0.00008737198,0.00039260313,0.00019343915,0.00013099454,0.00027658578],"domain_scores_gemma":[0.9989829,0.000052600146,0.00049029227,0.0002592055,0.00009211133,0.0001228597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010875676,0.00016969512,0.00047754587,0.00013844341,0.000026967102,0.000008540471,0.00019817676,0.00007232916,0.000029345043],"category_scores_gemma":[0.000092682945,0.0001260261,0.00009543215,0.00016149893,0.00034124244,0.0000060074985,0.00005043315,0.00023975354,0.000009392209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005213676,0.0007132283,0.94504815,0.000017111297,0.00033155867,0.0042094565,0.00032798116,0.000053332376,0.037595987,0.00031933558,0.0006267866,0.010235729],"study_design_scores_gemma":[0.008808289,0.038599286,0.41314992,0.00025493576,0.00036704208,0.2820439,0.0049199783,0.00002326222,0.23288614,0.0003615954,0.017083691,0.001501964],"about_ca_topic_score_codex":0.00003646762,"about_ca_topic_score_gemma":0.00018592624,"teacher_disagreement_score":0.5318982,"about_ca_system_score_codex":0.000016721877,"about_ca_system_score_gemma":0.00013671516,"threshold_uncertainty_score":0.51391953},"labels":[],"label_agreement":null},{"id":"W2033671580","doi":"10.1002/ajh.20246","title":"Megakaryocyte‐like giant myeloma cells","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Library science; Citation; Medicine; Medical laboratory; Family medicine; Pathology; Computer science","score_opus":0.013793857266544172,"score_gpt":0.29687643815796017,"score_spread":0.28308258089141597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033671580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234635,0.0007672127,0.0010740928,0.004435838,0.00020964255,0.00014779397,0.0000033548938,0.000017374321,0.0009983145],"genre_scores_gemma":[0.98180544,0.0001926259,0.017139459,0.0006279419,0.00009015825,0.0000032327912,0.0000023327216,0.00002112763,0.00011770334],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985502,0.00007084791,0.0004586325,0.00015209834,0.00036079335,0.00040744408],"domain_scores_gemma":[0.9986718,0.00010206897,0.0003546511,0.00022828099,0.00020387818,0.00043930634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015976751,0.00015219473,0.00072837766,0.00026298937,0.000051172174,0.000008885243,0.00014740098,0.00004441369,0.00013798918],"category_scores_gemma":[0.00008306783,0.00010698288,0.00020484992,0.00025346165,0.0003923557,0.00007144705,0.00003485126,0.0003106451,0.00015033383],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015647467,0.0067349277,0.1257543,0.00044541658,0.006524398,0.13851655,0.0033793997,0.0002178451,0.1966011,0.008797991,0.014876525,0.48250407],"study_design_scores_gemma":[0.041522104,0.035628352,0.1419518,0.00096023653,0.0009157777,0.23727797,0.004400442,0.00010561231,0.5066838,0.003270731,0.026350955,0.0009322234],"about_ca_topic_score_codex":0.00008364563,"about_ca_topic_score_gemma":0.0000098864675,"teacher_disagreement_score":0.48157185,"about_ca_system_score_codex":0.000134485,"about_ca_system_score_gemma":0.00041325216,"threshold_uncertainty_score":0.4362635},"labels":[],"label_agreement":null},{"id":"W2034363241","doi":"10.1002/ajh.1106","title":"An unusual presentation of extramedullary plasmacytoma occurring sequentially in the testis, subcutaneous tissue, and heart","year":2001,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Plasmacytoma; Medicine; Presentation (obstetrics); Subcutaneous tissue; Soft tissue; Pathology; Nasal cavity; Extramedullary plasmacytoma; Anatomy; Radiology; Multiple myeloma; Internal medicine","score_opus":0.020835054313758636,"score_gpt":0.35760829905816316,"score_spread":0.3367732447444045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034363241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982227,0.0006099665,0.00012617317,0.00073568174,0.00002821098,0.00016601068,0.0000025126174,0.000004349192,0.000104369574],"genre_scores_gemma":[0.9968688,0.00016417558,0.0027574264,0.00015508418,0.00003510596,0.0000029586,0.0000035419787,0.0000086650825,0.0000042605266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988097,0.00023208684,0.00037119762,0.000107201755,0.00026684784,0.0002129756],"domain_scores_gemma":[0.9990628,0.0003422145,0.00022825552,0.00013478144,0.00009813569,0.00013382272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023104098,0.00008983006,0.00040382752,0.00020553324,0.000029481836,0.000009703227,0.00010198122,0.000029352972,0.00002375701],"category_scores_gemma":[0.00015342316,0.00006054282,0.000037417452,0.00022592806,0.00031253873,0.00008234632,0.000014192554,0.00019875319,0.0000018224116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017274276,0.0005131438,0.92274463,0.00004591063,0.000106321844,0.012538947,0.0008744074,0.000016886312,0.01080929,0.00011798207,0.00007915834,0.05042587],"study_design_scores_gemma":[0.00430394,0.014873584,0.59586835,0.00020369623,0.0001351195,0.36784366,0.0039815987,0.00069048896,0.011004207,0.00026409802,0.0006873543,0.00014391597],"about_ca_topic_score_codex":0.00027447782,"about_ca_topic_score_gemma":0.00007458686,"teacher_disagreement_score":0.35530472,"about_ca_system_score_codex":0.000023119392,"about_ca_system_score_gemma":0.00012330624,"threshold_uncertainty_score":0.24688646},"labels":[],"label_agreement":null},{"id":"W2035386216","doi":"10.1002/ajh.23136","title":"Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves","year":2012,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Warfarin; Medicine; Atrial fibrillation; Mechanical heart; Stroke (engine); Antithrombotic; Intensive care medicine; Vitamin K antagonist; Cardiology; Internal medicine; Surgery","score_opus":0.11380909070893624,"score_gpt":0.4265956618241217,"score_spread":0.31278657111518543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035386216","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046472424,0.9926418,0.0007156877,0.0006343875,0.00043633577,0.0009014913,0.0000028056145,0.000007924348,0.000012324264],"genre_scores_gemma":[0.0055388184,0.9879056,0.0049876785,0.000025993197,0.0014382489,0.0000010516975,0.000013876129,0.000029487335,0.000059251943],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982619,0.00024636215,0.000974921,0.00015346329,0.00015770005,0.00020560568],"domain_scores_gemma":[0.9979908,0.0005866717,0.0011538488,0.00011455501,0.00006612951,0.00008801338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060998736,0.00019902561,0.002541287,0.00041362774,0.000026692898,0.000011244603,0.000054956985,0.00013023269,0.000026901975],"category_scores_gemma":[0.00015036014,0.00014376573,0.00091846584,0.00018608522,0.00008924459,0.00009330669,0.000023170875,0.00017453135,0.0000035185446],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000345814,0.000008256064,0.0087738605,0.0014981034,0.00052757247,0.0000053763088,0.000027110496,0.0000014282616,0.0000029069124,0.0014088375,0.000053153803,0.9873476],"study_design_scores_gemma":[0.0027564017,0.0026025234,0.0016307682,0.0024865898,0.002287826,0.0016245132,0.00007723814,0.000016019936,0.000003712903,0.00039062978,0.9859088,0.000214979],"about_ca_topic_score_codex":0.0000033059425,"about_ca_topic_score_gemma":0.0000016869492,"teacher_disagreement_score":0.9871326,"about_ca_system_score_codex":0.000045686353,"about_ca_system_score_gemma":0.00017525972,"threshold_uncertainty_score":0.58625966},"labels":[],"label_agreement":null},{"id":"W2035790980","doi":"10.1002/ajh.23194","title":"In multiple myeloma, bone‐marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; China Scholarship Council","keywords":"Chromosomal translocation; Bone marrow; Fluorescence in situ hybridization; CD20; Multiple myeloma; Pathology; Biology; Abnormality; Chromosome abnormality; Peripheral blood mononuclear cell; Lymphocyte; Immunology; Karyotype; Medicine; Lymphoma; Chromosome; Genetics; Gene","score_opus":0.018378740826383563,"score_gpt":0.281875947007928,"score_spread":0.26349720618154443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035790980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947416,0.001722971,0.000021198994,0.002017088,0.0006191792,0.00028256536,0.000014008398,0.000025044927,0.0005563078],"genre_scores_gemma":[0.99751985,0.0002341411,0.0012755466,0.00035101463,0.00037487908,0.000025152483,0.0000047097697,0.000037680857,0.00017705349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969696,0.00045598415,0.0008081195,0.00020087526,0.0005627707,0.0010026717],"domain_scores_gemma":[0.9971922,0.0013069871,0.00055902614,0.0003022845,0.00015372086,0.00048575734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071399537,0.0002869381,0.001100575,0.00033967302,0.00013128995,0.00002180461,0.00027530923,0.00009516849,0.00020694453],"category_scores_gemma":[0.0006442097,0.00018536566,0.00023322988,0.00032178825,0.00081417867,0.00029530158,0.000101868005,0.0005083988,0.00010274249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029183843,0.0007237115,0.97527736,0.00009275132,0.00061874156,0.004321617,0.0022763668,0.00002140687,0.0049311277,0.00048248144,0.00064713566,0.00768893],"study_design_scores_gemma":[0.025279187,0.008500942,0.61971,0.0006535259,0.0005433081,0.11458009,0.019311005,0.002357557,0.19842623,0.0001927862,0.009541634,0.0009036855],"about_ca_topic_score_codex":0.0010014903,"about_ca_topic_score_gemma":0.000101736776,"teacher_disagreement_score":0.35556728,"about_ca_system_score_codex":0.00026009497,"about_ca_system_score_gemma":0.0004600818,"threshold_uncertainty_score":0.7558992},"labels":[],"label_agreement":null},{"id":"W2036000990","doi":"10.1002/ajh.23105","title":"Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities","year":2011,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Sickle cell anemia; Stroke (engine); Anemia; Transfusion therapy; Pediatrics; Blood transfusion; Intensive care medicine; Internal medicine; Disease","score_opus":0.007949468046258895,"score_gpt":0.2369195214378361,"score_spread":0.2289700533915772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036000990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611105,0.0075464337,0.00039774663,0.029601868,0.000085905565,0.00061916036,0.000017378434,0.0000070245333,0.00061401865],"genre_scores_gemma":[0.9464497,0.015706467,0.009522361,0.02598215,0.00103353,0.00003969076,0.00018492289,0.00015764129,0.0009235503],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9985771,0.000116936346,0.0006371655,0.0001860276,0.00020170299,0.00028103354],"domain_scores_gemma":[0.9973887,0.00013878,0.0021515628,0.00013216717,0.00013232298,0.000056448167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020365852,0.00021507377,0.0011227987,0.00032691154,0.00003102971,0.0000047455924,0.000106255095,0.00032080107,0.000030346599],"category_scores_gemma":[0.000025681666,0.00015419544,0.00014297392,0.00011019048,0.0005010226,0.00010589217,0.000015696985,0.0011719301,4.7516534e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01655408,0.0022997227,0.54415804,0.019804131,0.0054280795,0.00334266,0.00998183,0.00006396051,0.005285613,0.00011969272,0.13596977,0.25699243],"study_design_scores_gemma":[0.08907461,0.22089973,0.2025851,0.016181074,0.018430503,0.22737621,0.018710649,0.00009125,0.023213856,0.0007642023,0.17865148,0.0040213247],"about_ca_topic_score_codex":0.00022420849,"about_ca_topic_score_gemma":0.000026010302,"teacher_disagreement_score":0.34157294,"about_ca_system_score_codex":0.0000665807,"about_ca_system_score_gemma":0.00054352003,"threshold_uncertainty_score":0.6287908},"labels":[],"label_agreement":null},{"id":"W2038661096","doi":"10.1002/ajh.20118","title":"Echocardiographic abnormalities in sickle cell disease","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Dartmouth General Hospital; Dalhousie University; Royal University Hospital","funders":"","keywords":"Medicine; Disease; Internal medicine; MEDLINE; Cardiology; Intensive care medicine; Pediatrics; Biology","score_opus":0.004141990782277265,"score_gpt":0.22762596931486084,"score_spread":0.2234839785325836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038661096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903198,0.003915101,0.00024586965,0.0037787338,0.00013000095,0.00007565855,0.0000012276339,0.000011386184,0.001522241],"genre_scores_gemma":[0.99732804,0.0011037692,0.00066267396,0.0008288746,0.000035064233,0.0000017660803,0.0000011839323,0.00001375205,0.000024845927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989788,0.000058209585,0.00043910765,0.000099886696,0.00016439949,0.00025957663],"domain_scores_gemma":[0.9992453,0.000043102795,0.00024885155,0.00014120543,0.000075854194,0.00024567574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016393351,0.00011094239,0.00055427436,0.0003847796,0.0000262216,0.000004589054,0.00008630477,0.000045204488,0.000026700789],"category_scores_gemma":[0.00004961629,0.000084916675,0.00022297281,0.00042257897,0.0003846881,0.000059636568,0.000015758393,0.00034466138,0.000013641288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024304464,0.0016969318,0.9531324,0.00036441075,0.00040770957,0.018054599,0.0032951583,0.0027031624,0.0004745505,0.0068662968,0.0010940944,0.009480277],"study_design_scores_gemma":[0.05978416,0.020681806,0.66409373,0.0041094273,0.0025212185,0.07479757,0.09724971,0.00016165532,0.008554526,0.039452787,0.026174895,0.002418492],"about_ca_topic_score_codex":0.0000868312,"about_ca_topic_score_gemma":0.0000050097315,"teacher_disagreement_score":0.2890386,"about_ca_system_score_codex":0.00004140252,"about_ca_system_score_gemma":0.0002767153,"threshold_uncertainty_score":0.34628016},"labels":[],"label_agreement":null},{"id":"W2038906686","doi":"10.1002/ajh.23408","title":"Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic‐phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Ariad Pharmaceuticals; Teva Pharmaceutical Industries; Pfizer","keywords":"Medicine; Internal medicine; Gastroenterology; Neutropenia; Adverse effect; Dasatinib; Myeloid leukemia; Rash; Phases of clinical research; Imatinib; Chemotherapy","score_opus":0.012338075314130881,"score_gpt":0.3062197094384318,"score_spread":0.2938816341243009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038906686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523014,0.0011329207,0.00022563372,0.0005017992,0.00028053104,0.0025257126,0.000057970996,0.000019641115,0.000025627949],"genre_scores_gemma":[0.9974998,0.000101304395,0.0018275782,0.00010624683,0.00016746207,0.00010124052,0.000023296536,0.00007869499,0.00009437575],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9956839,0.00019891305,0.0023360725,0.00045555911,0.0006396351,0.0006859232],"domain_scores_gemma":[0.9948005,0.00041399596,0.002384063,0.0006667146,0.0012239517,0.0005107729],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034176942,0.00047393117,0.0024852864,0.00065885624,0.00007824702,0.000010823732,0.00036403965,0.00010783739,0.00029450655],"category_scores_gemma":[0.000480758,0.00034058103,0.00032346987,0.0007127643,0.00037426004,0.00013827739,0.00010627951,0.00035598368,0.000012995472],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10546397,0.054115072,0.0101266755,0.0029825552,0.005764986,0.006311873,0.008727133,0.00042898982,0.32215354,0.00012278203,0.009087805,0.4747146],"study_design_scores_gemma":[0.19164225,0.5818952,0.0024285975,0.0017951024,0.002026487,0.0053767613,0.0042385687,0.0009067371,0.20671178,0.00004342105,0.002167924,0.0007671683],"about_ca_topic_score_codex":0.0007653378,"about_ca_topic_score_gemma":0.00021218407,"teacher_disagreement_score":0.5277801,"about_ca_system_score_codex":0.002757981,"about_ca_system_score_gemma":0.0022033115,"threshold_uncertainty_score":0.99990463},"labels":[],"label_agreement":null},{"id":"W2038935774","doi":"10.1002/ajh.20221","title":"Dissociation between the level of von Willebrand factor‐cleaving protease activity and disease in a patient with congenital thrombotic thrombocytopenic purpura","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Thrombotic thrombocytopenic purpura; ADAMTS13; Medicine; Von Willebrand factor; Splenectomy; Coagulopathy; Gastroenterology; Internal medicine; Immunology; Platelet; Atypical hemolytic uremic syndrome; Antibody; Spleen; Complement system","score_opus":0.026551036004678813,"score_gpt":0.2712749913259103,"score_spread":0.2447239553212315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038935774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751556,0.00067774876,0.00034100522,0.00087531307,0.000062816405,0.0004405905,0.00007432819,0.0000055597106,0.000007065924],"genre_scores_gemma":[0.9998546,0.000014879906,0.000060555943,0.00002892264,0.0000097238935,0.000012772202,0.0000050540975,0.0000114670465,0.000002027631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861425,0.0003879455,0.0005184241,0.00015749311,0.000086133565,0.00023576344],"domain_scores_gemma":[0.9983372,0.0003241723,0.0010120751,0.00016813424,0.00009593512,0.0000624551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001634133,0.00015509594,0.0006558673,0.000117154785,0.00008997175,0.000009481425,0.00017085626,0.000038665614,0.000033370812],"category_scores_gemma":[0.00021652883,0.00009908941,0.000079405894,0.00016058398,0.00063358777,0.00014933453,0.00006658166,0.00022461575,0.0000025440881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009015805,0.00031374305,0.98205656,0.0000498249,0.0005841191,0.00007667371,0.002011191,0.000039737217,0.0086606955,0.00030171507,0.000017948107,0.004986188],"study_design_scores_gemma":[0.002234222,0.0012854259,0.9872429,0.00018620142,0.00018922398,0.00042212039,0.0015135222,0.0000010980227,0.0063392404,0.00042788792,0.0000146501825,0.00014354392],"about_ca_topic_score_codex":0.0003070352,"about_ca_topic_score_gemma":0.000111566624,"teacher_disagreement_score":0.00518628,"about_ca_system_score_codex":0.000085402426,"about_ca_system_score_gemma":0.00024891258,"threshold_uncertainty_score":0.4040749},"labels":[],"label_agreement":null},{"id":"W2039127104","doi":"10.1002/ajh.21585","title":"Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study","year":2009,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Center for Research Resources; National Human Genome Research Institute; University of California, Irvine; Deutsches Krebsforschungszentrum; National Heart, Lung, and Blood Institute; University of Minnesota; National Cancer Institute; National Institutes of Health; Wake Forest University; Kaiser Permanente","keywords":"Heritability; Transferrin saturation; Hemochromatosis; Proband; Medicine; Internal medicine; Serum iron; Hereditary hemochromatosis; Population; Genotype; Serum ferritin; Ferritin; Genetics; Anemia; Biology; Gene","score_opus":0.014196600630362557,"score_gpt":0.2828052952023827,"score_spread":0.26860869457202013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039127104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942051,0.003102537,0.00012829495,0.0020177271,0.000043103708,0.0002177259,0.0000017400093,0.0000054327047,0.00027832575],"genre_scores_gemma":[0.9978691,0.00016059075,0.0010598439,0.0008731959,0.000025544221,0.0000014597276,2.973245e-7,0.000007805059,0.0000022177317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982805,0.00037218645,0.00062333175,0.00015428214,0.00034274682,0.00022694604],"domain_scores_gemma":[0.9989835,0.00016397868,0.0004377019,0.00024591942,0.00008730299,0.000081613965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008530293,0.00014543017,0.0008492694,0.00016400928,0.000040385523,0.000007196004,0.00015751761,0.000040065293,0.000012378244],"category_scores_gemma":[0.00018966904,0.00009475284,0.000096795506,0.00028230227,0.00034196198,0.00008024601,0.00002009351,0.0002766977,5.9340607e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076049863,0.0011729762,0.9138803,0.000067238674,0.000033701137,0.00016382938,0.005272841,0.00001580676,0.0020547432,0.00020330833,0.00013269577,0.0762421],"study_design_scores_gemma":[0.0021473365,0.0028848315,0.9501572,0.00005045333,0.00013494733,0.0010434157,0.043108024,0.000007432159,0.00020190743,0.000131595,0.000050772203,0.00008206882],"about_ca_topic_score_codex":0.00015831388,"about_ca_topic_score_gemma":0.00002995155,"teacher_disagreement_score":0.07616003,"about_ca_system_score_codex":0.000012036901,"about_ca_system_score_gemma":0.00006384824,"threshold_uncertainty_score":0.38639086},"labels":[],"label_agreement":null},{"id":"W2039735377","doi":"10.1002/ajh.22090","title":"Myeloma ASH 2010 highlights","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple myeloma; Medicine; Internal medicine","score_opus":0.03226952994917358,"score_gpt":0.30281670643244657,"score_spread":0.270547176483273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039735377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99169904,0.00041871401,0.00025174755,0.0017191818,0.00022449439,0.00010249008,0.0000016568733,0.0000151162485,0.005567588],"genre_scores_gemma":[0.98858714,0.00013211407,0.010565403,0.00024263807,0.00008161344,0.0000029844516,0.0000015231195,0.000015852891,0.00037072264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883026,0.00008770986,0.0003855577,0.00012189827,0.00025102057,0.00032357694],"domain_scores_gemma":[0.99876463,0.000087780376,0.0003428505,0.00021297229,0.00022086385,0.00037091365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014222096,0.000121265315,0.000605589,0.0002444252,0.00003922163,0.0000039881015,0.00014012985,0.00004162375,0.0005997195],"category_scores_gemma":[0.00011093788,0.00008093181,0.00015421804,0.00017733424,0.00035682047,0.000066357235,0.000030190766,0.00023525892,0.00018500617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065384754,0.0023065228,0.75187033,0.00009391152,0.002502602,0.02799793,0.0023784908,2.2643901e-7,0.0049736663,0.009260045,0.016796408,0.1752814],"study_design_scores_gemma":[0.007271871,0.01377286,0.8335663,0.00019586977,0.00035014583,0.070940085,0.0011740491,0.000020267074,0.05727079,0.001330868,0.013799898,0.0003069842],"about_ca_topic_score_codex":0.00008665583,"about_ca_topic_score_gemma":0.000009114289,"teacher_disagreement_score":0.17497443,"about_ca_system_score_codex":0.00003693306,"about_ca_system_score_gemma":0.00016245354,"threshold_uncertainty_score":0.6566508},"labels":[],"label_agreement":null},{"id":"W2039971449","doi":"10.1002/ajh.23172","title":"Referrals for suspected hematologic malignancy: A survey of primary care physicians","year":2012,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Healthcare Systems and Technology","field":"Business, Management and Accounting","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"National Institute of Nursing Research; Centers for Disease Control and Prevention","keywords":"Medicine; Hematologic malignancy; Primary care; Hematologic Neoplasms; Malignancy; Hematological malignancy; Hematologic tests; Family medicine; Intensive care medicine; Internal medicine; Cancer; Environmental health; Health services","score_opus":0.04210755597494975,"score_gpt":0.2763084119615964,"score_spread":0.23420085598664664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039971449","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35261023,0.032013446,0.0032633715,0.5881402,0.010278984,0.0042275065,0.0005763752,0.00050994137,0.008379991],"genre_scores_gemma":[0.8519661,0.00008120629,0.0010692866,0.14245923,0.0036673984,0.000051311956,0.00045747164,0.00015777163,0.00009025885],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966027,0.00018992981,0.0016779709,0.00034841237,0.00034599358,0.0008350048],"domain_scores_gemma":[0.99102104,0.0005133572,0.0060734428,0.00045036981,0.0019207515,0.00002101331],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070604583,0.00045162544,0.003182156,0.0008992003,0.00008921117,0.000027605725,0.0007347282,0.00068877434,0.000051710464],"category_scores_gemma":[0.00035267638,0.0003779244,0.00042054968,0.00073859014,0.0004853767,0.00024107925,0.00013923054,0.0011763861,0.000022693843],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035069027,0.00021270034,0.084482595,0.016283624,0.00090905785,0.0008891683,0.00023680259,6.2269066e-7,0.00014295246,0.0061104316,0.8454527,0.044928607],"study_design_scores_gemma":[0.0010972306,0.0005524632,0.008569673,0.0016664563,0.00040421868,0.001559504,0.0009529264,0.0000037137738,0.00009237078,0.0010634145,0.98327136,0.00076669274],"about_ca_topic_score_codex":0.002934929,"about_ca_topic_score_gemma":0.00044524638,"teacher_disagreement_score":0.49935585,"about_ca_system_score_codex":0.0001268503,"about_ca_system_score_gemma":0.00026540842,"threshold_uncertainty_score":0.99986726},"labels":[],"label_agreement":null},{"id":"W2040267768","doi":"10.1002/ajh.20680","title":"Waldenstrom's macroglobulinemia presenting with spinal cord compression: A case report","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Hepatosplenomegaly; Waldenstrom macroglobulinemia; Bone marrow; Cytopenia; Pathology; Lymphoplasmacytic Lymphoma; Macroglobulinemia; Spinal cord compression; Hyperviscosity syndrome; Back pain; Spinal cord; Lymphoma; Internal medicine; Disease; Multiple myeloma","score_opus":0.014939438870727854,"score_gpt":0.3321530409717257,"score_spread":0.31721360210099786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040267768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447715,0.00042060326,0.0015846192,0.0015037066,0.00010422974,0.0001661556,0.0000012774198,0.000023621982,0.0017186541],"genre_scores_gemma":[0.98683006,0.000008321989,0.012239809,0.000120791876,0.0003566014,0.000004258264,0.0000037666562,0.000030566465,0.00040582818],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9976893,0.00010858021,0.0008748019,0.0002533409,0.0005746399,0.0004993515],"domain_scores_gemma":[0.99766463,0.00016847698,0.0010196035,0.00039162883,0.0004919775,0.00026367526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003450169,0.00019021108,0.00090213976,0.0002075586,0.00008874499,0.000019675213,0.00015851921,0.00006077162,0.00009748496],"category_scores_gemma":[0.00015297454,0.00013044907,0.00014820279,0.0003584843,0.0007969224,0.00007447705,0.00008206014,0.00050188415,0.00001108829],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037862654,0.00018814088,0.020867528,0.00009585273,0.00016213926,0.9661161,0.000029603143,0.000025004958,0.00039740987,0.00025770647,0.004411974,0.0036622833],"study_design_scores_gemma":[0.0059986264,0.0035803257,0.0014545239,0.00023087139,0.00014399285,0.9834422,0.00052471005,0.00051456725,0.002077529,0.00006862655,0.0018415131,0.0001225454],"about_ca_topic_score_codex":0.0009690764,"about_ca_topic_score_gemma":0.000035768397,"teacher_disagreement_score":0.019413006,"about_ca_system_score_codex":0.0011026096,"about_ca_system_score_gemma":0.0029506274,"threshold_uncertainty_score":0.5319559},"labels":[],"label_agreement":null},{"id":"W2041029933","doi":"10.1002/ajh.20368","title":"Congenital methemoglobinemia caused by Hb‐M<sub>Ratnagiri</sub> (β‐63CAT→TAT, His→Tyr) in an Indian family","year":2005,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Methemoglobinemia; Methemoglobin; Hemoglobinopathy; Medicine; Hemoglobin; Pediatrics; Thalassemia; Internal medicine; Hemolytic anemia; Anesthesia","score_opus":0.006810323150346666,"score_gpt":0.25666667657975023,"score_spread":0.24985635342940357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041029933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98886764,0.005451518,0.00010574611,0.004526053,0.00022531445,0.00023380926,0.000012119945,0.000035032026,0.0005427484],"genre_scores_gemma":[0.99426967,0.0010337799,0.0010207292,0.0034428232,0.00012261678,0.0000067005526,0.000017659902,0.000058489222,0.000027526043],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99716467,0.00028572473,0.0011515735,0.00033361014,0.00036880362,0.00069559977],"domain_scores_gemma":[0.9979679,0.00015442952,0.0007326623,0.00034213244,0.00021752184,0.0005853363],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004604751,0.00034777843,0.0013245693,0.00056097924,0.00007039775,0.00001921204,0.0002856553,0.00025031535,0.00006242511],"category_scores_gemma":[0.0001576416,0.00028796782,0.00023180897,0.0006909793,0.0006001278,0.00021888856,0.000041514497,0.0010383883,0.00006231054],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028799144,0.004017812,0.12236521,0.00017818047,0.0016354227,0.010474245,0.010809025,0.00025834804,0.39308926,0.00064481894,0.044954542,0.40869322],"study_design_scores_gemma":[0.07764552,0.045339506,0.095920116,0.0017929354,0.0035905144,0.13031647,0.12703669,0.0023564212,0.39316195,0.0013281371,0.11533165,0.00618009],"about_ca_topic_score_codex":0.00012410717,"about_ca_topic_score_gemma":0.00016255052,"teacher_disagreement_score":0.40251315,"about_ca_system_score_codex":0.00020943797,"about_ca_system_score_gemma":0.0004669516,"threshold_uncertainty_score":0.99995726},"labels":[],"label_agreement":null},{"id":"W2041622724","doi":"10.1002/(sici)1096-8652(200001)63:1<54::aid-ajh12>3.0.co;2-b","title":"PCR-based diagnosis of the Filipino (??FIL) and Thai (??THAI) ?-thalassemia-1 deletions","year":2000,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Thalassemia; Medicine; Beta thalassemia; Genetics; Internal medicine; Biology","score_opus":0.005600731001218741,"score_gpt":0.23767255593268427,"score_spread":0.23207182493146553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041622724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842292,0.0018665049,0.000056606787,0.0126056895,0.00010153038,0.000114132665,0.000005249158,0.000008270165,0.0010128284],"genre_scores_gemma":[0.9965794,0.0012861021,0.00074900035,0.0012453793,0.000030007464,0.000005036536,0.0000011087371,0.000014849479,0.00008911139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882454,0.00014154131,0.0005005407,0.000118861724,0.0001950364,0.00021946344],"domain_scores_gemma":[0.9988832,0.00025822793,0.00039281455,0.00022191841,0.0001022155,0.00014162705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001566133,0.00012789638,0.00059442624,0.00011202514,0.00007352505,0.0000044121803,0.00013495288,0.000084627165,0.0005111137],"category_scores_gemma":[0.00013152791,0.000078032404,0.00020586335,0.0003352109,0.0007849516,0.000034117165,0.000017841432,0.00035734763,0.00000699113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005414421,0.0009115387,0.89076465,0.00015814602,0.00050390075,0.00029295988,0.0013040713,0.0002661096,0.0011046816,0.0006340586,0.01124787,0.09227059],"study_design_scores_gemma":[0.028972281,0.020381114,0.58054566,0.0059743943,0.005128815,0.08405112,0.028012471,0.0021475626,0.07316111,0.0027194608,0.1669431,0.0019629113],"about_ca_topic_score_codex":0.00006330343,"about_ca_topic_score_gemma":0.0000069051725,"teacher_disagreement_score":0.31021896,"about_ca_system_score_codex":0.000023574617,"about_ca_system_score_gemma":0.00018778165,"threshold_uncertainty_score":0.5596337},"labels":[],"label_agreement":null},{"id":"W2041712143","doi":"10.1002/ajh.20699","title":"Thymoma followed by paroxysmal nocturnal hemoglobinuria: A unique clinical association in the context of multiorgan autoimmunity with a potential role for CD8+ T lymphocytes","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Thymoma; Myasthenia gravis; Hemoglobinuria; Medicine; Context (archaeology); Immunology; Autoimmune hemolytic anemia; Pathology; Biology; Antibody","score_opus":0.005345291744602563,"score_gpt":0.26713961190231555,"score_spread":0.261794320157713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041712143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948929,0.00046838095,0.0011488309,0.0029629727,0.00009826326,0.00031844075,0.0000176781,0.000007389729,0.00008516488],"genre_scores_gemma":[0.9969318,0.000026387666,0.0022660748,0.00057311024,0.00011648895,0.000010469224,0.0000133608055,0.000019976482,0.00004233002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975725,0.00052629755,0.0011289534,0.00014409806,0.00032377662,0.0003044065],"domain_scores_gemma":[0.996944,0.00072900415,0.0016762074,0.0001960024,0.00037949395,0.0000753046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013231513,0.0001709755,0.0011007098,0.00012263036,0.000063408785,0.000013270745,0.00022393264,0.00012659181,0.000016228312],"category_scores_gemma":[0.00028549143,0.00010449952,0.00029829715,0.0002475364,0.0003244321,0.00006372406,0.000018373421,0.0004119173,0.0000010820721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009063265,0.0022462623,0.9580444,0.000054304972,0.0006852428,0.00043225754,0.0014568819,0.00001798323,0.011273632,0.0016218084,0.0053232675,0.009780679],"study_design_scores_gemma":[0.076307684,0.038251583,0.7656901,0.00081823237,0.0022659614,0.038526427,0.028611235,0.002039169,0.031925842,0.0032099525,0.011370093,0.0009837217],"about_ca_topic_score_codex":0.00064422976,"about_ca_topic_score_gemma":0.00015322228,"teacher_disagreement_score":0.19235432,"about_ca_system_score_codex":0.00012982145,"about_ca_system_score_gemma":0.00040191322,"threshold_uncertainty_score":0.42613667},"labels":[],"label_agreement":null},{"id":"W2042544679","doi":"10.1002/ajh.20653","title":"ADAMTS13 activity in sickle cell disease","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mach-Gaensslen Foundation of Canada; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Medicine; Disease; ADAMTS13; Internal medicine; Thrombotic thrombocytopenic purpura","score_opus":0.003780845232269668,"score_gpt":0.23214474781064134,"score_spread":0.22836390257837166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042544679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918378,0.0012143082,0.00019561974,0.0039918106,0.00009751898,0.00006933182,0.0000011001471,0.000008447221,0.0025840537],"genre_scores_gemma":[0.99894226,0.000119521996,0.0004096728,0.00033037766,0.000048613085,0.0000011781366,9.812395e-7,0.000012444747,0.0001349341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991147,0.000073941796,0.00033227983,0.00010301044,0.00014298462,0.00023309032],"domain_scores_gemma":[0.99927604,0.0000706312,0.00030656304,0.00012394914,0.000060388786,0.00016243843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118278505,0.000100055724,0.0004900647,0.00018149528,0.000021573605,0.0000034758712,0.00006816662,0.00004272689,0.00005847061],"category_scores_gemma":[0.00004112889,0.000076337754,0.00012435051,0.00025579418,0.00023498895,0.000048900398,0.00001536002,0.0003235313,0.000016876893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037069754,0.0036716333,0.9238783,0.00023410174,0.00011549818,0.011181978,0.0003948846,0.0004848805,0.008968889,0.0015568839,0.011170374,0.034635596],"study_design_scores_gemma":[0.014994766,0.0055320817,0.9181741,0.0006695021,0.0006392039,0.011315402,0.004295447,0.0009863977,0.013435194,0.003427702,0.02567502,0.00085520255],"about_ca_topic_score_codex":0.0001982821,"about_ca_topic_score_gemma":0.000016440752,"teacher_disagreement_score":0.033780392,"about_ca_system_score_codex":0.0000423881,"about_ca_system_score_gemma":0.00020224314,"threshold_uncertainty_score":0.3112963},"labels":[],"label_agreement":null},{"id":"W2043355737","doi":"10.1002/ajh.21896","title":"Quality of life in thalassemia: A comparison of SF‐36 results from the thalassemia longitudinal cohort to reported literature and the US norms","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Thalassemia; Cohort; Medicine; Quality of life (healthcare); Pediatrics; Beta thalassemia; Internal medicine","score_opus":0.014940780160300413,"score_gpt":0.3136953777836498,"score_spread":0.2987545976233494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043355737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863712,0.0017756961,0.00003343473,0.0109850895,0.00020608831,0.00026766534,0.000019175706,0.000004649955,0.00033695504],"genre_scores_gemma":[0.99865216,0.00027648467,0.00055189274,0.0004332739,0.000054103522,0.000003206161,0.0000076090387,0.00001154426,0.000009711953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709696,0.00031601457,0.0017943195,0.00021225627,0.0003574181,0.00022304316],"domain_scores_gemma":[0.9955526,0.0014119268,0.0020340977,0.0004760661,0.00035852814,0.00016680051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016447777,0.000168012,0.0015490868,0.00012236983,0.00004682814,0.000010789959,0.0002276328,0.00017764892,0.000011437334],"category_scores_gemma":[0.003256377,0.000080096754,0.0001784755,0.00053435384,0.0010450336,0.00004549307,0.00006826707,0.0013105986,7.9245746e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052162046,0.00019607828,0.98488086,0.000031712676,0.0003648257,0.00011223919,0.0046178824,0.000012496076,0.002269029,0.00033262707,0.0010915819,0.000874488],"study_design_scores_gemma":[0.0046251523,0.00058940693,0.9869239,0.00035077456,0.00018754549,0.0017306573,0.004021025,0.000073855146,0.0008614706,0.00026912728,0.00027080992,0.00009628568],"about_ca_topic_score_codex":0.0016595188,"about_ca_topic_score_gemma":0.000535571,"teacher_disagreement_score":0.012280929,"about_ca_system_score_codex":0.000015168239,"about_ca_system_score_gemma":0.00022720775,"threshold_uncertainty_score":0.56939715},"labels":[],"label_agreement":null},{"id":"W2043595799","doi":"10.1002/ajh.20747","title":"Aberrant expression of T‐cell‐associated markers CD4 and CD7 on B‐cell chronic lymphocytic leukemia","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Immunophenotyping; Chronic lymphocytic leukemia; CD5; Fluorescence in situ hybridization; CD20; Biology; Trisomy; Cancer research; Leukemia; Gene rearrangement; Pathology; Immunology; Flow cytometry; Antibody; Medicine; Chromosome; Gene; Genetics","score_opus":0.006723992156853539,"score_gpt":0.2558490728327741,"score_spread":0.24912508067592054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043595799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941822,0.0021164857,0.00012248263,0.0001630552,0.00011167208,0.0001931079,0.000003929902,0.00001715995,0.0030898969],"genre_scores_gemma":[0.99822676,0.00036758845,0.00064754253,0.00014217962,0.0001012762,0.000004235112,0.0000055547052,0.00004265765,0.00046218684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99738705,0.00023466769,0.0009316261,0.00027502794,0.0006239612,0.0005476506],"domain_scores_gemma":[0.99741775,0.0006511927,0.0011004489,0.00033985535,0.00024483676,0.00024594378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048647347,0.0002483749,0.0011813072,0.00037874715,0.000060169208,0.000009612713,0.00021552881,0.00013944601,0.00011212638],"category_scores_gemma":[0.00018122217,0.00019284712,0.00020297074,0.00036844407,0.00082175655,0.00006329711,0.00007633219,0.00040551426,0.000016396027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.01715146,0.0017764319,0.016864821,0.002855958,0.0008634941,0.010805518,0.0014339837,0.0030272363,0.877624,0.0009990116,0.05420347,0.012394639],"study_design_scores_gemma":[0.08204957,0.017525919,0.0073067667,0.0027958588,0.00063493877,0.019768286,0.0019660734,0.01206515,0.8529403,0.00055243756,0.001650496,0.00074415933],"about_ca_topic_score_codex":0.00090528827,"about_ca_topic_score_gemma":0.000020990019,"teacher_disagreement_score":0.06489811,"about_ca_system_score_codex":0.020883154,"about_ca_system_score_gemma":0.01333141,"threshold_uncertainty_score":0.99226207},"labels":[],"label_agreement":null},{"id":"W2046186673","doi":"10.1002/ajh.23202","title":"Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors","year":2012,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":366,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital; McMaster University","funders":"Daiichi Sankyo Europe; Grifols; Astellas Pharma; Eisai; Sanofi; CSL Behring; GlaxoSmithKline; Pfizer","keywords":"Dabigatran; Rivaroxaban; Medicine; Apixaban; Prothrombin complex concentrate; Intensive care medicine; Warfarin; Drug; Hemostasis; Antidote; Activated charcoal; Expert opinion; Pharmacology; Internal medicine; Atrial fibrillation","score_opus":0.1318674564263781,"score_gpt":0.398016953624913,"score_spread":0.2661494971985349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046186673","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00499435,0.9916634,0.000026440333,0.0021616882,0.0006278022,0.00032943487,0.0000045704014,0.0000054188336,0.00018689632],"genre_scores_gemma":[0.016597174,0.9823399,0.00038527997,0.00013040024,0.0003818213,9.709681e-7,0.0000024382982,0.000026013506,0.0001359677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982226,0.0002569316,0.0009770124,0.00011514501,0.0002461664,0.00018217572],"domain_scores_gemma":[0.9971724,0.00040856178,0.0020297547,0.00020484463,0.000083605766,0.0001007895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037793038,0.00021814751,0.002373672,0.00020009998,0.00003066091,0.0000040832065,0.00012735366,0.000076494034,0.00018758261],"category_scores_gemma":[0.00020832234,0.000114399176,0.00048786477,0.0002296671,0.00030896487,0.000039399027,0.00005630999,0.00029022188,0.000013757247],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016535842,0.000040514296,0.015655207,0.0039019124,0.0016806731,0.000055411467,0.00025747146,2.5065216e-7,0.0000077849645,0.0053436216,0.008923243,0.9639686],"study_design_scores_gemma":[0.0003116525,0.0007655586,0.0006471935,0.0025189333,0.0014706186,0.0007878092,0.00017847426,3.4211277e-7,0.00001889487,0.000029924286,0.9931476,0.00012300191],"about_ca_topic_score_codex":0.000009198729,"about_ca_topic_score_gemma":9.053449e-7,"teacher_disagreement_score":0.9842244,"about_ca_system_score_codex":0.000036382175,"about_ca_system_score_gemma":0.000098458666,"threshold_uncertainty_score":0.4665063},"labels":[],"label_agreement":null},{"id":"W2047177706","doi":"10.1002/ajh.21053","title":"Characteristics of participants with self‐reported hemochromatosis or iron overload at HEIRS study initial screening","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Center for Research Resources; U.S. Public Health Service","keywords":"Hemochromatosis; Medicine; Hereditary hemochromatosis; Internal medicine","score_opus":0.02664994957869372,"score_gpt":0.3279629238013846,"score_spread":0.3013129742226909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047177706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981536,0.00013592243,0.0010178195,0.00014591914,0.00013223487,0.0002181633,0.0000035333703,0.000019891995,0.00017286786],"genre_scores_gemma":[0.99494505,0.00004862889,0.004592002,0.0002756223,0.00007992437,0.0000022232398,0.0000032059768,0.000029810784,0.000023534698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762714,0.00011098304,0.0011695849,0.00018217332,0.00045460544,0.0004554981],"domain_scores_gemma":[0.997314,0.00021904963,0.0016455633,0.00026363894,0.00027017656,0.0002876166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000591944,0.00020391821,0.0012847343,0.00026102082,0.000063261774,0.0000052013384,0.00011649266,0.000053543874,0.00014188321],"category_scores_gemma":[0.0002471886,0.00013679334,0.000106361185,0.0003624766,0.00038371133,0.00007774407,0.000046311885,0.00023149312,0.000004185821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010620096,0.001644689,0.9682853,0.000120491786,0.0005268307,0.0050890762,0.0032187721,0.0000025332338,0.0011271912,0.000028342834,0.0001318322,0.009204808],"study_design_scores_gemma":[0.007224747,0.010339787,0.94322336,0.00017006755,0.0017583399,0.0146862855,0.0158914,0.000012267207,0.0062157786,0.000003892085,0.00022539381,0.00024869214],"about_ca_topic_score_codex":0.00006825962,"about_ca_topic_score_gemma":0.000050249895,"teacher_disagreement_score":0.025061987,"about_ca_system_score_codex":0.000033787946,"about_ca_system_score_gemma":0.00021090159,"threshold_uncertainty_score":0.55782706},"labels":[],"label_agreement":null},{"id":"W2048360052","doi":"10.1002/ajh.10255","title":"Severe chronic neutropenia: Treatment and follow‐up of patients in the Severe Chronic Neutropenia International Registry","year":2003,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":376,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; CancerCare Manitoba","funders":"Amgen","keywords":"Medicine; Neutropenia; Filgrastim; Internal medicine; Absolute neutrophil count; Congenital Neutropenia; Leukopenia; Granulocyte colony-stimulating factor; Adverse effect; Gastroenterology; Pediatrics; Surgery; Chemotherapy","score_opus":0.01105449617154365,"score_gpt":0.280331050174908,"score_spread":0.26927655400336437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048360052","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056250226,0.9425844,0.0000049505243,0.000085928754,0.0002928327,0.00039654877,0.00006720131,0.0000013721543,0.00031655552],"genre_scores_gemma":[0.08053095,0.9188986,0.00008702412,0.00006116155,0.00009285549,0.000030053723,0.00013639472,0.000034600896,0.00012835575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980436,0.00036680032,0.0008132091,0.00033436576,0.00015822411,0.0002838279],"domain_scores_gemma":[0.99790484,0.000054712407,0.0014579193,0.00040097354,0.00010805217,0.0000735147],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011975155,0.0003920589,0.0014980474,0.0001274386,0.00004330681,0.00001918123,0.0005168527,0.00018820027,0.000023411323],"category_scores_gemma":[0.000027862383,0.00024593747,0.00042579972,0.00015757763,0.0002795493,0.000008931479,0.00008962567,0.00024722063,0.0000032452228],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027945545,0.0010036842,0.011570316,0.0010534446,0.0028430177,0.00019841015,0.00012010052,0.000008521825,0.000009985363,0.00015093504,0.0020043838,0.9807578],"study_design_scores_gemma":[0.0056426665,0.006012102,0.00039134832,0.0010506485,0.0010536201,0.0048462464,0.00015929571,5.805767e-7,0.00004113358,0.000027342216,0.98037803,0.0003969915],"about_ca_topic_score_codex":0.00006201654,"about_ca_topic_score_gemma":0.00016725517,"teacher_disagreement_score":0.98036075,"about_ca_system_score_codex":0.00015323171,"about_ca_system_score_gemma":0.00068998936,"threshold_uncertainty_score":0.9999993},"labels":[],"label_agreement":null},{"id":"W2049540913","doi":"10.1002/ajh.21308","title":"Hemoglobin Kenya composed of α‐ and (<sup>A</sup>γβ)‐fusion‐globin chains, associated with hereditary persistence of fetal hemoglobin","year":2008,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; McGill University","keywords":"Fetal hemoglobin; Globin; Hemoglobinopathy; Compound heterozygosity; Hemoglobin; Asymptomatic; Gene; Genetics; Mutation; Biology; Fetus; Molecular biology; Hemolytic anemia; Medicine; Immunology; Internal medicine; Pregnancy; Biochemistry","score_opus":0.017567806367920345,"score_gpt":0.2635372216025085,"score_spread":0.24596941523458812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049540913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10641538,0.89182305,0.000039131646,0.00033179016,0.00013837896,0.0006822191,0.0000939224,0.000025987662,0.0004501185],"genre_scores_gemma":[0.07084002,0.9273706,0.0013013243,0.00014148388,0.00007255883,0.0000069851026,0.00007919939,0.00010154783,0.0000862978],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99466157,0.00064208434,0.0026558868,0.0005359592,0.000818437,0.0006860799],"domain_scores_gemma":[0.9928683,0.000698796,0.0046999315,0.0005381082,0.00070561713,0.0004892312],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00048660807,0.0008268161,0.007770166,0.0007698301,0.00011973276,0.000007938928,0.0004903596,0.00061184145,0.00006278231],"category_scores_gemma":[0.00043336322,0.00057198375,0.001144747,0.0012877071,0.0028703376,0.00009872092,0.00015517633,0.001446232,0.000004673363],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027816964,0.0042101373,0.00700285,0.024923692,0.014022612,0.014548923,0.003717384,0.00014637363,0.00005641703,0.0002954791,0.008126851,0.92016757],"study_design_scores_gemma":[0.022690425,0.036323473,0.0008142707,0.16216387,0.017715454,0.54001343,0.02356175,0.0010744435,0.0001462263,0.00006445661,0.19193026,0.0035019177],"about_ca_topic_score_codex":0.00008652721,"about_ca_topic_score_gemma":0.0000060823068,"teacher_disagreement_score":0.9166657,"about_ca_system_score_codex":0.00020720836,"about_ca_system_score_gemma":0.0016325947,"threshold_uncertainty_score":0.9998433},"labels":[],"label_agreement":null},{"id":"W2052482483","doi":"10.1002/ajh.20601","title":"Chronic eosinophilic leukemia presenting with autoimmune hemolytic anemia and erythrophagocytosis by eosinophils","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program; McMaster University; Grand River Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Autoimmune hemolytic anemia; Medicine; Immunology; Eosinophilic; Hemolytic anemia; Leukemia; Anemia; Eosinophilia; Eosinophil; Pathology; Internal medicine; Antibody; Asthma","score_opus":0.004466520734331537,"score_gpt":0.22946762718537334,"score_spread":0.2250011064510418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052482483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795464,0.015120188,0.00024690063,0.0039774273,0.00007596771,0.00018739868,0.000003596075,0.000032400225,0.00080966763],"genre_scores_gemma":[0.9970259,0.00036786855,0.0017804196,0.00027757388,0.00014968097,0.0000053326235,0.000008235554,0.000049678874,0.00033531798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791974,0.00008741667,0.0007923695,0.00030824222,0.00036621676,0.0005260141],"domain_scores_gemma":[0.99837476,0.00015698672,0.0008104456,0.00030693883,0.000163991,0.00018689281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019969937,0.0003045285,0.0012620543,0.00026025492,0.00012474596,0.000034023196,0.00016901745,0.000093692084,0.00006999592],"category_scores_gemma":[0.000042083862,0.00022816885,0.00013610139,0.00039426112,0.0011317289,0.00015469689,0.00005194099,0.00042869567,0.0000068090344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021791144,0.0017167742,0.76457906,0.001873477,0.0020674125,0.009599224,0.0016135153,0.00019211203,0.094207264,0.004455957,0.0312501,0.08626599],"study_design_scores_gemma":[0.028638138,0.03455848,0.43250528,0.0023607106,0.0031477418,0.42667052,0.0038956674,0.0010334317,0.038625922,0.0039027962,0.02201582,0.002645521],"about_ca_topic_score_codex":0.0002819858,"about_ca_topic_score_gemma":0.000012559236,"teacher_disagreement_score":0.41707128,"about_ca_system_score_codex":0.00019935172,"about_ca_system_score_gemma":0.00045015928,"threshold_uncertainty_score":0.93044555},"labels":[],"label_agreement":null},{"id":"W2053625299","doi":"10.1002/ajh.20305","title":"Immune heparin-induced thrombocytopenia can occur in patients receiving clopidogrel and aspirin","year":2005,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"","keywords":"Clopidogrel; Medicine; Aspirin; Ticlopidine; Platelet; Platelet activation; Heparin-induced thrombocytopenia; Heparin; Pharmacology; Ex vivo; Adenosine diphosphate; Internal medicine; Immunology; Chemistry; In vitro; Platelet aggregation; Biochemistry","score_opus":0.015692945655562212,"score_gpt":0.28432171746085916,"score_spread":0.26862877180529693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053625299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944521,0.00027801938,0.000012826747,0.0035479357,0.00022530183,0.0002667876,0.000002135967,0.000020195957,0.001194698],"genre_scores_gemma":[0.99617624,0.00022113329,0.002588396,0.0008185954,0.00011933474,0.000005659038,0.000004646137,0.00004352203,0.000022456297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731714,0.00021473618,0.0012379442,0.00033980265,0.0003086277,0.00058176037],"domain_scores_gemma":[0.9980548,0.00017860637,0.000819302,0.00036029247,0.00023200682,0.00035497843],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048043282,0.00031346764,0.0019380827,0.00048387903,0.00007916804,0.000024341565,0.00024587975,0.00013743572,0.000072793875],"category_scores_gemma":[0.00024254929,0.00027167425,0.00016876552,0.00049651874,0.00030601243,0.00021861019,0.00013422575,0.0007466565,0.000028309412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041975564,0.0005809597,0.9041431,0.000048402544,0.00025316406,0.00014811175,0.0011438979,0.0000032807732,0.0070938207,0.00039770512,0.00012802338,0.085639805],"study_design_scores_gemma":[0.004775934,0.002845977,0.980001,0.00033995134,0.00014471261,0.0019239933,0.0005248144,0.000036247646,0.007914366,0.000065883236,0.0011249109,0.00030224439],"about_ca_topic_score_codex":0.00034433763,"about_ca_topic_score_gemma":0.0003596614,"teacher_disagreement_score":0.085337564,"about_ca_system_score_codex":0.00023603733,"about_ca_system_score_gemma":0.0002939786,"threshold_uncertainty_score":0.99997354},"labels":[],"label_agreement":null},{"id":"W2053912111","doi":"10.1002/ajh.10057","title":"Platelet activation and hypercoagulability following treatment with porcine factor VIII (HYATE:C)","year":2002,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; McMaster University; University of Toronto; St. Michael's Hospital","funders":"Ipsen; Canadian Hemophilia Society","keywords":"Platelet; Prothrombinase; Coagulation; Platelet activation; Hemostasis; Tissue factor; Von Willebrand factor; In vivo; Chemistry; Internal medicine; Immunology; Platelet factor 4; Medicine; Endocrinology; Thrombin; Biology","score_opus":0.03100185183279867,"score_gpt":0.3006443947065569,"score_spread":0.2696425428737582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053912111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392194,0.00045218092,0.000056390603,0.005122574,0.000029558902,0.00016535902,0.0000011472753,0.000010723998,0.00024013205],"genre_scores_gemma":[0.99817044,0.00021320466,0.0012991333,0.00009504677,0.000048043086,0.0000036438817,0.0000018567796,0.000013991602,0.0001546403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906915,0.00006877949,0.0002823224,0.00014787297,0.00020895821,0.00022292671],"domain_scores_gemma":[0.9992342,0.00016302965,0.00018353129,0.00013945343,0.0000893354,0.00019046734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008228866,0.00014042911,0.0006535792,0.00015963544,0.0000588473,0.0000077535315,0.00003922631,0.000040777748,0.00014568875],"category_scores_gemma":[0.000047363978,0.0000785912,0.000094565214,0.00018017263,0.00021588392,0.00009033336,0.000010063519,0.00014453898,0.0000070746178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011650212,0.00094136345,0.8130169,0.000043222695,0.0010214573,0.0021110077,0.0013574605,0.000001531489,0.011216186,0.000042386793,0.0001356988,0.16894777],"study_design_scores_gemma":[0.046852164,0.1300095,0.4420751,0.0010201042,0.0014414549,0.075012006,0.008329158,0.00067192107,0.28176317,0.00027389938,0.0114179775,0.001133526],"about_ca_topic_score_codex":0.00003929099,"about_ca_topic_score_gemma":0.0000036468011,"teacher_disagreement_score":0.3709418,"about_ca_system_score_codex":0.000111778965,"about_ca_system_score_gemma":0.000057476762,"threshold_uncertainty_score":0.32048562},"labels":[],"label_agreement":null},{"id":"W2054534658","doi":"10.1002/ajh.23205","title":"The prognostic significance of lymphopenia in peripheral T‐cell and natural killer/T‐cell lymphomas: A study of 826 cases from the International Peripheral T‐cell Lymphoma Project","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institutes of Health","keywords":"Lymphoma; Anaplastic large-cell lymphoma; Medicine; Peripheral T-cell lymphoma; T-cell lymphoma; Internal medicine; Anaplastic lymphoma kinase; Not Otherwise Specified; Natural killer cell; Gastroenterology; Pathology; T cell; Immunology; Biology; Immune system; Cytotoxic T cell; Pleural effusion","score_opus":0.012272677754966764,"score_gpt":0.2720979502373004,"score_spread":0.2598252724823336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054534658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864208,0.011451991,0.0000033302097,0.00062422064,0.00051787094,0.0007314978,0.000011123874,0.00000612984,0.00023304592],"genre_scores_gemma":[0.99837375,0.0005724627,0.00057144824,0.0001890768,0.0001276478,0.00006416277,0.000004698825,0.000027053366,0.00006969783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747705,0.00037847308,0.001003737,0.0002434534,0.0004904925,0.00040680522],"domain_scores_gemma":[0.9964559,0.0016632042,0.0012148451,0.00032303488,0.00021784358,0.0001251853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038256086,0.00028953838,0.00096078473,0.00012667516,0.00009805207,0.000027919808,0.0003872816,0.00005532797,0.00003138167],"category_scores_gemma":[0.00018906951,0.00015752175,0.00018157835,0.00029114934,0.0006086548,0.00014062227,0.000120455494,0.00014093339,0.0000015525098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017077776,0.0053366455,0.9753547,0.00003734676,0.000333617,0.00045740913,0.008491655,0.0000061536025,0.0013117794,0.000037463185,0.00037288317,0.0065525994],"study_design_scores_gemma":[0.021205878,0.00651712,0.8881476,0.00024867544,0.0006098234,0.0058591547,0.06477763,0.00017710627,0.010758551,0.000030074829,0.0013518756,0.00031653262],"about_ca_topic_score_codex":0.0026102674,"about_ca_topic_score_gemma":0.00026865554,"teacher_disagreement_score":0.087207094,"about_ca_system_score_codex":0.000276697,"about_ca_system_score_gemma":0.00053154724,"threshold_uncertainty_score":0.642355},"labels":[],"label_agreement":null},{"id":"W2054820765","doi":"10.1002/1096-8652(200101)66:1<42::aid-ajh1006>3.0.co;2-v","title":"EBV-associated perianal Hodgkin's disease in an HIV-positive individual","year":2000,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"","keywords":"CD15; Lymphoma; Pathology; Medicine; Reed–Sternberg cell; Biopsy; CD20; Population; CD30; Incidence (geometry); Disease; Hodgkin lymphoma; Biology; CD34","score_opus":0.008123888830586136,"score_gpt":0.2742044161890516,"score_spread":0.2660805273584655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054820765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947537,0.0005570766,0.000016053937,0.0036038314,0.000067915236,0.00010323446,0.000030749357,0.000015209597,0.00085222675],"genre_scores_gemma":[0.99743986,0.00013890021,0.00019056349,0.0020151432,0.00006631139,0.000004025238,0.000032944372,0.00002337961,0.0000888979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982937,0.00026130295,0.00053342374,0.00019018797,0.00032094226,0.00040041996],"domain_scores_gemma":[0.99881136,0.00007563106,0.00043895945,0.00014129799,0.00013453566,0.00039819092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026499323,0.00017075615,0.00079557137,0.00025081504,0.000055311433,0.000017060935,0.00016083704,0.00007298077,0.00075415266],"category_scores_gemma":[0.00012963952,0.00014988103,0.00017358792,0.00042803827,0.00032399173,0.00015449048,0.000013278388,0.00041144143,0.00002114415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003723518,0.0012464578,0.949308,0.00001342738,0.00043205457,0.0028865195,0.0026163042,0.00014516905,0.000086410604,0.00022359096,0.002358578,0.036960013],"study_design_scores_gemma":[0.008664276,0.0050618737,0.9780888,0.0002249965,0.0005160379,0.00084971794,0.0045324,0.000218648,0.000082282735,0.00060242636,0.0008021837,0.00035637125],"about_ca_topic_score_codex":0.0001277029,"about_ca_topic_score_gemma":0.00008744344,"teacher_disagreement_score":0.036603644,"about_ca_system_score_codex":0.00016660811,"about_ca_system_score_gemma":0.00044233506,"threshold_uncertainty_score":0.8257443},"labels":[],"label_agreement":null},{"id":"W2056903619","doi":"10.1002/ajh.23138","title":"A novel mutation in MPL (Y252H) results in increased thrombopoietin sensitivity in essential thrombocythemia","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Thrombopoietin; Essential thrombocythemia; Medicine; Mutation; Plateletpheresis; Thrombopoietin receptor; Myelofibrosis; Platelet; Immunology; Internal medicine; Genetics; Biology; Haematopoiesis; Gene; Bone marrow","score_opus":0.014848053300557865,"score_gpt":0.30426786043168563,"score_spread":0.28941980713112775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056903619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967915,0.00018048582,0.00019085982,0.0021996782,0.00010233335,0.00022973953,0.0000072595235,0.000005671442,0.00029246233],"genre_scores_gemma":[0.9961101,0.00006905901,0.0033841194,0.00031032512,0.00008301023,0.000012110803,0.000012286803,0.000016310785,0.0000027097642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979861,0.00030591557,0.00087861595,0.00019055662,0.00023135782,0.00040748177],"domain_scores_gemma":[0.9984175,0.0006170993,0.00056158553,0.00014911756,0.00009784588,0.00015685495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010064611,0.0001856215,0.0010666981,0.00047265546,0.000018879517,0.0000064331616,0.000048848226,0.00008096414,0.000026149757],"category_scores_gemma":[0.00049124967,0.00015156758,0.00009333766,0.00048778864,0.00020169995,0.00015904948,0.000026834216,0.00040726722,0.000010739299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018335246,0.0026254803,0.97940546,0.000029286342,0.00008709918,0.0017989622,0.0030647197,0.000041819636,0.008443273,0.0006374467,0.000097718126,0.0019351891],"study_design_scores_gemma":[0.008833951,0.0009066118,0.96058875,0.00035073917,0.000055214943,0.008373481,0.0016102961,0.00013313022,0.018893905,0.00007377248,0.000039103666,0.00014103502],"about_ca_topic_score_codex":0.0017215692,"about_ca_topic_score_gemma":0.002253133,"teacher_disagreement_score":0.018816723,"about_ca_system_score_codex":0.00020499973,"about_ca_system_score_gemma":0.00020670601,"threshold_uncertainty_score":0.61807466},"labels":[],"label_agreement":null},{"id":"W2056966986","doi":"10.1002/ajh.21209","title":"Pure red cell aplasia in a patient with adult‐onset Still's disease","year":2008,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"University of Illinois at Urbana-Champaign","keywords":"Hematopathology; Library science; Columbia university; Medicine; Family medicine; Sociology; Media studies; Computer science","score_opus":0.0070040966609197725,"score_gpt":0.24407631142626096,"score_spread":0.23707221476534118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056966986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65740055,0.0019739259,0.000024198955,0.3393723,0.00010750288,0.0004294809,0.000018964443,0.000016028473,0.0006570668],"genre_scores_gemma":[0.79188544,0.0015464895,0.0005754461,0.20502524,0.0003068166,0.00003994909,0.0000989145,0.00012586926,0.00039582376],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968679,0.00033418802,0.0010745412,0.0003198342,0.00076714065,0.0006363771],"domain_scores_gemma":[0.99730664,0.00017618186,0.0013054723,0.0004896894,0.00046091748,0.00026108578],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00011205752,0.00037776443,0.0018033345,0.000783772,0.000044375265,0.000010509576,0.00029608322,0.0002533161,0.00013291341],"category_scores_gemma":[0.00019390612,0.00026950048,0.000264534,0.00043363275,0.0008267003,0.00007724407,0.00005670585,0.003105834,0.000032567987],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027820736,0.00029456965,0.032895453,0.00044053877,0.00020055306,0.20914987,0.00069690484,0.000007683951,0.0000103999155,0.0000031478262,0.7510542,0.0024645873],"study_design_scores_gemma":[0.007491268,0.012127702,0.010469199,0.002580371,0.00040140474,0.13045092,0.0027974453,0.000039212944,0.00020178205,0.0000802007,0.83245033,0.0009101755],"about_ca_topic_score_codex":0.00003726499,"about_ca_topic_score_gemma":0.000008114594,"teacher_disagreement_score":0.1344849,"about_ca_system_score_codex":0.00012525133,"about_ca_system_score_gemma":0.0015772285,"threshold_uncertainty_score":0.99997574},"labels":[],"label_agreement":null},{"id":"W2058115183","doi":"10.1002/ajh.21032","title":"What is the potential for overdiagnosis of heparin‐induced thrombocytopenia?","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"Regional Medical Associates of Hamilton; Sanofi; Heart and Stroke Foundation of Canada; GlaxoSmithKline","keywords":"Overdiagnosis; Heparin-induced thrombocytopenia; Medicine; Heparin; Intensive care medicine; Internal medicine","score_opus":0.024266096464233326,"score_gpt":0.3335324730200309,"score_spread":0.3092663765557976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058115183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98670125,0.0005884692,0.0015342572,0.009359007,0.0009740635,0.00046420627,0.0000046127366,0.000011866268,0.0003622525],"genre_scores_gemma":[0.994224,0.00081500347,0.0024632283,0.0021552984,0.0002488799,0.000008885836,0.0000023253444,0.00004062902,0.000041751475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99750847,0.00010748203,0.0011974818,0.0002558633,0.0003924736,0.0005382494],"domain_scores_gemma":[0.9966214,0.0008116213,0.0012609721,0.00048128137,0.0005686554,0.00025608958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011113265,0.0002524865,0.0017267542,0.00026017425,0.00012329848,0.00003075742,0.00039300616,0.00013298924,0.00014841261],"category_scores_gemma":[0.0002143956,0.00016886083,0.00061381236,0.0004319289,0.0005529437,0.00028620232,0.00008772551,0.0004086242,0.00001441826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009481397,0.003820371,0.13487764,0.0006848125,0.009114899,0.0012773555,0.010928437,0.000016944277,0.51392156,0.026988776,0.016942274,0.2719455],"study_design_scores_gemma":[0.0078056366,0.012214975,0.19739196,0.000810203,0.0024586886,0.016054163,0.017607851,0.0000782019,0.7311513,0.002371523,0.011391645,0.00066389894],"about_ca_topic_score_codex":0.00011803807,"about_ca_topic_score_gemma":0.00002776832,"teacher_disagreement_score":0.27128163,"about_ca_system_score_codex":0.00008320496,"about_ca_system_score_gemma":0.0003105855,"threshold_uncertainty_score":0.6885945},"labels":[],"label_agreement":null},{"id":"W2059259609","doi":"10.1002/ajh.20098","title":"Risk of thrombosis in patients with malignancy and heparin‐induced thrombocytopenia","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Malignancy; Thrombosis; Heparin-induced thrombocytopenia; Pulmonary embolism; Heparin; Internal medicine; Odds ratio; Venous thrombosis; Retrospective cohort study; Medical record; Surgery; Gastroenterology","score_opus":0.01067983743953367,"score_gpt":0.26095656197278605,"score_spread":0.2502767245332524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059259609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99852943,0.00012006288,0.0000698721,0.00051844,0.00008262429,0.00029299833,0.000005407299,0.0000100380985,0.00037110134],"genre_scores_gemma":[0.99525434,0.00025344544,0.0042747743,0.00015030768,0.000022576254,0.0000041904486,0.0000023957882,0.000035945006,0.000002023854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791366,0.00014633626,0.000931553,0.0002812888,0.00033503148,0.00039212973],"domain_scores_gemma":[0.997843,0.00012894692,0.0011417969,0.00033321622,0.0003093741,0.00024366273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029902934,0.00026881046,0.0019945295,0.00039661594,0.00005078223,0.000009381628,0.0001806633,0.000103776765,0.000038787588],"category_scores_gemma":[0.00014507744,0.0001961357,0.00013090622,0.00056461914,0.0005081347,0.00019221887,0.000069971255,0.0004838598,0.0000065944423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005932831,0.0007190561,0.99151844,0.00005249357,0.0004566969,0.00007483502,0.00076434034,0.0000069365897,0.002436539,0.0009898273,0.000008917708,0.0023786288],"study_design_scores_gemma":[0.0072832596,0.0066550616,0.97307414,0.00045351314,0.0003777912,0.00057726057,0.0005545532,0.0000013708611,0.010389089,0.00042142512,0.000017346858,0.00019520106],"about_ca_topic_score_codex":0.00060226227,"about_ca_topic_score_gemma":0.00012708329,"teacher_disagreement_score":0.018444316,"about_ca_system_score_codex":0.00011319137,"about_ca_system_score_gemma":0.0003340821,"threshold_uncertainty_score":0.7998182},"labels":[],"label_agreement":null},{"id":"W2060391786","doi":"10.1002/ajh.20436","title":"Co-existence of heparin-induced thrombocytopenia and thrombotic thrombocytopenic purpura in a postoperative cardiac surgery patient","year":2005,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Heparin; Thrombotic thrombocytopenic purpura; Cardiac surgery; Coronary artery bypass surgery; Platelet; Artery; Cardiology; Internal medicine; Population; Thrombocytopenic purpura; Purpura (gastropod); Surgery","score_opus":0.025804920280501076,"score_gpt":0.3048463944160927,"score_spread":0.2790414741355916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060391786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936063,0.001467671,0.000018016275,0.0027667193,0.00024285137,0.00056983717,0.0000117223035,0.000020218038,0.001296664],"genre_scores_gemma":[0.9955636,0.0010490614,0.002532574,0.0006807777,0.00007994238,0.000016730022,0.000006993623,0.000057049532,0.000013223586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99564034,0.0005682462,0.0020218834,0.00051595224,0.00053779094,0.0007158116],"domain_scores_gemma":[0.9963243,0.0008315164,0.0014156252,0.0005549236,0.00045215266,0.00042147283],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008509256,0.00048067112,0.0044201813,0.00069931324,0.00009647513,0.000029202207,0.00029098714,0.00018871852,0.00011800743],"category_scores_gemma":[0.00038471355,0.00040092805,0.00046056442,0.0007974906,0.0009407968,0.00044900243,0.00011521089,0.0007839258,0.0000317435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016860126,0.0019608734,0.6374817,0.00024032041,0.001811681,0.00093684,0.008895475,0.000015437625,0.2503605,0.0034158714,0.0011489457,0.09204637],"study_design_scores_gemma":[0.0030089933,0.008532137,0.6283492,0.0011073524,0.00077622745,0.012476809,0.006769237,0.00008025692,0.3357808,0.00027543318,0.0017626289,0.0010809473],"about_ca_topic_score_codex":0.0002673121,"about_ca_topic_score_gemma":0.000085798245,"teacher_disagreement_score":0.09096543,"about_ca_system_score_codex":0.00028072097,"about_ca_system_score_gemma":0.00085891434,"threshold_uncertainty_score":0.99984425},"labels":[],"label_agreement":null},{"id":"W2060522135","doi":"10.1002/ajh.20024","title":"Nodular regenerative hyperplasia of the liver: An under‐recognized cause of portal hypertension in hematological disorders","year":2004,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Nodular regenerative hyperplasia; Medicine; Portal hypertension; Cirrhosis; Pathology; Lymphoproliferative disorders; Fibrosis; Differential diagnosis; Myeloproliferative Disorders; Portopulmonary hypertension; Internal medicine; Gastroenterology; Lymphoma","score_opus":0.03380239150716408,"score_gpt":0.3139588351083652,"score_spread":0.2801564436012011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060522135","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22675847,0.7723858,0.00007825848,0.00013451664,0.00013381573,0.00043694716,0.000025760402,0.000005300551,0.000041140785],"genre_scores_gemma":[0.37232965,0.627169,0.0003819841,0.00005115367,0.000018206536,0.0000041523117,0.000023786097,0.000020105503,0.0000019309796],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99739444,0.00051611883,0.0013222218,0.00023866282,0.0003169152,0.000211635],"domain_scores_gemma":[0.99721974,0.0002617297,0.0018978736,0.0002879721,0.00019768941,0.00013500056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020343914,0.00029435678,0.0031755057,0.00032543877,0.000027916492,0.000002551426,0.00023094362,0.00018788053,0.00003364292],"category_scores_gemma":[0.00005058145,0.0001700013,0.0006551353,0.0004549085,0.0006337713,0.00007635213,0.000027164991,0.0004927237,0.0000021714773],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00732173,0.016060546,0.061288472,0.10718548,0.02206239,0.03342803,0.0066828737,0.00024170407,0.00039177274,0.022013862,0.0001810271,0.7231421],"study_design_scores_gemma":[0.030758316,0.02346386,0.02157919,0.22457589,0.089961536,0.5805738,0.011966604,0.00011103783,0.0038502533,0.0032796804,0.0068229917,0.003056858],"about_ca_topic_score_codex":0.00010127882,"about_ca_topic_score_gemma":0.00007083135,"teacher_disagreement_score":0.72008526,"about_ca_system_score_codex":0.00005280279,"about_ca_system_score_gemma":0.0009060026,"threshold_uncertainty_score":0.6932452},"labels":[],"label_agreement":null},{"id":"W2063827970","doi":"10.1002/ajh.20812","title":"Pathological splenic rupture: A rare complication of chronic myelomonocytic leukemia","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Chronic myelomonocytic leukemia; Medicine; Complication; Pathological; Spleen; Pathology; Internal medicine; Bone marrow; Myelodysplastic syndromes","score_opus":0.015037321804729647,"score_gpt":0.2978919273949417,"score_spread":0.282854605590212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063827970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905471,0.0021454298,0.0035692602,0.0025297103,0.00007287043,0.00020082008,0.0000046839814,0.000020281137,0.0009098089],"genre_scores_gemma":[0.9942476,0.00019937234,0.0049612266,0.00025561123,0.00022307543,0.000006825126,0.000012227113,0.000023625811,0.0000704173],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979683,0.00019962298,0.00088461087,0.00020752945,0.00035584893,0.00038408343],"domain_scores_gemma":[0.99787736,0.00029458484,0.00092573254,0.000355969,0.00039304653,0.00015331942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036636184,0.00017238982,0.0010619388,0.00030883285,0.000040677292,0.000005911601,0.00028585957,0.00011202828,0.0001742854],"category_scores_gemma":[0.00018326593,0.00012922063,0.00023898938,0.00048851373,0.00090537017,0.000063286534,0.000067911315,0.0006249634,0.000033110693],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008607465,0.0030644918,0.24425527,0.0015731092,0.0016059347,0.015943045,0.001054481,0.00091143046,0.3531701,0.051124018,0.06470518,0.2539855],"study_design_scores_gemma":[0.022107469,0.034592763,0.4620886,0.0012798739,0.001346294,0.34589764,0.002355095,0.005882505,0.08634541,0.0094677815,0.027357483,0.0012790593],"about_ca_topic_score_codex":0.00009497408,"about_ca_topic_score_gemma":0.000007967099,"teacher_disagreement_score":0.3299546,"about_ca_system_score_codex":0.000885754,"about_ca_system_score_gemma":0.0011826227,"threshold_uncertainty_score":0.5269464},"labels":[],"label_agreement":null},{"id":"W2064117411","doi":"10.1002/ajh.20104","title":"Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Serology; Thrombopoietin; Immunology; Platelet; Antibody; Anti-nuclear antibody; Prospective cohort study; Internal medicine; Autoantibody; Population; Gastroenterology; Biology","score_opus":0.030242953654040304,"score_gpt":0.2774411999630983,"score_spread":0.24719824630905798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064117411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976198,0.001101003,0.0001418258,0.00069294503,0.00001523863,0.00021847303,0.00000664745,0.0000063417974,0.00019772637],"genre_scores_gemma":[0.99674875,0.00021958361,0.0029256376,0.00007008509,0.00001530152,0.0000031593108,0.00000528993,0.000011306003,8.94474e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991369,0.00007951278,0.00032803262,0.00012741493,0.00016877003,0.00015934171],"domain_scores_gemma":[0.998605,0.0006489191,0.00050057506,0.000075876014,0.000111289024,0.000058323803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022045185,0.00012259725,0.0007018777,0.000078133984,0.00012991721,0.000008121426,0.000046650344,0.000044678793,0.000008270273],"category_scores_gemma":[0.00024946744,0.0000710164,0.000045411016,0.00013492907,0.0008170059,0.000060697123,0.00003616872,0.00021763473,6.340019e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038403802,0.00007887023,0.9969665,0.000025806445,0.00032371512,0.00011371369,0.00048569322,0.0000045453667,0.0000045740762,0.0006036654,0.000011772817,0.0009971106],"study_design_scores_gemma":[0.0052478737,0.001167452,0.98932123,0.00022868441,0.00021775805,0.0018601794,0.00067432615,0.0000022459042,0.000086144515,0.001112378,0.000011351795,0.00007034877],"about_ca_topic_score_codex":0.00006488399,"about_ca_topic_score_gemma":0.0000042097154,"teacher_disagreement_score":0.0076452373,"about_ca_system_score_codex":0.000021250316,"about_ca_system_score_gemma":0.000038381695,"threshold_uncertainty_score":0.30102924},"labels":[],"label_agreement":null},{"id":"W2064153027","doi":"10.1002/ajh.22268","title":"Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Myeloid leukemia; Neutropenia; Cohort; Chemotherapy; Bacteremia; Internal medicine; Leukemia; Mortality rate; Febrile neutropenia; Pediatrics; Intensive care medicine; Antibiotics","score_opus":0.020949786045548778,"score_gpt":0.2901529863597842,"score_spread":0.26920320031423545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064153027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99860054,0.000029289595,0.00014443703,0.00014790379,0.00017766914,0.00020376084,0.0000028555298,0.0000045815805,0.0006889309],"genre_scores_gemma":[0.99871874,0.000037592596,0.0010027968,0.00019857426,0.0000147306655,0.000004916684,0.000002667585,0.00001160023,0.000008377369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999087,0.00006228229,0.00043277108,0.000113922724,0.00015892644,0.00014510416],"domain_scores_gemma":[0.9988319,0.000043553966,0.0005830769,0.00016346492,0.00029939666,0.00007859459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009302011,0.00009843269,0.0005149994,0.0001529319,0.000015824358,0.0000016508642,0.000066161185,0.00003560621,0.0001650206],"category_scores_gemma":[0.00002214066,0.000071089235,0.00007110219,0.00022324629,0.00029774167,0.00009755861,0.000009692149,0.00019152787,0.0000028404543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009036372,0.00061812607,0.9855744,0.000016183003,0.00021646511,0.000037942253,0.0012005769,0.0000017895417,0.00022066654,0.00013898817,0.000090768815,0.0028477265],"study_design_scores_gemma":[0.010727042,0.007218221,0.9749872,0.00008249597,0.00017625815,0.0003753181,0.00056410773,0.0000016360418,0.0056465752,0.00003288416,0.00009705014,0.00009120664],"about_ca_topic_score_codex":0.000118529264,"about_ca_topic_score_gemma":0.000027654993,"teacher_disagreement_score":0.010587191,"about_ca_system_score_codex":0.00018022048,"about_ca_system_score_gemma":0.00026967213,"threshold_uncertainty_score":0.28989348},"labels":[],"label_agreement":null},{"id":"W2064429031","doi":"10.1002/ajh.10065","title":"Anti‐D (WinRho SD<sup>™</sup>) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production","year":2002,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine; St. Michael's Hospital","funders":"","keywords":"Cytokine; Medicine; Chemokine; Immunology; Platelet; Thrombocytopenic purpura; Internal medicine; Inflammation","score_opus":0.011145003135141635,"score_gpt":0.2483333806694292,"score_spread":0.23718837753428756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064429031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922584,0.0046529905,0.00007105427,0.0023129152,0.000059760714,0.000506107,0.000010964751,0.000023860555,0.00010392173],"genre_scores_gemma":[0.99695426,0.0018832854,0.0008659863,0.00005049448,0.000081387814,0.000010169218,0.000023230597,0.00004007232,0.000091102636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819434,0.00007233544,0.00073667086,0.00029816775,0.00030359588,0.0003948947],"domain_scores_gemma":[0.9985669,0.000045523822,0.00070684263,0.00035889185,0.00018239746,0.00013941238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007495131,0.00032688768,0.0017726355,0.00026565,0.000071154645,0.000008073281,0.00012297265,0.0000668226,0.00021991883],"category_scores_gemma":[0.000020945123,0.00021137833,0.0002475242,0.00041666883,0.0004839926,0.00012860782,0.000011893961,0.00017871664,0.000014288297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045224642,0.019167442,0.6818007,0.0002980036,0.017828906,0.0063112243,0.007333633,0.010079458,0.020015731,0.00014861437,0.00144259,0.23105124],"study_design_scores_gemma":[0.046416745,0.10855462,0.49512833,0.0011448131,0.0061268685,0.22702743,0.0014753283,0.003344922,0.10691579,0.00006533048,0.0025992168,0.0012005958],"about_ca_topic_score_codex":0.00012364116,"about_ca_topic_score_gemma":0.000009508321,"teacher_disagreement_score":0.22985063,"about_ca_system_score_codex":0.0002066076,"about_ca_system_score_gemma":0.0001359544,"threshold_uncertainty_score":0.8619758},"labels":[],"label_agreement":null},{"id":"W2064616188","doi":"10.1002/ajh.23124","title":"Approaches to investigating common bleeding disorders: An evaluation of North American coagulation laboratory practices","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Von Willebrand disease; Medicine; Platelet disorder; Coagulation testing; Von Willebrand factor; Coagulation Disorder; Partial thromboplastin time; Coagulation; Intensive care medicine; Prothrombin time; Platelet; Internal medicine","score_opus":0.1283962994660094,"score_gpt":0.3634657347021734,"score_spread":0.23506943523616403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064616188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980876,0.00034620913,0.0001395606,0.0009703053,0.00006864958,0.00021301501,0.0000031385005,0.000009107327,0.00016243674],"genre_scores_gemma":[0.9916653,0.00002563734,0.007990436,0.00021302274,0.00006649249,0.000008316827,0.0000127162275,0.000017387105,7.143717e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983751,0.0003398093,0.00050354237,0.000118618715,0.0004263575,0.0002365248],"domain_scores_gemma":[0.99686986,0.00017455399,0.0022872672,0.00015519738,0.00025312958,0.00025996962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000879116,0.0001301708,0.0006845808,0.00023668219,0.000053039214,0.0000071814598,0.00008229381,0.000021770345,0.000006931748],"category_scores_gemma":[0.0005400582,0.00010805614,0.000056194214,0.0005791317,0.00027825416,0.000399326,0.00001912925,0.00016310875,0.0000029008295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012296796,0.00046796264,0.91905224,0.0000225485,0.00018380991,0.000005835264,0.0014196457,0.0001617819,0.00018729143,0.00013897594,0.000019038096,0.07821789],"study_design_scores_gemma":[0.0011314228,0.002800176,0.9849863,0.00007492477,0.00072482135,0.000614896,0.006700918,0.001327622,0.0012625465,0.00013948671,0.00009287418,0.00014401032],"about_ca_topic_score_codex":0.00017096037,"about_ca_topic_score_gemma":0.00021167174,"teacher_disagreement_score":0.078073874,"about_ca_system_score_codex":0.00006652005,"about_ca_system_score_gemma":0.00017035686,"threshold_uncertainty_score":0.44064015},"labels":[],"label_agreement":null},{"id":"W2066067246","doi":"10.1002/ajh.1073","title":"CD34‐positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform","year":2001,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"Hamilton Health Sciences","keywords":"CD34; Acute promyelocytic leukemia; Medicine; Internal medicine; Gastroenterology; Immunophenotyping; Cohort; Immunology; Oncology; Retinoic acid; Biology; Stem cell; Flow cytometry; Cell culture","score_opus":0.0041231751177709846,"score_gpt":0.22577286097071583,"score_spread":0.22164968585294484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066067246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371564,0.0031116132,0.0026184088,0.00018662796,0.00005163229,0.00014418252,0.000014288014,0.00000710763,0.00015047005],"genre_scores_gemma":[0.99497426,0.0018166869,0.0026709368,0.00034123193,0.000050288407,0.000007986219,0.000032435797,0.000035037476,0.000071130715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982837,0.00017908089,0.00059592345,0.0003339882,0.0002154582,0.00039185316],"domain_scores_gemma":[0.9980408,0.00006923305,0.0010811937,0.0002677528,0.0003938187,0.00014717998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028559603,0.000279689,0.0007910251,0.00014205047,0.00008972585,0.000015246394,0.00031000166,0.00020678369,0.00001553567],"category_scores_gemma":[0.00009552144,0.00021494736,0.00016046602,0.0002765792,0.0011250003,0.000016881497,0.00009914359,0.00027932218,0.0000011035127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001494806,0.00016404652,0.038360298,0.00004701541,0.0007044744,0.0007042402,0.0004025665,0.000011874764,0.95281047,0.000030555773,0.0007670033,0.0045026345],"study_design_scores_gemma":[0.0020300003,0.0040107253,0.001990192,0.00020521894,0.0003012835,0.014138087,0.0008574011,0.000013405379,0.9752643,0.000105032064,0.00079501,0.00028934857],"about_ca_topic_score_codex":0.000025067635,"about_ca_topic_score_gemma":0.000005296701,"teacher_disagreement_score":0.036370106,"about_ca_system_score_codex":0.00006489339,"about_ca_system_score_gemma":0.00035095008,"threshold_uncertainty_score":0.87652993},"labels":[],"label_agreement":null},{"id":"W2067279861","doi":"10.1002/ajh.21266","title":"Hydroxycarbamide‐induced changes in E/beta thalassemia red blood cells","year":2008,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"National Center for Research Resources; National Institutes of Health; National Heart, Lung, and Blood Institute; Georgia Clinical and Translational Science Alliance","keywords":"Hydroxycarbamide; Beta thalassemia; Thalassemia; Medicine; Hemoglobinopathy; BETA (programming language); Internal medicine; Hemolytic anemia; Chemotherapy; Computer science","score_opus":0.01077056067768401,"score_gpt":0.24414454370764802,"score_spread":0.233373983029964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067279861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98783207,0.0010764278,0.000008092421,0.0091082025,0.00022619139,0.00011184082,6.9165225e-7,0.000015913807,0.0016205524],"genre_scores_gemma":[0.996541,0.001735937,0.0006900555,0.0008518093,0.000072267656,0.0000023554096,0.0000011102798,0.000025270634,0.00008019406],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985475,0.000119203454,0.00055871985,0.00017094963,0.00022862451,0.00037503077],"domain_scores_gemma":[0.9988656,0.0001095373,0.0005065066,0.0002109186,0.000106535765,0.00020091647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019794647,0.00017082182,0.00093979336,0.00037433614,0.00004493919,0.000002872751,0.00014358545,0.0001301531,0.000066029235],"category_scores_gemma":[0.00007379557,0.00013178319,0.00014706784,0.000465408,0.00031245145,0.00004314954,0.000028498187,0.0005939826,0.000015062138],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018462337,0.0030609383,0.48348475,0.00025729244,0.00169072,0.05552981,0.0075065144,0.000118667616,0.4151293,0.0005836126,0.012783104,0.018009046],"study_design_scores_gemma":[0.022751512,0.020052698,0.09955396,0.0015837299,0.0013067109,0.35258546,0.012846328,0.00023266928,0.47590733,0.00039255057,0.011479008,0.0013080509],"about_ca_topic_score_codex":0.00006960971,"about_ca_topic_score_gemma":0.000022093507,"teacher_disagreement_score":0.3839308,"about_ca_system_score_codex":0.000037600854,"about_ca_system_score_gemma":0.0002046686,"threshold_uncertainty_score":0.5373963},"labels":[],"label_agreement":null},{"id":"W2067456806","doi":"10.1002/ajh.1062","title":"Thalidomide‐associated hepatitis: A case report","year":2001,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Thalidomide; Medicine; Plasmacytosis; Multiple myeloma; Pomalidomide; Hepatitis; Aplastic anemia; Immunology; Internal medicine; Gastroenterology; Dermatology; Bone marrow","score_opus":0.022045487208967048,"score_gpt":0.3384723653067485,"score_spread":0.31642687809778147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067456806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586135,0.00035508175,0.00021855687,0.0019486388,0.000092140865,0.00011292112,0.00000270634,0.000015855916,0.0013927612],"genre_scores_gemma":[0.9976581,0.00020486036,0.0014907884,0.00025768531,0.00006545989,0.0000048156026,0.0000061506103,0.000016300235,0.00029586107],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99857056,0.00014251262,0.0005542944,0.00013028544,0.00027459374,0.0003277538],"domain_scores_gemma":[0.9983099,0.00020106645,0.000623122,0.000201229,0.00033182258,0.00033287142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031722325,0.00011599171,0.00070242933,0.00020616777,0.00005580573,0.000008083336,0.00006620664,0.000041832976,0.00020917311],"category_scores_gemma":[0.00093797664,0.00008547983,0.00017279544,0.00028899542,0.00024133701,0.00005988514,0.000022888818,0.00024467142,0.000029157542],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003362892,0.00021450191,0.416784,0.0000044256635,0.00033839737,0.57500726,0.00006547896,3.8551138e-7,0.00004273776,0.000030116427,0.0006464363,0.0065300097],"study_design_scores_gemma":[0.0023632476,0.0016814173,0.039110176,0.00006168689,0.000112730326,0.95481694,0.00039338804,0.00004051925,0.00027222815,0.00009061806,0.0009920814,0.00006498906],"about_ca_topic_score_codex":0.00086379447,"about_ca_topic_score_gemma":0.00014557071,"teacher_disagreement_score":0.37980968,"about_ca_system_score_codex":0.000105616986,"about_ca_system_score_gemma":0.00022555333,"threshold_uncertainty_score":0.34857664},"labels":[],"label_agreement":null},{"id":"W2069783144","doi":"10.1002/ajh.20937","title":"Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white <i>HFE</i> C282Y homozygotes in the hemochromatosis and iron overload screening study","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"National Center for Research Resources; National Human Genome Research Institute; National Heart, Lung, and Blood Institute","keywords":"Mean corpuscular volume; Transferrin saturation; Internal medicine; Hemochromatosis; Hereditary hemochromatosis; Medicine; Mean corpuscular hemoglobin; Serum iron; Gastroenterology; Mean corpuscular hemoglobin concentration; Confidence interval; Ferritin; Hemoglobin; Iron deficiency; Endocrinology; Anemia","score_opus":0.006403469100026115,"score_gpt":0.25860959348162926,"score_spread":0.25220612438160317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069783144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764717,0.001605179,0.00022820766,0.00024515105,0.000034080356,0.00021581563,0.0000021100373,0.0000021122983,0.000020158262],"genre_scores_gemma":[0.99847966,0.0004018087,0.0008321167,0.00025661994,0.000017174723,0.0000011937511,0.0000010131108,0.000008516404,0.000001900014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872607,0.00015621893,0.00060368364,0.00013484774,0.00017742337,0.00020177235],"domain_scores_gemma":[0.99913394,0.00015075879,0.00047585543,0.00010943353,0.00005360278,0.00007638877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077805837,0.00012254305,0.0006922119,0.00014656405,0.00003132925,0.000010793331,0.000060608654,0.000040323957,0.0000033777537],"category_scores_gemma":[0.000120604156,0.000090478134,0.000028339999,0.00019140537,0.00040586825,0.0000869753,0.000026392747,0.00018279118,1.2986365e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000341369,0.00017552498,0.9725985,0.00006503763,0.000010433589,0.00033486588,0.004502996,3.3198987e-7,0.00094465836,0.000024710123,0.000007739419,0.020993864],"study_design_scores_gemma":[0.0026352843,0.0010579235,0.9747763,0.00010887493,0.000099000594,0.0031067063,0.017730383,0.000060087586,0.0003119123,0.000015880038,0.000017940994,0.000079703656],"about_ca_topic_score_codex":0.00011976047,"about_ca_topic_score_gemma":0.00011519105,"teacher_disagreement_score":0.02091416,"about_ca_system_score_codex":0.000008536816,"about_ca_system_score_gemma":0.00003064409,"threshold_uncertainty_score":0.3689591},"labels":[],"label_agreement":null},{"id":"W2069848482","doi":"10.1002/(sici)1096-8652(200005)64:1<53::aid-ajh9>3.0.co;2-9","title":"Familial myelodysplastic syndrome with early age of onset","year":2000,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Bone marrow; Sepsis; Disease; Family member; Bone marrow failure; Myelodysplastic syndromes; Bone marrow transplantation; Leukemia; Pathogenesis; Internal medicine; Pediatrics; Immunology; Stem cell; Genetics; Biology; Haematopoiesis","score_opus":0.00852336114054926,"score_gpt":0.2665449508785553,"score_spread":0.25802158973800604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069848482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975075,0.00011752484,0.00026875123,0.0008590152,0.000043985037,0.00011295429,0.0000054566035,0.000010101096,0.0010746847],"genre_scores_gemma":[0.995354,0.00009909686,0.0038882932,0.00022712736,0.000040054543,0.0000023911275,0.0000029532364,0.000027367554,0.0003587376],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9983639,0.00013509211,0.0005645008,0.00014954775,0.00042820573,0.00035872703],"domain_scores_gemma":[0.9986287,0.00030128594,0.00036030475,0.0002520922,0.00020169005,0.00025592637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002224009,0.00015134375,0.001043109,0.0003027202,0.000029694898,0.0000051195393,0.00021824829,0.000056567183,0.0007095985],"category_scores_gemma":[0.00010683171,0.00010501576,0.000120668345,0.00044350437,0.0010784074,0.00006769532,0.000021306842,0.0005271343,0.00006439397],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04186022,0.0019735617,0.57810843,0.0006265564,0.0042466354,0.2386604,0.004260348,0.00018013826,0.012317631,0.0009915632,0.0072305235,0.10954402],"study_design_scores_gemma":[0.008281213,0.03686422,0.40784073,0.0007139465,0.00054354494,0.53834236,0.0013305115,0.000073006624,0.002597447,0.00021010601,0.0028373892,0.00036556824],"about_ca_topic_score_codex":0.00012979202,"about_ca_topic_score_gemma":0.0000066855196,"teacher_disagreement_score":0.29968193,"about_ca_system_score_codex":0.0000857516,"about_ca_system_score_gemma":0.0005280836,"threshold_uncertainty_score":0.77696055},"labels":[],"label_agreement":null},{"id":"W2070009478","doi":"10.1002/ajh.20765","title":"Absence of FTL3 mutations in patients with <i>JAK2<sup>V617F</sup></i> mutation negative essential thrombocythemia","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Essential thrombocythemia; Myeloproliferative Disorders; Mutation; Haematopoiesis; Janus kinase 2; Point mutation; Cancer research; Medicine; Tyrosine kinase; Myelofibrosis; Biology; Internal medicine; Immunology; Receptor; Genetics; Polycythemia vera; Gene; Stem cell; Bone marrow","score_opus":0.004263649426485132,"score_gpt":0.24554761506339826,"score_spread":0.24128396563691312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070009478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981962,0.000066718654,0.00051573594,0.0005561241,0.000029240091,0.00025327323,0.000011149065,0.0000059222916,0.00036567994],"genre_scores_gemma":[0.9936257,0.000014444879,0.0061532645,0.00010937632,0.000034933244,0.000013945574,0.000023273518,0.000015974747,0.000009061395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856764,0.000100194266,0.00065308425,0.00016506382,0.00031022666,0.00020377214],"domain_scores_gemma":[0.9982171,0.00030627073,0.0008196167,0.00012553955,0.00045596372,0.00007549519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009182244,0.00016251086,0.00076457835,0.00024100105,0.000038418453,0.0000060541524,0.0000677879,0.0000409989,0.00006330583],"category_scores_gemma":[0.000082844774,0.00011626139,0.00008759702,0.0003841467,0.00044172912,0.00011291069,0.000012535603,0.00018342413,0.0000052094383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007702926,0.0012951309,0.9916325,0.000032212498,0.00020765884,0.00027268552,0.0012345727,0.001395049,0.00009923019,0.0013255714,0.00016223462,0.0015728349],"study_design_scores_gemma":[0.007925641,0.0052366066,0.9676016,0.00036275192,0.00024183071,0.0009894362,0.001848173,0.00025009998,0.014523907,0.0008145277,0.000029309165,0.00017610431],"about_ca_topic_score_codex":0.00021182728,"about_ca_topic_score_gemma":0.00006751094,"teacher_disagreement_score":0.024030913,"about_ca_system_score_codex":0.00008536173,"about_ca_system_score_gemma":0.00020245618,"threshold_uncertainty_score":0.4741002},"labels":[],"label_agreement":null},{"id":"W2075346227","doi":"10.1002/ajh.20127","title":"<i>Cardiobacterium hominis</i> endocarditis associated with very severe thrombocytopenia and platelet autoantibodies","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Autoantibody; Endocarditis; Medicine; Platelet; Immune thrombocytopenia; Immunology; Internal medicine; Antibody","score_opus":0.00800485734598445,"score_gpt":0.25264153283738494,"score_spread":0.2446366754914005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075346227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781287,0.00028040956,0.000091503054,0.00053264183,0.000116889016,0.00012708407,0.000013318186,0.000022060622,0.0010032277],"genre_scores_gemma":[0.9984933,0.00020281716,0.0009437135,0.0002689998,0.00004622482,0.000004770547,0.000007390073,0.000017877996,0.000014891948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999143,0.000050738458,0.00029992787,0.0001411971,0.00013958631,0.00022552375],"domain_scores_gemma":[0.9991411,0.00011240647,0.000364746,0.00012308516,0.000114661925,0.00014398224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073091614,0.00015937064,0.0009533528,0.00011847666,0.000071751034,0.00001577304,0.000042383137,0.000047124417,0.000023198163],"category_scores_gemma":[0.000058583257,0.00010968371,0.00012294242,0.00017740298,0.00042853504,0.0001012847,0.000022127011,0.00020364398,0.0000054869884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005355882,0.00041611248,0.98100674,0.00002534518,0.0034549087,0.006171425,0.00039291786,0.000024335524,0.0005318525,0.0004454103,0.0002881169,0.006707219],"study_design_scores_gemma":[0.010300107,0.009235963,0.8149092,0.00054993236,0.00082710275,0.15531506,0.0009545199,0.0000014690827,0.005703734,0.00040116292,0.0015351331,0.00026660328],"about_ca_topic_score_codex":0.000041047326,"about_ca_topic_score_gemma":0.000015209796,"teacher_disagreement_score":0.16609755,"about_ca_system_score_codex":0.000092673225,"about_ca_system_score_gemma":0.00014588468,"threshold_uncertainty_score":0.4472772},"labels":[],"label_agreement":null},{"id":"W2075973291","doi":"10.1002/ajh.23569","title":"Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: Two‐year results including pharmacokinetics and concomitant hydroxyurea","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Novartis Pharma","keywords":"Deferasirox; Medicine; Internal medicine; Adverse effect; Concomitant; Renal function; Gastroenterology; Nausea; Pharmacokinetics; Thalassemia","score_opus":0.01025141505907404,"score_gpt":0.26232099904511985,"score_spread":0.2520695839860458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075973291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561113,0.001884336,0.000057883986,0.0015951234,0.000028192157,0.00025657812,0.000006031066,0.0000064081823,0.000554299],"genre_scores_gemma":[0.9970355,0.0011438946,0.0015926475,0.00017786688,0.000016233816,0.0000018398738,0.0000040346818,0.000017420321,0.0000105750505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986594,0.000104137776,0.0006806758,0.00015870114,0.00016315475,0.00023393118],"domain_scores_gemma":[0.99861217,0.0003170079,0.0005213088,0.00012797266,0.0001327092,0.00028880997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018056072,0.00015780298,0.0007977122,0.00018228647,0.0000341694,0.000006453031,0.00006888504,0.000038467297,0.000016065145],"category_scores_gemma":[0.00009635616,0.00010962249,0.00003935771,0.00022408256,0.0006136801,0.000052629915,0.000046478817,0.0003156713,0.000001496094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029702026,0.00156477,0.9276498,0.0005992099,0.0006505147,0.0014846836,0.0045128097,0.0008150568,0.019733433,0.0005475974,0.0009403448,0.01179978],"study_design_scores_gemma":[0.15519997,0.012780881,0.7805147,0.0031341058,0.0017776662,0.009243936,0.01982715,0.0055398215,0.008694409,0.00036871005,0.001826988,0.0010916697],"about_ca_topic_score_codex":0.000082752355,"about_ca_topic_score_gemma":0.000005994514,"teacher_disagreement_score":0.14713508,"about_ca_system_score_codex":0.000023877175,"about_ca_system_score_gemma":0.000091652095,"threshold_uncertainty_score":0.44702753},"labels":[],"label_agreement":null},{"id":"W2076592061","doi":"10.1002/ajh.22256","title":"A basis for updating our approach to resistant acute leukemia","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Occult; Oncology; Leukemia; Disease; Breast cancer; Acute leukemia; Minimal residual disease; Incidence (geometry); Bone marrow; Cancer; Surgery; Pathology","score_opus":0.037725766569255546,"score_gpt":0.32343155262773143,"score_spread":0.2857057860584759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076592061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9571602,0.00015656269,0.028860895,0.0044192104,0.00017568262,0.0006078975,0.000014173486,0.00003374605,0.008571658],"genre_scores_gemma":[0.7353321,0.000027632488,0.2634818,0.00082268787,0.00012219399,0.000026225387,0.0000019304427,0.00003667176,0.00014876934],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980962,0.00011782241,0.00069543044,0.0002487937,0.0003032408,0.00053849595],"domain_scores_gemma":[0.9980528,0.00015592531,0.0005302111,0.00032974483,0.00048377793,0.00044755678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072119426,0.00018007308,0.0009889717,0.00043617148,0.000073881085,0.000009490251,0.0003470873,0.00007149663,0.000031310625],"category_scores_gemma":[0.00067465025,0.00013840295,0.0002404881,0.0004683356,0.00014601316,0.000077097095,0.00008264698,0.00043947672,0.000022748882],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09843391,0.0033605187,0.10357414,0.001664489,0.014505398,0.010147054,0.03946405,0.000040284613,0.17108233,0.046064407,0.30471793,0.2069455],"study_design_scores_gemma":[0.03340388,0.0860893,0.07013854,0.0025365518,0.006082121,0.22960961,0.25674284,0.0017922742,0.2670971,0.0036193172,0.039539333,0.0033491584],"about_ca_topic_score_codex":0.00006282892,"about_ca_topic_score_gemma":0.0000016121992,"teacher_disagreement_score":0.2651786,"about_ca_system_score_codex":0.0004464498,"about_ca_system_score_gemma":0.0009062655,"threshold_uncertainty_score":0.5643908},"labels":[],"label_agreement":null},{"id":"W2077100867","doi":"10.1002/ajh.23557","title":"The Canadian “National Program for hemophilia mutation testing” database: A ten‐year review","year":2013,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; University of Calgary","funders":"Health Canada; Canada Research Chairs","keywords":"Medicine; Mutation; MEDLINE; National database; Database; Family medicine; Genetics; Biology; Computer science; Gene","score_opus":0.09550155514808802,"score_gpt":0.4310969407563657,"score_spread":0.3355953856082777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077100867","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007810866,0.99034125,0.000007473714,0.0059307567,0.00013514663,0.0028846576,0.00004635657,0.000013011388,0.0006335211],"genre_scores_gemma":[0.000018581866,0.9878501,0.010354587,0.00031903147,0.0003062836,0.0004960172,0.00020188159,0.000049497336,0.0004039788],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973478,0.00025746546,0.0010929845,0.00023555307,0.0005470416,0.0005191583],"domain_scores_gemma":[0.99493206,0.0014856176,0.0012126354,0.00029278282,0.0016045308,0.00047238253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011635292,0.00029662767,0.0021176713,0.00036332026,0.0002629425,0.000040535928,0.00033642244,0.0001205694,0.000060860053],"category_scores_gemma":[0.0031736793,0.00015420277,0.00052266795,0.0006525719,0.00052577106,0.000060557944,0.00003065738,0.0006350764,0.00008745881],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012667127,0.000072593546,0.000048958256,0.010756661,0.0004363367,0.0001997944,0.000005276248,1.7945434e-8,6.251732e-8,0.00039416173,0.025862612,0.96221083],"study_design_scores_gemma":[0.00034223503,0.0013681152,0.00000975498,0.022338593,0.0010724458,0.014993867,0.00002290158,0.000007514112,5.139724e-7,0.000101994345,0.9596086,0.0001334273],"about_ca_topic_score_codex":0.00089184515,"about_ca_topic_score_gemma":0.0007891161,"teacher_disagreement_score":0.96207744,"about_ca_system_score_codex":0.00043039327,"about_ca_system_score_gemma":0.006542175,"threshold_uncertainty_score":0.99908984},"labels":[],"label_agreement":null},{"id":"W2077500782","doi":"10.1002/ajh.20547","title":"Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; BC Cancer Agency; University of British Columbia; Children's & Women's Health Centre of British Columbia; Vancouver General Hospital","funders":"","keywords":"Hemolysis; Medicine; Concomitant; Methemoglobinemia; Drug; Methylene blue; Pharmacology; Internal medicine; Anesthesia; Biology; Biochemistry","score_opus":0.010023601895487438,"score_gpt":0.2827916983463329,"score_spread":0.27276809645084543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077500782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995686,0.0031067336,0.000011711374,0.0007320355,0.000033696393,0.00012748108,0.000004595354,0.0000024596036,0.0002953023],"genre_scores_gemma":[0.99708915,0.00042425067,0.0021995108,0.00024518964,0.000018186593,0.000004539766,0.000004071949,0.0000058975183,0.000009229025],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990741,0.000036235688,0.00046589394,0.00012619956,0.00015452474,0.00014303224],"domain_scores_gemma":[0.99940044,0.000049912444,0.0003488599,0.000072093644,0.00004638188,0.00008231369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013902698,0.00009070328,0.00045550888,0.00013456949,0.000014168465,0.0000019266133,0.00002673393,0.000023027433,0.000017995986],"category_scores_gemma":[0.000009351346,0.00007005598,0.000042978572,0.00015818849,0.00019479006,0.000016853022,0.00002114608,0.0001070466,6.601688e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022309406,0.005942524,0.075073265,0.0034382527,0.0005061741,0.0036150296,0.0020531642,0.000011904604,0.10784544,0.0008101732,0.0016570833,0.7767376],"study_design_scores_gemma":[0.012955917,0.00793769,0.024724856,0.0022425875,0.00029464343,0.008825825,0.012094761,0.00008636572,0.9293528,0.00056872616,0.0005649734,0.00035086446],"about_ca_topic_score_codex":0.00009422368,"about_ca_topic_score_gemma":0.0000021912153,"teacher_disagreement_score":0.82150733,"about_ca_system_score_codex":0.000047615657,"about_ca_system_score_gemma":0.000026814696,"threshold_uncertainty_score":0.28568},"labels":[],"label_agreement":null},{"id":"W2078398393","doi":"10.1002/ajh.21349","title":"Novel 27.9 kb α<sup>0</sup>‐thalassemia deletion in a Filipino woman","year":2008,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Citation; Medicine; Family medicine; Gerontology; Library science; Law; Political science; Computer science","score_opus":0.009475106342141194,"score_gpt":0.24912051913002453,"score_spread":0.23964541278788334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078398393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929586,0.0007729971,0.0008774118,0.0042272652,0.00012865703,0.00011419402,0.0000013084377,0.000016745365,0.00090279867],"genre_scores_gemma":[0.9946621,0.00077097735,0.0031800643,0.0011708327,0.00007261311,0.0000026498183,0.00000331342,0.00002368081,0.00011376633],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99840456,0.00008191326,0.00071877555,0.00017463631,0.00024027034,0.00037981785],"domain_scores_gemma":[0.9989091,0.00011373384,0.00043334003,0.00018435947,0.0001493814,0.00021008856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019368586,0.00017144995,0.00082622544,0.0003849415,0.000054544682,0.000003629162,0.00012954717,0.00013239174,0.00010145935],"category_scores_gemma":[0.00019586908,0.00013626544,0.00017975796,0.0004996836,0.0004504011,0.00007731058,0.000026637814,0.0006261445,0.00003684536],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025883673,0.003174646,0.88925683,0.00024031338,0.00077940227,0.014128113,0.012197006,0.0020185036,0.01104424,0.001301403,0.03330791,0.029963246],"study_design_scores_gemma":[0.025734032,0.013746802,0.17410561,0.0017822664,0.0005159874,0.70182425,0.031914063,0.0066294847,0.0039449628,0.00040258715,0.0380856,0.0013143657],"about_ca_topic_score_codex":0.00010154872,"about_ca_topic_score_gemma":0.0000061234564,"teacher_disagreement_score":0.71515125,"about_ca_system_score_codex":0.0000897146,"about_ca_system_score_gemma":0.00027699594,"threshold_uncertainty_score":0.5556744},"labels":[],"label_agreement":null},{"id":"W2079914174","doi":"10.1002/ajh.20499","title":"Transient monoclonal gammopathy in a patient withBartonella quintana endocarditis","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Bartonella species infections research","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Gammopathy; Monoclonal gammopathy; Endocarditis; Medicine; Monoclonal antibody; Hypergammaglobulinemia; Pathology; Monoclonal; Immunology; Antibody; Internal medicine","score_opus":0.004856152783218267,"score_gpt":0.2315188954570349,"score_spread":0.22666274267381664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079914174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918183,0.0028933964,0.0006185953,0.00052620354,0.0005875158,0.00013127789,0.0000106144025,0.000015295884,0.0033988205],"genre_scores_gemma":[0.99914825,0.00011098946,0.00048120003,0.00009439959,0.000044361397,0.000011391483,0.000006761098,0.000018983937,0.00008364761],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99779475,0.00049244455,0.0008516446,0.00022063818,0.000099363664,0.0005411905],"domain_scores_gemma":[0.9988785,0.00026549195,0.00041571195,0.0002200753,0.00017645383,0.00004379216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027532174,0.00018440283,0.00073125545,0.0005570954,0.00007988199,0.000010004471,0.0002384233,0.00010045251,0.0005258515],"category_scores_gemma":[0.00005947579,0.00016250667,0.00021092164,0.00047177845,0.0010445922,0.0000782462,0.000048424237,0.00063958886,0.00015242679],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040929494,0.0052586095,0.23639697,0.00009270373,0.0016929652,0.01179074,0.0059207925,0.003098988,0.36296594,0.036145967,0.08132485,0.25121853],"study_design_scores_gemma":[0.011680075,0.01599207,0.124074265,0.0003386192,0.00022215901,0.26589462,0.011956279,0.000055798537,0.25905573,0.003760463,0.3054161,0.0015538264],"about_ca_topic_score_codex":0.000614862,"about_ca_topic_score_gemma":0.00021895535,"teacher_disagreement_score":0.2541039,"about_ca_system_score_codex":0.00015616952,"about_ca_system_score_gemma":0.00017416877,"threshold_uncertainty_score":0.66268295},"labels":[],"label_agreement":null},{"id":"W2080106923","doi":"10.1002/ajh.21916","title":"Venous limb gangrene and fatal hemorrhage: Adverse consequences of hit “overdiagnosis” in a patient with antiphospholipid syndrome","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Antiphospholipid syndrome; Overdiagnosis; Gangrene; Catastrophic antiphospholipid syndrome; Adverse effect; Internal medicine; Intensive care medicine; Surgery; Thrombosis","score_opus":0.00734004925804221,"score_gpt":0.2482622453945034,"score_spread":0.24092219613646118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080106923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980821,0.000214922,0.000008888536,0.0011692105,0.00016364145,0.00016040966,0.000006272424,0.000006737784,0.00018782736],"genre_scores_gemma":[0.9958025,0.000106083215,0.0038325822,0.00021399382,0.000017663902,0.0000047863437,0.0000015052497,0.000018103521,0.0000027852873],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9986755,0.00006833553,0.00058371003,0.00018515745,0.00021016748,0.000277082],"domain_scores_gemma":[0.99854386,0.00023549251,0.0006662616,0.00020462292,0.00014458799,0.0002051498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017135775,0.00016985847,0.001238936,0.00027077127,0.000030348716,0.0000049241316,0.000112854985,0.00007413799,0.00007916934],"category_scores_gemma":[0.00017065044,0.00012692713,0.00008783293,0.00031887038,0.0011246088,0.00010180298,0.00004428328,0.00047246687,0.000004620949],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017915694,0.0019697212,0.83639705,0.0002598315,0.0005166202,0.02352736,0.002433202,0.000005817328,0.11862875,0.0008778844,0.00008750728,0.013504662],"study_design_scores_gemma":[0.005408639,0.033405725,0.38503906,0.0006985906,0.00050370384,0.40956303,0.005515643,0.000016994858,0.1588602,0.00017400827,0.00037172044,0.00044267485],"about_ca_topic_score_codex":0.00034920237,"about_ca_topic_score_gemma":0.00011102017,"teacher_disagreement_score":0.45135802,"about_ca_system_score_codex":0.000028932807,"about_ca_system_score_gemma":0.00031991745,"threshold_uncertainty_score":0.5175938},"labels":[],"label_agreement":null},{"id":"W2080451014","doi":"10.1002/ajh.21105","title":"Treatment of acquired factor X inhibitor by plasma exchange with concomitant intravenous immunoglobulin and corticosteroids","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Partial thromboplastin time; Concomitant; Medicine; Antibody; Gastroenterology; Thromboplastin; Coagulopathy; Fresh frozen plasma; Internal medicine; Coagulation; Immunology; Anesthesia","score_opus":0.015583202790570934,"score_gpt":0.2898794670456788,"score_spread":0.27429626425510784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080451014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565464,0.0028001023,0.00011741226,0.0010226466,0.000058089652,0.0002207805,0.00001130968,0.000006314274,0.00010869511],"genre_scores_gemma":[0.99789095,0.00089011586,0.0010042413,0.000041662715,0.000056437246,0.0000024748558,0.0000039905835,0.000017815137,0.00009230858],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872875,0.000057221652,0.000524292,0.0001326463,0.00024171824,0.00031537036],"domain_scores_gemma":[0.9987497,0.00025534918,0.00043235614,0.00014186605,0.00016528329,0.00025546085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010805217,0.0001652784,0.00090504886,0.00017637837,0.00003429702,0.000005370209,0.00005704906,0.000057911762,0.00005020989],"category_scores_gemma":[0.000030729334,0.000096670854,0.00007808195,0.00015409254,0.0006805981,0.000039558796,0.000015039025,0.000070865244,0.000002862374],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017175818,0.0028263235,0.45934474,0.00016242797,0.0019825874,0.007132791,0.005323648,2.1811883e-7,0.13740325,0.000052079144,0.000313746,0.36828235],"study_design_scores_gemma":[0.030789288,0.17409351,0.088888295,0.0004660486,0.0007304806,0.067971766,0.00809849,0.000026197898,0.6235193,0.000023003531,0.004954397,0.00043921306],"about_ca_topic_score_codex":0.00004707077,"about_ca_topic_score_gemma":0.000010478356,"teacher_disagreement_score":0.48611605,"about_ca_system_score_codex":0.00012174689,"about_ca_system_score_gemma":0.00014192893,"threshold_uncertainty_score":0.3942123},"labels":[],"label_agreement":null},{"id":"W2080733157","doi":"10.1002/ajh.22190","title":"Unintended benefit of anabolic steroid use in hemophilia B leiden","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Anabolic steroid; Medicine; Emergency department; Pediatrics; Leukocytosis; Internal medicine; Surgery; Anabolism","score_opus":0.04994917088565148,"score_gpt":0.3110085813182417,"score_spread":0.26105941043259023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080733157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976091,0.0003348015,0.000016840046,0.0011721293,0.00005345808,0.00010770556,0.0000014960807,0.000005114283,0.00069935614],"genre_scores_gemma":[0.9971526,0.0001986753,0.002196417,0.00015755669,0.000028430371,0.0000017783633,0.0000012629765,0.000016261625,0.00024699516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863416,0.0000878999,0.0006291359,0.00012486511,0.00022987615,0.00029404822],"domain_scores_gemma":[0.99880725,0.000109986984,0.00039674295,0.00022693483,0.00027269174,0.0001864158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023187307,0.00012401486,0.00087127986,0.0005656802,0.000014492536,0.0000029562739,0.00016283417,0.00005529073,0.00018340646],"category_scores_gemma":[0.00014853134,0.00008834302,0.00014605085,0.00040185626,0.00062133034,0.000101427904,0.000038314294,0.0002888327,0.000017162582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014041209,0.00059878343,0.9799973,0.00004661904,0.00025039053,0.0022018724,0.0011613898,8.94644e-7,0.002720953,0.0020731078,0.00022931311,0.009315255],"study_design_scores_gemma":[0.0062963977,0.00736849,0.909278,0.00052119524,0.00022487625,0.01451968,0.0035169348,0.00003876745,0.05484366,0.0025371402,0.0005972372,0.00025762478],"about_ca_topic_score_codex":0.00037271008,"about_ca_topic_score_gemma":0.00007265777,"teacher_disagreement_score":0.0707193,"about_ca_system_score_codex":0.000047331505,"about_ca_system_score_gemma":0.00015019553,"threshold_uncertainty_score":0.36025238},"labels":[],"label_agreement":null},{"id":"W2082486060","doi":"10.1002/ajh.24032","title":"“Bleeding in the jungle”","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; St. Lawrence College","funders":"British Heart Foundation","keywords":"Medicine; Hemostasis; Gastrointestinal bleeding; Surgery; Hemarthrosis; Von Willebrand disease; Medical history; Von Willebrand factor; Internal medicine","score_opus":0.02516470293026253,"score_gpt":0.30800015069586073,"score_spread":0.2828354477655982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082486060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904464,0.0006724319,0.00004928867,0.0057000103,0.00008027849,0.00004370035,1.8983692e-7,0.0000024900448,0.0030052355],"genre_scores_gemma":[0.9983271,0.000032235876,0.00064079574,0.0009518723,0.000025641502,6.784116e-7,4.6469307e-7,0.0000046853884,0.000016555607],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99941546,0.000053726282,0.00021687799,0.00004752868,0.00013644426,0.00012998917],"domain_scores_gemma":[0.9995371,0.00007664432,0.00017817678,0.00007535523,0.00006000833,0.00007268006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024537422,0.000055420052,0.00036148212,0.00010524526,0.00001153046,0.0000037701325,0.000079469995,0.000016751721,0.00000705735],"category_scores_gemma":[0.000098533594,0.000030444467,0.000049992632,0.00018567647,0.00010558194,0.000035990426,0.0000081121625,0.00014901723,0.000011942265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007570027,0.0009918436,0.9133079,0.000019411851,0.00032741603,0.02444814,0.007701972,0.000013234246,0.0001191546,0.0033724513,0.009228737,0.03971271],"study_design_scores_gemma":[0.030892491,0.02461418,0.18656872,0.00063983497,0.0009102834,0.55454427,0.14324676,0.00027083055,0.0013535481,0.013828118,0.042512905,0.00061804807],"about_ca_topic_score_codex":0.00003387655,"about_ca_topic_score_gemma":0.000007449037,"teacher_disagreement_score":0.7267392,"about_ca_system_score_codex":0.000025435775,"about_ca_system_score_gemma":0.0000897478,"threshold_uncertainty_score":0.124148935},"labels":[],"label_agreement":null},{"id":"W2083967734","doi":"10.1002/ajh.20102","title":"Adherence to deferoxamine therapy: Heeding Hippocrates and Osler","year":2004,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Deferoxamine; Thalassemia; Medicine; Citation; Pediatrics; Family medicine; Library science; Internal medicine; Computer science","score_opus":0.01662437718712059,"score_gpt":0.27333741492243707,"score_spread":0.2567130377353165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083967734","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41784495,0.0073418724,0.00012987835,0.57353145,0.00042525807,0.00023831333,0.0000037582176,0.00002088589,0.0004636504],"genre_scores_gemma":[0.3333236,0.0039321226,0.002716242,0.65862525,0.000937401,0.000007967439,0.000010786063,0.00009171233,0.00035494196],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982184,0.000082900966,0.00069954764,0.00026603392,0.00028778389,0.00044528823],"domain_scores_gemma":[0.9984724,0.0001640112,0.0006958966,0.00020276652,0.00024041894,0.00022452675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017537785,0.0003213866,0.0014708088,0.00041401575,0.000054234628,0.000019050898,0.0001715495,0.00037119546,0.00010610964],"category_scores_gemma":[0.00013357,0.00022571304,0.00018865068,0.00030981906,0.0004481358,0.000043680782,0.00004342682,0.0018280662,0.000028961858],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088070164,0.00021737046,0.011209561,0.00045943237,0.0015393035,0.014439378,0.0019797478,0.000012165536,0.0011485062,0.00013114368,0.85629964,0.11168307],"study_design_scores_gemma":[0.006885818,0.02997316,0.0016719388,0.0038553327,0.00082288473,0.11930793,0.0036159838,0.0000072066027,0.001509972,0.0016050446,0.82954866,0.001196092],"about_ca_topic_score_codex":0.00007192784,"about_ca_topic_score_gemma":0.0000016944913,"teacher_disagreement_score":0.11048698,"about_ca_system_score_codex":0.000069747424,"about_ca_system_score_gemma":0.00032275496,"threshold_uncertainty_score":0.920431},"labels":[],"label_agreement":null},{"id":"W2085785612","doi":"10.1002/ajh.21713","title":"Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: A diagnostic challenge","year":2010,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton; University of Alberta Hospital","funders":"","keywords":"Systemic mastocytosis; Medicine; Cutaneous Mastocytosis; Pathology; Biopsy; Urticaria pigmentosa; Leukemia; Bone marrow; Myeloid; Myeloid leukemia; Mastocytoma; Skin biopsy; Internal medicine; Cancer research","score_opus":0.016733704035326,"score_gpt":0.2547730907563595,"score_spread":0.2380393867210335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085785612","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008171167,0.9833882,0.00010598939,0.000061013754,0.0048963903,0.0009660203,0.0002090779,0.00010478463,0.0020973487],"genre_scores_gemma":[0.028599948,0.96911865,0.00026984993,0.000046276713,0.00027774065,0.00015576003,0.00032065457,0.0002883699,0.00092271954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99302983,0.0012633379,0.00272594,0.0010432543,0.0003035153,0.0016340934],"domain_scores_gemma":[0.9855995,0.005682282,0.0068250983,0.0010773807,0.00051212165,0.00030357818],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00070408947,0.0015924593,0.007896094,0.0010141649,0.00037353675,0.000055436474,0.0016855536,0.0018151543,0.0005120498],"category_scores_gemma":[0.0006489256,0.0012261538,0.0013314126,0.000878423,0.002025238,0.0001748115,0.0003155083,0.005049718,0.00066968286],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.010755409,0.0007825769,0.000044103537,0.010325249,0.023837768,0.011383045,0.0013184123,0.000047749054,0.00048867083,0.0013024595,0.007449646,0.9322649],"study_design_scores_gemma":[0.015060312,0.012323284,0.000010853446,0.011779759,0.015014255,0.029466003,0.0009831864,0.0000039768993,0.00011643889,0.000008477231,0.91326106,0.0019723994],"about_ca_topic_score_codex":0.00014509542,"about_ca_topic_score_gemma":0.00027038512,"teacher_disagreement_score":0.9302925,"about_ca_system_score_codex":0.004768281,"about_ca_system_score_gemma":0.0065415823,"threshold_uncertainty_score":0.9996823},"labels":[],"label_agreement":null},{"id":"W2086036138","doi":"10.1002/ajh.10466","title":"Hepatosplenic γδ T‐cell lymphoma in a 10‐year‐old boy successfully treated with hematopoietic stem cell transplantation","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Lymphoma; Hematopoietic stem cell transplantation; Medicine; Transplantation; Chemotherapy; Stem cell; T-cell lymphoma; Haematopoiesis; Oncology; Internal medicine; Biology","score_opus":0.006172396217719142,"score_gpt":0.22689735442727116,"score_spread":0.220724958209552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086036138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694514,0.000748639,0.000115297946,0.0012107026,0.00003589172,0.00023775437,0.0000055733453,0.000020723815,0.0006802474],"genre_scores_gemma":[0.9979804,0.00050293887,0.0010222328,0.00029200077,0.000024953153,0.000021061502,0.000009548043,0.000033636832,0.00011321306],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827933,0.000096896954,0.0006832923,0.00025518276,0.00030611776,0.00037917637],"domain_scores_gemma":[0.9987075,0.00010716532,0.00059395604,0.00022728833,0.00013720339,0.00022693117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012342923,0.00026235954,0.0009950706,0.00032088923,0.000040485706,0.00001623717,0.00012867835,0.000076747325,0.000053172913],"category_scores_gemma":[0.0000045213005,0.0001850065,0.0001660508,0.00045795704,0.00016332512,0.00010815823,0.000009894508,0.00012446292,0.000048388738],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050160284,0.0056037474,0.9550382,0.00043541775,0.000335586,0.022717053,0.0030972655,0.00015919801,0.0010311019,0.00063130795,0.00021928277,0.0057158195],"study_design_scores_gemma":[0.12201221,0.032608997,0.3501148,0.0026074129,0.0025612176,0.11782027,0.013980471,0.000047589427,0.35625815,0.00031714846,0.0004920197,0.0011797221],"about_ca_topic_score_codex":0.00043092686,"about_ca_topic_score_gemma":0.0000720862,"teacher_disagreement_score":0.6049234,"about_ca_system_score_codex":0.00029577533,"about_ca_system_score_gemma":0.00040913862,"threshold_uncertainty_score":0.75443465},"labels":[],"label_agreement":null},{"id":"W2087051409","doi":"10.1002/ajh.10092","title":"Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia","year":2002,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Badan Riset dan Inovasi Nasional","keywords":"Angiogenesis; Bone marrow; Endostatin; Vascular endothelial growth factor; Neovascularization; Pathology; Myeloid; In vivo; CD34; Cancer research; Biology; Medicine; Stem cell; Cell biology","score_opus":0.005133358588388156,"score_gpt":0.21614664697858763,"score_spread":0.21101328839019948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087051409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938541,0.005610565,0.000024926067,0.00031171305,0.0000416625,0.000058666334,0.000002762849,5.742895e-7,0.00009504743],"genre_scores_gemma":[0.99819607,0.0010823407,0.0004781459,0.0001653593,0.00003478445,0.000004039255,5.660979e-7,0.000011606434,0.00002709733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907446,0.00010351926,0.0004162106,0.00012725298,0.000089879846,0.000188654],"domain_scores_gemma":[0.99933004,0.000014177412,0.0004255169,0.00017275024,0.000023695826,0.000033807508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014792038,0.00009554257,0.00029699624,0.00007227847,0.00001667802,0.0000021905632,0.00024061512,0.00005256355,0.000029782801],"category_scores_gemma":[0.000020580117,0.000070108224,0.00015619649,0.00015415603,0.00019916277,0.0000030143485,0.00007270853,0.00007832085,0.0000014091243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005449471,0.00008479772,0.26335305,0.000007098079,0.000078707824,0.000016473148,0.00029464,0.00011720328,0.7202375,0.000018334293,0.00013803282,0.015599687],"study_design_scores_gemma":[0.0008304215,0.0006968256,0.10725117,0.000087313434,0.00004995139,0.0011406388,0.00090831215,0.00011639714,0.8852011,0.000046698584,0.0034872752,0.00018391848],"about_ca_topic_score_codex":0.000034944227,"about_ca_topic_score_gemma":0.000040138675,"teacher_disagreement_score":0.16496362,"about_ca_system_score_codex":0.00004752636,"about_ca_system_score_gemma":0.000042764827,"threshold_uncertainty_score":0.28589305},"labels":[],"label_agreement":null},{"id":"W2087600599","doi":"10.1002/ajh.21993","title":"Iron chelation adherence to deferoxamine and deferasirox in thalassemia","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Deferasirox; Deferoxamine; Thalassemia; Deferiprone; Medicine; Beta thalassemia; Chelation therapy; Chelation; Internal medicine; Chemistry","score_opus":0.017729159517385556,"score_gpt":0.267995170969387,"score_spread":0.25026601145200145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087600599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967451,0.00063421833,0.00028270108,0.0005714483,0.00006386818,0.000089064924,2.9540675e-7,0.0000057699012,0.0016075479],"genre_scores_gemma":[0.99579,0.00021358812,0.0035639876,0.0003819286,0.000013299943,0.0000017641958,4.824317e-7,0.000009528442,0.000025430252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992141,0.000049058486,0.00036449727,0.00010572967,0.000091943206,0.0001746876],"domain_scores_gemma":[0.9994333,0.000050811108,0.00020585825,0.00008924794,0.000065046755,0.00015575683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015172963,0.000089661844,0.00041118695,0.0002085861,0.000016046135,0.0000024625415,0.000053768123,0.000060836748,0.000053769407],"category_scores_gemma":[0.00011868301,0.00006831608,0.000040045154,0.00023401716,0.0001373681,0.000045578145,0.000019452642,0.00024183166,0.000011773182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007207594,0.00021813757,0.93754387,0.000045135235,0.000051176154,0.00053369714,0.0040177214,0.0000053030462,0.0028990759,0.00090884906,0.00019874271,0.052857563],"study_design_scores_gemma":[0.0032084596,0.010064982,0.95686334,0.0004747367,0.00015033777,0.015817832,0.0080422135,0.00006421666,0.0037850982,0.0007281141,0.0005371407,0.00026354005],"about_ca_topic_score_codex":0.000085997315,"about_ca_topic_score_gemma":0.000022397931,"teacher_disagreement_score":0.05259402,"about_ca_system_score_codex":0.000025699885,"about_ca_system_score_gemma":0.00005748185,"threshold_uncertainty_score":0.27858493},"labels":[],"label_agreement":null},{"id":"W2088730430","doi":"10.1002/ajh.21806","title":"Iron chelation therapy for patients with sickle cell disease and iron overload","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chelation therapy; Medicine; Deferoxamine; Deferasirox; Anemia; Ferritin; Internal medicine; Sickle cell anemia; Transfusion therapy; Blood transfusion; Gastroenterology; Pallor; Surgery; Disease; Thalassemia","score_opus":0.0026561151064067806,"score_gpt":0.22031226074461893,"score_spread":0.21765614563821215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088730430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975549,0.00044124643,0.0001656843,0.0013711526,0.00010898825,0.00022140681,0.0000031087206,0.0000061110086,0.0001273801],"genre_scores_gemma":[0.9978579,0.00021076236,0.0014615216,0.00037986116,0.00003871418,0.000003223844,0.0000063459242,0.00001539083,0.00002622312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994071,0.000019787361,0.00021216364,0.00009961891,0.00011234405,0.00014899814],"domain_scores_gemma":[0.9992207,0.00006741878,0.0003090506,0.00009715806,0.00012219221,0.00018344367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006737683,0.00009525013,0.0002944132,0.00007150437,0.00004507534,0.0000051102857,0.000038135135,0.000045599296,0.000027671718],"category_scores_gemma":[0.000038883456,0.000060315437,0.000055047727,0.000067397144,0.000235406,0.000054096618,0.000006289777,0.00021596874,0.000001700147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00680797,0.0010764874,0.93113744,0.00011952263,0.00010211681,0.000055061573,0.0006513275,0.000011312745,0.0039126026,0.00035652134,0.00077454734,0.054995082],"study_design_scores_gemma":[0.03551022,0.026318762,0.91401374,0.00023073745,0.00079156604,0.0010274807,0.0020175842,0.00035193938,0.0022917162,0.0007633716,0.016060432,0.0006224165],"about_ca_topic_score_codex":0.0000073685983,"about_ca_topic_score_gemma":0.0000016049255,"teacher_disagreement_score":0.05437267,"about_ca_system_score_codex":0.000008662961,"about_ca_system_score_gemma":0.00008133703,"threshold_uncertainty_score":0.24595922},"labels":[],"label_agreement":null},{"id":"W2088900228","doi":"10.1002/ajh.20359","title":"Anaplastic large‐cell lymphoma presenting as acute leukemia","year":2005,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Medicine; Lymphoma; Leukemia; Anaplastic large-cell lymphoma; Cancer research; Oncology; Internal medicine","score_opus":0.005965687940182669,"score_gpt":0.27116655238889104,"score_spread":0.2652008644487084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088900228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99300975,0.0010062075,0.00011332831,0.0023717682,0.00013375022,0.00008732192,0.0000027210613,0.000016888573,0.0032582502],"genre_scores_gemma":[0.9944789,0.00026170624,0.0034870442,0.0012594011,0.00020845578,0.000004985926,0.0000030506085,0.000021034712,0.0002754604],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99860525,0.00006298909,0.0005299914,0.00016501453,0.0002504389,0.00038633554],"domain_scores_gemma":[0.99859846,0.00021818971,0.00059041794,0.00019481174,0.00013841911,0.00025970815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012370711,0.0001688341,0.0007400382,0.00018308354,0.00006404855,0.0000130204435,0.00012166328,0.00004966049,0.00015709926],"category_scores_gemma":[0.00007802562,0.00012502799,0.00022237503,0.00019139714,0.00014612841,0.00009145159,0.0000435958,0.00010621891,0.00018677129],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032488217,0.009384124,0.6711595,0.00016206963,0.004632693,0.0335149,0.0034781022,0.000089899215,0.0020080158,0.0055155144,0.04132598,0.22548041],"study_design_scores_gemma":[0.071728684,0.022751082,0.19841251,0.0007379328,0.0055628894,0.36445156,0.0066300114,0.001682858,0.12323716,0.00059984135,0.20299238,0.0012131071],"about_ca_topic_score_codex":0.000030457535,"about_ca_topic_score_gemma":0.0000065994427,"teacher_disagreement_score":0.47274697,"about_ca_system_score_codex":0.00029357555,"about_ca_system_score_gemma":0.00043885683,"threshold_uncertainty_score":0.5098493},"labels":[],"label_agreement":null},{"id":"W2089751232","doi":"10.1002/ajh.22236","title":"If at first you don't succeed: Try, try again","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Chills; Rash; Gastroenterology; Erythrocyte sedimentation rate; Internal medicine; Elevated transaminases; Physical examination; Anemia; Surgery","score_opus":0.013043811899042468,"score_gpt":0.2567291399702445,"score_spread":0.24368532807120202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089751232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98063684,0.0014880704,0.00012446588,0.004426349,0.000343171,0.00009162695,0.0000036658485,0.000023032611,0.01286279],"genre_scores_gemma":[0.99630094,0.00049425673,0.00075933075,0.0018958491,0.000112686466,0.0000033336719,0.000002652275,0.000028522323,0.00040240693],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859184,0.00007071555,0.00054998713,0.00017057832,0.00022844465,0.00038845773],"domain_scores_gemma":[0.99856734,0.00006826674,0.00075908285,0.00020539724,0.00013901238,0.00026087256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021192696,0.00017227801,0.0008568113,0.00017968052,0.00008589595,0.0000047762887,0.00017213008,0.00009501446,0.0009099396],"category_scores_gemma":[0.00012764719,0.00013670223,0.0002619456,0.00025534444,0.0004137098,0.000066651206,0.000039123413,0.00032873143,0.000050728904],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004371589,0.0008685419,0.8570366,0.000110937515,0.0011352376,0.0026777866,0.006766998,0.0000085163765,0.00065132644,0.0012654118,0.10005586,0.025051227],"study_design_scores_gemma":[0.0588764,0.049579106,0.33881494,0.0017465415,0.004004995,0.075447485,0.09561988,0.0002677365,0.01829244,0.006737147,0.34740767,0.0032056503],"about_ca_topic_score_codex":0.00030341904,"about_ca_topic_score_gemma":0.00010277297,"teacher_disagreement_score":0.5182216,"about_ca_system_score_codex":0.00015934897,"about_ca_system_score_gemma":0.00017232416,"threshold_uncertainty_score":0.99632},"labels":[],"label_agreement":null},{"id":"W2090247704","doi":"10.1002/ajh.20205","title":"Prognostic variables in newly diagnosed childhood immune thrombocytopenia","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dartmouth General Hospital; Dalhousie University; University of Saskatchewan","funders":"","keywords":"Medicine; Prodrome; Internal medicine; Multivariate analysis; Mean platelet volume; Odds ratio; Univariate analysis; Immune thrombocytopenia; Pediatrics; Disease; Family history; Platelet","score_opus":0.006553087029186502,"score_gpt":0.2548230655183501,"score_spread":0.2482699784891636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090247704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951903,0.0015373634,0.0001807126,0.0023648748,0.000091157985,0.00018781204,0.0000013823551,0.000010012029,0.00043634075],"genre_scores_gemma":[0.9948371,0.00029167248,0.004413294,0.00039773216,0.000025523508,0.000005991848,0.0000039820775,0.000017584842,0.0000071238182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988654,0.000048227714,0.0005221411,0.00013224567,0.00014791323,0.0002840544],"domain_scores_gemma":[0.9991517,0.00013589291,0.00038211502,0.00014501828,0.0000673779,0.00011789418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012115931,0.0001442187,0.0010701923,0.00020879183,0.000029299517,0.000007308927,0.000110606656,0.000046512247,0.000048129517],"category_scores_gemma":[0.00020299642,0.00010852097,0.000116385825,0.00031755964,0.00017659097,0.00007991718,0.000021463697,0.00025179182,0.00002461362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077412,0.005509343,0.9172442,0.00005883635,0.0009820993,0.0462998,0.0023637698,0.00020342928,0.0011264997,0.0033694163,0.00013124787,0.021937232],"study_design_scores_gemma":[0.01721624,0.004905097,0.9214886,0.0006000304,0.00029650092,0.047291975,0.0013972339,0.0000056335844,0.0014966411,0.0048835403,0.00020857182,0.00020997415],"about_ca_topic_score_codex":0.00022326823,"about_ca_topic_score_gemma":0.00003417108,"teacher_disagreement_score":0.021727258,"about_ca_system_score_codex":0.000071129405,"about_ca_system_score_gemma":0.00031684054,"threshold_uncertainty_score":0.4425357},"labels":[],"label_agreement":null},{"id":"W2092734676","doi":"10.1002/ajh.23163","title":"Health‐related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Romiplostim; Medicine; Splenectomy; Immune thrombocytopenia; Quality of life (healthcare); Rituximab; Internal medicine; Clinical trial; Platelet; Immunology; Spleen; Thrombopoietin; Lymphoma","score_opus":0.01916317450765705,"score_gpt":0.339096856106367,"score_spread":0.31993368159870994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092734676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940638,0.0042176074,0.000027154438,0.0011790266,0.00015060134,0.00022153578,0.000017989225,0.000005303018,0.00011697424],"genre_scores_gemma":[0.9979599,0.00048056847,0.0013632384,0.00014766701,0.000010698829,0.0000023836112,0.0000146701395,0.000017690469,0.0000031968348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651724,0.0005224676,0.0019907563,0.00011440034,0.0005075802,0.00034758335],"domain_scores_gemma":[0.9965786,0.0005216564,0.0020963612,0.0001853126,0.00028447542,0.00033361203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000884531,0.00015581638,0.0033042147,0.00023084205,0.000025758396,0.0000013989743,0.0001361639,0.00009644802,0.0002532156],"category_scores_gemma":[0.001745846,0.000107292915,0.0001837141,0.00034268014,0.00033218833,0.000085151216,0.000045803594,0.00031571882,0.0000026974703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011490903,0.0010545362,0.972282,0.00028283193,0.00046916105,0.000118716955,0.0034065424,0.0000014823188,0.00007026953,0.00006943304,0.00006691884,0.010687235],"study_design_scores_gemma":[0.033261076,0.009018512,0.9483856,0.0014136463,0.00016191101,0.0012421842,0.0050706915,0.000008039365,0.0011698724,0.000045729063,0.000043811844,0.00017890474],"about_ca_topic_score_codex":0.0007513177,"about_ca_topic_score_gemma":0.00022503904,"teacher_disagreement_score":0.023896348,"about_ca_system_score_codex":0.0001280141,"about_ca_system_score_gemma":0.0009361819,"threshold_uncertainty_score":0.43752784},"labels":[],"label_agreement":null},{"id":"W2094170436","doi":"10.1002/ajh.22144","title":"Trilineage myelodysplasia and hemophagocytosis associated with systemic lupus erythematosus","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Hemophagocytosis; Gastroenterology; Internal medicine; Pancytopenia; Mean corpuscular volume; Proteinuria; Reference range; Bone marrow; Hemoglobin; Kidney","score_opus":0.01753851498276794,"score_gpt":0.2590140491020947,"score_spread":0.24147553411932676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094170436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581325,0.0020835374,0.0002890882,0.00022829673,0.00007357965,0.00016621135,0.0000014591171,0.000022965269,0.0013216345],"genre_scores_gemma":[0.998519,0.00029085152,0.00078013993,0.00015125316,0.000021827289,0.0000056775957,0.0000016505852,0.000030506724,0.00019911771],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9983564,0.00015949977,0.0006848162,0.00016440006,0.00029299993,0.00034191113],"domain_scores_gemma":[0.99831045,0.00017184539,0.00079114595,0.00021109496,0.00031042445,0.00020501782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043560227,0.00017990035,0.001166446,0.00029262732,0.00006575754,0.000008426645,0.00013848557,0.00007649213,0.00009892086],"category_scores_gemma":[0.0002527954,0.00012282081,0.00010864716,0.00033157892,0.00065355655,0.00010839992,0.000037745074,0.00038407894,0.000012309128],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056609213,0.0007203956,0.9605557,0.0003435677,0.0019426318,0.0063407775,0.0057293745,0.0000012634322,0.0026470367,0.0012771613,0.0012274439,0.013553736],"study_design_scores_gemma":[0.023622273,0.027280597,0.122404344,0.0029818814,0.001408206,0.7634809,0.037614595,0.00027287513,0.018378843,0.00039176166,0.0012089907,0.00095473457],"about_ca_topic_score_codex":0.00001735756,"about_ca_topic_score_gemma":0.0000041990415,"teacher_disagreement_score":0.83815134,"about_ca_system_score_codex":0.000048309703,"about_ca_system_score_gemma":0.00027931193,"threshold_uncertainty_score":0.5008487},"labels":[],"label_agreement":null},{"id":"W2094319690","doi":"10.1002/ajh.10181","title":"Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin‐induced thrombocytopenia","year":2002,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Argatroban; Lepirudin; Warfarin; Medicine; Gangrene; Heparin-induced thrombocytopenia; Heparin; Direct thrombin inhibitor; Venous thrombosis; Discovery and development of direct thrombin inhibitors; Thrombosis; Surgery; Platelet; Internal medicine; Thrombin; Atrial fibrillation","score_opus":0.028807812887572896,"score_gpt":0.26928670193862575,"score_spread":0.24047888905105286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094319690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943226,0.0022101619,0.000049981452,0.0018337466,0.00020505226,0.0006021026,0.0000037508805,0.00004902343,0.0007235873],"genre_scores_gemma":[0.99529773,0.001499329,0.0025520853,0.00027329096,0.00019191595,0.000030945783,0.0000025481224,0.000088695386,0.00006343231],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975423,0.00013559697,0.00091454206,0.00043402577,0.00030448005,0.0006690185],"domain_scores_gemma":[0.99780965,0.00028375318,0.0008815868,0.00042123802,0.00026959775,0.00033415033],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031548704,0.00041421986,0.0024183083,0.00033779122,0.00023831625,0.000045949157,0.00022139963,0.00013488768,0.0001007158],"category_scores_gemma":[0.0001216389,0.00031343068,0.00026389753,0.00042448458,0.0004252292,0.00023261139,0.000075956545,0.00049338193,0.000011409991],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037422185,0.0020066977,0.029960588,0.0002606569,0.0025573925,0.00089032843,0.0035610101,0.0000047938634,0.9358892,0.0004676745,0.0002185856,0.020440875],"study_design_scores_gemma":[0.024981119,0.048557088,0.23363942,0.0014017846,0.0010458996,0.055786006,0.0028517456,0.0001961635,0.62780243,0.00019533785,0.0021541507,0.0013888761],"about_ca_topic_score_codex":0.00011666517,"about_ca_topic_score_gemma":0.000023687013,"teacher_disagreement_score":0.30808678,"about_ca_system_score_codex":0.000132548,"about_ca_system_score_gemma":0.00014270566,"threshold_uncertainty_score":0.99993175},"labels":[],"label_agreement":null},{"id":"W2094729938","doi":"10.1002/ajh.22225","title":"Clinical trial opportunities in hemostasis and thrombosis: NHBLI State‐of‐the‐science symposium","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Clinical trial; Medicine; Biostatistics; Intensive care medicine; Family medicine; Hemostasis; Public health; Clinical research; Alternative medicine; Internal medicine; Nursing; Pathology","score_opus":0.1257868202256539,"score_gpt":0.3609994473338326,"score_spread":0.2352126271081787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094729938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938671,0.00011616977,0.00006240279,0.004182278,0.0003696283,0.00017888466,8.3201655e-7,0.0000037784378,0.0012189402],"genre_scores_gemma":[0.99645084,0.0012955351,0.0013291741,0.00087085314,0.00002152238,0.0000021083908,7.283908e-8,0.0000061282444,0.000023737512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985846,0.00013379198,0.0007698327,0.00011959503,0.00022097568,0.00017120571],"domain_scores_gemma":[0.9989904,0.000090443435,0.0004830777,0.00017753024,0.000119931974,0.00013861086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092518725,0.000079812184,0.00062029547,0.0002277555,0.000031179377,0.0000037089483,0.00017660372,0.000022507556,0.000034925633],"category_scores_gemma":[0.000092009584,0.000051268984,0.00010631888,0.0002737009,0.0018160946,0.00007074454,0.00006481631,0.00021690843,6.51041e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05563035,0.006785248,0.48307538,0.0004070225,0.001115752,0.0013000071,0.018726436,0.0000022440934,0.0031115424,0.01955597,0.002153178,0.40813687],"study_design_scores_gemma":[0.15403776,0.056667697,0.6833548,0.0016532396,0.001932225,0.0092181945,0.052998703,0.00007618401,0.027002541,0.0037885192,0.008436004,0.00083416066],"about_ca_topic_score_codex":0.00006670705,"about_ca_topic_score_gemma":0.00001830831,"teacher_disagreement_score":0.4073027,"about_ca_system_score_codex":0.000012298375,"about_ca_system_score_gemma":0.00027425488,"threshold_uncertainty_score":0.6691477},"labels":[],"label_agreement":null},{"id":"W2094956732","doi":"10.1002/1096-8652(200102)66:2<130::aid-ajh1030>3.0.co;2-b","title":"Platelet factor V New York: A defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation","year":2001,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Prothrombinase; Platelet; Factor V; Thrombin; Internal medicine; Chemistry; Endocrinology; Medicine; Thrombosis","score_opus":0.06502370894220214,"score_gpt":0.3033249035902591,"score_spread":0.23830119464805696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094956732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970586,0.00030107773,0.0008268756,0.0011126915,0.00019986952,0.00044019657,0.0000117178015,0.00002104406,0.000027956683],"genre_scores_gemma":[0.9979249,0.000033787175,0.0015640496,0.00027195757,0.00011351122,0.000009679481,0.000019966668,0.000032422668,0.00002972142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976113,0.0003337982,0.0010199257,0.00031139445,0.00029668942,0.00042688916],"domain_scores_gemma":[0.99845725,0.00024726952,0.0007790736,0.00022351381,0.000058959147,0.00023390369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020004757,0.00026094832,0.0011864338,0.00058665435,0.000030854026,0.00002490148,0.00014536364,0.00014410376,0.00031212953],"category_scores_gemma":[0.00033567817,0.00022188811,0.00016696175,0.0005464421,0.00009266444,0.00018707242,0.000031492655,0.00054410705,0.000010911986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008848931,0.0005677672,0.9208196,0.000021655504,0.00010570373,0.001281372,0.0047516963,0.000021497342,0.035747375,0.000104795006,0.00008444491,0.035609245],"study_design_scores_gemma":[0.00882059,0.0012462329,0.9579375,0.0004774189,0.000036231682,0.0010292508,0.0018602181,0.0008602235,0.026964603,0.00026511375,0.00017521271,0.00032743101],"about_ca_topic_score_codex":0.013178245,"about_ca_topic_score_gemma":0.028649693,"teacher_disagreement_score":0.03711792,"about_ca_system_score_codex":0.00028491774,"about_ca_system_score_gemma":0.00041376488,"threshold_uncertainty_score":0.99339306},"labels":[],"label_agreement":null},{"id":"W2095227834","doi":"10.1002/ajh.23181","title":"Introductory remarks for the THSNA meeting proceedings: Hemostasis and thrombosis at the cutting edge","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hemostasis; Medicine; Multidisciplinary approach; Medical education; Thrombosis; Family medicine; Political science; Internal medicine; Law","score_opus":0.01882364038494134,"score_gpt":0.30327249930597816,"score_spread":0.28444885892103683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095227834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9581134,0.00743333,0.00007499691,0.03322365,0.00022403219,0.00037220964,0.0000025845204,0.0000075152784,0.00054829376],"genre_scores_gemma":[0.9939725,0.0008742569,0.003000849,0.0015080153,0.00054460915,0.00004337551,9.84642e-7,0.00002149636,0.000033903867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998849,0.000060899074,0.00042176511,0.00014314761,0.0001799183,0.0003452725],"domain_scores_gemma":[0.99741334,0.0014336826,0.00063484453,0.00013144112,0.00025413447,0.00013257621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087165553,0.00016096291,0.0005855816,0.000060034276,0.00032730345,0.000017182296,0.000097618904,0.000035484914,0.000041900494],"category_scores_gemma":[0.0007089688,0.00007491164,0.0001378763,0.00013482402,0.00046604546,0.0000866396,0.00006771371,0.0002130244,0.0000030244912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038129566,0.00023307286,0.93142486,0.00009463356,0.001053255,0.0000074183763,0.0056524626,0.0000010613232,0.001202206,0.0023196952,0.022772685,0.03485737],"study_design_scores_gemma":[0.008916702,0.009188726,0.49951917,0.001410486,0.0065896036,0.045497596,0.0951813,0.00028700524,0.14416826,0.0005486264,0.18771406,0.0009784653],"about_ca_topic_score_codex":0.000012094363,"about_ca_topic_score_gemma":0.000003965029,"teacher_disagreement_score":0.43190566,"about_ca_system_score_codex":0.00008187008,"about_ca_system_score_gemma":0.00005341953,"threshold_uncertainty_score":0.30548078},"labels":[],"label_agreement":null},{"id":"W2095402186","doi":"10.1002/ajh.21470","title":"Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention","year":2009,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Vitamin k; Vitamin K antagonist; Intensive care medicine; Internal medicine; Warfarin","score_opus":0.07649233109302077,"score_gpt":0.39506578345155235,"score_spread":0.3185734523585316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095402186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023315432,0.9741961,0.000223188,0.00048387275,0.00021489266,0.0012000622,0.0000045856777,0.000010956751,0.0003509505],"genre_scores_gemma":[0.011779642,0.98620015,0.0017134403,0.000008742159,0.00011184024,0.000003523598,0.00004810265,0.00001559641,0.000118953794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99814564,0.00019049713,0.0012261292,0.0001555047,0.00014536367,0.00013685822],"domain_scores_gemma":[0.9974005,0.00016891914,0.002138402,0.00013708146,0.00009285449,0.00006222185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020597334,0.00018542884,0.002053859,0.0004897799,0.000028012486,0.0000068688023,0.000057185174,0.000071848386,0.000010811288],"category_scores_gemma":[0.000067169596,0.0001430053,0.00036027547,0.00030314884,0.00009300106,0.000067925095,0.000016474984,0.00010030108,0.0000018565883],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048527338,0.000110203546,0.04153162,0.00073987676,0.00021977423,0.000005950016,0.00005144493,3.8855515e-7,3.728125e-7,0.00020406178,0.000047378904,0.9570404],"study_design_scores_gemma":[0.004654717,0.01148801,0.09290734,0.024658687,0.004523576,0.0007421664,0.00029903743,0.000007879161,0.000006749615,0.00026585764,0.8600638,0.00038220547],"about_ca_topic_score_codex":0.0000048530364,"about_ca_topic_score_gemma":0.0000041086223,"teacher_disagreement_score":0.9566582,"about_ca_system_score_codex":0.00014294367,"about_ca_system_score_gemma":0.00011153639,"threshold_uncertainty_score":0.5831587},"labels":[],"label_agreement":null},{"id":"W2098169365","doi":"10.1002/ajh.21826","title":"Symptoms of depression and anxiety in patients with thalassemia: Prevalence and correlates in the thalassemia longitudinal cohort","year":2010,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Anxiety; Psychosocial; Depression (economics); Medicine; Thalassemia; Quality of life (healthcare); Cohort; Psychiatry; Clinical psychology; Internal medicine","score_opus":0.0026935431080394394,"score_gpt":0.2160993894289988,"score_spread":0.21340584632095938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098169365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97800094,0.0022895138,0.0000046154514,0.019168798,0.000098656485,0.00033553244,0.000004612416,0.0000030440253,0.00009430245],"genre_scores_gemma":[0.990239,0.0018053676,0.00012260894,0.007734843,0.0000490362,0.0000061665723,0.000008758669,0.000024064513,0.000010138515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982097,0.00018931847,0.0006505955,0.00027690866,0.00037656206,0.0002968981],"domain_scores_gemma":[0.9982193,0.00036247072,0.0009634154,0.00024777107,0.00014175358,0.000065293374],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003452077,0.0002572416,0.0010933792,0.00028215093,0.000029808152,0.000008831542,0.00017604926,0.0006611568,0.000011354759],"category_scores_gemma":[0.00011156643,0.0001392306,0.00006702118,0.00025134566,0.0008948696,0.00007355806,0.000050754603,0.0041764574,3.7044157e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002835773,0.000114082046,0.99199194,0.00030218365,0.00011367826,0.0005401125,0.00034163374,0.0000010619352,0.000008479217,0.0000038804897,0.004289215,0.002010154],"study_design_scores_gemma":[0.0019539185,0.0016376644,0.9870974,0.0016825657,0.00033294156,0.0060322825,0.00023645828,0.000009826929,0.000018069695,0.000024851637,0.0008303016,0.00014373947],"about_ca_topic_score_codex":0.00005381161,"about_ca_topic_score_gemma":0.000012279222,"teacher_disagreement_score":0.012238091,"about_ca_system_score_codex":0.000027306522,"about_ca_system_score_gemma":0.00012845245,"threshold_uncertainty_score":0.99812096},"labels":[],"label_agreement":null},{"id":"W2098215007","doi":"10.1002/ajh.24098","title":"Myeloproliferative neoplasm patient symptom burden and quality of life: Evidence of significant impairment compared to controls","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Public Health Agency; Queen's University Belfast","keywords":"Medicine; Myeloproliferative neoplasm; Internal medicine; Polycythaemia; Myelofibrosis; Quality of life (healthcare); Population; Gastroenterology; Bone marrow","score_opus":0.05208725393675259,"score_gpt":0.3397715469331797,"score_spread":0.28768429299642706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098215007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914728,0.0016491187,0.00039055402,0.0056249644,0.0000973226,0.0006456101,0.00001678056,0.0000064018423,0.000096456824],"genre_scores_gemma":[0.99489605,0.00015723577,0.004313986,0.00051601214,0.000059385042,0.000034566976,0.0000017018397,0.000014339979,0.0000066995253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691385,0.00047504238,0.0015320926,0.00024551194,0.00056204566,0.00027143172],"domain_scores_gemma":[0.99510765,0.0010795292,0.001667832,0.00025735277,0.0012019095,0.0006857036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006711986,0.00024047928,0.002138787,0.00022492466,0.000030595136,0.000008261256,0.00011989878,0.000049968607,0.000020365318],"category_scores_gemma":[0.0012214016,0.00016909342,0.00016109498,0.00024887032,0.00046441794,0.000079652666,0.00006791347,0.00017601179,0.000004312062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0128348665,0.0012999463,0.94465125,0.0002967422,0.0017542541,0.00019235472,0.01622871,0.00031547024,0.00889397,0.0020992146,0.0008226717,0.010610557],"study_design_scores_gemma":[0.030064126,0.11868461,0.6643805,0.004865174,0.0015242503,0.003681251,0.04947939,0.00047852754,0.12389933,0.00063181453,0.001217577,0.0010934772],"about_ca_topic_score_codex":0.00031438633,"about_ca_topic_score_gemma":0.000021550328,"teacher_disagreement_score":0.28027079,"about_ca_system_score_codex":0.0001138113,"about_ca_system_score_gemma":0.0006876039,"threshold_uncertainty_score":0.68954295},"labels":[],"label_agreement":null},{"id":"W2100083745","doi":"10.1002/ajh.24089","title":"Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trial","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute","keywords":"Medicine; Magnetic resonance imaging; Anemia; Sickle cell anemia; Transcranial Doppler; Stroke (engine); Clinical trial; Internal medicine; Radiology","score_opus":0.014282315929319318,"score_gpt":0.24310120521185946,"score_spread":0.22881888928254016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100083745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98761725,0.0016153572,0.0006690361,0.009260097,0.00011932724,0.0004177221,0.0000144272235,0.000008927368,0.00027784525],"genre_scores_gemma":[0.9977936,0.00056111964,0.00061345554,0.0008495163,0.00011051231,0.000002762776,0.00004020698,0.000016432183,0.000012366454],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981193,0.000342104,0.000696359,0.00018839398,0.00040171284,0.00025214735],"domain_scores_gemma":[0.99875855,0.00018399773,0.00050506473,0.00018757806,0.00017406969,0.00019073609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007370387,0.00015105851,0.0005567774,0.00003877191,0.00003351264,0.000009038345,0.00014332714,0.00010126402,0.000025468442],"category_scores_gemma":[0.00016260274,0.00008642806,0.00007372911,0.00021181702,0.00030479755,0.00006212018,0.00000858504,0.00053362263,0.000006962244],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51913375,0.007757044,0.251716,0.000068482535,0.0013810707,0.0011882086,0.018924123,0.0027566662,0.013746822,0.000034147535,0.15728042,0.026013292],"study_design_scores_gemma":[0.8881663,0.04638543,0.017669939,0.000890884,0.0021894206,0.0041144392,0.012998057,0.0013772545,0.017362379,0.00005953648,0.007737505,0.0010488633],"about_ca_topic_score_codex":0.00079744036,"about_ca_topic_score_gemma":0.00012880529,"teacher_disagreement_score":0.36903256,"about_ca_system_score_codex":0.00009834989,"about_ca_system_score_gemma":0.0005331304,"threshold_uncertainty_score":0.3524434},"labels":[],"label_agreement":null},{"id":"W2100618811","doi":"10.1002/ajh.1142","title":"Hemoglobin H (Hb H) disease in Canada: Molecular diagnosis and review of 116 cases","year":2001,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"Medical Research Council; Medical Research Council Canada","keywords":"Hydrops fetalis; Vietnamese; Compound heterozygosity; Disease; Genetics; Point mutation; Population; Medicine; Hemoglobinopathy; Gene; Biology; Mutation; Internal medicine; Pregnancy; Fetus","score_opus":0.006932173537876715,"score_gpt":0.25130158236865874,"score_spread":0.244369408830782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100618811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85127616,0.13839293,0.000014480155,0.010034405,0.000047251473,0.000112966365,0.0000032995422,0.0000019094814,0.00011662918],"genre_scores_gemma":[0.8789602,0.11789696,0.00015938288,0.0029565874,0.000007839671,0.0000036321537,0.0000013237866,0.000009473859,0.000004637015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988067,0.000098225224,0.00059617957,0.000108911736,0.00018693534,0.000203039],"domain_scores_gemma":[0.99892837,0.00014600385,0.0004035245,0.00013779417,0.00011442826,0.000269867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013785592,0.00011253001,0.000821635,0.000119383265,0.000013387616,0.0000012765694,0.00007015669,0.000024008888,0.00008212697],"category_scores_gemma":[0.00046898678,0.00008552885,0.000088246474,0.0003321714,0.00021049858,0.000027892618,0.00002221915,0.00019455585,7.3514644e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000286326,0.00020762238,0.93665904,0.001593974,0.00012817532,0.026875593,0.000053423028,0.000013206965,0.000056640893,0.00017475807,0.0029072508,0.031044004],"study_design_scores_gemma":[0.01549224,0.009015924,0.5308776,0.0973775,0.0039305435,0.24825788,0.010872042,0.00027684227,0.0037451116,0.00082458154,0.07765862,0.0016711308],"about_ca_topic_score_codex":0.12145839,"about_ca_topic_score_gemma":0.017261824,"teacher_disagreement_score":0.40578145,"about_ca_system_score_codex":0.00010671501,"about_ca_system_score_gemma":0.0011226493,"threshold_uncertainty_score":0.9632502},"labels":[],"label_agreement":null},{"id":"W2103541791","doi":"10.1002/ajh.24082","title":"Gray zone lymphoma with features intermediate between classical<scp>H</scp>odgkin lymphoma and diffuse large<scp>B</scp>‐cell lymphoma:<scp>C</scp>haracteristics, outcomes, and prognostication among a large multicenter cohort","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Vincristine; Internal medicine; Rituximab; CHOP; Gastroenterology; Hazard ratio; Dacarbazine; Oncology; Lymphoma; Prednisone; Cyclophosphamide; Diffuse large B-cell lymphoma; B symptoms; Surgery; Chemotherapy; Confidence interval","score_opus":0.008092142052280111,"score_gpt":0.24796022870251758,"score_spread":0.23986808665023746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103541791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946191,0.0022677318,0.00063541764,0.0004995347,0.00034576707,0.0009997992,0.00014595698,0.00009262133,0.00039409014],"genre_scores_gemma":[0.9948434,0.0008536376,0.0021248613,0.0009984002,0.0003035583,0.00011882312,0.00018078343,0.00014371457,0.00043281727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948439,0.00045843146,0.0014969836,0.00091683,0.00093476137,0.0013490937],"domain_scores_gemma":[0.9909929,0.0038801194,0.002152301,0.0006778615,0.00068354135,0.0016132446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000739645,0.0009297663,0.0027529646,0.0005860889,0.00022587275,0.0001761284,0.0003847879,0.000355231,0.000003299261],"category_scores_gemma":[0.0030569527,0.000659662,0.00030303566,0.0004477491,0.0013092136,0.00037776923,0.0003006747,0.00031744284,0.000034474047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012906751,0.005421891,0.9757278,0.00014715434,0.0014361459,0.002165,0.0026356138,2.6634342e-7,0.00005757053,0.00015898845,0.006358864,0.0057616523],"study_design_scores_gemma":[0.033219475,0.003228954,0.93629354,0.00040985705,0.0020271663,0.00393076,0.005183771,0.00009512685,0.0016752782,0.00006025671,0.013727409,0.00014839166],"about_ca_topic_score_codex":0.00013423117,"about_ca_topic_score_gemma":0.00008266106,"teacher_disagreement_score":0.03943423,"about_ca_system_score_codex":0.00047235648,"about_ca_system_score_gemma":0.0005225204,"threshold_uncertainty_score":0.99958545},"labels":[],"label_agreement":null},{"id":"W2112472918","doi":"10.1002/ajh.20145","title":"Cavernous sinus thrombosis presenting with diplopia in an allogeneic bone marrow transplant recipient","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Diplopia; Thrombosis; Autopsy; Surgery; Bone marrow transplant; Cavernous sinus; Bone marrow; Radiological weapon; Radiology; Transplantation; Bone marrow transplantation; Pathology","score_opus":0.01606951148575644,"score_gpt":0.27424067262381535,"score_spread":0.25817116113805894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112472918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967319,0.0002705919,0.00034184873,0.002088875,0.000114622184,0.00022485803,0.0000042275556,0.000025884365,0.00019720595],"genre_scores_gemma":[0.9911662,0.00010873406,0.008152293,0.0004204014,0.00008059472,0.000005818952,0.000005473293,0.00005146885,0.000009066027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977877,0.00013975264,0.0007964131,0.0002979438,0.00041805755,0.0005601219],"domain_scores_gemma":[0.99848574,0.00008474166,0.00063975906,0.00032201665,0.00015920465,0.00030852077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028151204,0.00025579132,0.0013203694,0.0003847272,0.0000645594,0.0000143115,0.00019758096,0.00008250068,0.00005892808],"category_scores_gemma":[0.00004357364,0.00019461365,0.00015087881,0.0004948205,0.00046550037,0.00015840401,0.000025573798,0.00047852006,0.000008688042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012497084,0.0019864116,0.9572962,0.00011140277,0.00046769503,0.008884076,0.0063454034,0.00049673644,0.020582875,0.0003823429,0.0000386048,0.0021585806],"study_design_scores_gemma":[0.007877173,0.015684033,0.83244044,0.001068196,0.0007581807,0.120365776,0.0030631218,0.00003547106,0.017579341,0.0003935482,0.00013317677,0.00060157717],"about_ca_topic_score_codex":0.00059155753,"about_ca_topic_score_gemma":0.0010884334,"teacher_disagreement_score":0.12485576,"about_ca_system_score_codex":0.0002738103,"about_ca_system_score_gemma":0.00036723498,"threshold_uncertainty_score":0.7936114},"labels":[],"label_agreement":null},{"id":"W2120300273","doi":"10.1002/ajh.23805","title":"Silent cerebral infarction, income, and grade retention among students with sickle cell anemia","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Quartile; Medicine; Demography; Anemia; Logistic regression; Psychological intervention; Sickle cell anemia; Educational attainment; Household income; Odds ratio; Pediatrics; Gerontology; Internal medicine; Confidence interval; Psychiatry","score_opus":0.003714131595690591,"score_gpt":0.229604361980888,"score_spread":0.2258902303851974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120300273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767816,0.00023442169,0.0005448194,0.00096225046,0.00010410051,0.00009990132,3.4542163e-7,0.0000122174015,0.00036379226],"genre_scores_gemma":[0.99860454,0.00015695396,0.00083412696,0.0002780181,0.000041367857,0.0000015992117,0.0000017042815,0.000015754198,0.00006594542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989254,0.000104861574,0.00038354602,0.00013246012,0.00025178908,0.00020196731],"domain_scores_gemma":[0.99901813,0.00005193916,0.00049165887,0.00012458154,0.00012206395,0.00019162026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022338124,0.00012202805,0.0004768375,0.00016193071,0.00006156039,0.000011577923,0.000080541955,0.00006413547,0.000024776646],"category_scores_gemma":[0.000036792735,0.00008250298,0.00006128739,0.00018548878,0.00044241932,0.000073863404,0.00002912449,0.00033879952,0.000004393816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022744131,0.00015596357,0.99617195,0.000059886697,0.00008376902,0.00007385601,0.00035444263,0.00001884638,0.00027876568,0.00009884516,0.0002485788,0.0022276705],"study_design_scores_gemma":[0.00547956,0.007110578,0.97039366,0.0003384914,0.00039770626,0.009373311,0.004203863,0.00013118221,0.0011049001,0.00022295487,0.0010236498,0.00022017273],"about_ca_topic_score_codex":0.00006986872,"about_ca_topic_score_gemma":0.000009200729,"teacher_disagreement_score":0.025778305,"about_ca_system_score_codex":0.000028449245,"about_ca_system_score_gemma":0.00004581017,"threshold_uncertainty_score":0.33643737},"labels":[],"label_agreement":null},{"id":"W2125406455","doi":"10.1002/ajh.20236","title":"Compound heterozygosity for a novel nine-nucleotide deletion and the Asn45Ser missense mutation in the glycoprotein IX gene in a patient with Bernard-Soulier syndrome","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Bernard–Soulier syndrome; Compound heterozygosity; Missense mutation; Mutation; Genetics; Molecular biology; Biology; Asparagine; Gene; Point mutation; Platelet membrane glycoprotein; Glycoprotein; Amino acid","score_opus":0.007550369079298915,"score_gpt":0.24034967625414705,"score_spread":0.23279930717484815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125406455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99044067,0.00037950347,0.0016029577,0.00690279,0.000018427989,0.0006353513,0.000002865093,0.0000024823507,0.000014985161],"genre_scores_gemma":[0.994784,0.000039366798,0.004309107,0.0008126204,0.0000065679374,0.000031989028,0.000004020223,0.000010272321,0.000002052503],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99911743,0.00008350964,0.00036580738,0.000113333386,0.00015261697,0.00016730353],"domain_scores_gemma":[0.9992603,0.00016602065,0.00036454137,0.000099658806,0.00006674284,0.000042710464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002516861,0.00011489951,0.0005817629,0.00011251508,0.000046184785,0.000010225261,0.00005514598,0.000027593578,0.0000020698803],"category_scores_gemma":[0.000054697484,0.0000565615,0.00006487732,0.00015968794,0.0002679324,0.000048578164,0.000008919558,0.00016450585,7.2456095e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19842248,0.019728798,0.24981269,0.00076641276,0.00607857,0.35375366,0.08028004,0.009929672,0.012279523,0.008110862,0.00045482366,0.060382467],"study_design_scores_gemma":[0.07844655,0.013295096,0.08886697,0.00063639606,0.00048453396,0.8061103,0.006674072,0.0004813937,0.0016199899,0.0028697185,0.00021285597,0.00030207948],"about_ca_topic_score_codex":0.0004718922,"about_ca_topic_score_gemma":0.00025665812,"teacher_disagreement_score":0.4523567,"about_ca_system_score_codex":0.00005559761,"about_ca_system_score_gemma":0.00005927314,"threshold_uncertainty_score":0.2306511},"labels":[],"label_agreement":null},{"id":"W2127359693","doi":"10.1002/ajh.20518","title":"Isolated pulmonary amyloidosis: Case report and review of the literature","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Amyloidosis; Medicine; Intensive care medicine; Dermatology; Pathology","score_opus":0.003966870314583004,"score_gpt":0.24881852142103272,"score_spread":0.2448516511064497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127359693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8853458,0.11185936,0.00004709256,0.0023521953,0.00010721164,0.00012807621,0.00001115738,0.000003120162,0.00014599402],"genre_scores_gemma":[0.9853937,0.012918516,0.0005180824,0.0009790257,0.00007038656,0.000007657901,0.000011475582,0.000017158221,0.00008396825],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9986428,0.00018798113,0.00067978597,0.00019433079,0.000118473334,0.00017659916],"domain_scores_gemma":[0.9981024,0.00005012676,0.0011960489,0.0003658336,0.00022330809,0.000062242114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021706035,0.00017043411,0.00054933276,0.00005759988,0.000051291336,0.000007102801,0.00017016658,0.00008022026,0.000010024609],"category_scores_gemma":[0.00016405353,0.00010905618,0.00022645519,0.0002343823,0.00034993433,0.0000066140456,0.0000877822,0.0001507914,6.212252e-7],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051325274,0.0012380442,0.7733726,0.0023719026,0.0016085618,0.12283512,0.00022479685,0.000015893636,0.044750694,0.00048300507,0.033106267,0.019479863],"study_design_scores_gemma":[0.00045826248,0.0007560796,0.010766913,0.0019055008,0.00031375143,0.9569938,0.00020052309,0.000003269275,0.023012485,0.000100668745,0.0052781156,0.00021062506],"about_ca_topic_score_codex":0.000060716236,"about_ca_topic_score_gemma":0.000012059858,"teacher_disagreement_score":0.83415866,"about_ca_system_score_codex":0.000013420642,"about_ca_system_score_gemma":0.00008714394,"threshold_uncertainty_score":0.44471818},"labels":[],"label_agreement":null},{"id":"W2130548892","doi":"10.1002/ajh.21781","title":"Necrosis following skull base irradiation and stem cell transplant for multiple myeloma","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"","keywords":"Multiple myeloma; Skull; Necrosis; Medicine; Stem cell; Pathology; Immunology; Surgery; Biology","score_opus":0.014132465732123279,"score_gpt":0.28194197702822843,"score_spread":0.26780951129610514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130548892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970566,0.00020692075,0.0011525877,0.0010568467,0.00017334145,0.00025866262,0.000016671556,0.000009407923,0.0000689775],"genre_scores_gemma":[0.98921865,0.00006511985,0.010430974,0.00013816233,0.00006060243,0.000014156491,0.000008290748,0.000019251896,0.00004480729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989984,0.000050757248,0.0003484663,0.00014616232,0.00017082787,0.0002853605],"domain_scores_gemma":[0.9987163,0.00048681407,0.00025547287,0.00012910739,0.00009818317,0.00031413056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022609935,0.00012298931,0.0005306825,0.00017576227,0.00007651023,0.000012438501,0.00006935241,0.000052140753,0.00001394469],"category_scores_gemma":[0.00007421779,0.00009312832,0.00018353129,0.000097550896,0.00012877546,0.00007759614,0.000009163057,0.0002372599,0.00000392826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030243588,0.00055255,0.7087587,0.0001969668,0.00056028186,0.0013559625,0.0014644287,0.0000029871837,0.11831012,0.00013351835,0.00037170656,0.16526839],"study_design_scores_gemma":[0.06222318,0.020996157,0.6029433,0.00052437006,0.0019612925,0.029337062,0.0048386836,0.00956807,0.25709683,0.00043851172,0.009076526,0.0009960214],"about_ca_topic_score_codex":0.00004820009,"about_ca_topic_score_gemma":0.000037303005,"teacher_disagreement_score":0.16427238,"about_ca_system_score_codex":0.000021609903,"about_ca_system_score_gemma":0.00011206438,"threshold_uncertainty_score":0.37976626},"labels":[],"label_agreement":null},{"id":"W2132432381","doi":"10.1002/ajh.24223","title":"Personalized risk prediction for event‐free survival at 24 months in patients with diffuse large B‐cell lymphoma","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Clinical endpoint; Statistic; Oncology; Population; Anthracycline; Framingham Risk Score; Disease; Lymphoma; Cancer; Clinical trial; Statistics; Mathematics; Breast cancer","score_opus":0.009678997285731131,"score_gpt":0.24355383513251344,"score_spread":0.2338748378467823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132432381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977776,0.0006609619,0.00024694327,0.00046026366,0.0002592063,0.00036527307,0.00009115089,0.00001040071,0.00012824048],"genre_scores_gemma":[0.99821454,0.00009171278,0.0013285144,0.00014874786,0.000056545246,0.000030530544,0.000028536002,0.000024971385,0.00007588216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985204,0.00013595504,0.0004830246,0.00018334515,0.0003673795,0.00030993554],"domain_scores_gemma":[0.99834675,0.00019594702,0.0006873692,0.00022127546,0.00027616514,0.0002724767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026976917,0.00017288388,0.00077370956,0.00016253369,0.000045527006,0.0000057924794,0.0001027327,0.000052219813,0.000013861278],"category_scores_gemma":[0.00018829493,0.00011596993,0.00015136947,0.00014990884,0.00014002017,0.00007030771,0.000038627535,0.00007260426,0.0000059117456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006496529,0.006275752,0.9807684,0.00001963089,0.00022858806,0.00014234628,0.0006966708,0.000003990522,0.000002251851,0.000075998534,0.002642819,0.00264703],"study_design_scores_gemma":[0.17879196,0.013733959,0.7982037,0.00013892513,0.00060107687,0.0006230198,0.0017619664,0.00014799896,0.00029242074,0.00013570212,0.005388602,0.00018069331],"about_ca_topic_score_codex":0.000102222766,"about_ca_topic_score_gemma":0.00008365384,"teacher_disagreement_score":0.18256472,"about_ca_system_score_codex":0.00044936698,"about_ca_system_score_gemma":0.00022302233,"threshold_uncertainty_score":0.47291166},"labels":[],"label_agreement":null},{"id":"W2132940313","doi":"10.1002/ajh.24018","title":"Non–injection‐site necrotic skin lesions complicating postoperative heparin thromboprophylaxis","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Heparin; Thrombosis; Complication; Rash; Thrombus; Surgery; Coagulopathy; Amputation; Necrosis; Anticoagulant; Internal medicine","score_opus":0.03589062673312375,"score_gpt":0.32067901952675026,"score_spread":0.2847883927936265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132940313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911154,0.00016509547,0.0012604835,0.0034398094,0.000318397,0.00027451976,0.000003869907,0.000031695174,0.0033907122],"genre_scores_gemma":[0.9905018,0.000033909782,0.008188456,0.0009919136,0.00014243434,0.000009033519,0.0000064554724,0.00004149572,0.00008450223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978728,0.00018427077,0.0008708333,0.00029841257,0.00033382993,0.00043981068],"domain_scores_gemma":[0.9973435,0.00018801737,0.0007446648,0.00040894854,0.0007326481,0.00058224006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004166945,0.00026911483,0.0015065498,0.00032770514,0.00015593982,0.000027564387,0.00023211518,0.000097289325,0.00010045022],"category_scores_gemma":[0.00033684474,0.00021444746,0.00024539864,0.0006573896,0.0005400879,0.00017595888,0.00010604851,0.0006419108,0.0002167816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023921165,0.0038336692,0.6971266,0.00022802447,0.003394314,0.0024102642,0.02947944,0.0003796095,0.14323701,0.009430157,0.017922278,0.0901665],"study_design_scores_gemma":[0.013046482,0.042757254,0.6633666,0.0010999046,0.0014533217,0.15472761,0.034098394,0.0014062119,0.075037844,0.0019808481,0.009267537,0.0017579884],"about_ca_topic_score_codex":0.00067010865,"about_ca_topic_score_gemma":0.000060957696,"teacher_disagreement_score":0.15231735,"about_ca_system_score_codex":0.0002109697,"about_ca_system_score_gemma":0.00061237573,"threshold_uncertainty_score":0.8744914},"labels":[],"label_agreement":null},{"id":"W2136426334","doi":"10.1002/ajh.24204","title":"Rituximab with high‐dose methotrexate in primary central nervous system lymphoma","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; BC Cancer Agency","funders":"","keywords":"Medicine; Primary central nervous system lymphoma; Rituximab; Methotrexate; Lymphoma; Dosing; Internal medicine; Chemotherapy; Retrospective cohort study; Surgery; Gastroenterology","score_opus":0.01188359765193602,"score_gpt":0.25186790290450295,"score_spread":0.23998430525256692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136426334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960262,0.0011890677,0.00014012576,0.001534333,0.00017780135,0.00016705497,0.0000029480263,0.000020637943,0.0007417935],"genre_scores_gemma":[0.9904344,0.000057030535,0.008952547,0.00042027078,0.00007787884,0.000007906045,0.0000046488362,0.00002826856,0.000017028935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982949,0.00019242644,0.0005936693,0.00019028127,0.0003234963,0.0004052342],"domain_scores_gemma":[0.99844426,0.00014049179,0.0005840779,0.00023418623,0.00018724975,0.00040973458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026564076,0.0002013484,0.0013573881,0.00027274125,0.000021302303,0.000010829267,0.00011498501,0.00004865531,0.000009403434],"category_scores_gemma":[0.000044238783,0.00013303116,0.000118318094,0.00033612247,0.00022991907,0.00007796587,0.000029286044,0.00011621156,0.00001998638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006401334,0.0039940528,0.6424238,0.00020749976,0.00094157207,0.046090465,0.0012465587,0.00008630434,0.00012760008,0.0026891574,0.0014304877,0.29436117],"study_design_scores_gemma":[0.02243434,0.0058419425,0.8666869,0.0005961368,0.00043422365,0.09839642,0.0029882295,0.000044859193,0.0013385699,0.000049986425,0.0009734517,0.00021494986],"about_ca_topic_score_codex":0.0004552229,"about_ca_topic_score_gemma":0.000030171941,"teacher_disagreement_score":0.29414624,"about_ca_system_score_codex":0.0007464416,"about_ca_system_score_gemma":0.0006998983,"threshold_uncertainty_score":0.54248536},"labels":[],"label_agreement":null},{"id":"W2136749314","doi":"10.1002/ajh.20253","title":"Intravascular T-cell lymphoma with bowel involvement: Case report and literature review","year":2005,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Lymphoma; Abdomen; Immunophenotyping; Abdominal pain; Laparotomy; Autopsy; Pathology; Surgery; Immunology","score_opus":0.00534744552747374,"score_gpt":0.2481279740461677,"score_spread":0.24278052851869397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136749314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83098745,0.16312477,0.000041913638,0.0054123625,0.000027942142,0.0001736942,0.0000015812521,0.0000075783155,0.00022273263],"genre_scores_gemma":[0.94845575,0.042572692,0.0056114,0.0031907898,0.000087635795,0.000007566002,0.0000062326,0.000019190036,0.000048769398],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99883586,0.00006168712,0.00053674437,0.0001850742,0.0001873931,0.00019325274],"domain_scores_gemma":[0.9986492,0.000059372887,0.0005869289,0.00026528214,0.00020462331,0.00023463556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022269864,0.00017258391,0.00080115953,0.000119731834,0.000041651732,0.000012955574,0.000046057143,0.000035529767,0.000027658994],"category_scores_gemma":[0.000037902155,0.000107846834,0.00012797798,0.00020895136,0.00020105389,0.000076164484,0.000020371215,0.00010437638,0.0000042772053],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017767708,0.0009871006,0.01897151,0.000627081,0.0004942516,0.8331327,0.00039820463,7.625197e-7,0.000030191593,0.000100524805,0.0039493414,0.14113064],"study_design_scores_gemma":[0.0026798295,0.0017582675,0.0020844983,0.0025851768,0.0006344204,0.9739653,0.0002968779,0.0000046466103,0.00092026184,0.0000072834446,0.014960279,0.000103193066],"about_ca_topic_score_codex":0.000028261715,"about_ca_topic_score_gemma":0.000012725122,"teacher_disagreement_score":0.14102745,"about_ca_system_score_codex":0.0000751483,"about_ca_system_score_gemma":0.00016773328,"threshold_uncertainty_score":0.43978664},"labels":[],"label_agreement":null},{"id":"W2137499479","doi":"10.1002/ajh.10009","title":"Autologous peripheral stem cell transplantation for aggressive hemophagocytic syndrome associated with T‐cell lymphoma: Case study and review","year":2001,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Lymphoma; Autologous stem-cell transplantation; Lymphoproliferative disorders; Transplantation; Stem cell; Peripheral T-cell lymphoma; Chemotherapy; T-cell lymphoma; Aggressive lymphoma; Oncology; Internal medicine; Immunology; T cell; Rituximab; Immune system; Biology","score_opus":0.014032784262379428,"score_gpt":0.29158919180393983,"score_spread":0.2775564075415604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137499479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97929174,0.019217163,0.00024091633,0.0003648452,0.000030112558,0.00074652606,0.000003406492,0.000014617444,0.00009066905],"genre_scores_gemma":[0.9947995,0.0045040143,0.00018095056,0.0002957089,0.000009246736,0.00003108693,0.00000449133,0.00002743578,0.00014757352],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9983672,0.00024473754,0.000644481,0.00018916538,0.00023709233,0.0003173243],"domain_scores_gemma":[0.99810135,0.0002481147,0.0010444592,0.00015169235,0.00030600466,0.00014838127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037845763,0.00018467636,0.0011724861,0.00015191433,0.00011283038,0.0000105846575,0.000090481204,0.00005115718,0.000027906652],"category_scores_gemma":[0.000045778896,0.00013286424,0.00010576731,0.0002702464,0.0002739771,0.00009884099,0.000012175646,0.00018815094,0.000001978382],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046410197,0.004348156,0.14427076,0.00412773,0.0013355643,0.74702716,0.006837363,0.00001593823,0.00028018106,0.000013992935,0.0009818234,0.08612033],"study_design_scores_gemma":[0.014284208,0.01971298,0.011837281,0.0015539787,0.0011598746,0.93131477,0.019303804,0.0001899198,0.00019783214,0.000007997999,0.00018302335,0.00025434798],"about_ca_topic_score_codex":0.000044569064,"about_ca_topic_score_gemma":0.000021541271,"teacher_disagreement_score":0.18428762,"about_ca_system_score_codex":0.00009383595,"about_ca_system_score_gemma":0.0003807664,"threshold_uncertainty_score":0.5418046},"labels":[],"label_agreement":null},{"id":"W2148765840","doi":"10.1002/ajh.23623","title":"Haptoglobin testing in hemolysis: Measurement and interpretation","year":2014,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Haptoglobin; Hemolysis; False positive paradox; Medicine; Gold standard (test); Immunology; Intensive care medicine; Internal medicine; Computer science; Artificial intelligence","score_opus":0.029832926257660746,"score_gpt":0.3126879756436792,"score_spread":0.2828550493860184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148765840","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008595525,0.9977404,0.00041359407,0.00025228228,0.00012860473,0.00021105152,5.132059e-7,0.000008188159,0.00038582366],"genre_scores_gemma":[0.019419499,0.97860885,0.0017166426,0.00016550772,0.00004471077,0.0000066812268,0.0000017225883,0.000031336414,0.000005075954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977467,0.00030084857,0.001260343,0.00019473096,0.0002621081,0.00023525236],"domain_scores_gemma":[0.9977605,0.00025437216,0.0014669544,0.00015062842,0.00022417206,0.00014339961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008437161,0.00025438645,0.00308861,0.000531512,0.000022853645,0.000009503128,0.00010488925,0.0001596922,0.0000074733584],"category_scores_gemma":[0.00092994916,0.00017599991,0.00026954853,0.00046385056,0.00023614895,0.000031958054,0.000033175493,0.0007056528,0.000007681832],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034702432,0.00006622714,0.00029303855,0.0037676222,0.00025120686,0.00022656428,0.00011446445,0.00000129861,0.0000013066002,0.000038087932,0.000079313046,0.9951262],"study_design_scores_gemma":[0.003029846,0.0057773967,0.00013627176,0.16714722,0.006444644,0.10448229,0.0019810947,0.00043210943,0.000005418226,0.00023587124,0.7094826,0.0008452252],"about_ca_topic_score_codex":0.000026833943,"about_ca_topic_score_gemma":0.000005222804,"teacher_disagreement_score":0.99428093,"about_ca_system_score_codex":0.00014306341,"about_ca_system_score_gemma":0.00040375267,"threshold_uncertainty_score":0.7177068},"labels":[],"label_agreement":null},{"id":"W2150604072","doi":"10.1002/ajh.23728","title":"Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; Ariad Pharmaceuticals; Teva Pharmaceutical Industries; Pfizer; Bristol-Myers Squibb","keywords":"Bosutinib; Medicine; Internal medicine; Imatinib; Dasatinib; Nilotinib; Nausea; Adverse effect; Gastroenterology; Myeloid leukemia; Oncology; Rash; Tyrosine-kinase inhibitor; Cancer","score_opus":0.010508573516696769,"score_gpt":0.2926125195130662,"score_spread":0.28210394599636945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150604072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98874474,0.0076712603,0.00047973622,0.0015658502,0.00039474078,0.00050387724,0.000009873636,0.00003184207,0.0005981077],"genre_scores_gemma":[0.9941012,0.0012711374,0.0029358834,0.0005138184,0.00038657078,0.00003864191,0.000010108422,0.000069290494,0.0006733194],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963194,0.0003326331,0.001559387,0.0005358709,0.00043001783,0.0008226843],"domain_scores_gemma":[0.99691474,0.0007503263,0.0011516603,0.00060577824,0.0001613155,0.00041619458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063420384,0.00047217414,0.0020068611,0.00038474865,0.00008580281,0.000021507993,0.0002787989,0.0001625356,0.00033874912],"category_scores_gemma":[0.00052713364,0.000361619,0.00021193399,0.0005368192,0.0008703522,0.00017776623,0.00008903295,0.0008053468,0.000033682223],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18792024,0.0029934228,0.055880774,0.0036773062,0.0031947247,0.015427278,0.010398862,0.00023347118,0.017889246,0.0014489847,0.013667528,0.68726814],"study_design_scores_gemma":[0.5152993,0.06958779,0.11118466,0.014887832,0.0025557159,0.047402874,0.0028350656,0.0058385762,0.015098103,0.0006743896,0.21125987,0.0033758332],"about_ca_topic_score_codex":0.0000670819,"about_ca_topic_score_gemma":0.00063168,"teacher_disagreement_score":0.6838923,"about_ca_system_score_codex":0.0038839302,"about_ca_system_score_gemma":0.0031229255,"threshold_uncertainty_score":0.99994},"labels":[],"label_agreement":null},{"id":"W2152551343","doi":"10.1002/ajh.23582","title":"Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Covis Pharma; McGill University","keywords":"Ferumoxytol; Clinical endpoint; Medicine; Placebo; Anemia; Adverse effect; Hemoglobin; Iron-deficiency anemia; Internal medicine; Gastroenterology; Iron deficiency; Randomized controlled trial; Pathology; Magnetic resonance imaging","score_opus":0.008095242062402119,"score_gpt":0.2712025239910979,"score_spread":0.26310728192869576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152551343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927355,0.0005233336,0.0021644533,0.0032460762,0.00006162644,0.0011280659,0.0000055623136,0.0000088654215,0.00012653464],"genre_scores_gemma":[0.9800468,0.00009158542,0.018247673,0.001362097,0.000028571028,0.000025757454,0.0000022733434,0.000025980913,0.00016926091],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984512,0.00009809698,0.00059582695,0.00023618793,0.00020115498,0.00041754925],"domain_scores_gemma":[0.9982556,0.00028309206,0.0004400492,0.00021939054,0.00041657616,0.00038526714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002352909,0.00019596062,0.00097055803,0.00025536495,0.000057573732,0.000010442846,0.00013843647,0.000048856196,0.000089865796],"category_scores_gemma":[0.0004736214,0.00012505917,0.00006128269,0.0003605451,0.00025065654,0.00009111018,0.00003861964,0.00014000123,0.000012436128],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4101947,0.003077913,0.07319879,0.0049880003,0.00020528397,0.0008142034,0.04041344,0.001542129,0.02272874,0.003910852,0.02421686,0.41470912],"study_design_scores_gemma":[0.10813354,0.249621,0.44724393,0.0048893997,0.0032812962,0.03481269,0.10718961,0.000230928,0.025055956,0.000411967,0.016135342,0.0029943492],"about_ca_topic_score_codex":0.00014465023,"about_ca_topic_score_gemma":0.000036729107,"teacher_disagreement_score":0.41171476,"about_ca_system_score_codex":0.00002769799,"about_ca_system_score_gemma":0.0002827553,"threshold_uncertainty_score":0.5099765},"labels":[],"label_agreement":null},{"id":"W2157580101","doi":"10.1002/ajh.23287","title":"Immune thrombocytopenia: Getting back to basics","year":2012,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Splenectomy; Rituximab; Thrombocytopenic purpura; Immune system; Immune thrombocytopenia; Immunology; Pediatrics; Platelet; Antibody; Spleen","score_opus":0.016265217894813878,"score_gpt":0.2846585623433377,"score_spread":0.2683933444485238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157580101","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15286462,0.003631965,0.0002865414,0.8376513,0.000964941,0.00038336942,0.000015441552,0.000018666116,0.004183168],"genre_scores_gemma":[0.1842444,0.0003186912,0.014399601,0.7970372,0.0024453525,0.0000095322885,0.00007437252,0.00016736992,0.0013034818],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99781114,0.00012153528,0.0008564589,0.00022058727,0.0003460287,0.00064423267],"domain_scores_gemma":[0.9978429,0.00021172123,0.0011478242,0.0003658384,0.00020980656,0.0002219313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019162107,0.0003577177,0.0027082174,0.00031955543,0.00005025809,0.000013922284,0.0002545466,0.00029023323,0.00047595327],"category_scores_gemma":[0.00008979804,0.00027124528,0.00039014802,0.00024291757,0.00021417876,0.00007553069,0.00007532693,0.0016279608,0.0005837999],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002658513,0.0002686681,0.012016158,0.0002027194,0.0018555722,0.027211728,0.00042623308,8.347986e-7,0.00012217918,0.00003622808,0.9416878,0.015905993],"study_design_scores_gemma":[0.0016183764,0.0022919835,0.0018760692,0.00048776908,0.00087812106,0.08441193,0.00022356126,8.950666e-7,0.00041925898,0.00009032609,0.90734965,0.00035206677],"about_ca_topic_score_codex":0.000039507195,"about_ca_topic_score_gemma":0.0000017611851,"teacher_disagreement_score":0.0572002,"about_ca_system_score_codex":0.000114630464,"about_ca_system_score_gemma":0.00021906113,"threshold_uncertainty_score":0.99997395},"labels":[],"label_agreement":null},{"id":"W2163744485","doi":"10.1002/ajh.24060","title":"Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of General Medical Sciences","keywords":"Depression (economics); Repeatable Battery for the Assessment of Neuropsychological Status; Beck Depression Inventory; Medicine; Internal medicine; Thrombotic thrombocytopenic purpura; Montreal Cognitive Assessment; Psychiatry; Cognition; Neuropsychology; Pediatrics; Cognitive impairment; Psychology; Anxiety; Platelet","score_opus":0.019180272897131517,"score_gpt":0.285127697248539,"score_spread":0.26594742435140745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163744485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859303,0.011943829,0.0005230977,0.0002389803,0.00096504897,0.00017717003,0.000019358662,0.000018228813,0.00018398066],"genre_scores_gemma":[0.9993546,0.000047006044,0.00032873088,0.00017343114,0.0000353094,0.000007323212,0.000018586505,0.000016110977,0.00001887966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829423,0.0005168781,0.0005896894,0.00022473988,0.00007859489,0.00029585016],"domain_scores_gemma":[0.9982786,0.00062764966,0.0007083942,0.00016576986,0.0001248185,0.000094735675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003185664,0.00018086015,0.00086388335,0.00013746013,0.000094029856,0.000016339085,0.00021002896,0.000067301204,0.00020217065],"category_scores_gemma":[0.00024362274,0.00014383702,0.00016476904,0.0001072884,0.0003195361,0.00017014412,0.00015019569,0.00021286805,0.000084755884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002600511,0.00068844913,0.93418247,0.000031845026,0.004564875,0.0006948498,0.0029963045,0.000011145756,0.015980605,0.00022027618,0.010469329,0.02755932],"study_design_scores_gemma":[0.03853676,0.020580428,0.721208,0.0036555103,0.0052066646,0.028411323,0.10012866,0.00002445277,0.06381931,0.010886056,0.0052918904,0.002250964],"about_ca_topic_score_codex":0.00015861887,"about_ca_topic_score_gemma":0.000019535993,"teacher_disagreement_score":0.21297452,"about_ca_system_score_codex":0.000055708428,"about_ca_system_score_gemma":0.00014414196,"threshold_uncertainty_score":0.58655035},"labels":[],"label_agreement":null},{"id":"W2174145330","doi":"10.1002/ajh.24240","title":"Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open‐label, 6‐month extension study","year":2015,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; Covis Pharma; McGill University","keywords":"Ferumoxytol; Medicine; Anemia; Iron-deficiency anemia; Transferrin saturation; Internal medicine; Placebo; Iron deficiency; Kidney disease; Gastroenterology; Ferritin; Adverse effect","score_opus":0.031461872049836,"score_gpt":0.30947648988227017,"score_spread":0.2780146178324342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174145330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849408,0.009458927,0.00003207055,0.0032925613,0.00013112072,0.0020112982,0.00008388111,0.0000021837043,0.000047125934],"genre_scores_gemma":[0.99688387,0.00082542875,0.00048696532,0.0016367196,0.000031855467,0.00001384235,0.00004031445,0.00003505225,0.00004593766],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99687856,0.00040377307,0.0016327451,0.00030394175,0.0005104697,0.00027052482],"domain_scores_gemma":[0.9946346,0.0006057375,0.0036535722,0.000524798,0.0005021237,0.00007912423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056913,0.00033499094,0.0026319195,0.0004128598,0.000023189383,0.0000018852326,0.0002786161,0.0001464646,0.000012005077],"category_scores_gemma":[0.0001674096,0.00018962477,0.00011792924,0.00019523845,0.0010976027,0.00006265757,0.000043406857,0.00034041956,7.993109e-8],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3919519,0.03956707,0.22759992,0.0016859496,0.0007122564,0.00042827748,0.030530656,0.00004891719,0.0008882468,0.000027970746,0.059528574,0.24703026],"study_design_scores_gemma":[0.45716074,0.25428373,0.2640731,0.0009023279,0.0038242827,0.00031032978,0.006270081,0.000018773553,0.00024927253,0.000021553755,0.0122443065,0.00064152933],"about_ca_topic_score_codex":0.001270137,"about_ca_topic_score_gemma":0.000050002887,"teacher_disagreement_score":0.24638873,"about_ca_system_score_codex":0.00018973711,"about_ca_system_score_gemma":0.0008197263,"threshold_uncertainty_score":0.7732674},"labels":[],"label_agreement":null},{"id":"W2176696615","doi":"10.1002/ajh.24211","title":"Inhibition of phagocytic recognition of anti‐<scp>D</scp> opsonized Rh <scp>D</scp>+ <scp>RBC</scp> by polymer‐mediated immunocamouflage","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"Canadian Institutes of Health Research; Health Canada; Centre for Blood Research, University of British Columbia; Michael Smith Health Research BC; University of British Columbia; Government of Canada; Canadian Blood Services; Australian Government","keywords":"Flow cytometry; Immune system; Monocyte; Antibody; Grafting; Blood transfusion; PEG ratio; Medicine; Red blood cell; Antigen; Immunology; Chemistry; Pharmacology; Andrology; Polymer","score_opus":0.013857806871574667,"score_gpt":0.24944345302375298,"score_spread":0.2355856461521783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2176696615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887982,0.0068705585,0.0010883007,0.0003233202,0.0005167419,0.0004554449,0.00010406948,0.00006061516,0.0017827721],"genre_scores_gemma":[0.99633914,0.0013009334,0.0011749289,0.00047400795,0.00018193804,0.000013385057,0.00019447302,0.000099815064,0.00022138834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99511015,0.0005428634,0.002150274,0.0004647414,0.00091995345,0.0008119883],"domain_scores_gemma":[0.99261355,0.0022559923,0.002849763,0.00047472824,0.0011525244,0.0006534629],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011000093,0.0005244837,0.0025140694,0.0008055603,0.000097148215,0.000021049194,0.0003098146,0.0003587376,0.00003113482],"category_scores_gemma":[0.0030246265,0.000457532,0.0005195571,0.0011861791,0.0010444318,0.00036033144,0.00007983937,0.0009168325,0.00005811726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051632087,0.0034563404,0.027689433,0.0008388554,0.0021049036,0.001445167,0.010686267,0.000008453392,0.9118025,0.0002526205,0.031797305,0.009401848],"study_design_scores_gemma":[0.019236663,0.009616223,0.003522222,0.0013626851,0.0017131452,0.011162246,0.026342062,0.00014504613,0.9231146,0.0006598508,0.0029902318,0.00013504204],"about_ca_topic_score_codex":0.00028924135,"about_ca_topic_score_gemma":0.000010771183,"teacher_disagreement_score":0.028807072,"about_ca_system_score_codex":0.000117154384,"about_ca_system_score_gemma":0.0006074694,"threshold_uncertainty_score":0.9997876},"labels":[],"label_agreement":null},{"id":"W2179085550","doi":"10.1002/ajh.24239","title":"Reply to H.J adams et al: “Is <scp>FDG‐PET/CT</scp> a sensitive and specific method for the detection of extranodal involvement in diffuse large <scp>B</scp>‐cell lymphoma?”","year":2015,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Lymphoma; Bone marrow; Rituximab; Radiology; Nuclear medicine; Internal medicine","score_opus":0.01974240030807576,"score_gpt":0.2907686698551946,"score_spread":0.27102626954711884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2179085550","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72110724,0.008018706,0.010641495,0.25652963,0.00085424277,0.0022953171,0.0002580627,0.00003092155,0.00026434686],"genre_scores_gemma":[0.35426772,0.0028803856,0.012651744,0.6289776,0.0005267848,0.00020826138,0.000060051967,0.00016866774,0.0002587684],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99617124,0.0005902796,0.0012788438,0.0006068458,0.00065180135,0.0007009864],"domain_scores_gemma":[0.99196887,0.004894337,0.001734951,0.0005579365,0.0005603833,0.00028349666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013624354,0.000556792,0.002201744,0.0006333489,0.00007564148,0.000031865435,0.00023073386,0.00009831599,0.0000033857061],"category_scores_gemma":[0.0005646676,0.0003812652,0.00046221568,0.00041489647,0.00029194684,0.000076304605,0.000110550405,0.00063807325,0.0000066270186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027782453,0.002545811,0.0032583505,0.00026313186,0.0013937273,0.011254499,0.004794193,0.000003465755,0.0010810163,0.00004462704,0.96225816,0.012825177],"study_design_scores_gemma":[0.013726248,0.0046887607,0.0023824591,0.00047121028,0.0008165452,0.023675794,0.008222921,0.00008334508,0.023160249,0.00011797391,0.9225394,0.00011505676],"about_ca_topic_score_codex":0.00057398365,"about_ca_topic_score_gemma":0.00008772579,"teacher_disagreement_score":0.37244797,"about_ca_system_score_codex":0.00043585774,"about_ca_system_score_gemma":0.00044365955,"threshold_uncertainty_score":0.9998639},"labels":[],"label_agreement":null},{"id":"W2191119087","doi":"10.1002/ajh.24258","title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10‐Color flow cytometry diagnosis and HyperCVAD therapy","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Induction chemotherapy; Retrospective cohort study; Acute leukemia; CD34; Gastroenterology; Surgery; Leukemia; Chemotherapy; Oncology; Stem cell","score_opus":0.027336212607212796,"score_gpt":0.3085883594998523,"score_spread":0.2812521468926395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191119087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406075,0.0028491116,0.0005323728,0.0016649435,0.00007509658,0.0002995776,0.000004363749,0.000016122936,0.0004976437],"genre_scores_gemma":[0.99362504,0.00093150523,0.0046004425,0.0004554409,0.00008615278,0.000021924707,0.000003827677,0.000040373878,0.00023531118],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9981666,0.00021933355,0.00044602368,0.00024261237,0.00053620903,0.00038921417],"domain_scores_gemma":[0.9975536,0.00082754163,0.00030781742,0.00019059182,0.0006442243,0.0004762248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021841747,0.00021824874,0.00083517976,0.00044277788,0.00006743899,0.000029507764,0.00015199062,0.00006291254,0.00016229105],"category_scores_gemma":[0.00043042548,0.0001579571,0.0000800029,0.00050884957,0.00080765027,0.000114265145,0.000040276656,0.00033693106,0.000041740106],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0122166565,0.0012146943,0.93397367,0.00019148637,0.0007925602,0.007377488,0.0035055145,0.0003565698,0.004185339,0.000044911816,0.008245069,0.027896052],"study_design_scores_gemma":[0.051658668,0.07921655,0.031940382,0.00073523994,0.0008784893,0.6968396,0.04110383,0.007875423,0.077703506,0.0005000649,0.010133509,0.001414784],"about_ca_topic_score_codex":0.000047835587,"about_ca_topic_score_gemma":0.000019350844,"teacher_disagreement_score":0.90203327,"about_ca_system_score_codex":0.00015981046,"about_ca_system_score_gemma":0.0008747155,"threshold_uncertainty_score":0.64413035},"labels":[],"label_agreement":null},{"id":"W2256816906","doi":"10.1002/ajh.24329","title":"Safety and efficacy of intrathecal rituximab in children with <scp>B</scp> cell lymphoid CD20+ malignancies: An international retrospective study","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Rituximab; CD20; Lymphoma; Adverse effect; Internal medicine; Oncology; Gastroenterology","score_opus":0.004908555378995419,"score_gpt":0.2480252671786096,"score_spread":0.24311671179961417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256816906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887705,0.0002168148,0.00009939036,0.00030506088,0.000042150157,0.00025437513,0.000012536481,0.00000602648,0.00018657278],"genre_scores_gemma":[0.9988471,0.00029363224,0.0007105923,0.00006635202,0.000046321944,0.0000042033353,0.0000018213768,0.000016744003,0.000013180963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867696,0.00010717782,0.0005318655,0.00022616635,0.00026006188,0.00019779266],"domain_scores_gemma":[0.99865013,0.00027508385,0.0005647872,0.00018815283,0.00018145693,0.00014035795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022157065,0.00016020438,0.00083989924,0.00023584395,0.000023090257,0.0000065050185,0.00012718019,0.00003535544,0.00001748892],"category_scores_gemma":[0.00015807145,0.00009174662,0.000067670255,0.0001727877,0.00039456596,0.00011009357,0.000036255493,0.00009278518,0.0000024249207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006168244,0.0053515597,0.98095614,0.0000035032324,0.00040316844,0.0002781598,0.0011172674,9.296894e-7,0.00030655487,0.0002606639,0.000016718686,0.010688497],"study_design_scores_gemma":[0.020126106,0.008955268,0.9580103,0.00013050756,0.00015532743,0.0077902908,0.0021640244,0.0000024385909,0.0025487894,0.000034208344,0.000036010326,0.000046712816],"about_ca_topic_score_codex":0.000114303475,"about_ca_topic_score_gemma":0.00003404778,"teacher_disagreement_score":0.022945838,"about_ca_system_score_codex":0.00018050455,"about_ca_system_score_gemma":0.00016675735,"threshold_uncertainty_score":0.37413183},"labels":[],"label_agreement":null},{"id":"W2277138589","doi":"10.1002/ajh.24287","title":"<sup>18</sup>FDG‐PET/CT: 21st century approach to leukemic tumors in 124 cases","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Occult; Leukemia; Chemotherapy; Disease; Radiology; Refractory (planetary science); Minimal residual disease; Oncology; Internal medicine; Pathology","score_opus":0.03395286486311565,"score_gpt":0.31540887691118596,"score_spread":0.2814560120480703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277138589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98627,0.00092276395,0.00014528145,0.0029395754,0.00011469851,0.00036104646,0.000006277917,0.000026821313,0.009213535],"genre_scores_gemma":[0.9905214,0.00020072453,0.0072399457,0.0015708838,0.0002070799,0.000019099809,0.0000080198715,0.000058729707,0.00017413693],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.996773,0.0003626911,0.0009980978,0.000366852,0.0006738834,0.00082549435],"domain_scores_gemma":[0.99729615,0.00038016553,0.0004555752,0.0004562125,0.00039368376,0.0010181956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009467325,0.0002970317,0.0014764305,0.0009977581,0.00004263595,0.000018873927,0.00048475427,0.00003137661,0.00009591945],"category_scores_gemma":[0.0011683012,0.00023934494,0.00015857421,0.0010789579,0.0005692662,0.00014102098,0.00017387146,0.0011304716,0.00012613843],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014040441,0.0046377145,0.3558478,0.00081861194,0.0015655955,0.3051454,0.012352711,0.005621804,0.003104679,0.008829663,0.21796319,0.070072375],"study_design_scores_gemma":[0.007653256,0.0065524047,0.0036346416,0.00046823037,0.00016058565,0.89005077,0.061427496,0.001498676,0.0015450004,0.0001665777,0.02623622,0.0006061307],"about_ca_topic_score_codex":0.0005401767,"about_ca_topic_score_gemma":0.0000098369555,"teacher_disagreement_score":0.5849054,"about_ca_system_score_codex":0.0010736743,"about_ca_system_score_gemma":0.001943496,"threshold_uncertainty_score":0.97602034},"labels":[],"label_agreement":null},{"id":"W2283900472","doi":"10.1002/ajh.24339","title":"Long‐term outcomes of thrombotic microangiopathy treated with plasma exchange: A systematic review","year":2016,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Thrombotic microangiopathy; Incidence (geometry); Population; Internal medicine; Stroke (engine); Neurocognitive; Cumulative incidence; Quality of life (healthcare); Pediatrics; Disease; Transplantation; Psychiatry; Cognition","score_opus":0.027690355300619817,"score_gpt":0.3202582878954277,"score_spread":0.2925679325948079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283900472","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00093113765,0.9966881,0.00004936346,0.00007071284,0.0002949012,0.0017738612,0.00013039367,0.000025164101,0.000036349007],"genre_scores_gemma":[0.0025302453,0.99685603,0.000048588918,0.000070824004,0.000020593785,0.00012979907,0.00004477236,0.000080388534,0.00021875958],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99334943,0.0022422636,0.0033333083,0.00038329643,0.0001420285,0.0005496493],"domain_scores_gemma":[0.98790145,0.001524474,0.009246921,0.00088956783,0.00035389088,0.0000836889],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006156313,0.00075911573,0.013190594,0.00060693175,0.000058974638,0.000008011562,0.0010491234,0.00019953122,0.00058227597],"category_scores_gemma":[0.0003159385,0.00038791265,0.0014270928,0.0004258569,0.00087988237,0.00007308205,0.00014081776,0.00036596166,0.0002651083],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007135695,0.00028533954,0.0022203,0.9556876,0.009454835,0.00039038688,0.00005820611,1.3149776e-8,0.000009263158,0.00007169903,0.0013355736,0.030415425],"study_design_scores_gemma":[0.0010881763,0.0015959861,0.00010390898,0.93559545,0.01673159,0.03473315,0.000073120566,7.458941e-9,0.000025163035,0.000003129039,0.009551028,0.0004992794],"about_ca_topic_score_codex":0.000010677062,"about_ca_topic_score_gemma":0.0000063526236,"teacher_disagreement_score":0.034342766,"about_ca_system_score_codex":0.00013361672,"about_ca_system_score_gemma":0.00041416986,"threshold_uncertainty_score":0.9998573},"labels":[],"label_agreement":null},{"id":"W2286519782","doi":"10.1002/ajh.24285","title":"Pediatric‐inspired therapy compared to allografting for <scp>P</scp>hiladelphia chromosome‐negative adult ALL in first complete remission","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Genentech; Health Resources and Services Administration; Medac; Swedish Orphan Biovitrum; Otsuka America; Incyte; Dana-Farber Cancer Institute; Blue Cross and Blue Shield Association; Kiadis Pharma; Therakos; Sigma-Tau Pharmaceuticals; Chimerix; Medical College of Wisconsin; Tarix Pharmaceuticals; StemCyte; Takeda Oncology; University of Minnesota; Otsuka America Pharmaceutical; Teva Pharmaceutical Industries; WellPoint; HistoGenetics; Ariad Pharmaceuticals; U.S. Navy; Osiris Therapeutics; Celgene; U.S. Department of Health and Human Services; Health Research; U.S. Public Health Service; Onyx Pharmaceuticals; U.S. Department of Defense; Sanofi; Be The Match Foundation; GlaxoSmithKline","keywords":"Medicine; Hazard ratio; Internal medicine; Cohort; Chemotherapy; Transplantation; Hematopoietic cell; Incidence (geometry); Hematopoietic stem cell transplantation; Gastroenterology; Regimen; Chemotherapy regimen; Leukemia; Oncology; Haematopoiesis; Stem cell; Confidence interval","score_opus":0.06018271158077865,"score_gpt":0.34214405059249414,"score_spread":0.2819613390117155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286519782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989135,0.00036982805,0.0020240513,0.007329264,0.00018220328,0.0007219059,0.000015309965,0.00002857271,0.00019386149],"genre_scores_gemma":[0.9751266,0.00018140847,0.021960296,0.0022381973,0.0003608119,0.000038557795,0.000012815622,0.000054776963,0.00002653145],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99703634,0.00017438731,0.0010826588,0.0003457572,0.00061552186,0.0007453549],"domain_scores_gemma":[0.99446654,0.0024000597,0.0008434513,0.00028941108,0.0011512355,0.0008492909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007370207,0.0002837412,0.0013886513,0.000637408,0.000067855035,0.000018504872,0.00040417464,0.000112490256,0.0000102025215],"category_scores_gemma":[0.004624513,0.00022289624,0.00019618376,0.0008079021,0.00029163447,0.000104815445,0.00009891421,0.0004658662,0.00002069079],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015620242,0.0034741168,0.54182816,0.00075777364,0.0020430435,0.0065568183,0.061547935,0.0017056065,0.030266369,0.0007000421,0.32569164,0.009808229],"study_design_scores_gemma":[0.24804106,0.1032651,0.13881506,0.0041025486,0.0015080611,0.06842456,0.10527921,0.05610826,0.035238963,0.0040476085,0.23270027,0.0024693024],"about_ca_topic_score_codex":0.00019749092,"about_ca_topic_score_gemma":0.000048489983,"teacher_disagreement_score":0.4030131,"about_ca_system_score_codex":0.0006149386,"about_ca_system_score_gemma":0.0010947891,"threshold_uncertainty_score":0.9089445},"labels":[],"label_agreement":null},{"id":"W2290639160","doi":"10.1002/ajh.24342","title":"Impact of HLA‐Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Meta‐Analysis","year":2016,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Deutscher Akademischer Austauschdienst","keywords":"Hematopoietic stem cell transplantation; Human leukocyte antigen; Meta-analysis; Transplantation; Stem cell; Medicine; Immunology; Internal medicine; Biology; Genetics; Antigen","score_opus":0.03981211741244985,"score_gpt":0.3509354095221212,"score_spread":0.3111232921096714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290639160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0060601826,0.9899193,0.002668942,0.000103284714,0.000094200244,0.0006633997,0.00009765802,0.000018319843,0.00037471217],"genre_scores_gemma":[0.062574975,0.9362432,0.00089913735,0.000019716565,0.000030734893,0.000032855543,0.00004195166,0.000084023195,0.00007344603],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9937349,0.0009614872,0.0037381558,0.00045772517,0.00057782663,0.0005298933],"domain_scores_gemma":[0.9926462,0.0017502154,0.0043406347,0.0005858833,0.00033668385,0.00034038728],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085901155,0.0007163154,0.01263088,0.002437584,0.000025406356,0.000010352381,0.00040166566,0.0003953234,0.0006294054],"category_scores_gemma":[0.000017554075,0.000431681,0.0061146384,0.0024817178,0.00037056507,0.000101326594,0.000016424156,0.00074011064,0.00004738167],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019176083,0.002283238,0.0073535335,0.13010092,0.6569774,0.013487782,0.0069256537,0.00009350732,0.000069856345,0.00046967427,0.00016734948,0.18015344],"study_design_scores_gemma":[0.0038127257,0.0031552126,0.00033441806,0.017677136,0.9066094,0.063125744,0.0004976667,0.000008509114,0.00024944192,0.00006298509,0.0035322728,0.0009344456],"about_ca_topic_score_codex":0.00008465191,"about_ca_topic_score_gemma":0.000011479011,"teacher_disagreement_score":0.24963202,"about_ca_system_score_codex":0.00021423365,"about_ca_system_score_gemma":0.0012103436,"threshold_uncertainty_score":0.9998135},"labels":[],"label_agreement":null},{"id":"W2295624617","doi":"10.1002/ajh.24351","title":"Central nervous system involvement by multiple myeloma: A multi‐institutional retrospective study of 172 patients in daily clinical practice","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"National Cancer Institute","keywords":"Multiple myeloma; Medicine; Retrospective cohort study; Central nervous system; Clinical Practice; Intensive care medicine; Oncology; Internal medicine; Family medicine","score_opus":0.025557997983065527,"score_gpt":0.3449735239218295,"score_spread":0.319415525938764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295624617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977887,0.00015262204,0.000600156,0.00041625075,0.00023787917,0.000688996,0.000033852415,0.00001010319,0.00007139506],"genre_scores_gemma":[0.99671227,0.000070983115,0.0030272796,0.00007492466,0.00005493711,0.000019678757,0.000006741889,0.00001714539,0.000016046044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964323,0.000646636,0.0014275077,0.00030487866,0.0007324036,0.00045626526],"domain_scores_gemma":[0.9966439,0.0006946689,0.0012626821,0.00026398775,0.00076383166,0.0003709125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065921654,0.00020551746,0.0011954377,0.000255538,0.000053794523,0.000005743599,0.00018328588,0.00006756103,0.000015070889],"category_scores_gemma":[0.0026352173,0.000120976896,0.00017196432,0.000280787,0.00047692476,0.00018431831,0.00007757999,0.00033556024,0.000009541809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00411747,0.009905272,0.9674785,0.00003672379,0.0007320056,0.0011849815,0.0004941077,0.0000023176765,0.00018496496,0.00007096075,0.00029571002,0.015496954],"study_design_scores_gemma":[0.025574002,0.01305693,0.9546252,0.00027903132,0.00013918726,0.00074185955,0.0050067166,0.00008229148,0.00019492369,0.000002909247,0.0001928913,0.00010406764],"about_ca_topic_score_codex":0.0007259763,"about_ca_topic_score_gemma":0.00018935754,"teacher_disagreement_score":0.021456532,"about_ca_system_score_codex":0.00058074686,"about_ca_system_score_gemma":0.00036842018,"threshold_uncertainty_score":0.49332947},"labels":[],"label_agreement":null},{"id":"W2296398034","doi":"10.1002/ajh.24360","title":"Long‐term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome‐positive leukemias treated with bosutinib","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Bosutinib; Medicine; Internal medicine; Imatinib; Tyrosine-kinase inhibitor; Nilotinib; Myeloid leukemia; Cardiology; Oncology; Cancer","score_opus":0.00965328692726936,"score_gpt":0.2594641061946532,"score_spread":0.24981081926738385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296398034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867123,0.0004446498,0.00004680104,0.00029979498,0.000021891512,0.0004352951,0.000012063782,0.0000057091133,0.000062561885],"genre_scores_gemma":[0.99947774,0.00011616144,0.00029869447,0.00003960376,0.000022513843,0.000009483535,0.000009091437,0.00002292871,0.000003773781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981839,0.000269637,0.0004861752,0.00022437291,0.0005867948,0.00024911357],"domain_scores_gemma":[0.9981347,0.0001566911,0.00074177835,0.00023450605,0.0005857763,0.00014655192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000350773,0.0002006093,0.0010186486,0.0002393339,0.000021754071,0.000003061577,0.00006876329,0.00005972783,0.00004675169],"category_scores_gemma":[0.00008724594,0.00010872901,0.000081147875,0.00027351177,0.000540871,0.00011768955,0.000021158947,0.00014548772,0.0000015987767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017036066,0.00031725658,0.9798031,0.000027806891,0.00085049594,0.0000719488,0.00027106615,0.00000518973,0.00060089055,0.00000855616,0.000012566078,0.016327536],"study_design_scores_gemma":[0.015673324,0.0065649743,0.9671029,0.00081974274,0.00091670797,0.0005345615,0.000108634624,0.000008933333,0.0081374515,0.000007505283,0.000003871631,0.00012140986],"about_ca_topic_score_codex":0.00006946043,"about_ca_topic_score_gemma":0.000020036436,"teacher_disagreement_score":0.016206125,"about_ca_system_score_codex":0.0008378127,"about_ca_system_score_gemma":0.0006409183,"threshold_uncertainty_score":0.44338402},"labels":[],"label_agreement":null},{"id":"W2341059062","doi":"10.1002/ajh.24386","title":"In memoriam: Bernard G. Forget","year":2016,"lang":"en","type":"editorial","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health; McGill University; Massachusetts General Hospital","keywords":"Internship; Medical school; Medical laboratory; Medicine; Family medicine; Medical education; Pathology","score_opus":0.0038785220571578294,"score_gpt":0.27859000961649605,"score_spread":0.2747114875593382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341059062","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00738782,0.00287544,0.00007744795,0.009378489,0.97837734,0.0001590455,0.000019271338,0.000013139703,0.0017120101],"genre_scores_gemma":[0.00699102,0.009147667,0.00093057274,0.00064950314,0.98053557,0.000006861002,0.00001640832,0.000118537304,0.0016038758],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974459,0.00014512456,0.001117195,0.00024323775,0.00058028725,0.0004682799],"domain_scores_gemma":[0.99700546,0.00068491604,0.0013780858,0.00028885782,0.0003962248,0.00024647987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004517473,0.00030160722,0.0020279356,0.0005672188,0.000025765914,0.000006604879,0.00027335118,0.0006455773,0.00010268726],"category_scores_gemma":[0.0011525613,0.000194234,0.0003620201,0.0002773467,0.00047544824,0.00007465431,0.000052945667,0.0016118379,0.000046054385],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073715823,0.00012678113,0.00060424354,0.00009085478,0.00027838352,0.0032124703,0.00014879837,4.693624e-7,0.000022456345,0.000065744316,0.99083877,0.003873878],"study_design_scores_gemma":[0.0029515089,0.001934687,0.000021334374,0.000892197,0.00021542411,0.003932608,0.00038464792,9.693349e-7,0.00005310663,0.00042424444,0.9889881,0.00020115716],"about_ca_topic_score_codex":0.00007655312,"about_ca_topic_score_gemma":0.000016500482,"teacher_disagreement_score":0.008728986,"about_ca_system_score_codex":0.00016359863,"about_ca_system_score_gemma":0.0010517273,"threshold_uncertainty_score":0.79206324},"labels":[],"label_agreement":null},{"id":"W2343370722","doi":"10.1002/ajh.24369","title":"Long‐term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment‐naïve patients with Gaucher disease","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Sanofi; Pfizer","keywords":"Medicine; Adverse effect; Internal medicine; Gastroenterology; Enzyme replacement therapy; Surgery; Disease","score_opus":0.009121903291583551,"score_gpt":0.28823567416420665,"score_spread":0.27911377087262307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343370722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958397,0.00024809327,0.00008472085,0.003237836,0.000035334793,0.00042270252,0.00004055898,0.0000049246955,0.00008608901],"genre_scores_gemma":[0.99923533,0.00021492587,0.00022781151,0.00016342242,0.000021485079,0.000007936126,0.000005983554,0.000023285233,0.00009981443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833727,0.00014386112,0.0006051983,0.00023846404,0.0003469175,0.00032827735],"domain_scores_gemma":[0.9981609,0.00027659762,0.00039283544,0.0002671217,0.00038272215,0.00051981775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011278265,0.00017848739,0.0007645164,0.00030347003,0.000024013872,0.0000045302922,0.000114373994,0.000037122685,0.00004020722],"category_scores_gemma":[0.0006355875,0.00009811052,0.00007349472,0.00029020276,0.0004154712,0.00008372782,0.00004024264,0.000109662964,0.0000070953483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057437696,0.0009153601,0.8710938,0.00003613484,0.00019546442,0.00097472995,0.00097404805,0.0000019828235,0.00021138834,0.000019058572,0.00016436583,0.06797595],"study_design_scores_gemma":[0.026594944,0.009076541,0.9622132,0.00053754856,0.00010241179,0.00022702155,0.00030092278,0.000002179982,0.0006988055,0.000011375929,0.000104104976,0.00013092726],"about_ca_topic_score_codex":0.00019362911,"about_ca_topic_score_gemma":0.000116142044,"teacher_disagreement_score":0.0911194,"about_ca_system_score_codex":0.00015414557,"about_ca_system_score_gemma":0.00020989054,"threshold_uncertainty_score":0.4000831},"labels":[],"label_agreement":null},{"id":"W2346165635","doi":"10.1002/ajh.24313","title":"Hepcidin as a new biomarker for detecting autologous blood transfusion","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Hepcidin; Biomarker; Medicine; Blood transfusion; Intensive care medicine; Immunology; Internal medicine; Anemia; Biology","score_opus":0.012878040328913015,"score_gpt":0.28581194794632125,"score_spread":0.2729339076174082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346165635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619299,0.0013239272,0.02385081,0.012124009,0.0002593653,0.00015506874,0.0000012530752,0.000021289297,0.00033437688],"genre_scores_gemma":[0.99121827,0.00040031623,0.006740605,0.0012896562,0.00011890732,0.0000034279228,3.4213386e-7,0.000024260418,0.0002042375],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998774,0.00007536364,0.000492968,0.00015269828,0.00020018619,0.00030480773],"domain_scores_gemma":[0.99861646,0.00036428578,0.00038856242,0.00014769174,0.00012591621,0.00035706555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003198704,0.00013343868,0.0006694481,0.00021453007,0.00005026662,0.0000041209746,0.00012451084,0.00007856602,0.00027977143],"category_scores_gemma":[0.0012569181,0.00007999511,0.00023228719,0.00016640408,0.00019780452,0.000062605046,0.000013485686,0.00011346952,0.000016369435],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002742136,0.00024590406,0.025359204,0.000070078786,0.00020439112,0.0005189745,0.00045060602,2.5499176e-7,0.06747256,0.0016321845,0.0024254941,0.8988782],"study_design_scores_gemma":[0.08511762,0.033001423,0.043207925,0.001995819,0.004469426,0.35566276,0.007752065,0.00005511779,0.3813716,0.014024288,0.071664006,0.0016779578],"about_ca_topic_score_codex":0.00008858756,"about_ca_topic_score_gemma":0.000018501287,"teacher_disagreement_score":0.8972002,"about_ca_system_score_codex":0.0000128048,"about_ca_system_score_gemma":0.00057110144,"threshold_uncertainty_score":0.3262106},"labels":[],"label_agreement":null},{"id":"W2346787971","doi":"10.1002/ajh.24412","title":"Identifying existing Choosing Wisely recommendations of high relevance and importance to hematology","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; St. Michael's Hospital","funders":"American Society of Hematology","keywords":"Relevance (law); Stewardship (theology); Medicine; Leverage (statistics); Harm; MEDLINE; Medical education; Psychology; Political science; Computer science; Law; Social psychology","score_opus":0.4357153574452297,"score_gpt":0.5454252801276466,"score_spread":0.10970992268241686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346787971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9007853,0.000825014,0.012629872,0.08443923,0.00076134107,0.000247356,0.000011028982,0.000025115698,0.0002756998],"genre_scores_gemma":[0.9582132,0.00054593734,0.037788805,0.0032012425,0.00012748732,0.00001672369,7.2658526e-7,0.000030746938,0.000075118565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947735,0.0020288462,0.0020922953,0.00029365244,0.00023459108,0.0005770961],"domain_scores_gemma":[0.98738265,0.007069092,0.004110972,0.0003409695,0.00076808175,0.00032825136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026779443,0.00017456048,0.0010903141,0.00032892264,0.0003454492,0.0000060166176,0.00028653056,0.000112469184,0.00009418305],"category_scores_gemma":[0.008330766,0.0001329901,0.00006653314,0.00040877235,0.00041646214,0.00040025506,0.00015472627,0.00062864425,0.000037790112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005524529,0.00014116011,0.7687132,0.00073603727,0.00019836509,0.00017512187,0.008087883,8.9972053e-7,0.005888959,0.104283735,0.0045057535,0.106716484],"study_design_scores_gemma":[0.0138655575,0.008130755,0.48314413,0.032707922,0.00077370746,0.022130253,0.15971917,0.000025661418,0.015410703,0.13203515,0.12888846,0.0031685124],"about_ca_topic_score_codex":0.00038635757,"about_ca_topic_score_gemma":0.00029359545,"teacher_disagreement_score":0.285569,"about_ca_system_score_codex":0.00014904157,"about_ca_system_score_gemma":0.00046635923,"threshold_uncertainty_score":0.9973307},"labels":[],"label_agreement":null},{"id":"W2406437958","doi":"10.1002/ajh.24399","title":"Enzyme replacement therapy with taliglucerase alfa: 36‐month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Amicus Therapeutics; Emory University; Sanofi; Pfizer","keywords":"Medicine; Enzyme replacement therapy; Adverse effect; Internal medicine; Gastroenterology; Pediatrics; Disease","score_opus":0.007541624364545126,"score_gpt":0.2585930362985003,"score_spread":0.25105141193395514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406437958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336946,0.0006361298,0.00017156714,0.0047771353,0.000011065066,0.00087998685,0.000021981601,0.00001872503,0.000113927694],"genre_scores_gemma":[0.9979348,0.0008849117,0.000524542,0.00042238136,0.000025007828,0.000023338405,0.000015659569,0.000057296675,0.00011206854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729884,0.0002989221,0.00071825535,0.00046997523,0.00065571954,0.00055829063],"domain_scores_gemma":[0.9972921,0.00029563103,0.0006930786,0.000461199,0.00063499843,0.00062301866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028993512,0.00033631024,0.000989663,0.00030977788,0.00006511059,0.000016002296,0.00015391296,0.000050359,0.00006803704],"category_scores_gemma":[0.00030667213,0.00015570014,0.000062505984,0.0004748045,0.0007907251,0.00016929963,0.000033423737,0.00029187396,0.000003867486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29710627,0.0015868738,0.67850935,0.000043029533,0.00040495358,0.002261713,0.00055207347,0.000009432043,0.000078534045,0.000021451513,0.00020535989,0.019220974],"study_design_scores_gemma":[0.1265266,0.05484735,0.8109596,0.0021944656,0.00027023698,0.0018231027,0.0007337689,0.00002423275,0.0011890036,0.000008452932,0.00087323895,0.00054999755],"about_ca_topic_score_codex":0.00026421013,"about_ca_topic_score_gemma":0.00017381522,"teacher_disagreement_score":0.17057969,"about_ca_system_score_codex":0.0002030403,"about_ca_system_score_gemma":0.00039957944,"threshold_uncertainty_score":0.63492674},"labels":[],"label_agreement":null},{"id":"W2408540430","doi":"10.1002/ajh.24429","title":"Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Multicenter study; Medicine; Hodgkin lymphoma; Central nervous system; Lymphoma; Oncology; Internal medicine; Intensive care medicine; Pediatrics","score_opus":0.008471791095465113,"score_gpt":0.280387025698044,"score_spread":0.27191523460257894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408540430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865097,0.000020563915,0.00026482824,0.0006622132,0.00017486907,0.00017000482,0.00003717117,0.0000062045033,0.000013185122],"genre_scores_gemma":[0.9973328,0.000060046405,0.0023674555,0.00016005828,0.000044578246,0.000003691529,0.000013186896,0.000014051084,0.0000041344406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987498,0.0000910891,0.0006202097,0.00014391514,0.0002472743,0.00014771738],"domain_scores_gemma":[0.9980761,0.00015237437,0.0009830258,0.0001427149,0.00047521948,0.00017059142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010763613,0.00012657158,0.00068671553,0.00010430605,0.000020335134,0.0000094505995,0.00006970362,0.000031833515,0.0000107945625],"category_scores_gemma":[0.00005146931,0.00006179937,0.000050793053,0.000072139796,0.00029016883,0.00013277541,0.000017823737,0.00003395959,9.709755e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021015191,0.0011039359,0.92390114,0.00002177641,0.0005570539,0.00013762794,0.00016086863,1.7727305e-7,0.000013180303,0.0002265102,0.0000128385245,0.07176339],"study_design_scores_gemma":[0.008418537,0.005407543,0.98434776,0.00027753357,0.00024164263,0.000301409,0.0006092143,0.000014806769,0.00016239933,0.0000011904428,0.00014867041,0.00006928046],"about_ca_topic_score_codex":0.000020626961,"about_ca_topic_score_gemma":0.000019285973,"teacher_disagreement_score":0.071694106,"about_ca_system_score_codex":0.000115941235,"about_ca_system_score_gemma":0.00013046405,"threshold_uncertainty_score":0.25201052},"labels":[],"label_agreement":null},{"id":"W2466941182","doi":"10.1002/ajh.24479","title":"Deferiprone‐induced agranulocytosis: 20 years of clinical observations","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Neutropenia; Deferiprone; Pediatrics; Leukopenia; Absolute neutrophil count; Internal medicine; Thalassemia; Chemotherapy","score_opus":0.03249723208838206,"score_gpt":0.3199428435003279,"score_spread":0.28744561141194586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466941182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980333,0.00050918764,0.0005682114,0.0006102009,0.00013573364,0.000044285425,0.000007823539,0.0000020299121,0.00008924575],"genre_scores_gemma":[0.99729955,0.0003419382,0.0020619528,0.00018265551,0.00006208808,0.0000027027309,0.000003097906,0.000011050566,0.000034961784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989454,0.0001105167,0.0005785426,0.00013182103,0.00008982815,0.00014385657],"domain_scores_gemma":[0.99889815,0.00006397575,0.000615668,0.00019848069,0.00013980686,0.00008389113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016939885,0.00008342312,0.00041714654,0.00004532429,0.000016706203,0.0000021365083,0.00016599186,0.00007145355,0.000011919166],"category_scores_gemma":[0.00018688022,0.000058160782,0.00020149413,0.000090224195,0.00023935767,0.0000045350534,0.000036006455,0.000057703008,0.000004885379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006126924,0.0007807414,0.5814834,0.000008920166,0.0010710694,0.0000514025,0.000059014455,0.0000014139553,0.15089977,0.00063301786,0.0022453787,0.26215315],"study_design_scores_gemma":[0.014654417,0.019632591,0.4745901,0.00021833749,0.0007061012,0.0020098672,0.0011323844,0.0000035706203,0.44834596,0.0019268406,0.0360223,0.0007575149],"about_ca_topic_score_codex":0.000013526633,"about_ca_topic_score_gemma":0.000017165317,"teacher_disagreement_score":0.2974462,"about_ca_system_score_codex":0.0000037183158,"about_ca_system_score_gemma":0.00012664853,"threshold_uncertainty_score":0.23717278},"labels":[],"label_agreement":null},{"id":"W2507407318","doi":"10.1002/ajh.24545","title":"<scp>I</scp>nvestigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health","keywords":"Dyskeratosis congenita; Biology; Mutation; Telomere; Germline mutation; Germline; Genetics; Germline mosaicism; Phenotype; X-inactivation; Telomerase; Skewed X-inactivation; X chromosome; Cancer research; Gene","score_opus":0.019486905393089594,"score_gpt":0.3107879121040287,"score_spread":0.29130100671093906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507407318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787945,0.00029488644,0.0007433308,0.0008084895,0.00008771669,0.00008535904,0.0000041419044,0.0000044070366,0.00009225059],"genre_scores_gemma":[0.9968835,0.00025678202,0.0027043254,0.00008256601,0.000041628224,0.0000013137078,0.0000015492477,0.000009260913,0.000019052613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985642,0.0001519786,0.00085756107,0.00012159004,0.00016688126,0.00013780486],"domain_scores_gemma":[0.99730426,0.0011772725,0.0010206138,0.00012258663,0.00024994602,0.00012530481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033727745,0.00008767338,0.00069012697,0.00028528034,0.000016678641,0.0000016116334,0.000067506815,0.000060818827,0.000010726755],"category_scores_gemma":[0.002245527,0.000062004496,0.000074382064,0.00030045077,0.0010147222,0.00011820896,0.000014091524,0.00014257939,0.0000011246844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012965704,0.0001757213,0.9341921,0.0000763366,0.000105712345,0.00004460176,0.0016422026,0.00000270611,0.034369998,0.00092292106,0.00008658413,0.028251449],"study_design_scores_gemma":[0.0031051475,0.0031453096,0.90931046,0.00068666536,0.00016411077,0.0013438083,0.009571241,0.00003708447,0.07114582,0.0011370784,0.0002776019,0.00007567477],"about_ca_topic_score_codex":0.00005876725,"about_ca_topic_score_gemma":0.00001863001,"teacher_disagreement_score":0.03677582,"about_ca_system_score_codex":0.000028390845,"about_ca_system_score_gemma":0.00024185497,"threshold_uncertainty_score":0.3738786},"labels":[],"label_agreement":null},{"id":"W2516537857","doi":"10.1002/ajh.24536","title":"Long‐term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Pfizer","keywords":"Bosutinib; Medicine; Nilotinib; Dasatinib; Internal medicine; Imatinib; Cumulative incidence; Adverse effect; Nausea; Myeloid leukemia; Gastroenterology; Oncology; Cohort","score_opus":0.014649612863998386,"score_gpt":0.3128337850963781,"score_spread":0.2981841722323797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516537857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98958784,0.0033233475,0.0035376048,0.0022931818,0.00023728742,0.00083193573,0.00008132976,0.000033712735,0.00007376886],"genre_scores_gemma":[0.9918969,0.0006729115,0.0061755776,0.00024122419,0.00048553938,0.00008915446,0.000013427975,0.00009001164,0.00033524923],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965968,0.0001444603,0.0015971871,0.0004685284,0.00040591406,0.0007870748],"domain_scores_gemma":[0.9957336,0.00092651224,0.0019357632,0.0005924143,0.00037293212,0.00043877537],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042132437,0.00047454645,0.0020690942,0.0003661497,0.00007032457,0.000012858968,0.00030288193,0.00017479349,0.0007563313],"category_scores_gemma":[0.00042841892,0.0002878034,0.00040707205,0.0002788465,0.0012418922,0.00020994374,0.00010655751,0.0003405265,0.000022002012],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043463975,0.001711409,0.09079879,0.0040569548,0.004915937,0.003927639,0.0027839206,0.000011650905,0.07453551,0.0010276206,0.0062202397,0.76654637],"study_design_scores_gemma":[0.36591187,0.16758233,0.07311727,0.014788823,0.006166178,0.14011836,0.0020226487,0.0006795864,0.2015271,0.0006519215,0.024536125,0.0028977667],"about_ca_topic_score_codex":0.000021972046,"about_ca_topic_score_gemma":0.00007846752,"teacher_disagreement_score":0.76364857,"about_ca_system_score_codex":0.0023786142,"about_ca_system_score_gemma":0.004695255,"threshold_uncertainty_score":0.9999574},"labels":[],"label_agreement":null},{"id":"W2529791032","doi":"10.1002/ajh.24575","title":"Reduced intensity conditioned allograft yields favorable survival for older adults with B‐cell acute lymphoblastic leukemia","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute","keywords":"Medicine; Internal medicine; Univariate analysis; Confidence interval; Cumulative incidence; Relative risk; Acute lymphocytic leukemia; Young adult; Gastroenterology; Leukemia; Surgery; Transplantation; Lymphoblastic Leukemia; Multivariate analysis","score_opus":0.008773666557131656,"score_gpt":0.2645232949211232,"score_spread":0.25574962836399157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529791032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94109887,0.00007373545,0.054112576,0.003662549,0.00027330633,0.0004526817,0.00002619518,0.000035998404,0.00026405993],"genre_scores_gemma":[0.99123114,0.00008341728,0.0072504967,0.000690313,0.00017173211,0.000029521201,0.000011135624,0.00006149295,0.000470733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975129,0.00012399467,0.00074260443,0.000380257,0.00052227353,0.00071798393],"domain_scores_gemma":[0.9956704,0.0013178983,0.000813374,0.0003848657,0.0013339665,0.00047949975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039098898,0.0003016345,0.0013656663,0.00034440687,0.0000998925,0.000014759017,0.00029870158,0.00014306775,0.00013871447],"category_scores_gemma":[0.000477599,0.00017471571,0.00023979398,0.0003568617,0.0010245891,0.00015541379,0.0000670064,0.0002863363,0.000034676734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24750032,0.005118315,0.07656907,0.00207424,0.014766983,0.023675317,0.006902549,0.00009429203,0.38594797,0.00313394,0.16603665,0.06818037],"study_design_scores_gemma":[0.19557934,0.07445175,0.03571667,0.008009518,0.0054712296,0.21583515,0.016768567,0.0017407578,0.43759888,0.0013645302,0.0047300872,0.0027335035],"about_ca_topic_score_codex":0.000065082284,"about_ca_topic_score_gemma":0.000010399526,"teacher_disagreement_score":0.19215983,"about_ca_system_score_codex":0.0008364756,"about_ca_system_score_gemma":0.0023162863,"threshold_uncertainty_score":0.71247},"labels":[],"label_agreement":null},{"id":"W2568877958","doi":"10.1002/ajh.24639","title":"Sepsis and persisting neutropenia in a drug addict","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; London Health Sciences Centre","funders":"","keywords":"Neutropenia; Medicine; Sepsis; Drug; Intensive care medicine; Drug addict; Internal medicine; Pharmacology; Chemotherapy; Addiction; Psychiatry","score_opus":0.005854179095339528,"score_gpt":0.2576043996369472,"score_spread":0.25175022054160767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568877958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969834,0.0013086317,0.000019497531,0.00074210734,0.0000459761,0.000029281251,0.0000017887373,8.4375546e-7,0.00086843566],"genre_scores_gemma":[0.99864256,0.00023860903,0.00088318303,0.00015355578,0.000029569546,0.0000014396619,0.0000013386125,0.000007799947,0.000041921056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994837,0.000043247936,0.00017513991,0.00011625013,0.00004391119,0.0001377443],"domain_scores_gemma":[0.99935657,0.000012996251,0.0003638118,0.00017154196,0.000036334426,0.00005875234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090372494,0.0000789426,0.0002488582,0.000043923785,0.00008697778,0.000019467678,0.00015963317,0.000026337959,0.0000064994906],"category_scores_gemma":[0.00007896271,0.00006578177,0.000054114294,0.00002069183,0.00024419682,0.000005368974,0.00007343296,0.00007280137,0.0000012197852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025190113,0.00016675548,0.9484951,0.000011770257,0.00023611463,0.00029004543,0.00027655275,0.0000041144863,0.004123273,0.00019410826,0.001239973,0.044710293],"study_design_scores_gemma":[0.019975942,0.008429524,0.83639085,0.0004474701,0.0005881607,0.015449433,0.011794242,0.000111093046,0.069217846,0.0014607859,0.034679096,0.0014555363],"about_ca_topic_score_codex":0.00014706419,"about_ca_topic_score_gemma":0.00016148816,"teacher_disagreement_score":0.11210423,"about_ca_system_score_codex":0.000004076391,"about_ca_system_score_gemma":0.000037154965,"threshold_uncertainty_score":0.2682503},"labels":[],"label_agreement":null},{"id":"W2589788830","doi":"10.1002/ajh.24693","title":"A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR‐CD) for untreated low‐grade non‐Hodgkin lymphoma requiring therapy","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene; Sanofi; Eli Lilly and Company; Amgen","keywords":"Medicine; Lenalidomide; Rituximab; Internal medicine; Follicular lymphoma; Gastroenterology; Cyclophosphamide; Lymphoplasmacytic Lymphoma; Dexamethasone; Lymphoma; Waldenstrom macroglobulinemia; Macroglobulinemia; Marginal zone B-cell lymphoma; Surgery; Oncology; Multiple myeloma; Chemotherapy; Immunology; B cell; Marginal zone","score_opus":0.027037348486308777,"score_gpt":0.34947976618728904,"score_spread":0.32244241770098026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589788830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559903,0.0021944658,0.00014808311,0.0010801434,0.00014731892,0.0007452918,0.000010260297,0.000010721048,0.00006468478],"genre_scores_gemma":[0.9958915,0.0010559203,0.0026669998,0.00019530213,0.00008221715,0.000051522806,0.0000027391582,0.000036984027,0.000016819957],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99805915,0.000111674686,0.0008991726,0.0003042603,0.0002596107,0.00036612267],"domain_scores_gemma":[0.9964915,0.00053448847,0.001870717,0.00054889,0.00030543865,0.0002489463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040392065,0.00029095213,0.0018217686,0.00023505362,0.00020719571,0.000035813016,0.00024098533,0.00007007112,0.000016518658],"category_scores_gemma":[0.00028463503,0.00020958373,0.00023403707,0.0001237076,0.0005934028,0.00014709035,0.000057092606,0.000096317366,0.000001859517],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013938725,0.029770074,0.5518094,0.00013234616,0.003384378,0.0025717642,0.0025324016,0.0000036385377,0.0047104135,0.00019719926,0.00040161322,0.39054805],"study_design_scores_gemma":[0.39440936,0.09093168,0.3786676,0.0010320735,0.0019961945,0.012649237,0.006744025,0.00021321236,0.11124162,0.00048070055,0.000989309,0.0006450075],"about_ca_topic_score_codex":0.0005542845,"about_ca_topic_score_gemma":0.0000320261,"teacher_disagreement_score":0.38990304,"about_ca_system_score_codex":0.00009027376,"about_ca_system_score_gemma":0.00019406801,"threshold_uncertainty_score":0.85465765},"labels":[],"label_agreement":null},{"id":"W2594382618","doi":"10.1002/ajh.24717","title":"Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"Foundation for the National Institutes of Health","keywords":"Amyloidosis; AL amyloidosis; Immunoglobulin light chain; Monoclonal; Amyloid (mycology); Chemistry; Exosome; Kidney; Laser capture microdissection; Molecular biology; Microvesicles; Medicine; Monoclonal antibody; Pathology; Antibody; Biology; Internal medicine; Biochemistry; Immunology","score_opus":0.006674407985861748,"score_gpt":0.28229529855705904,"score_spread":0.27562089057119726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594382618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984864,0.00028502726,0.00026453286,0.00065161265,0.000034378285,0.00019872421,0.00001807162,0.0000016748977,0.000059559112],"genre_scores_gemma":[0.9959631,0.00004140441,0.0038024387,0.000117246535,0.000013577577,0.000018426614,0.00000648403,0.000023180797,0.000014137981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998412,0.00025632815,0.0005795808,0.00023496554,0.00026874992,0.0002483641],"domain_scores_gemma":[0.99690646,0.00009370581,0.0021036419,0.0005197919,0.00028397437,0.00009240735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024920248,0.00020708954,0.00080467144,0.00015682858,0.000051315572,0.000008416773,0.00040175449,0.00006321704,0.000011463228],"category_scores_gemma":[0.00014012834,0.00014305492,0.00011110895,0.0000863259,0.0010423723,0.000017943205,0.00010450384,0.00013727059,1.7167632e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067373756,0.0010836092,0.98628384,0.000017794122,0.00048087424,0.00009308824,0.00011280712,0.00007753407,0.0036838793,0.000043158885,0.00013323757,0.0012527952],"study_design_scores_gemma":[0.004420661,0.018784601,0.90393656,0.00019258639,0.00009434324,0.00025777996,0.0003252515,0.0000030204085,0.07165496,0.000008609822,0.00016194033,0.00015968022],"about_ca_topic_score_codex":0.000023495239,"about_ca_topic_score_gemma":0.00001977237,"teacher_disagreement_score":0.08234728,"about_ca_system_score_codex":0.000035330686,"about_ca_system_score_gemma":0.00035022054,"threshold_uncertainty_score":0.583361},"labels":[],"label_agreement":null},{"id":"W2598501803","doi":"10.1002/ajh.24741","title":"Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Novo Nordisk","keywords":"Medicine; Glanzmann's thrombasthenia; Thrombasthenia; Platelet; Internal medicine; Surgery; Cardiology; Platelet aggregation","score_opus":0.017927975080819353,"score_gpt":0.32580165929613,"score_spread":0.30787368421531064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598501803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969115,0.000916189,0.000022411858,0.0018874618,0.00008516702,0.00008798858,0.000012916936,0.0000026835057,0.00007362993],"genre_scores_gemma":[0.9985363,0.00054969214,0.000794271,0.00006113383,0.000032766653,0.0000023578589,0.0000055267697,0.000009968126,0.000008017121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990329,0.000059846898,0.00040370197,0.00014508699,0.00020575085,0.00015272397],"domain_scores_gemma":[0.9981122,0.00048120704,0.0010371285,0.0001997977,0.00008996859,0.000079690406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023827335,0.00012374613,0.0007043698,0.000082108265,0.000107895175,0.000023370116,0.00014323801,0.000043641932,0.000014511299],"category_scores_gemma":[0.0002909745,0.00008092855,0.000046318422,0.000047079353,0.00060508744,0.00013415357,0.000075724754,0.00022458119,4.4516028e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041925232,0.00022995684,0.9806957,0.000017773493,0.00026753393,0.0006631073,0.00034140103,4.7710404e-7,0.0004810366,0.00016677343,0.0000478784,0.016669067],"study_design_scores_gemma":[0.0028866772,0.000295035,0.9922845,0.00021548878,0.000071057235,0.0019133873,0.0008578136,0.000020362615,0.0008910677,0.00031411138,0.00018245463,0.00006804874],"about_ca_topic_score_codex":0.0006200786,"about_ca_topic_score_gemma":0.000069637594,"teacher_disagreement_score":0.016601019,"about_ca_system_score_codex":0.000022398399,"about_ca_system_score_gemma":0.00008567293,"threshold_uncertainty_score":0.33001703},"labels":[],"label_agreement":null},{"id":"W2603194473","doi":"10.1002/ajh.24740","title":"Monocytosis in polycythemia vera: Clinical and molecular correlates","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Monocytosis; Leukocytosis; Medicine; Chronic myelomonocytic leukemia; Internal medicine; Gastroenterology; Myelofibrosis; Univariate analysis; Myeloid; Neutrophilia; Myelodysplastic syndromes; Bone marrow; Multivariate analysis","score_opus":0.021558517347115398,"score_gpt":0.35488325895712824,"score_spread":0.33332474161001285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603194473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98959327,0.0010444323,0.000059671034,0.0086097,0.00012434665,0.00008620918,8.9968967e-7,0.00000311943,0.0004783509],"genre_scores_gemma":[0.996331,0.0009766695,0.0019894857,0.00063365616,0.00004132969,0.000004420711,4.5557334e-7,0.000010893251,0.00001209071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896723,0.00008914712,0.000519296,0.00014836874,0.000107302876,0.00016865821],"domain_scores_gemma":[0.9987152,0.00023198662,0.0005832067,0.00022989124,0.00007303256,0.00016664261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002424745,0.000116347364,0.000838966,0.000103375714,0.000060752976,0.000016682015,0.000097781165,0.000057034693,0.000024430621],"category_scores_gemma":[0.0003717308,0.00008440887,0.0001172098,0.000039022038,0.00060830987,0.000057347614,0.000045203346,0.00028291938,0.0000075427874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003863439,0.0002216761,0.9755821,0.000007658016,0.00019266775,0.001853993,0.00010371771,5.872429e-7,0.000102153026,0.0012386878,0.00019178305,0.020118615],"study_design_scores_gemma":[0.0050764475,0.0036446634,0.9741372,0.0002624784,0.0002293477,0.0086244205,0.00033256382,0.00007127785,0.006064669,0.00074537797,0.00067628623,0.00013525796],"about_ca_topic_score_codex":0.000043048505,"about_ca_topic_score_gemma":0.00001095957,"teacher_disagreement_score":0.019983357,"about_ca_system_score_codex":0.00002341069,"about_ca_system_score_gemma":0.00009507971,"threshold_uncertainty_score":0.34420937},"labels":[],"label_agreement":null},{"id":"W2617335676","doi":"10.1002/ajh.24801","title":"Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Enzyme replacement therapy; Glucocerebrosidase; Medicine; Disease; Gaucher's disease; Pediatrics; Internal medicine","score_opus":0.024376949542531626,"score_gpt":0.3534491133295444,"score_spread":0.32907216378701276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617335676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365777,0.00097361486,0.00008387066,0.004120682,0.000058198966,0.00046587153,0.000014511014,0.0000028800168,0.0006225794],"genre_scores_gemma":[0.9982133,0.0010267121,0.00051648944,0.00011164532,0.000029620285,0.00003161748,0.000014410236,0.000015341733,0.0000408762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998098,0.00026708454,0.00074824423,0.00016185344,0.00051586994,0.00020892112],"domain_scores_gemma":[0.9980729,0.00016743856,0.0008889615,0.00037303378,0.00040279003,0.00009485557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053165935,0.00014892052,0.00048638356,0.0003028603,0.00006392839,0.00002045954,0.00037160004,0.000042285614,0.00015627738],"category_scores_gemma":[0.00036173817,0.000105803396,0.00010175129,0.00027912518,0.00042556046,0.00021660759,0.000027801965,0.0002828214,0.0000017428064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018617025,0.0028326833,0.93646467,0.00019519617,0.0006868181,0.002305585,0.017548297,0.00018339476,0.014317046,0.0012761919,0.00034549393,0.0052275783],"study_design_scores_gemma":[0.01816852,0.00365675,0.9240676,0.00065041805,0.0001478042,0.0016130446,0.02365457,0.0004032961,0.026415844,0.0005370742,0.00041661257,0.00026847265],"about_ca_topic_score_codex":0.00049141806,"about_ca_topic_score_gemma":0.00028845735,"teacher_disagreement_score":0.012397096,"about_ca_system_score_codex":0.00020398326,"about_ca_system_score_gemma":0.00033595026,"threshold_uncertainty_score":0.43145373},"labels":[],"label_agreement":null},{"id":"W2724756454","doi":"10.1002/ajh.24832","title":"Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia","year":2017,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Vascular Anomalies and Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Medicine; Mucocutaneous zone; Telangiectasia; ACVRL1; Endoglin; Anemia; Gastrointestinal bleeding; Gastroenterology; Internal medicine; Genetic disorder; Dermatology; Pathology; Disease","score_opus":0.007948102240533907,"score_gpt":0.25543178065029437,"score_spread":0.24748367840976046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724756454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93148714,0.0084028775,0.0000047974745,0.059164338,0.00032620644,0.0001769505,0.000022121285,0.0000055207224,0.00041007262],"genre_scores_gemma":[0.9818795,0.0011739412,0.00090031186,0.014998323,0.00074560737,0.000004582835,0.000020960711,0.000044418375,0.00023236075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985576,0.00010511181,0.00059703767,0.00020563522,0.00026954594,0.00026503368],"domain_scores_gemma":[0.9981373,0.00012603325,0.001168325,0.00037763914,0.000103616,0.00008710267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014259382,0.00022882539,0.001395342,0.00030237244,0.000025009382,0.000005716472,0.00020758004,0.00023289735,0.000041300504],"category_scores_gemma":[0.000108282955,0.00017207778,0.00022529408,0.000070269,0.00061509095,0.000055670873,0.000051521114,0.00090863684,0.0000032778105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019612024,0.00011695426,0.8600233,0.0013931879,0.0006989002,0.04867997,0.000185728,4.1630136e-7,0.000011263845,0.000004455235,0.08659903,0.0020906555],"study_design_scores_gemma":[0.007444725,0.010476252,0.48526418,0.005111278,0.0036423192,0.45129344,0.00049215666,0.00001141054,0.00043086408,0.00020841177,0.03494891,0.00067605707],"about_ca_topic_score_codex":0.00008908951,"about_ca_topic_score_gemma":0.000004081018,"teacher_disagreement_score":0.40261346,"about_ca_system_score_codex":0.000048169102,"about_ca_system_score_gemma":0.00019634438,"threshold_uncertainty_score":0.70171285},"labels":[],"label_agreement":null},{"id":"W2734059981","doi":"10.1002/ajh.24842","title":"ITACA: A new validated international erythropoietic stimulating agent‐response score that further refines the predictive power of previous scoring systems","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Predictive power; Medicine; Internal medicine","score_opus":0.041434262351583755,"score_gpt":0.34633243900680855,"score_spread":0.3048981766552248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734059981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98492926,0.0008514829,0.0017874101,0.011196814,0.0005976388,0.00030040607,0.000007789917,0.000013051411,0.000316154],"genre_scores_gemma":[0.99837965,0.00013484151,0.000792305,0.00013583581,0.00019119102,0.00000526903,0.0000014970358,0.00003523913,0.00032418582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977879,0.00039178203,0.0006848907,0.0002012772,0.0006164473,0.00031770617],"domain_scores_gemma":[0.996129,0.00071739196,0.0017821077,0.000612787,0.0005701998,0.00018851856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010343109,0.00018501349,0.000820698,0.0002496584,0.00014860791,0.00005488307,0.0006203617,0.00006853874,0.0001147311],"category_scores_gemma":[0.002240255,0.000115874325,0.00018604846,0.00013345982,0.0009331356,0.00018334959,0.0002195232,0.0005475293,0.000010317442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03311492,0.0005558295,0.8775286,0.00032993246,0.0062206746,0.005640015,0.021101424,0.0014745173,0.026419409,0.0006544657,0.013287274,0.013672919],"study_design_scores_gemma":[0.025380502,0.02373352,0.7036335,0.010446132,0.0017978427,0.1333941,0.062809296,0.010829257,0.01964944,0.0006783425,0.0064295246,0.0012185607],"about_ca_topic_score_codex":0.00031321455,"about_ca_topic_score_gemma":0.0000035278345,"teacher_disagreement_score":0.17389514,"about_ca_system_score_codex":0.00019635669,"about_ca_system_score_gemma":0.00065724575,"threshold_uncertainty_score":0.47252178},"labels":[],"label_agreement":null},{"id":"W2738096170","doi":"10.1002/ajh.24871","title":"Kidney function of transfused children with sickle cell anemia: Baseline data from the TWiTCH study with comparison to non‐transfused cohorts","year":2017,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Renal function; Albuminuria; Creatinine; Urology; Internal medicine; Kidney disease; Glomerular hyperfiltration; Kidney; Diabetic nephropathy","score_opus":0.013791860485723355,"score_gpt":0.2634233961170121,"score_spread":0.24963153563128873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738096170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74670184,0.00056029094,0.0076130894,0.24252571,0.00034543296,0.0017500725,0.0002742319,0.000024380515,0.00020494765],"genre_scores_gemma":[0.91591334,0.00014469832,0.0009802115,0.08147953,0.0006695489,0.000012005939,0.0006253099,0.00011430216,0.00006107622],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996625,0.0003822611,0.0011147204,0.0006135404,0.0008002437,0.0004642298],"domain_scores_gemma":[0.99541175,0.0003394431,0.0017556915,0.0018177184,0.00037889963,0.0002964916],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00056781416,0.00052282965,0.0026288459,0.00022912677,0.00016460159,0.000028329783,0.0010133948,0.0003527028,0.00012367363],"category_scores_gemma":[0.00008253282,0.00028097685,0.00016138503,0.00031894748,0.00069795235,0.000099009834,0.000058357225,0.0029962836,0.000010282046],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056899344,0.0012472797,0.30835605,0.0001307416,0.0029832635,0.0016280855,0.0016021931,0.00008967424,0.00014666878,2.1645508e-7,0.6765262,0.0015996839],"study_design_scores_gemma":[0.09486112,0.18185717,0.20911722,0.009214085,0.071331434,0.028774561,0.038469106,0.0005963605,0.0027548794,0.000022466376,0.35861838,0.00438321],"about_ca_topic_score_codex":0.002015041,"about_ca_topic_score_gemma":0.00027354746,"teacher_disagreement_score":0.3179078,"about_ca_system_score_codex":0.000039338538,"about_ca_system_score_gemma":0.0008654249,"threshold_uncertainty_score":0.99996424},"labels":[],"label_agreement":null},{"id":"W2739756331","doi":"10.1002/ajh.24877","title":"Outcomes after 18 months of eliglustat therapy in treatment‐naïve adults with <scp>G</scp>aucher disease type 1: The phase 3 ENGAGE trial","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Sanofi Genzyme","keywords":"Medicine; Disease; Phase (matter); Pediatrics; Internal medicine; Physics","score_opus":0.03070885738041767,"score_gpt":0.36448212080545594,"score_spread":0.33377326342503827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739756331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948785,0.0020071785,0.0000129384225,0.0019618955,0.00010815896,0.0006650842,0.000008174819,0.0000054200864,0.00035266663],"genre_scores_gemma":[0.99847955,0.000777144,0.0001527851,0.0002254042,0.000073830444,0.000036975165,0.0000021945525,0.000030689345,0.00022144335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982461,0.0003081496,0.00050128705,0.00019009736,0.0003980492,0.000356361],"domain_scores_gemma":[0.9975015,0.0006196898,0.0007681191,0.0005870869,0.000281398,0.00024220954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003016549,0.00021104413,0.00096713076,0.00018810427,0.000095709445,0.000021111413,0.00033473625,0.000047502264,0.000100459205],"category_scores_gemma":[0.0012307771,0.00010554375,0.00020541836,0.0001592829,0.000887253,0.00011422983,0.00003816716,0.00035603446,0.000007827307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18449247,0.0030589951,0.7708884,0.00004027712,0.00079337973,0.0046053585,0.0049239504,0.000003367181,0.000113336006,0.00003086085,0.0005948605,0.030454772],"study_design_scores_gemma":[0.37753242,0.059172813,0.535187,0.00046047583,0.0005191974,0.0011596467,0.019015819,0.000102759695,0.0018027816,0.00018648447,0.0046005645,0.00026002436],"about_ca_topic_score_codex":0.00034267682,"about_ca_topic_score_gemma":0.0001018266,"teacher_disagreement_score":0.23570138,"about_ca_system_score_codex":0.00007724046,"about_ca_system_score_gemma":0.00043590073,"threshold_uncertainty_score":0.43039495},"labels":[],"label_agreement":null},{"id":"W2759976150","doi":"10.1002/ajh.24914","title":"Safety and pharmacokinetics of the oral iron chelator SP‐420 in β‐thalassemia","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Pharmacokinetics; Medicine; Adverse effect; Dosing; Proteinuria; Internal medicine; Creatinine; Thalassemia; Pharmacology; Gastroenterology; Kidney","score_opus":0.007580817443427474,"score_gpt":0.2851408014773208,"score_spread":0.2775599840338933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759976150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904731,0.00093024276,0.000021478832,0.007344105,0.0001932328,0.00007794917,0.0000013861601,0.0000019886747,0.00095651514],"genre_scores_gemma":[0.9981641,0.001140679,0.00033972086,0.00027977204,0.000024427029,3.1972058e-7,1.8468491e-7,0.000009537354,0.00004126843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991213,0.0000656167,0.00043699628,0.00008159213,0.00013101357,0.00016348851],"domain_scores_gemma":[0.99881434,0.000056137953,0.00075233204,0.00021889778,0.00006879497,0.0000894782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022114247,0.00009044669,0.0005447661,0.00007022333,0.000061828694,0.000005003502,0.00017451619,0.00006158619,0.000025381434],"category_scores_gemma":[0.00019626616,0.000054536962,0.00008555225,0.00007813684,0.00077028375,0.00004034872,0.000064956716,0.00038295335,0.0000012341845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007308764,0.00015900919,0.9637686,0.00008198528,0.00012020342,0.00024870387,0.00057929195,0.000017856546,0.0043185293,0.00051217503,0.00052792457,0.02893483],"study_design_scores_gemma":[0.0069559705,0.001384478,0.9617244,0.00055635313,0.00035830087,0.010120416,0.00198961,0.00028911914,0.008147859,0.00021554403,0.00807459,0.0001833778],"about_ca_topic_score_codex":0.00007146703,"about_ca_topic_score_gemma":0.000012277855,"teacher_disagreement_score":0.028751453,"about_ca_system_score_codex":0.00002137033,"about_ca_system_score_gemma":0.00010346816,"threshold_uncertainty_score":0.28381425},"labels":[],"label_agreement":null},{"id":"W2769980455","doi":"10.1002/ajh.24980","title":"Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia","year":2017,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Jewish General Hospital; Queen's University; University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Randomized controlled trial; Cytarabine; Clinical trial; Oncology; Myeloid leukemia; Internal medicine; Intensive care medicine","score_opus":0.03236221611949127,"score_gpt":0.3474311390534881,"score_spread":0.31506892293399685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769980455","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5829207,0.00032279684,0.0035426232,0.4050642,0.0015846066,0.006101413,0.00007822062,0.000046420184,0.00033906844],"genre_scores_gemma":[0.46971008,0.0019807492,0.015233363,0.48909572,0.019494297,0.0012385123,0.0003597493,0.00085875555,0.0020287784],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99178976,0.00054551207,0.0032354784,0.0009228792,0.001981406,0.0015249578],"domain_scores_gemma":[0.98825675,0.004704793,0.0041510738,0.0013093199,0.0008975812,0.0006804555],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0026326624,0.0010610991,0.007988744,0.0017541976,0.00014467369,0.0001167049,0.0018813376,0.0011754663,0.00019920414],"category_scores_gemma":[0.002501495,0.0006955539,0.0010280246,0.0005672742,0.0023462703,0.00023668943,0.00029508982,0.008467093,0.000036167407],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8698031,0.0010863412,0.000016043125,0.0001565179,0.00293089,0.025195898,0.0011482659,0.0000010185355,0.00008071711,0.000010018824,0.08462753,0.014943689],"study_design_scores_gemma":[0.90889657,0.02979536,0.0000052396604,0.0026201827,0.0017330123,0.026853254,0.0006034803,0.00017990885,0.0001373,0.000021125612,0.028521474,0.0006330788],"about_ca_topic_score_codex":0.00038622064,"about_ca_topic_score_gemma":0.00009642227,"teacher_disagreement_score":0.11321057,"about_ca_system_score_codex":0.0015172443,"about_ca_system_score_gemma":0.0066546523,"threshold_uncertainty_score":0.99954957},"labels":[],"label_agreement":null},{"id":"W2783219391","doi":"10.1002/ajh.25034","title":"Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub‐Saharan Africa","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Heart, Lung, and Blood Institute; Wellcome Trust; Wellcome","keywords":"Baseline (sea); Medicine; Multicenter study; Demography; Geography; Internal medicine; Political science; Randomized controlled trial","score_opus":0.0076588171572207495,"score_gpt":0.27428832989895274,"score_spread":0.26662951274173197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783219391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985123,0.00039180307,0.000105519466,0.00045059586,0.00009239424,0.0003823318,0.000004588718,0.0000037710638,0.000056685807],"genre_scores_gemma":[0.9995699,0.00016240346,0.0001123958,0.0000991707,0.000030047815,0.0000046327395,9.2659013e-7,0.00001554834,0.000004956886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847287,0.00037390192,0.0005569563,0.00014954868,0.00020244287,0.0002442963],"domain_scores_gemma":[0.99867976,0.00018810388,0.00061068975,0.00018655616,0.0002480586,0.00008684405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007818881,0.00013978966,0.00078851037,0.00008851855,0.00005523291,0.000005825182,0.000101806785,0.00004607184,0.0000037554325],"category_scores_gemma":[0.00019334351,0.00007684809,0.000059371574,0.00026525304,0.0006439444,0.00003667566,0.00005253959,0.0002880406,8.018116e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031963822,0.00094018,0.9831087,0.00007736336,0.0002479243,0.00024164753,0.0031852978,0.00000132602,0.0034064725,0.000004836916,0.000042166845,0.0055477144],"study_design_scores_gemma":[0.00877313,0.006109855,0.9728825,0.0009873108,0.00024304203,0.001583726,0.006090025,0.00011667046,0.002665041,0.000005854343,0.00041810944,0.00012473651],"about_ca_topic_score_codex":0.000126223,"about_ca_topic_score_gemma":0.000046296653,"teacher_disagreement_score":0.010226189,"about_ca_system_score_codex":0.000033528166,"about_ca_system_score_gemma":0.000060067116,"threshold_uncertainty_score":0.3133774},"labels":[],"label_agreement":null},{"id":"W2793035957","doi":"10.1002/ajh.25059","title":"Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Rivaroxaban; Venous thromboembolism; Warfarin; Internal medicine; Cancer; Low molecular weight heparin; Major bleeding; Heparin; Surgery; Thrombosis; Atrial fibrillation","score_opus":0.009411923762697514,"score_gpt":0.29101764082430387,"score_spread":0.28160571706160636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793035957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799246,0.0008328967,0.00025235605,0.00024153001,0.0001068205,0.00054100197,0.000008607754,0.0000014152314,0.000022915443],"genre_scores_gemma":[0.99838793,0.0011445718,0.00035517878,0.000051481806,0.000032272088,0.000015901758,7.2667706e-7,0.000010934843,9.934445e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992504,0.000057525987,0.00033199386,0.00009417093,0.00011906207,0.0001468515],"domain_scores_gemma":[0.9988476,0.0002881873,0.0004695038,0.0001263896,0.00022801555,0.000040320065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014836476,0.00009673452,0.0011541017,0.00010310039,0.00002933138,0.0000015500904,0.000059502912,0.000020836478,0.000011287645],"category_scores_gemma":[0.000021352556,0.00005167407,0.000059908787,0.00012434929,0.0005181901,0.00002361614,0.000011004366,0.00003658047,2.0312113e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004835114,0.004004614,0.88395476,0.00029922152,0.0016764731,0.000015494606,0.0025606852,0.000022589496,0.00020927878,0.00074788055,0.0000654751,0.10160843],"study_design_scores_gemma":[0.0044780048,0.016603105,0.9743908,0.0003333193,0.00049123104,0.000038080638,0.00036213663,0.000011376865,0.0029824746,0.000051878596,0.0002088907,0.000048687085],"about_ca_topic_score_codex":0.00029768646,"about_ca_topic_score_gemma":0.000048748836,"teacher_disagreement_score":0.10155974,"about_ca_system_score_codex":0.000042322197,"about_ca_system_score_gemma":0.00007064895,"threshold_uncertainty_score":0.21072073},"labels":[],"label_agreement":null},{"id":"W2799641062","doi":"10.1002/ajh.25134","title":"Patient‐reported health‐related quality of life from the phase III TOURMALINE‐MM1 study of ixazomib‐lenalidomide‐dexamethasone versus placebo‐lenalidomide‐dexamethasone in relapsed/refractory multiple myeloma","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"Museums Association","keywords":"Placebo; Lenalidomide; Medicine; Clinical endpoint; Internal medicine; Multiple myeloma; Ixazomib; Quality of life (healthcare); Hazard ratio; Dexamethasone; Surgery; Gastroenterology; Randomized controlled trial; Confidence interval; Carfilzomib; Pathology","score_opus":0.06886877488201884,"score_gpt":0.3831735620730968,"score_spread":0.3143047871910779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799641062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942932,0.0021732962,0.00012673398,0.0012931894,0.00046129824,0.0014918022,0.000063951215,0.000023562054,0.000072945535],"genre_scores_gemma":[0.9973853,0.0001599337,0.001929092,0.00024475908,0.00014081881,0.000035219422,0.000031717547,0.00005957457,0.000013542529],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9890684,0.0035159718,0.004752568,0.00056963525,0.0012836087,0.0008098366],"domain_scores_gemma":[0.98323256,0.0074074534,0.0064821406,0.0010582497,0.0011108333,0.0007087767],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031713208,0.00048431032,0.0035890618,0.00061979704,0.00014508907,0.000012861262,0.00046145654,0.00017810869,0.00034631192],"category_scores_gemma":[0.009469239,0.00033765932,0.00043449507,0.0011252789,0.001545008,0.00015681631,0.00018110886,0.0010855342,0.000011580676],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27909696,0.016840357,0.62624854,0.00012859653,0.007242234,0.0014918203,0.017160894,0.000052714386,0.006364469,0.000037354588,0.0009892656,0.044346772],"study_design_scores_gemma":[0.43030068,0.08398566,0.3972766,0.0010142947,0.00096294796,0.0011590457,0.072248586,0.0009554719,0.010963785,0.00013200474,0.00026143587,0.0007394841],"about_ca_topic_score_codex":0.016509535,"about_ca_topic_score_gemma":0.0015881561,"teacher_disagreement_score":0.22897194,"about_ca_system_score_codex":0.00028462458,"about_ca_system_score_gemma":0.001200631,"threshold_uncertainty_score":0.99990755},"labels":[],"label_agreement":null},{"id":"W2799711263","doi":"10.1002/ajh.25125","title":"Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"","keywords":"Medicine; Placebo; Syk; Adverse effect; Internal medicine; Immune thrombocytopenia; Splenectomy; Nausea; Gastroenterology; Clinical endpoint; Randomized controlled trial; Platelet; Spleen; Tyrosine kinase; Receptor","score_opus":0.027664849115529702,"score_gpt":0.3570882363265265,"score_spread":0.3294233872109968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799711263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818345,0.012569546,0.00049052434,0.0026577925,0.00014696529,0.0020925931,0.00004333284,0.0000033721965,0.00016141938],"genre_scores_gemma":[0.9941511,0.0040827426,0.0014840161,0.0000550074,0.000090944406,0.000063834945,0.000005957531,0.000013366799,0.00005302395],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972131,0.0004305038,0.0018435441,0.00014003071,0.00016572197,0.00020706511],"domain_scores_gemma":[0.991716,0.004638365,0.0028984824,0.00022259822,0.0004435973,0.000080945625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012530104,0.00019441226,0.0056652594,0.0001334129,0.000066501445,0.0000052162663,0.000088572415,0.000038617713,0.000029735753],"category_scores_gemma":[0.0013859769,0.000089666704,0.0011087982,0.00009415135,0.0010984626,0.000033686534,0.000011568649,0.000061512816,9.4394096e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9297521,0.001981191,0.000086818196,0.000060246486,0.012242959,0.0000847458,0.002533375,0.000004903373,0.0025171821,0.00042925798,0.00017395953,0.050133273],"study_design_scores_gemma":[0.9360819,0.0363492,0.00001967018,0.00017979115,0.006046266,0.0018811944,0.0018567239,0.00069021474,0.016398465,0.000187631,0.0002330354,0.00007592988],"about_ca_topic_score_codex":0.00011243452,"about_ca_topic_score_gemma":0.000025561349,"teacher_disagreement_score":0.050057344,"about_ca_system_score_codex":0.000056289933,"about_ca_system_score_gemma":0.00021234267,"threshold_uncertainty_score":0.40473315},"labels":[],"label_agreement":null},{"id":"W2799775749","doi":"10.1002/ajh.25110","title":"Physician decision making in selection of second‐line treatments in immune thrombocytopenia in children","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Children's Hospital of Eastern Ontario; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Rituximab; Immune thrombocytopenia; Observational study; Pediatrics; Splenectomy; Internal medicine; Lymphoma","score_opus":0.007807345850754926,"score_gpt":0.30327939581495145,"score_spread":0.2954720499641965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799775749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999087,0.0003406091,0.000043369608,0.000102222635,0.000041663992,0.00015627085,0.0000015476041,0.0000024406113,0.00022492431],"genre_scores_gemma":[0.99811757,0.00008471854,0.0016413352,0.000113220456,0.000020522844,0.0000024474314,0.000002652956,0.000011998589,0.0000055376054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883306,0.00007036937,0.0006401589,0.00013179646,0.000116424155,0.00020820982],"domain_scores_gemma":[0.99926466,0.00006812511,0.00047540475,0.00009779324,0.00006132328,0.000032696364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014077061,0.00011973722,0.0010058328,0.00051110605,0.000013654731,0.0000024049539,0.00007364295,0.00004586051,0.000065522414],"category_scores_gemma":[0.00003560762,0.000095743366,0.00007144663,0.0005656981,0.00013911095,0.000084651525,0.000018328563,0.00017569204,0.000006124809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010773443,0.0009421912,0.9471035,0.000007881227,0.00013961944,0.00034494442,0.00037123228,0.000007915755,0.0020928408,0.00002903969,0.000010562735,0.047872927],"study_design_scores_gemma":[0.0053934874,0.003150374,0.9819788,0.000463459,0.000043326538,0.0027650755,0.00026433318,0.00007713579,0.005259179,0.0005290354,0.0000061067544,0.00006970993],"about_ca_topic_score_codex":0.00021240918,"about_ca_topic_score_gemma":0.0006781814,"teacher_disagreement_score":0.04780322,"about_ca_system_score_codex":0.000121187535,"about_ca_system_score_gemma":0.000083871426,"threshold_uncertainty_score":0.3904301},"labels":[],"label_agreement":null},{"id":"W2799971934","doi":"10.1002/ajh.25123","title":"Plasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"CXCL13; Medicine; Chemokine; Immunology; Cytokine; Pathogenesis; Germinal center; Hypergammaglobulinemia; Antibody; Inflammation; Chemokine receptor; B cell","score_opus":0.010089957079526878,"score_gpt":0.2780532486777299,"score_spread":0.26796329159820304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799971934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953655,0.0009620558,0.0002045394,0.002864261,0.00026805792,0.00019396955,0.0000028246209,0.000012210433,0.00012656474],"genre_scores_gemma":[0.99841595,0.0001649172,0.0006207372,0.0005654787,0.000159454,0.0000069239777,0.0000014635617,0.000021815762,0.000043274275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852794,0.00010357684,0.000600449,0.00016863266,0.00024922864,0.0003501906],"domain_scores_gemma":[0.9985913,0.000045762918,0.00068287004,0.00017375725,0.00024842113,0.00025787714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030974735,0.00014983404,0.000716839,0.00035640952,0.000050672767,0.000011336469,0.00013212241,0.000054919536,0.00005732167],"category_scores_gemma":[0.00052068266,0.00012567635,0.00013806713,0.00047144195,0.0005038036,0.00009509124,0.000032008968,0.0003365945,0.000024490266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010582754,0.0013816674,0.9489171,0.00035127485,0.0004831271,0.005525482,0.0052864556,0.000046912846,0.0051854122,0.0005431854,0.0038231043,0.01787351],"study_design_scores_gemma":[0.08503803,0.030957397,0.7433243,0.005490445,0.0029240472,0.026184356,0.04905841,0.008202455,0.033907294,0.004940335,0.0072419113,0.0027310324],"about_ca_topic_score_codex":0.000138477,"about_ca_topic_score_gemma":0.00017500274,"teacher_disagreement_score":0.20559283,"about_ca_system_score_codex":0.00017995045,"about_ca_system_score_gemma":0.00042056394,"threshold_uncertainty_score":0.5124933},"labels":[],"label_agreement":null},{"id":"W2885564727","doi":"10.1002/ajh.25245","title":"A common functional <i>PIEZO1</i> deletion allele associates with red blood cell density in sickle cell disease patients","year":2018,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Genentech; Johns Hopkins University; National Institutes of Health; Alnylam Pharmaceuticals; Novo Nordisk; Doris Duke Charitable Foundation","keywords":"PIEZO1; Allele; Sickle cell anemia; Medicine; Internal medicine; Immunology; Biology; Genetics; Disease; Gene; Mechanosensitive channels","score_opus":0.006793025150322906,"score_gpt":0.20960515029112964,"score_spread":0.20281212514080674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885564727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93762535,0.00022191509,0.00009503075,0.060815237,0.00049141626,0.00025969328,0.00002243655,0.000023036639,0.00044587167],"genre_scores_gemma":[0.7776762,0.0001330074,0.00075147324,0.21877888,0.0014792178,0.000012764024,0.00059445127,0.00007651131,0.00049747847],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973723,0.00047046493,0.0008095132,0.00038619275,0.00048695496,0.00047451642],"domain_scores_gemma":[0.9967325,0.0002965438,0.0017836666,0.00031677613,0.0006479444,0.00022260398],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019186325,0.0003758142,0.0015292517,0.00038766168,0.00007708763,0.000009689221,0.0001528803,0.00035625248,0.00023187854],"category_scores_gemma":[0.00007941939,0.00029653238,0.00027306122,0.0002845784,0.0004955358,0.0000670788,0.000048539034,0.0018090366,0.000054007614],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033415512,0.0010858437,0.312674,0.00021719032,0.00022154032,0.002834487,0.00009726891,0.000006707018,0.00023634307,0.0000019781864,0.67915726,0.00012584991],"study_design_scores_gemma":[0.042347714,0.053202346,0.42436948,0.0016276223,0.0060707047,0.009907946,0.00076116924,0.00009254611,0.00337394,0.00070602295,0.45493996,0.002600549],"about_ca_topic_score_codex":0.00005465009,"about_ca_topic_score_gemma":0.00003303752,"teacher_disagreement_score":0.2242173,"about_ca_system_score_codex":0.00013953731,"about_ca_system_score_gemma":0.0004155028,"threshold_uncertainty_score":0.9999487},"labels":[],"label_agreement":null},{"id":"W2888496958","doi":"10.1002/ajh.25259","title":"Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Cilag; Pharmacyclics","keywords":"Ibrutinib; Chlorambucil; Obinutuzumab; Chemoimmunotherapy; Medicine; Ofatumumab; Fludarabine; Chronic lymphocytic leukemia; Internal medicine; Rituximab; Bendamustine; Oncology; Cyclophosphamide; Alemtuzumab; Neutropenia; Venetoclax; Leukemia; Chemotherapy; Lymphoma; Transplantation","score_opus":0.0710266598013649,"score_gpt":0.43057955698391287,"score_spread":0.35955289718254796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888496958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513626,0.002676759,0.00036159402,0.000108128705,0.0005794077,0.0010089249,0.000014596874,0.000018698482,0.000095650736],"genre_scores_gemma":[0.9972745,0.00018018983,0.0018518199,0.000062183964,0.00044493822,0.000042474272,0.000012989587,0.000056272587,0.000074588395],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997221,0.000116227275,0.0011538864,0.0003276599,0.00055914,0.0006220718],"domain_scores_gemma":[0.99547535,0.0009413218,0.0015742978,0.0004874771,0.001317689,0.0002038415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000274498,0.00032959247,0.0020103366,0.00026602898,0.00012910874,0.000015889933,0.00024289262,0.00010074447,0.000049675145],"category_scores_gemma":[0.00039356964,0.00022518043,0.000304715,0.00036457006,0.0026312077,0.00009270696,0.000047231802,0.00014066746,0.000008913943],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.9325014,0.0038019132,0.0034109417,0.0004024068,0.008463874,0.00024192799,0.005236479,0.00006386517,0.0031685978,0.00020872123,0.0021535617,0.040346343],"study_design_scores_gemma":[0.7007091,0.22677672,0.00007825063,0.00037172518,0.0007116428,0.00071779476,0.0014788845,0.0008683064,0.064833365,0.000020379986,0.0031960395,0.00023776304],"about_ca_topic_score_codex":0.00015898567,"about_ca_topic_score_gemma":0.00004114523,"teacher_disagreement_score":0.23179224,"about_ca_system_score_codex":0.043387916,"about_ca_system_score_gemma":0.015848048,"threshold_uncertainty_score":0.9897312},"labels":[],"label_agreement":null},{"id":"W2890915995","doi":"10.1002/ajh.25284","title":"The “American (cancer) patients first” plan to reduce drug prices—A critical assessment","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer drugs; Prescription drug; Reimbursement; Drug prices; Health care; Medical prescription; Competition (biology); Actuarial science; Patient Protection and Affordable Care Act; Business; Health insurance; Medicine; Drug; Finance; Public economics; Economics; Economic growth; Pharmacology","score_opus":0.018034998622509898,"score_gpt":0.30256395135945496,"score_spread":0.28452895273694506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890915995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96984255,0.0007617616,0.0019299991,0.020893754,0.0016255345,0.00013769668,0.000048968093,0.000012221652,0.004747491],"genre_scores_gemma":[0.9940537,0.000462632,0.0027378039,0.0021351676,0.00048784353,0.000017029432,7.602993e-7,0.000028624992,0.00007641144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794626,0.00003487687,0.0011033167,0.00029054302,0.000072612755,0.0005524123],"domain_scores_gemma":[0.9970437,0.00042199958,0.001682001,0.00029756295,0.00025995498,0.00029475853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005935619,0.00019047313,0.0009097789,0.00020724913,0.00029983185,0.000080298516,0.00061372464,0.000031629465,0.00012418839],"category_scores_gemma":[0.00053289725,0.00016116754,0.00015683616,0.00034892588,0.0011563924,0.00021897806,0.00009294787,0.00027566962,0.00018530474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076041627,0.0004104209,0.6165746,0.000027887443,0.0003181636,0.000023499448,0.0017492509,0.000023895995,0.000012389926,0.26558155,0.068111755,0.04640618],"study_design_scores_gemma":[0.0012037415,0.0053467005,0.5063532,0.000112038186,0.000041159386,0.00015676352,0.0011606616,0.00014483229,0.0003190833,0.020356936,0.46408924,0.0007156141],"about_ca_topic_score_codex":0.0004116986,"about_ca_topic_score_gemma":0.00013607705,"teacher_disagreement_score":0.3959775,"about_ca_system_score_codex":0.00023872545,"about_ca_system_score_gemma":0.00013797887,"threshold_uncertainty_score":0.65722215},"labels":[],"label_agreement":null},{"id":"W2892305705","doi":"10.1002/ajh.25273","title":"A dose‐ranging study of ticagrelor in children aged 3‐17 years with sickle cell disease: A 2‐part phase 2 study","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"AstraZeneca","keywords":"Ticagrelor; Medicine; Dosing; Adverse effect; Myocardial infarction; Placebo; Internal medicine; Acute coronary syndrome; Platelet; Pharmacology; Anesthesia","score_opus":0.005830681435395879,"score_gpt":0.2717543100705577,"score_spread":0.26592362863516184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892305705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865496,0.00032607222,0.000025368412,0.00020856143,0.00005424834,0.00060086796,0.0000020356274,0.000010061175,0.00011784131],"genre_scores_gemma":[0.9995575,0.000023125629,0.00017425022,0.00012450483,0.000054404652,0.0000058566825,0.000001336844,0.00002378221,0.000035216894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843293,0.00018082005,0.00061236083,0.00019085371,0.00029705785,0.00028598472],"domain_scores_gemma":[0.9988208,0.00006169526,0.0005258461,0.00025661345,0.00012202912,0.00021303441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002889735,0.00015465659,0.00083138613,0.0003394894,0.000041062962,0.000005211485,0.00014296474,0.000031605032,0.00007868699],"category_scores_gemma":[0.00005280538,0.00010965836,0.00007931219,0.0005521777,0.00041495604,0.00004711905,0.000034564568,0.00033678705,0.00000712064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004660053,0.013107375,0.96474797,0.000022151416,0.0005507296,0.002138148,0.009830918,0.000022804426,0.00014659982,0.000005152311,0.00058002485,0.0041881036],"study_design_scores_gemma":[0.046571527,0.06596917,0.8073138,0.00035275175,0.0012891365,0.0025806958,0.075248085,0.00005182536,0.00016111159,0.000014470641,0.00013771288,0.00030969275],"about_ca_topic_score_codex":0.0001166294,"about_ca_topic_score_gemma":0.00003120574,"teacher_disagreement_score":0.15743412,"about_ca_system_score_codex":0.00002662594,"about_ca_system_score_gemma":0.00018097552,"threshold_uncertainty_score":0.4471738},"labels":[],"label_agreement":null},{"id":"W2892405030","doi":"10.1002/ajh.25296","title":"Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Portola Pharmaceuticals","keywords":"Medicine; Quartile; Internal medicine; Albumin; Odds ratio; Hypoalbuminemia; Gastroenterology; Venous thromboembolism; Surgery; Confidence interval; Thrombosis","score_opus":0.011655674733558533,"score_gpt":0.2711215888406412,"score_spread":0.25946591410708264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892405030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955058,0.000113158225,0.00067151105,0.0023961866,0.0004440313,0.0005891806,0.00004890806,0.0000069234893,0.00022431319],"genre_scores_gemma":[0.99709636,0.00012099233,0.0012357237,0.0012604973,0.00024124447,0.000008664047,0.000007260384,0.000019729527,0.000009513786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974634,0.00045210705,0.0011264439,0.0001986184,0.00048373162,0.00027571447],"domain_scores_gemma":[0.99542534,0.00091063627,0.002181106,0.00059679494,0.0007439667,0.00014218036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096499897,0.00018234528,0.0016966898,0.00034180764,0.00012636249,0.00000925048,0.00042710194,0.00007119252,0.00015330533],"category_scores_gemma":[0.0012834654,0.00010163745,0.0005144075,0.001174381,0.00097638136,0.0000729217,0.00011307765,0.0002900639,0.000013972726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037457463,0.001484604,0.9615713,0.000015423087,0.00787131,0.000020176692,0.010144523,0.000061049446,0.000021034622,0.00060136744,0.0084052645,0.006058201],"study_design_scores_gemma":[0.0062977807,0.005381676,0.97646767,0.00006969066,0.0065519884,0.000009713815,0.0036748454,0.000038461898,0.00034109902,0.00025796276,0.0008082037,0.00010092511],"about_ca_topic_score_codex":0.0016415962,"about_ca_topic_score_gemma":0.00051839213,"teacher_disagreement_score":0.014896353,"about_ca_system_score_codex":0.00004476,"about_ca_system_score_gemma":0.00009702116,"threshold_uncertainty_score":0.4144655},"labels":[],"label_agreement":null},{"id":"W2895436157","doi":"10.1002/ajh.25305","title":"Point‐of‐care screening for sickle cell disease in low‐resource settings: A multi‐center evaluation of HemoTypeSC, a novel rapid test","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Institut National de la Santé et de la Recherche Médicale","keywords":"Medicine; Point of care; Newborn screening; Point-of-care testing; Sickle cell trait; Disease; Sickle cell anemia; Pediatrics; Anemia; Dipstick; Internal medicine; Immunology; Pathology","score_opus":0.012646056030886187,"score_gpt":0.28882393077649976,"score_spread":0.27617787474561356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895436157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918159,0.0017860052,0.0041524926,0.0014288053,0.00008034266,0.00043814856,0.000022935106,0.000006251644,0.0002691221],"genre_scores_gemma":[0.9898559,0.000028200982,0.009628222,0.00038564907,0.0000537773,0.0000050415497,0.000010343445,0.000022179081,0.000010678872],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99852794,0.00008807299,0.0007084276,0.0001522896,0.0002851911,0.00023806945],"domain_scores_gemma":[0.99775624,0.00023437379,0.0008875293,0.00016929045,0.00080504164,0.000147543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005359597,0.00013010821,0.0006370904,0.00027090477,0.00003115714,0.0000026693476,0.00011008781,0.00006188346,0.00004213337],"category_scores_gemma":[0.0008336369,0.00010458497,0.00019102119,0.00026213322,0.00042456755,0.000047007066,0.000028604974,0.00018966744,0.00000180226],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019213496,0.012613153,0.6551638,0.004429543,0.0009689193,0.0002532209,0.030586964,0.0014182981,0.046427067,0.00017670025,0.0045500947,0.22419871],"study_design_scores_gemma":[0.21452741,0.060485333,0.09775529,0.024734125,0.006658575,0.005644526,0.23190454,0.1753229,0.16465962,0.00027530311,0.01574832,0.0022840614],"about_ca_topic_score_codex":0.000019257255,"about_ca_topic_score_gemma":0.0000061525607,"teacher_disagreement_score":0.5574085,"about_ca_system_score_codex":0.00004030608,"about_ca_system_score_gemma":0.00025724733,"threshold_uncertainty_score":0.42648515},"labels":[],"label_agreement":null},{"id":"W2900157951","doi":"10.1002/ajh.25343","title":"Development of a patient‐reported outcomes symptom measure for patients with nontransfusion‐dependent thalassemia (NTDT‐PRO<sup>©</sup>)","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Sanofi Genzyme; Celgene; Sanofi","keywords":"Medicine; Quality of life (healthcare); Thalassemia; Physical therapy; Internal medicine; Nursing","score_opus":0.006970634728578485,"score_gpt":0.24483701213062634,"score_spread":0.23786637740204786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900157951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961551,0.00014168255,0.0021791796,0.00056072004,0.00015674208,0.00052243716,0.0000048210604,0.000015359215,0.00026394957],"genre_scores_gemma":[0.9855107,0.000019730916,0.014109263,0.0002592723,0.000025175892,0.00001356993,0.0000076040387,0.000034562065,0.000020103967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975779,0.00006128957,0.0011742053,0.00022921537,0.00057442836,0.00038298237],"domain_scores_gemma":[0.9970823,0.00012683522,0.001131473,0.0002395332,0.0011909571,0.0002288942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024477585,0.00024487896,0.0011066429,0.00024533656,0.00011119661,0.0000057487755,0.00013895865,0.000118596276,0.00006245452],"category_scores_gemma":[0.00020281965,0.00015198988,0.00019256181,0.00026420463,0.0004224343,0.0000670698,0.00002689024,0.00025470715,0.000003918139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035400032,0.001475776,0.91725993,0.00013202171,0.00201218,0.0001322016,0.008288209,0.000018904198,0.00030942442,0.000059442402,0.0003694495,0.06640243],"study_design_scores_gemma":[0.08891287,0.082524635,0.65537125,0.004988478,0.0060652886,0.015812902,0.07068291,0.00046702602,0.050602596,0.00036369337,0.021270543,0.0029377704],"about_ca_topic_score_codex":0.000016481765,"about_ca_topic_score_gemma":0.000012573404,"teacher_disagreement_score":0.26188868,"about_ca_system_score_codex":0.00007677777,"about_ca_system_score_gemma":0.0005989665,"threshold_uncertainty_score":0.61979675},"labels":[],"label_agreement":null},{"id":"W2900357627","doi":"10.1002/ajh.25342","title":"Treatment‐free remission with first‐ and second‐generation tyrosine kinase inhibitors","year":2018,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Bristol-Myers Squibb","keywords":"Nilotinib; Dasatinib; Discontinuation; Medicine; Imatinib; Bosutinib; Clinical trial; Tyrosine-kinase inhibitor; Tyrosine kinase; Myeloid leukemia; Oncology; Intensive care medicine; Imatinib mesylate; Internal medicine; Cancer","score_opus":0.027303292112272524,"score_gpt":0.3110332930561482,"score_spread":0.2837300009438757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900357627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01116729,0.9876006,0.000020546382,0.00035736003,0.00020427685,0.00044423036,0.000016433594,0.000015670628,0.00017356926],"genre_scores_gemma":[0.0014804283,0.99406356,0.0031789944,0.000056582143,0.00067136344,0.000020810441,0.000053820233,0.00007544324,0.00039902137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800044,0.0001592285,0.0009351337,0.00036744075,0.00023715069,0.0003006331],"domain_scores_gemma":[0.99695283,0.00023677936,0.0017823653,0.00052813033,0.00017108669,0.00032883376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000121865385,0.00049772725,0.0030877935,0.00036359136,0.00008773272,0.000016301674,0.00013655346,0.0001880618,0.00014994245],"category_scores_gemma":[0.00014469161,0.00028501378,0.00030502473,0.00029135798,0.0005015931,0.00007415404,0.000050702798,0.00030593327,0.000015489339],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035771108,0.00038266435,0.0006053905,0.004629202,0.001810539,0.0032254334,0.00020724924,1.526617e-7,0.000013005943,0.00004015044,0.013691047,0.97503746],"study_design_scores_gemma":[0.0035431716,0.0104820235,0.000015489422,0.010964943,0.0030722737,0.084644414,0.000052409738,0.000003859804,0.00015008799,0.000006246868,0.88681567,0.00024942902],"about_ca_topic_score_codex":0.00003684507,"about_ca_topic_score_gemma":0.00008943804,"teacher_disagreement_score":0.974788,"about_ca_system_score_codex":0.0009696087,"about_ca_system_score_gemma":0.0015602405,"threshold_uncertainty_score":0.9999602},"labels":[],"label_agreement":null},{"id":"W2913633350","doi":"10.1002/ajh.25425","title":"How we diagnose and manage altered oxygen affinity hemoglobin variants","year":2019,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University; University of Toronto","funders":"","keywords":"P50; Hemoglobin; Oxygen–haemoglobin dissociation curve; Oxygen; Pathophysiology; Hemoglobin variants; Globin; Medicine; Chemistry; Gene; Computational biology; Biology; Internal medicine; Biochemistry","score_opus":0.027600631122274254,"score_gpt":0.3042322498232529,"score_spread":0.2766316187009787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913633350","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000826915,0.9932165,0.000070388975,0.0041335826,0.0006662738,0.00054715946,0.000017840386,0.000019169103,0.00050214777],"genre_scores_gemma":[0.0011704429,0.99691814,0.0009130526,0.0003383197,0.00017976495,0.000008098978,0.000013106204,0.00007792254,0.0003811446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973833,0.00038475703,0.0010436138,0.00039269443,0.00028772748,0.00050791836],"domain_scores_gemma":[0.9965051,0.00047830565,0.0020148684,0.00047322756,0.00013527925,0.00039324362],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035066882,0.0005256494,0.0050586397,0.0005281352,0.00005880864,0.00004208146,0.00030856073,0.0003904754,0.000054330423],"category_scores_gemma":[0.00031861206,0.0003563939,0.0007095712,0.00047589923,0.00050277397,0.000097301985,0.00013841581,0.0012534661,0.00005201304],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008370235,0.00018989938,0.00008606947,0.0100810295,0.0012813184,0.0022321704,0.00013853809,1.7306685e-7,8.7343716e-7,0.0002817207,0.005116459,0.980508],"study_design_scores_gemma":[0.0012210972,0.0013568966,0.00004287253,0.011583778,0.003031498,0.046997376,0.0006640491,0.0000030799852,0.0000010588676,0.000081111044,0.9346787,0.00033853648],"about_ca_topic_score_codex":0.000015401776,"about_ca_topic_score_gemma":0.000001932756,"teacher_disagreement_score":0.98016953,"about_ca_system_score_codex":0.00008637377,"about_ca_system_score_gemma":0.00046042824,"threshold_uncertainty_score":0.9998888},"labels":[],"label_agreement":null},{"id":"W2916734627","doi":"10.1002/ajh.25444","title":"Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program","year":2019,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services; Hamilton Health Sciences","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Nausea; Immune thrombocytopenia; Placebo; Gastroenterology; Randomized controlled trial; Rituximab; Platelet","score_opus":0.022707622681206886,"score_gpt":0.37527865384977466,"score_spread":0.35257103116856775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916734627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973599,0.00065656815,0.000009776027,0.00047882873,0.00016058836,0.0011838464,0.0000052265978,0.000010554346,0.0001347376],"genre_scores_gemma":[0.99850696,0.00038056876,0.0009241544,0.000037045134,0.00005774658,0.000020878135,0.000006468235,0.000019168314,0.000046989375],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99833596,0.00013248104,0.0009146555,0.00016304708,0.0002091555,0.00024471307],"domain_scores_gemma":[0.99804324,0.00020472587,0.0011860087,0.00032014397,0.00013119695,0.000114711365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014922238,0.00017869874,0.0016303277,0.00007840472,0.00003791039,0.000007387781,0.00012406295,0.00004780231,0.000094448216],"category_scores_gemma":[0.000032170137,0.00008639451,0.00030290816,0.00015323007,0.00039910656,0.000054219374,0.000017970806,0.0001621006,0.000013965209],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29686955,0.015928669,0.41721472,0.000118389165,0.0030679295,0.0038731643,0.0013260244,0.0000013554272,0.00036214732,0.00003455956,0.000017336533,0.26118612],"study_design_scores_gemma":[0.50372136,0.26308984,0.19977818,0.0005675353,0.0011400589,0.023966527,0.0019042926,0.000019847112,0.005220082,0.00001781326,0.0003485912,0.00022584951],"about_ca_topic_score_codex":0.000023878087,"about_ca_topic_score_gemma":0.000012041676,"teacher_disagreement_score":0.26096028,"about_ca_system_score_codex":0.000040810624,"about_ca_system_score_gemma":0.0001813461,"threshold_uncertainty_score":0.35230657},"labels":[],"label_agreement":null},{"id":"W2926453305","doi":"10.1002/ajh.25484","title":"Optimizing survival outcomes with post‐remission therapy in acute myeloid leukemia","year":2019,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Medicine; Myeloid leukemia; Oncology; Internal medicine; Leukemia; Overall survival","score_opus":0.04014980143188264,"score_gpt":0.36836509498511977,"score_spread":0.32821529355323714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2926453305","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010918876,0.9860685,0.00012606909,0.0011436818,0.00033116146,0.00088716805,0.00001091929,0.00002464867,0.000488982],"genre_scores_gemma":[0.00063257874,0.9924143,0.0058818893,0.00038013537,0.00011759644,0.000018045623,0.000028670669,0.000166162,0.0003606317],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954589,0.0007054607,0.0017119764,0.00050676375,0.000793347,0.00082356296],"domain_scores_gemma":[0.9950522,0.0011272626,0.00223639,0.00071474037,0.0004622749,0.0004071125],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00091265625,0.0007213552,0.008233725,0.0013906329,0.000047526664,0.000026088595,0.000731508,0.00036511707,0.00015191497],"category_scores_gemma":[0.00022617758,0.00041097176,0.00086407317,0.0009968878,0.0005116168,0.00013737193,0.00014393886,0.0027695938,0.000066144945],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013634707,0.0001459063,0.003632189,0.0028667657,0.0025664528,0.0064249234,0.0002511383,0.000005317921,0.000023522241,0.00005726118,0.0004029951,0.98226005],"study_design_scores_gemma":[0.01015414,0.0149559975,0.0008309416,0.034381136,0.003136359,0.11230494,0.0015064663,0.000021143062,0.000057943926,0.000015241721,0.8212778,0.0013578907],"about_ca_topic_score_codex":0.00009427588,"about_ca_topic_score_gemma":0.000006356827,"teacher_disagreement_score":0.9809022,"about_ca_system_score_codex":0.0014161934,"about_ca_system_score_gemma":0.0064580366,"threshold_uncertainty_score":0.99983424},"labels":[],"label_agreement":null},{"id":"W2930335684","doi":"10.1002/ajh.25471","title":"Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso‐occlusive pain","year":2019,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Maternal and Child Health Bureau; National Center for Complementary and Integrative Health; National Heart, Lung, and Blood Institute; Health Resources and Services Administration","keywords":"Medicine; Bolus (digestion); Emergency department; Sickle cell anemia; Anemia; Anesthesia; Vaso-occlusive crisis; Saline; Hemoglobin; Internal medicine; Disease","score_opus":0.002380926632563807,"score_gpt":0.19961123653444918,"score_spread":0.19723030990188536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930335684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99754715,0.0010219436,0.00012428514,0.00077102165,0.000036947695,0.0004184797,0.000008247647,0.00000854449,0.0000633765],"genre_scores_gemma":[0.9973529,0.00053350144,0.00024716253,0.001753967,0.000026781747,0.000004271789,0.00001240374,0.00003067567,0.00003833758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979827,0.00047715742,0.00062304694,0.00022794279,0.00025054903,0.00043860462],"domain_scores_gemma":[0.99860233,0.00024321815,0.0006900707,0.0001422053,0.0001387482,0.0001834191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008129103,0.0002254899,0.0009101912,0.00034751566,0.000030335701,0.000006681889,0.00008905246,0.000118567725,0.00008363605],"category_scores_gemma":[0.00017095137,0.00015370634,0.00006380158,0.000579753,0.00013122731,0.00010920271,0.000021062806,0.00052810804,0.000004653827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009276877,0.00039366,0.9963066,0.00002828587,0.00016707295,0.00052302884,0.00048985705,0.00010473032,0.000034287328,0.0000031046925,0.0004952169,0.0005264466],"study_design_scores_gemma":[0.0129854055,0.005503068,0.9771704,0.00009089296,0.0003101346,0.0017472071,0.0013556323,0.0005002676,0.000036842248,0.000011021524,0.0000367887,0.00025234613],"about_ca_topic_score_codex":0.00036303286,"about_ca_topic_score_gemma":0.00017562084,"teacher_disagreement_score":0.01913623,"about_ca_system_score_codex":0.0000702758,"about_ca_system_score_gemma":0.00021203022,"threshold_uncertainty_score":0.6267963},"labels":[],"label_agreement":null},{"id":"W2934060647","doi":"10.1002/ajh.25479","title":"Second‐line treatments in children with immune thrombocytopenia: Effect on platelet count and patient‐centered outcomes","year":2019,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University; Children's Hospital of Eastern Ontario","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute","keywords":"Romiplostim; Medicine; Rituximab; Immune thrombocytopenia; Eltrombopag; Thrombopoietin; Internal medicine; Platelet; Observational study; Quality of life (healthcare); Splenectomy; Randomized controlled trial; Pediatrics","score_opus":0.004745746361677056,"score_gpt":0.24962198573607897,"score_spread":0.24487623937440192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2934060647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983732,0.0005615994,0.000001011064,0.00035821993,0.000053675412,0.0004365498,0.000009101172,0.00000613044,0.00020051279],"genre_scores_gemma":[0.99932086,0.000072988354,0.00014067789,0.00038742172,0.000004528637,0.000005248015,0.000012333814,0.000020214273,0.00003572993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896127,0.00007036224,0.00038424006,0.00017942238,0.00016559381,0.00023911109],"domain_scores_gemma":[0.99920446,0.00010910717,0.00038976633,0.00016739001,0.0000350302,0.000094225456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056630724,0.00021424123,0.0014422325,0.00018741349,0.000021157244,0.000007270433,0.00005977476,0.0000430906,0.00009735045],"category_scores_gemma":[0.00001325058,0.00012425333,0.00008364915,0.000114938426,0.000114551476,0.0000677217,0.000018912764,0.00020443607,0.000023662022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019669903,0.0005348698,0.9845875,0.000012514229,0.0011316995,0.0011430529,0.00018763014,0.0000026015277,0.00015391989,0.00001500049,0.00001765438,0.010246559],"study_design_scores_gemma":[0.01738457,0.03046436,0.9325545,0.00017951083,0.00017191959,0.016092168,0.00022339946,0.0000054096267,0.0027108246,0.000019090809,0.000059280475,0.00013496599],"about_ca_topic_score_codex":0.000053370553,"about_ca_topic_score_gemma":0.000017172815,"teacher_disagreement_score":0.052033007,"about_ca_system_score_codex":0.00006440136,"about_ca_system_score_gemma":0.00004422256,"threshold_uncertainty_score":0.5066904},"labels":[],"label_agreement":null},{"id":"W2934397726","doi":"10.1002/ajh.25475","title":"Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum","year":2019,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":313,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Janssen Pharmaceuticals; Spark Therapeutics; Shionogi; Ochsner Health; Asahi Kasei Pharma Corporation; Bristol-Myers Squibb Canada; Thomas Jefferson University; Shire; CSL Behring; University of Washington; Johns Hopkins University; Henry Ford Health System; Alexion Pharmaceuticals; LEO Pharma Research Foundation; Pfizer; Heart and Stroke Foundation of Canada; Bayer; Kaiser Permanente; Novo Nordisk; Servier Canada","keywords":"Rivaroxaban; Dabigatran; Idarucizumab; Apixaban; Medicine; Intensive care medicine; Stewardship (theology); Warfarin; Atrial fibrillation; Internal medicine; Political science","score_opus":0.09804816687785856,"score_gpt":0.39920515714931276,"score_spread":0.3011569902714542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2934397726","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013113394,0.9954044,0.00040317033,0.0014850624,0.00068620796,0.00043124444,0.000018805677,0.000009656531,0.00025007883],"genre_scores_gemma":[0.011094895,0.9864014,0.0016668638,0.00018767346,0.00043673365,5.972876e-7,0.00003084407,0.00003588684,0.00014513012],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99760365,0.00035564386,0.0013393648,0.0001757168,0.00031933413,0.00020628604],"domain_scores_gemma":[0.995069,0.0011264677,0.0031982425,0.00038209354,0.00016641535,0.000057779416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041755725,0.00024606404,0.0041589895,0.00020114765,0.00003148242,0.0000094763545,0.0002624039,0.000106246574,0.00006867305],"category_scores_gemma":[0.0004208497,0.00013904476,0.0008520959,0.0003700573,0.00025626106,0.00007254952,0.00007120281,0.00026490807,0.000029184605],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025549636,0.000025209578,0.102199815,0.0028408002,0.0026695384,0.00009174426,0.000088649205,0.0000047751337,0.0000063146617,0.000861666,0.0068954234,0.88406056],"study_design_scores_gemma":[0.0007166762,0.0005835462,0.0031781811,0.0075860093,0.005172393,0.0006438667,0.00022327389,0.000014297816,0.000008932707,0.000054398894,0.9816304,0.00018803553],"about_ca_topic_score_codex":0.000059714974,"about_ca_topic_score_gemma":0.0000035583018,"teacher_disagreement_score":0.97473496,"about_ca_system_score_codex":0.00004184124,"about_ca_system_score_gemma":0.00022907116,"threshold_uncertainty_score":0.5670081},"labels":[],"label_agreement":null},{"id":"W2963795579","doi":"10.1002/ajh.25590","title":"Early loss of immunity against measles following allogeneic hematopoietic stem cell transplantation","year":2019,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Measles; Medicine; Immunity; Hematopoietic stem cell transplantation; Immunology; Vaccination; Transplantation; Measles vaccine; Immune system; Internal medicine","score_opus":0.013638942982270164,"score_gpt":0.2522506622606989,"score_spread":0.23861171927842875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963795579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96945715,0.0014651414,0.0022187473,0.024656577,0.00080494996,0.00053381285,0.000043459564,0.000029473837,0.00079071044],"genre_scores_gemma":[0.96767175,0.00088301697,0.0016445287,0.029057683,0.00029828266,0.000009322894,0.00012631624,0.00013755636,0.00017154441],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952254,0.0006438587,0.0021275084,0.00038666205,0.0010213418,0.00059520354],"domain_scores_gemma":[0.99487275,0.0010827947,0.0028382498,0.00063630595,0.00042449962,0.00014541815],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063216075,0.00056501344,0.003037684,0.00076030666,0.000057081565,0.000016563365,0.0005049574,0.0006186716,0.00004326063],"category_scores_gemma":[0.000022973592,0.0004969267,0.0010478781,0.00041424815,0.00042918726,0.00012773917,0.000023155566,0.0019790647,0.000053199765],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008207987,0.0028027524,0.41911316,0.09096223,0.017457468,0.16169742,0.067607775,0.00029983412,0.11028017,0.00033909478,0.105086684,0.016145434],"study_design_scores_gemma":[0.04369528,0.027615087,0.036393996,0.047254574,0.036153886,0.27872157,0.021560589,0.00006763251,0.45994473,0.0006327697,0.040597893,0.0073619946],"about_ca_topic_score_codex":0.000058145208,"about_ca_topic_score_gemma":0.0000021595777,"teacher_disagreement_score":0.38271916,"about_ca_system_score_codex":0.0001192435,"about_ca_system_score_gemma":0.00060864893,"threshold_uncertainty_score":0.99974823},"labels":[],"label_agreement":null},{"id":"W2964265037","doi":"10.1002/ajh.25581","title":"IgA‐mediated autoimmune hemolytic anemia","year":2019,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Autoimmune hemolytic anemia; Medicine; Coombs test; Haptoglobin; Internal medicine; Immunology; Cold Agglutinin; Hemolytic anemia; Spherocytosis; Hemolysis; Hereditary spherocytosis; Anemia; Gastroenterology; Antibody; Spleen; Splenectomy","score_opus":0.024920370886816527,"score_gpt":0.32345504839614014,"score_spread":0.2985346775093236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964265037","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007202064,0.9972911,0.000063315274,0.00041586594,0.00059387553,0.0003735409,0.000007834917,0.000022693348,0.0005115921],"genre_scores_gemma":[0.001485386,0.99710804,0.0006368215,0.0003046127,0.00016947859,0.0000049928008,0.000036684694,0.00008225321,0.00017174208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729013,0.00020843348,0.0015035018,0.00026944763,0.00032684908,0.00040160527],"domain_scores_gemma":[0.9967793,0.00048655595,0.001856499,0.000456881,0.00018432965,0.00023643885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031772468,0.00042570857,0.005922433,0.00050830684,0.000033873315,0.000009322615,0.00029536008,0.00028870173,0.00022197336],"category_scores_gemma":[0.00012381886,0.0002830278,0.0010522723,0.00056521536,0.0003357171,0.000046387748,0.00004272267,0.001310882,0.00027397892],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009904991,0.0002317699,0.0001215644,0.01225635,0.0008063164,0.00201971,0.00006221541,1.0264787e-7,0.000006892356,0.00016302352,0.0009164649,0.98331654],"study_design_scores_gemma":[0.0012036145,0.0022175165,0.000050870298,0.015229664,0.0048432103,0.08779209,0.00007469898,0.0000023038492,0.000003894144,0.000014722151,0.88829786,0.00026957472],"about_ca_topic_score_codex":0.000019640645,"about_ca_topic_score_gemma":8.841692e-7,"teacher_disagreement_score":0.98304695,"about_ca_system_score_codex":0.00008835867,"about_ca_system_score_gemma":0.0009877047,"threshold_uncertainty_score":0.9999622},"labels":[],"label_agreement":null},{"id":"W2966833955","doi":"10.1002/ajh.25601","title":"Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features","year":2019,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Isochromosome; Myeloid; Medicine; Internal medicine; Biology; Genetics; Gene","score_opus":0.008288603416969935,"score_gpt":0.24722726755154503,"score_spread":0.2389386641345751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966833955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6081951,0.005585109,0.000096654294,0.3851434,0.00024715828,0.00045683852,0.00005886215,0.000044704324,0.00017210896],"genre_scores_gemma":[0.7496586,0.0020283696,0.0009872793,0.24400418,0.00094807456,0.00001511397,0.00009838933,0.00024346905,0.0020165376],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9967574,0.00039952647,0.00075979903,0.0005172763,0.00073217653,0.0008338604],"domain_scores_gemma":[0.9950652,0.0016341251,0.0019643595,0.0003882263,0.00070511864,0.00024293347],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00033629383,0.000593625,0.002861637,0.0007523986,0.00010848811,0.00006077175,0.00030097176,0.0006977926,0.00008270201],"category_scores_gemma":[0.0008790562,0.0004109219,0.0001578632,0.0004738489,0.0017948294,0.00012450997,0.00015146763,0.004042524,0.000014252275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012882606,0.00008775361,0.04044259,0.00086038176,0.0027993747,0.030114269,0.0005243482,0.000001646452,0.0007708174,0.000021486516,0.9220391,0.0010499683],"study_design_scores_gemma":[0.017806198,0.03445541,0.12271601,0.012006095,0.0054483465,0.6758082,0.004344443,0.00022056582,0.00093157147,0.000218981,0.123349175,0.0026949807],"about_ca_topic_score_codex":0.00003907176,"about_ca_topic_score_gemma":0.000012398639,"teacher_disagreement_score":0.7986899,"about_ca_system_score_codex":0.00027844866,"about_ca_system_score_gemma":0.0009100725,"threshold_uncertainty_score":0.99983424},"labels":[],"label_agreement":null},{"id":"W2972627544","doi":"10.1002/ajh.25637","title":"Rifaximin for sickle cell disease","year":2019,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health","keywords":"Rifaximin; Medicine; Disease; Internal medicine; Intensive care medicine; Biology; Antibiotics; Genetics","score_opus":0.007621559220972164,"score_gpt":0.2486370862614922,"score_spread":0.24101552704052004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972627544","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022323994,0.004807045,0.0007460085,0.9684836,0.0015194876,0.0006051707,0.00004637115,0.00002188732,0.0014464086],"genre_scores_gemma":[0.043375533,0.0007797856,0.0025111672,0.9452262,0.002611982,0.000017275785,0.00012699502,0.00016676646,0.0051843245],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981761,0.00009186261,0.00072145765,0.0002481615,0.0002829776,0.0004794422],"domain_scores_gemma":[0.9975815,0.00040170815,0.0011900793,0.00035583836,0.00027757042,0.0001933334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001516026,0.0002956285,0.001517992,0.00030983557,0.000039511495,0.000009283261,0.00022700368,0.00036700227,0.00012486514],"category_scores_gemma":[0.00015614834,0.00021778792,0.0006593324,0.00014517117,0.00036799134,0.000033642915,0.000029003982,0.0016726628,0.00008435733],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053728867,0.000111419264,0.00080427976,0.00071111904,0.0002529836,0.0027924979,0.00007890613,0.0000049837663,0.00003152032,0.000022148495,0.9926873,0.0019655458],"study_design_scores_gemma":[0.0020727909,0.0022610538,0.0000588835,0.00034311722,0.0009456138,0.0035017484,0.0002996583,0.000027723023,0.000115045696,0.00017197244,0.9899527,0.00024971055],"about_ca_topic_score_codex":0.000010100871,"about_ca_topic_score_gemma":2.1573437e-7,"teacher_disagreement_score":0.023257457,"about_ca_system_score_codex":0.000058376405,"about_ca_system_score_gemma":0.0006950065,"threshold_uncertainty_score":0.8881134},"labels":[],"label_agreement":null},{"id":"W2981294727","doi":"10.1002/ajh.25660","title":"Serotonin‐release assay‐negative heparin‐induced thrombocytopenia","year":2019,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research","keywords":"Heparin-induced thrombocytopenia; Medicine; Platelet factor 4; Internal medicine; Immunoassay; Heparin; Platelet; Antibody; Gastroenterology; Platelet activation; Cohort; Immunology","score_opus":0.018391238843773628,"score_gpt":0.2994848147493245,"score_spread":0.28109357590555084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981294727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868743,0.000104596314,0.00011069525,0.0026504237,0.0005474006,0.0005509401,0.0000034552636,0.00004274229,0.009115461],"genre_scores_gemma":[0.9948538,0.00008932995,0.003222763,0.0013847769,0.00014420503,0.0000111815125,0.000003776801,0.0000660405,0.00022414449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969796,0.00037756265,0.0010751953,0.00042006743,0.00048870716,0.00065887306],"domain_scores_gemma":[0.9966492,0.00049863645,0.0011659357,0.0006250984,0.0005072567,0.000553894],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006185516,0.0003905954,0.0025365984,0.00038405068,0.000087246684,0.000030017281,0.0004039764,0.00017051131,0.0011618279],"category_scores_gemma":[0.00037715145,0.0003147612,0.00043398154,0.0006273575,0.00036810525,0.00028034186,0.00013043587,0.00094550045,0.0008678013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033106462,0.0018647469,0.6583144,0.0003010896,0.0037118199,0.0024774075,0.0030486735,0.000020552317,0.28112763,0.01257745,0.0030278717,0.030217707],"study_design_scores_gemma":[0.017255053,0.024143547,0.481895,0.001238085,0.0017291597,0.05019914,0.008104907,0.0003584667,0.40171933,0.0019833648,0.009587044,0.0017869063],"about_ca_topic_score_codex":0.00021151864,"about_ca_topic_score_gemma":0.000020964659,"teacher_disagreement_score":0.17641939,"about_ca_system_score_codex":0.00020427942,"about_ca_system_score_gemma":0.0007293347,"threshold_uncertainty_score":0.99993044},"labels":[],"label_agreement":null},{"id":"W2990454217","doi":"10.1002/ajh.25688","title":"Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management","year":2019,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Leukocytosis; Monocytosis; Medicine; Myeloproliferative neoplasm; Hepatosplenomegaly; Disease; Chronic myelomonocytic leukemia; Immunology; Bone marrow; Bioinformatics; Cancer research; Oncology; Myelodysplastic syndromes; Internal medicine; Myelofibrosis; Biology","score_opus":0.018840278390420205,"score_gpt":0.3197540739869434,"score_spread":0.3009137955965232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990454217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040254937,0.99227893,0.000011499284,0.0016960192,0.00025546644,0.0015224188,0.000017681108,0.000013297995,0.00017918022],"genre_scores_gemma":[0.0042470437,0.993443,0.0008881328,0.00069443235,0.00025206726,0.00031937737,0.000036425958,0.00009595524,0.000023574205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969907,0.00031952496,0.0012232081,0.00058550766,0.00039536593,0.00048571854],"domain_scores_gemma":[0.9971778,0.00028323458,0.0015845823,0.0004832249,0.00013749406,0.00033366831],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018291803,0.0006663822,0.0043514087,0.0004296892,0.000053408297,0.000029267183,0.00025051483,0.00019218109,0.00008082621],"category_scores_gemma":[0.000031430252,0.0004617684,0.00067387347,0.00032722627,0.0003279201,0.000032905784,0.00013326372,0.0007225195,0.00013017902],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060613598,0.00033167933,0.0021482748,0.009785156,0.0034588154,0.005142622,0.000024075154,0.0000038786197,3.7014948e-7,0.0015067179,0.0028842667,0.97465354],"study_design_scores_gemma":[0.0015843958,0.007251038,0.00039407815,0.016042804,0.006977901,0.0107711535,0.000024425988,0.0000032236592,0.000065028704,0.000039601935,0.9564444,0.00040198368],"about_ca_topic_score_codex":0.000005292399,"about_ca_topic_score_gemma":0.000002491589,"teacher_disagreement_score":0.97425157,"about_ca_system_score_codex":0.0005946384,"about_ca_system_score_gemma":0.00061417057,"threshold_uncertainty_score":0.9997834},"labels":[],"label_agreement":null},{"id":"W2992753565","doi":"10.1002/ajh.25699","title":"Characterizing the effect of exposure to microgravity on anemia: more space is worse","year":2019,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Spaceflight effects on biology","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Anemia; Space (punctuation); Internal medicine; Computer science","score_opus":0.004368688696197927,"score_gpt":0.27463480894738546,"score_spread":0.2702661202511875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992753565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769904,0.00025255722,0.000013134167,0.021849945,0.00032013166,0.0004096622,0.0000031247673,0.000009897864,0.00015111669],"genre_scores_gemma":[0.9954617,0.00002305622,0.00047963322,0.0038407496,0.00009727405,0.000005038836,0.0000012107349,0.000022881119,0.0000684391],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849176,0.00035554016,0.0004252062,0.00019888094,0.00020996387,0.00031863907],"domain_scores_gemma":[0.99766505,0.00086405256,0.00073264167,0.00044607228,0.00012720877,0.00016498167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058864057,0.00020548941,0.0012347492,0.00023138276,0.000027225577,0.0000047206117,0.00023360681,0.000099743214,0.000092852926],"category_scores_gemma":[0.00025984936,0.00011362752,0.0002358882,0.00034362345,0.00033126312,0.000028251547,0.00005105254,0.0005103081,0.00008557466],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004650769,0.0001117262,0.5866757,0.00015929378,0.00026423618,0.0003521249,0.0015130108,0.0000036577733,0.39442745,0.00008111657,0.0027102837,0.0090506505],"study_design_scores_gemma":[0.003301833,0.058630377,0.1727346,0.0006082774,0.00030030165,0.016730817,0.001311551,0.00000385636,0.7402919,0.000010015332,0.005829734,0.00024675304],"about_ca_topic_score_codex":0.000026300097,"about_ca_topic_score_gemma":0.0000014532415,"teacher_disagreement_score":0.4139411,"about_ca_system_score_codex":0.00004321279,"about_ca_system_score_gemma":0.00006050054,"threshold_uncertainty_score":0.46335956},"labels":[],"label_agreement":null},{"id":"W2993637233","doi":"10.1002/ajh.25701","title":"The road to biosimilars in rare diseases ‐ ongoing lessons from Gaucher disease","year":2019,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Allergan; Sanofi Genzyme; Sanofi; Pfizer; Amgen","keywords":"Biosimilar; Medicine; European union; Comparability; Orphan drug; Business; International trade; Bioinformatics","score_opus":0.047903286074954005,"score_gpt":0.3767017784107156,"score_spread":0.32879849233576164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993637233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002467508,0.9930356,0.00006168931,0.0049137445,0.0010895453,0.00034341277,0.00024190413,0.0000111373765,0.00005622514],"genre_scores_gemma":[0.0008330656,0.99725,0.00041348202,0.0010883432,0.000093032344,0.000021507787,0.000025887419,0.00005036412,0.00022427844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955508,0.0018578838,0.0013942388,0.0004577496,0.00009109093,0.0006482285],"domain_scores_gemma":[0.995239,0.0025495351,0.001286026,0.0006211445,0.0001070203,0.00019727167],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051133294,0.0004906714,0.0034032417,0.0003589716,0.00012307496,0.00003548566,0.0010505423,0.00031425242,0.00022514448],"category_scores_gemma":[0.0009045982,0.0002776122,0.00096656306,0.0005667346,0.000792575,0.000050572165,0.0002465117,0.0011294443,0.00017475565],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021681597,0.00013369112,0.00052529253,0.00037998884,0.00077129796,0.00021521404,0.000039046623,4.4921728e-7,0.0000062647896,0.0002766092,0.007316151,0.99011916],"study_design_scores_gemma":[0.00034418632,0.00030441213,0.0005946517,0.004487647,0.0015556285,0.00036583852,0.00021705139,5.118466e-7,0.000009754877,0.00020458981,0.9915548,0.00036091145],"about_ca_topic_score_codex":0.000042884192,"about_ca_topic_score_gemma":0.000032226068,"teacher_disagreement_score":0.98975825,"about_ca_system_score_codex":0.0001129694,"about_ca_system_score_gemma":0.00062944693,"threshold_uncertainty_score":0.99996763},"labels":[],"label_agreement":null},{"id":"W2997593504","doi":"10.1002/ajh.25711","title":"Long‐term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2‐year follow‐up of the CHRONOS‐1 study","year":2019,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Bayer","keywords":"Medicine; Internal medicine; Adverse effect; Clinical endpoint; Neutropenia; Pneumonitis; Common Terminology Criteria for Adverse Events; Gastroenterology; Surgery; Diarrhea; Clinical trial; Chemotherapy; Lung","score_opus":0.00603779465155581,"score_gpt":0.24111143628222584,"score_spread":0.23507364163067002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997593504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985056,0.00019475645,9.567455e-7,0.00026279935,0.00024403598,0.0007380942,0.0000052853648,0.0000022190738,0.000046278434],"genre_scores_gemma":[0.99975306,0.000043737175,0.000040758136,0.00009775062,0.00001751866,0.000004249821,9.791606e-7,0.000016298007,0.000025621106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983231,0.00023160006,0.0007035559,0.00016693158,0.0003827433,0.0001920936],"domain_scores_gemma":[0.99793446,0.00030047368,0.0011271873,0.0004024093,0.00015967953,0.00007576984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020481844,0.00016317447,0.0009328747,0.000106231266,0.000033961143,0.0000034622817,0.00017523083,0.000043084034,0.000027085842],"category_scores_gemma":[0.000114014976,0.00007075084,0.00012572814,0.00028439148,0.0003642702,0.000049580103,0.00010154842,0.00013562327,0.0000016705429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007912025,0.003445642,0.9807691,0.00004020882,0.00032623613,0.000040678984,0.0013946178,0.000002191474,0.000027443732,0.000016532405,0.000040659343,0.005984654],"study_design_scores_gemma":[0.037935194,0.011282011,0.94781333,0.00053669914,0.00023137104,0.00018910758,0.0010984918,5.727869e-7,0.0008132162,0.0000012031601,0.00003188638,0.00006688666],"about_ca_topic_score_codex":0.000077388795,"about_ca_topic_score_gemma":0.000055040935,"teacher_disagreement_score":0.03295575,"about_ca_system_score_codex":0.00016955289,"about_ca_system_score_gemma":0.0003771975,"threshold_uncertainty_score":0.28851354},"labels":[],"label_agreement":null},{"id":"W3005954983","doi":"10.1002/ajh.25754","title":"Fixing the MRI R2‐iron calibration in liver","year":2020,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Calibration; Medicine; Radiology; Nuclear medicine; Mathematics; Statistics","score_opus":0.008765878781771229,"score_gpt":0.23791694013416528,"score_spread":0.22915106135239405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005954983","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013380131,0.0028754917,0.00035153114,0.98235154,0.00033704884,0.00016781442,0.0000020218488,0.000011298808,0.0005231014],"genre_scores_gemma":[0.14212933,0.0018477503,0.0005354258,0.85413843,0.0011420448,0.000003940756,0.000019656805,0.000052607054,0.00013082824],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99835217,0.00025776788,0.0006663664,0.00016894657,0.00026792058,0.0002868279],"domain_scores_gemma":[0.99865,0.00024598793,0.00077996845,0.00018072002,0.000068935005,0.00007437505],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00013763839,0.00019739485,0.00091179874,0.00020144234,0.000043929675,0.000011837969,0.00019622235,0.00027703814,0.000104481995],"category_scores_gemma":[0.00012599536,0.000119452634,0.00021559736,0.0003092934,0.00040296503,0.000047669626,0.000036760695,0.002953239,0.000020303723],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014717862,0.000037650036,0.0024482068,0.00016294398,0.00015039757,0.015193219,0.0010952229,0.000024701882,0.000026837342,0.0000372982,0.97566533,0.00501103],"study_design_scores_gemma":[0.0016419842,0.0020671308,0.00041708324,0.00083713146,0.0004986682,0.029299065,0.0026084962,0.0008424837,0.000102626414,0.0002092021,0.9611371,0.0003390386],"about_ca_topic_score_codex":0.00008171265,"about_ca_topic_score_gemma":0.000005885325,"teacher_disagreement_score":0.12874919,"about_ca_system_score_codex":0.00006164766,"about_ca_system_score_gemma":0.00026268695,"threshold_uncertainty_score":0.999347},"labels":[],"label_agreement":null},{"id":"W3006298960","doi":"10.1002/ajh.25753","title":"Genotype‐phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; McMaster University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Center for Advancing Translational Sciences; Agios Pharmaceuticals","keywords":"Missense mutation; Pyruvate kinase deficiency; Compound heterozygosity; Genotype; Genetics; Hemolytic anemia; Medicine; Internal medicine; Biology; Allele; Mutation; Gene; Pyruvate kinase","score_opus":0.014172899727697764,"score_gpt":0.2619822443655167,"score_spread":0.24780934463781895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006298960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911172,0.0011056969,0.004365511,0.0030722918,0.00010202732,0.00006391401,6.5655337e-7,0.000008400961,0.00016431103],"genre_scores_gemma":[0.9941137,0.000108909335,0.0018373479,0.0038896748,0.00003634315,8.072736e-7,0.0000018797672,0.000009412964,0.000001955828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918664,0.00010553251,0.00034075955,0.00013402848,0.00008951144,0.0001435103],"domain_scores_gemma":[0.9993653,0.00005633558,0.00026747963,0.00007756033,0.000083933366,0.0001493789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000968244,0.000088817156,0.00044901128,0.000104679515,0.00001953119,0.0000026983564,0.000045001412,0.00004550083,0.000036130303],"category_scores_gemma":[0.00015951334,0.00007475943,0.000057621743,0.00024039492,0.0001870178,0.000035972564,0.000021303686,0.00023703472,0.000016141765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005025546,0.00042541506,0.5549098,0.00022010019,0.00015861665,0.0037970007,0.0025646437,0.00070692116,0.38743305,0.0056375414,0.0005559975,0.038565308],"study_design_scores_gemma":[0.018167794,0.04271356,0.8250953,0.0004130282,0.0008152465,0.02093374,0.005048087,0.010529733,0.06354749,0.0031065051,0.0083148265,0.0013146978],"about_ca_topic_score_codex":0.000012600829,"about_ca_topic_score_gemma":0.0000035731236,"teacher_disagreement_score":0.32388556,"about_ca_system_score_codex":0.000018095612,"about_ca_system_score_gemma":0.0000747695,"threshold_uncertainty_score":0.30486012},"labels":[],"label_agreement":null},{"id":"W3007085808","doi":"10.1002/ajh.25766","title":"Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Obinutuzumab; Chlorambucil; Medicine; Internal medicine; Ibrutinib; IGHV@; Rituximab; Oncology; Gastroenterology; Surgery; Chronic lymphocytic leukemia; Leukemia; Chemotherapy; Lymphoma; Cyclophosphamide","score_opus":0.07603734731203367,"score_gpt":0.4028478104530401,"score_spread":0.3268104631410064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007085808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871439,0.0015433031,0.0010847879,0.005852978,0.00011611273,0.004206134,0.00002400343,0.000014392092,0.000014422752],"genre_scores_gemma":[0.9982482,0.00027770657,0.00044457524,0.0005513495,0.00021324019,0.00016392577,0.000014102869,0.000037187496,0.000049707272],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9938681,0.002375135,0.0022721929,0.00042417998,0.0007098258,0.00035055508],"domain_scores_gemma":[0.9876288,0.008793566,0.0023260193,0.0004192746,0.0006053664,0.00022693357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056398725,0.00029367805,0.0022356866,0.00010987422,0.00013322741,0.000029391102,0.00033837036,0.00006608191,0.000009141941],"category_scores_gemma":[0.0038290916,0.0001345043,0.00032075023,0.00034267522,0.0013313658,0.000083085826,0.0000974187,0.0003513129,0.0000027959861],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.72321534,0.016428139,0.031171983,0.0007933631,0.025504952,0.0018844294,0.0677169,0.0016192497,0.0004977958,0.00067711866,0.025995653,0.10449508],"study_design_scores_gemma":[0.6657861,0.12923655,0.0034492146,0.00016727796,0.0031046192,0.0012297238,0.04726394,0.14698823,0.00020597897,0.000026541771,0.0022766774,0.0002651838],"about_ca_topic_score_codex":0.0013160517,"about_ca_topic_score_gemma":0.00022515905,"teacher_disagreement_score":0.14536898,"about_ca_system_score_codex":0.013153909,"about_ca_system_score_gemma":0.009738111,"threshold_uncertainty_score":0.9958758},"labels":[],"label_agreement":null},{"id":"W3008307159","doi":"10.1002/ajh.25768","title":"Venous limb gangrene and pulseless electrical activity (PEA) cardiac arrest during management of deep‐vein thrombosis and progressive limb ischemic necrosis following vascular surgery","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University","funders":"","keywords":"Medicine; Surgery; Gangrene; Thrombosis; Revascularization; Aspirin; Deep vein; Anesthesia; Myocardial infarction; Internal medicine","score_opus":0.01279358704368465,"score_gpt":0.2622809764237684,"score_spread":0.24948738938008375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008307159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912734,0.0060711983,0.0001743632,0.0019051649,0.0001692189,0.0003172494,0.0000019369807,0.000019376297,0.000068073656],"genre_scores_gemma":[0.99216425,0.006361455,0.0010884958,0.00021264244,0.00011265629,0.000019890791,0.0000021157239,0.00003697737,0.0000015203894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814284,0.00014811946,0.00057337846,0.00034201858,0.00036505898,0.00042855623],"domain_scores_gemma":[0.99846864,0.00021053485,0.00068720256,0.00020298474,0.000108445915,0.00032217533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029807497,0.00025363595,0.0020451706,0.0002091635,0.00009289721,0.000022584756,0.00011871254,0.00006796509,0.000010060818],"category_scores_gemma":[0.000098774,0.00022553984,0.00041819067,0.0004325502,0.0002631098,0.0001158104,0.00015184032,0.000290058,0.0000012244875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026380348,0.0060657756,0.66269195,0.00701756,0.031288326,0.0064049615,0.0057801395,0.00004979574,0.07580137,0.0005177401,0.0030800798,0.19866426],"study_design_scores_gemma":[0.003559683,0.0074505964,0.9151893,0.0017485393,0.0069594565,0.00063324213,0.0042149974,0.00021669555,0.0583262,0.000054218326,0.00077683834,0.00087020244],"about_ca_topic_score_codex":0.000032364933,"about_ca_topic_score_gemma":0.0000012875079,"teacher_disagreement_score":0.25249738,"about_ca_system_score_codex":0.00005474372,"about_ca_system_score_gemma":0.000056046843,"threshold_uncertainty_score":0.91972476},"labels":[],"label_agreement":null},{"id":"W3009946828","doi":"10.1002/ajh.25776","title":"Safety and efficacy of self‐administered romiplostim in patients with immune thrombocytopenia: Results of an integrated database of five clinical trials","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Argenx; Sanofi Genzyme; Zafgen; Daiichi Sankyo Europe; Agios Pharmaceuticals; Celgene; Shionogi; Sanofi; Alnylam Pharmaceuticals; Pfizer; Amgen","keywords":"Romiplostim; Medicine; Adverse effect; Immune thrombocytopenia; Clinical trial; Internal medicine; Randomized controlled trial; Self-administration; Platelet; Pediatrics; Thrombopoietin","score_opus":0.041102499621267656,"score_gpt":0.3620563649409327,"score_spread":0.320953865319665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009946828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871385,0.00016930097,0.000039661525,0.00053151307,0.000027918923,0.00032277085,0.00015870866,0.0000032691457,0.000033001743],"genre_scores_gemma":[0.994964,0.00018095376,0.004680989,0.00007747138,0.000008050004,5.987285e-7,0.0000745466,0.000012189989,0.0000012124664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964857,0.0006416936,0.002357674,0.00018517282,0.00019417575,0.00013554607],"domain_scores_gemma":[0.995643,0.0010359331,0.0026692392,0.00020932205,0.00027102965,0.00017144621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086603645,0.00014686189,0.0031016383,0.00012718748,0.000010438411,0.00000167353,0.00011910919,0.000059677022,0.000013991694],"category_scores_gemma":[0.0018374956,0.000093730305,0.00012435278,0.0002550212,0.00043664098,0.0000802589,0.000041712585,0.00024774132,5.134811e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33276224,0.011690577,0.6156615,0.0003320882,0.003805051,0.0017097745,0.0042247907,0.000022037606,0.0009424384,0.00006913723,0.00011362716,0.028666696],"study_design_scores_gemma":[0.12025718,0.06443236,0.8036592,0.0010636692,0.0013274853,0.0006297549,0.002688598,0.00018693374,0.005463007,0.00001417377,0.000076028795,0.00020159165],"about_ca_topic_score_codex":0.00010606923,"about_ca_topic_score_gemma":0.0000131271145,"teacher_disagreement_score":0.21250507,"about_ca_system_score_codex":0.000014027327,"about_ca_system_score_gemma":0.00024981948,"threshold_uncertainty_score":0.38222107},"labels":[],"label_agreement":null},{"id":"W3011341107","doi":"10.1002/ajh.25783","title":"Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: <scp>CALGB</scp>/Alliance 50403","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"National Cancer Institute; Lymphoma Research Foundation","keywords":"Medicine; Mantle cell lymphoma; Internal medicine; Bortezomib; Etoposide; Progression-free survival; Surgery; Transplantation; Cytarabine; Clinical endpoint; Autologous stem-cell transplantation; Oncology; Gastroenterology; Multiple myeloma; Randomized controlled trial; Chemotherapy; Lymphoma","score_opus":0.013162266208827433,"score_gpt":0.2597290467004244,"score_spread":0.24656678049159697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011341107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879941,0.0026813624,0.0063438932,0.0022453289,0.0001363513,0.00036896107,0.000015632437,0.000021924212,0.00019249303],"genre_scores_gemma":[0.9871107,0.002325972,0.008590019,0.0017708595,0.00005245759,0.000025736908,0.000011161898,0.000028660945,0.000084446845],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869835,0.00006664728,0.0005509652,0.00023971697,0.00015005264,0.00029425017],"domain_scores_gemma":[0.9984341,0.00052507565,0.00062877126,0.00010912994,0.00011264472,0.00019024477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012417542,0.0001997881,0.00081780384,0.000059446415,0.000073191295,0.000017993392,0.00009558565,0.00006953227,0.0000063183484],"category_scores_gemma":[0.000036588805,0.00014688815,0.00019484977,0.00014879611,0.00014303869,0.000090754074,0.000008753248,0.000078001685,0.000006524772],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01484119,0.006144558,0.25494167,0.004070777,0.0040397537,0.019239116,0.02712926,0.00009399763,0.10700116,0.0020245856,0.02328336,0.53719056],"study_design_scores_gemma":[0.08187821,0.02619838,0.08752909,0.00104845,0.0029558905,0.028390389,0.016966289,0.0017168799,0.7311908,0.0002791954,0.021256154,0.00059029064],"about_ca_topic_score_codex":0.000012200657,"about_ca_topic_score_gemma":0.0000018181498,"teacher_disagreement_score":0.6241896,"about_ca_system_score_codex":0.000078004094,"about_ca_system_score_gemma":0.00021794521,"threshold_uncertainty_score":0.59899247},"labels":[],"label_agreement":null},{"id":"W3021624220","doi":"10.1002/ajh.25851","title":"Management of <scp>CLL</scp> patients early in the <scp>COVID</scp>‐19 pandemic: An international survey of <scp>CLL</scp> experts","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Genentech; National Institutes of Health; National Cancer Institute; Gilead Sciences","keywords":"Medicine; Discontinuation; Pandemic; Immunosenescence; Immunology; Chronic lymphocytic leukemia; Intensive care medicine; Internal medicine; Disease; Coronavirus disease 2019 (COVID-19); Leukemia; Immune system","score_opus":0.05015140238158752,"score_gpt":0.3411833603282778,"score_spread":0.29103195794669023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021624220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606925,0.00052463834,0.00059484545,0.000245345,0.00027867526,0.00054714817,0.000044845325,0.000022645123,0.0016726189],"genre_scores_gemma":[0.99682516,0.00058563106,0.000892924,0.0013006952,0.000131223,0.000022812192,0.000050842944,0.000060874507,0.00012986556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939728,0.0011467468,0.0018320697,0.0005343047,0.0017088549,0.00080521876],"domain_scores_gemma":[0.9921098,0.0040119127,0.0017644854,0.00066428963,0.00083790993,0.00061160413],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019915327,0.00039201567,0.0015275278,0.0005421112,0.00006347323,0.00003243203,0.0014721397,0.00017178117,0.000028853841],"category_scores_gemma":[0.005262591,0.00029462538,0.00028519536,0.0011397983,0.0009574029,0.0002826211,0.00036019424,0.0007389953,0.00002173232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015107448,0.0010369027,0.9701098,0.00031234545,0.0008601242,0.0014052364,0.014194546,0.000099966055,0.00038683641,0.00042707767,0.007247154,0.0037688971],"study_design_scores_gemma":[0.03259415,0.0091327485,0.89702183,0.00069732184,0.00035900477,0.0045664017,0.039138556,0.0021115234,0.0016981128,0.00034855757,0.012212901,0.00011890801],"about_ca_topic_score_codex":0.0016249939,"about_ca_topic_score_gemma":0.00009093514,"teacher_disagreement_score":0.07308803,"about_ca_system_score_codex":0.0015770801,"about_ca_system_score_gemma":0.0020804617,"threshold_uncertainty_score":0.9999506},"labels":[],"label_agreement":null},{"id":"W3034069616","doi":"10.1002/ajh.25901","title":"Limitations of the particle immunofiltration assay test for diagnosis of heparin‐induced thrombocytopenia","year":2020,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McMaster University","funders":"","keywords":"Heparin; Immunoassay; Platelet factor 4; Medicine; Heparin-induced thrombocytopenia; Platelet; Antibody; Platelet activation; Immunology; Internal medicine; Gastroenterology","score_opus":0.1485544085621829,"score_gpt":0.3655095292608665,"score_spread":0.21695512069868358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034069616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.095084496,0.8969754,0.000231233,0.003732965,0.0007377893,0.002661197,0.00011654041,0.00002369777,0.0004366688],"genre_scores_gemma":[0.3972275,0.60130847,0.0011613227,0.000080919854,0.00007707002,0.000078927114,0.0000096901485,0.000047314395,0.000008802813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964762,0.00045112887,0.002171774,0.00026589737,0.00032224815,0.00031277235],"domain_scores_gemma":[0.99066055,0.0041613947,0.0039061608,0.00053824723,0.00055694015,0.00017669454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005353171,0.0003586633,0.0051171365,0.00013660993,0.000083681225,0.000011693163,0.00052427594,0.00019684873,0.000034125496],"category_scores_gemma":[0.0034969873,0.00023391281,0.0013217615,0.0008684062,0.0004766292,0.00010191215,0.00010080091,0.0005522077,0.000009618224],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015459259,0.0013532672,0.012150697,0.0065295985,0.0035084009,0.00004126756,0.0008893898,0.0000010430292,0.0037430308,0.004650718,0.00081114675,0.96616685],"study_design_scores_gemma":[0.00496983,0.018759545,0.009503241,0.028145539,0.029018484,0.00802875,0.0019385386,0.000051821673,0.06397783,0.00046705856,0.8338787,0.0012606377],"about_ca_topic_score_codex":0.00004522079,"about_ca_topic_score_gemma":0.000020436477,"teacher_disagreement_score":0.9649062,"about_ca_system_score_codex":0.000115565,"about_ca_system_score_gemma":0.0014380249,"threshold_uncertainty_score":0.9538688},"labels":[],"label_agreement":null},{"id":"W3039763738","doi":"10.1002/ajh.25926","title":"Characterization of the severe phenotype of pyruvate kinase deficiency","year":2020,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Pyruvate kinase deficiency; Phenotype; Pyruvate kinase; Medicine; Genetics; Biology; Internal medicine; Gene; Glycolysis; Metabolism","score_opus":0.012940307487476729,"score_gpt":0.23895412364590066,"score_spread":0.22601381615842392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039763738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64757425,0.00021284698,0.0003190413,0.3502786,0.0010399623,0.00018008015,0.00003349091,0.0000089636715,0.000352755],"genre_scores_gemma":[0.67669827,0.00020235166,0.00037737563,0.32166004,0.0008224658,0.000001969056,0.000050244515,0.00003965188,0.00014760451],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982959,0.00025036727,0.0008420295,0.0001584451,0.0002704414,0.00018280016],"domain_scores_gemma":[0.9964547,0.00013578785,0.0026738746,0.00028768554,0.0003933799,0.00005455776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000819214,0.00018342889,0.0013009284,0.000166946,0.000028193148,0.0000016608607,0.00023510976,0.00018495512,0.00017628855],"category_scores_gemma":[0.00018344502,0.00011804429,0.00032865227,0.0003901319,0.0006406013,0.000029059438,0.000051408915,0.0010590731,0.000009586865],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022170588,0.0003741759,0.011074586,0.0024394863,0.00075887085,0.0016213758,0.00155778,0.0000081678945,0.6850246,0.0004466666,0.28630224,0.008174952],"study_design_scores_gemma":[0.0072521092,0.025027068,0.043865167,0.0036218904,0.003993584,0.026946504,0.0014977689,0.00008797314,0.11474411,0.0014034215,0.7701821,0.001378327],"about_ca_topic_score_codex":0.000010509575,"about_ca_topic_score_gemma":4.882346e-7,"teacher_disagreement_score":0.57028055,"about_ca_system_score_codex":0.00002562686,"about_ca_system_score_gemma":0.00036723696,"threshold_uncertainty_score":0.48137066},"labels":[],"label_agreement":null},{"id":"W3084307312","doi":"10.1002/ajh.25992","title":"Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute","keywords":"Histopathology; Medicine; Pathology; Clinical endpoint; Internal medicine; Lymph node; Plasma cell; Disease; Etiology; Pathogenesis; Clinical trial; Bone marrow","score_opus":0.051173255153865796,"score_gpt":0.330022158712673,"score_spread":0.2788489035588072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084307312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980629,0.0038458211,0.00082278915,0.014199512,0.00014199966,0.00030587483,0.000007759159,0.000014757608,0.000032443375],"genre_scores_gemma":[0.99367046,0.00047577184,0.001590576,0.004151574,0.000048507012,0.000008227842,9.936989e-7,0.000018136432,0.000035733214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982719,0.00015289939,0.00071457005,0.00024901362,0.00030131798,0.00031032696],"domain_scores_gemma":[0.99787295,0.00012950103,0.0006323579,0.00022312118,0.00031958806,0.00082250556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015478423,0.00017978293,0.00094772823,0.0002197411,0.00003696095,0.0000075772405,0.00014747868,0.00003583051,0.000032033236],"category_scores_gemma":[0.0019912063,0.00013814923,0.00020759602,0.0006420374,0.00014460458,0.000060533446,0.00003774415,0.00011476082,0.000031070096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014099459,0.002394171,0.9043369,0.0002873767,0.00029928453,0.011099318,0.015686378,0.0013288279,0.010173346,0.0003178022,0.0053431108,0.034634],"study_design_scores_gemma":[0.014844809,0.14870633,0.76877093,0.0027715922,0.0029291266,0.0046445574,0.013684462,0.00085913326,0.0063718176,0.00007860658,0.03493034,0.0014082681],"about_ca_topic_score_codex":0.00018582698,"about_ca_topic_score_gemma":0.000014261254,"teacher_disagreement_score":0.14631216,"about_ca_system_score_codex":0.00040126633,"about_ca_system_score_gemma":0.0005010249,"threshold_uncertainty_score":0.5633562},"labels":[],"label_agreement":null},{"id":"W3093977038","doi":"10.1002/ajh.26036","title":"Immune thrombocytopenia (<scp>ITP</scp>) <scp>World Impact Survey</scp> (<scp>I‐WISh</scp>): Impact of <scp>ITP</scp> on health‐related quality of life","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Chugai Pharmaceutical; Novartis Pharma; Grifols; Swedish Orphan Biovitrum; Novo Nordisk; Momenta Pharmaceuticals; Gilead Sciences; Pfizer; Novartis Pharmaceuticals Corporation; Amgen; Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Medicine; Immune thrombocytopenia; Quality of life (healthcare); Work productivity; Productivity; Disease; Immune system; Internal medicine; Pediatrics; Immunology; Platelet; Nursing","score_opus":0.04085826417815964,"score_gpt":0.3482589772983303,"score_spread":0.30740071312017064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093977038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98216426,0.011759915,0.00013057671,0.001322137,0.00047355288,0.0011124668,0.0005091988,0.00011402648,0.0024138542],"genre_scores_gemma":[0.99473274,0.0020824305,0.0006052135,0.0015273857,0.00016350637,0.000018330491,0.00026219155,0.00023772093,0.00037049912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9868122,0.002597666,0.0054384065,0.0011303364,0.0016289608,0.0023924499],"domain_scores_gemma":[0.97407615,0.012138843,0.008947009,0.0013075932,0.0011218434,0.0024085743],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0030422334,0.0014549923,0.009281408,0.0012062367,0.00028959484,0.00006713767,0.0011647645,0.0005342397,0.00007374807],"category_scores_gemma":[0.016087111,0.0011429726,0.0022977167,0.0030590065,0.001482582,0.00046410869,0.00031218954,0.0023404125,0.00016877794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009595246,0.006540697,0.8462319,0.0010621602,0.01631846,0.003073188,0.011769619,0.0006802532,0.008258786,0.0005168729,0.10144474,0.0031437934],"study_design_scores_gemma":[0.019375203,0.028919369,0.91929066,0.0009917981,0.0010980619,0.0053593786,0.011400888,0.00025232538,0.0102978,0.0006910168,0.0021061783,0.00021732211],"about_ca_topic_score_codex":0.0066580437,"about_ca_topic_score_gemma":0.000329127,"teacher_disagreement_score":0.09933857,"about_ca_system_score_codex":0.0005825934,"about_ca_system_score_gemma":0.0029707523,"threshold_uncertainty_score":0.99996126},"labels":[],"label_agreement":null},{"id":"W3094089270","doi":"10.1002/ajh.26034","title":"Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Université de Lille","keywords":"Splenectomy; Medicine; Myelofibrosis; Hazard ratio; Transplantation; Incidence (geometry); Surgery; Hematopoietic cell; Internal medicine; Hematopoietic stem cell transplantation; Confidence interval; Bone marrow; Haematopoiesis; Spleen; Stem cell","score_opus":0.014417830692706574,"score_gpt":0.2808319163925815,"score_spread":0.2664140856998749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094089270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883154,0.0004308896,0.0035529872,0.006747713,0.000078895835,0.0007563807,0.000016373173,0.000018025832,0.00008332543],"genre_scores_gemma":[0.990803,0.000092676,0.00761126,0.0012229856,0.00011865353,0.00009625291,0.000016150165,0.000026593198,0.000012427606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984864,0.00010524035,0.0006752137,0.00023610586,0.00026395073,0.0002330783],"domain_scores_gemma":[0.99853516,0.00024520676,0.0005539244,0.00011778173,0.00030431183,0.0002436431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014620366,0.00020037216,0.0008935669,0.00014130774,0.00007193414,0.000012599851,0.000107077554,0.000042992684,0.00007693212],"category_scores_gemma":[0.00008300291,0.0001506567,0.00021978107,0.00024983782,0.00009455689,0.000066156674,0.000010772545,0.00014846162,0.00001200184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010738233,0.0017509487,0.9743026,0.00038243315,0.0007762501,0.00071652746,0.012429786,0.000039715214,0.0014993815,0.0003916989,0.00090852176,0.005728325],"study_design_scores_gemma":[0.026742617,0.09069215,0.76294535,0.00045284475,0.0042886212,0.010955848,0.015229441,0.0002339836,0.08476291,0.0006690959,0.002310575,0.00071656174],"about_ca_topic_score_codex":0.000017289822,"about_ca_topic_score_gemma":0.000027141185,"teacher_disagreement_score":0.21135724,"about_ca_system_score_codex":0.000037299225,"about_ca_system_score_gemma":0.00018387882,"threshold_uncertainty_score":0.6143602},"labels":[],"label_agreement":null},{"id":"W3094480710","doi":"10.1002/ajh.26033","title":"Fresh <i>vs.</i> frozen allogeneic peripheral blood stem cell grafts: A successful timely option","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cryopreservation; Medicine; Transplantation; Surgery; Fresh frozen plasma; Cord blood; Graft-versus-host disease; Internal medicine; Platelet; Biology","score_opus":0.011772557782038307,"score_gpt":0.24336316391779336,"score_spread":0.23159060613575505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094480710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814892,0.0010906414,0.007963249,0.008164414,0.000121440105,0.00022816946,0.000011164338,0.000045597117,0.00088616373],"genre_scores_gemma":[0.9873171,0.00023281128,0.006502101,0.0056253965,0.00022494457,0.000005158644,0.00001023634,0.0000475601,0.000034731656],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997796,0.00021346609,0.00092761946,0.00028634974,0.0004100042,0.00036653617],"domain_scores_gemma":[0.99811673,0.00014253902,0.0007920988,0.00017742484,0.00023397656,0.000537219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018157388,0.0002497938,0.0011172703,0.00011068484,0.00005869681,0.000018606188,0.00024502407,0.0001038407,0.0003320126],"category_scores_gemma":[0.000027068092,0.00021403591,0.0002544576,0.00035723395,0.0003230502,0.00011590778,0.000025086261,0.00041456372,0.00006553041],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013142847,0.002095006,0.5479577,0.0036826495,0.0028916402,0.01631159,0.032226972,0.00076305424,0.3530542,0.0014593039,0.014042828,0.012372211],"study_design_scores_gemma":[0.04254849,0.056489535,0.013495686,0.0016921377,0.008062252,0.10021319,0.031831466,0.0032620896,0.72159106,0.00027498422,0.017964147,0.0025749689],"about_ca_topic_score_codex":0.000021351088,"about_ca_topic_score_gemma":0.0000029919113,"teacher_disagreement_score":0.53446203,"about_ca_system_score_codex":0.00003866335,"about_ca_system_score_gemma":0.00024912177,"threshold_uncertainty_score":0.8728131},"labels":[],"label_agreement":null},{"id":"W3103365133","doi":"10.1002/ajh.26045","title":"Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Immune thrombocytopenia; Quality of life (healthcare); Disease; Pediatrics; Internal medicine; Platelet","score_opus":0.01685971017784169,"score_gpt":0.2921030030863628,"score_spread":0.27524329290852106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103365133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99483013,0.0035643673,0.000011324997,0.0013127566,0.000017945385,0.00017362743,0.000039532402,0.00000452637,0.00004579495],"genre_scores_gemma":[0.9972986,0.0021061047,0.00023263926,0.00031507228,0.000013822532,0.0000053809954,0.000011253061,0.000013771293,0.0000033781375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909127,0.000112581125,0.00037584073,0.00015211526,0.00009871955,0.0001694616],"domain_scores_gemma":[0.99901325,0.00021866239,0.0003777697,0.00008960526,0.00007150616,0.00022921438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005596469,0.00016900296,0.0011453172,0.00010135757,0.000047571702,0.000009228388,0.000033925837,0.000025739757,0.000031657964],"category_scores_gemma":[0.000037145543,0.00011504797,0.00008790859,0.0001749658,0.00036842772,0.00006452713,0.000029776544,0.00010245741,0.0000012774586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004334323,0.00043713395,0.93672645,0.000020067315,0.0007314611,0.00027015468,0.0015970528,0.0000015738091,0.0010132808,0.000020019997,0.00013595585,0.05861344],"study_design_scores_gemma":[0.0028618495,0.016720178,0.97589535,0.00009580627,0.0003857805,0.0015471118,0.0013882134,0.000025728905,0.0008038002,0.0000370715,0.00011730247,0.00012182468],"about_ca_topic_score_codex":0.00045296925,"about_ca_topic_score_gemma":0.0000991398,"teacher_disagreement_score":0.058491614,"about_ca_system_score_codex":0.000034759734,"about_ca_system_score_gemma":0.00006445507,"threshold_uncertainty_score":0.469152},"labels":[],"label_agreement":null},{"id":"W3112349182","doi":"10.1002/ajh.26078","title":"On the trail of blood doping—<scp>microRNA</scp> fingerprints to monitor autologous blood transfusions in vivo","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Israel Science Foundation; World Anti-Doping Agency","keywords":"Medicine; Whole blood; Blood transfusion; Autologous blood; microRNA; Blood sampling; Blood volume; Internal medicine; Surgery; Gene; Biology","score_opus":0.008007889183901915,"score_gpt":0.23867889120692143,"score_spread":0.23067100202301952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112349182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546474,0.00077444396,0.0006192984,0.0027008909,0.00008921402,0.00015775414,0.000018713601,0.0000055099326,0.00016940632],"genre_scores_gemma":[0.9967695,0.00012451863,0.0014638745,0.0015052191,0.00008819279,0.0000075959792,0.0000010488747,0.000025930573,0.00001410591],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984218,0.00024492183,0.0006011435,0.00026082798,0.00016948479,0.00030180582],"domain_scores_gemma":[0.99871606,0.00023769101,0.0004256221,0.00029228925,0.00009974448,0.00022859486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021930282,0.00018313316,0.000484732,0.000096777236,0.000043849734,0.000007748947,0.00055987516,0.00009120091,0.00002599719],"category_scores_gemma":[0.000902517,0.00014407463,0.0002112012,0.00026953884,0.00032113315,0.000003731401,0.00007932908,0.00029006242,0.0000061905544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015121221,0.0004016427,0.0041644275,0.000025195452,0.00022428673,0.0002694365,0.0008243774,0.00018117703,0.9911255,0.00052594143,0.0009846684,0.0011221354],"study_design_scores_gemma":[0.0009651748,0.0027003426,0.0017596582,0.000075252006,0.00015132254,0.0007936072,0.0010545899,0.0000141432865,0.9911059,0.00014919993,0.0011317134,0.00009905784],"about_ca_topic_score_codex":0.000013944065,"about_ca_topic_score_gemma":0.000010223808,"teacher_disagreement_score":0.0024047694,"about_ca_system_score_codex":0.0000081297585,"about_ca_system_score_gemma":0.00013127811,"threshold_uncertainty_score":0.5875193},"labels":[],"label_agreement":null},{"id":"W3112794144","doi":"10.1002/ajh.26075","title":"Serotonin‐release assay‐positive but platelet factor 4‐dependent enzyme‐immunoassay negative: <scp>HIT</scp> or not <scp>HIT</scp>?","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research; McMaster University","keywords":"Heparin-induced thrombocytopenia; Medicine; Immunoassay; Platelet factor 4; Heparin; Antibody; Platelet; Immunology; Serology; Monoclonal antibody; Internal medicine","score_opus":0.03117714273087011,"score_gpt":0.2936135034304565,"score_spread":0.26243636069958637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112794144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899097,0.0004201387,0.0014001589,0.0042181094,0.0005545933,0.0008767924,0.00013615904,0.00012108189,0.0023632303],"genre_scores_gemma":[0.9903638,0.0004651968,0.0020556499,0.0059148567,0.00047352165,0.000039379822,0.000024948959,0.00016176535,0.0005008803],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99371797,0.0010272703,0.001943961,0.00086663564,0.001066468,0.0013777041],"domain_scores_gemma":[0.9908122,0.003922725,0.0022231513,0.00064594945,0.0007867081,0.0016092742],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006383499,0.00089101435,0.003618672,0.00046847743,0.0002873235,0.00009858505,0.00083796616,0.0004040339,0.00036519652],"category_scores_gemma":[0.0034804903,0.0007042232,0.000679663,0.0009841128,0.00093172817,0.00044671222,0.0003238734,0.0022556551,0.000488018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053954856,0.005133348,0.10403277,0.0011667367,0.018460272,0.049073834,0.045466047,0.00018142602,0.6983263,0.0042514857,0.033755973,0.034756355],"study_design_scores_gemma":[0.008443248,0.011109398,0.03809947,0.0005185506,0.0009911756,0.021269228,0.016769337,0.00019319668,0.89082074,0.000073832074,0.011363279,0.0003485466],"about_ca_topic_score_codex":0.0002984927,"about_ca_topic_score_gemma":0.00003101913,"teacher_disagreement_score":0.19249447,"about_ca_system_score_codex":0.00033774722,"about_ca_system_score_gemma":0.0013233483,"threshold_uncertainty_score":0.99954087},"labels":[],"label_agreement":null},{"id":"W3127681212","doi":"10.1002/ajh.26114","title":"Young platelet millionaires with essential thrombocythemia","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Essential thrombocythemia; Medicine; Thrombocytosis; Context (archaeology); Incidence (geometry); Aspirin; Internal medicine; Thrombosis; Young adult; Platelet","score_opus":0.006870433168835954,"score_gpt":0.2670210640124645,"score_spread":0.26015063084362855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127681212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928596,0.0010389846,0.00041132848,0.0045778863,0.00012509723,0.0000681957,0.000002702505,0.000008737766,0.0009074435],"genre_scores_gemma":[0.99207854,0.00038913536,0.00674848,0.0005747385,0.00011517432,0.0000054657553,0.000006358426,0.000017673245,0.00006443182],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989502,0.00007425168,0.0003558076,0.00016079067,0.00024817933,0.00021078555],"domain_scores_gemma":[0.9988432,0.00014380198,0.00035123766,0.00015695964,0.00034890606,0.00015590744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007016756,0.0001452149,0.00078980776,0.000091118345,0.000051737417,0.000011009532,0.000055113465,0.0000358315,0.000288569],"category_scores_gemma":[0.000059384784,0.00009343074,0.00012587651,0.00021311671,0.000274706,0.000049118156,0.000019928553,0.00020104667,0.000016350383],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021818567,0.0017821743,0.908863,0.00010128062,0.0032911543,0.04350885,0.0016440162,0.000029660325,0.0064033833,0.007363088,0.0073258705,0.017505674],"study_design_scores_gemma":[0.008348755,0.00816238,0.13159138,0.00069446414,0.00082472374,0.37999022,0.0038459937,0.000027372867,0.45981658,0.00042280904,0.005887693,0.00038764527],"about_ca_topic_score_codex":0.000018170338,"about_ca_topic_score_gemma":0.000033360073,"teacher_disagreement_score":0.7772716,"about_ca_system_score_codex":0.00004805707,"about_ca_system_score_gemma":0.0003958569,"threshold_uncertainty_score":0.3809995},"labels":[],"label_agreement":null},{"id":"W3131061582","doi":"10.1002/ajh.26136","title":"A <scp>Phase I</scp> dose‐escalation study of <scp>DCLL9718S</scp>, an antibody‐drug conjugate targeting <scp>C</scp>‐type lectin‐like molecule‐1 (<scp>CLL</scp>‐1) in patients with acute myeloid leukemia","year":2021,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Jewish General Hospital; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"National Center for Advancing Translational Sciences; Genentech","keywords":"Antibody-drug conjugate; Cancer research; Myeloid leukemia; Antibody; Myeloid; Chemistry; Monoclonal antibody; Molecular biology; Immunology; Medicine; Biology","score_opus":0.007897356507361076,"score_gpt":0.2654896933773154,"score_spread":0.25759233686995436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131061582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930754,0.0021893205,0.0012108696,0.0005679134,0.0015480333,0.0010370765,0.00010243239,0.00003550168,0.0002334893],"genre_scores_gemma":[0.9627191,0.0015165985,0.0025513228,0.027679667,0.001399706,0.00007802015,0.002209867,0.00052077166,0.0013249862],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919347,0.001253251,0.0023791902,0.0015826182,0.0011973877,0.001652809],"domain_scores_gemma":[0.9912599,0.0007747457,0.0046428787,0.0012075535,0.0016596013,0.00045536718],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00089688663,0.0013316674,0.0028796808,0.0008566411,0.00024902934,0.00014520016,0.0012687317,0.0009611596,0.0000064381998],"category_scores_gemma":[0.00082196447,0.0012583244,0.00053640857,0.0012358607,0.00059384946,0.00007448475,0.00042393792,0.0025821696,0.000008004178],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074984477,0.008292243,0.04965034,0.001004951,0.013646198,0.009233393,0.0144633725,0.0014700117,0.5527214,0.00008153295,0.3441638,0.0045229364],"study_design_scores_gemma":[0.041493952,0.066759415,0.0057438915,0.0014039038,0.0045519467,0.0052162646,0.032561034,0.00043624613,0.31313998,0.00039079817,0.52729696,0.0010056391],"about_ca_topic_score_codex":0.00026626568,"about_ca_topic_score_gemma":0.00013526416,"teacher_disagreement_score":0.23958139,"about_ca_system_score_codex":0.00027525928,"about_ca_system_score_gemma":0.0014829533,"threshold_uncertainty_score":0.99994344},"labels":[],"label_agreement":null},{"id":"W3131177835","doi":"10.1002/ajh.26131","title":"Upgrading the evidence for the use of ambroxol in Gaucher disease and <scp>GBA</scp> related Parkinson: Investigator initiated registry based on real life data","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Cambridge","keywords":"Medicine; Glucocerebrosidase; Adverse effect; Internal medicine; Ambroxol; Disease; Clinical trial; Pediatrics; Anesthesia","score_opus":0.2050609579674024,"score_gpt":0.38075330447263694,"score_spread":0.17569234650523455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131177835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767475,0.0044115367,0.00029516243,0.018099103,0.0000602855,0.0003291052,0.000020953988,0.000005770294,0.000030588973],"genre_scores_gemma":[0.995447,0.0013376517,0.0007888299,0.002295474,0.000040054703,0.000013554892,0.000014027813,0.000023703951,0.000039712253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776137,0.00063888845,0.0006333015,0.0002757781,0.00039496995,0.0002956888],"domain_scores_gemma":[0.9902537,0.0076286015,0.00062335335,0.00079005776,0.00031474163,0.00038956144],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0008451425,0.00014675078,0.00058760995,0.0001436727,0.00008265334,0.000027638536,0.00040861085,0.00006193584,0.000018219474],"category_scores_gemma":[0.038440306,0.000087362685,0.00009429165,0.00066130375,0.0011028392,0.000160537,0.00013025476,0.00056735484,0.0000011895436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027212105,0.00055799447,0.96270496,0.00043270612,0.00066495273,0.0036189607,0.0011144197,0.0003104115,0.0019626194,0.0011186345,0.020753115,0.004040037],"study_design_scores_gemma":[0.011608695,0.004071605,0.83783287,0.005956221,0.0015843627,0.004830839,0.012787132,0.09894293,0.002855242,0.0006591108,0.018512646,0.00035833628],"about_ca_topic_score_codex":0.00016831575,"about_ca_topic_score_gemma":0.000027007887,"teacher_disagreement_score":0.12487205,"about_ca_system_score_codex":0.000046994362,"about_ca_system_score_gemma":0.0015139455,"threshold_uncertainty_score":0.9696593},"labels":[],"label_agreement":null},{"id":"W3133701599","doi":"10.1002/ajh.26147","title":"Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the <scp>MCRN</scp>‐003/<scp>MYX</scp>.1 single arm phase <scp>II</scp> trial","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Ottawa Hospital; University of Ottawa; Western University; Saint John Regional Hospital; Hôtel-Dieu de Québec; Hotel Dieu Hospital; Princess Margaret Cancer Centre; Micropharma (Canada); University of Alberta; University of New Brunswick; Université de Montréal; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal","funders":"Amgen Canada; Amgen","keywords":"Carfilzomib; Lenalidomide; Medicine; Dexamethasone; Multiple myeloma; Regimen; Clinical endpoint; Internal medicine; Cyclophosphamide; Adverse effect; Gastroenterology; Phases of clinical research; Metastatic breast cancer; Thalidomide; Progression-free survival; Refractory (planetary science); Oncology; Neutropenia; Toxicity; Chemotherapy; Clinical trial; Cancer; Breast cancer","score_opus":0.04164704233889885,"score_gpt":0.3148523281370852,"score_spread":0.27320528579818637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133701599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846366,0.011469126,0.00006681659,0.0013554344,0.00043575317,0.0010657408,0.00030438343,0.000024858817,0.00064126716],"genre_scores_gemma":[0.9919819,0.0033747603,0.0029662277,0.00039160516,0.0004712583,0.00007696561,0.00014996645,0.000070750255,0.0005165175],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99376214,0.0014763048,0.0018617627,0.000749988,0.0010573551,0.0010924549],"domain_scores_gemma":[0.9757234,0.020479225,0.0017794553,0.0009794667,0.00045590548,0.00058258086],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010345171,0.00063840405,0.0023041486,0.00034794334,0.00032024243,0.00006387773,0.00051499554,0.00025121396,0.000012687938],"category_scores_gemma":[0.011681371,0.00038958102,0.0005578533,0.0009050035,0.0012757679,0.0001878218,0.00014811526,0.0009886397,0.000014903144],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.068102114,0.10758278,0.25121787,0.00037832028,0.014771211,0.08258182,0.13479853,0.00022490868,0.063463286,0.00041439213,0.04352061,0.23294415],"study_design_scores_gemma":[0.5232677,0.09627019,0.1087203,0.00084649026,0.002200758,0.012673602,0.08238831,0.0005710273,0.08669425,0.0005618817,0.085579425,0.00022607998],"about_ca_topic_score_codex":0.0012618338,"about_ca_topic_score_gemma":0.0004732263,"teacher_disagreement_score":0.45516557,"about_ca_system_score_codex":0.00044320588,"about_ca_system_score_gemma":0.001177446,"threshold_uncertainty_score":0.99985564},"labels":[],"label_agreement":null},{"id":"W3137319952","doi":"10.1002/ajh.26172","title":"Effect of age and frailty on the efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Alberta Cancer Foundation; University of Calgary; University of Alberta","funders":"Karyopharm Therapeutics","keywords":"Tolerability; Bortezomib; Medicine; Dexamethasone; Multiple myeloma; Carfilzomib; Oncology; Internal medicine; Adverse effect","score_opus":0.023214654556878978,"score_gpt":0.32930533429055875,"score_spread":0.30609067973367976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137319952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967924,0.0018555162,0.000013687668,0.0008959214,0.000013059313,0.0003694946,0.000008116464,0.0000034742734,0.00004835897],"genre_scores_gemma":[0.9985263,0.0005768738,0.0007997329,0.000052315154,0.000011877678,0.0000066338084,0.0000035147966,0.000011336941,0.000011432458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799734,0.0007827668,0.00057089963,0.00021082589,0.00020996493,0.0002281962],"domain_scores_gemma":[0.9951016,0.0039467155,0.00039411994,0.00023104834,0.00014443933,0.00018210622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072111853,0.00016205158,0.001214104,0.00013346074,0.000030456216,0.0000060506723,0.00006305062,0.000055513676,0.000017469729],"category_scores_gemma":[0.0026791054,0.00009487796,0.00007375898,0.0002563318,0.0007810068,0.000033647957,0.000053578726,0.0002915149,3.4085775e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004915869,0.0005040457,0.86431015,0.0002472522,0.0003344104,0.00136004,0.0005490846,0.0000021069945,0.008612954,0.000030765597,0.000022366792,0.119110964],"study_design_scores_gemma":[0.011746477,0.012548207,0.91667163,0.00049832655,0.00019569304,0.0028820455,0.0004514508,0.00034969175,0.054488417,0.00003316982,0.00004167071,0.00009320028],"about_ca_topic_score_codex":0.0002459893,"about_ca_topic_score_gemma":0.00008211922,"teacher_disagreement_score":0.119017765,"about_ca_system_score_codex":0.000028340773,"about_ca_system_score_gemma":0.0001013635,"threshold_uncertainty_score":0.3869011},"labels":[],"label_agreement":null},{"id":"W3138379858","doi":"10.1002/ajh.26159","title":"Risk of infection in <scp>MPN</scp> patients in the era of <scp>C</scp>ovid‐<scp>19</scp>: A prospective multicenter study of <scp>257</scp> patients from the <scp>CML‐MPN Q</scp>uebec <scp>R</scp>esearch <scp>G</scp>roup","year":2021,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université du Québec; Jewish General Hospital; McGill University; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Ruxolitinib; Internal medicine; Population; Cohort; Essential thrombocythemia; Prospective cohort study; Myelofibrosis; Polycythemia vera; Concordance; Immunology","score_opus":0.01385321085323726,"score_gpt":0.27859430188749085,"score_spread":0.2647410910342536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138379858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97835827,0.0043114433,0.00018294997,0.0018078071,0.0021669026,0.009750544,0.001661333,0.00013460964,0.0016261148],"genre_scores_gemma":[0.97432977,0.0055997185,0.0009176521,0.012179704,0.0018436239,0.0018461071,0.0013244933,0.0007816763,0.0011772825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9660738,0.009810948,0.008784493,0.003909699,0.006756368,0.0046646823],"domain_scores_gemma":[0.90751684,0.06786506,0.014054663,0.003630589,0.0056232098,0.0013096345],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.004443605,0.004039604,0.010694488,0.003768801,0.0009007975,0.00041725277,0.0033470436,0.0024683764,0.00004575386],"category_scores_gemma":[0.0557643,0.0029837617,0.0028043776,0.005680203,0.0029633543,0.0011312253,0.0016739115,0.013011022,0.00015666276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006519121,0.0160682,0.7537246,0.0008108475,0.006395117,0.0020359848,0.054080695,0.0002390744,0.00014266557,0.00004643609,0.16547823,0.0009129917],"study_design_scores_gemma":[0.027058648,0.018702371,0.8172393,0.003767967,0.0043732715,0.00078746694,0.07899041,0.0002339235,0.0053144363,0.00050338113,0.042808935,0.00021988992],"about_ca_topic_score_codex":0.01242612,"about_ca_topic_score_gemma":0.0050518843,"teacher_disagreement_score":0.12266929,"about_ca_system_score_codex":0.0024985832,"about_ca_system_score_gemma":0.002499583,"threshold_uncertainty_score":0.99975},"labels":[],"label_agreement":null},{"id":"W3151335737","doi":"10.1002/ajh.26181","title":"Ineffectiveness of high‐dose methotrexate for prevention of <scp>CNS</scp> relapse in diffuse large <scp>B</scp>‐cell lymphoma","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health; Alberta Health Services; University of Calgary; Alberta Advanced Education; Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine; Methotrexate; Internal medicine; Lymphoma; Diffuse large B-cell lymphoma; Primary central nervous system lymphoma; Central nervous system; Gastroenterology; Antifolate; Chemotherapy; Oncology; Antimetabolite","score_opus":0.011175951484408767,"score_gpt":0.2873974435163136,"score_spread":0.2762214920319048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3151335737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940999,0.0033719928,0.0015311564,0.00017253633,0.00021226166,0.00039775606,0.000034572215,0.000008578673,0.0001712487],"genre_scores_gemma":[0.9930014,0.0007254415,0.005841336,0.00011106276,0.000046262867,0.000040897092,0.000024608082,0.000042496573,0.00016650447],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973949,0.0004793727,0.0011337203,0.00029789706,0.00028800737,0.00040609334],"domain_scores_gemma":[0.99421275,0.003114093,0.001627222,0.00034941142,0.0005168866,0.00017964035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058310584,0.00025646397,0.0018401203,0.0004294483,0.00003350943,0.0000062269237,0.00014365572,0.00011923773,0.000009678942],"category_scores_gemma":[0.0015984692,0.00021561593,0.0005032277,0.00061439845,0.00020880948,0.000091975984,0.000072651856,0.00013815808,0.0000033060317],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013541636,0.07651389,0.7144473,0.002925792,0.0038643177,0.005971529,0.0061643836,0.00009686465,0.062229224,0.008636088,0.0037342825,0.114062145],"study_design_scores_gemma":[0.045422677,0.006829862,0.3716313,0.0011840333,0.0012113373,0.0046069273,0.005178377,0.00008548028,0.55927426,0.0018768794,0.002613904,0.000084965824],"about_ca_topic_score_codex":0.00009958561,"about_ca_topic_score_gemma":0.00004537539,"teacher_disagreement_score":0.49704504,"about_ca_system_score_codex":0.00016158771,"about_ca_system_score_gemma":0.00041139533,"threshold_uncertainty_score":0.87925625},"labels":[],"label_agreement":null},{"id":"W3154787439","doi":"10.1002/ajh.26193","title":"Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from <scp>CYP‐C</scp>","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Public Health Ontario; Hospital for Sick Children; SickKids Foundation; University of Toronto; McMaster University; McMaster Children's Hospital; Izaak Walton Killam Health Centre; Nova Scotia Cancer Centre; Nova Scotia Health Authority; Hôpital de l'Enfant-Jésus","funders":"Pediatric Oncology Group of Ontario; Government of Canada; Public Health Agency; Australian Government; Public Health Agency of Canada","keywords":"Medicine; Interquartile range; Internal medicine; Pulmonary embolism; Proportional hazards model; Retrospective cohort study; Cohort; Thrombosis; Population; Lymphoblastic Leukemia; Acute lymphocytic leukemia; Gastroenterology; Surgery; Leukemia","score_opus":0.010659307495026027,"score_gpt":0.2711803409569189,"score_spread":0.26052103346189287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154787439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617875,0.0002561799,0.0015780893,0.0010414465,0.000097649965,0.0002141788,0.000030651587,0.000032031545,0.00057101966],"genre_scores_gemma":[0.99483734,0.00015885335,0.0036251056,0.00084387674,0.000121343386,0.000012376924,0.000065426706,0.00008674134,0.00024894282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960279,0.0003704028,0.0010670419,0.00057467306,0.0011301644,0.0008298422],"domain_scores_gemma":[0.9952039,0.0015371309,0.0013244426,0.0005937407,0.0008630411,0.00047770713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047820795,0.00039969626,0.0021139446,0.00040686678,0.000072856856,0.000035423112,0.0003179254,0.00019456443,0.000112553134],"category_scores_gemma":[0.0016268361,0.00028424704,0.00019133244,0.0016211114,0.0008941207,0.00016012056,0.00012979707,0.0009205661,0.00002345454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059381453,0.00047374243,0.927639,0.000012817278,0.0055822697,0.060516883,0.00083719636,0.00003494276,0.0007310158,0.00003537434,0.0031227644,0.00042014965],"study_design_scores_gemma":[0.014441346,0.0034376723,0.7413367,0.00086207694,0.0018123477,0.2269216,0.0032980093,0.00027837296,0.007058036,0.00013360819,0.00016772783,0.00025247328],"about_ca_topic_score_codex":0.0007278549,"about_ca_topic_score_gemma":0.00025760496,"teacher_disagreement_score":0.1863023,"about_ca_system_score_codex":0.001562539,"about_ca_system_score_gemma":0.00682346,"threshold_uncertainty_score":0.99996096},"labels":[],"label_agreement":null},{"id":"W3156234252","doi":"10.1002/ajh.26186","title":"Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Myelofibrosis; Decitabine; Medicine; Azacitidine; Internal medicine; Myeloproliferative neoplasm; Venetoclax; Essential thrombocythemia; Neuroblastoma RAS viral oncogene homolog; Gastroenterology; KRAS; Myeloid; Leukemia; Polycythemia vera; Oncology; Bone marrow; Chronic lymphocytic leukemia; Biology; Cancer","score_opus":0.020234828184528552,"score_gpt":0.3300823838677404,"score_spread":0.3098475556832119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156234252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576557,0.00039173043,0.00042574905,0.002924201,0.00005299518,0.00024564072,0.000026302354,0.0000070607343,0.00016075272],"genre_scores_gemma":[0.98758185,0.00028547522,0.011412122,0.0004651709,0.00005131471,0.000013826369,0.0000088729685,0.000030090005,0.0001512654],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9978574,0.000321209,0.0008211263,0.00023817603,0.0003503685,0.0004117326],"domain_scores_gemma":[0.9968399,0.00095219945,0.00063499034,0.00023646446,0.0010907855,0.00024567996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023760223,0.00022170733,0.0014148614,0.00038386133,0.00003464202,0.00000883242,0.00012836068,0.0000646314,0.00028654342],"category_scores_gemma":[0.0012962384,0.00014860205,0.00010591833,0.0008029082,0.0012211888,0.0001409885,0.00007052349,0.0005599542,0.000005506088],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20393409,0.0037756022,0.27165455,0.00087483815,0.0041439324,0.41124943,0.016938766,0.00022582825,0.065825865,0.0015901563,0.0030442548,0.016742693],"study_design_scores_gemma":[0.038022213,0.033096462,0.0075849565,0.001880894,0.00043282393,0.48273036,0.054527577,0.0004959909,0.37859973,0.000079456986,0.0020807027,0.00046881317],"about_ca_topic_score_codex":0.000087356864,"about_ca_topic_score_gemma":0.00033602127,"teacher_disagreement_score":0.31277388,"about_ca_system_score_codex":0.00029761498,"about_ca_system_score_gemma":0.0033273827,"threshold_uncertainty_score":0.6059815},"labels":[],"label_agreement":null},{"id":"W3159913046","doi":"10.1002/ajh.26212","title":"Diagnostic value of D‐dimers for limb deep vein thrombosis in children: A prospective study","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"University of Toronto","keywords":"Medicine; Receiver operating characteristic; Post-thrombotic syndrome; Confidence interval; Odds ratio; Prospective cohort study; D-dimer; Deep vein; Percentile; Area under the curve; Logistic regression; Thrombosis; Internal medicine; Surgery","score_opus":0.00847039046746402,"score_gpt":0.29376159854236444,"score_spread":0.28529120807490044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159913046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610984,0.000993211,0.000494327,0.0012648246,0.00013266786,0.0008344354,0.000002872207,0.0000062228773,0.00016157958],"genre_scores_gemma":[0.99658173,0.00031665704,0.0025386582,0.00041567313,0.00005956088,0.00005546722,0.0000025362658,0.000023899462,0.0000058223095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839824,0.00015335191,0.00071944715,0.00022312943,0.0002293035,0.00027651718],"domain_scores_gemma":[0.99815524,0.0006142698,0.00060117757,0.00022645803,0.00030000124,0.00010287607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003383902,0.00015272359,0.0014615691,0.00026535697,0.00003150235,0.00000611351,0.00012673954,0.000036785732,0.000046599882],"category_scores_gemma":[0.00090394233,0.00013111444,0.00021834159,0.0004376936,0.00019746079,0.000051152714,0.000058443067,0.00019752452,0.0000024913902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017630759,0.005622461,0.9842907,0.00006670219,0.0014021235,0.0002486888,0.0023327933,0.00008353731,0.0001825623,0.0023750986,0.00036793167,0.002851072],"study_design_scores_gemma":[0.0032403083,0.009480848,0.97227263,0.00017643218,0.0007725077,0.00080605625,0.010524845,0.000024142573,0.0021105914,0.00042963223,0.00004180951,0.00012018932],"about_ca_topic_score_codex":0.00011513835,"about_ca_topic_score_gemma":0.000058755344,"teacher_disagreement_score":0.0120180845,"about_ca_system_score_codex":0.00007800276,"about_ca_system_score_gemma":0.00019076446,"threshold_uncertainty_score":0.53466916},"labels":[],"label_agreement":null},{"id":"W3165381538","doi":"10.1002/ajh.26261","title":"Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Alberta Cancer Foundation; University of Calgary; University of Alberta","funders":"Karyopharm Therapeutics","keywords":"Bortezomib; Dexamethasone; Multiple myeloma; Medicine; Internal medicine; Gastroenterology; Population; Oncology","score_opus":0.017818009130890246,"score_gpt":0.31031762290113085,"score_spread":0.2924996137702406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165381538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984193,0.01374705,0.00019298906,0.0013415406,0.000075847835,0.00033465595,0.000034037173,0.000018222729,0.00006263567],"genre_scores_gemma":[0.9811829,0.006374138,0.012075261,0.0001773847,0.000030271329,0.000018489234,0.00002456016,0.00004365812,0.00007336652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706435,0.0005904759,0.0008677013,0.00045878967,0.00037168484,0.00064702245],"domain_scores_gemma":[0.99632055,0.0018253137,0.00060350785,0.0003413658,0.0002858062,0.00062348763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004941077,0.00034679993,0.0016679168,0.0003348171,0.00008287324,0.000028345654,0.00011625038,0.00012408782,0.000058179066],"category_scores_gemma":[0.0023631516,0.00027242073,0.00015763514,0.0005034755,0.00056451216,0.000099276884,0.00009964686,0.0005650275,0.0000062964623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002766934,0.0005180883,0.9236912,0.000047299254,0.0008927444,0.0031871893,0.00026171535,0.000002248416,0.0021220397,0.0000087833,0.00021523125,0.0662865],"study_design_scores_gemma":[0.041708723,0.0056099016,0.9244523,0.00021171584,0.0008254822,0.011075004,0.0021991339,0.0006031403,0.011869359,0.00005589396,0.00097106316,0.00041830362],"about_ca_topic_score_codex":0.0006621837,"about_ca_topic_score_gemma":0.000457062,"teacher_disagreement_score":0.06586819,"about_ca_system_score_codex":0.00011811221,"about_ca_system_score_gemma":0.00029494977,"threshold_uncertainty_score":0.9999728},"labels":[],"label_agreement":null},{"id":"W3170705440","doi":"10.1002/ajh.26268","title":"Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Hemostasis and Thrombosis Research Society; Cancer Prevention and Research Institute of Texas; American Society of Hematology; National Hemophilia Foundation","keywords":"Medicine; Internal medicine; Thrombosis; Anticoagulant; Retrospective cohort study; Surgery; Transplantation; Hematology; Hematopoietic stem cell transplantation; Logistic regression; Warfarin","score_opus":0.017241189200122308,"score_gpt":0.31534603708270537,"score_spread":0.29810484788258307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170705440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779475,0.000550354,0.00042003085,0.0007946962,0.00009051529,0.000078287754,0.0000023703215,0.0000038137973,0.00026518805],"genre_scores_gemma":[0.9967215,0.002111716,0.0009852692,0.00013289244,0.000029805742,0.000002220868,0.0000029097519,0.000010840889,0.000002837623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991095,0.00006093236,0.0004060077,0.00011529411,0.00017163598,0.0001366524],"domain_scores_gemma":[0.9991745,0.00009598614,0.0003901307,0.00010062171,0.00015329025,0.000085508786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012229892,0.00010210568,0.0006919203,0.00015914772,0.00001974092,0.000006608374,0.00003104601,0.000028659388,0.00009346956],"category_scores_gemma":[0.00002058351,0.00007913997,0.00015501787,0.00016168776,0.000102321275,0.00005167798,0.00001098027,0.000110226545,0.000002121428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012764466,0.0034475012,0.93691474,0.0015222454,0.001346214,0.00089244853,0.0064260843,0.00014575775,0.025724469,0.002410449,0.0010666618,0.018826976],"study_design_scores_gemma":[0.0011165745,0.003918249,0.97816646,0.0005918648,0.0006448925,0.0014445919,0.0007916421,0.00003437432,0.013018272,0.00015184315,0.000025169862,0.000096079144],"about_ca_topic_score_codex":0.00001666159,"about_ca_topic_score_gemma":0.0000022692477,"teacher_disagreement_score":0.0412517,"about_ca_system_score_codex":0.000033500157,"about_ca_system_score_gemma":0.00007040665,"threshold_uncertainty_score":0.32272345},"labels":[],"label_agreement":null},{"id":"W3173172916","doi":"10.1002/ajh.26274","title":"Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (<scp>FILO</scp>)","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus","funders":"","keywords":"Chronic lymphocytic leukemia; Leukemia cutis; Merkel cell carcinoma; IGHV@; Leukemia; Medicine; Pathology; Carcinoma; Immunology","score_opus":0.02323319188451987,"score_gpt":0.32291421686711275,"score_spread":0.29968102498259286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173172916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983321,0.00069531886,0.00018020326,0.0000916156,0.0002060261,0.000371784,0.000008846375,0.000009565001,0.0001045641],"genre_scores_gemma":[0.99853253,0.0006724367,0.00040089988,0.00016757334,0.0001279464,0.0000056855692,0.000008294578,0.00003421467,0.000050388855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953385,0.0008888317,0.0023117987,0.00041411255,0.0005834227,0.0004633529],"domain_scores_gemma":[0.99391824,0.0018145929,0.0018855485,0.00056494924,0.0016328403,0.0001838036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010705685,0.00027573723,0.0020531453,0.00033319718,0.00005899283,0.000011577536,0.00040887174,0.00025683115,0.000035598925],"category_scores_gemma":[0.0067308904,0.00019103105,0.00014400568,0.0027632082,0.0019222472,0.00008028944,0.00042134195,0.00096265296,0.0000035784042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00022602736,0.0004287556,0.9819481,0.0002967663,0.00067407626,0.0017835277,0.0025776548,0.00011074658,0.0047426187,0.0008471406,0.0004576516,0.005906978],"study_design_scores_gemma":[0.026273038,0.0069301315,0.9271559,0.0007156016,0.00027509587,0.014444337,0.007866063,0.0018058901,0.014064475,0.00012633187,0.00018450024,0.0001585986],"about_ca_topic_score_codex":0.0008080271,"about_ca_topic_score_gemma":0.00010963282,"teacher_disagreement_score":0.05479212,"about_ca_system_score_codex":0.018886408,"about_ca_system_score_gemma":0.06540164,"threshold_uncertainty_score":0.9848799},"labels":[],"label_agreement":null},{"id":"W3174342652","doi":"10.1002/ajh.26276","title":"Clinical outcomes after 4.5 years of eliglustat therapy for <scp>Gaucher</scp> disease type 1: Phase 3 <scp>ENGAGE</scp> trial final results","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; Sanofi Genzyme; Sanofi","keywords":"Medicine; Adverse effect; Placebo; Concomitant; Internal medicine; Gastroenterology; Clinical endpoint; Enzyme replacement therapy; Disease; Clinical trial; Pathological; Pathology","score_opus":0.06823739378827903,"score_gpt":0.4201139288326081,"score_spread":0.3518765350443291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174342652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99318904,0.0036362505,0.0003255423,0.0014302917,0.0005963074,0.0005848417,0.00007225207,0.000016192018,0.00014927094],"genre_scores_gemma":[0.9929133,0.0014316496,0.0030934466,0.0011416003,0.00037308945,0.0000281256,0.000032634474,0.000061523104,0.00092465035],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99589056,0.00077884767,0.0016340315,0.0004112574,0.0006715424,0.00061375246],"domain_scores_gemma":[0.99100786,0.0056792595,0.0010665596,0.0005227606,0.0010835908,0.0006399941],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001419191,0.00025905613,0.0017284644,0.0002726973,0.000059550395,0.000021213214,0.00031814055,0.00014694397,0.000052836953],"category_scores_gemma":[0.021917574,0.00021288962,0.0008348388,0.0005484432,0.0007561502,0.000102616024,0.00008706718,0.00081442646,0.000020900648],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26898447,0.0174318,0.42677784,0.00048074767,0.0050148102,0.02255931,0.00410682,0.000021089896,0.0016785683,0.0003165271,0.09351926,0.15910876],"study_design_scores_gemma":[0.5141823,0.055816934,0.22198053,0.00053982576,0.0014188961,0.0031437497,0.012318325,0.00017908146,0.0043413197,0.0013684389,0.18439221,0.0003183677],"about_ca_topic_score_codex":0.000020294345,"about_ca_topic_score_gemma":0.000007067984,"teacher_disagreement_score":0.24519785,"about_ca_system_score_codex":0.00006213988,"about_ca_system_score_gemma":0.0015748942,"threshold_uncertainty_score":0.9863212},"labels":[],"label_agreement":null},{"id":"W3176714232","doi":"10.1002/ajh.26282","title":"Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone","year":2021,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary; University of Alberta","funders":"Karyopharm Therapeutics","keywords":"Medicine; Bortezomib; Multiple myeloma; Internal medicine; Dexamethasone; Family medicine; Library science; Gerontology","score_opus":0.011060448868156745,"score_gpt":0.24692227025848532,"score_spread":0.23586182139032857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176714232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98215383,0.002385633,0.000066481814,0.014722058,0.000049528833,0.0005474845,0.000018180997,0.000023247041,0.00003356615],"genre_scores_gemma":[0.9698151,0.0007062731,0.0014810602,0.02714143,0.00025857068,0.000040439998,0.00028158017,0.000115542665,0.00016001027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963158,0.0010881562,0.0008511874,0.0005652929,0.0004799463,0.00069963664],"domain_scores_gemma":[0.99711156,0.0008327333,0.0008429149,0.0002991592,0.00056772854,0.0003459017],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003383594,0.00052194216,0.0019758523,0.0005787641,0.00008716638,0.000048728987,0.000105483916,0.00027347292,0.000048448117],"category_scores_gemma":[0.0007470364,0.00037341335,0.00013445214,0.00049240753,0.0005478206,0.00010839633,0.00006153553,0.0016163689,0.0000014471682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019273999,0.00027855168,0.9343681,0.00020943569,0.00078603317,0.01938028,0.00021339474,0.0000015442106,0.0000353859,3.3952244e-7,0.0048412425,0.037958343],"study_design_scores_gemma":[0.02781411,0.029923001,0.88987815,0.0024173113,0.0011724725,0.032525446,0.0006013999,0.0009314333,0.00015268219,0.000004174452,0.013760135,0.00081970094],"about_ca_topic_score_codex":0.00039231352,"about_ca_topic_score_gemma":0.00012348285,"teacher_disagreement_score":0.044489916,"about_ca_system_score_codex":0.00017369456,"about_ca_system_score_gemma":0.00027938944,"threshold_uncertainty_score":0.9998718},"labels":[],"label_agreement":null},{"id":"W3191391516","doi":"10.1002/ajh.26310","title":"Diagnostic work‐up for severe aplastic anemia in children: Consensus of the <scp>North American Pediatric Aplastic Anemia Consortium</scp>","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Aplastic anemia; Hematologist; Bone marrow failure; Anemia; Pediatrics; Bone marrow; Myelodysplastic syndromes; Intensive care medicine; Internal medicine; Haematopoiesis; Disease; Stem cell","score_opus":0.00793597049063087,"score_gpt":0.24326854051857652,"score_spread":0.23533257002794566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191391516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688816,0.0008139648,0.0007454613,0.0005027198,0.0004041377,0.000512185,0.000047006935,0.000015724841,0.000070659786],"genre_scores_gemma":[0.9968109,0.0003559431,0.0022513813,0.00031219074,0.00013733518,0.000020116462,0.00001888657,0.000048067865,0.00004514963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687517,0.0003612775,0.0014145926,0.00034509305,0.00043850442,0.0005653774],"domain_scores_gemma":[0.9870332,0.010204252,0.0016618946,0.00037571514,0.00046276095,0.0002621813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028751235,0.00031241836,0.0014903088,0.00034440786,0.00006469627,0.0000106770585,0.00025610236,0.00008898841,0.000026156871],"category_scores_gemma":[0.0046704686,0.00024481866,0.00029360972,0.0016397306,0.0008923835,0.000035365287,0.00004065348,0.0005899531,0.000009229798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018187,0.00021715798,0.9955788,0.0003876399,0.00013987983,0.00053177145,0.0005649263,0.00028611236,0.00016411253,0.00008102469,0.0012101497,0.0006565068],"study_design_scores_gemma":[0.0036338808,0.0011450016,0.94644123,0.00033817207,0.0011139365,0.04329233,0.0017435197,0.000032234268,0.0020347377,0.000047408266,0.000048272464,0.0001292514],"about_ca_topic_score_codex":0.000035769317,"about_ca_topic_score_gemma":0.000076040866,"teacher_disagreement_score":0.04913759,"about_ca_system_score_codex":0.00008898553,"about_ca_system_score_gemma":0.0010095633,"threshold_uncertainty_score":0.99834156},"labels":[],"label_agreement":null},{"id":"W3195845985","doi":"10.1002/ajh.26323","title":"The International Hemoglobinopathy Research Network (<scp>INHERENT</scp>): An international initiative to study the role of genetic modifiers in hemoglobinopathies","year":2021,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"H2020 Marie Skłodowska-Curie Actions; European Regional Development Fund; Consumers, Health and Food Executive Agency; National Heart, Lung, and Blood Institute; Research and Innovation Foundation; European Commission","keywords":"Hemoglobinopathy; Medicine; Thalassemia; Hemolytic anemia; Internal medicine","score_opus":0.029790262350011795,"score_gpt":0.32182424314323804,"score_spread":0.29203398079322623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195845985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7965741,0.0047062715,0.000044803706,0.19331369,0.0018842813,0.0010630476,0.00002469162,0.000014464556,0.0023746414],"genre_scores_gemma":[0.9365384,0.0022151412,0.00083849486,0.058024675,0.0019863697,0.00010100346,0.000042319458,0.00010164396,0.00015197284],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99295044,0.0019012337,0.0018055069,0.00054858136,0.0018052893,0.0009889279],"domain_scores_gemma":[0.993732,0.002120204,0.0014005698,0.00078209053,0.0017496642,0.000215504],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0024008378,0.00044060173,0.0013866749,0.00073435897,0.00027976028,0.00011321903,0.0018740507,0.0003828976,0.00003672136],"category_scores_gemma":[0.0016134888,0.00027537716,0.00034878834,0.0012881595,0.0012489195,0.0001260155,0.000534336,0.0045565246,0.000013742785],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018084166,0.003444058,0.31145445,0.00012136504,0.008189431,0.022078246,0.03661105,0.002083206,0.00042093228,0.000991348,0.5260795,0.08671803],"study_design_scores_gemma":[0.006081405,0.013444898,0.051928475,0.0015103343,0.00081779895,0.018470649,0.3627464,0.00062695506,0.0009216089,0.0046551446,0.5382076,0.00058872387],"about_ca_topic_score_codex":0.00020941849,"about_ca_topic_score_gemma":0.000081410275,"teacher_disagreement_score":0.32613534,"about_ca_system_score_codex":0.0003132535,"about_ca_system_score_gemma":0.0009913053,"threshold_uncertainty_score":0.99996984},"labels":[],"label_agreement":null},{"id":"W3201926699","doi":"10.1002/ajh.26368","title":"Tracking immature reticulocyte proteins for improved detection of recombinant human erythropoietin (rhEPO) abuse","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency; Partnership for Clean Competition","keywords":"Erythropoietin; Reticulocyte; Erythropoiesis; Medicine; Biomarker; Hemoglobin; Internal medicine; Transferrin receptor; Endocrinology; Pharmacology; Immunology; Transferrin; Anemia; Chemistry; Biochemistry","score_opus":0.011658667282752288,"score_gpt":0.2895959310689638,"score_spread":0.27793726378621153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201926699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904494,0.0011518063,0.0030101272,0.0045630485,0.0003832819,0.00035505838,0.0000029793275,0.000016785856,0.00006750152],"genre_scores_gemma":[0.97931504,0.00031836957,0.01987845,0.00016383322,0.0001076737,0.00001505599,0.000007856403,0.000032548814,0.00016119632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984625,0.00010925588,0.00079322903,0.00020756832,0.00015074848,0.0002766729],"domain_scores_gemma":[0.9977828,0.0001257543,0.0010626242,0.00024840864,0.00065013557,0.0001302651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024861982,0.00017852681,0.0009899441,0.00013009881,0.00009271918,0.000008636633,0.00008066547,0.00010280073,0.000046301164],"category_scores_gemma":[0.00020196933,0.00013805964,0.00036505883,0.00023369004,0.00034182312,0.000049582275,0.000017079801,0.00033033759,0.0000014197542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017102637,0.0011291946,0.002038885,0.0004531133,0.0005659288,0.00067007414,0.001457152,0.0000017731262,0.95975685,0.00042047442,0.00044587997,0.03135043],"study_design_scores_gemma":[0.004845722,0.00875819,0.0024785292,0.00074121624,0.0004630203,0.019289048,0.003986804,0.000034086395,0.9555187,0.00041812638,0.0032717308,0.0001948157],"about_ca_topic_score_codex":0.00003352002,"about_ca_topic_score_gemma":0.000034062123,"teacher_disagreement_score":0.031155614,"about_ca_system_score_codex":0.00009376832,"about_ca_system_score_gemma":0.00018954484,"threshold_uncertainty_score":0.56299084},"labels":[],"label_agreement":null},{"id":"W3205845588","doi":"10.1002/ajh.26377","title":"A population‐based study of outcomes in polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the United States from 2001 to 2015: Comparison with data from a Mayo Clinic single institutional series","year":2021,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Myelofibrosis; Polycythemia vera; Essential thrombocythemia; Medicine; Population; Internal medicine; Oncology; Relative survival; Myeloproliferative neoplasm; Myeloid leukemia; Immunology; Epidemiology; Bone marrow; Cancer registry","score_opus":0.049623567506686936,"score_gpt":0.34078069779412856,"score_spread":0.2911571302874416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205845588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90674734,0.00036579082,0.000060999842,0.091859765,0.000083777726,0.00047441424,0.00039624813,0.00000428047,0.0000073617102],"genre_scores_gemma":[0.9515143,0.0000762956,0.0058764126,0.037835382,0.00016395346,0.00003486702,0.004457313,0.000031856882,0.000009606488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691206,0.0006003587,0.0012024603,0.00044327983,0.00056834973,0.00027350523],"domain_scores_gemma":[0.996514,0.0015858052,0.0010686785,0.0005831884,0.00016717734,0.000081120335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023714278,0.00035035875,0.0023545434,0.0005020152,0.000052513522,0.000031590887,0.0003241774,0.000145068,0.00014239145],"category_scores_gemma":[0.00013800208,0.00022159996,0.00007588833,0.0005088129,0.0002697999,0.00011219816,0.00012522459,0.00088154734,0.0000018664324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015762985,0.0023403415,0.97174543,0.00004940606,0.000895552,0.0016536377,0.0020794289,0.00007082897,0.000040110026,0.0000016670284,0.01945647,0.000090803085],"study_design_scores_gemma":[0.0075230785,0.006156316,0.9716677,0.0012396623,0.0009995353,0.00049031724,0.008483615,0.00005707922,0.00022435297,0.0000361512,0.0028019971,0.0003202082],"about_ca_topic_score_codex":0.009765232,"about_ca_topic_score_gemma":0.0045602815,"teacher_disagreement_score":0.05402438,"about_ca_system_score_codex":0.00016589709,"about_ca_system_score_gemma":0.000466878,"threshold_uncertainty_score":0.99682885},"labels":[],"label_agreement":null},{"id":"W3210624555","doi":"10.1002/ajh.26400","title":"Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non‐Hodgkin lymphomas: A phase <scp>IB</scp>/<scp>II</scp> study","year":2021,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Roche","keywords":"Medicine; Internal medicine; Obinutuzumab; Tolerability; Rituximab; Oncology; Bendamustine; Antibody-drug conjugate; Lymphoma; Phases of clinical research; Follicular lymphoma; Refractory (planetary science); Gastroenterology; Chemotherapy; Immunology; Adverse effect; Monoclonal antibody; Antibody; Biology","score_opus":0.01415377187334877,"score_gpt":0.29010160797930074,"score_spread":0.27594783610595197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210624555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719665,0.010889613,0.00013019789,0.013812247,0.0008643595,0.0016927723,0.00016655533,0.00003619454,0.00044154195],"genre_scores_gemma":[0.9531329,0.0025255813,0.0027562587,0.038266037,0.0018084462,0.0001357229,0.00029261305,0.00028487178,0.0007975424],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938928,0.0005911422,0.0026031202,0.0009683263,0.00089560024,0.0010490065],"domain_scores_gemma":[0.98593897,0.0075799534,0.00418082,0.0009937162,0.0008245435,0.00048197422],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057553325,0.0010198666,0.005179494,0.00090905745,0.0002393951,0.00004312677,0.0004956771,0.00068672927,0.000022377126],"category_scores_gemma":[0.0024797767,0.00082946644,0.0010986598,0.0005914439,0.00084025366,0.00013376847,0.00024543543,0.0014352524,0.000009480586],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023159424,0.019630114,0.020680051,0.0014893843,0.017448626,0.04124773,0.014738021,0.000013945481,0.0009805574,0.00013933178,0.8449269,0.036389425],"study_design_scores_gemma":[0.10507799,0.07705944,0.0110657755,0.0024996197,0.008025249,0.03676284,0.018656164,0.000054014323,0.0050734053,0.00009371917,0.7352027,0.00042908042],"about_ca_topic_score_codex":0.00016365187,"about_ca_topic_score_gemma":0.000012749265,"teacher_disagreement_score":0.109724164,"about_ca_system_score_codex":0.0011246942,"about_ca_system_score_gemma":0.0027941603,"threshold_uncertainty_score":0.99941564},"labels":[],"label_agreement":null},{"id":"W4200605356","doi":"10.1002/ajh.26434","title":"Efficacy and tolerability of <scp>once‐weekly</scp> selinexor, bortezomib, and dexamethasone in comparison with standard <scp>twice‐weekly</scp> bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the <scp>BOSTON</scp> study","year":2021,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"Karyopharm Therapeutics","keywords":"Medicine; Bortezomib; Dexamethasone; Multiple myeloma; Internal medicine; Population; Pharmacology; Nephrotoxicity; Renal function; Tolerability; Oncology; Kidney; Adverse effect","score_opus":0.01931272400488909,"score_gpt":0.29232031986818535,"score_spread":0.27300759586329626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200605356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98151726,0.010592007,0.00038629846,0.0040840995,0.00004820311,0.0030027584,0.00029717237,0.00003923164,0.000033002136],"genre_scores_gemma":[0.98949575,0.0014304611,0.005966009,0.0021020307,0.00022037387,0.00015282138,0.00039944387,0.00016451461,0.00006857338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9881267,0.0033649052,0.0030686858,0.0018375996,0.00187885,0.0017232725],"domain_scores_gemma":[0.9769798,0.016416868,0.003424283,0.0013668234,0.00096414285,0.000848076],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0023840694,0.0014479562,0.007811993,0.0016677537,0.00022425951,0.00016908164,0.0006157887,0.0006331663,0.000016341619],"category_scores_gemma":[0.0037208123,0.00094727764,0.00040998132,0.0031544862,0.0024706558,0.0002823892,0.000352716,0.0039339457,0.000001328868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00197108,0.002696073,0.9592174,0.00032374606,0.010279067,0.008896335,0.00897672,0.000063327316,0.000240999,0.0000010659697,0.0032292213,0.0041049058],"study_design_scores_gemma":[0.0319764,0.02199393,0.9106079,0.0013326268,0.006533222,0.002831516,0.021370683,0.0007717282,0.00074904534,0.00001448886,0.0016160528,0.00020241221],"about_ca_topic_score_codex":0.0065779993,"about_ca_topic_score_gemma":0.0068899444,"teacher_disagreement_score":0.048609562,"about_ca_system_score_codex":0.0005265865,"about_ca_system_score_gemma":0.0009764071,"threshold_uncertainty_score":0.999827},"labels":[],"label_agreement":null},{"id":"W4205503064","doi":"10.1002/ajh.26465","title":"Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta‐analysis","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Cancer Prevention and Research Institute of Texas","keywords":"Disease; Malignancy; Hematologic malignancy; Myeloid; Allele; Hematologic disease; Hematology; Genetic association; Haematopoiesis","score_opus":0.03151317610258437,"score_gpt":0.3728961058598902,"score_spread":0.34138292975730583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205503064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77418196,0.08325445,0.0040598195,0.13461332,0.00012063176,0.003187908,0.00014701608,0.000048570426,0.00038632948],"genre_scores_gemma":[0.98924434,0.0012278229,0.0059509235,0.0031174847,0.000009458038,0.000084384505,0.000008489452,0.00002035071,0.00033674538],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99631953,0.0011847882,0.001466734,0.00015620647,0.000681592,0.000191146],"domain_scores_gemma":[0.9942856,0.0021655932,0.0026176241,0.00026033897,0.0005197924,0.00015107967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027119094,0.00013078423,0.004615956,0.0004355262,0.00007200153,0.000004761393,0.0001648464,0.000030092197,0.00044769482],"category_scores_gemma":[0.0013248431,0.000081857215,0.0008628873,0.0011594838,0.00025797955,0.00004962134,0.00007288309,0.0005089697,0.0000021500152],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032114025,0.00058194523,0.2998836,0.038184326,0.6571503,0.0005852023,0.00047261486,0.000035365272,0.000008123212,0.0006864768,0.0020681622,0.000022720013],"study_design_scores_gemma":[0.0013554166,0.0023827958,0.008188247,0.00048733794,0.9755946,0.008760431,0.0028894173,0.000053952426,0.0000140417815,0.000078182406,0.000052606716,0.0001430015],"about_ca_topic_score_codex":0.000035050398,"about_ca_topic_score_gemma":0.000010430817,"teacher_disagreement_score":0.31844425,"about_ca_system_score_codex":0.00016697294,"about_ca_system_score_gemma":0.00038415127,"threshold_uncertainty_score":0.4901944},"labels":[],"label_agreement":null},{"id":"W4210289504","doi":"10.1002/ajh.26481","title":"Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Leukocytosis; Ruxolitinib; Monocytosis; Chronic myelomonocytic leukemia; Immunology; Oncology; Disease; Myelodysplastic syndromes; Cancer research; Bioinformatics; Myelofibrosis; Bone marrow; Internal medicine; Biology","score_opus":0.00728513728808696,"score_gpt":0.24919690401785277,"score_spread":0.2419117667297658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210289504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97905934,0.00868192,0.000009276753,0.011139521,0.00018313465,0.00044920176,0.000013311413,0.000014909491,0.00044937935],"genre_scores_gemma":[0.98559713,0.011359305,0.0004842846,0.0019778905,0.00014238073,0.00035100884,0.000013494515,0.00003014145,0.00004437377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983733,0.00018793537,0.00049689715,0.00029403198,0.00031892635,0.0003288744],"domain_scores_gemma":[0.9988884,0.00015278059,0.0004972123,0.00021079877,0.000056411198,0.00019445266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022103709,0.00021787877,0.00079449045,0.00033072903,0.0001917611,0.000013698064,0.00014068582,0.00002615101,0.00053446414],"category_scores_gemma":[0.000013889755,0.00017355537,0.00014308633,0.0002646987,0.00016881146,0.000037735474,0.00015170666,0.00042981614,0.000019672598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012396611,0.0013383355,0.85272497,0.00019918887,0.002013195,0.0066224905,0.00033363674,0.00034753617,0.00016700079,0.012647181,0.025314424,0.09705239],"study_design_scores_gemma":[0.017343104,0.052767422,0.5822427,0.00042902355,0.002105205,0.042676676,0.002810697,0.00021264082,0.004229535,0.00065099914,0.29363456,0.0008973684],"about_ca_topic_score_codex":0.00001150118,"about_ca_topic_score_gemma":0.0000074183,"teacher_disagreement_score":0.2704822,"about_ca_system_score_codex":0.0004506289,"about_ca_system_score_gemma":0.00019151716,"threshold_uncertainty_score":0.7077383},"labels":[],"label_agreement":null},{"id":"W4210974090","doi":"10.1002/ajh.26493","title":"Immunogenicity of a 5‐dose pneumococcal vaccination schedule following allogeneic hematopoietic stem cell transplantation","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"St. Antonius Ziekenhuis; ZonMw","keywords":"Medicine; Pneumococcal polysaccharide vaccine; Pneumococcal conjugate vaccine; Immunogenicity; Vaccination; Hematopoietic stem cell transplantation; Immunology; Pneumococcal vaccine; Transplantation; Serotype; Vaccination schedule; Pneumococcal infections; Internal medicine; Streptococcus pneumoniae; Antibody; Immunization; Pneumococcal disease; Antibiotics","score_opus":0.010245731203748954,"score_gpt":0.26769308146892973,"score_spread":0.2574473502651808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210974090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717414,0.00052203686,0.0010176146,0.0006592162,0.00028970098,0.00015359203,0.000005190546,0.00001404714,0.00016445942],"genre_scores_gemma":[0.99944085,0.000057050227,0.00021924905,0.0002013379,0.00002482706,0.000013809312,0.0000037478153,0.00001798652,0.000021147955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983841,0.00028260046,0.00070096663,0.00013209826,0.00030318354,0.00019700703],"domain_scores_gemma":[0.9987285,0.00013067687,0.0007589397,0.00016031705,0.00012140086,0.00010016573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037503164,0.00012430437,0.0006451164,0.00033596973,0.00014861349,0.0000038479775,0.00013369192,0.000038265443,0.000105281484],"category_scores_gemma":[0.000014371837,0.000112015536,0.00036997703,0.0004272233,0.00007372243,0.000071558425,0.000028535043,0.00036779075,0.0000036453882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006769902,0.0010576393,0.14736669,0.00024282781,0.00047376665,0.000980467,0.0024628856,0.0005820412,0.84062093,0.00038664974,0.00003308623,0.005116014],"study_design_scores_gemma":[0.01659792,0.023244238,0.33805236,0.00033557805,0.00354427,0.1339437,0.026717713,0.0002941423,0.4530481,0.0005069169,0.0027529006,0.0009621547],"about_ca_topic_score_codex":0.00000938579,"about_ca_topic_score_gemma":0.0000019981605,"teacher_disagreement_score":0.38757282,"about_ca_system_score_codex":0.00009414593,"about_ca_system_score_gemma":0.00026921296,"threshold_uncertainty_score":0.4567861},"labels":[],"label_agreement":null},{"id":"W4211256599","doi":"10.1002/ajh.26492","title":"A predictive algorithm for identifying children with sickle cell anemia among children admitted to hospital with severe anemia in Africa","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Institutes of Health; Department for International Development; National Institute for Health and Care Research; Medical Research Council Canada; University College London; Wellcome Trust","keywords":"Medicine; Anemia; Sickle cell anemia; Pediatrics; Malaria; Blood transfusion; Algorithm; Internal medicine; Disease; Immunology","score_opus":0.003990007576450975,"score_gpt":0.21823796224987302,"score_spread":0.21424795467342203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211256599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358135,0.00046841492,0.0038865579,0.00075958483,0.00007135594,0.0009548401,0.000041081847,0.000025335516,0.00021146549],"genre_scores_gemma":[0.9888782,0.000025765405,0.010570351,0.00027145373,0.000049610873,0.000063369145,0.000026174052,0.000053521355,0.00006156035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980915,0.000112524795,0.000542817,0.00032767016,0.00040181997,0.0005236268],"domain_scores_gemma":[0.9985901,0.00008907408,0.0006544363,0.00020441349,0.00017028594,0.0002916889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024360271,0.00024477646,0.0008649376,0.00041575116,0.00015196775,0.000012945033,0.00022576828,0.00006491149,0.000054686752],"category_scores_gemma":[0.000036149988,0.00018191138,0.00012091262,0.0008414306,0.00027388023,0.000098171324,0.00008093233,0.00077354873,0.0000019920785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002060846,0.00076683995,0.97796977,0.000036123954,0.00045947102,0.0007122469,0.00423339,0.0013975402,0.00007265624,0.000011440867,0.0015741107,0.010705598],"study_design_scores_gemma":[0.015397649,0.039438136,0.8870976,0.0003450439,0.0007359459,0.029973803,0.025127815,0.0003824018,0.0005447478,0.000046740766,0.00019725242,0.0007128584],"about_ca_topic_score_codex":0.00017117982,"about_ca_topic_score_gemma":0.000015394944,"teacher_disagreement_score":0.09087213,"about_ca_system_score_codex":0.00015964622,"about_ca_system_score_gemma":0.00036074597,"threshold_uncertainty_score":0.74181306},"labels":[],"label_agreement":null},{"id":"W4212859128","doi":"10.1002/ajh.26500","title":"Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volume","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Dalhousie University; University Health Network; University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation; Genome Canada","keywords":"Medicine; Internal medicine; Hazard ratio; Refractory (planetary science); Oncology; Gastroenterology; Transplantation; Lymphoma; Classical Hodgkin lymphoma; Salvage therapy; Confidence interval; Chemotherapy; Hodgkin lymphoma","score_opus":0.011533827656359238,"score_gpt":0.2596016456974174,"score_spread":0.24806781804105815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212859128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409324,0.002853834,0.0005763835,0.0018551394,0.00016502159,0.0002985849,0.00006613581,0.00001465288,0.000076985176],"genre_scores_gemma":[0.99274755,0.00028217168,0.0064149103,0.00028631891,0.000098795426,0.00008589633,0.00002809303,0.000023355087,0.00003288838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834985,0.00027393206,0.00062331004,0.00023595057,0.0002672488,0.0002497161],"domain_scores_gemma":[0.9981949,0.00044545715,0.0008786297,0.00017754278,0.00013055999,0.00017291823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004182006,0.00017043599,0.00076220994,0.00018741122,0.0002251859,0.00001551133,0.000106572545,0.000033353554,0.000041570653],"category_scores_gemma":[0.00021079456,0.00013008023,0.00015787825,0.00016826559,0.000259871,0.00007135522,0.00002863836,0.0002284732,0.0000021473986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00436778,0.0024385361,0.75473034,0.00010943646,0.0013238707,0.001249612,0.002448516,0.000022903312,0.0023577856,0.014194859,0.0059880097,0.21076833],"study_design_scores_gemma":[0.020819224,0.03320059,0.81002307,0.00030782953,0.0034552573,0.060363196,0.014480543,0.0016108691,0.007484751,0.0015839207,0.04597384,0.0006969031],"about_ca_topic_score_codex":0.000079958576,"about_ca_topic_score_gemma":0.000020933276,"teacher_disagreement_score":0.21007143,"about_ca_system_score_codex":0.00013398826,"about_ca_system_score_gemma":0.0003647352,"threshold_uncertainty_score":0.5304518},"labels":[],"label_agreement":null},{"id":"W4213100173","doi":"10.1002/ajh.21294","title":"2nd Mayo/NASCOLA Coagulation Testing Quality Conference","year":2008,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; University of Waterloo; McMaster University","funders":"","keywords":"Citation; Quality (philosophy); Information retrieval; Computer science; Library science; Medicine; Philosophy; Epistemology","score_opus":0.07455863133513141,"score_gpt":0.30334295183456406,"score_spread":0.22878432049943265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213100173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98299193,0.000051463507,0.0022600247,0.0034343589,0.00022807141,0.000053217558,3.869447e-7,0.00003347991,0.01094709],"genre_scores_gemma":[0.9952782,0.00001527325,0.0028358125,0.0016683387,0.000157303,0.0000012505851,0.000001369942,0.000009135844,0.000033315817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989044,0.000053170672,0.0005378243,0.0001137175,0.000241161,0.00014974552],"domain_scores_gemma":[0.99760574,0.0003226788,0.0013186631,0.00009794864,0.0006357939,0.000019185387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047989126,0.00009853526,0.0003551256,0.0002143014,0.00016096943,0.000046751928,0.00016399831,0.000030398325,0.00027911502],"category_scores_gemma":[0.00059988745,0.00008543844,0.000064403794,0.0004381344,0.00023566592,0.000920793,0.000028641325,0.00018792943,0.000054836953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029894087,0.00039988186,0.7845962,0.00009012682,0.00013358712,0.00025930977,0.00038809967,0.00007983407,0.001524504,0.13635299,0.0020454952,0.073831044],"study_design_scores_gemma":[0.0042446856,0.00039396962,0.89241266,0.00018546601,0.0003029561,0.0060802614,0.0052249124,0.003702214,0.0008350789,0.013928369,0.071813166,0.00087628636],"about_ca_topic_score_codex":0.00035883143,"about_ca_topic_score_gemma":0.0000430897,"teacher_disagreement_score":0.12242462,"about_ca_system_score_codex":0.000008301273,"about_ca_system_score_gemma":0.00006573619,"threshold_uncertainty_score":0.34840783},"labels":[],"label_agreement":null},{"id":"W4213242181","doi":"10.1002/ajh.26505","title":"Myeloid neoplasm with <scp>PDGFRB</scp> rearrangement, presenting as systemic mastocytosis‐chronic eosinophilic leukemia","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Surrey Memorial Hospital; Royal Columbian Hospital","funders":"","keywords":"Medicine; Pathology; Systemic mastocytosis; Bone marrow; Neutrophilia; Eosinophilia; Myelofibrosis; Extramedullary hematopoiesis; Eosinophilic; Leukemia; Immunology; Haematopoiesis; Biology","score_opus":0.007780135260848282,"score_gpt":0.2418526578116358,"score_spread":0.23407252255078753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213242181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894017,0.0039687157,0.00015725872,0.0015897743,0.00026151218,0.00036756025,0.0000049945706,0.000041727988,0.004206762],"genre_scores_gemma":[0.9971303,0.0002445577,0.0005494751,0.0006254735,0.00014479195,0.00004519562,0.0000073633355,0.000064732696,0.001188139],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9971308,0.00031486398,0.00086506625,0.00035238537,0.0007016937,0.0006351592],"domain_scores_gemma":[0.9975067,0.00032668933,0.0012836936,0.00042319545,0.000179331,0.00028043598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005044995,0.00029811639,0.0012858511,0.0004626493,0.00026906384,0.00002628553,0.0003846318,0.000054039283,0.00018523395],"category_scores_gemma":[0.00016239223,0.00024127444,0.00024038377,0.0006585549,0.00044770903,0.000120964505,0.00016562192,0.0008172352,0.000028085577],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00247482,0.0025764345,0.7480372,0.00302474,0.008586847,0.036780637,0.023595521,0.0043491987,0.052788094,0.011377286,0.058779657,0.04762955],"study_design_scores_gemma":[0.012837542,0.03112304,0.016428076,0.0013357466,0.0016439998,0.7919682,0.08504624,0.0004983879,0.0030562358,0.0009798222,0.05447421,0.00060846057],"about_ca_topic_score_codex":0.000101758786,"about_ca_topic_score_gemma":0.000010674512,"teacher_disagreement_score":0.75518763,"about_ca_system_score_codex":0.0005066255,"about_ca_system_score_gemma":0.0011073337,"threshold_uncertainty_score":0.9838886},"labels":[],"label_agreement":null},{"id":"W4213365409","doi":"10.1002/ajh.26508","title":"Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open‐label study","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Autoimmune hemolytic anemia; Adverse effect; Anemia; Internal medicine; Clinical endpoint; Gastroenterology; Haptoglobin; Syk; Clinical trial; Tyrosine kinase","score_opus":0.03779419354714667,"score_gpt":0.3875418852873847,"score_spread":0.349747691740238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213365409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924096,0.0019834961,0.0007783066,0.0030503832,0.00027514237,0.0014439477,0.000022074668,0.0000064172364,0.00003065829],"genre_scores_gemma":[0.9977637,0.00026479436,0.0015075514,0.00028441835,0.000034519602,0.000066513116,0.000008891972,0.000022737504,0.00004690849],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9985061,0.00015350536,0.0007275601,0.00015656136,0.0002346966,0.00022151899],"domain_scores_gemma":[0.998292,0.00046520316,0.00071685057,0.00030415182,0.00014333887,0.00007844783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038296284,0.00015142662,0.0009905071,0.00011766437,0.00020464462,0.00000860731,0.000300998,0.000018306539,0.00009820379],"category_scores_gemma":[0.000034076398,0.00009186651,0.00016191458,0.00023386844,0.0001834624,0.000043602446,0.00006404024,0.00019377872,8.174009e-7],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043857753,0.25228843,0.07020084,0.0003423733,0.006147634,0.0037066115,0.032720104,0.000065182976,0.05799196,0.0007864496,0.0011854076,0.53070724],"study_design_scores_gemma":[0.33741662,0.4728967,0.011071581,0.0002275497,0.0075422605,0.02435426,0.10181051,0.0034908608,0.01656655,0.00016539962,0.023903329,0.0005543809],"about_ca_topic_score_codex":0.0002023811,"about_ca_topic_score_gemma":0.0000066221105,"teacher_disagreement_score":0.53015286,"about_ca_system_score_codex":0.00006187513,"about_ca_system_score_gemma":0.0001495434,"threshold_uncertainty_score":0.37462074},"labels":[],"label_agreement":null},{"id":"W4220684932","doi":"10.1002/ajh.26534","title":"A t(6;14;9)(p22;q22;q34) <scp>three‐way</scp> translocation: Description of a cytogenetically visible variant t(6;9) in acute myeloid leukemia","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Chromosomal translocation; Myeloid leukemia; Medicine; Myeloid; Biology; Cancer research; Gene; Genetics","score_opus":0.01851038053093702,"score_gpt":0.2822152237193325,"score_spread":0.2637048431883955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220684932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800602,0.001435089,0.013494438,0.0035226233,0.00020882687,0.00045011824,0.000018705241,0.000024167086,0.00078579935],"genre_scores_gemma":[0.98696184,0.00065760774,0.011153636,0.00082610024,0.00009582547,0.00005433205,0.000014518343,0.00006310729,0.00017302149],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9958153,0.00050969276,0.0015732031,0.0003976308,0.0009883224,0.0007158964],"domain_scores_gemma":[0.99713033,0.0005371483,0.0009811685,0.00050388987,0.0005025916,0.00034489293],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013814097,0.0002946562,0.0015389883,0.0011326318,0.000121059406,0.000016413209,0.0005987683,0.000118177675,0.00025023843],"category_scores_gemma":[0.00044171428,0.00027604456,0.0003161425,0.0017388914,0.000683515,0.00015777854,0.00017705484,0.0014040639,0.0000179708],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011661583,0.0045001055,0.18044685,0.00097334763,0.0056324955,0.04429204,0.018464768,0.0048657283,0.55175775,0.014629506,0.025345413,0.13743038],"study_design_scores_gemma":[0.049931865,0.05856628,0.18713889,0.0014191624,0.0027653484,0.50763685,0.031965565,0.019824114,0.09807149,0.007614074,0.03377365,0.00129275],"about_ca_topic_score_codex":0.0002866806,"about_ca_topic_score_gemma":0.000058189355,"teacher_disagreement_score":0.46334478,"about_ca_system_score_codex":0.0011164991,"about_ca_system_score_gemma":0.002470699,"threshold_uncertainty_score":0.9999692},"labels":[],"label_agreement":null},{"id":"W4220971510","doi":"10.1002/ajh.26536","title":"Health‐related quality of life in patients with <scp>light chain</scp> amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the <scp>ANDROMEDA</scp> study","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada; Alberta Health Services","funders":"Janssen Research and Development","keywords":"Medicine; Andromeda; Daratumumab; Internal medicine; Bortezomib; Population; Amyloidosis; Cyclophosphamide; Oncology; Multiple myeloma; Chemotherapy","score_opus":0.008644266222533767,"score_gpt":0.24692164534710165,"score_spread":0.23827737912456787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220971510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454534,0.0035985166,0.000011303157,0.0007753302,0.000074843316,0.00070788997,0.00021465361,0.0000117445115,0.000060362498],"genre_scores_gemma":[0.998472,0.0003730492,0.00033126256,0.0005081907,0.00002043115,0.00007077096,0.00012539663,0.00005666412,0.000042254607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99549127,0.0011459889,0.0016346757,0.0006262163,0.0005555411,0.0005463381],"domain_scores_gemma":[0.9944428,0.0012354039,0.003167327,0.00064978027,0.00022614257,0.0002785258],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000977288,0.0004327395,0.0016814336,0.00020192006,0.0002358661,0.000019588328,0.00048147517,0.000096051226,0.0000066613707],"category_scores_gemma":[0.0009955666,0.00028746575,0.00013838035,0.0007608496,0.0005414881,0.000018455834,0.00023551076,0.0004982889,9.225165e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096575124,0.0017466111,0.9908326,0.000012078114,0.0013373564,0.00006710462,0.0029802923,0.00009399257,0.00013474359,0.000009821488,0.00088861363,0.0009309884],"study_design_scores_gemma":[0.012985119,0.0120144775,0.9596095,0.00004812137,0.00017178313,0.00011717227,0.013350799,0.000003600122,0.001056625,0.00001180662,0.0005368517,0.00009410663],"about_ca_topic_score_codex":0.002762643,"about_ca_topic_score_gemma":0.00066886697,"teacher_disagreement_score":0.031223109,"about_ca_system_score_codex":0.0001035221,"about_ca_system_score_gemma":0.0003343893,"threshold_uncertainty_score":0.99995774},"labels":[],"label_agreement":null},{"id":"W4230800436","doi":"10.1002/ajh.25128","title":"Issue Information – Table of Contents","year":2018,"lang":"en","type":"paratext","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Table (database); Citation; Information retrieval; Computer science; Table of contents; World Wide Web; Library science; Database","score_opus":0.012158247047930275,"score_gpt":0.29746320147343985,"score_spread":0.28530495442550957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230800436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7173594,0.016102506,0.002758543,0.015258723,0.014400245,0.0024097173,0.0005914297,0.000030666703,0.23108874],"genre_scores_gemma":[0.9702319,0.0050404053,0.005505543,0.003057515,0.00097111566,0.000038127368,0.00026880056,0.000060294966,0.014826321],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812996,0.00009320539,0.001111443,0.00011217555,0.00032051225,0.00023270807],"domain_scores_gemma":[0.995711,0.00015942927,0.0026289416,0.00021892154,0.001120433,0.00016125606],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014409063,0.00024096614,0.0018588263,0.00037524203,0.000032756623,0.000009442054,0.00013640583,0.0001397294,0.0035221614],"category_scores_gemma":[0.00015601795,0.00017023864,0.0002105091,0.0002084012,0.00041572336,0.00013351008,0.000033424112,0.00030292163,0.0019102488],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083423953,0.00038864397,0.0075355787,0.00033426384,0.0014167282,0.00008203731,0.0005573465,0.0000038695002,0.000059883245,0.00018340637,0.9796249,0.008979047],"study_design_scores_gemma":[0.0030670464,0.010135679,0.0011639645,0.0012531277,0.00059836806,0.0052836156,0.0009604969,0.000009195697,0.014845833,0.00002412384,0.9624495,0.000209045],"about_ca_topic_score_codex":0.000089733694,"about_ca_topic_score_gemma":0.0000034144098,"teacher_disagreement_score":0.25287244,"about_ca_system_score_codex":0.000082033526,"about_ca_system_score_gemma":0.00039700768,"threshold_uncertainty_score":0.99886686},"labels":[],"label_agreement":null},{"id":"W4231993637","doi":"10.1002/ajh.21469","title":"Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment","year":2009,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Garcia; Medicine; Chapel; Art; Humanities; Library science; Art history; Computer science","score_opus":0.07805500487584956,"score_gpt":0.3916754681790257,"score_spread":0.31362046330317617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231993637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022757692,0.9749999,0.00004995364,0.0005794639,0.00017030157,0.001079707,0.000007856385,0.000009540565,0.00034559195],"genre_scores_gemma":[0.011355594,0.98716676,0.0011920054,0.000009586544,0.000108880806,0.000004464551,0.000042454252,0.000015795713,0.00010444187],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982773,0.00015023703,0.0011342743,0.00016323547,0.00012483087,0.00015008604],"domain_scores_gemma":[0.99773026,0.00022260481,0.0017454115,0.0001522905,0.00007372087,0.000075734264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001157478,0.00022308002,0.0024587556,0.00046463983,0.000029165632,0.000006520597,0.00005028547,0.00006496768,0.0000101123205],"category_scores_gemma":[0.00004139064,0.00015549,0.00037824074,0.00026290634,0.000101183956,0.00004620392,0.000012143027,0.00006783005,0.0000021236788],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005393172,0.00014765697,0.05430849,0.00038476757,0.00033144266,0.000012779025,0.00008094624,4.0679816e-7,2.5609364e-7,0.00014074298,0.000027694623,0.9445109],"study_design_scores_gemma":[0.0040654438,0.013005992,0.044353884,0.009166966,0.00361379,0.00058216706,0.00021992784,0.00000404376,0.0000060221896,0.000052271273,0.9246759,0.00025358543],"about_ca_topic_score_codex":0.000012242564,"about_ca_topic_score_gemma":0.0000062140034,"teacher_disagreement_score":0.9442573,"about_ca_system_score_codex":0.00027881775,"about_ca_system_score_gemma":0.00012479091,"threshold_uncertainty_score":0.6340698},"labels":[],"label_agreement":null},{"id":"W4233703217","doi":"10.1002/ajh.23701","title":"The Canadian “National Program for hemophilia mutation testing” database: A ten‐year review","year":2014,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; National database; Mutation; Database; Pediatrics; Genetics; Biology; Computer science; Gene","score_opus":0.07830894096168113,"score_gpt":0.431359321562862,"score_spread":0.3530503806011809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233703217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000046552295,0.99118507,0.000019236028,0.0058520758,0.00014489461,0.0020368889,0.000042544998,0.000013308068,0.00070134364],"genre_scores_gemma":[0.000037217997,0.9905807,0.007782078,0.00042119395,0.00039223925,0.00026943677,0.00021171293,0.000050164486,0.00025525867],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727196,0.0003189012,0.0011160637,0.00024030525,0.00055231387,0.00050044496],"domain_scores_gemma":[0.9947769,0.0018344072,0.0012813591,0.00030467423,0.0013556563,0.00044700323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017511678,0.00028968055,0.0023497646,0.00036148616,0.00027063835,0.00003194054,0.00033650454,0.00011923929,0.000027374266],"category_scores_gemma":[0.004238844,0.00015416913,0.0005645558,0.00062190974,0.00052244036,0.000039540377,0.000028150762,0.00062112533,0.000048296562],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020413681,0.00006486881,0.000056381043,0.014261042,0.0004053865,0.00018925534,0.00000466757,2.9222724e-8,3.5103394e-8,0.0006158495,0.016757218,0.96762484],"study_design_scores_gemma":[0.00037271474,0.0015590179,0.000009147533,0.025768911,0.0011752791,0.014461964,0.000012790191,0.00000977717,3.536336e-7,0.000101253194,0.95639986,0.00012892346],"about_ca_topic_score_codex":0.00047968063,"about_ca_topic_score_gemma":0.001045693,"teacher_disagreement_score":0.9674959,"about_ca_system_score_codex":0.0003916856,"about_ca_system_score_gemma":0.0059632347,"threshold_uncertainty_score":0.99967206},"labels":[],"label_agreement":null},{"id":"W4236133913","doi":"10.1002/ajh.22083","title":"Fourth Congress of the International BioIron Society (IBIS) Biennial World Meeting (BioIron 2011) May 22 – 26, 2011 Sheraton Vancouver Wall Centre Hotel Vancouver, BC, Canada","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ibis; Citation; Library science; Political science; Media studies; Law; Sociology; Computer science","score_opus":0.006774097912266287,"score_gpt":0.20366736705121546,"score_spread":0.19689326913894917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236133913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095106,0.0010475718,0.00023284327,0.0008515518,0.0053286348,0.0001397266,0.0000621295,0.000004839064,0.0013816176],"genre_scores_gemma":[0.99494684,0.00057278137,0.0021710633,0.0012692066,0.0002648864,0.000002179803,0.0000063373927,0.00003614928,0.0007305502],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847215,0.00008093406,0.00059696415,0.000254771,0.00026283532,0.00033236927],"domain_scores_gemma":[0.9980551,0.00006267482,0.0011337847,0.0003081434,0.0003089512,0.00013133741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020354401,0.00021469627,0.0004269926,0.000054081913,0.00007479525,0.000009490212,0.00060729583,0.000084261286,0.00025281566],"category_scores_gemma":[0.000059762006,0.00016808225,0.00026511925,0.000077497796,0.0003789579,0.000009378026,0.00019892634,0.00022531279,0.0000022622337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045308055,0.00020141268,0.118686214,0.000027001815,0.00052434934,0.000046479658,0.00034309662,0.00016898933,0.018854726,0.00015378458,0.8583875,0.002153381],"study_design_scores_gemma":[0.0047863326,0.0014668519,0.010853795,0.00026213,0.00040785392,0.00045319687,0.004607936,0.0004406338,0.54484314,0.00033575404,0.43035394,0.001188417],"about_ca_topic_score_codex":0.054341916,"about_ca_topic_score_gemma":0.51815736,"teacher_disagreement_score":0.52598846,"about_ca_system_score_codex":0.000111231966,"about_ca_system_score_gemma":0.000762498,"threshold_uncertainty_score":0.9519553},"labels":[],"label_agreement":null},{"id":"W4238367063","doi":"10.1002/ajh.22074","title":"Erratum to: Unexpectedly low pulse oximetry measurements associated with variant hemoglobins: A systematic review","year":2011,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Hemoglobin; Pulse oximetry; Hemoglobin variants; Asymptomatic; Medicine; Hypoxemia; Hemoglobinopathy; Hemoglobin A2; Gastroenterology; Internal medicine; Anesthesia; Hemolytic anemia","score_opus":0.02117126790640444,"score_gpt":0.28036718651291537,"score_spread":0.2591959186065109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238367063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000077731565,0.997148,0.00075092306,0.000032630964,0.00044382535,0.0010504054,0.00002545836,0.000012040774,0.00045899645],"genre_scores_gemma":[0.0013485219,0.996414,0.00070272695,0.0009881696,0.00015120594,0.000083294835,0.00011404761,0.00010195225,0.00009608144],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957649,0.0010370519,0.0018071873,0.0004993995,0.00039045312,0.00050101295],"domain_scores_gemma":[0.99471223,0.000067861736,0.0035255572,0.00073013926,0.00064667757,0.00031750786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085487886,0.0006519479,0.0048658242,0.00027645254,0.00006661075,0.00002270417,0.0006868142,0.00034035524,0.000033761917],"category_scores_gemma":[0.0012248767,0.0004257296,0.0007114046,0.000830331,0.00017380687,0.000008796018,0.00009987708,0.00051154656,0.000027611834],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037926764,0.0008006893,0.00006746789,0.8549572,0.017606178,0.0012225395,0.00014754508,0.0000021661524,0.00020588108,0.00009848798,0.027930766,0.09658181],"study_design_scores_gemma":[0.0009051219,0.0064669745,0.000008482446,0.817165,0.0147582665,0.030466905,0.000119604105,4.439321e-7,0.00018209068,0.000027066833,0.12834089,0.001559109],"about_ca_topic_score_codex":0.00000973288,"about_ca_topic_score_gemma":0.000010987673,"teacher_disagreement_score":0.100410126,"about_ca_system_score_codex":0.00012764722,"about_ca_system_score_gemma":0.00064690434,"threshold_uncertainty_score":0.99981946},"labels":[],"label_agreement":null},{"id":"W4240889406","doi":"10.1002/(sici)1096-8652(200005)64:1<82::aid-ajh20>3.3.co;2-u","title":"Decreased expression of p33ING1 mRNA in lymphoid malignancies","year":2000,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine","score_opus":0.007835042333373116,"score_gpt":0.26017268592153003,"score_spread":0.2523376435881569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240889406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967517,0.0014795766,0.000010424677,0.0006287418,0.000036879268,0.00006801664,0.000001533607,0.000004584937,0.0010185428],"genre_scores_gemma":[0.99669623,0.0006902018,0.0022341416,0.00030447496,0.000024964873,0.000004319013,0.0000012457041,0.000009375514,0.000035071356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892044,0.00007586409,0.0005445743,0.0001015608,0.00017440255,0.0001831616],"domain_scores_gemma":[0.99911416,0.00015420609,0.00038062836,0.00014886753,0.00007674055,0.0001253963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001220586,0.000106945365,0.00073181005,0.00017356413,0.000015350079,0.000002512388,0.00007935366,0.00003546566,0.00040599643],"category_scores_gemma":[0.000059334154,0.00007463806,0.00013592825,0.00018788673,0.00019798498,0.00004629226,0.000010045195,0.00006191388,0.000011450628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001083246,0.0011307661,0.93959916,0.00003607526,0.00008204069,0.0016538879,0.00045923772,0.000013806385,0.0091037685,0.00018207009,0.00064530224,0.046010636],"study_design_scores_gemma":[0.012037305,0.005298033,0.52873814,0.0018038913,0.00024793687,0.03171228,0.0014644358,0.000026921662,0.41510874,0.00036791808,0.0029552416,0.00023916073],"about_ca_topic_score_codex":0.0001645929,"about_ca_topic_score_gemma":0.000005595232,"teacher_disagreement_score":0.41086102,"about_ca_system_score_codex":0.000075411255,"about_ca_system_score_gemma":0.00019109108,"threshold_uncertainty_score":0.44453764},"labels":[],"label_agreement":null},{"id":"W4245969999","doi":"10.1002/ajh.25052","title":"ISSUE INFORMATION – TABLE OF CONTENTS","year":2018,"lang":"en","type":"paratext","venue":"American Journal of Hematology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Table (database); Citation; Information retrieval; Computer science; Table of contents; World Wide Web; Database","score_opus":0.01643390759841842,"score_gpt":0.2487697075030919,"score_spread":0.23233579990467348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245969999","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09308834,0.033345655,0.017512105,0.002983797,0.028175388,0.0005667588,0.002134313,0.000015969312,0.8221777],"genre_scores_gemma":[0.9532903,0.008428623,0.0029888595,0.002815208,0.0018608435,0.000012226608,0.000095285686,0.00009194944,0.030416716],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733037,0.000021462662,0.002134822,0.00014941527,0.0000449731,0.0003189513],"domain_scores_gemma":[0.9915267,0.00007001348,0.0076670893,0.0002718393,0.00034634199,0.00011798126],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003822504,0.00022451457,0.002044128,0.0005934612,0.000037045294,0.00002839448,0.0004778513,0.0002067529,0.0046083624],"category_scores_gemma":[0.0002242916,0.00023721262,0.00024357346,0.00021258192,0.0005126996,0.0005924788,0.00005573818,0.00032343896,0.008276706],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001905382,0.000061573846,0.0021642605,0.00013414104,0.0003558526,0.0000038266617,0.00049371214,0.000027613376,0.000002916839,0.012719828,0.97844565,0.005400105],"study_design_scores_gemma":[0.0005904614,0.000993477,0.0003258779,0.00011968626,0.000019917197,0.0001569091,0.00023050896,0.000016113976,0.00020113261,0.0016255957,0.995487,0.00023333695],"about_ca_topic_score_codex":0.00042921008,"about_ca_topic_score_gemma":0.000006429292,"teacher_disagreement_score":0.86020195,"about_ca_system_score_codex":0.00011680693,"about_ca_system_score_gemma":0.00017444314,"threshold_uncertainty_score":0.99630153},"labels":[],"label_agreement":null},{"id":"W4247033018","doi":"10.1002/ajh.24349","title":"Issue Information – Masthead","year":2016,"lang":"en","type":"paratext","venue":"American Journal of Hematology","topic":"Corporate Taxation and Avoidance","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Library science; World Wide Web; Computer science","score_opus":0.008828484369616923,"score_gpt":0.23533607091181277,"score_spread":0.22650758654219585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247033018","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025964204,0.0021240362,0.026580863,0.043372843,0.02619365,0.00057500444,0.00004805901,0.000099415054,0.8750419],"genre_scores_gemma":[0.8233159,0.0014557325,0.0021505493,0.04485719,0.021372588,0.000030745847,0.00024404004,0.0002002214,0.106373034],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857724,0.000023922932,0.000804356,0.000104327715,0.00024773786,0.00024241713],"domain_scores_gemma":[0.99406826,0.000060466533,0.0051086727,0.0001801839,0.0005617229,0.000020661944],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00023721857,0.00022211448,0.00073522143,0.0006593525,0.00006405277,0.00010974484,0.00037404316,0.00009355863,0.0059903054],"category_scores_gemma":[0.00010867503,0.00015855777,0.00015414738,0.00034828417,0.00020889999,0.0012651902,0.00007421269,0.000288152,0.04034952],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008985638,0.000022143748,0.0002642611,0.00014906148,0.000053502612,0.000016380043,0.0000310628,0.000009645437,0.000020376798,0.004025354,0.9193156,0.07600278],"study_design_scores_gemma":[0.0003474295,0.00004940699,0.000078554134,0.00020930293,0.00003277991,0.00017825725,0.00023317951,0.0000137691695,0.000037689642,0.00041485822,0.99821246,0.00019234412],"about_ca_topic_score_codex":0.00005062845,"about_ca_topic_score_gemma":0.0000055226506,"teacher_disagreement_score":0.7973517,"about_ca_system_score_codex":0.000034236833,"about_ca_system_score_gemma":0.00011164425,"threshold_uncertainty_score":0.99491835},"labels":[],"label_agreement":null},{"id":"W4252684203","doi":"10.1002/1096-8652(200007)64:3<206::aid-ajh12>3.3.co;2-r","title":"β‐thalassemia intermedia caused by compound heterozygosity for Hb Malay (β codon 19 AAC→AGC; Asn→Ser) and codons 41/42 (‐CTTT) β0‐thalassemia mutation","year":2000,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"University of Hong Kong","keywords":"Thalassemia; Intermedia; Compound heterozygosity; Loss of heterozygosity; Hemoglobinopathy; Mutation; Genetics; Malay; Medicine; Hemolytic anemia; Biology; Internal medicine; Allele; Gene","score_opus":0.006762114833858221,"score_gpt":0.26577169687254637,"score_spread":0.2590095820386881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252684203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088395,0.0019080957,0.0010515491,0.004870238,0.0002950873,0.00040549383,0.000037280093,0.00003883333,0.0005094842],"genre_scores_gemma":[0.99596286,0.0010479222,0.0010208314,0.0014700281,0.000089291774,0.000012429445,0.000057506346,0.000051435076,0.00028769363],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99771136,0.00019581529,0.0009314011,0.00033579607,0.00028841442,0.0005372185],"domain_scores_gemma":[0.9977799,0.0005605831,0.00070643396,0.0002428961,0.00021859317,0.0004915821],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035771856,0.00032456382,0.0012244779,0.00022326039,0.00015953576,0.000032174932,0.00017615074,0.0002337979,0.00018834525],"category_scores_gemma":[0.00020173533,0.00026868674,0.00023932435,0.00026518223,0.000793396,0.00014628207,0.000030761177,0.0006055046,0.00002029187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011317881,0.0033377989,0.41641688,0.0014972531,0.0046443236,0.0074875313,0.010450621,0.0002471971,0.049970835,0.0007880775,0.3315277,0.16231391],"study_design_scores_gemma":[0.08070514,0.054957747,0.14318305,0.0045836726,0.0066397456,0.29770058,0.031392187,0.008033999,0.048733756,0.0028171677,0.31647167,0.00478128],"about_ca_topic_score_codex":0.000097362186,"about_ca_topic_score_gemma":0.000027623644,"teacher_disagreement_score":0.29021305,"about_ca_system_score_codex":0.0001348957,"about_ca_system_score_gemma":0.00020540706,"threshold_uncertainty_score":0.9999765},"labels":[],"label_agreement":null},{"id":"W4280569962","doi":"10.1002/ajh.26587","title":"Optical genome mapping for structural variation analysis in hematologic malignancies","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Fluorescence in situ hybridization; Karyotype; Chromosomal translocation; Biology; Copy-number variation; Comparative genomic hybridization; Computational biology; Microarray; Myeloid leukemia; Structural variation; Cytogenetics; DNA microarray; Genome; Breakpoint; Genetics; Chromosome; Cancer research; Gene","score_opus":0.019104876557572377,"score_gpt":0.3051088845966437,"score_spread":0.28600400803907133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280569962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824641,0.00032469153,0.013047707,0.0037869534,0.000078762045,0.0002197804,0.000007728405,0.000009295073,0.000061012677],"genre_scores_gemma":[0.9766939,0.000020534733,0.022725245,0.00043212122,0.000044609074,0.00002986546,0.000013882272,0.000013578242,0.000026248032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981902,0.00019882918,0.00070701167,0.0001917994,0.000329868,0.0003822634],"domain_scores_gemma":[0.9985625,0.00042620912,0.0005196986,0.00017829955,0.00019369731,0.00011959366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077508297,0.00011997073,0.0010601694,0.0011329465,0.00010004043,0.000008727241,0.00022474786,0.00003718082,0.0002472264],"category_scores_gemma":[0.00036339,0.00010090547,0.0002752483,0.0014878794,0.00020662045,0.000058484526,0.00010538508,0.00047369895,0.0000018911485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008151783,0.0007966392,0.80467284,0.0005000009,0.008812588,0.0091902865,0.0108719235,0.012663831,0.09057641,0.042677253,0.0011175284,0.009968893],"study_design_scores_gemma":[0.011615484,0.010718903,0.8158094,0.000071728915,0.002516924,0.08442552,0.031801756,0.029277641,0.0021052158,0.00743474,0.0033672329,0.000855433],"about_ca_topic_score_codex":0.00003471663,"about_ca_topic_score_gemma":0.0000055028772,"teacher_disagreement_score":0.0884712,"about_ca_system_score_codex":0.00046743758,"about_ca_system_score_gemma":0.00034775326,"threshold_uncertainty_score":0.41148055},"labels":[],"label_agreement":null},{"id":"W4280590103","doi":"10.1002/ajh.26599","title":"Assessment of donor cell engraftment after hematopoietic stem cell transplantation for sickle cell disease: A review of current and future methods","year":2022,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Libin Cardiovascular Institute of Alberta; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Hematopoietic stem cell transplantation; Medicine; Stem cell; Transplantation; Immunology; Haematopoiesis; Disease; Red blood cell; Hematopoietic stem cell; Flow cytometry; Biology; Internal medicine","score_opus":0.018938787312093516,"score_gpt":0.36853629157915807,"score_spread":0.34959750426706454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280590103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027896513,0.995376,0.0020695673,0.00021939611,0.00039822175,0.0014187278,0.00011812718,0.000005263461,0.000115725925],"genre_scores_gemma":[0.00044411817,0.9924965,0.0065731294,0.000115664625,0.0000646943,0.00016881744,0.00006304474,0.000052546355,0.00002151755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99630994,0.00079837284,0.0019484096,0.00030705577,0.00035680467,0.00027944177],"domain_scores_gemma":[0.9955267,0.00054170954,0.003183652,0.0003030134,0.00017117914,0.0002737548],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082903553,0.00040924305,0.004076857,0.00029994972,0.000039709903,0.000004009177,0.00018275589,0.00011022195,0.00017748725],"category_scores_gemma":[0.00001061064,0.00028392972,0.0011060281,0.0003441112,0.00020992325,0.000032539898,0.000041732772,0.0006589206,5.2347195e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013842815,0.00060204027,0.000037540827,0.4723619,0.00022064027,0.00010974902,0.00023120458,4.875791e-7,0.0000045412803,0.000080076585,0.000250502,0.5259629],"study_design_scores_gemma":[0.0013764923,0.0020699988,0.00001982843,0.048182655,0.01195727,0.001429882,0.00090986403,0.0000040628834,0.00007014396,0.000017479195,0.9336709,0.000291442],"about_ca_topic_score_codex":0.000001985866,"about_ca_topic_score_gemma":1.3650138e-7,"teacher_disagreement_score":0.93342036,"about_ca_system_score_codex":0.0000922059,"about_ca_system_score_gemma":0.00096551573,"threshold_uncertainty_score":0.99996126},"labels":[],"label_agreement":null},{"id":"W4281285399","doi":"10.1002/ajh.26618","title":"Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia","year":2022,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Medicine; Myeloid leukemia; Population; Cancer registry; Cancer; Internal medicine; Oncology; Incidence (geometry); Leukemia; Tyrosine-kinase inhibitor; Clinical trial","score_opus":0.02980958234156228,"score_gpt":0.2920588869648335,"score_spread":0.26224930462327123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281285399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93513006,0.007995277,0.0007076167,0.053785615,0.0012394241,0.0009882506,0.00009687847,0.0000139605945,0.000042893138],"genre_scores_gemma":[0.8751089,0.004539518,0.0077993055,0.09040473,0.0195283,0.00017263091,0.001456321,0.00041298987,0.000577313],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968865,0.0002205068,0.0015552307,0.0003890897,0.0004650382,0.00048365857],"domain_scores_gemma":[0.9964317,0.00030551146,0.0024740123,0.00038834018,0.00031306795,0.000087381464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038137217,0.00041795635,0.001950777,0.00080819614,0.00009105204,0.000011150321,0.00021962202,0.00035518548,0.00076394295],"category_scores_gemma":[0.000116138304,0.00038192933,0.00040813198,0.00043204005,0.0003316901,0.000098013916,0.00005276344,0.0014872246,0.0000017810013],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008600892,0.0022109367,0.0051812776,0.0031395964,0.0038957186,0.014298604,0.0022444597,0.0040085055,0.080328904,0.00017568331,0.8057396,0.07017587],"study_design_scores_gemma":[0.031170715,0.027187372,0.00075767684,0.0015420637,0.0008075629,0.021190189,0.0002155923,0.0039091352,0.04259261,0.00015507298,0.86947095,0.0010010595],"about_ca_topic_score_codex":0.00017578657,"about_ca_topic_score_gemma":0.00025651578,"teacher_disagreement_score":0.06917481,"about_ca_system_score_codex":0.006864468,"about_ca_system_score_gemma":0.0044682384,"threshold_uncertainty_score":0.99986327},"labels":[],"label_agreement":null},{"id":"W4281616742","doi":"10.1002/ajh.26623","title":"Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populations","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Cancer Prevention and Research Institute of Texas","keywords":"Medicine; Pacific islanders; Comorbidity; Internal medicine; Cancer; Pulmonary embolism; Incidence (geometry); Deep vein; Retrospective cohort study; Cohort; Thrombosis; Population; Environmental health","score_opus":0.01096841307301755,"score_gpt":0.2681943746078794,"score_spread":0.2572259615348619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281616742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99845076,0.00060073246,0.0000495751,0.00041930666,0.000120434,0.00020622843,0.000114575916,0.000005995639,0.000032382144],"genre_scores_gemma":[0.9986814,0.0005840197,0.00047223247,0.00017284632,0.000017773822,0.000022072729,0.0000159255,0.000018122297,0.000015559557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901235,0.00016260422,0.00034606716,0.00014709514,0.00017222803,0.00015965312],"domain_scores_gemma":[0.9988149,0.00011398575,0.0007439676,0.00014507794,0.000079352714,0.00010276337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009606255,0.00013251188,0.0010754272,0.0001492746,0.00016361097,0.0000059858285,0.000057353674,0.000017253391,0.0001317806],"category_scores_gemma":[0.00002291784,0.00009344371,0.00005731395,0.00010520933,0.00014475359,0.000054546414,0.000051837964,0.00017797337,1.5529778e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009624735,0.00088134944,0.98839325,0.000013335619,0.0007860375,0.00003180434,0.001478468,0.00007898917,0.00000657823,0.00015155213,0.00009492822,0.007987475],"study_design_scores_gemma":[0.0023733943,0.003573478,0.9908255,0.000042639458,0.0008582021,0.00004763353,0.0017813423,0.000013857253,0.000032678723,0.00011966852,0.0002476892,0.000083923],"about_ca_topic_score_codex":0.011580332,"about_ca_topic_score_gemma":0.0006241327,"teacher_disagreement_score":0.0109562,"about_ca_system_score_codex":0.000058969912,"about_ca_system_score_gemma":0.000052570747,"threshold_uncertainty_score":0.9950016},"labels":[],"label_agreement":null},{"id":"W4281909242","doi":"10.1002/ajh.26624","title":"Circulating rhabdoid tumor cells in the peripheral blood of a neonate","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Peripheral blood; Medicine; Pathology; Peripheral; Immunology; Internal medicine","score_opus":0.005448422926695108,"score_gpt":0.2362852525992625,"score_spread":0.23083682967256738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281909242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982056,0.0010618654,0.00021243704,0.00023455708,0.00009112831,0.000041654625,0.0000051954926,0.0000011454509,0.00014640842],"genre_scores_gemma":[0.9984575,0.000030385398,0.0009341053,0.00050558324,0.00004785145,0.000005107532,0.00000214432,0.000009289711,0.000008014643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899286,0.00023163679,0.00037682417,0.000101651836,0.00014997229,0.00014704338],"domain_scores_gemma":[0.9992659,0.000032922006,0.00047642406,0.00015073897,0.000049807673,0.000024197885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037578784,0.00007493333,0.0002550984,0.000048609185,0.000050536437,0.0000036428555,0.0002738828,0.000012309216,0.00003303549],"category_scores_gemma":[0.000031147654,0.000058145593,0.00011432157,0.00014081576,0.00012882467,0.0000016947873,0.00006109004,0.00018430044,1.8677169e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003080526,0.0003495196,0.008092578,0.000042943793,0.00017820341,0.00054518896,0.0021180448,0.015262069,0.96504277,0.00022920559,0.0006799197,0.007151527],"study_design_scores_gemma":[0.011288567,0.02164769,0.006098842,0.00023501004,0.0005131167,0.17402914,0.08741402,0.007094627,0.65711516,0.0019010025,0.0310583,0.0016045427],"about_ca_topic_score_codex":0.00004824296,"about_ca_topic_score_gemma":0.000006161603,"teacher_disagreement_score":0.3079276,"about_ca_system_score_codex":0.000011390343,"about_ca_system_score_gemma":0.00012340184,"threshold_uncertainty_score":0.23711085},"labels":[],"label_agreement":null},{"id":"W4283458238","doi":"10.1002/ajh.26644","title":"Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Akebia Therapeutics","keywords":"Darbepoetin alfa; Transferrin saturation; Anemia; Hepcidin; Erythropoietin; Medicine; Erythropoiesis; Internal medicine; Mean corpuscular volume; Kidney disease; Ferritin; Endocrinology; Hemoglobin; Serum iron; Mean corpuscular hemoglobin; Gastroenterology; Iron deficiency","score_opus":0.002878125387538174,"score_gpt":0.21766477630844827,"score_spread":0.2147866509209101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283458238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971896,0.00046431465,0.000022110251,0.0019041722,0.00007554132,0.0002776138,0.000009793105,0.000008736583,0.00004813078],"genre_scores_gemma":[0.9990898,0.00003199409,0.00035195122,0.00040354906,0.000014765687,0.000014348157,0.00002620872,0.000028100128,0.000039285445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984548,0.00021220015,0.00041440176,0.00016693649,0.00046040711,0.00029121907],"domain_scores_gemma":[0.9984,0.00019866327,0.00075439375,0.00018902586,0.00015090089,0.00030705056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001151344,0.0001716601,0.00081112003,0.00021781241,0.000055997974,0.0000025539296,0.00010398354,0.00002151522,0.00014362772],"category_scores_gemma":[0.00015866706,0.00011595073,0.00008398675,0.0004694555,0.0004870853,0.000037617832,0.00003994331,0.00037706355,0.0000011089096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002809158,0.001984389,0.98967487,0.00021485168,0.00028405993,0.0024524403,0.00033335117,0.00007129515,0.00003737677,0.000051471623,0.001001782,0.0010849752],"study_design_scores_gemma":[0.028325254,0.051709402,0.91370124,0.0015958485,0.0009279835,0.0012431531,0.001121803,0.00002481568,0.000650282,0.00004849423,0.00034608482,0.00030565585],"about_ca_topic_score_codex":0.00003991318,"about_ca_topic_score_gemma":0.000008837308,"teacher_disagreement_score":0.07597363,"about_ca_system_score_codex":0.0004369816,"about_ca_system_score_gemma":0.00087360485,"threshold_uncertainty_score":0.47283334},"labels":[],"label_agreement":null},{"id":"W4283703366","doi":"10.1002/ajh.26645","title":"Real‐life incidence of thrombotic events in leukemia patients treated with ponatinib","year":2022,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ponatinib; Medicine; Incidence (geometry); Leukemia; Internal medicine; Oncology; Myeloid leukemia; Dasatinib","score_opus":0.011279186742634548,"score_gpt":0.2667247574138395,"score_spread":0.25544557067120494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283703366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97876036,0.00020281933,0.0000051894554,0.019957198,0.00015567214,0.000461234,0.000027228449,0.000013515525,0.00041675684],"genre_scores_gemma":[0.9623379,0.000304546,0.0007743802,0.035924062,0.00017247054,0.000028885981,0.0001809566,0.00011051696,0.00016628261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99592084,0.0004804408,0.0015613926,0.00041097397,0.001073989,0.0005523684],"domain_scores_gemma":[0.9949455,0.00057756744,0.0033958259,0.00054286246,0.0003638211,0.00017439517],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00025507167,0.00047152303,0.0028219891,0.0008429204,0.000038477327,0.0000026766793,0.0004407309,0.0002634594,0.0005498665],"category_scores_gemma":[0.00031198218,0.00036094693,0.00025882293,0.0007526135,0.0004936745,0.000087030596,0.000109812936,0.0023342893,0.000009390203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019452954,0.00047675375,0.9348206,0.00038871632,0.0012937367,0.008835478,0.00045066324,0.000041097228,0.000022523416,0.000012546919,0.050840173,0.00087242934],"study_design_scores_gemma":[0.04242426,0.051733576,0.8471582,0.005715951,0.0035982004,0.031312186,0.0014333961,0.0000882391,0.00051062065,0.00013658023,0.014323464,0.0015653543],"about_ca_topic_score_codex":0.0015298965,"about_ca_topic_score_gemma":0.000035791978,"teacher_disagreement_score":0.08766241,"about_ca_system_score_codex":0.0031082353,"about_ca_system_score_gemma":0.0035116097,"threshold_uncertainty_score":0.99996734},"labels":[],"label_agreement":null},{"id":"W4284895899","doi":"10.1002/ajh.26654","title":"Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosis","year":2022,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Medicine; Disease; Transplantation; Hematopoietic stem cell transplantation; Ruxolitinib; Stem cell; Oncology; Immunology; Internal medicine; Bone marrow; Biology","score_opus":0.028133156894663783,"score_gpt":0.32871746541423763,"score_spread":0.30058430851957385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284895899","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015879383,0.9804995,0.000106922074,0.0008410651,0.00041535628,0.0014480993,0.000113251735,0.000019955132,0.0006764354],"genre_scores_gemma":[0.028387895,0.9696611,0.0009575192,0.0003847561,0.000048941896,0.0003584874,0.000025983078,0.00008563032,0.00008966628],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605507,0.0004596144,0.002043676,0.00046720737,0.00046459073,0.00050981593],"domain_scores_gemma":[0.99636495,0.0010641005,0.0017664857,0.00036804212,0.00017193433,0.00026446386],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036395612,0.00065718975,0.006575029,0.001085847,0.000062611885,0.000028330638,0.0003157666,0.00013796373,0.00026168508],"category_scores_gemma":[0.000029966955,0.00044150156,0.0006778216,0.0013164965,0.0001875665,0.00008279197,0.00007740435,0.0009901128,0.000031128737],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004766116,0.0024134603,0.010002068,0.013297397,0.0028666165,0.0076911324,0.0060937693,0.0000057926813,0.000010320114,0.003047302,0.0005263398,0.9535692],"study_design_scores_gemma":[0.0047210003,0.023685442,0.000843462,0.01785743,0.0044995733,0.02484102,0.01725403,0.0000013880422,0.00040899706,0.000134694,0.9041889,0.0015640853],"about_ca_topic_score_codex":0.000042700634,"about_ca_topic_score_gemma":0.000015034643,"teacher_disagreement_score":0.9520051,"about_ca_system_score_codex":0.00041354602,"about_ca_system_score_gemma":0.0015110641,"threshold_uncertainty_score":0.99980366},"labels":[],"label_agreement":null},{"id":"W4290841268","doi":"10.1002/ajh.26686","title":"Ponatinib after failure of <scp>second‐generation</scp> tyrosine kinase inhibitor in resistant <scp>chronic‐phase</scp> chronic myeloid leukemia","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institute for Health and Care Research","keywords":"Ponatinib; Myeloid leukemia; Medicine; Tyrosine kinase; Dasatinib; Cancer research; Internal medicine; Receptor; Imatinib","score_opus":0.009934436151821244,"score_gpt":0.2624419304253864,"score_spread":0.2525074942735651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290841268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98713213,0.010571712,0.00007810386,0.00067345065,0.00046324395,0.0005398309,0.00013164515,0.000030400028,0.00037947475],"genre_scores_gemma":[0.99564356,0.0002641899,0.0018814923,0.0005121823,0.0005812801,0.00013236288,0.00009829644,0.00010309348,0.00078354817],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99501395,0.00053044,0.0020356085,0.00059316016,0.00091524346,0.0009115805],"domain_scores_gemma":[0.9957336,0.0008116453,0.00200696,0.00069827883,0.00035091175,0.0003986108],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072964776,0.00052694563,0.0019599444,0.00094830047,0.00015794834,0.000021900581,0.00044524347,0.00016067034,0.000848938],"category_scores_gemma":[0.0007157759,0.0004910292,0.00042765753,0.0011163346,0.00065553404,0.0002097169,0.00025118137,0.0013068866,0.000032340766],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0022558093,0.005691116,0.052487146,0.002011173,0.003298271,0.02866984,0.008920158,0.0021817973,0.71849865,0.0024435262,0.14849515,0.025047353],"study_design_scores_gemma":[0.08796166,0.05878712,0.024048897,0.0019895977,0.0016985033,0.046446476,0.01572466,0.0024861305,0.3629584,0.00037223607,0.39686292,0.00066336984],"about_ca_topic_score_codex":0.00014828095,"about_ca_topic_score_gemma":0.00061200594,"teacher_disagreement_score":0.35554025,"about_ca_system_score_codex":0.0066724913,"about_ca_system_score_gemma":0.006509891,"threshold_uncertainty_score":0.99975413},"labels":[],"label_agreement":null},{"id":"W4294990810","doi":"10.1002/ajh.26721","title":"Understanding pulse oximetry in hematology patients: Hemoglobinopathies, racial differences, and beyond","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"","keywords":"Pulse oximetry; Carboxyhemoglobin; Medicine; Hypoxemia; Oxygen saturation; Hemoglobin; Phlebotomy; Intensive care medicine; Internal medicine; Cardiology; Anesthesia; Oxygen; Chemistry","score_opus":0.013570490142779794,"score_gpt":0.22994376044178208,"score_spread":0.21637327029900227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294990810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695694,0.001391848,0.00054005417,0.00038537956,0.00024576826,0.000085640844,0.000013166023,0.000003888072,0.00037732458],"genre_scores_gemma":[0.9986749,0.00012649754,0.00039739662,0.0006957895,0.000049203783,0.000009383649,0.000012588079,0.000019654775,0.000014577243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982625,0.00036039276,0.0005547797,0.00026605945,0.000207857,0.00034841374],"domain_scores_gemma":[0.99908674,0.000060680948,0.00048807164,0.0001777502,0.000055414937,0.0001313742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035914927,0.0001781351,0.00056607387,0.00024743605,0.0001164,0.0000112967,0.0002466935,0.00007170156,0.000040764204],"category_scores_gemma":[0.00012771995,0.00017241454,0.00009290583,0.00026183279,0.00035082723,0.0000081606295,0.00022253269,0.00033634336,7.6819435e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014126095,0.00071670074,0.9579204,0.00004896557,0.00024626273,0.0006004197,0.0009965679,0.000033608074,0.017698158,0.008375858,0.0021432638,0.009807242],"study_design_scores_gemma":[0.05885947,0.10257242,0.3572556,0.0003555993,0.00096560863,0.08284486,0.17237537,0.0008143928,0.13248715,0.037138302,0.045426294,0.008904916],"about_ca_topic_score_codex":0.000023715495,"about_ca_topic_score_gemma":0.000046077996,"teacher_disagreement_score":0.60066473,"about_ca_system_score_codex":0.00008178273,"about_ca_system_score_gemma":0.00012699938,"threshold_uncertainty_score":0.70308614},"labels":[],"label_agreement":null},{"id":"W4296276644","doi":"10.1002/ajh.26726","title":"Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Cancer Society; Wellcome Trust; Princess Margaret Cancer Foundation; Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada","keywords":"Stem cell; Lymphoma; Transplantation; Hematopoietic stem cell transplantation; Haematopoiesis; Medicine; Oncology; Autologous stem-cell transplantation; Immunology; Biology; Cancer research; Internal medicine; Genetics","score_opus":0.02238040149386456,"score_gpt":0.33572820172904616,"score_spread":0.3133478002351816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296276644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457234,0.00031968008,0.0018042228,0.002730103,0.00009150468,0.00033854868,0.000026914298,0.0000035716719,0.00011311608],"genre_scores_gemma":[0.994427,0.00009781064,0.0050419676,0.00033546446,0.00003511839,0.00003065429,0.0000049369737,0.000014752296,0.000012253099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971245,0.00077512476,0.0012826988,0.00014810722,0.00042168144,0.00024789007],"domain_scores_gemma":[0.9954213,0.002829943,0.001302,0.0001890622,0.00019708335,0.000060618528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002366134,0.000101235564,0.0009685912,0.0002474332,0.000053775915,0.0000020020866,0.000348017,0.00004372196,0.000032899155],"category_scores_gemma":[0.00011607935,0.00007442314,0.00025750775,0.00044941553,0.00042963732,0.00003354173,0.000031894586,0.00036590878,4.8719e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023765437,0.0035955796,0.68487513,0.003076005,0.00085765566,0.0030515527,0.021753054,0.0007657826,0.01857432,0.0049071726,0.0055552376,0.22922304],"study_design_scores_gemma":[0.03441675,0.043215144,0.56861,0.0006400945,0.0015255747,0.1002212,0.16067705,0.0043315794,0.080070116,0.0018817544,0.0036346533,0.00077609136],"about_ca_topic_score_codex":0.000047898797,"about_ca_topic_score_gemma":0.000005750539,"teacher_disagreement_score":0.22844696,"about_ca_system_score_codex":0.00010035316,"about_ca_system_score_gemma":0.0007477833,"threshold_uncertainty_score":0.30348873},"labels":[],"label_agreement":null},{"id":"W4306411219","doi":"10.1002/ajh.26767","title":"Utilization of <scp>real‐world</scp> data in assessing treatment effectiveness for diffuse large <scp>B‐cell</scp> lymphoma","year":2022,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"MorphoSys; Verastem Oncology; Teva Pharmaceutical Industries; Genentech; Celgene; Adaptive Biotechnologies; Gilead Sciences; TG Therapeutics; Pfizer; Bristol-Myers Squibb","keywords":"Observational study; Medicine; Covariate; Clinical trial; Randomized controlled trial; Oncology; Propensity score matching; Diffuse large B-cell lymphoma; Sample size determination; Comparative effectiveness research; Clinical study design; Internal medicine; Lymphoma; Computer science; Statistics; Machine learning; Pathology; Alternative medicine","score_opus":0.08210967973667803,"score_gpt":0.396500964877894,"score_spread":0.31439128514121595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306411219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05873776,0.93776286,0.00034216838,0.000024005043,0.00044743257,0.0017672001,0.00037106243,0.000022343607,0.0005251806],"genre_scores_gemma":[0.030520208,0.9668202,0.0010501521,0.00004802938,0.00012097306,0.00032786906,0.0009088337,0.00012532713,0.000078441844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951757,0.0011501596,0.0018783956,0.0006779065,0.00045908365,0.0006587276],"domain_scores_gemma":[0.9852165,0.009708739,0.0036651944,0.0009869221,0.00016302527,0.00025965102],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010213571,0.00068700494,0.0060001495,0.0011557745,0.00011715121,0.00003110784,0.0005559476,0.00017661908,0.000016581165],"category_scores_gemma":[0.000943909,0.000500703,0.0008678871,0.001071897,0.00022178693,0.00017782165,0.00024218089,0.00022458824,0.0000044207554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048637,0.011315733,0.027975554,0.010141035,0.0020315165,0.0015008387,0.00035008125,0.0000023349291,0.0000029213563,0.00043090343,0.0006635048,0.9455369],"study_design_scores_gemma":[0.013761772,0.004432075,0.0053331,0.008409262,0.0067250254,0.0040117344,0.0013871483,0.000057638365,0.00021716804,0.000045863762,0.95548964,0.00012958754],"about_ca_topic_score_codex":0.00021677538,"about_ca_topic_score_gemma":0.00006333073,"teacher_disagreement_score":0.9548261,"about_ca_system_score_codex":0.0014652007,"about_ca_system_score_gemma":0.0019997028,"threshold_uncertainty_score":0.9997445},"labels":[],"label_agreement":null},{"id":"W4313453663","doi":"10.1002/ajh.26809","title":"Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Microsemi (Canada); McGill University; Jewish General Hospital","funders":"","keywords":"Venetoclax; Medicine; Lymphoma; Brentuximab vedotin; Obinutuzumab; Follicular lymphoma; Rituximab; Oncology; Internal medicine; Antibody-drug conjugate; Cancer research; Antibody; Immunology; Chronic lymphocytic leukemia; Leukemia; Monoclonal antibody; CD30","score_opus":0.02619885197197588,"score_gpt":0.33404745906188976,"score_spread":0.3078486070899139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313453663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943776,0.003940978,0.0000147328565,0.0011615563,0.00003410307,0.00038742466,0.00002651082,0.000013647894,0.000043433007],"genre_scores_gemma":[0.9955731,0.0020552487,0.0021683036,0.00008841596,0.000041061,0.000025251331,0.000010467776,0.000020883213,0.000017291197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827486,0.00017148045,0.00070438784,0.0003816121,0.00019047575,0.00027716783],"domain_scores_gemma":[0.9980942,0.0009829312,0.0004583203,0.00018723191,0.000057376055,0.0002199335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027077962,0.00022769933,0.001104112,0.00021116216,0.00006373045,0.00002054824,0.00005108116,0.000051783365,0.000001905714],"category_scores_gemma":[0.00012852534,0.00015295018,0.0000468744,0.0002478581,0.00028095886,0.0000913055,0.000047310765,0.00009597011,0.0000010056332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021296343,0.003924951,0.890343,0.000049691283,0.0013532183,0.0097531825,0.015362108,0.00009510329,0.000175394,0.00013738546,0.00029546302,0.057214133],"study_design_scores_gemma":[0.11592716,0.029861944,0.8314572,0.0008043074,0.0008784275,0.0021334735,0.013883447,0.0031364402,0.0002947505,0.00084208034,0.00038184956,0.00039892003],"about_ca_topic_score_codex":0.00079848646,"about_ca_topic_score_gemma":0.00033269092,"teacher_disagreement_score":0.094630815,"about_ca_system_score_codex":0.00021348252,"about_ca_system_score_gemma":0.0002328792,"threshold_uncertainty_score":0.6237127},"labels":[],"label_agreement":null},{"id":"W4313453780","doi":"10.1002/ajh.26830","title":"Early‐onset reduced bone mineral density in patients with pyruvate kinase deficiency","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Agios Pharmaceuticals","keywords":"Pyruvate kinase deficiency; Medicine; Bone mineral; Thalassemia; Osteoporosis; Osteopenia; Internal medicine; Pyruvate kinase; Hemolytic anemia; Endocrinology; Iron deficiency; Bone density; Bone disease; Anemia; Glycolysis","score_opus":0.010876141273883252,"score_gpt":0.24196212256145427,"score_spread":0.23108598128757102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313453780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9271222,0.00007038396,0.00001689021,0.07183314,0.0006707313,0.00019045532,0.000013158975,0.000026552476,0.00005649593],"genre_scores_gemma":[0.86005837,0.000046091125,0.00069318473,0.13804072,0.0005950449,0.0000072816374,0.00012687579,0.00008348461,0.0003489298],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9975033,0.00030390432,0.0008690988,0.00036307197,0.00040901842,0.0005516015],"domain_scores_gemma":[0.9976294,0.00023445778,0.001228275,0.0003615484,0.00040328715,0.00014304504],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001966222,0.00034592857,0.001820006,0.00082454743,0.000045089324,0.000007572963,0.00015778406,0.00033183716,0.000056474095],"category_scores_gemma":[0.00019357944,0.000256112,0.00021345713,0.00063590135,0.0005938768,0.00005170992,0.000048742597,0.0021766366,0.00008062978],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044588787,0.0004438574,0.40528503,0.00023524663,0.00025656167,0.025659418,0.00038295393,0.0000057532434,0.00043909028,0.000009150858,0.5613661,0.001457949],"study_design_scores_gemma":[0.008114513,0.01803981,0.9456107,0.0008798814,0.000520375,0.010593939,0.00025067825,0.000006177344,0.00018316622,0.00013108036,0.014916669,0.00075303303],"about_ca_topic_score_codex":0.00009845183,"about_ca_topic_score_gemma":0.000012879143,"teacher_disagreement_score":0.5464494,"about_ca_system_score_codex":0.00010894705,"about_ca_system_score_gemma":0.00032918822,"threshold_uncertainty_score":0.9999891},"labels":[],"label_agreement":null},{"id":"W4313645529","doi":"10.1002/ajh.26837","title":"Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso‐occlusive pain: A multicenter pediatric emergency medicine perspective","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"National Center for Complementary and Integrative Health; Maternal and Child Health Bureau; National Heart, Lung, and Blood Institute; School of Medicine, Emory University; National Center for Advancing Translational Sciences; Health Resources and Services Administration; University at Buffalo; Doris Duke Charitable Foundation; Scheme for Promotion of Academic and Research Collaboration; Seattle Children's Research Institute; National Institutes of Health; U.S. Department of Health and Human Services; Cincinnati Children's Hospital Medical Center; Emory University; Nationwide Children's Hospital","keywords":"Medicine; Emergency department; Interquartile range; Vaso-occlusive crisis; Fentanyl; Acute chest syndrome; Odds ratio; Emergency medicine; Pediatric emergency medicine; Sickle cell anemia; Pediatrics; Anesthesia; Internal medicine; Disease","score_opus":0.004811454954734607,"score_gpt":0.24153338180287254,"score_spread":0.23672192684813792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313645529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792815,0.008851831,0.00018239951,0.010960599,0.00021991358,0.0003915614,0.00002186169,0.00001999548,0.000070335576],"genre_scores_gemma":[0.9829404,0.016387258,0.000062128944,0.00025496838,0.00025968364,0.000009428129,0.00001738091,0.000028113143,0.000040655992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984029,0.0002080799,0.00051157275,0.00027155224,0.00027559593,0.0003302843],"domain_scores_gemma":[0.9986171,0.00015254958,0.00048443917,0.00017562327,0.00016852826,0.00040175612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002700834,0.00022735032,0.00056412857,0.00014679797,0.00015723733,0.000004231264,0.00011007627,0.000044990935,0.00020311034],"category_scores_gemma":[0.00015921473,0.00012214521,0.00009356494,0.00044755117,0.0005323144,0.00007052208,0.000063475105,0.00035737982,0.0000048287147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049706496,0.000195464,0.98803246,0.000029351979,0.0004311191,0.0002302834,0.0041106115,0.0000046700166,0.000026738353,0.00006508448,0.0059931683,0.00038398153],"study_design_scores_gemma":[0.0029428366,0.001970278,0.9663224,0.00007541986,0.0014609902,0.00026863418,0.026119608,0.00026012273,0.000013076122,0.00027047133,0.00010392693,0.00019223288],"about_ca_topic_score_codex":0.00036529585,"about_ca_topic_score_gemma":0.00006708278,"teacher_disagreement_score":0.022008996,"about_ca_system_score_codex":0.000031717937,"about_ca_system_score_gemma":0.000075241245,"threshold_uncertainty_score":0.4980937},"labels":[],"label_agreement":null},{"id":"W4313649378","doi":"10.1002/ajh.26838","title":"A young woman with persistent sore throat, <scp>Epstein–Barr</scp> virus, lymphadenopathy, and aberrant <scp>CD4</scp> + <scp>CD7</scp>‐ T‐cells","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"VGH and UBC Hospital Foundation","keywords":"Sore throat; Medicine; Immunology; Virus; Viremia; Hematopoietic stem cell transplantation; Population; Lymphocytosis; Transplantation; Internal medicine","score_opus":0.0097441918260875,"score_gpt":0.24099911838518745,"score_spread":0.23125492655909996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313649378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98443174,0.008745188,0.00012228038,0.0012410932,0.0005265866,0.00046958597,0.000041328436,0.00015180957,0.0042704004],"genre_scores_gemma":[0.99064565,0.004155366,0.00063441246,0.0021331336,0.00025740717,0.00004006056,0.000025866531,0.0001666485,0.0019414689],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9950471,0.00033120965,0.0012453358,0.0007677792,0.0010301787,0.001578388],"domain_scores_gemma":[0.9952496,0.0010633309,0.0017553682,0.0005639917,0.0004532684,0.0009144231],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007422442,0.0007313241,0.0023400367,0.00077306834,0.00037605292,0.00009787005,0.000474215,0.00029915175,0.000022371236],"category_scores_gemma":[0.00084410666,0.0005836039,0.0005983254,0.0014606242,0.0012389815,0.000279163,0.00015855255,0.00084996596,0.00010034014],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042992595,0.0019827175,0.44648808,0.0010229639,0.008793417,0.014257007,0.05726357,0.00060096476,0.03413609,0.0009643367,0.42650017,0.007560745],"study_design_scores_gemma":[0.035443313,0.032402985,0.08096586,0.0026394017,0.0069688386,0.061038602,0.6683416,0.0012433856,0.019142678,0.0012079906,0.0899442,0.0006611784],"about_ca_topic_score_codex":0.00043933626,"about_ca_topic_score_gemma":0.000187452,"teacher_disagreement_score":0.611078,"about_ca_system_score_codex":0.00034567498,"about_ca_system_score_gemma":0.00074372755,"threshold_uncertainty_score":0.99966156},"labels":[],"label_agreement":null},{"id":"W4317867940","doi":"10.1002/ajh.26861","title":"Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with <i>BCR‐ABL</i> negative myeloproliferative neoplasms","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; University Health Network; Kingston Health Sciences Centre; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation","keywords":"Esophagogastroduodenoscopy; Medicine; Myeloproliferative Disorders; Portal hypertension; Internal medicine; Myelofibrosis; Gastroenterology; Endoscopy; Bone marrow; Cirrhosis","score_opus":0.013368725638416056,"score_gpt":0.25538521505860007,"score_spread":0.242016489420184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317867940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8509018,0.0005330109,0.0013799254,0.14367864,0.0004321314,0.0023808354,0.0005954358,0.000033619475,0.00006461516],"genre_scores_gemma":[0.85957897,0.00026035128,0.031774648,0.105526604,0.0009192563,0.00029286704,0.001070214,0.00035027714,0.00022678895],"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.996396,0.00024575178,0.001408635,0.00055734994,0.00073690485,0.00065536797],"domain_scores_gemma":[0.9945213,0.0014248062,0.0024997392,0.00030708782,0.0010664768,0.00018058855],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023663616,0.0006230145,0.0032085867,0.00064897264,0.00007538156,0.000014704635,0.00020340586,0.0003221389,0.000039685732],"category_scores_gemma":[0.0003203358,0.00043793514,0.00034395442,0.0005119617,0.00056373194,0.00011971762,0.000048413614,0.001316642,0.0000048967568],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006890096,0.0011214975,0.375278,0.00032128894,0.002889288,0.0044591506,0.0007990332,0.000054050815,0.00010002122,0.00004851099,0.6063246,0.0017144752],"study_design_scores_gemma":[0.16949588,0.44381782,0.18408196,0.02417341,0.01292105,0.021161575,0.009868416,0.00049817975,0.076227464,0.00096136256,0.050477635,0.006315271],"about_ca_topic_score_codex":0.000082443585,"about_ca_topic_score_gemma":0.00002473618,"teacher_disagreement_score":0.555847,"about_ca_system_score_codex":0.00012070673,"about_ca_system_score_gemma":0.0004519639,"threshold_uncertainty_score":0.99980724},"labels":[],"label_agreement":null},{"id":"W4321374903","doi":"10.1002/ajh.26881","title":"Impact of sex on outcomes in patients with hairy cell leukemia. An <scp>HCL</scp> patient data registry analysis","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"Hairy Cell Leukemia Foundation","keywords":"Medicine; Leukemia; Internal medicine; Oncology","score_opus":0.021657586152965563,"score_gpt":0.3240060220795596,"score_spread":0.302348435926594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321374903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951075,0.00007926468,0.00003560474,0.003780593,0.00012311486,0.0003634511,0.00028380024,0.000020092839,0.00020659601],"genre_scores_gemma":[0.9828663,0.00006841141,0.0006120342,0.0143816,0.00027601796,0.000009113766,0.0012468455,0.00016858465,0.00037108653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944267,0.0005330269,0.0016543394,0.0007541656,0.001716385,0.0009153569],"domain_scores_gemma":[0.9918922,0.0017334889,0.0029919788,0.0025490848,0.0004969612,0.00033623923],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00052153284,0.00057473534,0.003783989,0.0022395367,0.00003559542,0.000021453177,0.0012562105,0.0004518617,0.000039661463],"category_scores_gemma":[0.0008028448,0.00038058741,0.0005784438,0.0017643449,0.00078597653,0.00014653582,0.00031761642,0.0027298024,0.00001988879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00069338176,0.0008413482,0.72997636,0.00036867906,0.0061233356,0.01037604,0.0006173503,0.0006395534,0.0000037263223,9.967001e-7,0.24867658,0.0016826374],"study_design_scores_gemma":[0.09394322,0.11749019,0.72982585,0.0034406409,0.01426876,0.0070444606,0.0069954013,0.00653502,0.0004942085,0.00007171344,0.018143717,0.0017467985],"about_ca_topic_score_codex":0.002835399,"about_ca_topic_score_gemma":0.00008884131,"teacher_disagreement_score":0.23053285,"about_ca_system_score_codex":0.008172589,"about_ca_system_score_gemma":0.010880591,"threshold_uncertainty_score":0.9998646},"labels":[],"label_agreement":null},{"id":"W4321600787","doi":"10.1002/ajh.26890","title":"Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first‐line JAK‐inhibitor","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myelofibrosis; Medicine; Ruxolitinib; Internal medicine; Oncology; Second line; Surgery; First line; Bone marrow","score_opus":0.04967768675891962,"score_gpt":0.37728214272357113,"score_spread":0.3276044559646515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321600787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83113724,0.0010716938,0.000088573885,0.16698015,0.00026384738,0.0003021011,0.00013751126,0.000009117331,0.000009752559],"genre_scores_gemma":[0.9909821,0.0013386591,0.001868541,0.005231122,0.0004173133,0.000015069564,0.0000759294,0.000056755187,0.000014522915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995432,0.00036317317,0.002973046,0.00033798028,0.0005183283,0.00037546616],"domain_scores_gemma":[0.99345076,0.003932961,0.0020810205,0.00025029152,0.0001507121,0.00013423983],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055047247,0.00042827826,0.005952395,0.00053046277,0.00003548566,0.0000066998714,0.00018002847,0.00043777225,0.000020144498],"category_scores_gemma":[0.00013271545,0.00029084206,0.0008901715,0.00025468727,0.00049489306,0.00004615287,0.000023829713,0.0013701712,0.0000019818729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042261952,0.00033306822,0.9823049,0.00057835603,0.0030816395,0.0018310831,0.0014254145,0.0000022084762,0.00002577579,0.000008747654,0.008098347,0.0018878944],"study_design_scores_gemma":[0.010044127,0.012134164,0.95090985,0.0068046465,0.004177592,0.001064294,0.0012555753,0.000018341067,0.0030893204,0.000082914084,0.009885919,0.00053323136],"about_ca_topic_score_codex":0.00016910511,"about_ca_topic_score_gemma":0.00022195795,"teacher_disagreement_score":0.16174902,"about_ca_system_score_codex":0.000032930133,"about_ca_system_score_gemma":0.00017274181,"threshold_uncertainty_score":0.99995434},"labels":[],"label_agreement":null},{"id":"W4323353705","doi":"10.1002/ajh.26900","title":"Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopenia","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Assistance publique-Hôpitaux de Paris; Ministère des Affaires Sociales et de la Santé; GlaxoSmithKline; Amgen","keywords":"Medicine; Immune thrombocytopenia; Cohort; Multivariate analysis; Pediatrics; Internal medicine; Immunology; Antibody","score_opus":0.00878671072839698,"score_gpt":0.285020243960318,"score_spread":0.276233533231921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323353705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855614,0.0010760174,0.0000031622565,0.00012044111,0.000023105724,0.00016203856,0.000011614001,0.0000071904747,0.000040267365],"genre_scores_gemma":[0.9978783,0.0018694259,0.00017055387,0.000015493646,0.0000093553435,0.000008595873,0.000023446259,0.000012846085,0.000011965773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901617,0.00007449198,0.0004204279,0.00012033613,0.00014026284,0.00022828585],"domain_scores_gemma":[0.99913573,0.00018315975,0.00042919637,0.00011427578,0.000059731356,0.00007792805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104834326,0.00012641224,0.00084271585,0.0002850158,0.000034021476,0.0000034274462,0.00006328154,0.000037822556,0.000041972315],"category_scores_gemma":[0.000051817264,0.00008013216,0.00008708979,0.0003766561,0.00022243572,0.000055779485,0.00004333488,0.00015211456,0.000007401516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003094672,0.0004178445,0.99173653,0.000025013387,0.0001275316,0.0052134204,0.000255727,0.000009855125,0.00007919023,0.000012220596,0.000047575173,0.0017656097],"study_design_scores_gemma":[0.003577965,0.0067276396,0.9859483,0.000048764614,0.00012583894,0.003239745,0.00014956633,0.0000047715193,0.000051819785,0.000052714477,0.0000051351403,0.00006773864],"about_ca_topic_score_codex":0.0000837791,"about_ca_topic_score_gemma":0.000025194593,"teacher_disagreement_score":0.006309795,"about_ca_system_score_codex":0.00011104741,"about_ca_system_score_gemma":0.00011487043,"threshold_uncertainty_score":0.32676947},"labels":[],"label_agreement":null},{"id":"W4360983730","doi":"10.1002/ajh.26920","title":"<i>JAK2</i> unmutated erythrocytosis: 2023 Update on diagnosis and management","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.015402661478499939,"score_gpt":0.29491209372074717,"score_spread":0.2795094322422472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360983730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97781485,0.0006439571,0.000029361316,0.01999423,0.0001672227,0.00027283028,0.0000093380995,0.00003951909,0.0010286955],"genre_scores_gemma":[0.9792962,0.016298788,0.0012324054,0.0028819423,0.000058153917,0.0000864236,0.000010609989,0.0000262472,0.000109238936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986368,0.000094204624,0.00046765132,0.00023031468,0.00026301303,0.0003080453],"domain_scores_gemma":[0.9988562,0.000296067,0.00034942402,0.00017970048,0.000103206905,0.00021544339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020023926,0.00019533465,0.00080852566,0.00040640202,0.00007430622,0.0000143794805,0.00007893472,0.00003897221,0.00009705426],"category_scores_gemma":[0.000056512785,0.000142132,0.00012507272,0.00056054804,0.0002248334,0.000047281057,0.00005333625,0.00018100573,0.00020331709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021151674,0.001909045,0.6391939,0.00038451244,0.004791165,0.020410921,0.0007819651,0.000077793746,0.000132112,0.020053437,0.14489493,0.16525507],"study_design_scores_gemma":[0.023921775,0.037816223,0.62002075,0.003878797,0.003963424,0.02733027,0.008607542,0.00025592156,0.042616803,0.0030109466,0.22708766,0.0014899154],"about_ca_topic_score_codex":0.0000111957315,"about_ca_topic_score_gemma":0.000006581089,"teacher_disagreement_score":0.16376516,"about_ca_system_score_codex":0.00005356046,"about_ca_system_score_gemma":0.000038092454,"threshold_uncertainty_score":0.57959753},"labels":[],"label_agreement":null},{"id":"W4366352141","doi":"10.1002/ajh.26933","title":"Sodium‐glucose co‐transporter‐2 inhibitor use and <i>JAK2</i> unmutated erythrocytosis in 100 consecutive cases","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Erythropoietin; Canagliflozin; Internal medicine; Hematocrit; Diabetes mellitus; Endocrinology; Type 2 diabetes","score_opus":0.024676470683525832,"score_gpt":0.28041496752649064,"score_spread":0.2557384968429648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366352141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8340897,0.0008128322,0.000013395703,0.1639318,0.00042833295,0.00047901008,0.00007710663,0.00005231431,0.000115504896],"genre_scores_gemma":[0.7017079,0.0033085083,0.00088333833,0.29193255,0.0007607864,0.000050505303,0.00037583627,0.00018932216,0.00079126353],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975052,0.000191786,0.0009839067,0.0003882461,0.00035380793,0.00057706336],"domain_scores_gemma":[0.99744177,0.0009734553,0.00097418245,0.00026575776,0.000179237,0.00016562632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019720643,0.00045088376,0.0021515402,0.000993138,0.000041576528,0.00003501884,0.00013343806,0.00026793077,0.000044199965],"category_scores_gemma":[0.0001313269,0.00037187114,0.0002610781,0.00045015308,0.0008630638,0.00014397601,0.000044602064,0.0011634206,0.00003162753],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008884034,0.00032166063,0.073772766,0.0004824269,0.002153525,0.16071714,0.0006719383,8.0762624e-7,0.00011587347,0.000030266816,0.7579608,0.0028844075],"study_design_scores_gemma":[0.018014044,0.019128678,0.021080276,0.005552056,0.0070274286,0.038875055,0.00475126,0.000014494066,0.0076488433,0.0002337359,0.8757848,0.0018893406],"about_ca_topic_score_codex":0.00027553705,"about_ca_topic_score_gemma":0.00006390737,"teacher_disagreement_score":0.13238181,"about_ca_system_score_codex":0.00014718554,"about_ca_system_score_gemma":0.00022056204,"threshold_uncertainty_score":0.99987334},"labels":[],"label_agreement":null},{"id":"W4368356099","doi":"10.1002/ajh.26932","title":"Stereochemistry and functions of the new cysteinyl‐resolvin, <scp>4S</scp>,<scp>5R‐RCTR1</scp>, in efferocytosis and erythrophagocytosis of human senescent erythrocytes","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Efferocytosis; Phagocytosis; Lipid signaling; Phagocyte; Inflammation; Macrophage; Chemistry; Docosahexaenoic acid; Apoptosis; Mediator; Biochemistry; Phosphatidylserine; Cell biology; Biology; In vitro; Immunology; Fatty acid; Receptor; Polyunsaturated fatty acid; Phospholipid; Membrane","score_opus":0.014947140477903128,"score_gpt":0.2877475472222326,"score_spread":0.2728004067443295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4368356099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437135,0.0028821877,0.000052454827,0.0020760705,0.00022272636,0.00021034604,0.000020029014,0.000019088051,0.00014575917],"genre_scores_gemma":[0.99846137,0.000753717,0.0003655599,0.00015724044,0.00009722943,0.000005713597,0.000003700604,0.000033949484,0.000121521676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99720573,0.00038723377,0.0010064164,0.0002982629,0.00045705916,0.00064532075],"domain_scores_gemma":[0.99619234,0.0018515048,0.0010317543,0.00036693655,0.00021183066,0.0003456081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005477433,0.0002542471,0.0011073863,0.00046482147,0.00021764514,0.000025129828,0.00034996873,0.00013471227,0.00001021206],"category_scores_gemma":[0.0011206873,0.00019766137,0.00017813302,0.00094131305,0.001197425,0.000120556346,0.00021572241,0.00063603587,0.0000037534287],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032898327,0.000544845,0.46512485,0.0022600219,0.00047723754,0.00018225638,0.009019207,0.000060708764,0.48157683,0.00024007724,0.028529374,0.011655628],"study_design_scores_gemma":[0.004476656,0.0043448117,0.15938178,0.0014979802,0.00022918035,0.0028124547,0.033318292,0.00013143136,0.79115474,0.0008270812,0.0016832907,0.00014228135],"about_ca_topic_score_codex":0.0005390262,"about_ca_topic_score_gemma":0.00021646089,"teacher_disagreement_score":0.30957794,"about_ca_system_score_codex":0.000098963246,"about_ca_system_score_gemma":0.00023569442,"threshold_uncertainty_score":0.8060397},"labels":[],"label_agreement":null},{"id":"W4375955263","doi":"10.1002/ajh.26950","title":"Recurrent severe thrombocytopenia in critical illness complicated by hemolysis","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto; Hamilton Health Sciences; Hamilton General Hospital; Hamilton Regional Laboratory Medicine Program; Trillium Health Centre","funders":"","keywords":"Medicine; Disseminated intravascular coagulation; Sepsis; Internal medicine; Platelet; Gastroenterology; Acute kidney injury; Intensive care unit; Anesthesia","score_opus":0.03492234752198582,"score_gpt":0.3655232383113049,"score_spread":0.3306008907893191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375955263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98534906,0.0002987736,0.000109015906,0.012850966,0.00030751745,0.00017450338,0.000011715015,0.000054351156,0.00084410136],"genre_scores_gemma":[0.99810475,0.00032450297,0.000713663,0.000690344,0.000056666828,0.000012112495,0.000019446079,0.00004005444,0.00003844608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974588,0.0002588163,0.0009920422,0.00033446125,0.0003437918,0.0006120475],"domain_scores_gemma":[0.99810696,0.00054401724,0.00036722812,0.00035359932,0.00025613434,0.00037205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046982267,0.00025477458,0.0019090559,0.0005041608,0.000083385006,0.000019010322,0.0003045097,0.000117746946,0.00027171758],"category_scores_gemma":[0.00048236898,0.00021526328,0.00023104616,0.0015873277,0.0005968799,0.00013137616,0.00010939384,0.000656308,0.0002391307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038460556,0.005209132,0.4871161,0.00080867566,0.002512689,0.010451569,0.006075675,0.00003194122,0.18977587,0.014850586,0.12158193,0.15773977],"study_design_scores_gemma":[0.023385227,0.018021867,0.65862465,0.0032265054,0.0023260966,0.104220085,0.023951704,0.0014237482,0.092633896,0.0067616096,0.061724428,0.003700167],"about_ca_topic_score_codex":0.00010006271,"about_ca_topic_score_gemma":0.000019969264,"teacher_disagreement_score":0.17150855,"about_ca_system_score_codex":0.00014645705,"about_ca_system_score_gemma":0.00023052545,"threshold_uncertainty_score":0.87781817},"labels":[],"label_agreement":null},{"id":"W4377093091","doi":"10.1002/ajh.26935","title":"Comprehensive profiling of clinical <scp>JAK</scp> inhibitors in myeloproliferative neoplasms","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Cancer Institute; MPN Research Foundation; National Institutes of Health; Alvin J. Siteman Cancer Center; Institute of Clinical and Translational Sciences; Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"Ruxolitinib; Myeloproliferative neoplasm; Cancer research; Janus kinase; STAT3; stat; Myelofibrosis; Biology; Medicine; Pharmacology; Cytokine; Signal transduction; Immunology; Bone marrow; Genetics","score_opus":0.04216840408838109,"score_gpt":0.3690324555668604,"score_spread":0.3268640514784793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377093091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967293,0.0006381957,0.000043678338,0.001341499,0.0004187271,0.00040290054,0.000008595841,0.000023123343,0.00039396517],"genre_scores_gemma":[0.99367654,0.0008990331,0.0046596294,0.00046797874,0.00018710655,0.000027186188,0.0000111978625,0.00003125798,0.000040049566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964171,0.00043939686,0.0019876645,0.00031208104,0.00041152106,0.00043221505],"domain_scores_gemma":[0.9945965,0.0028543754,0.0014437963,0.00022432464,0.00060714205,0.00027387647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006419931,0.00026675442,0.0022103735,0.0006160015,0.000045321893,0.0000079552,0.00013849935,0.00012746445,0.000016427784],"category_scores_gemma":[0.0013331318,0.0001996181,0.00036609496,0.0009859191,0.0006251993,0.000086772925,0.0000712459,0.0006271787,0.000045912362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031808106,0.00063772855,0.98434424,0.00009529567,0.0005177826,0.0017633855,0.0014040114,0.000081860526,0.00072349067,0.0015339572,0.0018297819,0.006750353],"study_design_scores_gemma":[0.011459012,0.015428585,0.8311599,0.0012121416,0.00039809637,0.006624494,0.020194354,0.0006337463,0.108144216,0.0008398028,0.0036657322,0.00023990488],"about_ca_topic_score_codex":0.000031710668,"about_ca_topic_score_gemma":0.000017893175,"teacher_disagreement_score":0.15318435,"about_ca_system_score_codex":0.000058560454,"about_ca_system_score_gemma":0.00052305305,"threshold_uncertainty_score":0.81401896},"labels":[],"label_agreement":null},{"id":"W4378172560","doi":"10.1002/ajh.26958","title":"Carbon monoxide as a clinical marker of hemolysis","year":2023,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Institute of Child Health and Human Development","keywords":"Hemolysis; Carboxyhemoglobin; Carbon monoxide; Heme; Medicine; Hematology; Internal medicine; Chemistry; Gastroenterology; Biochemistry; Catalysis","score_opus":0.03504164081012351,"score_gpt":0.381328292745936,"score_spread":0.3462866519358125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378172560","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04011447,0.9585604,0.00003562448,0.00006196564,0.00041340562,0.00018637016,0.000016420514,0.000008747603,0.00060257205],"genre_scores_gemma":[0.0034604778,0.9950107,0.0005613405,0.00011648015,0.00038276752,0.000014788631,0.000025461803,0.00010403834,0.00032395683],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955745,0.00084755215,0.0024588457,0.00044186908,0.00026731644,0.00040997047],"domain_scores_gemma":[0.9953285,0.00028415644,0.0032291876,0.0006604239,0.00022957109,0.0002681821],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011008037,0.0004337961,0.0038426137,0.00031467073,0.00002158364,0.000008171006,0.0006728099,0.00045642589,0.000020304165],"category_scores_gemma":[0.0007206648,0.00034756452,0.00182828,0.0004485664,0.00055163464,0.0000024811281,0.00021041726,0.0005548205,0.000024236255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030648394,0.00028751162,0.00089299463,0.0033182255,0.0049799024,0.0008921171,0.000031422245,0.0000019969907,0.00040870416,0.000116909294,0.003834252,0.9849295],"study_design_scores_gemma":[0.00055847067,0.002515669,0.00003393153,0.0028154415,0.0019233219,0.005715622,0.0002411185,0.0000031589332,0.00081251,0.00008238585,0.9846995,0.0005988552],"about_ca_topic_score_codex":0.00006143603,"about_ca_topic_score_gemma":0.000015504958,"teacher_disagreement_score":0.98433065,"about_ca_system_score_codex":0.000025742902,"about_ca_system_score_gemma":0.0009744457,"threshold_uncertainty_score":0.99989766},"labels":[],"label_agreement":null},{"id":"W4381158392","doi":"10.1002/ajh.26990","title":"A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (<scp>CARAMEL</scp>)","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Carfilzomib; Medicine; Melphalan; Multiple myeloma; Autologous stem-cell transplantation; Clinical endpoint; Internal medicine; Transplantation; Urology; Cohort; Oncology; Adverse effect; Surgery; Lenalidomide; Clinical trial","score_opus":0.028734602147727665,"score_gpt":0.3382647170175598,"score_spread":0.3095301148698321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381158392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931231,0.00035607113,0.005327923,0.00024240317,0.000064255764,0.0006403586,0.0001800819,0.00002223976,0.000043550062],"genre_scores_gemma":[0.99400693,0.0001734168,0.005434628,0.000048319667,0.00003996321,0.00007590642,0.00010222362,0.000024567144,0.00009405451],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986932,0.00007720963,0.0005081489,0.00016960572,0.00017462591,0.00037715974],"domain_scores_gemma":[0.99689275,0.0019704015,0.00051861315,0.00010434,0.00030663918,0.00020726645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027627795,0.00013922516,0.00076249725,0.0003577418,0.00008682295,0.00000848491,0.00007539701,0.00005857789,0.000002835304],"category_scores_gemma":[0.00023341803,0.00011400629,0.00016899603,0.00022011205,0.00025900945,0.000070549046,0.000011317741,0.00011658634,0.0000022343186],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018686974,0.004294836,0.34846827,0.008574952,0.0051247412,0.007310084,0.020847145,0.00013729473,0.20347303,0.0033194846,0.007683621,0.37207955],"study_design_scores_gemma":[0.12672253,0.056901563,0.11747826,0.00075518084,0.002125394,0.020619985,0.03337185,0.012890739,0.6251783,0.0011363679,0.002479091,0.00034073467],"about_ca_topic_score_codex":0.000024645691,"about_ca_topic_score_gemma":0.0000068439904,"teacher_disagreement_score":0.42170528,"about_ca_system_score_codex":0.000029463992,"about_ca_system_score_gemma":0.0001446618,"threshold_uncertainty_score":0.46490416},"labels":[],"label_agreement":null},{"id":"W4381470212","doi":"10.1002/ajh.26994","title":"Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplasty","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Institute for Clinical Evaluative Sciences; Ottawa Hospital; Bruyère; University of Ottawa","funders":"Servier; University of Ottawa; LEO Pharma; Ottawa Hospital Research Institute; Pfizer","keywords":"Medicine; Venous thromboembolism; Kidney disease; Arthroplasty; Anticoagulant; Hip arthroplasty; Surgery; Internal medicine; Thrombosis","score_opus":0.010248397083041342,"score_gpt":0.26176314311540816,"score_spread":0.25151474603236684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381470212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971373,0.00027091496,0.00013726405,0.0013404351,0.00029986323,0.0006566788,0.000044638393,0.000048230737,0.00006463823],"genre_scores_gemma":[0.99729115,0.00056933064,0.00097474444,0.00074546033,0.00018684992,0.00005647527,0.000009962543,0.00007053599,0.00009552055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738747,0.00020046312,0.00081577705,0.00035236657,0.0006370634,0.00060688594],"domain_scores_gemma":[0.99704635,0.00030229345,0.0013295184,0.0005202276,0.00018413788,0.0006174529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040188673,0.00034562967,0.0020183139,0.00057385967,0.000094128925,0.000020542137,0.00017213765,0.00005732888,0.00042382916],"category_scores_gemma":[0.00047323323,0.00019842808,0.00022237109,0.000786339,0.000808691,0.000118675925,0.00009436307,0.000444742,0.00006887149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01768898,0.008731467,0.8460411,0.0038777504,0.0057383566,0.06160924,0.003364038,0.00056725077,0.0002407088,0.00062756625,0.008709731,0.042803813],"study_design_scores_gemma":[0.004370483,0.02678297,0.9585158,0.0012934469,0.002727737,0.0027316927,0.0011372331,0.00014293716,0.0005744546,0.0001185841,0.0012263536,0.00037830343],"about_ca_topic_score_codex":0.00008391297,"about_ca_topic_score_gemma":0.000031459527,"teacher_disagreement_score":0.11247471,"about_ca_system_score_codex":0.00010208042,"about_ca_system_score_gemma":0.00096018676,"threshold_uncertainty_score":0.8091662},"labels":[],"label_agreement":null},{"id":"W4382011805","doi":"10.1002/ajh.27007","title":"Classification of accelerated phase chronic myeloid leukemia in the era of the <scp>BCR</scp>::<scp>ABL1</scp> tyrosine kinase inhibitors: A work in progress","year":2023,"lang":"en","type":"editorial","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Takeda Canada; Ascentage Pharma; British Mycological Society; Novartis","keywords":"Myeloid leukemia; Tyrosine kinase; Cancer research; Medicine; Internal medicine; Receptor","score_opus":0.017855564900483584,"score_gpt":0.30960908258422964,"score_spread":0.2917535176837461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382011805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90955967,0.0053737448,0.000007969921,0.0006106712,0.08297219,0.0012559545,0.00008008154,0.000030208097,0.00010953821],"genre_scores_gemma":[0.937661,0.0019342992,0.00028556256,0.00007555718,0.059257187,0.00019103794,0.00022879694,0.00018767793,0.00017890644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929464,0.00106048,0.0028876832,0.0006125309,0.0015735204,0.00091939425],"domain_scores_gemma":[0.98614985,0.006253105,0.0054381927,0.0011311707,0.0008286471,0.00019905034],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00161946,0.0007061655,0.0028854317,0.0008473077,0.00008052172,0.0000331954,0.0012295196,0.0007743356,0.000015695556],"category_scores_gemma":[0.006827075,0.0004522725,0.0005269475,0.003700227,0.0016882465,0.00014914107,0.00019454,0.0037524558,0.000017012213],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00069429644,0.0021351678,0.018888494,0.0012488896,0.0010844397,0.0016913753,0.0053534256,0.00012846426,0.002889188,0.000059917344,0.951512,0.014314343],"study_design_scores_gemma":[0.119970225,0.032127213,0.08731573,0.05138699,0.0057285577,0.0053987973,0.03458574,0.0010681659,0.042809036,0.00038945387,0.6182408,0.0009793116],"about_ca_topic_score_codex":0.00042217082,"about_ca_topic_score_gemma":0.00018994622,"teacher_disagreement_score":0.3332712,"about_ca_system_score_codex":0.004149049,"about_ca_system_score_gemma":0.009951271,"threshold_uncertainty_score":0.9997929},"labels":[],"label_agreement":null},{"id":"W4385667521","doi":"10.1002/ajh.27052","title":"Re‐assessing the effect of fetal hemoglobin on stroke in the Cooperative Study of Sickle Cell Disease","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Montreal Heart Institute","funders":"Canadian Institutes of Health Research","keywords":"Fetal hemoglobin; Medicine; Stroke (engine); Disease; Fetus; Hemoglobin; Cell; Internal medicine; Pregnancy; Intensive care medicine; Pediatrics; Biology; Genetics","score_opus":0.009550435321044886,"score_gpt":0.2921621345025671,"score_spread":0.28261169918152224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385667521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87615645,0.00061358657,0.000007892661,0.12180047,0.00026938753,0.0007016516,0.00001549549,0.0000064105257,0.00042865492],"genre_scores_gemma":[0.9759437,0.00009891597,0.00001327595,0.023560576,0.00019424803,0.0000142441695,0.000009261482,0.00004514982,0.00012063916],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.99592763,0.0018187803,0.0010278334,0.00023153707,0.0006521415,0.00034208744],"domain_scores_gemma":[0.995424,0.0023709936,0.0015027386,0.00047622315,0.0001546833,0.00007141178],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0008964898,0.00032495114,0.001726459,0.00035260082,0.00007258886,0.000013139612,0.00043933876,0.0001808039,0.000024407778],"category_scores_gemma":[0.00038050447,0.0001505388,0.00035036032,0.0005929976,0.0007436261,0.00003596979,0.000056161003,0.0025980107,0.000006774146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076042116,0.004721238,0.19843543,0.003425229,0.0038503488,0.053311344,0.024164956,0.0016922343,0.0005949094,0.000033005323,0.6914489,0.01071816],"study_design_scores_gemma":[0.057895858,0.25846407,0.05032296,0.012220207,0.014805376,0.0086632855,0.544627,0.0008351883,0.006590313,0.00014711135,0.04286197,0.0025666354],"about_ca_topic_score_codex":0.00012410418,"about_ca_topic_score_gemma":0.000011639407,"teacher_disagreement_score":0.648587,"about_ca_system_score_codex":0.000050650873,"about_ca_system_score_gemma":0.00028506314,"threshold_uncertainty_score":0.99970305},"labels":[],"label_agreement":null},{"id":"W4386303249","doi":"10.1002/ajh.27073","title":"Risk of progression in chronic <scp>phase‐chronic</scp> myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the <scp>TFR‐PRO</scp> study","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University; Jewish General Hospital","funders":"Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca; Università degli Studi di Milano-Bicocca","keywords":"Discontinuation; Medicine; Cohort; Internal medicine; Myeloid leukemia; Prospective cohort study; Cohort study; Oncology","score_opus":0.016880785678153112,"score_gpt":0.32471810413039887,"score_spread":0.30783731845224577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386303249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964696,0.0013681657,0.00013042867,0.00011587901,0.00024626643,0.0015113007,0.000091405986,0.00002297983,0.000043950313],"genre_scores_gemma":[0.998599,0.00029876945,0.00050386967,0.000027180207,0.00015952901,0.00011250403,0.00008290038,0.000051834588,0.00016444031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956047,0.0004413851,0.0019550254,0.0004698503,0.00085497805,0.0006740925],"domain_scores_gemma":[0.99369955,0.0013556017,0.0034472377,0.0006797017,0.0006205635,0.00019735962],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096677704,0.000394393,0.0021336437,0.0012222936,0.00012084647,0.000013882353,0.0004362337,0.0001343649,0.000014670274],"category_scores_gemma":[0.0019134098,0.00026839811,0.00066503417,0.0034036313,0.0005678896,0.00015369983,0.00018552366,0.00052788144,0.000006340479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030764766,0.0028880362,0.96042967,0.00025690254,0.0034681056,0.00014027009,0.0029000419,0.0015204825,0.003571359,0.000038471244,0.0024114463,0.022067565],"study_design_scores_gemma":[0.046477724,0.03293223,0.83967406,0.0015410769,0.00894291,0.00019305512,0.00818399,0.0071145995,0.053323902,0.000097959906,0.0013608478,0.00015764066],"about_ca_topic_score_codex":0.00023231626,"about_ca_topic_score_gemma":0.0003290733,"teacher_disagreement_score":0.12075561,"about_ca_system_score_codex":0.002153057,"about_ca_system_score_gemma":0.0023941244,"threshold_uncertainty_score":0.9999768},"labels":[],"label_agreement":null},{"id":"W4386415343","doi":"10.1002/ajh.27079","title":"A globally applicable “triple <scp>A</scp>” risk model for essential thrombocythemia based on <scp>A</scp>ge, <scp>A</scp>bsolute neutrophil count, and <scp>A</scp>bsolute lymphocyte count","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Associazione Italiana per la Ricerca sul Cancro; Università degli Studi di Firenze; Ministero della Salute","keywords":"Medicine; Myelofibrosis; Internal medicine; Essential thrombocythemia; Absolute neutrophil count; Gastroenterology; Akaike information criterion; International Prognostic Scoring System; Lymphocyte; Neutropenia; Myelodysplastic syndromes; Bone marrow; Platelet; Chemotherapy","score_opus":0.014006456477845966,"score_gpt":0.27438056488019474,"score_spread":0.26037410840234876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386415343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728652,0.00343054,0.014312897,0.0011198048,0.0009748263,0.0027368814,0.0011846669,0.00032707726,0.0030480826],"genre_scores_gemma":[0.9656832,0.009252416,0.013611437,0.0049519013,0.0012436019,0.0010384826,0.00035226325,0.0005409762,0.0033257147],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9896568,0.00056713726,0.0027751268,0.0019697533,0.0020523258,0.0029788574],"domain_scores_gemma":[0.98112476,0.010676772,0.0036325408,0.0014365817,0.0014312104,0.0016981313],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0018253872,0.0017750782,0.0047181277,0.0012030021,0.0009568832,0.00030201167,0.0010515708,0.000706413,0.000017995175],"category_scores_gemma":[0.0044723647,0.0015306007,0.0012286224,0.0018826872,0.0014542058,0.0004420925,0.00037735832,0.0014473205,0.0002303723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011296505,0.007022245,0.09408377,0.0016880566,0.008997803,0.0055022915,0.0076140994,0.03072522,0.0065871566,0.009159508,0.8232318,0.0042583584],"study_design_scores_gemma":[0.07207309,0.027601441,0.033093896,0.0027215069,0.010099064,0.016900806,0.017669136,0.46085572,0.037067443,0.007786634,0.31316552,0.00096574036],"about_ca_topic_score_codex":0.0003535242,"about_ca_topic_score_gemma":0.00016336949,"teacher_disagreement_score":0.51006633,"about_ca_system_score_codex":0.0010616708,"about_ca_system_score_gemma":0.002365364,"threshold_uncertainty_score":0.9994995},"labels":[],"label_agreement":null},{"id":"W4386466734","doi":"10.1002/ajh.27088","title":"A novel missense variant in <scp><i>ATP11C</i></scp> is associated with reduced red blood cell phosphatidylserine flippase activity and mild hereditary hemolytic anemia","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Tokyo Women's Medical University","keywords":"Flippase; Phosphatidylserine; Red blood cell; Cell biology; Biology; Echinocyte; Biochemistry; Chemistry; Phospholipid; Membrane","score_opus":0.012570485368829022,"score_gpt":0.24239866990177783,"score_spread":0.22982818453294881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386466734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964714,0.00031384404,0.000049949806,0.0024950462,0.0002161698,0.00018990417,0.000014615022,0.000048064037,0.00020100626],"genre_scores_gemma":[0.99636126,0.00028966516,0.0013091045,0.0016016796,0.000099363766,0.0000066805287,0.00001464227,0.000043772667,0.00027386472],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9981943,0.00017415358,0.00055632513,0.00034770064,0.00024544192,0.00048212023],"domain_scores_gemma":[0.99762505,0.0008599648,0.00074858306,0.00025665612,0.0001957405,0.00031400757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035753878,0.00027320068,0.0012117396,0.00038635914,0.00006161288,0.000007862975,0.000099607685,0.00014612716,0.000036552345],"category_scores_gemma":[0.0005793769,0.00022147027,0.00010863656,0.0010011625,0.00035673525,0.00008775041,0.00004914673,0.0006318494,0.000009899897],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005690701,0.004007681,0.02059395,0.00056961755,0.0013585982,0.09659515,0.005447335,0.00011187653,0.83898443,0.00003969171,0.024198936,0.0024020155],"study_design_scores_gemma":[0.053869013,0.031346522,0.27358553,0.0019105308,0.0021455248,0.38692492,0.013195672,0.002432223,0.23220465,0.00028027847,0.0012503035,0.00085482973],"about_ca_topic_score_codex":0.00011289597,"about_ca_topic_score_gemma":0.000035501234,"teacher_disagreement_score":0.6067798,"about_ca_system_score_codex":0.00005442814,"about_ca_system_score_gemma":0.0003060715,"threshold_uncertainty_score":0.9031295},"labels":[],"label_agreement":null},{"id":"W4386817435","doi":"10.1002/ajh.27098","title":"Bone marrow fibrosis is associated with non‐response to <scp>CD19 CAR T</scp>‐cell therapy in <scp>B</scp>‐acute lymphoblastic leukemia","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"CURE Childhood Cancer Association","keywords":"Stromal cell; Bone marrow; Medicine; CD19; Fibrosis; T cell; Cancer research; B cell; Myelofibrosis; Cell therapy; Immunology; Pathology; Cell; Flow cytometry; Biology; Immune system; Antibody","score_opus":0.012103395241732408,"score_gpt":0.2796308972548362,"score_spread":0.26752750201310377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386817435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965361,0.00038737323,0.00009708182,0.0017084153,0.0001601164,0.0005354855,0.000028395583,0.00006998186,0.00047707773],"genre_scores_gemma":[0.98945224,0.0007717193,0.00058025477,0.0020685603,0.000105673564,0.000046807087,0.000012900111,0.00015236883,0.006809503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953598,0.00072261324,0.0010393576,0.0005299538,0.001049992,0.0012983232],"domain_scores_gemma":[0.9915864,0.005761989,0.0008114236,0.00057497784,0.00053570274,0.0007295181],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015815387,0.00047343937,0.0019951996,0.0017089873,0.000103762184,0.00004550934,0.0004776378,0.000215477,0.0001730164],"category_scores_gemma":[0.0019055244,0.0003839406,0.00035462296,0.0033595944,0.0005358109,0.000117170726,0.00011604718,0.00087256246,0.00021987758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00586323,0.00062317745,0.08164273,0.000079855476,0.0018081156,0.014303101,0.013406591,0.00032193444,0.81102604,0.000007791195,0.06650334,0.0044141193],"study_design_scores_gemma":[0.051424637,0.07244724,0.29093808,0.0024474722,0.0010601939,0.030748215,0.042049516,0.0021284106,0.45506972,0.00021292648,0.05073254,0.0007410599],"about_ca_topic_score_codex":0.00015644306,"about_ca_topic_score_gemma":0.000040104147,"teacher_disagreement_score":0.3559563,"about_ca_system_score_codex":0.0009136392,"about_ca_system_score_gemma":0.0015475987,"threshold_uncertainty_score":0.99986124},"labels":[],"label_agreement":null},{"id":"W4387563093","doi":"10.1002/ajh.27123","title":"Severe autoimmune heparin‐induced thrombocytopenia postcardiac surgery: Implications for subsequent cardiac surgery","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program; Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Medicine; Cardiology; Partial thromboplastin time; Internal medicine; Atrial fibrillation; Mitral valve replacement; Myocardial infarction; Cardiac surgery; Surgery; Heart failure; Mitral valve; Platelet","score_opus":0.05798426349889981,"score_gpt":0.330738227842445,"score_spread":0.2727539643435452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387563093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982941,0.00045330657,0.00009781853,0.013684609,0.0015840968,0.0006458555,0.00007017392,0.00014666273,0.00037649323],"genre_scores_gemma":[0.99695027,0.0010453268,0.00068337034,0.0005721976,0.00035224768,0.00010281572,0.00011715401,0.00010592199,0.0000706745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99628943,0.00036553852,0.0015808431,0.00047109512,0.00033402146,0.000959074],"domain_scores_gemma":[0.99373823,0.0029858283,0.0011910824,0.0007916642,0.0008087854,0.00048440142],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017300913,0.000412398,0.004041034,0.0008671817,0.00024564448,0.000040585357,0.00030556414,0.00019443285,0.000062117266],"category_scores_gemma":[0.0011426493,0.00036557636,0.0016336415,0.0015302165,0.0003528875,0.00022348645,0.00012033684,0.00047814692,0.0001391323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008678293,0.00048787938,0.769532,0.00030066102,0.0042505804,0.00029511322,0.0006830248,0.0000075161192,0.08812625,0.0040416187,0.07799308,0.05341444],"study_design_scores_gemma":[0.0008026329,0.0008607009,0.9629081,0.00027367412,0.0009606831,0.004341467,0.0009818957,0.000014010678,0.012328625,0.00074342004,0.015170638,0.00061418855],"about_ca_topic_score_codex":0.00016823498,"about_ca_topic_score_gemma":0.0000098266855,"teacher_disagreement_score":0.19337606,"about_ca_system_score_codex":0.00024831895,"about_ca_system_score_gemma":0.0015143404,"threshold_uncertainty_score":0.9998796},"labels":[],"label_agreement":null},{"id":"W4387799247","doi":"10.1002/ajh.27134","title":"Lung function decline in children with sickle cell disease treated with hydroxyurea","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Lung function; Disease; Sickle cell anemia; Intensive care medicine; Pediatrics; Lung; Internal medicine","score_opus":0.0037829985380958345,"score_gpt":0.21570553633115866,"score_spread":0.21192253779306283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387799247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7545743,0.0014372544,0.00016805028,0.24293588,0.000108220156,0.00043068003,0.000014514813,0.00005571335,0.00027538653],"genre_scores_gemma":[0.81711644,0.00073566457,0.00030555512,0.17969039,0.0007116594,0.000019781153,0.00033978646,0.00021642755,0.0008642611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794346,0.00014439621,0.0006600445,0.00032612003,0.00042998625,0.00049601623],"domain_scores_gemma":[0.99821746,0.00011127895,0.000959076,0.00031287942,0.00016336366,0.0002359529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001332909,0.00038816125,0.0013680803,0.0006629111,0.00004373251,0.000012020801,0.00015893504,0.00029196753,0.000057201174],"category_scores_gemma":[0.000032242428,0.00023725492,0.00017630735,0.0007778264,0.00045406193,0.000055397377,0.000030427727,0.0021767044,0.000027957994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003468715,0.00029658157,0.7134916,0.00022192781,0.0011616186,0.01674575,0.000087458124,0.00018388394,0.000008591325,0.000003959028,0.26310527,0.0012245893],"study_design_scores_gemma":[0.05794953,0.05589662,0.5465885,0.009991528,0.022537388,0.10151863,0.002879302,0.00096166495,0.00023797539,0.00027138452,0.19693637,0.0042311214],"about_ca_topic_score_codex":0.00024428344,"about_ca_topic_score_gemma":0.000022144479,"teacher_disagreement_score":0.16690315,"about_ca_system_score_codex":0.00009370009,"about_ca_system_score_gemma":0.0004774369,"threshold_uncertainty_score":0.96749747},"labels":[],"label_agreement":null},{"id":"W4389242311","doi":"10.1002/ajh.27167","title":"Dosage of high‐dose methotrexate as <scp>CNS</scp> prophylaxis in <scp>DLBCL: A</scp> detailed analysis of toxicity and impact on <scp>CNS</scp> relapse","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center; Centre Léon Bérard; Cambridge University Hospitals; BeiGene; Aalborg Universitet; Gilead Sciences; Atara Biotherapeutics; Assistance publique-Hôpitaux de Paris; University Hospital Southampton NHS Foundation Trust; Aalborg Universitetshospital; Incyte; Brown University; University of Cambridge; University Hospitals Bristol NHS Foundation Trust; Celgene","keywords":"Methotrexate; Medicine; Retrospective cohort study; Internal medicine; Oncology; Lymphoma; Toxicity; Antifolate; Antimetabolite","score_opus":0.013641142485164737,"score_gpt":0.2928576976669626,"score_spread":0.2792165551817979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389242311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872299,0.0027570126,0.00003843457,0.007952149,0.00036424084,0.000857214,0.00036147804,0.00005154677,0.00038802018],"genre_scores_gemma":[0.983061,0.0025717635,0.0011519861,0.011665343,0.00039694938,0.000066123204,0.00021519227,0.00023956891,0.0006320611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9910752,0.0014935535,0.0033167994,0.001194938,0.0015014183,0.0014180893],"domain_scores_gemma":[0.9790565,0.01236162,0.0058918027,0.0013498379,0.00068708276,0.00065318285],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0014499697,0.0013390534,0.008327167,0.0052317106,0.000102105194,0.000049978087,0.00069729896,0.0010368703,0.000049278085],"category_scores_gemma":[0.00523053,0.0009917903,0.0022537266,0.0042088614,0.0012900459,0.0001666676,0.0002612333,0.0025364358,0.000048753922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005014737,0.0075788265,0.5515427,0.001875405,0.051649164,0.05456179,0.0063032694,0.00048789295,0.003275891,0.00021309491,0.30566865,0.016341843],"study_design_scores_gemma":[0.019975523,0.039795,0.83566594,0.003560667,0.027900249,0.011173074,0.0065519204,0.00024550367,0.036897995,0.0011120334,0.0166823,0.00043980934],"about_ca_topic_score_codex":0.0019279931,"about_ca_topic_score_gemma":0.00026595482,"teacher_disagreement_score":0.28898636,"about_ca_system_score_codex":0.0006254417,"about_ca_system_score_gemma":0.0008679677,"threshold_uncertainty_score":0.99993604},"labels":[],"label_agreement":null},{"id":"W4390053864","doi":"10.1002/ajh.27181","title":"Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Osteoporosis Canada; McMaster University; Princess Margaret Cancer Centre; McMaster University Medical Centre; Kingston Health Sciences Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Australian and New Zealand Society of Blood Transfusion; NHS Blood and Transplant","keywords":"Medicine; Myelodysplastic syndromes; Randomized controlled trial; Life expectancy; Blood transfusion; Chronic myelomonocytic leukemia; Transfusion therapy; Intensive care medicine; Pediatrics; Internal medicine; Population","score_opus":0.02184465338928655,"score_gpt":0.2907618449598854,"score_spread":0.26891719157059885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390053864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79603523,0.0024720537,0.000061951665,0.19767955,0.0010702312,0.0023283185,0.000050202747,0.000048500526,0.0002539421],"genre_scores_gemma":[0.9594609,0.0062611997,0.0006810069,0.03241589,0.0003392645,0.000076294105,0.00020584968,0.00015282384,0.00040675307],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9932993,0.0014681597,0.0031607863,0.0006191364,0.0008106934,0.0006419472],"domain_scores_gemma":[0.99009264,0.005735371,0.0029343204,0.0005143906,0.00055065716,0.00017264172],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014417276,0.00065827323,0.009706533,0.00083773874,0.00007645245,0.000015422589,0.00028848674,0.00050415535,0.000025316624],"category_scores_gemma":[0.0019490472,0.00037989308,0.00090671267,0.0006478576,0.0014064838,0.00005966687,0.000050843348,0.003005338,0.000016880218],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.905088,0.00047816636,0.0057408866,0.00043132342,0.0049124514,0.020832365,0.002906839,0.00017056947,0.000025318443,0.000003877189,0.059197254,0.00021296217],"study_design_scores_gemma":[0.9779737,0.006278712,0.00028290245,0.0039385995,0.003847464,0.0021002318,0.0037718683,0.00021127667,0.000027074273,0.00040374632,0.000656583,0.0005078704],"about_ca_topic_score_codex":0.00041832696,"about_ca_topic_score_gemma":0.00010137781,"teacher_disagreement_score":0.16526367,"about_ca_system_score_codex":0.00021502054,"about_ca_system_score_gemma":0.00047949777,"threshold_uncertainty_score":0.9998653},"labels":[],"label_agreement":null},{"id":"W4390492268","doi":"10.1002/ajh.27175","title":"A framework for the clinical implementation of optical genome mapping in hematologic malignancies","year":2024,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Radboud Universitair Medisch Centrum; Generalitat de Catalunya; Centres de Recerca de Catalunya","keywords":"Scope (computer science); Computer science; Medicine; Medical physics","score_opus":0.05847066041567659,"score_gpt":0.402547554615472,"score_spread":0.34407689419979537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390492268","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0074678543,0.9832755,0.008251489,0.00023811721,0.000346732,0.00035709082,0.000047877224,0.0000021652675,0.0000131867355],"genre_scores_gemma":[0.02615378,0.96295744,0.010449275,0.00006584473,0.00024471455,0.00005896397,0.000026318648,0.000027672093,0.00001598939],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975997,0.00021012322,0.001644663,0.00021863835,0.00008988595,0.00023694367],"domain_scores_gemma":[0.9978132,0.00046611042,0.0013178006,0.00024448076,0.000113710215,0.00004466489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080682506,0.00021190899,0.0015212636,0.00014788995,0.00003266299,0.000014738172,0.00038832924,0.00020981359,0.000020126461],"category_scores_gemma":[0.00018911158,0.00013091815,0.00071071694,0.00019414289,0.00033213315,0.0000030094272,0.000117952906,0.00031704854,0.0000046411833],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001710098,0.00040130474,0.0027678637,0.018474882,0.0055387095,0.00019774324,0.0013590694,0.000020160227,0.00015971027,0.12924154,0.0016543998,0.8400136],"study_design_scores_gemma":[0.00055150845,0.0018705614,0.00023741293,0.0036012952,0.0020466717,0.0064471406,0.0096766595,0.0000029266962,0.0001382033,0.004109467,0.9708236,0.0004945902],"about_ca_topic_score_codex":0.000008038131,"about_ca_topic_score_gemma":0.000009959417,"teacher_disagreement_score":0.96916914,"about_ca_system_score_codex":0.000025078798,"about_ca_system_score_gemma":0.0005175696,"threshold_uncertainty_score":0.53386873},"labels":[],"label_agreement":null},{"id":"W4390507753","doi":"10.1002/ajh.27171","title":"Risk factors and clinical impact of thrombosis during induction chemotherapy for pediatric acute lymphoblastic leukemia: A report from <scp>CYP‐C</scp>","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; McMaster University; McMaster Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine; Izaak Walton Killam Health Centre; Nova Scotia Cancer Centre; Hospital for Sick Children; Stollery Children's Hospital; Nova Scotia Health Authority","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Internal medicine; Induction chemotherapy; Acute lymphocytic leukemia; Cohort; Population; Retrospective cohort study; Univariate analysis; Oncology; Logistic regression; Chemotherapy; Pediatrics; Multivariate analysis; Leukemia; Lymphoblastic Leukemia; Confidence interval","score_opus":0.0186039726505061,"score_gpt":0.3538590728196733,"score_spread":0.3352551001691672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390507753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945013,0.0007861056,0.0037328778,0.0001860284,0.0004167916,0.00027215635,0.00005385093,0.000032439948,0.000018456069],"genre_scores_gemma":[0.9937857,0.0028847374,0.0025655637,0.000027421995,0.0006220562,0.0000064722494,0.000011625815,0.00006517697,0.000031287775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997127,0.0001672821,0.0014336358,0.0004116837,0.00041874102,0.00044165124],"domain_scores_gemma":[0.99441093,0.0032651324,0.0013038286,0.00030209863,0.00034043242,0.00037757802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006377282,0.00028818936,0.0015717543,0.0005584092,0.00006533322,0.00002529185,0.00016958766,0.00022305688,0.000026163945],"category_scores_gemma":[0.0021662794,0.00019581248,0.0006736602,0.00057505444,0.0005885687,0.00016082435,0.00006198442,0.000650993,0.000003715694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064054574,0.00019732493,0.98242044,0.00017930006,0.0049193557,0.0012105921,0.0008478911,0.000015579442,0.0035645722,0.000011954536,0.0037096937,0.002282756],"study_design_scores_gemma":[0.005970837,0.0067619467,0.95101404,0.00021489107,0.0032389872,0.024444934,0.0011596914,0.0015022991,0.0050879605,0.00035668237,0.00010539431,0.00014233687],"about_ca_topic_score_codex":0.0005137946,"about_ca_topic_score_gemma":0.0000036302936,"teacher_disagreement_score":0.031406395,"about_ca_system_score_codex":0.0008670242,"about_ca_system_score_gemma":0.002351852,"threshold_uncertainty_score":0.7985001},"labels":[],"label_agreement":null},{"id":"W4391395206","doi":"10.1002/ajh.27222","title":"Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and <scp>meta‐analysis</scp>","year":2024,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital; Ottawa Public Health; University of Ottawa","funders":"","keywords":"Medicine; Thrombophilia; Odds ratio; Internal medicine; Factor V Leiden; Meta-analysis; Methylenetetrahydrofolate reductase; Oncology; Venous thrombosis; Cancer; Prothrombin G20210A; Confidence interval; Thrombosis; Allele; Genetics; Gene; Biology","score_opus":0.019731462516299154,"score_gpt":0.3148006937872948,"score_spread":0.29506923127099566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391395206","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014959533,0.982744,0.000015293272,0.000084357845,0.00005973268,0.0020011426,0.00010785695,0.000010464461,0.000017668557],"genre_scores_gemma":[0.004879437,0.9941857,0.00044639313,0.00017639743,0.000019747857,0.00018958759,0.000031604657,0.000063379506,0.0000077425975],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9961502,0.0006342865,0.0020897267,0.0004176267,0.00038539286,0.0003227896],"domain_scores_gemma":[0.9949425,0.00052134215,0.0035972348,0.0004313401,0.0003123058,0.00019529894],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0006626039,0.00052867876,0.018743746,0.0011659629,0.000043343978,0.000020294561,0.00019599806,0.00012117043,0.000017340026],"category_scores_gemma":[0.00024748058,0.00031437562,0.0009576783,0.0017881982,0.0004562834,0.000066421606,0.00010065656,0.0005992543,0.0000028096522],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000049886617,0.0007105355,0.0013937788,0.7333894,0.2598361,0.00018137913,0.0004960503,0.000003332352,4.215913e-8,0.00010165271,0.00019827121,0.0036845095],"study_design_scores_gemma":[0.0004037349,0.0013421415,0.0026344475,0.113011256,0.8807418,0.00057824486,0.00017202976,0.0000020920363,1.8956749e-7,0.000036461923,0.0009473765,0.00013026681],"about_ca_topic_score_codex":0.00026915022,"about_ca_topic_score_gemma":0.000070425966,"teacher_disagreement_score":0.62090564,"about_ca_system_score_codex":0.00008232979,"about_ca_system_score_gemma":0.00028701714,"threshold_uncertainty_score":0.99993086},"labels":[],"label_agreement":null},{"id":"W4391401303","doi":"10.1002/ajh.27223","title":"Iron‐triggered signaling via <scp>ETS1</scp> and the p38/<scp>JNK MAPK</scp> pathway regulates <i>Bmp6</i> expression","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Trace Elements in Health","field":"Nursing","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Narodowym Centrum Nauki; Instytut Biologii Doswiadczalnej im. M. Nenckiego PAN; Narodowe Centrum Nauki; Institute of Genetics; Amgen","keywords":"p38 mitogen-activated protein kinases; MAPK/ERK pathway; Signal transduction; Cell biology; Biology","score_opus":0.00855457474667531,"score_gpt":0.26385296963110405,"score_spread":0.25529839488442874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391401303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973903,0.017915016,0.0015862965,0.003514037,0.0022287997,0.0003768423,0.00001082573,0.00011995148,0.0003452569],"genre_scores_gemma":[0.9924282,0.0003452725,0.005376105,0.001102613,0.00049773196,0.000015686872,0.000004037518,0.0001023961,0.00012798102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954756,0.0010679936,0.0014321724,0.00050823163,0.0006035304,0.0009125066],"domain_scores_gemma":[0.9914512,0.0062990263,0.0012757094,0.00046574624,0.00017254462,0.00033579284],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017310369,0.00042855018,0.0012272132,0.0004040253,0.00038479376,0.00015097849,0.00056455104,0.00016938102,0.000024860956],"category_scores_gemma":[0.00090500584,0.0002906724,0.0002795499,0.0005695975,0.0012623628,0.0003356016,0.00014605442,0.0011532233,0.00003555976],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014458601,0.0011392644,0.026283465,0.0028041757,0.0016333646,0.00398382,0.06957823,0.0010075973,0.45462018,0.012563021,0.13218038,0.29276064],"study_design_scores_gemma":[0.0091047175,0.0054599773,0.0025728836,0.004174317,0.0009617771,0.034921523,0.03562631,0.00298786,0.71698684,0.028804496,0.15789649,0.0005028148],"about_ca_topic_score_codex":0.00006255208,"about_ca_topic_score_gemma":0.0000080803275,"teacher_disagreement_score":0.29225782,"about_ca_system_score_codex":0.00013524808,"about_ca_system_score_gemma":0.00015906696,"threshold_uncertainty_score":0.9999545},"labels":[],"label_agreement":null},{"id":"W4391691583","doi":"10.1002/ajh.27244","title":"Reducing transfusion utilization for children with sickle cell anemia in sub‐Saharan Africa with hydroxyurea: Analysis from the phase <scp>I</scp>/<scp>II REACH</scp> trial","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Fogarty International Center; National Heart, Lung, and Blood Institute; Doris Duke Charitable Foundation; Wellcome Trust; Bristol-Myers Squibb; American Society of Hematology; National Institutes of Health; Cincinnati Children's Hospital Medical Center","keywords":"Medicine; Blood transfusion; Incidence (geometry); Anemia; Sickle cell anemia; Dosing; Pediatrics; Rate ratio; Confidence interval; Clinical trial; Internal medicine; Disease","score_opus":0.010454792346352378,"score_gpt":0.25785140205692586,"score_spread":0.24739660971057348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391691583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829671,0.009180135,0.0054563372,0.001010137,0.00012957107,0.000796052,0.000034542732,0.00003949868,0.00038664832],"genre_scores_gemma":[0.9964187,0.0021572944,0.0008434262,0.00014818502,0.00016950603,0.000024164356,0.00010255622,0.00005556322,0.00008057273],"study_design_codex":"qualitative","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99772394,0.00021530905,0.0007971644,0.00042142317,0.00037448492,0.00046770243],"domain_scores_gemma":[0.9976257,0.0012008614,0.0005207555,0.00030840113,0.00014363509,0.00020060864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005079143,0.00030662364,0.0011484948,0.0005334043,0.00017088774,0.000035497047,0.00020189268,0.00016323867,0.000010706756],"category_scores_gemma":[0.0002687741,0.0001740342,0.0003285511,0.0019181316,0.0003788734,0.00012192855,0.000019125046,0.0007220535,0.0000028610177],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09655647,0.02300004,0.12289201,0.0015084308,0.045632362,0.009219043,0.23750883,0.023131829,0.08231697,0.0008373472,0.15071164,0.20668502],"study_design_scores_gemma":[0.4421136,0.13844463,0.016387723,0.0063653304,0.072652966,0.018109307,0.11591646,0.03118937,0.08901738,0.00092581747,0.06759287,0.0012845416],"about_ca_topic_score_codex":0.00032092494,"about_ca_topic_score_gemma":0.00010631716,"teacher_disagreement_score":0.34555712,"about_ca_system_score_codex":0.00007294986,"about_ca_system_score_gemma":0.0003799687,"threshold_uncertainty_score":0.70969087},"labels":[],"label_agreement":null},{"id":"W4391722392","doi":"10.1002/ajh.27243","title":"Donor germ‐line variants associate with outcomes of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromes","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Moonshot; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; U.S. Navy; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Astellas Pharma; Adaptive Biotechnologies; Norges Idrettshøgskole; Kiadis Pharma; bluebird bio; TG Therapeutics; Jazz Pharmaceuticals; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; BeiGene; HistoGenetics; U.S. Department of Defense; Moonshot Research and Development Program; Sanofi; GlaxoSmithKline; Actinium Pharmaceuticals; CareDx; Incyte; Pfizer; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Amgen; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences","keywords":"Myelodysplastic syndromes; Stem cell; Medicine; Hematopoietic stem cell transplantation; Transplantation; Oncology; Germline; Hematopoietic cell; Haematopoiesis; Internal medicine; Biology; Genetics; Bone marrow; Gene","score_opus":0.009485209127532675,"score_gpt":0.25296472988582397,"score_spread":0.2434795207582913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391722392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93648237,0.00035276054,0.00030861856,0.061920118,0.00020319954,0.0005425877,0.00009209545,0.00001911653,0.0000791409],"genre_scores_gemma":[0.9766973,0.00021414037,0.0014370059,0.020806152,0.00012896323,0.000021181248,0.00011685039,0.0001763333,0.0004020577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959567,0.00036020315,0.0014179145,0.0004551856,0.0011121684,0.00069782656],"domain_scores_gemma":[0.99627775,0.00084455695,0.0018268205,0.00037938316,0.0005034737,0.00016799397],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00037366027,0.0005441374,0.0030236794,0.0012155597,0.000029225135,0.00001864761,0.000381681,0.0003821197,0.000078497724],"category_scores_gemma":[0.000035082165,0.00034457396,0.00023797565,0.0006839607,0.0005350447,0.00012308256,0.000042267184,0.002589434,0.000031362564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064318823,0.0010063744,0.8737708,0.00831789,0.0061073876,0.06979264,0.002143716,0.00011086787,0.00008555044,0.000033063818,0.0304845,0.001715348],"study_design_scores_gemma":[0.04879124,0.058910206,0.7696378,0.017084109,0.014537578,0.078919195,0.0022554647,0.00011223703,0.0021873598,0.00023358385,0.004201923,0.0031293114],"about_ca_topic_score_codex":0.0000561957,"about_ca_topic_score_gemma":0.0000133490985,"teacher_disagreement_score":0.10413299,"about_ca_system_score_codex":0.00042022532,"about_ca_system_score_gemma":0.001154977,"threshold_uncertainty_score":0.99990064},"labels":[],"label_agreement":null},{"id":"W4391738483","doi":"10.1002/ajh.27246","title":"Long‐term follow‐up of <scp>VIALE‐A</scp>: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"AbbVie Canada; Genentech; Genentech Foundation","keywords":"Venetoclax; Azacitidine; Medicine; Internal medicine; Placebo; Myeloid leukemia; Oncology; Neutropenia; Febrile neutropenia; Hazard ratio; Clinical endpoint; Leukemia; Chemotherapy; Gastroenterology; Clinical trial; Confidence interval; Chronic lymphocytic leukemia; Pathology","score_opus":0.011525101525683406,"score_gpt":0.2991369166163655,"score_spread":0.28761181509068207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391738483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920938,0.0051717306,0.00031602147,0.0013417056,0.00021433325,0.000266034,0.000012462542,0.00003317114,0.00055072835],"genre_scores_gemma":[0.99305075,0.004646791,0.0010810405,0.00035103504,0.00014861976,0.000009023845,0.0000125034185,0.000068326495,0.0006318982],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756145,0.00015413002,0.00095936714,0.00034043728,0.00040562017,0.0005790165],"domain_scores_gemma":[0.998097,0.00061703456,0.00041188163,0.00030646764,0.00025232398,0.00031531233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005055296,0.0002962653,0.0014871673,0.0010161316,0.000031926047,0.000025454716,0.00025950803,0.00015398352,0.00007948097],"category_scores_gemma":[0.00023731423,0.00023597328,0.00022346736,0.0011301623,0.0007793097,0.000148091,0.000085702624,0.00081685575,0.000018395194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005050099,0.0003821037,0.56112796,0.0020362413,0.0063227937,0.034606725,0.007688834,0.0000670547,0.23616268,0.0020839265,0.025533296,0.1189383],"study_design_scores_gemma":[0.04853394,0.022242574,0.24273983,0.007029,0.0025501968,0.20948355,0.0051350933,0.0042715096,0.4393232,0.0021524192,0.015536196,0.0010025017],"about_ca_topic_score_codex":0.00020106624,"about_ca_topic_score_gemma":0.000026790049,"teacher_disagreement_score":0.31838813,"about_ca_system_score_codex":0.0007183074,"about_ca_system_score_gemma":0.001698272,"threshold_uncertainty_score":0.9622711},"labels":[],"label_agreement":null},{"id":"W4392354102","doi":"10.1002/ajh.27273","title":"Assessing hypercoagulability and <scp>VTE</scp> risk using thromboelastography and Khorana score in women with cancers receiving chemotherapy","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Lawrence College; Queen's University","funders":"","keywords":"Medicine; Thromboelastography; Internal medicine; Cancer; Thrombosis; Chemotherapy; Framingham Risk Score; Risk assessment; Oncology; Surgery; Gastroenterology; Coagulation; Disease","score_opus":0.013957983649479488,"score_gpt":0.2918712535595464,"score_spread":0.27791326991006693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392354102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938139,0.0044115935,0.00084853056,0.0005301312,0.00009767536,0.00016956528,0.0000012191748,0.000017354845,0.00011008613],"genre_scores_gemma":[0.99111146,0.0031787525,0.005218613,0.00040284763,0.000050975388,0.000005475903,2.3128159e-7,0.000030168854,0.0000014678049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866915,0.00012802036,0.00040119753,0.00027849156,0.00018052504,0.00034259437],"domain_scores_gemma":[0.9990179,0.00031249743,0.00029436406,0.00014071663,0.00006685704,0.00016769845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006363345,0.0001807391,0.0010024343,0.00041380624,0.0000708036,0.00007251348,0.000061733896,0.00004533527,0.000010312686],"category_scores_gemma":[0.00008112904,0.0001348655,0.000050947117,0.0005489682,0.00060635735,0.00023700588,0.000030672574,0.00037113772,2.6010545e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013648144,0.00023072916,0.8315576,0.0005352334,0.0009791785,0.00054827397,0.010227752,0.00015023141,0.0015134648,0.0001559256,0.0001782193,0.15378696],"study_design_scores_gemma":[0.0014460712,0.0022715477,0.96208006,0.0018174328,0.00037565205,0.0033925723,0.02622837,0.00080097315,0.00022760627,0.0005810511,0.0006495949,0.0001290687],"about_ca_topic_score_codex":0.0005200594,"about_ca_topic_score_gemma":0.00007492631,"teacher_disagreement_score":0.15365788,"about_ca_system_score_codex":0.00018986604,"about_ca_system_score_gemma":0.0002144967,"threshold_uncertainty_score":0.54996556},"labels":[],"label_agreement":null},{"id":"W4393015884","doi":"10.1002/ajh.27283","title":"Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor <scp>ECOG</scp> performance status with relapsed or refractory large B‐cell lymphoma after 2 or more lines of prior therapy","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; bluebird bio; Pharmacyclics; Daiichi Sankyo Europe; Takeda Oncology; AstraZeneca; Genentech; Adaptive Biotechnologies; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Seagen; CareDx; BeiGene; Swedish Orphan Biovitrum; Astellas Pharma; GlaxoSmithKline; Kiadis Pharma; Sanofi; TG Therapeutics; Medac; Ipsen; Jazz Pharmaceuticals; Boston Scientific Corporation; StemCyte; U.S. Navy; Legend Biotech; HistoGenetics; Omeros Corporation; Vertex Pharmaceuticals; Leukemia and Lymphoma Society; U.S. Department of Defense; Celgene; CSL Behring; Bristol-Myers Squibb; Amgen; National Heart, Lung, and Blood Institute; Ascentage Pharma; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Mallinckrodt Pharmaceuticals; Society for Immunotherapy of Cancer; Astellas Pharma US; Atara Biotherapeutics; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences","keywords":"Chemoimmunotherapy; Medicine; Internal medicine; Hazard ratio; Refractory (planetary science); Propensity score matching; Lymphoma; Regimen; Salvage therapy; Gastroenterology; Surgery; Oncology; Chemotherapy; Confidence interval; Rituximab","score_opus":0.010061085264894416,"score_gpt":0.2739395781119439,"score_spread":0.2638784928470495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393015884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964622,0.0026300787,0.000016078999,0.00010796588,0.00012138901,0.0005536207,0.000032659078,0.0000128013235,0.00006319845],"genre_scores_gemma":[0.99329174,0.0045483285,0.0011408469,0.00022723411,0.00003574273,0.000028059556,0.000012729516,0.000091146314,0.00062419975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974711,0.000098623,0.00087592355,0.00032611605,0.0006693211,0.00055895],"domain_scores_gemma":[0.9976118,0.000592435,0.00069821393,0.0003337018,0.0005695851,0.00019422194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026172877,0.00032827447,0.001213343,0.00054199813,0.00003351346,0.000013719573,0.0001965152,0.00011264152,0.00040745863],"category_scores_gemma":[0.0000845409,0.00017543293,0.00010927755,0.0007509417,0.00052823353,0.00018280515,0.000044375298,0.00037333122,0.0000020467103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17754357,0.0049851146,0.6260374,0.0007904191,0.0010550396,0.00058672007,0.0065189446,0.000004158523,0.0037548605,0.00000275228,0.00017363999,0.17854734],"study_design_scores_gemma":[0.098877825,0.07991399,0.7702038,0.001997006,0.0002156076,0.00052090076,0.004139993,0.0001519824,0.0373883,0.000002439741,0.006277054,0.00031106058],"about_ca_topic_score_codex":0.000047032987,"about_ca_topic_score_gemma":0.00005267178,"teacher_disagreement_score":0.17823629,"about_ca_system_score_codex":0.00012817535,"about_ca_system_score_gemma":0.0007673252,"threshold_uncertainty_score":0.71539474},"labels":[],"label_agreement":null},{"id":"W4393233690","doi":"10.1002/ajh.27298","title":"Bleeding self‐assessments by patients with immune thrombocytopenia (ITP): An agreement study","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McMaster University","funders":"Novartis","keywords":"Medicine; Immune thrombocytopenia; Genitourinary system; Clinical trial; Surgery; Internal medicine; Pediatrics; Platelet","score_opus":0.009841349555028312,"score_gpt":0.29615227452975906,"score_spread":0.28631092497473076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393233690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567898,0.0008134301,0.000020441395,0.040678926,0.00046577177,0.000793804,0.000036032183,0.000034290082,0.00036748825],"genre_scores_gemma":[0.94264513,0.00012152876,0.0013687682,0.05475975,0.00031251812,0.000030507621,0.0002874687,0.00014670768,0.00032759292],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99688816,0.00018569823,0.0009934057,0.00048564008,0.00088283943,0.00056422694],"domain_scores_gemma":[0.9977135,0.00008181755,0.0012773414,0.000433858,0.00030953405,0.00018393318],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019197766,0.0005495294,0.0026231015,0.00039972406,0.00008456992,0.00005602396,0.0003284748,0.00019355779,0.0001403112],"category_scores_gemma":[0.000009969894,0.00036389843,0.00020743148,0.0003169165,0.00018632125,0.00016655511,0.00008437517,0.001660644,0.000053323343],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011415835,0.008789898,0.30938452,0.0003899031,0.016885724,0.058047857,0.0016881968,8.124459e-7,0.00002975749,0.0000065236986,0.59725827,0.006376932],"study_design_scores_gemma":[0.06329274,0.32445288,0.080087066,0.0051164203,0.03408155,0.043680828,0.01616417,0.000048791444,0.0003723743,0.00030479868,0.42838824,0.0040101525],"about_ca_topic_score_codex":0.000104371735,"about_ca_topic_score_gemma":0.0000064632927,"teacher_disagreement_score":0.31566298,"about_ca_system_score_codex":0.00025925445,"about_ca_system_score_gemma":0.0002852023,"threshold_uncertainty_score":0.9998813},"labels":[],"label_agreement":null},{"id":"W4393259335","doi":"10.1002/ajh.27307","title":"The presence of additional cytogenetic abnormalities (<scp>ACAs</scp>) or Philadelphia chromosome variants do not adversely affect the achievement of treatment‐free remission in chronic myeloid leukemia","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Syndax Pharmaceuticals; Celgene","keywords":"Philadelphia chromosome; Myeloid leukemia; Affect (linguistics); Medicine; Complete remission; Chromosome; Internal medicine; Oncology; Genetics; Chromosomal translocation; Biology; Gene; Psychology; Chemotherapy","score_opus":0.02149606550150339,"score_gpt":0.2822251817310658,"score_spread":0.2607291162295624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393259335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65310556,0.031149864,0.00003427077,0.3037018,0.002147481,0.003923711,0.004535033,0.00007490724,0.0013273954],"genre_scores_gemma":[0.95925266,0.012904397,0.00076016504,0.018905679,0.0034229555,0.00034225668,0.0005797904,0.0002857687,0.0035463457],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946575,0.000759655,0.0020213346,0.00055387843,0.0011456481,0.00086197513],"domain_scores_gemma":[0.9896946,0.0058973306,0.002752477,0.0012078069,0.00028200855,0.00016579445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062143937,0.0007292265,0.0022493878,0.00053609285,0.0001357738,0.000027407186,0.0010685392,0.00043394597,0.0005458188],"category_scores_gemma":[0.0008418813,0.0003760987,0.00067999464,0.00066323846,0.001784533,0.00010496763,0.00027740016,0.0018983128,0.000022751507],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0014248338,0.0003263729,0.0011072302,0.0017722418,0.0051025217,0.009953477,0.0015471134,0.00026144774,0.0030132483,0.00020910037,0.9710761,0.0042063524],"study_design_scores_gemma":[0.01746321,0.03273599,0.008492366,0.0145482365,0.004931865,0.06379868,0.0036834124,0.0003530676,0.018553358,0.0008075136,0.83392245,0.00070983596],"about_ca_topic_score_codex":0.00040272422,"about_ca_topic_score_gemma":0.00012556376,"teacher_disagreement_score":0.3061471,"about_ca_system_score_codex":0.0053549013,"about_ca_system_score_gemma":0.008772312,"threshold_uncertainty_score":0.9998691},"labels":[],"label_agreement":null},{"id":"W4394614492","doi":"10.1002/ajh.27309","title":"Feminist issues in clinic care, research, and healthcare professionals in thrombosis and hemostasis","year":2024,"lang":"en","type":"editorial","venue":"American Journal of Hematology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Corporation; Officer; Citation; Medicine; Library science; Management; Law; Political science; Computer science","score_opus":0.07008537270898255,"score_gpt":0.49014362377936327,"score_spread":0.42005825107038075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394614492","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25450554,0.09075136,4.3374e-7,0.10117797,0.5478996,0.000640215,0.0001397785,0.000024586003,0.0048605306],"genre_scores_gemma":[0.69306344,0.081241965,0.0004814828,0.001020451,0.223091,0.000019258016,0.00002923309,0.000058968548,0.0009941957],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960252,0.0012633756,0.0006189254,0.0003053634,0.0013395391,0.00044759785],"domain_scores_gemma":[0.9958937,0.0029256165,0.000373225,0.000116636234,0.00047032465,0.00022049127],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0047760825,0.00015039968,0.0010837137,0.00069779856,0.00018994631,0.000063590865,0.00045618214,0.00041041212,0.000041838903],"category_scores_gemma":[0.0018041088,0.00013084126,0.00005454881,0.00070283347,0.0029815459,0.000074774296,0.00023356591,0.0021979504,0.0000068493177],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009157972,0.00005962493,0.018546754,0.0003884126,0.00004126001,0.00040929727,0.06374048,1.3358243e-8,1.8543442e-7,0.0008766369,0.9113548,0.00449097],"study_design_scores_gemma":[0.00031396712,0.00086839095,0.00027957163,0.0018007762,0.000024537192,0.00001709247,0.46178073,6.658779e-8,0.0000012931582,0.0015766185,0.533231,0.00010594563],"about_ca_topic_score_codex":0.0074776285,"about_ca_topic_score_gemma":0.008392885,"teacher_disagreement_score":0.4385579,"about_ca_system_score_codex":0.00021874669,"about_ca_system_score_gemma":0.0015280433,"threshold_uncertainty_score":0.9997318},"labels":[],"label_agreement":null},{"id":"W4394873978","doi":"10.1002/ajh.27311","title":"Novel germline <scp><i>JAK2</i><sup>R715T</sup></scp> mutation causing <scp>PV</scp>‐like erythrocytosis in 3 generations. Amelioration by Ropeg‐Interferon","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Walloon excellence in life sciences and biotechnology; Agentura Pro Zdravotnický Výzkum České Republiky; Fonds De La Recherche Scientifique - FNRS; NextGenerationEU; Grantová Agentura České Republiky; Ludwig Institute for Cancer Research; MPN Research Foundation","keywords":"Biology; Germline mutation; Polycythemia vera; Germline; Mutation; Janus kinase 2; Somatic cell; Myelopoiesis; Molecular biology; Exon; Haematopoiesis; Cancer research; Erythropoietin; Ruxolitinib; Genetics; Myelofibrosis; Immunology; Gene; Stem cell; Bone marrow","score_opus":0.014020668776503457,"score_gpt":0.28183050315371994,"score_spread":0.2678098343772165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394873978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96795064,0.004626745,0.02344892,0.0027671715,0.00037839997,0.00043054906,0.000042108837,0.000058228215,0.00029724184],"genre_scores_gemma":[0.9888893,0.00092330185,0.007988697,0.0013382955,0.0003327546,0.00006896829,0.00013491823,0.000076217766,0.00024757438],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99686515,0.00023220861,0.0013589308,0.00051094923,0.0004967791,0.00053599884],"domain_scores_gemma":[0.99729127,0.0010627545,0.00067055214,0.0002683167,0.00042993514,0.00027716294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045546622,0.0004308815,0.0012220509,0.0008010454,0.00013841146,0.00012530459,0.00012397817,0.00015794084,0.000038224545],"category_scores_gemma":[0.00052071974,0.00035708793,0.0002572813,0.0009054945,0.00028734407,0.00040882576,0.00004985282,0.0006221779,0.00005168677],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008330031,0.01195317,0.20619774,0.0017550255,0.00797799,0.018755984,0.04687647,0.027563766,0.2726211,0.010978031,0.3058915,0.08859621],"study_design_scores_gemma":[0.026101578,0.036187354,0.026683677,0.0071485513,0.00505556,0.1292318,0.040533025,0.13115247,0.47126308,0.0011525087,0.124334104,0.0011562846],"about_ca_topic_score_codex":0.00015645784,"about_ca_topic_score_gemma":0.00011248413,"teacher_disagreement_score":0.19864202,"about_ca_system_score_codex":0.000435128,"about_ca_system_score_gemma":0.00044427012,"threshold_uncertainty_score":0.9998881},"labels":[],"label_agreement":null},{"id":"W4395005490","doi":"10.1002/ajh.27321","title":"Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management","year":2024,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Leukocytosis; Neutrophilia; Monocytosis; Myeloid; Basophilia; Medicine; Chronic myelomonocytic leukemia; Immunology; Myeloproliferative neoplasm; Myeloid leukemia; Bone marrow; Leukemia; Pathology; Myelodysplastic syndromes; Myelofibrosis","score_opus":0.019823295514765547,"score_gpt":0.33458905212729784,"score_spread":0.3147657566125323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395005490","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003572504,0.99313647,0.000056669272,0.001543465,0.00040521525,0.0010555343,0.000042340536,0.00003117092,0.00015664913],"genre_scores_gemma":[0.0026773238,0.9947567,0.0007885383,0.00015790755,0.0010135958,0.0001453299,0.000039914725,0.00014777872,0.00027291593],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955671,0.00054140156,0.0016972824,0.0008953479,0.00055593497,0.0007429694],"domain_scores_gemma":[0.99665415,0.0004981538,0.0013278701,0.0007720682,0.00017135369,0.000576403],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000661445,0.00075675786,0.0035545568,0.0010381712,0.0001300004,0.00008866298,0.00047354263,0.00038451425,0.00014472369],"category_scores_gemma":[0.00010887772,0.00054607686,0.00047567923,0.0007311465,0.001363933,0.00006801472,0.0003433911,0.003118032,0.00020451569],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014557107,0.0000419354,0.00012612327,0.015636295,0.00201835,0.0020703278,0.000034264034,0.000005888329,0.0000015181226,0.0017366909,0.016854597,0.96132845],"study_design_scores_gemma":[0.0011918187,0.0038845586,0.0003702665,0.012271203,0.0068593672,0.017958246,0.00008635562,0.000093054165,0.000011921072,0.00028803694,0.9565037,0.0004814695],"about_ca_topic_score_codex":0.000020462881,"about_ca_topic_score_gemma":0.00001880914,"teacher_disagreement_score":0.96084696,"about_ca_system_score_codex":0.005040356,"about_ca_system_score_gemma":0.0038726171,"threshold_uncertainty_score":0.99969906},"labels":[],"label_agreement":null},{"id":"W4395040003","doi":"10.1002/ajh.27337","title":"Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Association Bordelaise pour l'Avancement des Sciences Pediatriques; Novartis; GlaxoSmithKline; Amgen","keywords":"Medicine; Immune thrombocytopenia; Refractory (planetary science); Outcome (game theory); Identification (biology); Immune system; Intensive care medicine; Pediatrics; Immunology; Platelet; Biology","score_opus":0.008462896752927128,"score_gpt":0.2827949769451584,"score_spread":0.2743320801922313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395040003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99044645,0.00801134,0.000108162356,0.0008159018,0.00043390295,0.00009940141,0.000008409108,0.000016108768,0.00006035388],"genre_scores_gemma":[0.9976617,0.0018766889,0.00014179695,0.000093799295,0.000112126254,0.0000025980794,0.000015106263,0.000019363426,0.0000767889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988296,0.00003939156,0.000663356,0.00015028391,0.000145767,0.00017160481],"domain_scores_gemma":[0.9991339,0.000096812575,0.00039455356,0.00013844416,0.00013359847,0.000102717626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013336391,0.00012411136,0.0007556378,0.0002225905,0.0000408495,0.000023430786,0.000069397036,0.000041063624,0.000062374194],"category_scores_gemma":[0.00008994993,0.00009247818,0.00009907693,0.00018262459,0.00015805145,0.00011596262,0.00002464836,0.00023662123,0.00005190499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001188696,0.0003869358,0.9506443,0.00026539245,0.00039936733,0.0018449407,0.0002892914,1.0160136e-7,0.00031975293,0.00041671324,0.00065929565,0.044655036],"study_design_scores_gemma":[0.0014182031,0.0020370514,0.98658586,0.00008495329,0.0006234729,0.005304529,0.00013543386,0.000018698609,0.00014948704,0.00015987463,0.0033424161,0.00014000743],"about_ca_topic_score_codex":0.000011439053,"about_ca_topic_score_gemma":0.0000011513364,"teacher_disagreement_score":0.04451503,"about_ca_system_score_codex":0.000085025844,"about_ca_system_score_gemma":0.00014531915,"threshold_uncertainty_score":0.37711507},"labels":[],"label_agreement":null},{"id":"W4395466827","doi":"10.1002/ajh.27345","title":"Management of post‐autologous transplant relapse in patients with T‐cell lymphomas","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Oncology; Internal medicine; Lymphoma","score_opus":0.003466785784256579,"score_gpt":0.22099655403061624,"score_spread":0.21752976824635967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395466827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961563,0.0018601479,0.000029528666,0.00078873,0.00010846887,0.00015340233,0.000007278741,0.00000925423,0.00088690117],"genre_scores_gemma":[0.9977496,0.0002874733,0.0017646773,0.00013862093,0.000008240674,0.0000055838946,0.0000059476065,0.000015605232,0.000024215586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989225,0.00004563471,0.000479555,0.00014465541,0.00021672218,0.00019088303],"domain_scores_gemma":[0.99937826,0.000086999644,0.00022341586,0.00013834884,0.000083302446,0.00008965775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008616879,0.00013237786,0.0006261063,0.000269375,0.000010741999,0.000004289527,0.00007452371,0.00003221581,0.000037992515],"category_scores_gemma":[0.0000032715304,0.000083153194,0.00011087398,0.00026024997,0.00015919351,0.000043026448,0.000011943431,0.00009226393,0.000009898889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019258659,0.0019972452,0.93328077,0.00043266237,0.00080739247,0.016581716,0.00077100866,0.000010339426,0.000027984852,0.00216583,0.00020846975,0.04179072],"study_design_scores_gemma":[0.008907031,0.010901999,0.96966827,0.0019459483,0.0008320221,0.003995749,0.00090645475,0.000016606,0.0020854631,0.00010999713,0.00046982968,0.00016061509],"about_ca_topic_score_codex":0.000046793288,"about_ca_topic_score_gemma":0.0000045566712,"teacher_disagreement_score":0.041630108,"about_ca_system_score_codex":0.000106950276,"about_ca_system_score_gemma":0.00011605522,"threshold_uncertainty_score":0.3390889},"labels":[],"label_agreement":null},{"id":"W4396578328","doi":"10.1002/ajh.27352","title":"High prevalence of iron deficiency and socioeconomic disparities in laboratory screening of <scp>non‐pregnant</scp> females of reproductive age: A retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Socioeconomic status; Retrospective cohort study; Cohort study; Cohort; Pregnancy; Demography; Obstetrics; Pediatrics; Environmental health; Internal medicine; Population; Biology; Genetics","score_opus":0.008281016965829545,"score_gpt":0.2688305231877425,"score_spread":0.2605495062219129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396578328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98211926,0.017148811,0.00012991116,0.00010491963,0.000111572524,0.00028714509,0.000019679548,0.0000053153544,0.00007336204],"genre_scores_gemma":[0.9975024,0.0013694989,0.0010373482,0.000016524633,0.000026929045,0.000006075632,7.2667956e-7,0.000015863241,0.000024656603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983232,0.00017575803,0.00081785716,0.00028182325,0.00021165244,0.00018968414],"domain_scores_gemma":[0.99843603,0.00028445703,0.00078352774,0.00022573941,0.00021442205,0.000055823624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007862316,0.00014363806,0.001221816,0.00037972743,0.000020343341,0.000004357291,0.000118471275,0.00004470746,0.00000981544],"category_scores_gemma":[0.00047491593,0.00012108384,0.00008478053,0.00028940378,0.0012836809,0.00013062535,0.00005216642,0.00027643453,4.587013e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105503495,0.00031641824,0.98973733,0.0010700277,0.000085817985,0.00010434322,0.005175051,0.00001941623,0.0015264875,0.0012487257,0.000045653585,0.00056523527],"study_design_scores_gemma":[0.0007835239,0.0018266384,0.9724934,0.0004601659,0.0003261047,0.00018942167,0.020673105,0.0000066810453,0.0028449367,0.00034756563,0.000002230541,0.00004619358],"about_ca_topic_score_codex":0.00032176054,"about_ca_topic_score_gemma":0.000017590311,"teacher_disagreement_score":0.017243888,"about_ca_system_score_codex":0.00003267606,"about_ca_system_score_gemma":0.00020429346,"threshold_uncertainty_score":0.49376556},"labels":[],"label_agreement":null},{"id":"W4396705273","doi":"10.1002/ajh.27312","title":"Clinically meaningful improvements in patient‐reported outcomes in mitapivat‐treated patients with pyruvate kinase deficiency","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Agios Pharmaceuticals","keywords":"Medicine; Pyruvate kinase; Clinical trial; Pyruvate kinase deficiency; Disease; Intensive care medicine; Internal medicine; Pediatrics","score_opus":0.013119453093576821,"score_gpt":0.27553756114615213,"score_spread":0.2624181080525753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396705273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9547899,0.00018466654,0.0000114128725,0.043451473,0.0007944669,0.00045029348,0.000014302239,0.000027002476,0.00027649527],"genre_scores_gemma":[0.80298007,0.00007249046,0.00070988754,0.1956427,0.00016625413,0.00002467605,0.00012897138,0.00010320613,0.00017173156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954154,0.00032040983,0.0024961869,0.0005730229,0.0005431153,0.00065189763],"domain_scores_gemma":[0.9963259,0.00040663892,0.0022393279,0.00043371902,0.0004463752,0.00014800155],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00027978286,0.00050213764,0.0025011022,0.0012634194,0.00002610129,0.000013076965,0.00021075337,0.00043757042,0.000097971795],"category_scores_gemma":[0.0004404454,0.00034035725,0.0003133681,0.00080861896,0.00044762035,0.0000767238,0.00007913418,0.0029212865,0.000037272966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017414069,0.0008570568,0.93280303,0.00022883312,0.00044127606,0.02773049,0.00036357137,0.0000038010257,0.000082917235,0.0000059167355,0.031340536,0.004401165],"study_design_scores_gemma":[0.037665334,0.09816224,0.75478107,0.0068046316,0.0028110654,0.008856693,0.002510673,0.000059313217,0.00036586775,0.00081367063,0.084273,0.0028964446],"about_ca_topic_score_codex":0.0001529588,"about_ca_topic_score_gemma":0.000029834795,"teacher_disagreement_score":0.17802197,"about_ca_system_score_codex":0.00021299723,"about_ca_system_score_gemma":0.00041726523,"threshold_uncertainty_score":0.9999049},"labels":[],"label_agreement":null},{"id":"W4396925099","doi":"10.1002/ajh.27364","title":"Three‐dimensional telomere profiling predicts risk of progression in smoldering multiple myeloma","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Ontario Genomics","funders":"","keywords":"Oncology; Internal medicine; Medicine; Biomarker; Multiple myeloma; Risk stratification; Cohort; Predictive value; Correlation; Proportional hazards model; Biology; Genetics","score_opus":0.0180515829767489,"score_gpt":0.3237621007054432,"score_spread":0.3057105177286943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396925099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949246,0.0037125822,0.00043046943,0.0003973596,0.00014022707,0.00029160047,0.000010136147,0.000020414935,0.00007260768],"genre_scores_gemma":[0.9825934,0.00010916937,0.017167274,0.00001712976,0.000064133375,0.000011994244,0.000005525544,0.000024943736,0.0000064035594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982067,0.00011129836,0.0006720704,0.00020900965,0.00045214265,0.00034878418],"domain_scores_gemma":[0.9986061,0.0004889609,0.0003605552,0.00016630303,0.00016557108,0.00021255201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041890552,0.00015783303,0.00072240963,0.0005405814,0.0000341007,0.000008499518,0.00010571738,0.000060773775,0.000039497685],"category_scores_gemma":[0.00048933027,0.00010763733,0.00016554547,0.0004536263,0.00031249406,0.000095726384,0.00006154774,0.0005120545,0.00000925107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011994906,0.00030457077,0.8683021,0.00025610015,0.0004009183,0.0036252148,0.0001771544,0.000053755346,0.004119697,0.00010856525,0.000070198665,0.12138222],"study_design_scores_gemma":[0.009140256,0.00951068,0.8138686,0.006693964,0.0004125495,0.021253668,0.0010182154,0.043019254,0.09348066,0.0009648715,0.00026979894,0.00036752975],"about_ca_topic_score_codex":0.00009760696,"about_ca_topic_score_gemma":0.000038926173,"teacher_disagreement_score":0.12101469,"about_ca_system_score_codex":0.000079865786,"about_ca_system_score_gemma":0.00035881792,"threshold_uncertainty_score":0.4389323},"labels":[],"label_agreement":null},{"id":"W4396972100","doi":"10.1002/ajh.27366","title":"Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in <i>IDH1</i>‐ or <i>IDH2</i>‐mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Daiichi-Sankyo; bluebird bio; Sarepta Therapeutics; Sierra Oncology; Jazz Pharmaceuticals; Dana-Farber Cancer Institute; Celgene","keywords":"Venetoclax; IDH1; Medicine; IDH2; Myeloid leukemia; Hypomethylating agent; Oncology; Internal medicine; Chemotherapy; Mutant; Leukemia; Biology; Gene; Genetics; DNA methylation","score_opus":0.023066902626930397,"score_gpt":0.3297877690618693,"score_spread":0.3067208664349389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396972100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952132,0.0004467108,0.00018326384,0.002553119,0.0003764634,0.0011391205,0.0000026482533,0.00003335103,0.000052085983],"genre_scores_gemma":[0.99533695,0.002274662,0.001153182,0.00097000063,0.000105123836,0.00005018977,0.000006634964,0.00006883389,0.000034411438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755305,0.00032515332,0.00073607196,0.0004145756,0.0005388696,0.00043230256],"domain_scores_gemma":[0.9979406,0.00064631214,0.00044137196,0.00024507672,0.0005216505,0.00020501373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007203486,0.00029780235,0.00104562,0.0007071509,0.000066070126,0.000053566957,0.00016798507,0.000096171214,0.000054970933],"category_scores_gemma":[0.00028782067,0.00019941638,0.000086547145,0.0009967517,0.00042072908,0.0002584052,0.00005257554,0.0009945594,0.0000062421022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056392763,0.0009914121,0.7063696,0.0001424362,0.005750726,0.021508683,0.0148814935,0.000088468645,0.020920713,0.00006215053,0.0012380282,0.17165352],"study_design_scores_gemma":[0.13952552,0.09512122,0.6164533,0.0021317366,0.0014446469,0.031166252,0.073602274,0.009878971,0.02530481,0.00013797972,0.0038628776,0.0013704436],"about_ca_topic_score_codex":0.00034353853,"about_ca_topic_score_gemma":0.00005731765,"teacher_disagreement_score":0.17028308,"about_ca_system_score_codex":0.0012375771,"about_ca_system_score_gemma":0.0009798032,"threshold_uncertainty_score":0.81319636},"labels":[],"label_agreement":null},{"id":"W4399245093","doi":"10.1002/ajh.27384","title":"Molecular landscape of mature B‐cell lymphoproliferative disorders with <i>BCL3</i>‐translocation: A Groupe Francophone de Cytogénétique Hématologique (GFCH)/French Innovative Leukemia Organization (FILO) study","year":2024,"lang":"fr","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Ligue Contre le Cancer","keywords":"Chromosomal translocation; Leukemia; French; Lymphoproliferative disorders; Medicine; Immunology; Biology; Genetics; Humanities; Philosophy; Lymphoma; Gene","score_opus":0.003968826039970044,"score_gpt":0.24739581251065076,"score_spread":0.24342698647068073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399245093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9291186,0.009561127,0.034298807,0.023675816,0.0008759018,0.0019263021,0.00005928378,0.00006235482,0.00042181349],"genre_scores_gemma":[0.98359954,0.001437912,0.0038856014,0.009593702,0.0007918807,0.00009293552,0.00014192813,0.00030902357,0.0001474523],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9911996,0.002321019,0.0027592352,0.00089719956,0.0014901788,0.0013327827],"domain_scores_gemma":[0.9909254,0.0014329277,0.003022275,0.000923382,0.0033136797,0.0003823767],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014921314,0.0011327307,0.0038962506,0.0014207537,0.0001532424,0.000068347166,0.0009941638,0.0011199388,0.0003480855],"category_scores_gemma":[0.0007455519,0.0008996775,0.0003161713,0.006941538,0.0021430263,0.00021588123,0.00019616431,0.0050749574,0.00006468081],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.01238619,0.009842499,0.3343189,0.02690366,0.033000816,0.1423649,0.22710171,0.0100124,0.02275113,0.0041396315,0.16768344,0.009494714],"study_design_scores_gemma":[0.14489734,0.083570644,0.01172113,0.024474159,0.008271004,0.28316033,0.21740802,0.007448652,0.20347501,0.0023639554,0.0067408807,0.0064688707],"about_ca_topic_score_codex":0.0010509829,"about_ca_topic_score_gemma":0.00018799213,"teacher_disagreement_score":0.32259777,"about_ca_system_score_codex":0.008777287,"about_ca_system_score_gemma":0.043108933,"threshold_uncertainty_score":0.99934536},"labels":[],"label_agreement":null},{"id":"W4399676872","doi":"10.1002/ajh.27419","title":"Still high risk? A review of translocation t(14;16) in multiple myeloma","year":2024,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Hamilton Health Sciences Foundation; Hamilton Health Sciences","keywords":"Multiple myeloma; Presentation (obstetrics); Chromosomal translocation; Medicine; Biomarker; Disease; Internal medicine; Oncology; Intensive care medicine; Bioinformatics; Biology; Surgery; Genetics; Gene","score_opus":0.04152078225076134,"score_gpt":0.379898403241376,"score_spread":0.3383776209906147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399676872","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00066570676,0.99770117,0.00009059861,0.0003767274,0.00016353144,0.0008670028,0.00006406268,0.000010129964,0.00006108297],"genre_scores_gemma":[0.009814759,0.9884546,0.0013669685,0.00007193363,0.00007794231,0.000053312564,0.00006254382,0.000059586968,0.00003835344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99601036,0.00071034447,0.0020995531,0.00031023388,0.00048736436,0.00038216152],"domain_scores_gemma":[0.9963855,0.0006742009,0.0019649079,0.00039961914,0.0003117485,0.0002640254],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077582075,0.00039668352,0.00540632,0.00091744115,0.000014279041,0.000005611964,0.00026578346,0.00014890189,0.00011721635],"category_scores_gemma":[0.0010960366,0.0002539042,0.00093224447,0.0010246524,0.0003557757,0.00005038598,0.000039286308,0.0010881631,0.00006734828],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001286378,0.00024434747,0.00046787164,0.09929793,0.0010147532,0.0012555125,0.00006152049,1.08081565e-7,3.3180282e-7,0.0000464816,0.0005822224,0.8969003],"study_design_scores_gemma":[0.0023166365,0.0026457738,0.00025731855,0.47210598,0.0054801856,0.01593024,0.00008230756,0.000010738183,0.00001613546,0.000083661,0.500776,0.0002949951],"about_ca_topic_score_codex":0.00029725622,"about_ca_topic_score_gemma":0.000058558202,"teacher_disagreement_score":0.8966053,"about_ca_system_score_codex":0.00027473381,"about_ca_system_score_gemma":0.00110194,"threshold_uncertainty_score":0.9999913},"labels":[],"label_agreement":null},{"id":"W4401376323","doi":"10.1002/ajh.27436","title":"Long‐term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A <scp>STELLAR</scp> interim analysis","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"Hematopoietic cell; Interim; Hematopoietic stem cell transplantation; Term (time); Quality of life (healthcare); Disease; Medicine; Pediatrics; Internal medicine; Haematopoiesis; Stem cell; Genetics; Biology","score_opus":0.008603079502140853,"score_gpt":0.26369086692839655,"score_spread":0.2550877874262557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401376323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9216597,0.019201849,0.0010577621,0.056568865,0.000451086,0.00060305046,0.00023334249,0.000022841636,0.0002014774],"genre_scores_gemma":[0.9473233,0.0011974246,0.00026624417,0.0503809,0.0002998004,0.000032546362,0.00013529653,0.000104094455,0.00026037582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954592,0.00036789777,0.0023981966,0.0005408824,0.0005254128,0.00070841756],"domain_scores_gemma":[0.9962466,0.0007928162,0.0017446106,0.0005559754,0.00021412052,0.00044592374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048339268,0.0005726848,0.003684745,0.0014203065,0.000028543069,0.000022528353,0.00037601648,0.00053207576,0.000092095725],"category_scores_gemma":[0.00014809487,0.00044258343,0.0019303162,0.0009610568,0.0005693929,0.000052474843,0.00005747198,0.0021582681,0.000017224826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043248315,0.005591592,0.6023126,0.0478268,0.015328298,0.052615333,0.021269755,0.00024184177,0.00047870234,0.00003681999,0.24908821,0.00088515953],"study_design_scores_gemma":[0.07708477,0.038607787,0.36689657,0.044688135,0.2372798,0.027293928,0.035362516,0.0011444058,0.013194123,0.0032925927,0.14723198,0.0079233665],"about_ca_topic_score_codex":0.00007137683,"about_ca_topic_score_gemma":0.00001817157,"teacher_disagreement_score":0.23541607,"about_ca_system_score_codex":0.00008414803,"about_ca_system_score_gemma":0.0007164578,"threshold_uncertainty_score":0.9998026},"labels":[],"label_agreement":null},{"id":"W4401548384","doi":"10.1002/ajh.27458","title":"The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi‐center analysis of 719 disease episodes","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto; University of British Columbia; St. Michael's Hospital; Vancouver Coastal Health","funders":"","keywords":"Southern Hemisphere; Thrombotic thrombocytopenic purpura; Medicine; Etiology; Northern Hemisphere; Climatology; Demography; Internal medicine; Platelet","score_opus":0.012238776473041613,"score_gpt":0.2924952732071757,"score_spread":0.2802564967341341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401548384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9568253,0.03833491,0.0015311172,0.0011588712,0.00033104647,0.00018254468,0.00161465,0.000018361787,0.0000032097828],"genre_scores_gemma":[0.9985874,0.00077061896,0.00009160956,0.00009863821,0.000009841143,0.000014016592,0.0004032592,0.000013319091,0.000011258472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996392,0.0010914393,0.0016479826,0.00032466766,0.00012522582,0.0004187],"domain_scores_gemma":[0.99530137,0.0026201482,0.0013325801,0.00043077485,0.00024044365,0.00007465851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078376965,0.00026384264,0.0016259293,0.00028167426,0.00016181776,0.000018765582,0.0006675195,0.00008812151,0.00045738503],"category_scores_gemma":[0.0005957609,0.00017296759,0.0010568303,0.000860781,0.0017682356,0.0001270135,0.00015065164,0.0003635437,0.000019295858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005126269,0.0003644973,0.9654634,0.00006327386,0.010684325,0.000023093327,0.00023572828,0.00003801098,0.01765267,0.00090928806,0.0030795461,0.0009735157],"study_design_scores_gemma":[0.0011340484,0.0005151454,0.98513335,0.00036745562,0.0038220396,0.00010508487,0.0013718343,0.00031238497,0.0054305256,0.00069547934,0.0008688378,0.00024380133],"about_ca_topic_score_codex":0.00050995423,"about_ca_topic_score_gemma":0.000021468311,"teacher_disagreement_score":0.04176215,"about_ca_system_score_codex":0.00006217303,"about_ca_system_score_gemma":0.00014765217,"threshold_uncertainty_score":0.70534134},"labels":[],"label_agreement":null},{"id":"W4401586147","doi":"10.1002/ajh.27455","title":"Imatinib versus newer generation <scp>TKIs</scp> for upfront therapy in chronic phase <scp>chronic myeloid leukemia</scp>: What is the rationale for paying more to get the same survival benefit?","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myeloid leukemia; Imatinib; Hematology; Internal medicine; Transplantation; Imatinib mesylate; Disease; Oncology; Immunology","score_opus":0.0374721474033498,"score_gpt":0.32962715616823646,"score_spread":0.29215500876488665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401586147","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50728077,0.0503478,0.0036449858,0.42725348,0.0050569796,0.0059377486,0.0003405079,0.00006642218,0.00007127355],"genre_scores_gemma":[0.06513273,0.030007776,0.0149131995,0.82105213,0.04905523,0.006455377,0.0038878948,0.001523682,0.007971987],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949415,0.0003100464,0.001751913,0.00088116183,0.0008527145,0.001262683],"domain_scores_gemma":[0.9901963,0.006289499,0.0017115977,0.00096451817,0.00061929977,0.00021876906],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010794252,0.00090336654,0.0020975953,0.00055626937,0.00031863342,0.00024629995,0.0008377652,0.00052905903,0.000051667303],"category_scores_gemma":[0.0007850009,0.0005631629,0.00095114665,0.0005805858,0.00053180323,0.00033995396,0.000120796714,0.0020958635,0.00004247722],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00046126437,0.00017784728,0.0000691856,0.0005153866,0.0030391242,0.000495201,0.00851451,0.0012783364,0.0017616765,0.0003400465,0.91976947,0.06357799],"study_design_scores_gemma":[0.021343116,0.009464759,0.00005560502,0.0009247271,0.0011670465,0.0022034403,0.007166261,0.008285462,0.0035630504,0.0004909609,0.94509584,0.00023971904],"about_ca_topic_score_codex":0.00017311615,"about_ca_topic_score_gemma":0.0002766133,"teacher_disagreement_score":0.44214806,"about_ca_system_score_codex":0.0071890117,"about_ca_system_score_gemma":0.005867409,"threshold_uncertainty_score":0.9997684},"labels":[],"label_agreement":null},{"id":"W4401656522","doi":"10.1002/ajh.27459","title":"Intra‐tumoral and peripheral blood <scp>TIGIT</scp> and <scp>PD</scp>‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Medical Research Council; Astellas Pharma; Irish Research Council; University of Queensland; National Cancer Institute; National Research Foundation; Cancer Australia; Leukaemia Foundation; EUSA Pharma; Mater Foundation; National Research Foundation Singapore; Gilead Sciences; Regeneron Pharmaceuticals; Leukemia and Lymphoma Society; BeiGene; Daiichi Sankyo Europe; Sanofi; Amgen; American Association for Cancer Research; Bristol-Myers Squibb; National Health and Medical Research Council; American Society of Hematology","keywords":"TIGIT; CD8; Immune system; Cancer research; Lymphoma; Immunophenotyping; Biology; Hodgkin's lymphoma; T cell; Lymphocyte; Immunology; Tumor microenvironment; Flow cytometry","score_opus":0.005422366018276542,"score_gpt":0.24567511970297534,"score_spread":0.2402527536846988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401656522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9467827,0.0511663,0.000029025367,0.00097004196,0.0002953134,0.00028498203,0.000008579638,0.000035307676,0.00042771798],"genre_scores_gemma":[0.99256486,0.005079652,0.0016381501,0.00041857103,0.00010734988,0.000028880435,0.0000065462095,0.000058002657,0.00009801296],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99733955,0.00020972858,0.0009679537,0.00050023844,0.00033272913,0.0006498147],"domain_scores_gemma":[0.9978696,0.0008545339,0.0004559624,0.0002815718,0.00010854864,0.00042980016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043799193,0.00043070753,0.0014717089,0.0005243808,0.000087459746,0.00009928485,0.0001626771,0.0001354985,0.000020434245],"category_scores_gemma":[0.00041717943,0.0003303883,0.0002328504,0.00048924016,0.0009181902,0.00019737703,0.0001157202,0.0002000626,0.000015569267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007406985,0.0030449918,0.6616057,0.0008367371,0.0068513323,0.081979364,0.0089214565,0.000011833223,0.011625328,0.003425735,0.0039631464,0.21699364],"study_design_scores_gemma":[0.0340635,0.016056508,0.4188029,0.0032764615,0.0029102527,0.42701447,0.015177213,0.0011628979,0.056864966,0.0011921094,0.02311434,0.00036437457],"about_ca_topic_score_codex":0.0004727124,"about_ca_topic_score_gemma":0.000019384244,"teacher_disagreement_score":0.3450351,"about_ca_system_score_codex":0.0002966668,"about_ca_system_score_gemma":0.0006468138,"threshold_uncertainty_score":0.9999148},"labels":[],"label_agreement":null},{"id":"W4401701543","doi":"10.1002/ajh.27451","title":"Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (<scp>WBMT</scp>)","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McMaster University","funders":"Medac; JCR Pharmaceuticals; National Cancer Institute; Prothena; Hamilton Health Sciences; Celgene; Gilead Sciences; Sanofi; Pfizer; Amgen","keywords":"Medicine; Multiple myeloma; Internal medicine; Cumulative incidence; Transplantation; Lenalidomide; Hematopoietic stem cell transplantation; Clinical endpoint; Oncology; Multivariate analysis; Surgery; Clinical trial","score_opus":0.011718091949148926,"score_gpt":0.28239324345271366,"score_spread":0.27067515150356475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401701543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943803,0.0011087081,0.0027665223,0.00026165607,0.00013851614,0.0011380339,0.00018943343,0.000009817132,0.0000070318274],"genre_scores_gemma":[0.99686176,0.0003784636,0.0025863699,0.00003539568,0.00003121516,0.000055767418,0.000014720603,0.000018897754,0.000017419676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850684,0.00013792352,0.0006812816,0.00019134271,0.00021429991,0.0002682798],"domain_scores_gemma":[0.9968312,0.002290169,0.00047796618,0.0001256374,0.00015225117,0.0001227717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024930053,0.0001755128,0.0008847637,0.00011079067,0.00006616353,0.0000132512705,0.00009411545,0.000052676536,9.332868e-7],"category_scores_gemma":[0.00010205354,0.00011432529,0.000152271,0.00021795544,0.00022400192,0.000054379,0.000011974312,0.00011238934,1.3753638e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013387598,0.0006476363,0.9766855,0.0018925497,0.00092461176,0.00043124423,0.0035555044,0.000017579297,0.00057697046,0.00014260675,0.0000596971,0.013727323],"study_design_scores_gemma":[0.011436496,0.005490214,0.96962154,0.00042571002,0.0022514747,0.0036178892,0.0034038462,0.0006528302,0.002827836,0.00017340906,0.000025868654,0.00007290673],"about_ca_topic_score_codex":0.00005095119,"about_ca_topic_score_gemma":0.00012148137,"teacher_disagreement_score":0.013654416,"about_ca_system_score_codex":0.000021253421,"about_ca_system_score_gemma":0.000121106175,"threshold_uncertainty_score":0.466205},"labels":[],"label_agreement":null},{"id":"W4402415968","doi":"10.1002/ajh.27473","title":"Quadruplets in newly diagnosed transplant‐ineligible multiple myeloma","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Quadruplets; Multiple myeloma; Medicine; MEDLINE; Oncology; Internal medicine; Biology; Pregnancy; Genetics","score_opus":0.01985682815134042,"score_gpt":0.3086462158474822,"score_spread":0.28878938769614176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402415968","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3700257,0.005773669,0.00012985467,0.62184566,0.0007524019,0.00067385583,0.00010712858,0.000054699885,0.0006370639],"genre_scores_gemma":[0.85147405,0.0015915589,0.0020086265,0.14229862,0.0015592166,0.00005235919,0.00019447702,0.00016189202,0.0006592163],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964778,0.0002970115,0.0011731099,0.00044748833,0.00070994004,0.0008946731],"domain_scores_gemma":[0.99738616,0.0011433329,0.00057424995,0.00040407316,0.00018497695,0.00030718168],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000275731,0.00048202515,0.0022184332,0.0014171726,0.00003455211,0.000030736162,0.00034639842,0.0004051733,0.00019183781],"category_scores_gemma":[0.00028232535,0.00035945696,0.0005345558,0.00059299875,0.0004252019,0.00007381505,0.00004502874,0.003226552,0.00024701297],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011224626,0.00028990768,0.100419775,0.0007073958,0.0011012265,0.3143193,0.00064223696,0.000004449783,0.00009428384,0.000011579215,0.5684956,0.012791792],"study_design_scores_gemma":[0.022139682,0.007984447,0.04053721,0.0064232983,0.0014329675,0.13310985,0.0007221127,0.0004386415,0.0011902712,0.00044962822,0.78432375,0.0012481619],"about_ca_topic_score_codex":0.00065193005,"about_ca_topic_score_gemma":0.00015896648,"teacher_disagreement_score":0.48144835,"about_ca_system_score_codex":0.0002240534,"about_ca_system_score_gemma":0.00067697227,"threshold_uncertainty_score":0.99988574},"labels":[],"label_agreement":null},{"id":"W4402484136","doi":"10.1002/ajh.27479","title":"Cybersecurity and the blood supply: The vulnerabilities of the technological revolution","year":2024,"lang":"en","type":"editorial","venue":"American Journal of Hematology","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"","keywords":"Business; Computer security; Computer science","score_opus":0.005361818181300017,"score_gpt":0.2295723148160244,"score_spread":0.22421049663472437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402484136","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1413755,0.017580958,0.000097111,0.20658477,0.62746125,0.000929027,0.000041049607,0.00010317276,0.0058271396],"genre_scores_gemma":[0.91016984,0.0012275091,0.000051048402,0.00063666236,0.08775225,0.00001411782,0.000003076972,0.000022338098,0.00012313647],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982728,0.00023077418,0.0006416398,0.00017041735,0.0005253115,0.00015906084],"domain_scores_gemma":[0.99517673,0.0025348302,0.0015971743,0.00028303656,0.00040030284,0.000007901241],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0019731708,0.00018391681,0.0006286154,0.00016355798,0.00022318224,0.00011230338,0.0006711058,0.00019624925,0.00007195005],"category_scores_gemma":[0.0030197122,0.00007322486,0.00025101705,0.00047645136,0.0031316543,0.00023571998,0.00023700275,0.0015561072,0.0000067245874],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003525318,0.0001427586,0.00083849713,0.000325716,0.0005420041,0.000026185464,0.00035932957,0.0000023150951,0.000010387667,0.35204837,0.64044166,0.0049102493],"study_design_scores_gemma":[0.000950142,0.00005876306,0.00013617541,0.00019936751,0.0012853027,0.00029837133,0.002770742,0.000028345597,0.00003167006,0.034911357,0.9592063,0.00012347111],"about_ca_topic_score_codex":0.00046119757,"about_ca_topic_score_gemma":0.00014393033,"teacher_disagreement_score":0.76879436,"about_ca_system_score_codex":0.000011167031,"about_ca_system_score_gemma":0.00011022316,"threshold_uncertainty_score":0.9995813},"labels":[],"label_agreement":null},{"id":"W4402868174","doi":"10.1002/ajh.27487","title":"Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions","year":2024,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"National Heart, Lung, and Blood Institute; Dell Medical School, University of Texas at Austin; Terumo BCT; U.S. Food and Drug Administration; National Institutes of Health; Grifols; McGovern Medical School; Vanderbilt University Medical Center; Omeros Corporation; Swedish Orphan Biovitrum; University of Texas at Austin; Janssen Pharmaceuticals; Vanderbilt University; Gilead Sciences; Momenta Pharmaceuticals; Sanofi; AstraZeneca; Amgen","keywords":"Neonatal Fc receptor; Medicine; Immunology; Antibody; Immune system; Adverse effect; Hematology; Thrombocytopenic purpura; Immunoglobulin G; Clinical trial; In vivo; Pharmacology; Biology; Internal medicine","score_opus":0.01407092375757604,"score_gpt":0.3413138708524309,"score_spread":0.3272429470948549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402868174","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009527752,0.9892237,0.000109951136,0.00017646312,0.0002227393,0.00051470665,0.00018627603,0.000007570886,0.000030807907],"genre_scores_gemma":[0.014513772,0.98477495,0.000431902,0.000014893013,0.0000404247,0.00006160179,0.00011652957,0.000029603163,0.000016324166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801946,0.00011343851,0.0012250276,0.00024303824,0.0001696746,0.00022937538],"domain_scores_gemma":[0.9983071,0.0001337309,0.0011712188,0.00016346757,0.000076573866,0.0001479165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108432054,0.00028906984,0.002914195,0.00072240905,0.000026155823,0.00000810015,0.000113203525,0.000089061745,0.000038293507],"category_scores_gemma":[0.000025637344,0.00020078394,0.00039323122,0.0005267937,0.0004824874,0.000044307573,0.00005702921,0.00060260436,0.000042001655],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046134108,0.00034464645,0.00021635229,0.0063718846,0.0006118294,0.001303068,0.000095673226,2.617642e-7,0.0000012345441,0.0001818318,0.0014104645,0.9894166],"study_design_scores_gemma":[0.0015321043,0.0017805711,0.00003723095,0.01991415,0.004192179,0.07543032,0.00045274897,0.000004062231,0.00001404657,0.0013488962,0.89490014,0.0003935338],"about_ca_topic_score_codex":0.000008290948,"about_ca_topic_score_gemma":0.000005745011,"teacher_disagreement_score":0.9890231,"about_ca_system_score_codex":0.000048683087,"about_ca_system_score_gemma":0.00041535523,"threshold_uncertainty_score":0.8187731},"labels":[],"label_agreement":null},{"id":"W4403184720","doi":"10.1002/ajh.27499","title":"The invisible lifeline: Intricacies of the global plasma supply","year":2024,"lang":"en","type":"editorial","venue":"American Journal of Hematology","topic":"Anarchism and Radical Politics","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Business; Political science","score_opus":0.005786884733839829,"score_gpt":0.3112073898392508,"score_spread":0.30542050510541097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403184720","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051355534,0.005851542,0.000040767467,0.037255105,0.945911,0.00014834452,0.00016413523,0.000018916766,0.005474635],"genre_scores_gemma":[0.17864981,0.008404397,0.00029487757,0.00037054412,0.81080693,0.0000040389514,0.000004286421,0.000038625036,0.0014264925],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967735,0.0006835295,0.0008206038,0.0001462386,0.0011077331,0.00046839745],"domain_scores_gemma":[0.9943494,0.0036155512,0.0012027182,0.00022135056,0.0004182595,0.00019270476],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0009972539,0.00017749918,0.00073960744,0.00007850117,0.0004166221,0.00005568645,0.0014268112,0.0002791657,0.000016427677],"category_scores_gemma":[0.0051729083,0.000088846566,0.00039329674,0.0006487651,0.00852509,0.000046617784,0.00019711595,0.0011624235,0.000016585076],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037103706,0.000023232576,0.0003490384,0.000023124565,0.00013113987,0.000033895958,0.0008577833,0.0000015294488,1.6368327e-7,0.050239902,0.94505036,0.003252698],"study_design_scores_gemma":[0.00011216129,0.00023001031,0.00002282623,0.00012032939,0.0001329378,0.00007917605,0.003924782,0.000004711142,0.000004816028,0.018131739,0.97714204,0.00009446034],"about_ca_topic_score_codex":0.0011272734,"about_ca_topic_score_gemma":0.00064284785,"teacher_disagreement_score":0.17351426,"about_ca_system_score_codex":0.00017212763,"about_ca_system_score_gemma":0.0031608993,"threshold_uncertainty_score":0.9941731},"labels":[],"label_agreement":null},{"id":"W4403406073","doi":"10.1002/ajh.27506","title":"Characterizing coagulation responses in humans and nonhuman primates following kidney xenotransplantation—A narrative review","year":2024,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Xenotransplantation and immune response","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Lawrence College; Queen's University; University of Ottawa; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; American Society of Nephrology; U.S. Department of Health and Human Services","keywords":"Xenotransplantation; Thrombomodulin; Coagulation; Immunology; Thrombotic microangiopathy; Medicine; Von Willebrand factor; Coagulopathy; Kidney; Transplantation; Platelet; Thrombin; Internal medicine; Disease","score_opus":0.033210962994010544,"score_gpt":0.3926634263194095,"score_spread":0.35945246332539893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403406073","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007053528,0.99072963,0.000036407662,0.0012723651,0.00022829343,0.00056720246,0.000024482202,0.000020471402,0.00006762878],"genre_scores_gemma":[0.002520859,0.9958388,0.0004643605,0.0008638022,0.000049958868,0.00002475115,0.00010994204,0.00005462945,0.00007287139],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9967352,0.0007746098,0.0016966648,0.00028331907,0.0002531106,0.0002570783],"domain_scores_gemma":[0.997863,0.0005557745,0.0011320111,0.00017637222,0.00009444582,0.000178414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008667169,0.0003853095,0.0034854063,0.00090347073,0.00006414566,0.00002695924,0.00012563226,0.00012665626,0.00003720498],"category_scores_gemma":[0.00030039405,0.0002844508,0.0005390448,0.0005349315,0.00020331959,0.00015140038,0.000016433936,0.0007430961,0.000016873268],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022798688,0.00035976924,0.0009981444,0.4107398,0.0036662181,0.012280838,0.018784098,1.6029615e-7,0.00093449943,0.00075842655,0.0014250929,0.54777306],"study_design_scores_gemma":[0.0014195072,0.0015155004,0.0006337287,0.57124615,0.010485821,0.03433069,0.0009710624,0.0000028970428,0.000039105184,0.000034379496,0.37871253,0.000608607],"about_ca_topic_score_codex":0.000009379648,"about_ca_topic_score_gemma":0.000002832001,"teacher_disagreement_score":0.54716444,"about_ca_system_score_codex":0.00010895972,"about_ca_system_score_gemma":0.0008280608,"threshold_uncertainty_score":0.9999608},"labels":[],"label_agreement":null},{"id":"W4405323708","doi":"10.1002/ajh.27555","title":"Effect of Ferric Derisomaltose on Fatigue in Iron Deficiency Anemia Associated With Abnormal Uterine Bleeding","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; University of Toronto","funders":"","keywords":"Medicine; Iron-deficiency anemia; Context (archaeology); Anemia; Iron deficiency; Population; Internal medicine; Post-hoc analysis; Etiology; Pediatrics; Gynecology","score_opus":0.011077726736898262,"score_gpt":0.2951890012336696,"score_spread":0.2841112744967713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405323708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96397555,0.0005496255,0.000015851227,0.03443509,0.00026002992,0.00024464962,0.000013667031,0.000018233352,0.0004872761],"genre_scores_gemma":[0.9882426,0.00007486732,0.00022136213,0.010986952,0.00022156196,0.000011488706,0.000038151386,0.00007453885,0.00012844295],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99764264,0.00024946884,0.0008706285,0.0003024378,0.00045241954,0.00048243612],"domain_scores_gemma":[0.9978919,0.00047204242,0.001201349,0.00023641477,0.0001011373,0.000097155884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029304618,0.00043598865,0.0020331414,0.00085293094,0.000024001407,0.000011842547,0.00018266926,0.00025012248,0.000050472263],"category_scores_gemma":[0.0001108475,0.00027738346,0.00022811847,0.0005491713,0.00027657085,0.00005155162,0.000050910814,0.0016273204,0.000008076386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007734183,0.0016512643,0.53520554,0.010110676,0.00225848,0.31678388,0.0012283372,0.00010028902,0.0007562664,0.00008261115,0.09497768,0.029110791],"study_design_scores_gemma":[0.041957144,0.4951962,0.11853976,0.040246088,0.011500764,0.25195464,0.0006264003,0.00026677016,0.015702765,0.000112345755,0.020595843,0.0033012899],"about_ca_topic_score_codex":0.00007789397,"about_ca_topic_score_gemma":0.000008188965,"teacher_disagreement_score":0.49354494,"about_ca_system_score_codex":0.00022878416,"about_ca_system_score_gemma":0.00017240485,"threshold_uncertainty_score":0.9999678},"labels":[],"label_agreement":null},{"id":"W4405584069","doi":"10.1002/ajh.27563","title":"Treatment Effectiveness of Venetoclax‐Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real‐World Study","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Incyte; Pharmacyclics; Genentech; Grifols; Galápagos; MEI Pharma; BeiGene; National Cancer Institute; AbbVie; Seagen; Gilead Sciences; Loxo Oncology; TG Therapeutics; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Venetoclax; Medicine; Chronic lymphocytic leukemia; Discontinuation; Ibrutinib; Internal medicine; Oncology; Clinical trial; Idelalisib; Leukemia","score_opus":0.018615806460144102,"score_gpt":0.34243286789192356,"score_spread":0.32381706143177946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405584069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98962855,0.0022006242,0.000011643555,0.0057513923,0.00084894925,0.0012964653,0.000026647824,0.000029901516,0.00020583198],"genre_scores_gemma":[0.9923728,0.0008752486,0.000091277696,0.0045628306,0.0015356529,0.00019503648,0.00007837495,0.00015570183,0.00013308192],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99493325,0.0011637763,0.0014979024,0.00068366906,0.001052185,0.0006692231],"domain_scores_gemma":[0.99656963,0.0010739235,0.0009637075,0.0008015246,0.0003926525,0.00019853849],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078050373,0.0006219158,0.0025658924,0.00217857,0.000024887684,0.000031262785,0.0005079715,0.00034459893,0.00012370416],"category_scores_gemma":[0.00008216006,0.00046710018,0.0004990214,0.00093238056,0.0007390155,0.00012346669,0.000091492875,0.0015020168,0.000019476638],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.09354831,0.0050184363,0.1024501,0.010356015,0.016256612,0.64251286,0.00510343,0.0088648535,0.0069874576,0.00012366717,0.026367586,0.0824107],"study_design_scores_gemma":[0.36715153,0.24228081,0.04087737,0.029001437,0.0050855237,0.050323255,0.0017989798,0.031551357,0.08037864,0.00035286314,0.14712337,0.0040748985],"about_ca_topic_score_codex":0.00880258,"about_ca_topic_score_gemma":0.00045516706,"teacher_disagreement_score":0.59218955,"about_ca_system_score_codex":0.20636262,"about_ca_system_score_gemma":0.0677271,"threshold_uncertainty_score":0.9997781},"labels":[],"label_agreement":null},{"id":"W4405708568","doi":"10.1002/ajh.27565","title":"Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: <scp>EPICOVIDEHA</scp>‐<scp>EPIFLUEHA</scp> Report","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Respiratory viral infections research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; Instituto de Salud Carlos III; Universitätsklinikum Köln; Universität Innsbruck; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; Szegedi Tudományegyetem; European Hematology Association; Università degli Studi di Roma Tor Vergata; Universität zu Köln; National and Kapodistrian University of Athens; Masarykova Univerzita; Università degli Studi di Genova; Medizinische Universität Innsbruck; Fakultní nemocnice Hradec Králové; Deutsches Zentrum für Infektionsforschung; Ostravská Univerzita v Ostravě; Eskişehir Osmangazi Üniversitesi; Univerzita Komenského v Bratislave","keywords":"Boreal; Malignancy; Respiratory system; Medicine; Internal medicine; Biology; Ecology","score_opus":0.02920221971966039,"score_gpt":0.3447772890787328,"score_spread":0.3155750693590724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405708568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99213475,0.0023478346,0.000186021,0.00027801734,0.0005207161,0.0005555825,0.000011362771,0.000067767345,0.0038979778],"genre_scores_gemma":[0.9970448,0.000046103123,0.00059222773,0.0015685103,0.00016736469,0.000067223715,0.0000068914665,0.00009013967,0.00041672765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943538,0.0007113843,0.0022011567,0.000745541,0.0009650992,0.0010230449],"domain_scores_gemma":[0.99589366,0.0017242478,0.0007963566,0.000638614,0.00047480114,0.00047231672],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014463505,0.00048636037,0.0018644161,0.0022732744,0.00007424427,0.00008098349,0.00039389898,0.00027295193,0.000091977156],"category_scores_gemma":[0.003701918,0.00035683834,0.00032177122,0.0023124078,0.0010461183,0.00043535253,0.00016746894,0.0020108896,0.00014227815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019492109,0.00077548146,0.94691324,0.00021394576,0.00024177574,0.03465217,0.0003323659,0.000019816243,0.00020944908,0.0005096657,0.014097522,0.0018396226],"study_design_scores_gemma":[0.004096782,0.01154659,0.8685758,0.0021074621,0.00016843757,0.019907834,0.001637598,0.00003956506,0.0022993311,0.0004304022,0.0889975,0.00019266483],"about_ca_topic_score_codex":0.00017455478,"about_ca_topic_score_gemma":0.00012964188,"teacher_disagreement_score":0.07833742,"about_ca_system_score_codex":0.00043940917,"about_ca_system_score_gemma":0.0010498145,"threshold_uncertainty_score":0.99988836},"labels":[],"label_agreement":null},{"id":"W4406679947","doi":"10.1002/ajh.27588","title":"Association Between Anticoagulant‐Related Bleeding and Mortality in Patients With Solid Tumors and Cancer‐Associated Venous Thromboembolism","year":2025,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Heart, Lung, and Blood Institute; American Society of Hematology","keywords":"Medicine; Cancer; Case fatality rate; Internal medicine; Mortality rate; Diagnosis code; Disease; Surgery; Epidemiology; Population","score_opus":0.009192973311584213,"score_gpt":0.27500349730888773,"score_spread":0.26581052399730354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406679947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9282488,0.00058063713,0.0000043584964,0.0703876,0.00021308812,0.00039188378,0.000035732955,0.000016196076,0.000121705736],"genre_scores_gemma":[0.9662216,0.0011122023,0.000053050113,0.0322264,0.00021929464,0.0000102315635,0.000071632414,0.00004105181,0.00004456574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743164,0.00021740756,0.0009790868,0.00034456936,0.0005040206,0.000523261],"domain_scores_gemma":[0.996926,0.0003282603,0.0021635257,0.00016489501,0.00031100743,0.00010633019],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045606183,0.00034083272,0.0033635322,0.0005597669,0.00007514757,0.000030171595,0.00012673248,0.00036073325,0.00001693009],"category_scores_gemma":[0.00018552669,0.00028193908,0.000097141085,0.00039223066,0.00024339822,0.00008843783,0.00008203217,0.001456167,6.866714e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003292544,0.00028105668,0.96371144,0.00028160153,0.0039411145,0.00048468905,0.0004136566,0.0000033393242,0.0000016512423,0.000016127111,0.028957197,0.0018751733],"study_design_scores_gemma":[0.0023079505,0.0016371213,0.9890963,0.0016162135,0.0035169926,0.000059334914,0.00014222602,0.000008307286,0.000011541144,0.00013488362,0.0012165703,0.0002525502],"about_ca_topic_score_codex":0.0007182546,"about_ca_topic_score_gemma":0.000047895348,"teacher_disagreement_score":0.0381612,"about_ca_system_score_codex":0.00038774128,"about_ca_system_score_gemma":0.00024471586,"threshold_uncertainty_score":0.9999633},"labels":[],"label_agreement":null},{"id":"W4406775014","doi":"10.1002/ajh.27539","title":"Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Chugai Pharmaceutical; Genentech; Grifols; AOP Orphan; Novo Nordisk; Argenx; Regeneron Pharmaceuticals; Bristol-Myers Squibb; CSL Behring; Celgene; CTI Biopharma; Swedish Orphan Biovitrum; Apellis Pharmaceuticals; BioCryst; Alnylam Pharmaceuticals; Sanofi; Alexion Pharmaceuticals; Amgen; Pfizer","keywords":"Immune thrombocytopenia; Bruton's tyrosine kinase; Medicine; Tyrosine-kinase inhibitor; Internal medicine; Tyrosine kinase; Immunology; Gastroenterology; Antibody; Receptor; Cancer","score_opus":0.011007295989296182,"score_gpt":0.3249805975566005,"score_spread":0.31397330156730435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406775014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978606,0.0002500329,0.000047924972,0.00073480053,0.000078404875,0.00082071364,0.000007817747,0.000014568826,0.00018509773],"genre_scores_gemma":[0.999083,0.000033786782,0.0005926582,0.0001583693,0.000037781363,0.000007694226,0.000015264104,0.0000276522,0.00004383911],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99726623,0.0003647331,0.0010147883,0.00038896466,0.00049778575,0.00046747495],"domain_scores_gemma":[0.9980249,0.0003161364,0.0005307674,0.0004903265,0.00038425482,0.00025365956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007489205,0.0002608682,0.0014902086,0.00042910528,0.000083341416,0.00002262403,0.00019902097,0.0000616276,0.000018063414],"category_scores_gemma":[0.0002957728,0.00016996705,0.000042770906,0.0008463829,0.00082504615,0.00017122994,0.0001030738,0.00054807233,0.0000022143765],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41837743,0.02623699,0.49392167,0.00022145286,0.0014780068,0.00809416,0.0038220133,0.00007038039,0.00038292445,0.00032127913,0.00082361966,0.046250056],"study_design_scores_gemma":[0.4877947,0.08678254,0.41432863,0.0013764476,0.0004893985,0.0024913286,0.0034624035,0.00015667663,0.0017007102,0.000015871996,0.001032571,0.0003687283],"about_ca_topic_score_codex":0.00050316233,"about_ca_topic_score_gemma":0.00019262424,"teacher_disagreement_score":0.07959303,"about_ca_system_score_codex":0.0013222356,"about_ca_system_score_gemma":0.0032851524,"threshold_uncertainty_score":0.6931055},"labels":[],"label_agreement":null},{"id":"W4406963855","doi":"10.1002/ajh.27621","title":"Non‐Transfusion‐Dependent Thalassemia: An Image Gallery Worth a Thousand Words","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Swedish Orphan Biovitrum; Novo Nordisk; Argenx; Regeneron Pharmaceuticals; Alnylam Pharmaceuticals; Agios Pharmaceuticals; Bristol-Myers Squibb; Vertex Pharmaceuticals; Amgen","keywords":"Medicine; Thalassemia; Ineffective erythropoiesis; Anemia; Splenectomy; Pediatrics; Internal medicine; Intensive care medicine; Erythropoiesis","score_opus":0.0043185632314264285,"score_gpt":0.26813236606553603,"score_spread":0.2638138028341096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406963855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809731,0.0011028151,0.003263514,0.006045566,0.00040558068,0.00016223687,0.0000014526612,0.000025243235,0.008020466],"genre_scores_gemma":[0.9940788,0.0018476015,0.0022163137,0.0013646221,0.00006261864,0.0000036872377,0.000002279906,0.000021858175,0.0004021769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843556,0.00009949622,0.00065132184,0.00021196621,0.000247313,0.00035437127],"domain_scores_gemma":[0.998836,0.000095322626,0.00034161343,0.0002811878,0.00020454005,0.00024134987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003174833,0.00019181875,0.00088605186,0.00036245675,0.000088390676,0.000016214903,0.00018639193,0.00013472281,0.0001490653],"category_scores_gemma":[0.00007155807,0.00013940182,0.00021808289,0.00047205924,0.00040776024,0.00010214799,0.000035631838,0.00072935666,0.000012699758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007313617,0.004442341,0.7157113,0.0006556666,0.003194801,0.016795173,0.006740488,0.00012978344,0.03469098,0.0019827045,0.029095957,0.1792472],"study_design_scores_gemma":[0.06579008,0.042038053,0.33461452,0.009855903,0.008002903,0.22430429,0.18476401,0.002243292,0.055399142,0.0064910813,0.06256877,0.003927983],"about_ca_topic_score_codex":0.000056734138,"about_ca_topic_score_gemma":0.000028286544,"teacher_disagreement_score":0.38109678,"about_ca_system_score_codex":0.000051361447,"about_ca_system_score_gemma":0.00044233206,"threshold_uncertainty_score":0.5684641},"labels":[],"label_agreement":null},{"id":"W4407592569","doi":"10.1002/ajh.27642","title":"Moving the Therapeutic Needle in Immunoglobulin Light Chain and <scp>TTR</scp> Cardiac Amyloidosis","year":2025,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cardiac amyloidosis; Medicine; Amyloidosis; Restrictive cardiomyopathy; AL amyloidosis; Internal medicine; Cardiomyopathy; Heart failure; Cardiology; Multiple myeloma; Monoclonal gammopathy of undetermined significance; Pathology; Immunoglobulin light chain; Monoclonal; Antibody; Immunology","score_opus":0.005749001782372957,"score_gpt":0.2396141922997072,"score_spread":0.23386519051733426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407592569","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4556571,0.08043129,0.00022137818,0.46086356,0.0012158409,0.0006699558,0.00006407496,0.00002042448,0.0008563662],"genre_scores_gemma":[0.65143406,0.017297419,0.00065921625,0.32716295,0.0014293648,0.00014108494,0.000082148224,0.00014362225,0.0016501395],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969592,0.00074896816,0.0008816007,0.00049330626,0.0002614689,0.0006554677],"domain_scores_gemma":[0.99719954,0.0007550691,0.0011795887,0.00064410496,0.00014172267,0.00007996733],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004492762,0.000544561,0.0014628732,0.0003542592,0.00011573573,0.000054468834,0.000720562,0.00054937304,0.000008128492],"category_scores_gemma":[0.00031198902,0.00039177807,0.0004921268,0.00034959413,0.00053877785,0.000008904154,0.00026989245,0.0012510958,0.0000062912422],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000983786,0.00022291107,0.17252755,0.00022028349,0.004376359,0.0008047377,0.00097495335,0.000024378762,0.0063964855,0.0001392343,0.79972297,0.014491789],"study_design_scores_gemma":[0.0013459995,0.0014020385,0.010077798,0.0003350427,0.0007931308,0.0014501661,0.0029300535,0.0000065947165,0.017214607,0.00017701156,0.96385914,0.00040843218],"about_ca_topic_score_codex":0.00014493694,"about_ca_topic_score_gemma":0.000015643138,"teacher_disagreement_score":0.19577697,"about_ca_system_score_codex":0.00008809712,"about_ca_system_score_gemma":0.00029970647,"threshold_uncertainty_score":0.99985343},"labels":[],"label_agreement":null},{"id":"W4407714303","doi":"10.1002/ajh.27636","title":"Steady‐State Ratio of <scp>von</scp> Willebrand Factor Antigen to <scp>ADAMTS13</scp> Activity Predicts Low Platelet Count at Hospitalization for Sickle Cell Disease Vaso‐Occlusive Episodes","year":2025,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; University of Illinois at Chicago; University of Illinois at Urbana-Champaign; National Institutes of Health","keywords":"Von Willebrand factor; ADAMTS13; Platelet; Antigen; Medicine; Immunology","score_opus":0.005413511609739836,"score_gpt":0.23603778055631724,"score_spread":0.23062426894657742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407714303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594489,0.0022085237,0.0059774267,0.02828452,0.0009975361,0.0018268923,0.0009069892,0.000045223715,0.00030400557],"genre_scores_gemma":[0.91536045,0.00399602,0.0008279351,0.07407163,0.00082651095,0.000083691906,0.0005637891,0.00023961953,0.0040303376],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995929,0.00031634656,0.0013963204,0.0006462016,0.00079295476,0.0009191499],"domain_scores_gemma":[0.99342865,0.0018506284,0.0026483748,0.0005543386,0.00097485585,0.0005431309],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028008266,0.00071975915,0.002642973,0.0007218377,0.00020031347,0.000035232824,0.00042794948,0.0005833178,0.000024444194],"category_scores_gemma":[0.0013166345,0.0005973376,0.00066947576,0.0005802599,0.0006432845,0.00018415537,0.00016174854,0.0012456458,0.000012966927],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006597014,0.0007102452,0.021642072,0.0038230151,0.0018905384,0.0027918008,0.0039913873,0.0007866494,0.0022410923,0.000020771366,0.95927125,0.0021714955],"study_design_scores_gemma":[0.018497052,0.014987379,0.01737493,0.006325502,0.004033634,0.0024030246,0.0059411037,0.0014995005,0.08824106,0.0005887732,0.83918554,0.0009225276],"about_ca_topic_score_codex":0.00006277461,"about_ca_topic_score_gemma":0.00001054268,"teacher_disagreement_score":0.12008572,"about_ca_system_score_codex":0.00030236953,"about_ca_system_score_gemma":0.0012644299,"threshold_uncertainty_score":0.9996478},"labels":[],"label_agreement":null},{"id":"W4407908356","doi":"10.1002/ajh.27637","title":"Five‐Year Real‐World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B‐Cell Precursor Acute Lymphoblastic Leukemia","year":2025,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; Pfizer","keywords":"Lymphoblastic Leukemia; Hematopoietic stem cell transplantation; Hematopoietic cell; Medicine; Transplantation; Leukemia; Stem cell; Immunology; Haematopoiesis; Oncology; Internal medicine; Biology; Genetics","score_opus":0.00682411759801206,"score_gpt":0.2611636252635529,"score_spread":0.25433950766554086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407908356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8601942,0.0010344314,0.004098815,0.11694202,0.001388251,0.0026687013,0.0006190967,0.00010310501,0.012951355],"genre_scores_gemma":[0.9360807,0.003512798,0.0044820346,0.04311037,0.0009024502,0.000053875014,0.00039681996,0.00030064705,0.011160323],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99366987,0.0006639532,0.0027562408,0.0006680815,0.0012020699,0.0010397572],"domain_scores_gemma":[0.99398315,0.0017820334,0.0026372448,0.0007455616,0.0005995495,0.000252455],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005413356,0.00073221896,0.0036835268,0.0025222453,0.000058894206,0.000017730954,0.0008488849,0.0007201351,0.0001257677],"category_scores_gemma":[0.00006369941,0.00063092634,0.0006020927,0.0015170564,0.000949465,0.0001286914,0.00012348837,0.0029774639,0.00003998908],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025678882,0.0012676961,0.023617208,0.030910796,0.003936039,0.08391866,0.013806349,0.0006108751,0.0022608866,0.000590091,0.8041337,0.009268789],"study_design_scores_gemma":[0.22978604,0.07547134,0.027524287,0.08893285,0.042335983,0.20033006,0.022979438,0.006334551,0.15848133,0.003025115,0.13435549,0.0104435105],"about_ca_topic_score_codex":0.0005366794,"about_ca_topic_score_gemma":0.0001142912,"teacher_disagreement_score":0.6697782,"about_ca_system_score_codex":0.0036720787,"about_ca_system_score_gemma":0.007085788,"threshold_uncertainty_score":0.9996142},"labels":[],"label_agreement":null},{"id":"W4408337415","doi":"10.1002/ajh.27655","title":"<scp><i>TP53</i></scp>‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Astellas Pharma; Celgene; AbbVie Canada; Kura Oncology","keywords":"Myeloid leukemia; Medicine; Venetoclax; Cancer; Oncology; Myelodysplastic syndromes; Internal medicine; Myeloid; Population; Bioinformatics; Cancer research; Immunology; Leukemia; Biology; Bone marrow","score_opus":0.01547931291521099,"score_gpt":0.3319085732240816,"score_spread":0.31642926030887064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408337415","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063384115,0.9929304,0.00020777911,0.0013056,0.00044852664,0.0011719299,0.00006469433,0.00003587065,0.0032013492],"genre_scores_gemma":[0.00011519916,0.9946116,0.0026678606,0.00061266904,0.00015529667,0.00017687552,0.000075615804,0.00007911445,0.0015057633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99546343,0.0008365962,0.0018054475,0.00065020536,0.00058799994,0.0006563193],"domain_scores_gemma":[0.9933015,0.0027383016,0.0023955714,0.00074117,0.00036444032,0.00045900812],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009073504,0.00064409024,0.004054753,0.0015534153,0.0001331993,0.000056368404,0.00057724357,0.00027832537,0.00009441902],"category_scores_gemma":[0.0011145723,0.00048107907,0.00054457394,0.0014215116,0.0007211982,0.0000775855,0.00019972108,0.0020458593,0.00017120119],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006058475,0.00021202173,0.00044419008,0.01193872,0.0023679326,0.0021732245,0.000071486094,0.0000015116104,2.479881e-7,0.0011625586,0.124601565,0.85696596],"study_design_scores_gemma":[0.00095910183,0.0011962723,0.00009580484,0.014258297,0.00371518,0.008429113,0.00044095915,0.000005554282,0.000020009367,0.0001789717,0.9705387,0.0001620771],"about_ca_topic_score_codex":0.000024464629,"about_ca_topic_score_gemma":0.0000055464516,"teacher_disagreement_score":0.8568039,"about_ca_system_score_codex":0.00040137873,"about_ca_system_score_gemma":0.0012455396,"threshold_uncertainty_score":0.9997641},"labels":[],"label_agreement":null},{"id":"W4408460398","doi":"10.1002/ajh.27665","title":"Topics of Interest in Women With Myeloproliferative Neoplasms","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Essential thrombocythemia; Polycythemia vera; Medicine; Myelofibrosis; Internal medicine; Myeloproliferative neoplasm; Disease; Oncology; Gynecology; Bone marrow","score_opus":0.040912619085824165,"score_gpt":0.3393716473534898,"score_spread":0.2984590282676656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408460398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02181625,0.9762118,0.000037885537,0.00065563933,0.00013996213,0.00064137555,0.00001650968,0.0000059061626,0.00047470382],"genre_scores_gemma":[0.006369452,0.99134266,0.0017439999,0.00021461013,0.000072735274,0.0001074913,0.000006896214,0.000028605444,0.00011352514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748343,0.0003115776,0.0014361708,0.0002712731,0.00016003297,0.00033748537],"domain_scores_gemma":[0.99675393,0.0007158408,0.0017744454,0.00028198786,0.0003019677,0.0001718329],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023032115,0.00041919562,0.0055178404,0.0007841416,0.000020399373,0.000007844367,0.00019586056,0.00014783013,0.00007141653],"category_scores_gemma":[0.00021438622,0.00025112007,0.0002904038,0.00068526797,0.00037942312,0.000043575812,0.000055512097,0.0006740265,0.000004764939],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008040822,0.0007043698,0.0040216176,0.008868688,0.0019118877,0.0017219007,0.0008422704,8.977204e-7,2.186049e-7,0.00318042,0.0002781265,0.97766554],"study_design_scores_gemma":[0.007327287,0.034162324,0.0014085978,0.18224844,0.004269087,0.03258787,0.0035827768,0.0000026295575,0.0001993329,0.0005001307,0.73273444,0.0009770991],"about_ca_topic_score_codex":0.000015609938,"about_ca_topic_score_gemma":0.000053505835,"teacher_disagreement_score":0.97668844,"about_ca_system_score_codex":0.00031190924,"about_ca_system_score_gemma":0.0017198545,"threshold_uncertainty_score":0.9999941},"labels":[],"label_agreement":null},{"id":"W4409964068","doi":"10.1002/ajh.27688","title":"Integration of Optical Genome Mapping in the Cytogenomic and Molecular Work‐Up of Hematological Malignancies: Expert Recommendations From the International Consortium for Optical Genome Mapping","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Workflow; Identification (biology); Computational biology; Computer science; Bioinformatics; Biology; Database","score_opus":0.05738899509302728,"score_gpt":0.343285930744665,"score_spread":0.28589693565163776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409964068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060216643,0.92231566,0.00784641,0.008038455,0.00025041748,0.001108202,0.00008868402,0.000005212778,0.00013033385],"genre_scores_gemma":[0.106739186,0.87195504,0.020012591,0.0008180548,0.000089796056,0.00020692364,0.00014885512,0.00002219677,0.0000073473966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973997,0.00025059472,0.0016420268,0.00026333975,0.00022105203,0.0002232836],"domain_scores_gemma":[0.99492633,0.003260606,0.0012611137,0.00028112915,0.00020214457,0.000068646696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005810602,0.00027562896,0.0022881194,0.0002988802,0.000046177123,0.000019180437,0.00041183914,0.00014531909,0.00003184321],"category_scores_gemma":[0.00058158895,0.00014822204,0.0005210225,0.00032591255,0.00054721296,0.000033686312,0.00010795171,0.0003014728,0.0000010910322],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074013486,0.0024529947,0.0045076148,0.0042795683,0.0075781825,0.0010083333,0.007403783,0.0000065581494,0.0024000641,0.055105068,0.0011230308,0.9133947],"study_design_scores_gemma":[0.014635893,0.0050130156,0.014268379,0.09125959,0.0097510815,0.031364225,0.054290403,0.000080336635,0.0017358239,0.0030525855,0.7727515,0.00179716],"about_ca_topic_score_codex":0.000022617134,"about_ca_topic_score_gemma":0.0000030115352,"teacher_disagreement_score":0.9115975,"about_ca_system_score_codex":0.00017698333,"about_ca_system_score_gemma":0.00041539394,"threshold_uncertainty_score":0.6044319},"labels":[],"label_agreement":null},{"id":"W4410004675","doi":"10.1002/ajh.27691","title":"Profound Thrombocytopenia and Dyspnea 11 Days After Cardiac Surgery","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; Hamilton Health Sciences; Hamilton General Hospital; McMaster University","funders":"McMaster University","keywords":"Medicine; Cardiac surgery; Cardiology; Internal medicine; Surgery","score_opus":0.014011126601404677,"score_gpt":0.2914392502934344,"score_spread":0.27742812369202974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410004675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919864,0.0014419339,0.00013133703,0.003991543,0.0008415397,0.00021599277,0.0000053567296,0.000021187472,0.0013647354],"genre_scores_gemma":[0.9968048,0.0005008062,0.0011541743,0.0012279453,0.00012630159,0.000014591631,0.0000029296364,0.000025897889,0.00014260157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980706,0.0002293652,0.00079083507,0.00028002396,0.00020788201,0.00042127716],"domain_scores_gemma":[0.99815935,0.0005307464,0.00042918042,0.00034381848,0.00028304293,0.00025383933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005513161,0.0002462851,0.0022374822,0.00043459574,0.000079649995,0.000029651243,0.00013166059,0.000108305925,0.00013162919],"category_scores_gemma":[0.00030698345,0.00019655227,0.00030028843,0.00048965355,0.000660701,0.00015546678,0.00010494242,0.00038940267,0.00002502551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051026966,0.00020332195,0.97278243,0.00017589153,0.0009679755,0.00060028554,0.00041062915,1.0809213e-7,0.0036803593,0.0020412763,0.0059112483,0.012716185],"study_design_scores_gemma":[0.0015598565,0.0012617086,0.9315359,0.000885709,0.0015339417,0.005686172,0.0023868403,0.000009054799,0.017034201,0.00094375544,0.036648136,0.0005147071],"about_ca_topic_score_codex":0.00007967904,"about_ca_topic_score_gemma":0.00001961592,"teacher_disagreement_score":0.04124653,"about_ca_system_score_codex":0.00008521565,"about_ca_system_score_gemma":0.00055295107,"threshold_uncertainty_score":0.8015169},"labels":[],"label_agreement":null},{"id":"W4410036934","doi":"10.1002/ajh.27696","title":"Thrombocytopenia and Anemia After Cardiac Surgery","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton General Hospital; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"","keywords":"Medicine; Anemia; Cardiac surgery; Surgery; Internal medicine; Cardiology","score_opus":0.011611686637571771,"score_gpt":0.28732023212119845,"score_spread":0.27570854548362667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410036934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99160045,0.0021989692,0.00008305141,0.0037218435,0.00054731633,0.00011999577,0.0000034805912,0.000015921258,0.0017089511],"genre_scores_gemma":[0.9965001,0.0008016948,0.0011099329,0.0013711997,0.000096191354,0.00000672868,0.0000016989484,0.000017854954,0.00009464973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985143,0.00016657673,0.0006359834,0.00021017164,0.00015313976,0.00031985863],"domain_scores_gemma":[0.9985127,0.00046616173,0.00032593944,0.0002674519,0.00021693742,0.00021079696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004045975,0.00018802022,0.0018782774,0.00037670674,0.000052268268,0.000018035316,0.00009765375,0.00008962843,0.000105799576],"category_scores_gemma":[0.00024665787,0.00015029959,0.00026389697,0.00040741178,0.000515534,0.00010472773,0.00007365268,0.00035758122,0.000018090193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006904225,0.00015319174,0.950521,0.00016900415,0.0007671209,0.0006622487,0.00032224727,1.0944741e-7,0.005435832,0.0013877373,0.009590286,0.03030083],"study_design_scores_gemma":[0.0010638649,0.0009507132,0.9501281,0.00063845195,0.0010517918,0.004971082,0.0012931877,0.0000039277484,0.01805691,0.0006500369,0.020852357,0.0003395911],"about_ca_topic_score_codex":0.00005053829,"about_ca_topic_score_gemma":0.0000056067283,"teacher_disagreement_score":0.02996124,"about_ca_system_score_codex":0.00006179849,"about_ca_system_score_gemma":0.00043494682,"threshold_uncertainty_score":0.61290395},"labels":[],"label_agreement":null},{"id":"W4410251140","doi":"10.1002/ajh.27710","title":"Hypoferremic Response to Chronic Inflammation Is Controlled via the Hemojuvelin/Hepcidin/Ferroportin Axis and Does Not Involve Hepcidin‐Independent Regulation of <i>Fpn</i><scp>mRNA</scp>","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Hepcidin; Ferroportin; Inflammation; Endocrinology; Internal medicine; Medicine; Anemia; Kidney disease","score_opus":0.006159806434292575,"score_gpt":0.26187840857365774,"score_spread":0.25571860213936515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410251140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772838,0.0021107625,0.0037172157,0.015780482,0.00032933094,0.00060003134,0.0000050327194,0.000014689409,0.0001586495],"genre_scores_gemma":[0.9964981,0.00038351037,0.00085404736,0.0017908998,0.00010980018,0.00001755139,0.0000030230353,0.00002026422,0.00032277565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970505,0.00048153373,0.0014056566,0.00025561126,0.00047372686,0.00033294363],"domain_scores_gemma":[0.9964923,0.001027824,0.0014544916,0.00038603402,0.00047365413,0.00016565387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016446216,0.00024430073,0.0013349815,0.0005230594,0.00010868611,0.000019434798,0.00022790366,0.00011312732,0.00004227845],"category_scores_gemma":[0.0018020142,0.0001502982,0.00023570012,0.00046857327,0.00046767076,0.00012233247,0.00008213386,0.00034829043,0.0000071683207],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028134871,0.00029479712,0.04829895,0.00039763507,0.000700082,0.000110906665,0.006553637,0.00020327845,0.87103957,0.0024207002,0.0049423045,0.03690324],"study_design_scores_gemma":[0.037885234,0.0055777873,0.24173212,0.0008312534,0.0021721274,0.0031389063,0.026117582,0.0013412508,0.66776186,0.0043711546,0.008662816,0.00040792528],"about_ca_topic_score_codex":0.00010574636,"about_ca_topic_score_gemma":0.00005908893,"teacher_disagreement_score":0.20327775,"about_ca_system_score_codex":0.00010031621,"about_ca_system_score_gemma":0.00055163703,"threshold_uncertainty_score":0.6128983},"labels":[],"label_agreement":null},{"id":"W4410543268","doi":"10.1002/ajh.27721","title":"Mixed Autoimmune Hemolytic Anemia: A Systematic Review of Epidemiology, Clinical Characteristics, Therapies, and Outcomes","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Rituximab; Autoimmune hemolytic anemia; Anemia; Epidemiology; Etiology; Disease; Intensive care medicine; Therapeutic approach; Internal medicine; Autoantibody; Pediatrics; Immunology; Lymphoma; Antibody","score_opus":0.05142610830383273,"score_gpt":0.39577066878111417,"score_spread":0.34434456047728146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410543268","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013918625,0.99638236,0.00014400795,0.0016756934,0.0004661153,0.0011337165,0.000021350428,0.0000113989245,0.000026193155],"genre_scores_gemma":[0.00022222736,0.99616396,0.0017890255,0.0016312879,0.000052890242,0.00002403512,0.000025397669,0.000034334014,0.00005683436],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99036425,0.0024174396,0.006377148,0.0003285738,0.00019293668,0.00031962586],"domain_scores_gemma":[0.98477656,0.0073772473,0.0066975337,0.0006396554,0.0003124491,0.0001965811],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.004176393,0.00048018066,0.021737529,0.0003497295,0.00003405974,0.0000032483986,0.00031479576,0.00034428103,0.000031564756],"category_scores_gemma":[0.0065371017,0.00027749574,0.0016740685,0.0003458356,0.00089830346,0.00002788894,0.00007679016,0.0011790957,0.000004465833],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028550121,0.00017415915,0.0015746658,0.79406065,0.0014069517,0.00018337017,0.000013440959,5.7650745e-10,5.5466828e-8,0.00042981395,0.00019834423,0.20193],"study_design_scores_gemma":[0.0006936209,0.0012688538,0.0007142034,0.9425579,0.021258997,0.014973914,0.000048567286,4.0923376e-7,1.01641845e-7,0.000045271467,0.018241135,0.0001970818],"about_ca_topic_score_codex":0.000012573913,"about_ca_topic_score_gemma":7.583237e-7,"teacher_disagreement_score":0.20173292,"about_ca_system_score_codex":0.00004000935,"about_ca_system_score_gemma":0.00071465666,"threshold_uncertainty_score":0.9999677},"labels":[],"label_agreement":null},{"id":"W4411255343","doi":"10.1002/ajh.27736","title":"Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T‐Cell Lymphoma","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"National Cancer Institute; National Institutes of Health; Norges Forskningsråd; Leukemia and Lymphoma Society","keywords":"Angioimmunoblastic T-cell lymphoma; Transcriptome; Lymphoma; Medicine; Cancer research; Computational biology; Oncology; Internal medicine; Biology; Immunology; T cell; Gene; Genetics; Gene expression","score_opus":0.004244613251270105,"score_gpt":0.24985277281071286,"score_spread":0.24560815955944276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411255343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876095,0.010018728,0.00044862935,0.0010803635,0.00007303787,0.00012360893,0.000004658498,0.000005752591,0.0006357017],"genre_scores_gemma":[0.99722373,0.00062016386,0.001527601,0.00039652627,0.000010407406,0.0000124084845,0.0000029928,0.00000769636,0.00019844998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869585,0.00016448279,0.00063506054,0.0001830543,0.00009240693,0.00022915035],"domain_scores_gemma":[0.99896115,0.00039737657,0.00029263328,0.00016043498,0.00010578796,0.00008258859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002154726,0.00016955701,0.0012998891,0.00080687384,0.00003787812,0.000012359978,0.000083467494,0.000044186785,0.000042283835],"category_scores_gemma":[0.00007166442,0.00012048961,0.00025491032,0.0007059844,0.00031995677,0.000056494024,0.000018484687,0.000105351595,0.0000027038272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007203935,0.00095612643,0.9796906,0.00008114275,0.0023550729,0.00038612445,0.0019125907,0.00004871332,0.0026848302,0.0015312497,0.0003614612,0.009271692],"study_design_scores_gemma":[0.0073675276,0.0021255678,0.96733224,0.00030221048,0.0032152624,0.0011635234,0.008456117,0.00021671284,0.0078099295,0.0012686512,0.00054974214,0.00019254217],"about_ca_topic_score_codex":0.00030794548,"about_ca_topic_score_gemma":0.00008670207,"teacher_disagreement_score":0.012358389,"about_ca_system_score_codex":0.00024646663,"about_ca_system_score_gemma":0.0002473201,"threshold_uncertainty_score":0.49134237},"labels":[],"label_agreement":null},{"id":"W4411960460","doi":"10.1002/ajh.27761","title":"Addressing Anemia in High‐Altitude Populations: Global Impact, Prevalence, Challenges, and Potential Solutions","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"High Altitude and Hypoxia","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Université de Poitiers; Fondation Université Grenoble Alpes","keywords":"Anemia; Population; Medicine; Socioeconomic status; Psychological intervention; Global health; Environmental health; Altitude (triangle); Effects of high altitude on humans; Demography; Public health; Pathology; Internal medicine","score_opus":0.05229311928526361,"score_gpt":0.37027671570567594,"score_spread":0.31798359642041235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411960460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022198702,0.99682105,0.00023114067,0.000092882474,0.00022986239,0.00017687531,0.000056998277,0.000003926939,0.0001673708],"genre_scores_gemma":[0.021146394,0.9772566,0.0012882227,0.000029842558,0.00017302093,0.000011377254,0.000049823528,0.00001615886,0.000028569382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797547,0.00036949266,0.0008255672,0.00032511647,0.00013364827,0.00037072416],"domain_scores_gemma":[0.9985796,0.000039821185,0.00086738815,0.00027173813,0.0001088265,0.00013258988],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027168635,0.0003089582,0.0014883928,0.0002456073,0.00007093354,0.000019499716,0.0003116126,0.0002707894,0.000012917724],"category_scores_gemma":[0.00014538935,0.00025601007,0.00033351805,0.0002184538,0.00028178617,0.0000093849285,0.00017122751,0.00032986645,0.0000022808165],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087291955,0.0002240906,0.00096052233,0.007928618,0.00052843546,0.0004513461,0.000033425502,0.000028137478,0.000016071815,0.002776361,0.0011765426,0.9857892],"study_design_scores_gemma":[0.0054961313,0.0070798104,0.021834837,0.070377246,0.007965604,0.11383303,0.0005610128,0.000014740784,0.000017794628,0.0037465878,0.7652399,0.0038333249],"about_ca_topic_score_codex":0.00004019708,"about_ca_topic_score_gemma":0.000078309706,"teacher_disagreement_score":0.9819558,"about_ca_system_score_codex":0.000074251984,"about_ca_system_score_gemma":0.0007778301,"threshold_uncertainty_score":0.9999892},"labels":[],"label_agreement":null},{"id":"W4412422543","doi":"10.1002/ajh.70011","title":"Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Vascular Anomalies and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Cure HHT","keywords":"Medicine; Terminology; Clinical trial; MEDLINE; Intensive care medicine; Guideline; Evidence-based medicine; Disease; Telangiectasia; Medical literature; Alternative medicine; Pathology","score_opus":0.06010240532466238,"score_gpt":0.39932953119228115,"score_spread":0.3392271258676188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412422543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003033552,0.9938227,0.0009822078,0.00064975343,0.00060767384,0.00043219683,0.00014099249,0.0000067672927,0.0003241641],"genre_scores_gemma":[0.013759387,0.9708813,0.014935967,0.000059382503,0.00009227719,0.000027022235,0.00018266228,0.00002468797,0.000037358797],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9981282,0.000089799556,0.0013348921,0.00017886616,0.00012021825,0.00014802965],"domain_scores_gemma":[0.9978669,0.00041683624,0.0012929295,0.00014359716,0.00022678857,0.00005293925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029052093,0.00018863965,0.0023532584,0.0006178665,0.000021874594,0.0000054931543,0.0000830527,0.00012056633,0.000014411753],"category_scores_gemma":[0.0005436227,0.00014684715,0.00038915296,0.00016866464,0.00022369334,0.000024144249,0.000041189403,0.00019546115,3.9413672e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005959565,0.00065532885,0.0552182,0.030570144,0.006184195,0.029230304,0.00015243061,0.0000024183084,0.0000030621206,0.002626647,0.0016766719,0.87308466],"study_design_scores_gemma":[0.005896173,0.0026633763,0.0010317471,0.029362496,0.008820774,0.7041944,0.0012817064,0.000017615408,0.000017329648,0.0008856877,0.24536872,0.000459925],"about_ca_topic_score_codex":0.000013030967,"about_ca_topic_score_gemma":0.0000045877787,"teacher_disagreement_score":0.8726247,"about_ca_system_score_codex":0.0000965166,"about_ca_system_score_gemma":0.00038090325,"threshold_uncertainty_score":0.5988253},"labels":[],"label_agreement":null},{"id":"W4412690814","doi":"10.1002/ajh.70015","title":"Practical Guidance on Clinical Management of Belantamab Mafodotin‐Associated Ocular Events","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"GlaxoSmithKline","keywords":"Medicine; MEDLINE; Intensive care medicine; Political science","score_opus":0.09633654355105074,"score_gpt":0.501464673043311,"score_spread":0.40512812949226024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412690814","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009524878,0.9952842,0.00019303613,0.00069564197,0.00037535775,0.00093520444,0.00004043039,0.000013730605,0.0015098874],"genre_scores_gemma":[0.0018113761,0.9920053,0.005478928,0.00011396609,0.00006241823,0.000021332731,0.000036971334,0.000035093293,0.00043463238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99495065,0.0012527046,0.0022807652,0.00035391963,0.0007025361,0.00045943356],"domain_scores_gemma":[0.9940991,0.0017613843,0.003007798,0.0004940165,0.00030819382,0.0003295399],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011432341,0.00037191203,0.0049527725,0.00046365638,0.000038052814,0.0000049026903,0.00031475807,0.00022697737,0.000072360934],"category_scores_gemma":[0.0013918659,0.00025475406,0.0012933469,0.0005453284,0.00034525158,0.00003156748,0.00013947897,0.001064243,0.000056403274],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088744995,0.0026876081,0.006129207,0.011275694,0.011856448,0.01444992,0.0000071540576,1.1900597e-7,4.7085e-8,0.0007955924,0.0038989794,0.94801176],"study_design_scores_gemma":[0.012761263,0.021325065,0.0062237913,0.21050291,0.019153032,0.022977937,0.00023173697,0.000008616215,0.00000987165,0.0001704286,0.7059115,0.00072386063],"about_ca_topic_score_codex":0.000009533071,"about_ca_topic_score_gemma":9.940991e-7,"teacher_disagreement_score":0.9472879,"about_ca_system_score_codex":0.00021385876,"about_ca_system_score_gemma":0.0009339495,"threshold_uncertainty_score":0.99999046},"labels":[],"label_agreement":null},{"id":"W4413753180","doi":"10.1002/ajh.70048","title":"Contemporary Outcomes of Adults With Acute Lymphoblastic Leukemia With <scp> <i>KMT2A</i> </scp> Rearrangements Treated With Immunotherapy‐Based Regimens","year":2025,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Blinatumomab; Internal medicine; Oncology; Acute lymphocytic leukemia; Cyclophosphamide; Vincristine; Retrospective cohort study; Chemotherapy; Leukemia; Lymphoblastic Leukemia","score_opus":0.008947255443592646,"score_gpt":0.25648859713857014,"score_spread":0.2475413416949775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413753180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8566971,0.0015067717,0.0067333686,0.12564568,0.00025162043,0.002935446,0.00031631367,0.00017070478,0.0057430305],"genre_scores_gemma":[0.7247609,0.0004023377,0.01696213,0.25098372,0.00048538152,0.0001790222,0.0004773792,0.0006014513,0.0051476755],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9942823,0.00048011667,0.0016017356,0.00076586567,0.0018054681,0.0010645252],"domain_scores_gemma":[0.99087316,0.0023486528,0.0036765458,0.0011944589,0.00158964,0.0003175425],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003183979,0.001056942,0.004615052,0.0014228881,0.00009600378,0.000031647232,0.0008110979,0.00052688096,0.000033671877],"category_scores_gemma":[0.00018298847,0.0006123047,0.00039358187,0.0013035384,0.002423626,0.00014758692,0.00007768853,0.0021284544,0.000009633501],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024091821,0.0006069361,0.08823149,0.0014929675,0.023225544,0.071792684,0.00067200843,0.00004468213,0.00040555585,0.000010093456,0.78873,0.0006961977],"study_design_scores_gemma":[0.28043398,0.19833538,0.018058095,0.050390117,0.020481685,0.18319854,0.008695607,0.00074405706,0.026330862,0.00004157427,0.21044734,0.0028427518],"about_ca_topic_score_codex":0.00058035215,"about_ca_topic_score_gemma":0.000014064912,"teacher_disagreement_score":0.57828265,"about_ca_system_score_codex":0.0013421125,"about_ca_system_score_gemma":0.011324186,"threshold_uncertainty_score":0.99963284},"labels":[],"label_agreement":null},{"id":"W4413826493","doi":"10.1002/ajh.70042","title":"Real‐World Outcomes of Transplant Ineligible Older Adults With Multiple Myeloma Treated With Novel Regimens: A Population‐Based Retrospective Cohort Study","year":2025,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"National Cancer Institute; National Institutes of Health; Hamilton Health Sciences","keywords":"Multiple myeloma; Retrospective cohort study; Medicine; Cohort; Population; Cohort study; Internal medicine; Oncology; Environmental health","score_opus":0.011374241173232678,"score_gpt":0.29021689182726296,"score_spread":0.2788426506540303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413826493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96815044,0.00005985128,0.00025606825,0.028638836,0.00005300612,0.002323551,0.00022452507,0.000038504437,0.00025522316],"genre_scores_gemma":[0.9880691,0.000036047375,0.0036899918,0.0069955382,0.00009862188,0.00011459654,0.00036869186,0.000081858656,0.000545517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961999,0.00026888328,0.0011538339,0.00059250684,0.0011852405,0.0005996449],"domain_scores_gemma":[0.9956626,0.00066713657,0.0017816894,0.00067898945,0.001005038,0.00020452478],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022665597,0.00061328546,0.0035659177,0.001534325,0.00007908911,0.000013853557,0.00027268942,0.00018596354,0.00005090587],"category_scores_gemma":[0.00011814987,0.000365611,0.00029184576,0.001067301,0.0003896112,0.000074347794,0.000024397246,0.0013602751,0.0000016541541],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009575782,0.0015457454,0.9702199,0.00030905113,0.0059686624,0.006833249,0.00026970296,0.000008613745,0.0000093252975,0.000004707306,0.0050564148,0.00019886003],"study_design_scores_gemma":[0.019417122,0.008053839,0.9659829,0.0021450173,0.0019125843,0.001464815,0.0003447949,0.000049853053,0.000187639,0.0000019009839,0.00014852289,0.00029099043],"about_ca_topic_score_codex":0.0075229187,"about_ca_topic_score_gemma":0.0013493211,"teacher_disagreement_score":0.021643298,"about_ca_system_score_codex":0.00039908214,"about_ca_system_score_gemma":0.0006653697,"threshold_uncertainty_score":0.9998796},"labels":[],"label_agreement":null},{"id":"W4413954079","doi":"10.1002/ajh.70065","title":"Triple A Plus ( <scp>AAA</scp> <sup>+</sup> ) Survival Prediction Model for Essential Thrombocythemia: Analysis Involving 7308 Patients","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Medicine; Internal medicine; Essential thrombocythemia; Gastroenterology; Confidence interval; Cohort; Survival analysis; Platelet","score_opus":0.012702881087114148,"score_gpt":0.28619297085756173,"score_spread":0.2734900897704476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413954079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94222033,0.00040981005,0.055600677,0.00069979933,0.00022775354,0.00046299578,0.000061007424,0.000023145773,0.000294512],"genre_scores_gemma":[0.993978,0.00023832727,0.0048775454,0.00040635376,0.000105388026,0.00007052638,0.000071835224,0.000023695407,0.00022828784],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978085,0.0001453785,0.0009456202,0.00033820458,0.00036029043,0.00040196942],"domain_scores_gemma":[0.9973464,0.00074753875,0.00074375776,0.00025953096,0.00070567324,0.00019710198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031722095,0.0002714648,0.0016665822,0.00069096574,0.0001556103,0.000024206716,0.00014708492,0.00011618432,0.000018972267],"category_scores_gemma":[0.00064568873,0.00021438624,0.00058922695,0.0008187282,0.00022461302,0.00011773455,0.000051721236,0.00029236157,0.0000029565765],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086508295,0.0017789279,0.95164275,0.00017969985,0.010467981,0.00008442537,0.0029060012,0.0165253,0.0001548172,0.0033245147,0.009486791,0.0025836937],"study_design_scores_gemma":[0.029501975,0.0077772406,0.090744406,0.0006112767,0.01997175,0.00047440888,0.008072902,0.83089566,0.008274363,0.0020064167,0.0013281497,0.0003414434],"about_ca_topic_score_codex":0.00004286988,"about_ca_topic_score_gemma":0.000031263015,"teacher_disagreement_score":0.8608984,"about_ca_system_score_codex":0.0002741143,"about_ca_system_score_gemma":0.0005175981,"threshold_uncertainty_score":0.8742417},"labels":[],"label_agreement":null},{"id":"W4414083471","doi":"10.1002/ajh.70071","title":"Spirometry Interpretation in Children With Sickle Cell Disease: <scp>GLI</scp> Global Versus Race‐Specific Normative Equations","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Spirometry; Normative; Population; Cohort; Pulmonary function testing; Generalized estimating equation; Interpretation (philosophy)","score_opus":0.004574226025516468,"score_gpt":0.25455177657776257,"score_spread":0.2499775505522461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414083471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765757,0.003126925,0.016133305,0.0012211986,0.00019379464,0.00021246744,0.000008168339,0.000015390877,0.0025130734],"genre_scores_gemma":[0.9978405,0.00027512645,0.0015045246,0.0002924421,0.000021301275,0.000004853561,0.00001097427,0.000009838619,0.000040388855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876463,0.000120210425,0.0004996408,0.00015909671,0.00020109856,0.00025529225],"domain_scores_gemma":[0.9987673,0.00029830393,0.00044459832,0.00016395954,0.00016063517,0.00016521064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013712884,0.00015554974,0.0005437525,0.00036505162,0.000050963263,0.000012689085,0.00012980554,0.000060422644,0.00001740615],"category_scores_gemma":[0.00026517062,0.00011864688,0.00010983001,0.0010843313,0.0003544004,0.00010739665,0.000030174035,0.00037646922,0.000015902515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029070738,0.0012741128,0.95101607,0.000109560926,0.0010221951,0.00043552954,0.0018263528,0.0011473396,0.00015440716,0.0076497346,0.0037491848,0.028708419],"study_design_scores_gemma":[0.028199006,0.007879304,0.9114715,0.0015907494,0.0015385267,0.0026858,0.03844467,0.0020766414,0.0012172558,0.001848121,0.0026601646,0.00038829917],"about_ca_topic_score_codex":0.00002465718,"about_ca_topic_score_gemma":0.0000080773825,"teacher_disagreement_score":0.039544627,"about_ca_system_score_codex":0.00016033815,"about_ca_system_score_gemma":0.00034562833,"threshold_uncertainty_score":0.48382795},"labels":[],"label_agreement":null},{"id":"W4414554914","doi":"10.1002/ajh.70081","title":"Ferritin, C‐Reactive Protein, and Soluble <scp>CD25</scp> Distinguish <scp>TAFRO</scp> From <scp>HLH</scp>","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Vancouver General Hospital; University of British Columbia; Hospital for Sick Children; Dalhousie University; Memorial University of Newfoundland","funders":"Recordati Rare Diseases; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; Clinton Foundation; University of Pennsylvania","keywords":"Cytokine; Cytokine storm; Antibody; Interleukin 6","score_opus":0.010724883894434187,"score_gpt":0.2841429791099243,"score_spread":0.2734180952154901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414554914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96557355,0.0080117015,0.001061907,0.0011083465,0.00036270925,0.0007012469,0.00002519879,0.000070080605,0.023085242],"genre_scores_gemma":[0.9892416,0.00051455223,0.0019656757,0.0012147616,0.000287282,0.00007301252,0.00003308,0.000092741015,0.006577285],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99526834,0.00048421056,0.0015928292,0.00067202916,0.00076471426,0.0012178853],"domain_scores_gemma":[0.9934167,0.0028891112,0.0014978648,0.0006598514,0.0009860918,0.0005503731],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087745534,0.0005657561,0.0023310492,0.00074710726,0.00035977844,0.00010770817,0.0006078374,0.00030331773,0.0000507105],"category_scores_gemma":[0.010006963,0.0005006386,0.00040026207,0.0008840367,0.0015724358,0.00032868734,0.0003681846,0.0017167497,0.000093288654],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036329075,0.0026586053,0.50300974,0.0014293686,0.006664347,0.007897946,0.014625516,0.000025216927,0.074575454,0.009876238,0.33546126,0.043413036],"study_design_scores_gemma":[0.015892396,0.007942866,0.19895765,0.0038282033,0.0016127902,0.008685684,0.13535047,0.00079425354,0.077739276,0.013668827,0.53518975,0.0003378211],"about_ca_topic_score_codex":0.0004848224,"about_ca_topic_score_gemma":0.000035991165,"teacher_disagreement_score":0.30405205,"about_ca_system_score_codex":0.00019842325,"about_ca_system_score_gemma":0.0012926924,"threshold_uncertainty_score":0.99974453},"labels":[],"label_agreement":null},{"id":"W4414889454","doi":"10.1002/ajh.70101","title":"Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia—A Retrospective, Dual‐Center Study","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Young adult; Cumulative incidence; Hematopoietic stem cell transplantation; Incidence (geometry); Transplantation; Minimal residual disease; Comorbidity; Retrospective cohort study","score_opus":0.0048947925967025374,"score_gpt":0.25414679212259195,"score_spread":0.24925199952588942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414889454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971736,0.0002832311,0.0014827425,0.00023451228,0.00011677449,0.0005431813,0.0000051449742,0.000014746052,0.00014606224],"genre_scores_gemma":[0.99899626,0.0002848155,0.000369272,0.00020850862,0.000022620625,0.000017369148,0.0000024385827,0.00003013045,0.00006858757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977273,0.00022538856,0.00075447926,0.0003722458,0.00047525787,0.00044532644],"domain_scores_gemma":[0.9987651,0.00011302862,0.00041934734,0.00024347464,0.00026476214,0.00019425008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025896178,0.000265651,0.0010539301,0.00064599403,0.000054519878,0.000018596858,0.00016199477,0.0000777091,0.0000069472344],"category_scores_gemma":[0.000022931472,0.00019963967,0.000076041186,0.00068889605,0.00038844682,0.00010332958,0.00005188907,0.00043566155,0.00000500226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00751477,0.000779406,0.97746915,0.00042814543,0.00036962065,0.008609839,0.0029059271,0.0000118965245,0.0005383259,0.000044668992,0.000058798796,0.0012694628],"study_design_scores_gemma":[0.036520556,0.008740815,0.87851393,0.0032282104,0.00089048,0.056157824,0.013092162,0.000319574,0.0021698463,0.000038729708,0.000009908039,0.00031797637],"about_ca_topic_score_codex":0.00017858426,"about_ca_topic_score_gemma":0.00016511313,"teacher_disagreement_score":0.09895522,"about_ca_system_score_codex":0.0011546433,"about_ca_system_score_gemma":0.00091016415,"threshold_uncertainty_score":0.81410694},"labels":[],"label_agreement":null},{"id":"W4415432833","doi":"10.1002/ajh.70118","title":"<i>JAK2</i> Unmutated Erythrocytosis: 2026 Update on Diagnosis and Management","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Hematology; MEDLINE; Prospective cohort study; Hematologic tests","score_opus":0.02068847504912243,"score_gpt":0.3436894408646349,"score_spread":0.32300096581551246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415432833","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033100904,0.99488276,0.000026734455,0.0022456292,0.00025986342,0.0009071989,0.00003424796,0.000020067338,0.0012924597],"genre_scores_gemma":[0.00030647955,0.99589705,0.001613891,0.0015892783,0.00007832645,0.00030453652,0.000032982593,0.000046237932,0.00013123942],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728674,0.00032081545,0.0012448928,0.00045483053,0.00031467644,0.00037805687],"domain_scores_gemma":[0.9969853,0.0008560971,0.0013712011,0.0003672645,0.00015260724,0.000267494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022171525,0.0005800748,0.004810022,0.0007870156,0.000081206665,0.000025384421,0.00018690508,0.00014891532,0.000099356024],"category_scores_gemma":[0.00009766451,0.00038692553,0.00062494265,0.0005930136,0.0003046741,0.000040471106,0.00010957324,0.000549108,0.000054571854],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013746838,0.0006360557,0.0008364536,0.010640186,0.0039993245,0.0033317641,0.000031047686,4.0139233e-7,1.8694038e-8,0.0029255787,0.012887278,0.9645744],"study_design_scores_gemma":[0.0012482642,0.002667756,0.00006868816,0.041105185,0.007104033,0.006146709,0.00009423993,3.901347e-7,0.00002137314,0.000055753742,0.94121265,0.00027496045],"about_ca_topic_score_codex":0.000006809872,"about_ca_topic_score_gemma":0.000003581395,"teacher_disagreement_score":0.96429944,"about_ca_system_score_codex":0.00018253701,"about_ca_system_score_gemma":0.00029232257,"threshold_uncertainty_score":0.99985826},"labels":[],"label_agreement":null},{"id":"W4416070382","doi":"10.1002/ajh.70127","title":"A Multicenter Prospective Cohort Study on the Use of Weight‐Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer‐Associated Venous Thromboembolism—The <scp>WAVe</scp> Study","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; University of Alberta; McMaster University; Hôpital Saint-François d'Assise; Dalhousie University; University Health Network; University of Toronto; Centre Hospitalier de l’Université de Montréal; McGill University; Ottawa Hospital","funders":"University of Ottawa; Pfizer","keywords":"Prospective cohort study; Dosing; Cumulative incidence; Incidence (geometry); Low molecular weight heparin; Cohort study; Thrombosis; Venous thrombosis","score_opus":0.017557711373158515,"score_gpt":0.2849356814790295,"score_spread":0.26737797010587094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416070382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513835,0.000060426217,0.000012409342,0.0006068106,0.00025418002,0.003700574,0.000010757273,0.000012827876,0.00020364251],"genre_scores_gemma":[0.99844325,0.00009449285,0.000036806883,0.0011123993,0.00002479439,0.00019768659,0.0000026145883,0.000031284562,0.000056653018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971364,0.00058938767,0.0008926751,0.00033804402,0.0006216917,0.00042177513],"domain_scores_gemma":[0.996948,0.00076077174,0.0012175816,0.00050257635,0.0004897987,0.00008128788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053254457,0.00029785268,0.0018992841,0.0003333415,0.00013189578,0.000024532597,0.00029441385,0.000049358536,0.0000184173],"category_scores_gemma":[0.0003537504,0.00015825208,0.0001322181,0.00089188473,0.00037051467,0.00009035184,0.00013919026,0.0005747519,0.0000021460621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000448407,0.020193351,0.9618918,0.000017316777,0.0066211103,0.0002821552,0.007430705,0.000055189463,0.000009275392,0.00019569391,0.002490033,0.00036498928],"study_design_scores_gemma":[0.0061471057,0.011393088,0.9694663,0.00030644963,0.0022640734,0.000019712686,0.010057412,0.000046650133,0.0000853773,0.000019020166,0.00013116996,0.000063621046],"about_ca_topic_score_codex":0.0017524529,"about_ca_topic_score_gemma":0.0010796395,"teacher_disagreement_score":0.008800264,"about_ca_system_score_codex":0.00030642241,"about_ca_system_score_gemma":0.00021980058,"threshold_uncertainty_score":0.64533323},"labels":[],"label_agreement":null},{"id":"W4416297626","doi":"10.1002/ajh.70141","title":"<scp>DNA</scp> Methylation Episignature as a Novel Diagnostic Tool for Diamond‐Blackfan Anemia Syndrome","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"Ministero dell’Istruzione, dell’Università e della Ricerca; European Commission; Ontario Genomics; Ontario Genomics Institute; Genome Canada","keywords":"dNaM; DNA methylation; Epigenetics; Biomarker; Fanconi anemia; Erythropoiesis; Human genetics; Disease; Diagnostic biomarker","score_opus":0.005634187898551996,"score_gpt":0.26930857024350763,"score_spread":0.2636743823449556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416297626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9283927,0.0027470079,0.06712972,0.0008857694,0.00026975846,0.00020883016,0.000021442987,0.0000059735917,0.00033881605],"genre_scores_gemma":[0.9944779,0.000326583,0.003700162,0.00079792115,0.00008748318,0.000045527904,0.000030285124,0.000018682626,0.00051542517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889594,0.00006904219,0.0004430963,0.00023667536,0.00010411254,0.00025115622],"domain_scores_gemma":[0.99843615,0.00045057992,0.0004865699,0.00026889483,0.00028420528,0.00007358533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025157176,0.00015709725,0.00039676743,0.00014715371,0.0000803488,0.000019647097,0.000270244,0.00014133306,0.00000732481],"category_scores_gemma":[0.0014326201,0.00014022125,0.00018674722,0.00023720693,0.00020560667,0.000009075383,0.000041546005,0.00016696026,0.0000038491426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003382121,0.00068718457,0.020355128,0.00022982557,0.0011692405,0.000116293544,0.00039817623,0.0007632646,0.8630053,0.024396263,0.05562457,0.032916557],"study_design_scores_gemma":[0.0059281504,0.007212857,0.047260337,0.00037033213,0.0008470174,0.007392624,0.0025589804,0.00019732489,0.6072211,0.00963177,0.31075084,0.0006286522],"about_ca_topic_score_codex":0.000009061569,"about_ca_topic_score_gemma":0.000004815319,"teacher_disagreement_score":0.25578415,"about_ca_system_score_codex":0.000028499535,"about_ca_system_score_gemma":0.00026970252,"threshold_uncertainty_score":0.57180566},"labels":[],"label_agreement":null},{"id":"W4416953116","doi":"10.1002/ajh.70155","title":"Albuminuria Predicts a Rapid Decline in Kidney Function in 2 International, Longitudinal Cohorts of Adults With Sickle Cell Anemia","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; Novartis Pharma; National Institutes of Health; Novartis","keywords":"Renal function; Albuminuria; Kidney disease; Creatinine; Anemia; Cystatin C; Sickle cell anemia","score_opus":0.0037885926527832844,"score_gpt":0.236623730938176,"score_spread":0.23283513828539273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416953116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238217,0.00096549717,0.00042622635,0.0041778814,0.00027511144,0.00015871316,0.0000021997585,0.000005923206,0.0016062829],"genre_scores_gemma":[0.9978156,0.00053226005,0.00071014254,0.0008527467,0.000022988415,0.0000036695137,0.0000077649665,0.000009626982,0.000045177872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869585,0.00006935299,0.00069843914,0.00015347476,0.000196335,0.00018652719],"domain_scores_gemma":[0.99897844,0.00009307882,0.00049923226,0.00012560398,0.00019645196,0.00010718011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023942685,0.00012145031,0.0006563712,0.00055818685,0.000011727004,0.0000031232742,0.000109257766,0.00008248197,0.00007357907],"category_scores_gemma":[0.0001561437,0.00009080391,0.000069463385,0.0005576338,0.00026056974,0.000059419337,0.000030608822,0.000374285,0.0000017270289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077048745,0.0008099071,0.9789167,0.0002457888,0.00016199918,0.00087102526,0.0005637234,0.00015151312,0.0005520849,0.00010659143,0.002472527,0.0074432762],"study_design_scores_gemma":[0.055055067,0.019163458,0.8593143,0.013072421,0.00093152554,0.010449131,0.019925607,0.0016046037,0.0106506245,0.00061863114,0.008600411,0.00061420066],"about_ca_topic_score_codex":0.00022010559,"about_ca_topic_score_gemma":0.00011747851,"teacher_disagreement_score":0.11960237,"about_ca_system_score_codex":0.00006498746,"about_ca_system_score_gemma":0.00040855602,"threshold_uncertainty_score":0.37028757},"labels":[],"label_agreement":null},{"id":"W4417488423","doi":"10.1002/ajh.70169","title":"Basiliximab in the Prophylaxis of <scp>aGVHD</scp> for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: A Prospective, Multicenter, Open‐Label, Randomized Controlled Study","year":2025,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Guangxi Medical University; Natural Science Foundation of Guangxi Province","keywords":"Basiliximab; Transplantation; Busulfan; Alemtuzumab; Hematopoietic stem cell transplantation; Randomized controlled trial; Fludarabine; Thalassemia","score_opus":0.008739896312929008,"score_gpt":0.2631857706983192,"score_spread":0.25444587438539024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417488423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686642,0.00038065124,0.0012545951,0.00662083,0.00022311408,0.022442782,0.000062731946,0.000013247272,0.00033782495],"genre_scores_gemma":[0.991387,0.00010442877,0.0013166296,0.005565731,0.000045431294,0.0012719232,0.00009423041,0.00007637029,0.00013825],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9922469,0.0024826638,0.0032419837,0.00057241414,0.0008825895,0.0005734476],"domain_scores_gemma":[0.98687947,0.008291553,0.0034980145,0.00048162104,0.00077175704,0.00007759341],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023129962,0.0006448139,0.0065589864,0.0011437726,0.00005609243,0.000043950993,0.0007202287,0.00040010613,0.0000080731115],"category_scores_gemma":[0.00028851064,0.00038031238,0.00040648654,0.0008917115,0.00043891612,0.00015458136,0.000027618382,0.0017645232,0.0000016651836],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5703032,0.01321186,0.35195813,0.010991603,0.0048054024,0.003957699,0.03796657,0.00003202504,0.000107530184,0.00007867263,0.0061604604,0.00042685456],"study_design_scores_gemma":[0.9595958,0.0119320555,0.010045247,0.004243468,0.004853433,0.00076249964,0.007329715,0.00008643131,0.00075369346,0.00007304012,0.00007364887,0.00025099114],"about_ca_topic_score_codex":0.000112444686,"about_ca_topic_score_gemma":0.000050147144,"teacher_disagreement_score":0.3892926,"about_ca_system_score_codex":0.00020721018,"about_ca_system_score_gemma":0.0006989252,"threshold_uncertainty_score":0.9998649},"labels":[],"label_agreement":null},{"id":"W7117123621","doi":"10.1002/ajh.70166","title":"Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS‐COV‐2—A Report From the EPICOVIDEHA/EPIRESEHA Registry","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Respiratory viral infections research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Universitätsklinikum Hamburg-Eppendorf; Universitätsklinikum Köln; National Cancer Institute; Marmara Üniversitesi; Mansoura University; Universität zu Köln; Universitat de Barcelona; NIH Clinical Center; Università degli Studi di Parma; Università Cattolica del Sacro Cuore; Rigshospitalet; AstraZeneca; Gentofte Hospital; Aristotle University of Thessaloniki; King Faisal Specialist Hospital and Research Centre; Deutsches Zentrum für Infektionsforschung","keywords":"Malignancy; Asymptomatic; Hematological malignancy; Population; Human metapneumovirus; Respiratory system; Respiratory infection; Comorbidity","score_opus":0.034223667055211175,"score_gpt":0.3682761180429798,"score_spread":0.33405245098776865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117123621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326056,0.0003537803,0.0003085782,0.0050976234,0.000114622184,0.0004384714,0.000003668336,0.000014915025,0.00040779434],"genre_scores_gemma":[0.99466103,0.00001613094,0.00030376384,0.0049212533,0.000042623764,0.000024583524,0.000002470322,0.000012231913,0.00001588137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977358,0.00045217885,0.0008429135,0.00026736126,0.0003847915,0.0003169308],"domain_scores_gemma":[0.997598,0.00085559627,0.000538466,0.00048191802,0.00042539425,0.00010060995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006491361,0.00018506731,0.00078520493,0.00030120875,0.00015913667,0.000047855392,0.00021366,0.00006723966,0.000015845315],"category_scores_gemma":[0.001765755,0.000094826224,0.00008068785,0.00096124364,0.0010509907,0.000114977534,0.00013688632,0.00068623654,0.0000050597027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011886015,0.00019330806,0.99256635,0.000018191537,0.00015356549,0.0005394075,0.00018925132,0.000016356516,0.0002697254,0.0006298226,0.0034358313,0.00079961645],"study_design_scores_gemma":[0.0016572118,0.0012221838,0.98737794,0.0002121022,0.00007423416,0.0021226977,0.0005213338,0.000007793699,0.0014463477,0.0005857894,0.004673648,0.000098712786],"about_ca_topic_score_codex":0.0011001894,"about_ca_topic_score_gemma":0.0006003829,"teacher_disagreement_score":0.005188377,"about_ca_system_score_codex":0.00013497355,"about_ca_system_score_gemma":0.00032575565,"threshold_uncertainty_score":0.3872419},"labels":[],"label_agreement":null},{"id":"W7117712244","doi":"10.1002/ajh.70181","title":"Factor <scp>XIII</scp> Supplementation in Postpartum Hemorrhage: From Biological Rationale to Clinical Implementation","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"","keywords":"Observational study; Fibrin; Factor XIII; Fibrinogen; Randomized controlled trial; Coagulation; Clinical trial; Pregnancy","score_opus":0.037164312564713,"score_gpt":0.37611391521101306,"score_spread":0.3389496026463001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117712244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98852885,0.000230291,0.0025249799,0.007983511,0.0003054409,0.0002969418,0.000016645772,0.000008970858,0.000104375125],"genre_scores_gemma":[0.9895672,0.00007000604,0.006497488,0.0035962528,0.00012650041,0.000012509863,0.000070735405,0.0000070500996,0.000052258565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826837,0.00022619794,0.0009696485,0.00018387001,0.00015883158,0.00019308606],"domain_scores_gemma":[0.9987413,0.00046080287,0.00039545583,0.000115846175,0.00018021342,0.000106359024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028877595,0.00011018498,0.0005707564,0.00023179868,0.000036764894,0.000013077849,0.00009317967,0.000060521004,0.0002055098],"category_scores_gemma":[0.00032395305,0.00008562615,0.0001095848,0.00030796294,0.00009208646,0.00008352712,0.00003728719,0.00021674634,0.000016158443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003545803,0.00021356314,0.9520442,0.000013225254,0.00010235003,0.00007610557,0.00056581205,0.000006906657,0.0022059518,0.00046683662,0.0029110892,0.041039374],"study_design_scores_gemma":[0.0032261023,0.0027038488,0.9706039,0.00007136106,0.000095486874,0.00025365298,0.009281928,0.00010189315,0.009034388,0.0006470308,0.0039208275,0.000059604285],"about_ca_topic_score_codex":0.00015485534,"about_ca_topic_score_gemma":0.00010744639,"teacher_disagreement_score":0.04097977,"about_ca_system_score_codex":0.000059680115,"about_ca_system_score_gemma":0.00020084223,"threshold_uncertainty_score":0.34917328},"labels":[],"label_agreement":null},{"id":"W7485085","doi":"10.1002/ajh.2830500312","title":"Platform Regulation on Seller Heterogeneity","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Digital Platforms and Economics","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Quality (philosophy); Incentive; Monopoly; Microeconomics; Profit (economics); Industrial organization; Strategic complements; Business; Economics","score_opus":0.014955614930410489,"score_gpt":0.21064237595853041,"score_spread":0.19568676102811994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7485085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98452544,0.000011211948,0.00015192055,0.0004909304,0.00023803809,0.000054590197,1.6679684e-7,0.000012743944,0.014514978],"genre_scores_gemma":[0.99732006,0.0000030540343,0.0002420283,0.0021142156,0.00027372185,0.0000015780219,0.0000022589347,0.000012017143,0.000031089872],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99929154,9.0928955e-7,0.00035908972,0.00008744193,0.0000828179,0.00017818558],"domain_scores_gemma":[0.99908155,0.000036264217,0.0006504941,0.00010641067,0.000107029344,0.000018277698],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011375432,0.00009814121,0.00029368617,0.00018067942,0.00004609476,0.000161223,0.00014306029,0.000027602284,0.00027285473],"category_scores_gemma":[0.00003145366,0.00007549712,0.00009195204,0.00011551796,0.000086196684,0.0024080344,0.00003534616,0.00009483281,0.0008358079],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049286545,0.00053957594,0.10540914,0.00011221766,0.0004087803,0.00007434638,0.00012692875,0.0017336635,0.00046615239,0.48100477,0.05618326,0.3534483],"study_design_scores_gemma":[0.0055603497,0.0021829088,0.24575645,0.00035538108,0.0002396814,0.0030323404,0.007690513,0.01759553,0.0032355208,0.55957484,0.15242259,0.0023538894],"about_ca_topic_score_codex":0.000071654904,"about_ca_topic_score_gemma":0.000011712256,"teacher_disagreement_score":0.3510944,"about_ca_system_score_codex":0.00001939518,"about_ca_system_score_gemma":0.000010238566,"threshold_uncertainty_score":0.9999422},"labels":[],"label_agreement":null}]}